Citrus Sinensis ID: 041755
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 678 | 2.2.26 [Sep-21-2011] | |||||||
| Q5XF57 | 579 | Probable receptor-like se | no | no | 0.417 | 0.488 | 0.453 | 4e-69 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.414 | 0.391 | 0.425 | 2e-68 | |
| Q8RXC8 | 460 | Receptor-like cytosolic s | no | no | 0.452 | 0.667 | 0.421 | 1e-67 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.415 | 0.398 | 0.429 | 1e-66 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.426 | 0.401 | 0.424 | 2e-66 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.442 | 0.460 | 0.412 | 2e-66 | |
| Q8H1D6 | 467 | Receptor-like cytosolic s | no | no | 0.466 | 0.676 | 0.389 | 5e-66 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.421 | 0.375 | 0.425 | 6e-66 | |
| Q9LK03 | 717 | Proline-rich receptor-lik | no | no | 0.418 | 0.396 | 0.424 | 8e-66 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.514 | 0.491 | 0.380 | 2e-65 |
| >sp|Q5XF57|Y5576_ARATH Probable receptor-like serine/threonine-protein kinase At5g57670 OS=Arabidopsis thaliana GN=At5g57670 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 263 bits (672), Expect = 4e-69, Method: Compositional matrix adjust.
Identities = 133/293 (45%), Positives = 187/293 (63%), Gaps = 10/293 (3%)
Query: 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKIL-KPSEDV--LKEFASEI 377
F+Y E+ AT++F +VG GG+S VYRG L DG+ +AVK L K S D+ KEF +E+
Sbjct: 255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLTEL 314
Query: 378 EIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV 437
II+ + H N L G C E L LV+ F G+L LH N + + W RYK+AV
Sbjct: 315 GIISHVSHPNTALLLGCCVE-KGLYLVFRFSENGTLYSALHEN--ENGSLDWPVRYKIAV 371
Query: 438 GVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAG 497
GVA L YLH C +IH+D+KSSN+LL D+EPQ++DFGLA WL +H V G
Sbjct: 372 GVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEG 431
Query: 498 TFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557
TFGYLAPE M G + EK D+YAFGI+LLE+++G++P+N Q+ +++WAKP ++ G
Sbjct: 432 TFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVNPT----QKHILLWAKPAMETG 487
Query: 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEA 610
S+L+DP L YD+ Q+ ++VL A+ + ++P +RP + VL+LL EA
Sbjct: 488 NTSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGNEA 540
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 260 bits (665), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 123/289 (42%), Positives = 196/289 (67%), Gaps = 8/289 (2%)
Query: 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKP-SEDVLKEFASEIEI 379
F+Y+EL T F ++VG+GG VY+G L +GK +A+K LK S + +EF +E+EI
Sbjct: 358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417
Query: 380 ITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGV 439
I+ +HHR+++SL G+C + + L+Y+F+ +L+ +LHG K+ W+ R ++A+G
Sbjct: 418 ISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLPVLEWSRRVRIAIGA 475
Query: 440 AEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF 499
A+ L YLH C +IH+D+KSSNILL D+FE Q++DFGLA T+ SH++ T V GTF
Sbjct: 476 AKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHIS-TRVMGTF 534
Query: 500 GYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL----K 555
GYLAPEY GK++++ DV++FG+VLLEL++G+KP+++ P G+ESLV WA+P L +
Sbjct: 535 GYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPRLIEAIE 594
Query: 556 DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLL 604
G +S+++DP L+ DY ++ +M+ A + + RP++ V++ L
Sbjct: 595 KGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL 643
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RXC8|RBK2_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK2 OS=Arabidopsis thaliana GN=RBK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (659), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 137/325 (42%), Positives = 204/325 (62%), Gaps = 18/325 (5%)
Query: 314 YSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILK---PSEDVL 370
+ S+ + FS ++ AT NF PE ++G+GG++ VY+G LP+GK +AVK L P E
Sbjct: 124 FQSSLQNFSISDIEIATDNFSPENIIGRGGYADVYQGILPEGKLIAVKRLTKGTPDEQT- 182
Query: 371 KEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWT 430
EF SE+ II + H N G C E + LV+ GSL LHG K W+
Sbjct: 183 AEFLSELGIIAHVDHPNTAKFIGCCIE-GGMHLVFRLSPLGSLGSLLHGPSK--YKLTWS 239
Query: 431 ERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490
RY VA+G A+ L YLH C++ +IH+D+K+ NILL++DF+PQ+ DFGLA WL +H
Sbjct: 240 RRYNVALGTADGLVYLHEGCQRRIIHRDIKADNILLTEDFQPQICDFGLAKWLPKQLTHH 299
Query: 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA 550
+ GTFGY APEYFMHG V EK DV+AFG++LLEL++G ++ + Q+SLV+WA
Sbjct: 300 NVSKFEGTFGYFAPEYFMHGIVDEKTDVFAFGVLLLELITGHPALD----ESQQSLVLWA 355
Query: 551 KPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEA 610
KP+L+ + +L+DPSL +Y+ +++ R+ A+L I ++ +RP+++ V++LL G E+
Sbjct: 356 KPLLERKAIKELVDPSLGDEYNREELIRLTSTASLCIDQSSLLRPRMSQVVELLLGHEDV 415
Query: 611 ANWAKE------QVSASEE-LDSID 628
+E Q + SEE LDS++
Sbjct: 416 VMTPREAKIKMMQRTYSEELLDSVE 440
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (649), Expect = 1e-66, Method: Compositional matrix adjust.
Identities = 125/291 (42%), Positives = 187/291 (64%), Gaps = 9/291 (3%)
Query: 320 LFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILK-PSEDVLKEFASEIE 378
LFSY+EL+ AT+ F E L+G+GG VY+G LPDG+ +AVK LK +EF +E+E
Sbjct: 364 LFSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVE 423
Query: 379 IITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVG 438
++ +HHR+++S+ G C + LL+YD++S L +LHG K + W R K+A G
Sbjct: 424 TLSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGEK---SVLDWATRVKIAAG 480
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
A L YLH C +IH+D+KSSNILL D+F+ ++SDFGLA ++H+T T V GT
Sbjct: 481 AARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHIT-TRVIGT 539
Query: 499 FGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG- 557
FGY+APEY GK++EK DV++FG+VLLEL++G+KP+++ P G ESLV WA+P++
Sbjct: 540 FGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAI 599
Query: 558 ---KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605
+ L DP L +Y ++ RM+ AA + T RP++ +++ +
Sbjct: 600 ETEEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFE 650
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 254 bits (649), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 126/297 (42%), Positives = 199/297 (67%), Gaps = 8/297 (2%)
Query: 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKP-SEDVLKEFASEIEI 379
FSY+EL T F + ++G+GG VY+G L DGK +AVK LK S +EF +E+EI
Sbjct: 359 FSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEI 418
Query: 380 ITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGV 439
I+ +HHR+++SL G+C D + LL+Y+++S +LE +LHG K W++R ++A+G
Sbjct: 419 ISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG--KGLPVLEWSKRVRIAIGS 476
Query: 440 AEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF 499
A+ L YLH C +IH+D+KS+NILL D++E Q++DFGLA T+ +H++ T V GTF
Sbjct: 477 AKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVS-TRVMGTF 535
Query: 500 GYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL----K 555
GYLAPEY GK++++ DV++FG+VLLEL++G+KP++ P G+ESLV WA+P+L +
Sbjct: 536 GYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIE 595
Query: 556 DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEAAN 612
G +S+L+D L+ Y ++ RM+ A + + RP++ V++ L D ++ +
Sbjct: 596 TGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCDGDSGD 652
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (648), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 128/310 (41%), Positives = 202/310 (65%), Gaps = 10/310 (3%)
Query: 303 LPKELEGLQERYSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKI 362
LP GL +S + F+Y+EL AT+ F L+G+GG +V++G LP GKE+AVK
Sbjct: 252 LPPPSPGLVLGFSKST--FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQ 309
Query: 363 LKP-SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNK 421
LK S +EF +E+EII+ +HHR+++SL G+C LLVY+F+ +LE +LHG
Sbjct: 310 LKAGSGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKG 369
Query: 422 KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481
+ W+ R K+A+G A+ L YLH C +IH+D+K+SNIL+ FE +++DFGLA
Sbjct: 370 RP--TMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAK 427
Query: 482 WLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541
S +++H++ T V GTFGYLAPEY GK++EK DV++FG+VLLEL++G++P+++ N
Sbjct: 428 IASDTNTHVS-TRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVY 486
Query: 542 GQESLVMWAKPIL----KDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQI 597
+SLV WA+P+L ++G L D + +YD +++ RMV A + + RP++
Sbjct: 487 VDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRM 546
Query: 598 NLVLKLLQGD 607
+ +++ L+G+
Sbjct: 547 SQIVRALEGN 556
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8H1D6|RBK1_ARATH Receptor-like cytosolic serine/threonine-protein kinase RBK1 OS=Arabidopsis thaliana GN=RBK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (645), Expect = 5e-66, Method: Compositional matrix adjust.
Identities = 130/334 (38%), Positives = 210/334 (62%), Gaps = 18/334 (5%)
Query: 317 TCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKIL----KPSEDVLKE 372
+ R F+Y+EL AT F PE ++GKGGH+ VY+G L +G+ +A+K L K E+ + +
Sbjct: 137 SWRNFTYEELAVATDYFNPENMIGKGGHAEVYKGVLINGETVAIKKLMSHAKEEEERVSD 196
Query: 373 FASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER 432
F SE+ II ++H N L GF D L V ++ GSL L G+++ W R
Sbjct: 197 FLSELGIIAHVNHPNAARLRGFS-SDRGLHFVLEYAPYGSLASMLFGSEE---CLEWKIR 252
Query: 433 YKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492
YKVA+G+A+ L YLHN+C + +IH+D+K+SNILL+ D+E Q+SDFGLA WL + H
Sbjct: 253 YKVALGIADGLSYLHNACPRRIIHRDIKASNILLNHDYEAQISDFGLAKWLPENWPHHVV 312
Query: 493 TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552
+ GTFGYLAPEYFMHG V EKIDV+AFG++LLE+++ ++ +++ + ++S+V WAKP
Sbjct: 313 FPIEGTFGYLAPEYFMHGIVDEKIDVFAFGVLLLEIITSRRAVDTAS---RQSIVAWAKP 369
Query: 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEAAN 612
L+ + ++DP L ++ +++R++L A++ + +RP + +++LL+G++ A
Sbjct: 370 FLEKNSMEDIVDPRLGNMFNPTEMQRVMLTASMCVHHIAAMRPDMTRLVQLLRGEDGPAE 429
Query: 613 WAKEQVSASEELDSIDGEASPTNIQSHLNLALLD 646
Q A E S++ ++Q H + + L+
Sbjct: 430 L---QQKAGERTMSVNA----CDLQDHTSSSYLN 456
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 252 bits (644), Expect = 6e-66, Method: Compositional matrix adjust.
Identities = 125/294 (42%), Positives = 189/294 (64%), Gaps = 8/294 (2%)
Query: 314 YSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILK-PSEDVLKE 372
+ + LFSY+EL+ AT+ F E L+G+GG VY+G LPD + +AVK LK +E
Sbjct: 411 FGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDRE 470
Query: 373 FASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER 432
F +E++ I+ +HHRN++S+ G+C +N LL+YD++ +L +LH G W R
Sbjct: 471 FKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAGTPG--LDWATR 528
Query: 433 YKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492
K+A G A L YLH C +IH+D+KSSNILL ++F +SDFGLA ++H+T
Sbjct: 529 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHIT- 587
Query: 493 TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552
T V GTFGY+APEY GK++EK DV++FG+VLLEL++G+KP+++ P G ESLV WA+P
Sbjct: 588 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP 647
Query: 553 ILKDG----KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602
+L + + + L DP L +Y ++ RM+ AA I + T RP+++ +++
Sbjct: 648 LLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVR 701
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 252 bits (643), Expect = 8e-66, Method: Compositional matrix adjust.
Identities = 124/292 (42%), Positives = 193/292 (66%), Gaps = 8/292 (2%)
Query: 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKP-SEDVLKEFASEIEI 379
F+Y+EL AT+ F L+G+GG +V++G L +GKE+AVK LK S +EF +E+ I
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401
Query: 380 ITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGV 439
I+ +HHR++++L G+C D LLVY+F+ +LE +LHG + W+ R K+AVG
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGKGRP--TMEWSSRLKIAVGS 459
Query: 440 AEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF 499
A+ L YLH +C +IH+D+K+SNIL+ FE +++DFGLA S +++H++ T V GTF
Sbjct: 460 AKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVS-TRVMGTF 518
Query: 500 GYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKD--- 556
GYLAPEY GK++EK DV++FG+VLLEL++G++PI+ N SLV WA+P+L
Sbjct: 519 GYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSE 578
Query: 557 -GKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607
G ++D L+ +YD +++ RMV A + RP+++ V ++L+G+
Sbjct: 579 LGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGN 630
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 250 bits (639), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 138/363 (38%), Positives = 215/363 (59%), Gaps = 14/363 (3%)
Query: 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILK-PSEDVLKEFASEIEI 379
F+Y+EL T F ++G+GG VY+G L DGK +AVK LK S +EF +E+EI
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400
Query: 380 ITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGV 439
I+ +HHR+++SL G+C D+ LL+Y+++ +LE +LHG + W R ++A+G
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGKGRP--VLEWARRVRIAIGS 458
Query: 440 AEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF 499
A+ L YLH C +IH+D+KS+NILL D+FE Q++DFGLA ++ +H++ T V GTF
Sbjct: 459 AKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVS-TRVMGTF 517
Query: 500 GYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL----K 555
GYLAPEY GK++++ DV++FG+VLLEL++G+KP++ P G+ESLV WA+P+L +
Sbjct: 518 GYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIE 577
Query: 556 DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEAANWAK 615
G S+L+D L+ Y +++ RM+ A + + RP++ V++ L + + + +
Sbjct: 578 TGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISN 637
Query: 616 -EQVSASEELDSIDGEASPTNIQSHLNLALLDLDDDSVSAGSTQQIISVEDYLQGRWSRT 674
+V S DS N DD S S G SV+D +G +
Sbjct: 638 GNKVGQSSAYDS----GQYNNDTMKFRKMAFGFDDSSDS-GMYSGDYSVQDSRKGSNGAS 692
Query: 675 SSF 677
S F
Sbjct: 693 SEF 695
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 678 | ||||||
| 224096079 | 720 | predicted protein [Populus trichocarpa] | 0.991 | 0.933 | 0.663 | 0.0 | |
| 224083486 | 720 | predicted protein [Populus trichocarpa] | 0.976 | 0.919 | 0.663 | 0.0 | |
| 255550554 | 674 | ATP binding protein, putative [Ricinus c | 0.917 | 0.922 | 0.661 | 0.0 | |
| 255558560 | 758 | ATP binding protein, putative [Ricinus c | 0.989 | 0.885 | 0.609 | 0.0 | |
| 225431701 | 729 | PREDICTED: uncharacterized protein LOC10 | 0.985 | 0.916 | 0.641 | 0.0 | |
| 296088527 | 726 | unnamed protein product [Vitis vinifera] | 0.967 | 0.903 | 0.645 | 0.0 | |
| 224082346 | 697 | predicted protein [Populus trichocarpa] | 0.982 | 0.955 | 0.643 | 0.0 | |
| 356507449 | 705 | PREDICTED: probable receptor protein kin | 0.985 | 0.947 | 0.626 | 0.0 | |
| 449459248 | 680 | PREDICTED: probable receptor-like serine | 0.951 | 0.948 | 0.633 | 0.0 | |
| 356516377 | 700 | PREDICTED: probable receptor protein kin | 0.986 | 0.955 | 0.621 | 0.0 |
| >gi|224096079|ref|XP_002310531.1| predicted protein [Populus trichocarpa] gi|222853434|gb|EEE90981.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 932 bits (2408), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/723 (66%), Positives = 560/723 (77%), Gaps = 51/723 (7%)
Query: 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITE---STGSLLSLVKTFDS 60
G+VVVVGVKFDG S+ELLTW+L+K+AQPGD +IA+HVLD+ TE T SLLSLVKTFDS
Sbjct: 1 GEVVVVGVKFDGPSKELLTWSLMKMAQPGDHVIAVHVLDSATECMAGTASLLSLVKTFDS 60
Query: 61 MLSVYEGFCNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVA 120
+L+VYEGFCNLKQVDLKLKVCRG SV+KI+V+EAK+ AK+IVG SK H+ + SS S A
Sbjct: 61 LLAVYEGFCNLKQVDLKLKVCRGESVRKILVREAKANSAAKLIVGTSKKHQKLYSSTSTA 120
Query: 121 KYCARKLSKNFGVFAVENGKIVFQREGT----HNLQD--------DNVKVTVDD-----A 163
KYCA+KLSK F V+AV NGK+VFQRE + LQ + K+ D A
Sbjct: 121 KYCAKKLSKGFSVYAVRNGKLVFQREASVPNIDTLQGFSSLLFWVSSRKIITDATYFVVA 180
Query: 164 DDVPGECTNCDSRTQ-----SC---------------EELARDETVVDNSLALVPVQSDN 203
D + E NC ++Q +C EE RD DNSLALVP+Q++
Sbjct: 181 DKLNQESRNCSQKSQIKNSINCTPRLLLLDESGAHELEESCRDGNG-DNSLALVPIQTNK 239
Query: 204 SLV-----VRESPRSKQDGWPFLRRVLLPKHQDPEKTSAKKTSLIQWVLRLPSRYTSAVV 258
L V E + GW FLRRV K Q EK KK S+++WV RLP+R +S+VV
Sbjct: 240 PLSNSDSDVSEGLVESKQGWSFLRRVFFHKQQHTEKAHIKKISVVKWVCRLPTRNSSSVV 299
Query: 259 YPDHKQNHSADTSEDNRSNLDGESGAIVSVEHDSACPPLSP---YNELPKELEGLQERYS 315
YPD KQN ++ ED SN + ++ AIV V + A P+SP N +P+EL+ L E+YS
Sbjct: 300 YPDQKQN-TSHVDEDQNSNSERKNYAIVPVGPEVAWTPISPCHGLNGIPEELKDLHEKYS 358
Query: 316 STCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFAS 375
S+CRLFSY+EL+ ATSNF+PE +VGKGG SHVY+GCLPDGKELAVKILKPSEDV+KEF +
Sbjct: 359 SSCRLFSYEELVMATSNFIPENMVGKGGSSHVYKGCLPDGKELAVKILKPSEDVIKEFVA 418
Query: 376 EIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKV 435
EIEIIT LHH+NIISLFGFCFE N LLLVYDFLSRGSLEENLHGNKKD NA GW ERYKV
Sbjct: 419 EIEIITTLHHKNIISLFGFCFEHNKLLLVYDFLSRGSLEENLHGNKKDWNAVGWQERYKV 478
Query: 436 AVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDV 495
AVGVAEALDYLHN C+QPVIHKDVKSSNILLSDDFEPQLSDFGLASW ST S + TCTDV
Sbjct: 479 AVGVAEALDYLHNCCDQPVIHKDVKSSNILLSDDFEPQLSDFGLASWAST-SCNATCTDV 537
Query: 496 AGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILK 555
AGTFGYLAPEYFMHGKVS+K+DV+AFG+VLLELLSG+ PINSE+PKGQESLVMWAKPIL+
Sbjct: 538 AGTFGYLAPEYFMHGKVSDKVDVFAFGVVLLELLSGRMPINSEHPKGQESLVMWAKPILE 597
Query: 556 DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEAANWAK 615
GKVSQLLDP L ++YD+D IERMVLAATL I R+P RPQ++L+LKLLQGDEE NWA+
Sbjct: 598 GGKVSQLLDPHLGSEYDDDHIERMVLAATLCIRRSPRCRPQMSLILKLLQGDEEVKNWAR 657
Query: 616 EQVSASEELDSIDGEASPTNIQSHLNLALLDLDDDSVSAGSTQQIISVEDYLQGRWSRTS 675
QV ASEELD++DGEA PTNIQSHLNLALLDL+DDS+S ST+Q +SVEDYLQGRWSRTS
Sbjct: 658 HQVCASEELDAVDGEAFPTNIQSHLNLALLDLEDDSLSISSTEQGVSVEDYLQGRWSRTS 717
Query: 676 SFD 678
SFD
Sbjct: 718 SFD 720
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224083486|ref|XP_002307046.1| predicted protein [Populus trichocarpa] gi|222856495|gb|EEE94042.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 898 bits (2320), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 462/696 (66%), Positives = 545/696 (78%), Gaps = 34/696 (4%)
Query: 12 KFDGESRELLTWALVKVAQPGDRIIALHVLDTIT----------ESTGSLLSLVKTFDSM 61
K DG+SRELLTW+LVK+AQPGDR+IALHVLD+ T TGS+LSLVK FDS+
Sbjct: 28 KLDGQSRELLTWSLVKMAQPGDRVIALHVLDSGTGNGNSGKECVAGTGSVLSLVKIFDSL 87
Query: 62 LSVYEGFCNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAK 121
L+VYEGFCNLKQVDLKLKVCRG SV+KI+VKEAK+ AK+IVG SKT + + SS S AK
Sbjct: 88 LAVYEGFCNLKQVDLKLKVCRGESVRKILVKEAKASNVAKLIVGTSKTRQKLNSSTSTAK 147
Query: 122 YCARKLSKNFGVFAVENGKIVFQREGTHNLQDDNVKVTVDDADDVPGECTNCDSRTQSCE 181
YCA+KLSK V+AV +GKI+FQRE T D + ++ + + N +S ++
Sbjct: 148 YCAKKLSKGCSVYAVRSGKILFQREATVASNDPLQEKLNQESRNRSQKSQNKNSLNRTPP 207
Query: 182 ELARDETVV------------DNSLALVPVQ-----SDNSLVVRESPRSKQDGWPFLRRV 224
L D++ DNS ALVP+Q SD+ V E+ SKQ GW FLRRV
Sbjct: 208 LLLPDDSGTHVLEQSCWDGNDDNSWALVPIQTSKTPSDSDSNVSEALESKQ-GWSFLRRV 266
Query: 225 LLPKHQDPEKTSAKKTSLIQWVLRLPSRYTSAVVYPDHKQNHSADTSEDNRSNLDGESGA 284
L PK Q EK K+ S+++WV R+P+R +S+VV+PD KQN S ++ N SNL+ E+ A
Sbjct: 267 LFPKQQHSEKAHVKRLSVVKWVFRIPTRNSSSVVHPDQKQNISLADADQN-SNLEVENYA 325
Query: 285 IVSVEHDSACPPLSP---YNELPKELEGLQERYSSTCRLFSYQELLSATSNFLPEYLVGK 341
IV V + A P+SP N +P+EL+ L+ERYSS+CRLFSY+EL ATSNF+PE ++GK
Sbjct: 326 IVPVGPEVAWTPISPCHDLNGIPEELKNLRERYSSSCRLFSYEELAMATSNFIPENMIGK 385
Query: 342 GGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNL 401
GG SHVY+GCLPDGKELAVKILKPSEDVLKEF +EIEIIT LHH+NIISLFGFCFE N L
Sbjct: 386 GGSSHVYKGCLPDGKELAVKILKPSEDVLKEFIAEIEIITTLHHKNIISLFGFCFEQNKL 445
Query: 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKS 461
LLVYD LSRGSLEENLHGN+KD NA GW ERYKVAVGVAEALDYLHN C+QPVIHKDVKS
Sbjct: 446 LLVYDLLSRGSLEENLHGNRKDVNAIGWQERYKVAVGVAEALDYLHNCCDQPVIHKDVKS 505
Query: 462 SNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAF 521
SNILLSDDFEPQLSDFGLA W ST S H TCTDVAGTFGYLAPEYFMHGKVS+K+DV+AF
Sbjct: 506 SNILLSDDFEPQLSDFGLACWAST-SCHTTCTDVAGTFGYLAPEYFMHGKVSDKVDVFAF 564
Query: 522 GIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVL 581
G+VLLELLSG+KPINSE+PKGQESLVMWAKPIL+ GKVSQLL P L ++YD+D IERMVL
Sbjct: 565 GVVLLELLSGRKPINSEHPKGQESLVMWAKPILEGGKVSQLL-PRLGSEYDDDHIERMVL 623
Query: 582 AATLSISRAPTVRPQINLVLKLLQGDEEAANWAKEQVSASEELDSIDGEASPTNIQSHLN 641
AATL + R+P RPQ++LVLKLLQGDEE NWA+ QV ASEE D++DGE P+NIQSHLN
Sbjct: 624 AATLCLRRSPKWRPQMSLVLKLLQGDEEVKNWARHQVCASEEHDAMDGETFPSNIQSHLN 683
Query: 642 LALLDLDDDSVSAGSTQQIISVEDYLQGRWSRTSSF 677
LALLDL+DDS+S ST+Q +S+EDYLQGRWSRTSSF
Sbjct: 684 LALLDLEDDSLSISSTEQGVSIEDYLQGRWSRTSSF 719
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255550554|ref|XP_002516327.1| ATP binding protein, putative [Ricinus communis] gi|223544557|gb|EEF46074.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 877 bits (2267), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/689 (66%), Positives = 525/689 (76%), Gaps = 67/689 (9%)
Query: 12 KFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTG---SLLSLVKTFDSMLSVYEGF 68
K DG+SRELLTW L+K+A+PGDR+IALHVLD++TE G SLLSLVKTFD L+VYEGF
Sbjct: 31 KLDGDSRELLTWTLMKLAKPGDRVIALHVLDSLTEFVGGRTSLLSLVKTFDCFLAVYEGF 90
Query: 69 CNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAKYCARKLS 128
CNLKQVDLKLKVCRG+SV+K +V+EAKS G A +I G SK IRSS SVAKYCAR LS
Sbjct: 91 CNLKQVDLKLKVCRGSSVRKTLVREAKSSGAAMLITGTSKKRHKIRSSTSVAKYCARNLS 150
Query: 129 KNFGVFAVENGKIVFQREGT----HNLQD------DNVKVTVDDADDVPGECTNCDSRTQ 178
K+F VFAV NGKI+FQRE T ++ QD N D D +S T
Sbjct: 151 KSFSVFAVSNGKIMFQREATPASVNHFQDKLNQESQNSSQNNDSLDSPSLLSIAHNSETN 210
Query: 179 SCEELARDETVVDNSLALVPVQSD------NSLVVRESPRSKQDGWPFLRRVLLPKHQDP 232
S EE + D+ VDNSLALVPVQ++ NS VV SP K GW LRRV LPK +
Sbjct: 211 SLEE-SLDDGEVDNSLALVPVQTNEAVTNFNSSVVERSPEYKH-GWSILRRVFLPKRRHR 268
Query: 233 EKTSAKKTSLIQWVLRLPSRYTSAVVYPDHKQNHSADTSEDNRSNLDGESGAIVSVEHDS 292
E++ K+TS+++WV ++PSR +S+VV
Sbjct: 269 EESHGKRTSVVKWVFKVPSRNSSSVV---------------------------------- 294
Query: 293 ACPPLSPYNELPKELEGLQERYSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCL 352
LP+EL+GL ERYSS+CRLFSY+EL SATSNF+PE LVGKGG SHVY+GCL
Sbjct: 295 ---------GLPEELKGLHERYSSSCRLFSYEELCSATSNFMPENLVGKGGSSHVYKGCL 345
Query: 353 PDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGS 412
PDGKELAVKILKPSEDVLKEF +EI+IIT LHH NIISLFGFCFE NNLLLVYDFLSRGS
Sbjct: 346 PDGKELAVKILKPSEDVLKEFIAEIDIITTLHHNNIISLFGFCFEHNNLLLVYDFLSRGS 405
Query: 413 LEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP 472
LEENLHGNKKDGN+FGW R+KVAVGVAEALDYLH+ C+QPVIH+DVKSSNILLSDDFEP
Sbjct: 406 LEENLHGNKKDGNSFGWQGRFKVAVGVAEALDYLHSFCDQPVIHRDVKSSNILLSDDFEP 465
Query: 473 QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGK 532
QLSDFGLASW+STSSSH+ CTDVAGTFGYLAPEYF+HGKVS+K+DV+AFG+VLLELLSG+
Sbjct: 466 QLSDFGLASWVSTSSSHMACTDVAGTFGYLAPEYFLHGKVSDKVDVFAFGVVLLELLSGR 525
Query: 533 KPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPT 592
PIN ENPKGQESLVMWAKPIL GKVS+LLDP + T+Y++DQIERMVLAATL I R+P
Sbjct: 526 MPINGENPKGQESLVMWAKPILDGGKVSELLDPHIGTNYNDDQIERMVLAATLCIRRSPR 585
Query: 593 VRPQINLVLKLLQGDEEAANWAKEQVSA--SEELDSIDGEASPTNIQSHLNLALLDL-DD 649
RPQI+LVLKLLQGD+E NWA++QVSA E +D EA PTNIQSHLNLA LDL D+
Sbjct: 586 SRPQISLVLKLLQGDDEVKNWARQQVSALEEVEDVEVDEEAIPTNIQSHLNLAFLDLEDE 645
Query: 650 DSVSAGSTQQIISVEDYLQGRWSRTSSFD 678
DS+S ST+Q IS+EDYLQGRWSRTSSFD
Sbjct: 646 DSLSVSSTEQGISLEDYLQGRWSRTSSFD 674
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255558560|ref|XP_002520305.1| ATP binding protein, putative [Ricinus communis] gi|223540524|gb|EEF42091.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 859 bits (2220), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/755 (60%), Positives = 540/755 (71%), Gaps = 84/755 (11%)
Query: 1 GGQG-KVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVL--DTITESTG--SLLSLV 55
GG G + V+VGVK D ESRELLTWA+VKVAQPGD +IALHVL + I + G SLLSLV
Sbjct: 11 GGSGCRTVMVGVKLDSESRELLTWAMVKVAQPGDTVIALHVLGNNEIVDREGKSSLLSLV 70
Query: 56 KTFDSMLSVYEGFCNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS 115
K FDS+L+VYEGFCNLKQVDLKLK+CRG+S++KI+V+EAKSY +IVG ++TH TIRS
Sbjct: 71 KAFDSVLAVYEGFCNLKQVDLKLKICRGSSIRKILVREAKSYSATNIIVGAARTHHTIRS 130
Query: 116 SVSVAKYCARKLSKNFGVFAVENGKIVFQREGT-------HNLQDD-------------- 154
SVAKYCA+KLSK+ V AV NGK+VFQ+EG+ H +DD
Sbjct: 131 PTSVAKYCAKKLSKDCLVLAVHNGKVVFQKEGSTAKTGDSHGSEDDQRKGFVNIFHRSIS 190
Query: 155 ---NVKVTVDDADD-----VPGE-------------------------CTNC-------- 173
N KV + + V GE CT C
Sbjct: 191 LSKNSKVISESGINEAPKYVVGEGNEQTFHQALVKARPNSLGSIMKQNCTVCGAVGNSLD 250
Query: 174 DSRTQSCEELARDETVVDNSLALVPVQ------SDNSLVVRESPRSKQDGWPFLRRVLLP 227
+S QS E+ + D + SLALVPV S ++ + P K GWP LRR +LP
Sbjct: 251 ESCNQSAEKSSGDNGGDNKSLALVPVSKVEGRSSSFRSLIAQVPELKP-GWPLLRRAILP 309
Query: 228 KHQDPEKTSAKKTSLIQWVLRLPSR-YTSAVVYPDHKQNHSADTSEDNRSNLDGESGAIV 286
Q +++S ++ S++QW +RLPSR +S++ DHKQN S LDGESGAIV
Sbjct: 310 GGQASDRSSLRQISVVQWAMRLPSRQLSSSISNLDHKQNGEGQPS------LDGESGAIV 363
Query: 287 SVEHDSACPPLSPYN--ELPKELEGLQERYSSTCRLFSYQELLSATSNFLPEYLVGKGGH 344
+V D+ P SP + +LP ELEG E+YS+TCRLF YQELLSATSNFL EYLVGKGG
Sbjct: 364 AVGTDALTIPPSPDHNAKLPIELEGFHEKYSATCRLFQYQELLSATSNFLAEYLVGKGGS 423
Query: 345 SHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404
S VY+GCLPDGKELAVKILKPSEDVLKEF EIEIIT L+H+NIISL GFCFE N LLLV
Sbjct: 424 SQVYKGCLPDGKELAVKILKPSEDVLKEFVLEIEIITTLNHKNIISLLGFCFEYNKLLLV 483
Query: 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNI 464
YDFLSRGSLEENLHGN+KD AF W ERYKVAVGVAEAL+YLH QPVIH+DVKSSNI
Sbjct: 484 YDFLSRGSLEENLHGNRKDPLAFNWYERYKVAVGVAEALNYLHTGTAQPVIHRDVKSSNI 543
Query: 465 LLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIV 524
LLSDDFEPQLSDFGLA W STSSSH+ CTDVAGTFGYLAPEYFM+GKV+EKIDVYAFG+V
Sbjct: 544 LLSDDFEPQLSDFGLAKWASTSSSHIICTDVAGTFGYLAPEYFMYGKVNEKIDVYAFGVV 603
Query: 525 LLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAAT 584
LLELLSG+KPI+++ PKGQESLVMWAKPIL DGK QLLDPSL DYD DQ+ERMVLAAT
Sbjct: 604 LLELLSGRKPISNDLPKGQESLVMWAKPILDDGKFCQLLDPSLGDDYDQDQMERMVLAAT 663
Query: 585 LSISRAPTVRPQINLVLKLLQGDEEAANWAKEQVSASEELDSIDGEASP-TNIQSHLNLA 643
L + R+P RPQ++LVLKLL GD E WA+ QV+ EE D +D E P +NIQSHLNLA
Sbjct: 664 LCVKRSPRARPQMSLVLKLLHGDAEVTKWARLQVNKVEESDMLDDETCPRSNIQSHLNLA 723
Query: 644 LLDLDDDSVSAGSTQQIISVEDYLQGRWSRTSSFD 678
LD++DDS+S S +Q +S+EDYLQGR SR+SSFD
Sbjct: 724 FLDVEDDSLSISSIEQTVSLEDYLQGRCSRSSSFD 758
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431701|ref|XP_002264653.1| PREDICTED: uncharacterized protein LOC100243137 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 857 bits (2214), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/712 (64%), Positives = 534/712 (75%), Gaps = 44/712 (6%)
Query: 6 VVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLD-----TITESTGSLLSLVKTFDS 60
VVVVGVK D S+ELLTWALVKVAQ GDR++A+HVL T+T SLLSL TF +
Sbjct: 21 VVVVGVKLDQRSKELLTWALVKVAQSGDRVVAVHVLTDAAAVTMTGGKSSLLSLFDTFKT 80
Query: 61 MLSVYEGFCNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTI-RSSVSV 119
+L+ YEGFCNLKQV+LKLKVCRG+SV KI+V+EAKS+ KVIVGIS+T+ TI RS V
Sbjct: 81 LLAAYEGFCNLKQVELKLKVCRGSSVPKILVREAKSHANVKVIVGISRTNHTIWRSPAWV 140
Query: 120 AKYCARKLSKNFGVFAVENGKIVFQREGTHNLQDDNVKVTVDD--------ADDVPGECT 171
AKYCARKLS NF VFAV+NGKIVFQR T D + V ++ A + G T
Sbjct: 141 AKYCARKLSSNFSVFAVDNGKIVFQRRATAKTTDYSRVVALNQDSGSYLQKARSLCGRNT 200
Query: 172 ------NCDSRT--------QSCEELA-RDETVVDNSLALVPVQSDNSLVVRESPRSKQD 216
+C + Q EEL+ DE++ DNS ALVP++ S+ S D
Sbjct: 201 LIRSFLSCSPYSVLPEKDCSQVMEELSDEDESIEDNSFALVPIEPMESVSCSNS--VVVD 258
Query: 217 GWP-------FLRRVLLPKHQDPEKTSAKKTSLIQWVLRLPSRYTSAVVYPDHKQNHSAD 269
+P LRR+ L Q EK+S +K L QWVLRLPS + SAVVYPD K + S
Sbjct: 259 DFPELKPVRLSLRRIFLRNRQSSEKSSLRKMPLSQWVLRLPSCHNSAVVYPDKKHSSSDS 318
Query: 270 TSEDNR-SNLDGESGAIVSVEHDSACPPLSP---YNELPKELEGLQERYSSTCRLFSYQE 325
+++ +NLDGE GAI+ + D+ P SP LPKELEGL E+YSSTCRLF+YQE
Sbjct: 319 DQDEDHSANLDGEKGAILLLGSDAGFTPESPNGSAKSLPKELEGLHEKYSSTCRLFTYQE 378
Query: 326 LLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHH 385
LL ATSNF PE +VGKGG+S VY+GCLPD +ELAVKILK S DVLKEF EIEIIT LHH
Sbjct: 379 LLLATSNFRPENMVGKGGNSQVYKGCLPDDRELAVKILKQSGDVLKEFVLEIEIITTLHH 438
Query: 386 RNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDY 445
+NIISLFGFCFEDNNLLLVYDFLSRGSLEENLHG KKD FGW ERY+VA+GVAEALDY
Sbjct: 439 KNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGKKKDPMTFGWGERYRVALGVAEALDY 498
Query: 446 LHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
LHN C QPVIH+DVKSSNILLSDDFEPQLSDFGLA+W +T +SH C DVAGTFGYLAPE
Sbjct: 499 LHNGCGQPVIHRDVKSSNILLSDDFEPQLSDFGLAAWANT-ASHKNCPDVAGTFGYLAPE 557
Query: 506 YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565
YFM+GKV++KIDVYAFG+VLLELLSG+KPI+SE PKGQESLVMWAKPIL+ GK+S+LLDP
Sbjct: 558 YFMYGKVNDKIDVYAFGVVLLELLSGRKPISSEYPKGQESLVMWAKPILRSGKISKLLDP 617
Query: 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEAANWAKEQVSASEELD 625
LD++YD+ QIERMVLAATL + RAP RPQI LVLKLL GD E WAK+QVSA E
Sbjct: 618 DLDSNYDDPQIERMVLAATLCLRRAPRFRPQIGLVLKLLLGDMEIIQWAKQQVSAMEG-Q 676
Query: 626 SIDGEASPTNIQSHLNLALLDLDDDSVSAGSTQQIISVEDYLQGRWSRTSSF 677
++GE+ P+NIQSHLNLALLDL+DDS+S ST+Q IS+EDYLQGRWSR+SSF
Sbjct: 677 EVEGESFPSNIQSHLNLALLDLEDDSLSISSTEQSISLEDYLQGRWSRSSSF 728
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088527|emb|CBI37518.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 849 bits (2193), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/689 (64%), Positives = 519/689 (75%), Gaps = 33/689 (4%)
Query: 6 VVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLD-----TITESTGSLLSLVKTFDS 60
VVVVGVK D S+ELLTWALVKVAQ GDR++A+HVL T+T SLLSL TF +
Sbjct: 53 VVVVGVKLDQRSKELLTWALVKVAQSGDRVVAVHVLTDAAAVTMTGGKSSLLSLFDTFKT 112
Query: 61 MLSVYEGFCNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTI-RSSVSV 119
+L+ YEGFCNLKQV+LKLKVCRG+SV KI+V+EAKS+ KVIVGIS+T+ TI RS V
Sbjct: 113 LLAAYEGFCNLKQVELKLKVCRGSSVPKILVREAKSHANVKVIVGISRTNHTIWRSPAWV 172
Query: 120 AKYCARKLSKNFGVFAVENGKIVFQREGTHNLQDDNVKVTVDDADDVPGECTNCDSRTQS 179
AKYCARKLS NF VFAV+NGKIVFQR T D + V ++ + S Q
Sbjct: 173 AKYCARKLSSNFSVFAVDNGKIVFQRRATAKTTDYSRVVALNQ---------DSGSYLQK 223
Query: 180 CEELARDETVVDNSLALVPVQSDNSLVVRESPRSKQDGWP-------FLRRVLLPKHQDP 232
L T++ + L+ P S + D +P LRR+ L Q
Sbjct: 224 ARSLCGRNTLIRSFLSCSPYSSVSCSNS-----VVVDDFPELKPVRLSLRRIFLRNRQSS 278
Query: 233 EKTSAKKTSLIQWVLRLPSRYTSAVVYPDHKQNHSADTSEDNR-SNLDGESGAIVSVEHD 291
EK+S +K L QWVLRLPS + SAVVYPD K + S +++ +NLDGE GAI+ + D
Sbjct: 279 EKSSLRKMPLSQWVLRLPSCHNSAVVYPDKKHSSSDSDQDEDHSANLDGEKGAILLLGSD 338
Query: 292 SACPPLSP---YNELPKELEGLQERYSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVY 348
+ P SP LPKELEGL E+YSSTCRLF+YQELL ATSNF PE +VGKGG+S VY
Sbjct: 339 AGFTPESPNGSAKSLPKELEGLHEKYSSTCRLFTYQELLLATSNFRPENMVGKGGNSQVY 398
Query: 349 RGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408
+GCLPD +ELAVKILK S DVLKEF EIEIIT LHH+NIISLFGFCFEDNNLLLVYDFL
Sbjct: 399 KGCLPDDRELAVKILKQSGDVLKEFVLEIEIITTLHHKNIISLFGFCFEDNNLLLVYDFL 458
Query: 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD 468
SRGSLEENLHG KKD FGW ERY+VA+GVAEALDYLHN C QPVIH+DVKSSNILLSD
Sbjct: 459 SRGSLEENLHGKKKDPMTFGWGERYRVALGVAEALDYLHNGCGQPVIHRDVKSSNILLSD 518
Query: 469 DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLEL 528
DFEPQLSDFGLA+W +T +SH C DVAGTFGYLAPEYFM+GKV++KIDVYAFG+VLLEL
Sbjct: 519 DFEPQLSDFGLAAWANT-ASHKNCPDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLEL 577
Query: 529 LSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSIS 588
LSG+KPI+SE PKGQESLVMWAKPIL+ GK+S+LLDP LD++YD+ QIERMVLAATL +
Sbjct: 578 LSGRKPISSEYPKGQESLVMWAKPILRSGKISKLLDPDLDSNYDDPQIERMVLAATLCLR 637
Query: 589 RAPTVRPQINLVLKLLQGDEEAANWAKEQVSASEELDSIDGEASPTNIQSHLNLALLDLD 648
RAP RPQI LVLKLL GD E WAK+QVSA E ++GE+ P+NIQSHLNLALLDL+
Sbjct: 638 RAPRFRPQIGLVLKLLLGDMEIIQWAKQQVSAMEG-QEVEGESFPSNIQSHLNLALLDLE 696
Query: 649 DDSVSAGSTQQIISVEDYLQGRWSRTSSF 677
DDS+S ST+Q IS+EDYLQGRWSR+SSF
Sbjct: 697 DDSLSISSTEQSISLEDYLQGRWSRSSSF 725
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082346|ref|XP_002306655.1| predicted protein [Populus trichocarpa] gi|222856104|gb|EEE93651.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2180), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/695 (64%), Positives = 525/695 (75%), Gaps = 29/695 (4%)
Query: 7 VVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDT--ITESTG--SLLSLVKTFDSML 62
V+VGVK D SRELLTWALVKVAQPGD +IALH+LD I + G SLLSLVK FD++L
Sbjct: 9 VIVGVKLDPASRELLTWALVKVAQPGDTVIALHILDNNEIVDREGKSSLLSLVKAFDNVL 68
Query: 63 SVYEGFCNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAKY 122
+VYEGFCNLKQVDLKLK+CRG+S+++I+V+EAKSY KVIVG ++ H +I S SVAKY
Sbjct: 69 AVYEGFCNLKQVDLKLKICRGSSIRRILVREAKSYTATKVIVGATRNHLSIWPSTSVAKY 128
Query: 123 CARKLSKNFGVFAVENGKIVFQREGTHNLQDDNVKVTVDDADDVPGECTNC--------D 174
CA+KL K+ V A NGK+VFQRE T N + + A + C+ C D
Sbjct: 129 CAKKLPKDCSVLAFNNGKVVFQRERTPN---NTGNFSCSLASIMKENCSVCGSVMKPADD 185
Query: 175 SRTQSCEELARDETVVDNSLALVPV------QSDNSLVVRESPRSKQDGWPFLRRVLLPK 228
S QS E D D SLALVPV S S ++ + P K GWP LR +LP
Sbjct: 186 SCNQSAEASCGDRDGDDKSLALVPVPRVEEPTSSVSTLIGQVPELKP-GWPLLRSSVLPN 244
Query: 229 HQDPEKTSAKKTSLIQWVLRLPSRYTS-AVVYPDHKQNHSADTSEDNRSNLDGESGAIVS 287
+ ++ ++ S++QW +RLPSR S + V DHKQ+ S D E+ + NLDGESGAIV+
Sbjct: 245 RKTSNRSLVRQISVVQWAMRLPSRQLSLSTVNSDHKQDVS-DKGEE-QLNLDGESGAIVA 302
Query: 288 VEHDSACPPLSP---YNELPKELEGLQERYSSTCRLFSYQELLSATSNFLPEYLVGKGGH 344
V ++A PLSP LPKELEGL E+YS+TCRLF QELLSATSNFL E L+GKGG
Sbjct: 303 VGMETATAPLSPDHNSRSLPKELEGLHEKYSATCRLFQCQELLSATSNFLAENLIGKGGS 362
Query: 345 SHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404
S VY+GCLPDGKELAVKILKPSEDVLKEF EIEIIT L H+NIISL GFCFE NLLLV
Sbjct: 363 SQVYKGCLPDGKELAVKILKPSEDVLKEFVQEIEIITTLSHKNIISLLGFCFEGKNLLLV 422
Query: 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNI 464
YDFLSRGSLEENLHGNKKD AFGW ERYKVA+G+AEALDYLH+ QPVIH+DVKSSNI
Sbjct: 423 YDFLSRGSLEENLHGNKKDPRAFGWNERYKVALGIAEALDYLHSCSAQPVIHRDVKSSNI 482
Query: 465 LLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIV 524
LLSDDFEPQLSDFGLA W TSSSH+ C DVAGTFGYLAPEYFM+GKV+ KIDVYAFG+V
Sbjct: 483 LLSDDFEPQLSDFGLAKWAPTSSSHIICNDVAGTFGYLAPEYFMYGKVNNKIDVYAFGVV 542
Query: 525 LLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAAT 584
LLELLSGKKPI+++ PKGQESLVMWAKPIL GKVSQLLDP L D DQ+ERMVLAAT
Sbjct: 543 LLELLSGKKPISNDLPKGQESLVMWAKPILNGGKVSQLLDPILGDSCDRDQMERMVLAAT 602
Query: 585 LSISRAPTVRPQINLVLKLLQGDEEAANWAKEQVSASEELDSIDGEASP-TNIQSHLNLA 643
L + RAP RPQ++LV+KLLQGD E WA+ QV+A EE D +D EA P +N+QSHLNLA
Sbjct: 603 LCVRRAPRARPQMSLVVKLLQGDAEVTRWARLQVNAVEESDVLDDEACPRSNLQSHLNLA 662
Query: 644 LLDLDDDSVSAGSTQQIISVEDYLQGRWSRTSSFD 678
LLD+++DS+S+ S +Q IS++DYLQGRWSR+SS D
Sbjct: 663 LLDVENDSLSSSSLEQSISLQDYLQGRWSRSSSLD 697
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507449|ref|XP_003522479.1| PREDICTED: probable receptor protein kinase TMK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 835 bits (2156), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/709 (62%), Positives = 529/709 (74%), Gaps = 41/709 (5%)
Query: 1 GGQGKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITES------TGSLLSL 54
G G+ V+VGVK D SRELLTWALVKVA+PGD +IALHVLDTIT S T SLLSL
Sbjct: 7 GAGGRKVLVGVKLDPRSRELLTWALVKVAEPGDLVIALHVLDTITGSFLSLTGTASLLSL 66
Query: 55 VKTFDSMLSVYEGFCNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIR 114
VKTFDS+L+VYEGFCNLKQV L+LKVCRG SV+K +V+EAK++G + VI+G SK+H TIR
Sbjct: 67 VKTFDSVLAVYEGFCNLKQVGLRLKVCRGDSVRKALVQEAKAFGVSTVILGTSKSHHTIR 126
Query: 115 SSVSVAKYCARKLSKNFGVFAVENGKIVFQREGTHNLQDDN---------VKVTVDDADD 165
SS VAKYCA+KL K VF+V+NGKI F+RE N D K V +
Sbjct: 127 SSAWVAKYCAKKLPKCISVFSVDNGKIAFRREANGNCSDREKLCEGSSLSSKSLVVYTNK 186
Query: 166 VPGECTNCDSRTQSCEELARD---ETVVDNSLALVPVQSDN-----SLVVRESPRSKQDG 217
C +C+ + S E + + +N LALVP + + S++V S + G
Sbjct: 187 NMKSCGSCELQECSGNEFEQGLCGDVEKENPLALVPFKKLDDAPCFSVLVDNSKH--KPG 244
Query: 218 WPFLRRVLLPKHQDPEKTSAKKTSLIQWVLRLPSRYTSAVVYPDHKQNHSADTSEDNRSN 277
W LR V K + K+S K T + Q LR P+ ++SAVV+PDHKQ + + S
Sbjct: 245 WSLLRHVFHHK-KHTHKSSMKNTFVFQRALRQPNCHSSAVVHPDHKQ---ISIEQIDDSP 300
Query: 278 LDGESGAIVSVEHD--------SACPPLSPYNELPKELEGLQERYSSTCRLFSYQELLSA 329
LDG SGAIV E S C LS LP+EL LQE+Y+S+CRL+S QEL+SA
Sbjct: 301 LDGVSGAIVPFESTTTTIFTLPSICSDLS---SLPEELLVLQEKYTSSCRLYSLQELVSA 357
Query: 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNII 389
TSNF+ E LVGKGG S+VYRGCLPDGKELAVKILKPSE+V+KEF EIEIIT L H+NII
Sbjct: 358 TSNFVSENLVGKGGCSYVYRGCLPDGKELAVKILKPSENVIKEFVQEIEIITTLRHKNII 417
Query: 390 SLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
S+ GFC E N+LLLVYDFLSRGSLEENLHGNK D +AFGW ERYKVAVGVAEALDYLHN
Sbjct: 418 SISGFCLEGNHLLLVYDFLSRGSLEENLHGNKVDCSAFGWQERYKVAVGVAEALDYLHNG 477
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH 509
C Q VIH+DVKSSNILL+DDFEPQLSDFGLASW +SSSH+TCTDVAGTFGYLAPEYFMH
Sbjct: 478 CAQAVIHRDVKSSNILLADDFEPQLSDFGLASW-GSSSSHITCTDVAGTFGYLAPEYFMH 536
Query: 510 GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569
G+V++KIDVY+FG+VLLELLS +KPIN+E+PKGQESLVMWA PIL+ GK SQLLDPSL +
Sbjct: 537 GRVTDKIDVYSFGVVLLELLSNRKPINNESPKGQESLVMWATPILEGGKFSQLLDPSLGS 596
Query: 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEAANWAKEQVSASEELDSIDG 629
+Y+ QI+RM+LAATL I R P +RPQINL+LKLL GDEE WA+++V+A +ELD D
Sbjct: 597 EYNTCQIKRMILAATLCIRRIPRLRPQINLILKLLHGDEEVIRWAEQEVNAPQELDGCDE 656
Query: 630 EASPTNIQSHLNLALLDLDDDSVSAGSTQQIISVEDYLQGRWSRTSSFD 678
E PTNIQSHLNLALLDL+DD+VS ST+Q +S+EDYLQGRWSR+SSFD
Sbjct: 657 EPVPTNIQSHLNLALLDLEDDTVSISSTEQSVSLEDYLQGRWSRSSSFD 705
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449459248|ref|XP_004147358.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Cucumis sativus] gi|449524802|ref|XP_004169410.1| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 829 bits (2141), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/682 (63%), Positives = 513/682 (75%), Gaps = 37/682 (5%)
Query: 12 KFDGESRELLTWALVKVAQPGDRIIALHVLDT--ITESTGSLLSLVKTFDSMLSVYEGFC 69
K D SRELLTWALVKVAQPGD +IALHVLD+ + E +LLSLVK+FDS+LS YEGFC
Sbjct: 21 KMDSHSRELLTWALVKVAQPGDSVIALHVLDSAAVPEGKSTLLSLVKSFDSVLSAYEGFC 80
Query: 70 NLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAKYCARKLSK 129
NLKQV+LKLKVCRG+ V+K+I +E SY EA +I+G SKTH IRSS SVAKYCARKLS
Sbjct: 81 NLKQVELKLKVCRGSPVRKVIRREVNSYEEASLILGTSKTHHRIRSSASVAKYCARKLSS 140
Query: 130 NFGVFAVENGKIVFQREGTHNLQDDNVKVTVDDADDVPGECTNCDSRTQSCEELARDETV 189
F V AV NGK++FQR T + D + P DS +EL D V
Sbjct: 141 RFTVLAVNNGKVIFQRLAT--FPNKGQSPERDCVEGAPSSLERNDSGIDLVDELPEDNDV 198
Query: 190 VDNSLALVPVQS------DNSLVVRESPRSKQDGWPFLRRVLLPKHQDPEKTSAKKTSLI 243
NSLALVP NS+V RES K WP LRR+ L KHQ + S+KK S+
Sbjct: 199 -GNSLALVPFHKPRENLKSNSIVCRESSHWKS-SWPLLRRIFLSKHQ--AEKSSKKFSVF 254
Query: 244 QWVLRLPS-RYTSAVVYPDHKQNHSADTSEDNRSNLDGESGAIVSVEHDSACPPLSPYNE 302
Q VL +P+ + +SA+VYPD K N S +D +DGE GAIV PY
Sbjct: 255 QGVLHIPNFQSSSALVYPDQKPNCS---DQDQGFTIDGECGAIV------------PYGS 299
Query: 303 ------LPKELEGLQERYSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGK 356
LPKE+ L+++YSSTCR+F+Y+EL ATSNF+ E+LVG+GG S+VYRG LPDGK
Sbjct: 300 SHILESLPKEVLDLKDKYSSTCRVFTYEELSFATSNFMSEHLVGRGGSSYVYRGLLPDGK 359
Query: 357 ELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEEN 416
E+AVKILKPSE+VLKEF E+ II H+NIISL GFC EDNNLLLVYDFLSRGS+EEN
Sbjct: 360 EIAVKILKPSENVLKEFVQEVGIIATSSHKNIISLIGFCLEDNNLLLVYDFLSRGSMEEN 419
Query: 417 LHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSD 476
LHG KKD N+FGW ER+KVAVG+AEALDYLHN E+PV+H+DVKSSNILLS++FEPQLSD
Sbjct: 420 LHGCKKDMNSFGWQERFKVAVGIAEALDYLHNCREEPVVHRDVKSSNILLSENFEPQLSD 479
Query: 477 FGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPIN 536
FGLASW ++S +TCTDVAGTFGYLAPEYFMHGKVS+KIDVYAFG+VLLELLSG+KPI+
Sbjct: 480 FGLASW-ASSCFQVTCTDVAGTFGYLAPEYFMHGKVSDKIDVYAFGVVLLELLSGRKPIS 538
Query: 537 SENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ 596
+ PKGQESLVMWAKPIL +GKVSQLLDPSL +DY++DQI RM+LAATL I RAP +RPQ
Sbjct: 539 NNCPKGQESLVMWAKPILTEGKVSQLLDPSLGSDYNHDQIGRMILAATLCIRRAPRLRPQ 598
Query: 597 INLVLKLLQGDEEAANWAKEQVSASEELDSIDGEASPTNIQSHLNLALLDLDDDSVSAGS 656
I+L+LKLLQGDEE WA++Q+ S+E+D+ DGE PTNIQSHLNLALL L+DDS+S GS
Sbjct: 599 ISLILKLLQGDEEITTWARQQIDESDEMDASDGEPLPTNIQSHLNLALLGLEDDSLSVGS 658
Query: 657 TQQIISVEDYLQGRWSRTSSFD 678
Q IS+EDYLQGR SR+SSF+
Sbjct: 659 GIQSISIEDYLQGRCSRSSSFN 680
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516377|ref|XP_003526871.1| PREDICTED: probable receptor protein kinase TMK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 827 bits (2135), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/703 (62%), Positives = 519/703 (73%), Gaps = 34/703 (4%)
Query: 1 GGQGKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVKTFDS 60
G + V+VGVK D SRELLTWALVKVA+PGD +IALHVLD+ITE T SLLSLVKTFDS
Sbjct: 7 GAGCRKVLVGVKLDPRSRELLTWALVKVAEPGDLVIALHVLDSITEGTASLLSLVKTFDS 66
Query: 61 MLSVYEGFCNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVA 120
+L VYEGFCNLKQV L+LKVCRG SV+K +V+EAK++G + VI+G SK++ TIRSS VA
Sbjct: 67 VLGVYEGFCNLKQVGLRLKVCRGGSVRKALVQEAKAFGVSTVILGTSKSYHTIRSSAWVA 126
Query: 121 KYCARKLSKNFGVFAVENGKIVFQREGTHNLQDDN---------VKVTVDDADDVPGECT 171
KYCA+KL K VF+V+NGKI F+RE N D K V + C
Sbjct: 127 KYCAKKLPKCISVFSVDNGKIAFRREANGNCSDREKLCEGSSLSSKSLVVYTNKNMKSCG 186
Query: 172 NCDSRTQSCEELAR---DETVVDNSLALVPVQSDN-----SLVVRESPRSKQDGWPFLRR 223
+C + S E + ++ +N LALVP + S+VV S + GW LR
Sbjct: 187 SCALQEGSGTEFEQGLCEDVEKENPLALVPFKKLEDAPCFSVVVDNS--KPKPGWSLLRH 244
Query: 224 VLLPKHQDPEKTSAKKTSLIQWVLRLPSRYTSAVVYPDHKQNHSADTSEDNRSNLDGESG 283
V K + + +S K T + Q LR P+ ++SAVV+PDHKQ + + S LDG SG
Sbjct: 245 VFHHKKHNHKSSSMKNTFVFQRALRQPNCHSSAVVHPDHKQ---ISFKQIDDSPLDGVSG 301
Query: 284 AIVSVEH--------DSACPPLSPYNELPKELEGLQERYSSTCRLFSYQELLSATSNFLP 335
AIV E S C LS LP+EL LQE+YSS CRL+ QELLSATSNF
Sbjct: 302 AIVPFESATTTLFTLPSICSGLS---SLPEELLVLQEKYSSLCRLYRLQELLSATSNFAS 358
Query: 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+ L+G+GG S+VYRGCLPDG+ELAVKILKPSE+V+KEF EIEIIT L H+NIIS+ GFC
Sbjct: 359 DNLIGRGGCSYVYRGCLPDGEELAVKILKPSENVIKEFVQEIEIITTLRHKNIISISGFC 418
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
E N+LLLVYDFLSRGSLEENLHGNK D +AFGW ERYKVAVGVAEALDYLHN C Q VI
Sbjct: 419 LEGNHLLLVYDFLSRGSLEENLHGNKVDCSAFGWQERYKVAVGVAEALDYLHNGCAQAVI 478
Query: 456 HKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEK 515
H+DVKSSNILLSDDFEPQLSDFGLASW +SSSH+TCTDVAGTFGYLAPEYFMHG+V++K
Sbjct: 479 HRDVKSSNILLSDDFEPQLSDFGLASW-GSSSSHITCTDVAGTFGYLAPEYFMHGRVTDK 537
Query: 516 IDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQ 575
IDVYAFG+VLLELLS +KPIN+E PKGQ SLVMWA PIL+ GK SQLLDPSL ++YD+ Q
Sbjct: 538 IDVYAFGVVLLELLSNRKPINNECPKGQGSLVMWAIPILEGGKFSQLLDPSLGSEYDDCQ 597
Query: 576 IERMVLAATLSISRAPTVRPQINLVLKLLQGDEEAANWAKEQVSASEELDSIDGEASPTN 635
I RM+LAATL I R P +RPQI+L+LKLL GDEE WA+++V A +ELD D E PTN
Sbjct: 598 IRRMILAATLCIRRVPRLRPQISLILKLLHGDEEVIRWAEQEVIAPQELDGCDEEPVPTN 657
Query: 636 IQSHLNLALLDLDDDSVSAGSTQQIISVEDYLQGRWSRTSSFD 678
IQSHLNLALLDL+DD++S ST+Q +S+EDYL GRWSR+SSFD
Sbjct: 658 IQSHLNLALLDLEDDTISISSTEQSVSLEDYLHGRWSRSSSFD 700
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 678 | ||||||
| TAIR|locus:2195975 | 794 | AT1G77280 [Arabidopsis thalian | 0.707 | 0.604 | 0.590 | 8.8e-195 | |
| TAIR|locus:2160801 | 705 | AT5G63940 [Arabidopsis thalian | 0.966 | 0.929 | 0.567 | 8.3e-193 | |
| TAIR|locus:2026957 | 756 | AT1G21590 [Arabidopsis thalian | 0.740 | 0.664 | 0.551 | 4.4e-180 | |
| TAIR|locus:2059919 | 617 | AT2G16750 [Arabidopsis thalian | 0.463 | 0.508 | 0.544 | 4.3e-111 | |
| TAIR|locus:2172555 | 579 | AT5G57670 [Arabidopsis thalian | 0.441 | 0.516 | 0.439 | 1.4e-72 | |
| TAIR|locus:2155700 | 456 | AT5G65530 [Arabidopsis thalian | 0.477 | 0.710 | 0.424 | 1.3e-70 | |
| TAIR|locus:2035686 | 676 | AT1G55200 [Arabidopsis thalian | 0.477 | 0.479 | 0.409 | 2e-69 | |
| TAIR|locus:2044420 | 392 | AT2G18890 [Arabidopsis thalian | 0.460 | 0.795 | 0.448 | 1.7e-68 | |
| TAIR|locus:2091511 | 753 | AT3G13690 [Arabidopsis thalian | 0.514 | 0.463 | 0.382 | 6e-68 | |
| TAIR|locus:2165041 | 669 | AT5G56790 [Arabidopsis thalian | 0.430 | 0.436 | 0.427 | 7.7e-68 |
| TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1435 (510.2 bits), Expect = 8.8e-195, Sum P(2) = 8.8e-195
Identities = 299/506 (59%), Positives = 375/506 (74%)
Query: 184 ARDETVVDNSLALVPVQ-SDNS-----LVVRESPRSKQDGWPFLRRVLLPKHQDPEKTSA 237
+ D+ + ++ +VPV S++S ++VR+ P + GWP LRR + Q +
Sbjct: 304 SEDDDECNKAMEIVPVNGSEDSGGSVTMLVRKLPEPRP-GWPLLRRAVSTLGQS---VTP 359
Query: 238 KKTSLIQWVLRLPSRYTSAVVYPDHKQNHSADTSEDNRSNLDG-ESGAIVSVEHDSACPP 296
K ++QW L+LP R T + Y D+SEDN S L+ I S+ + S P
Sbjct: 360 HKIPVVQWALKLPPRDTKQLGY---------DSSEDNLSTLNALVPFGINSITNKSI-PD 409
Query: 297 LSPYNELPKELEGLQERYSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGK 356
SP +LP+ELEGL ER+SSTCR F Y+EL+S TSNF + +GKGG S V+RGCL +G+
Sbjct: 410 NSP-RKLPEELEGLYERFSSTCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSNGR 468
Query: 357 ELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEEN 416
+AVKILK +EDVL +F +EIEIIT LHH+NIISL GFCFED+NLLLVY++LSRGSLEEN
Sbjct: 469 VVAVKILKQTEDVLNDFVAEIEIITTLHHKNIISLLGFCFEDHNLLLVYNYLSRGSLEEN 528
Query: 417 LHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSD 476
LHGNKKD AF W+ERYKVAVGVAEALDYLHN+ QPVIH+DVKSSNILLSDDFEPQLSD
Sbjct: 529 LHGNKKDPLAFCWSERYKVAVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFEPQLSD 588
Query: 477 FGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPIN 536
FGLA W S S++H+ C+DVAGTFGYLAPEYFM+GKV++KIDVYAFG+VLLELLSG+KPI+
Sbjct: 589 FGLARWASISTTHIICSDVAGTFGYLAPEYFMYGKVNDKIDVYAFGVVLLELLSGRKPIS 648
Query: 537 SENPKGQESLVMWAKPILKDGKVSQLLDPSL-DTDYDND-QIERMVLAATLSISRAPTVR 594
S PKGQESLVMWAKPIL DGK SQLLDPSL D + +ND Q++RM LAATL I R+P R
Sbjct: 649 SGCPKGQESLVMWAKPILDDGKYSQLLDPSLRDNNNNNDDQMQRMALAATLCIRRSPQAR 708
Query: 595 PQINLVLKLLQGDEEAANWAKEQV-SASEELDSI-DGEASPTNIQSHXXXXXXXXXXXSV 652
P++++VLKLL+GDE+ WA +QV S+SEE + + D + +N+QSH S+
Sbjct: 709 PKMSIVLKLLKGDEDTLEWAMQQVNSSSEESEMLKDEQCQRSNLQSHLNLALLDVEDDSI 768
Query: 653 SAGSTQQIISVEDYLQGRWSRTSSFD 678
S GS +Q +SVEDYL+GR SR+SSFD
Sbjct: 769 SMGSIEQGVSVEDYLKGRTSRSSSFD 794
|
|
| TAIR|locus:2160801 AT5G63940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1868 (662.6 bits), Expect = 8.3e-193, P = 8.3e-193
Identities = 389/685 (56%), Positives = 489/685 (71%)
Query: 14 DGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLKQ 73
D SRE+LTW+LV VA+PGDRI+ALHVLD E + SL+SLV+ FD+ML VYE FCNLKQ
Sbjct: 29 DEWSREVLTWSLVNVARPGDRIVALHVLDYSLEGSTSLISLVRNFDTMLGVYESFCNLKQ 88
Query: 74 VDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAKYCARKLSKNFGV 133
VDLKLKV RG S +K++V+E KS G +IVG S+ H TIRSS S+AKYCAR L+K+ V
Sbjct: 89 VDLKLKVFRGKSARKVLVQEVKSCGATSLIVGSSRKHHTIRSSASLAKYCARNLAKDVSV 148
Query: 134 FAVENGKIVFQREGTHNLQDD---NVKVTVDDADDV------------PGECTNCDSRTQ 178
FAV++GKI+F+R N D N+ V + D+ P ++ +RT
Sbjct: 149 FAVKSGKIMFRRVPNTNGADGPQMNIPSLVCGSPDIAIEAAKIGNSFSPARTSSRWTRTS 208
Query: 179 SCEELARDETV-VDNSLALVPVQSDNSLVVRESPRSKQDGWPFLRRVLLPKHQDPEKTSA 237
L +++ VDN LALVPVQ++ + GW FLR + + K SA
Sbjct: 209 RSSSLQSPDSLGVDNLLALVPVQTNET---DSGSLESGPGWHFLRGLYGNNRKSWTKVSA 265
Query: 238 KKTSLIQWVLRLPSRYTSAVVYPDHKQNHSADTSEDNRSNLDGESGAIVSVEHDSACPPL 297
KK +++QWV RL R++ V+Y D K++ S ED S++DGE +I + PL
Sbjct: 266 KK-AVLQWVSRLRGRHSETVIYLDRKRSDSG-CDEDCSSSIDGEDVSISRFGSELMQSPL 323
Query: 298 SPY---NELPKELEGLQERYSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPD 354
SP+ N +P+ELEGL E+YSSTCRLF+Y+E+LS TSNF E LVG+GG+S+VYRG LPD
Sbjct: 324 SPFIGSNNIPEELEGLHEKYSSTCRLFTYEEVLSITSNFASENLVGEGGNSYVYRGDLPD 383
Query: 355 GKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLE 414
G+ELAVKILKP DVLKEF EIE+IT++HH+NI+SLFGFCFE+NNL+LVYD+L RGSLE
Sbjct: 384 GRELAVKILKPCLDVLKEFILEIEVITSVHHKNIVSLFGFCFENNNLMLVYDYLPRGSLE 443
Query: 415 ENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQL 474
ENLHGN+KD FGW ERYKVAVGVAEALDYLHN+ + VIH+DVKSSN+LL+DDFEPQL
Sbjct: 444 ENLHGNRKDAKKFGWMERYKVAVGVAEALDYLHNTHDPEVIHRDVKSSNVLLADDFEPQL 503
Query: 475 SDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKP 534
SDFG AS S++S H+ D+AGTFGYLAPEYFMHGKV++KIDVYAFG+VLLEL+SG+KP
Sbjct: 504 SDFGFASLASSTSQHVAGGDIAGTFGYLAPEYFMHGKVTDKIDVYAFGVVLLELISGRKP 563
Query: 535 INSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVR 594
I + KGQESLV+WA PIL GK +QLLDPSL+ D ND IE+++LAATL I R P R
Sbjct: 564 ICVDQSKGQESLVLWANPILDSGKFAQLLDPSLENDNSNDLIEKLLLAATLCIKRTPHDR 623
Query: 595 PQINLVLKLLQGDEEAANWAKEQVSASEELDSIDGEASPTNIQSHXXXXXXXXXXXSVSA 654
PQI LVLK+LQG+EEA W K+QV ASE++ A TNI+SH + S
Sbjct: 624 PQIGLVLKILQGEEEATEWGKQQVRASEDVS-----AYLTNIESHINLALLDLEDDAASD 678
Query: 655 GSTQ-QIISVEDYLQGRWSRTSSFD 678
S + ISVE+YL+GRWSRT+SF+
Sbjct: 679 SSPEASSISVEEYLKGRWSRTASFN 703
|
|
| TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1354 (481.7 bits), Expect = 4.4e-180, Sum P(2) = 4.4e-180
Identities = 286/519 (55%), Positives = 362/519 (69%)
Query: 175 SRTQSCEELARDETVVDNSLALVPVQSDNSL------VVRESPRSKQDGWPFLRRVLLPK 228
SR+ SC D + ++ALVP + L +V+E P + GWP L RV
Sbjct: 240 SRSSSCNGDQDDNADLHKAMALVPAKFPEDLTPFITMLVKELPEFRP-GWPLLCRVASSD 298
Query: 229 --HQDPEKTSAKKTSLIQWVLRLPSRYTSAVVYPDHKQ-NHSADTSEDNR--SNLDGESG 283
P +S +K ++QWVL+LP+R S V D KQ + SE+N S+ + E
Sbjct: 299 VLASAPRSSSFRKIPVVQWVLKLPARTNSVVGSSDTKQIGFDSSESEENDKLSSSNVERQ 358
Query: 284 AIVSVEHDSA-CPPLSPYNELPKELEGLQERYSSTCRLFSYQELLSATSNFLPEYLVGKG 342
AIV E C P+ +EGLQ R S++C+ F+Y+EL+S TSNF + +GKG
Sbjct: 359 AIVPDESMIVKCSLDHSSGRFPENVEGLQARISTSCQFFTYKELVSVTSNFCADNFIGKG 418
Query: 343 GHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL 402
G S V+RG LP+G+E+AVKILK +E VLK+F +EI+IIT LHH+N+ISL G+CFE+NNLL
Sbjct: 419 GSSRVFRGYLPNGREVAVKILKRTECVLKDFVAEIDIITTLHHKNVISLLGYCFENNNLL 478
Query: 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSS 462
LVY++LSRGSLEENLHGNKKD AF W ERYKVAVG+AEALDYLHN QPVIH+DVKSS
Sbjct: 479 LVYNYLSRGSLEENLHGNKKDLVAFRWNERYKVAVGIAEALDYLHNDAPQPVIHRDVKSS 538
Query: 463 NILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFG 522
NILLSDDFEPQLSDFGLA W S S++ + C+DVAGTFGYLAPEYFM+GK++ KIDVYA+G
Sbjct: 539 NILLSDDFEPQLSDFGLAKWASESTTQIICSDVAGTFGYLAPEYFMYGKMNNKIDVYAYG 598
Query: 523 IVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLA 582
+VLLELLSG+KP+NSE+PK Q+SLVMWAKPIL D + SQLLD SL D ++DQ+E+M LA
Sbjct: 599 VVLLELLSGRKPVNSESPKAQDSLVMWAKPILDDKEYSQLLDSSLQDDNNSDQMEKMALA 658
Query: 583 ATLSISRAPTVRPQINLVLKLLQGDEEAANWAKEQVSASEELDSI---DGEASPTNIQSH 639
ATL I P RP + +VL+LL+GD E WAK QVS E DS+ D + +N+QSH
Sbjct: 659 ATLCIRHNPQTRPTMGMVLELLKGDVEMLKWAKLQVSNPLE-DSMLLKDEKLRRSNLQSH 717
Query: 640 XXXXXXXXXXXSVSAGSTQQIISVEDYLQGRWSRTSSFD 678
S+S GS +Q ISVE+YL+GR SR+SSF+
Sbjct: 718 LNLAFLDMEDDSLSMGSMEQGISVEEYLKGRTSRSSSFN 756
|
|
| TAIR|locus:2059919 AT2G16750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 901 (322.2 bits), Expect = 4.3e-111, Sum P(2) = 4.3e-111
Identities = 176/323 (54%), Positives = 232/323 (71%)
Query: 319 RLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPS-EDVLKEFASEI 377
R FSY L +ATS+F E L+GKGG + VY+G L DGK +AVKILKPS ++ +KEF E+
Sbjct: 263 RWFSYDVLKTATSDFSLENLIGKGGCNEVYKGFLEDGKGVAVKILKPSVKEAVKEFVHEV 322
Query: 378 EIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV 437
I+++L H NI L G C N+L+ VY+ S+GSLEE L G + W ER K+A+
Sbjct: 323 SIVSSLSHSNISPLIGVCVHYNDLISVYNLSSKGSLEETLQGK----HVLRWEERLKIAI 378
Query: 438 GVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAG 497
G+ EALDYLHN C PVIH+DVKSSN+LLSD+FEPQLSDFGL+ W S S + DV G
Sbjct: 379 GLGEALDYLHNQCSNPVIHRDVKSSNVLLSDEFEPQLSDFGLSMWGSKSCRYTIQRDVVG 438
Query: 498 TFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557
TFGYLAPEYFM+GKVS+K+DVYAFG+VLLEL+SG+ I+S++P+GQESLVMWAKP+++ G
Sbjct: 439 TFGYLAPEYFMYGKVSDKVDVYAFGVVLLELISGRTSISSDSPRGQESLVMWAKPMIEKG 498
Query: 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEAANWAKEQ 617
+LLDP++ +D DQ +MVLAAT ++RA T RP I +LKLL+G+++ + W K
Sbjct: 499 NAKELLDPNIAGTFDEDQFHKMVLAATHCLTRAATYRPNIKEILKLLRGEDDVSKWVK-- 556
Query: 618 VSASEELDSIDGEASP-TNIQSH 639
+ +E D D E P +N + H
Sbjct: 557 IEEDDE-DGFDDEVYPNSNTELH 578
|
|
| TAIR|locus:2172555 AT5G57670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 662 (238.1 bits), Expect = 1.4e-72, Sum P(2) = 1.4e-72
Identities = 137/312 (43%), Positives = 198/312 (63%)
Query: 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKIL-KPSEDVLKE--FASEI 377
F+Y E+ AT++F +VG GG+S VYRG L DG+ +AVK L K S D+ KE F +E+
Sbjct: 255 FTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRRIAVKRLAKESGDMNKEKEFLTEL 314
Query: 378 EIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV 437
II+ + H N L G C E L LV+ F G+L LH N + + W RYK+AV
Sbjct: 315 GIISHVSHPNTALLLGCCVE-KGLYLVFRFSENGTLYSALHEN--ENGSLDWPVRYKIAV 371
Query: 438 GVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAG 497
GVA L YLH C +IH+D+KSSN+LL D+EPQ++DFGLA WL +H V G
Sbjct: 372 GVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEPQITDFGLAKWLPNKWTHHAVIPVEG 431
Query: 498 TFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557
TFGYLAPE M G + EK D+YAFGI+LLE+++G++P+N P Q+ +++WAKP ++ G
Sbjct: 432 TFGYLAPESLMQGTIDEKTDIYAFGILLLEIITGRRPVN---PT-QKHILLWAKPAMETG 487
Query: 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLL-QGDEE--AANWA 614
S+L+DP L YD+ Q+ ++VL A+ + ++P +RP + VL+LL G+E A +W
Sbjct: 488 NTSELVDPKLQDKYDDQQMNKLVLTASHCVQQSPILRPTMTQVLELLTNGNEAEIAKSWR 547
Query: 615 KEQVSASEELDS 626
+ +++ D+
Sbjct: 548 MPKDMTNDDDDN 559
|
|
| TAIR|locus:2155700 AT5G65530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 715 (256.8 bits), Expect = 1.3e-70, P = 1.3e-70
Identities = 144/339 (42%), Positives = 222/339 (65%)
Query: 295 PPLSPYNELPKELEGLQERYSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPD 354
P LSP +E + + + S R F++ EL++AT NF PE ++GKGGH+ VY+G LPD
Sbjct: 107 PKLSPCSENDFDCDQILVAKPSW-RNFTFDELVAATDNFNPENMIGKGGHAEVYKGVLPD 165
Query: 355 GKELAVKIL----KPSEDVLKEFASEIEIITALHHRNIISLFGF-CFEDNNLLLVYDFLS 409
G+ +A+K L K E+ + +F SE+ II ++H N L GF C D L V ++ S
Sbjct: 166 GETVAIKKLTRHAKEVEERVSDFLSELGIIAHVNHPNAARLRGFSC--DRGLHFVLEYSS 223
Query: 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD 469
GSL L G+++ W +RYKVA+G+A+ L YLHN C + +IH+D+K+SNILLS D
Sbjct: 224 HGSLASLLFGSEE---CLDWKKRYKVAMGIADGLSYLHNDCPRRIIHRDIKASNILLSQD 280
Query: 470 FEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELL 529
+E Q+SDFGLA WL H + GTFGYLAPEYFMHG V EK DV+AFG++LLE++
Sbjct: 281 YEAQISDFGLAKWLPEHWPHHIVFPIEGTFGYLAPEYFMHGIVDEKTDVFAFGVLLLEII 340
Query: 530 SGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISR 589
+G++ +++++ ++S+VMWAKP+L+ + +++DP L D+D +++R++ A++ I
Sbjct: 341 TGRRAVDTDS---RQSIVMWAKPLLEKNNMEEIVDPQLGNDFDETEMKRVMQTASMCIHH 397
Query: 590 APTVRPQINLVLKLLQGDEEAANWAKEQVSASEELDSID 628
T+RP +N +++LL+GD++ A K + + LD D
Sbjct: 398 VSTMRPDMNRLVQLLRGDDQLAE-QKPGGARTVSLDDCD 435
|
|
| TAIR|locus:2035686 AT1G55200 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 675 (242.7 bits), Expect = 2.0e-69, Sum P(2) = 2.0e-69
Identities = 138/337 (40%), Positives = 209/337 (62%)
Query: 275 RSNLDGESGAIVSVEHDSACPPLSPYNELPKELEGLQERYSSTCRLFSYQELLSATSNFL 334
R +L+ SG + ++ ++ PP+SP L + + R FSY+EL AT+ F
Sbjct: 325 RKDLEEYSGTLRALSRNA--PPVSP--PLCSICQHKAPVFGKPPRFFSYKELELATNGFS 380
Query: 335 PEYLVGKGGHSHVYRGCLPDGKELAVK---ILKPSEDVLKEFASEIEIITALHHRNIISL 391
+ +GG V+RG LP+G+ +AVK + DV EF SE+E+++ HRN++ L
Sbjct: 381 RANFLAEGGFGSVHRGVLPEGQIVAVKQHKVASTQGDV--EFCSEVEVLSCAQHRNVVML 438
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
GFC ED LLVY+++ GSL+ +L+G KD GW R K+AVG A L YLH C
Sbjct: 439 IGFCIEDTRRLLVYEYICNGSLDSHLYGRHKD--TLGWPARQKIAVGAARGLRYLHEECR 496
Query: 452 QP-VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510
++H+D++ +NIL++ D+EP + DFGLA W + T V GTFGYLAPEY G
Sbjct: 497 VGCIVHRDMRPNNILITHDYEPLVGDFGLARWQPDGELGVD-TRVIGTFGYLAPEYAQSG 555
Query: 511 KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570
+++EK DVY+FG+VL+EL++G+K ++ PKGQ+ L WA+ +L++ V +L+DP L+
Sbjct: 556 QITEKADVYSFGVVLIELITGRKAMDIYRPKGQQCLTEWARSLLEEYAVEELVDPRLEKR 615
Query: 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607
Y Q+ M+ A+L I R P +RP+++ VL+LL+GD
Sbjct: 616 YSETQVICMIHTASLCIRRDPHLRPRMSQVLRLLEGD 652
|
|
| TAIR|locus:2044420 AT2G18890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 695 (249.7 bits), Expect = 1.7e-68, P = 1.7e-68
Identities = 147/328 (44%), Positives = 208/328 (63%)
Query: 305 KELEGLQER---YSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCL-PDGKELAV 360
K +EG QE + FS+QE+ AT+ F E LVG+GG + VY+G L +G+E+AV
Sbjct: 37 KCVEGFQETDQFQRPKWKCFSFQEIYDATNGFSSENLVGRGGFAEVYKGILGKNGEEIAV 96
Query: 361 KIL----KPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEEN 416
K + + E KEF EI I + H N++SL G C DN L LV+ F SRGSL
Sbjct: 97 KRITRGGRDDERREKEFLMEIGTIGHVSHPNVLSLLGCCI-DNGLYLVFIFSSRGSLASL 155
Query: 417 LHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSD 476
LH + W RYK+A+G A+ L YLH C++ +IH+D+KSSN+LL+ DFEPQ+SD
Sbjct: 156 LHDLNQA--PLEWETRYKIAIGTAKGLHYLHKGCQRRIIHRDIKSSNVLLNQDFEPQISD 213
Query: 477 FGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPIN 536
FGLA WL + SH + + GTFG+LAPEY+ HG V EK DV+AFG+ LLEL+SGKKP++
Sbjct: 214 FGLAKWLPSQWSHHSIAPIEGTFGHLAPEYYTHGIVDEKTDVFAFGVFLLELISGKKPVD 273
Query: 537 SENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ 596
+ + +SL WAK I+KDG++ +L+DP + ++D Q+ R+ AA+L I + RP
Sbjct: 274 ASH----QSLHSWAKLIIKDGEIEKLVDPRIGEEFDLQQLHRIAFAASLCIRSSSLCRPS 329
Query: 597 INLVLKLLQGDE-EAANWAKEQVSASEE 623
+ VL++LQG++ E W E+ +E
Sbjct: 330 MIEVLEVLQGEDIEKEKWKMEEEEEVKE 357
|
|
| TAIR|locus:2091511 AT3G13690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 652 (234.6 bits), Expect = 6.0e-68, Sum P(2) = 6.0e-68
Identities = 136/356 (38%), Positives = 210/356 (58%)
Query: 254 TSAVVYPDHKQNHSADTSEDNRSNLDGESGAIVSVEHDSACPPLSPYNELPKELEGLQER 313
T A++ K + S R +L+ ++ + PP P L +
Sbjct: 334 TKALLEKFSKLDVEVGLSSSRRMDLEFSGNVRDAISLSRSAPPGPP--PLCSICQHKAPV 391
Query: 314 YSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILK-PSEDVLKE 372
+ RLF+Y EL AT F + +GG+ V+RG LP+G+ +AVK K S E
Sbjct: 392 FGKPPRLFTYAELELATGGFSQANFLAEGGYGSVHRGVLPEGQVVAVKQHKLASSQGDVE 451
Query: 373 FASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER 432
F SE+E+++ HRN++ L GFC ED+ LLVY+++ GSL+ +L+G +K+ W R
Sbjct: 452 FCSEVEVLSCAQHRNVVMLIGFCIEDSRRLLVYEYICNGSLDSHLYGRQKE--TLEWPAR 509
Query: 433 YKVAVGVAEALDYLHNSCEQP-VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491
K+AVG A L YLH C ++H+D++ +NIL++ D EP + DFGLA W +
Sbjct: 510 QKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILITHDNEPLVGDFGLARWQPDGEMGVD 569
Query: 492 CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK 551
T V GTFGYLAPEY G+++EK DVY+FG+VL+EL++G+K I+ PKGQ+ L WA+
Sbjct: 570 -TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELVTGRKAIDITRPKGQQCLTEWAR 628
Query: 552 PILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607
P+L++ + +L+DP L + ++ M+ AA+L I R P +RP+++ VL++L+GD
Sbjct: 629 PLLEEYAIDELIDPRLGNRFVESEVICMLHAASLCIRRDPHLRPRMSQVLRILEGD 684
|
|
| TAIR|locus:2165041 AT5G56790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 651 (234.2 bits), Expect = 7.7e-68, Sum P(2) = 7.7e-68
Identities = 127/297 (42%), Positives = 189/297 (63%)
Query: 313 RYSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILK-PSEDVLK 371
++ + R F+Y EL +AT F + +GG V+ G LPDG+ +AVK K S +
Sbjct: 370 KFGNPPRWFTYSELETATKGFSKGSFLAEGGFGSVHLGTLPDGQIIAVKQYKIASTQGDR 429
Query: 372 EFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTE 431
EF SE+E+++ HRN++ L G C ED LLVY+++ GSL +L+G ++ GW+
Sbjct: 430 EFCSEVEVLSCAQHRNVVMLIGLCVEDGKRLLVYEYICNGSLHSHLYGMGRE--PLGWSA 487
Query: 432 RYKVAVGVAEALDYLHNSCEQP-VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490
R K+AVG A L YLH C ++H+D++ +NILL+ DFEP + DFGLA W +
Sbjct: 488 RQKIAVGAARGLRYLHEECRVGCIVHRDMRPNNILLTHDFEPLVGDFGLARWQPEGDKGV 547
Query: 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA 550
T V GTFGYLAPEY G+++EK DVY+FG+VL+EL++G+K ++ + PKGQ+ L WA
Sbjct: 548 E-TRVIGTFGYLAPEYAQSGQITEKADVYSFGVVLVELITGRKAMDIKRPKGQQCLTEWA 606
Query: 551 KPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607
+P+L+ +++LLDP L Y ++ M L A L I R P RP+++ VL++L+GD
Sbjct: 607 RPLLQKQAINELLDPRLMNCYCEQEVYCMALCAYLCIRRDPNSRPRMSQVLRMLEGD 663
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 678 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-43 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-26 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-26 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-22 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 9e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-18 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-18 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-16 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-13 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-13 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-12 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-11 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-09 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 5e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-08 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 2e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-08 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-07 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 2e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-07 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 8e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-06 | |
| pfam00582 | 139 | pfam00582, Usp, Universal stress protein family | 3e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 5e-45
Identities = 71/195 (36%), Positives = 114/195 (58%), Gaps = 13/195 (6%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFC 395
+G+GG VY GK++A+KI+K S +L+E EIEI+ L+H NI+ L+G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
++N+L LV ++ GSL++ L N+ E ++ + + E L+YLH +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLH---SNGII 114
Query: 456 HKDVKSSNILL-SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVS 513
H+D+K NILL SD+ + +L+DFGL+ L++ S + GT Y+APE + G S
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 514 EKIDVYAFGIVLLEL 528
EK D+++ G++L EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 2e-43
Identities = 74/214 (34%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGF 394
+G G VY+ GK +AVKILK + EI I+ L H NI+ L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
+ ++L LV ++ G L + L G E K+A+ + L+YLH +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE-YFMHGKVS 513
IH+D+K NILL ++ +++DFGLA L SSS L T GT Y+APE
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGNGYG 177
Query: 514 EKIDVYAFGIVLLELLSGKKPINSENPKGQESLV 547
K+DV++ G++L ELL+GK P + EN Q L+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 1e-41
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 17/202 (8%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPSEDV--LKEFASEIEIITALHHRNIISLFGF 394
+G+G VY GK +A+K++K + + EI+I+ L H NI+ L+
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQ 452
+++ L LV ++ G L + L + +E + AL+YLH +
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGR------LSEDEARFYLRQILSALEYLH---SK 116
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
++H+D+K NILL +D +L+DFGLA L T GT Y+APE +
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLTTFVGTPEYMAPEVLLGKGY 173
Query: 513 SEKIDVYAFGIVLLELLSGKKP 534
+ +D+++ G++L ELL+GK P
Sbjct: 174 GKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 4e-39
Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 340 GKGGHSHVYRGCL---PDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNIISLF 392
G+G VY+G L DGKE+ AVK LK SE ++EF E I+ L H NI+ L
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLL 67
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
G C E+ L++V +++ G L + L K ++ A+ +A ++YL +
Sbjct: 68 GVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLE---SK 122
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLA-SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
IH+D+ + N L+ ++ ++SDFGL+ + + ++APE GK
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEGK 180
Query: 512 VSEKIDVYAFGIVLLELLS-GKKP 534
+ K DV++FG++L E+ + G++P
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 4e-39
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 340 GKGGHSHVYRGCL----PDGKEL-AVKILKP--SEDVLKEFASEIEIITALHHRNIISLF 392
G+G VY+G L K AVK LK SE ++EF E I+ L H N++ L
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLL 67
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
G C E+ L +V +++ G L L +K+ ++ A+ +A ++YL +
Sbjct: 68 GVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLE---SK 121
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLA-SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
IH+D+ + N L+ ++ ++SDFGL+ + ++APE GK
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEGK 179
Query: 512 VSEKIDVYAFGIVLLELLS-GKKP 534
+ K DV++FG++L E+ + G++P
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 8e-37
Identities = 68/206 (33%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEF-ASEIEIITALHHRNIISLFGFCF 396
+GKGG VY+ GKE+A+K++K KE +EI+I+ H NI+ +G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQPV 454
+ + L +V +F S GSL++ L + TE V + + L+YLH+ +
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQ-----TLTESQIAYVCKELLKGLEYLHS---NGI 119
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSE 514
IH+D+K++NILL+ D E +L DFGL++ LS + + + GT ++APE
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDY 176
Query: 515 KIDVYAFGIVLLELLSGKKPINSENP 540
K D+++ GI +EL GK P + P
Sbjct: 177 KADIWSLGITAIELAEGKPPYSELPP 202
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 339 VGKGGHSHVYRGCL--PDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNIISLF 392
+G+G VY+G L DGK AVK LK SE+ K+F E ++ L H N++ L
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 393 GFCFEDNNLLLVYDFLSRGSL-----EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH 447
G C E+ L LV +++ G L + + + + A+ +A+ ++YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF 507
+ +H+D+ + N L+ +D ++SDFGL+ + + T ++APE
Sbjct: 123 ---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 508 MHGKVSEKIDVYAFGIVLLELLS-GKKP 534
G + K DV++FG++L E+ + G P
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 24/208 (11%)
Query: 340 GKGGHSHVYRGCL---PDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNIISLF 392
G+G VY+G L +G E AVK LK SE+ +EF E I+ L H NI+ L
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLL 67
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
G C + L +V +++ G L + L + + ++A+ +A+ ++YL +
Sbjct: 68 GVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGMEYLE---SK 121
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYF 507
+H+D+ + N L++++ ++SDFGL+ + + G L APE
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG-----GKLPIKWMAPESL 176
Query: 508 MHGKVSEKIDVYAFGIVLLELLS-GKKP 534
GK + K DV++FG++L E+ + G++P
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 338 LVGKGGHSHVYRGCLPD-GKELAVK---ILKPSEDVLKEFASEIEIITALHHRNIISLFG 393
L+G+G VY D G+ +AVK + SE+ L+ EI I+++L H NI+ +G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 394 FCF--EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
E N L + +++S GSL L K K + E L YLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGK----LPEPVIRKYTRQILEGLAYLH---S 119
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
++H+D+K +NIL+ D +L+DFG A L + V GT ++APE +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 512 VSEKIDVYAFGIVLLELLSGKKP 534
D+++ G ++E+ +GK P
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 6e-31
Identities = 88/365 (24%), Positives = 137/365 (37%), Gaps = 39/365 (10%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKILKPS----EDVLKEFASEIEIITAL-HHRNIISLF 392
+G+G VY D K +A+K+L ++ F EI+I+ +L H NI+ L+
Sbjct: 7 KLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
F ++ +L LV +++ GSLE+ L +E + + AL+YLH +
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYLH---SK 120
Query: 453 PVIHKDVKSSNILLS-DDFEPQLSDFGLASWLSTSSSHLT----CTDVAGTFGYLAPEYF 507
+IH+D+K NILL D +L DFGLA L S + + GT GY+APE
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 508 MH---GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVM---------------- 548
+ S D+++ GI L ELL+G P E S +
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLS 240
Query: 549 WAKPILKDGKVSQLLDPSLDTD----YDNDQIERMVLAATLSISRAPTVRPQINLVLKLL 604
+ P L S LL L D + L A L + + L
Sbjct: 241 PSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPL 300
Query: 605 QGDEEAANWAKEQVSASEELDSIDGEASPTNIQSHLNLALLDLDDDSVSAGSTQQIISVE 664
+ + A S + D + +N L + + S+ S
Sbjct: 301 RLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLLLSTASSKR 360
Query: 665 DYLQG 669
L
Sbjct: 361 SSLPK 365
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 9/215 (4%)
Query: 332 NFLPEYLVGKGGHSHVYRG-CLPDGKELAVKIL---KPSEDVLKEFASEIEIITALHHRN 387
+ +GKG VY DGK +K + SE ++ +E++I+ L+H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 388 IISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH 447
II + E L +V ++ G L + + KK+G F + V + AL YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF 507
+ ++H+D+K NI L+ + +L DFG++ LS++ V GT YL+PE
Sbjct: 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL--AKTVVGTPYYLSPELC 175
Query: 508 MHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
+ + K D+++ G VL EL + K P EN
Sbjct: 176 QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 13/201 (6%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFG 393
L+G+G VY+G L G +A+K + E+ LK EI+++ L H NI+ G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
++L ++ ++ GSL + + KK G F + V + L YLH EQ
Sbjct: 67 SIETSDSLYIILEYAENGSLRQII---KKFGP-FPESLVAVYVYQVLQGLAYLH---EQG 119
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVS 513
VIH+D+K++NIL + D +L+DFG+A+ L + V GT ++APE S
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 514 EKIDVYAFGIVLLELLSGKKP 534
D+++ G ++ELL+G P
Sbjct: 178 TASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 19/208 (9%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFE 397
+G+G VY+ GKE+A+K ++ + + +EI I+ H NI+ + +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD-SYL 85
Query: 398 DNNLL-LVYDFLSRGSLEENLHGNKKDGN----AFGWTERYKVAVGVAEALDYLHNSCEQ 452
+ L +V +++ GSL + + N N A+ V V + L+YLH+ Q
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-------VCREVLQGLEYLHS---Q 135
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
VIH+D+KS NILLS D +L+DFG A+ L + V GT ++APE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQL--TKEKSKRNSVVGTPYWMAPEVIKRKDY 193
Query: 513 SEKIDVYAFGIVLLELLSGKKPINSENP 540
K+D+++ GI+ +E+ G+ P E P
Sbjct: 194 GPKVDIWSLGIMCIEMAEGEPPYLREPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 60/207 (28%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKIL---KPSEDVLKEFASEIEIITALHHRNIISLFGF 394
+G G + VY CLP+ +++A+K + K V E E++ ++ +H N++ +
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNHPNVVKYYTS 67
Query: 395 CFEDNNLLLVYDFLSRGSLEENL-HGNKKDGNAFGWTERYKVAV--GVAEALDYLHNSCE 451
+ L LV +LS GSL + + + G E V V + L+YLH
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGL----DEAIIATVLKEVLKGLEYLH---S 120
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS--SSHLTCTDVAGTFGYLAPEYF-- 507
IH+D+K+ NILL +D +++DFG+++ L+ + GT ++APE
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 508 MHGKVSEKIDVYAFGIVLLELLSGKKP 534
+HG K D+++FGI +EL +G P
Sbjct: 181 VHG-YDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 18/203 (8%)
Query: 339 VGKGGHSHVYRGCLP-----DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISL 391
+G+G V G+++AVK L S E +F EIEI+ L H NI+
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 392 FGFCFED--NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
G C + +L L+ ++L GSL + L ++ N + + + +DYL +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL---KRLLLFSSQICKGMDYLGS- 127
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT--FGYLAPEYF 507
Q IH+D+ + NIL+ + ++SDFGLA L + + + F Y APE
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 508 MHGKVSEKIDVYAFGIVLLELLS 530
K S DV++FG+ L EL +
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 65/201 (32%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLK--EFASEIEIITALHHRNIISLFGFCF 396
+G G V+ G + +A+KILK S+D+LK +F E++ + L H+++ISLF C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILK-SDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIH 456
+ ++ + + +GSL L +G +A VAE + YL EQ IH
Sbjct: 73 VGEPVYIITELMEKGSLLAFL--RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIH 127
Query: 457 KDVKSSNILLSDDFEPQLSDFGLASWLSTS--SSHLTCTDVAGTFGYLAPEYFMHGKVSE 514
+D+ + NIL+ +D +++DFGLA + S T APE HG S
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----APEAASHGTFST 183
Query: 515 KIDVYAFGIVLLELLS-GKKP 534
K DV++FGI+L E+ + G+ P
Sbjct: 184 KSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 16/200 (8%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFE 397
+GKG V G G+++AVK LK + F +E ++T L H N++ L G +
Sbjct: 13 TIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 398 DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHK 457
N L +V +++++GSL + L + ++ A+ V E ++YL E+ +H+
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITL--AQQLGFALDVCEGMEYLE---EKNFVHR 126
Query: 458 DVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF--GYLAPEYFMHGKVSEK 515
D+ + N+L+S+D ++SDFGLA S + G + APE K S K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK--EASQGQDS-----GKLPVKWTAPEALREKKFSTK 179
Query: 516 IDVYAFGIVLLELLS-GKKP 534
DV++FGI+L E+ S G+ P
Sbjct: 180 SDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-26
Identities = 85/306 (27%), Positives = 142/306 (46%), Gaps = 33/306 (10%)
Query: 306 ELEGLQERYSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILK 364
EL+ + S + + ++LS+ E ++ +G Y+G + +G + VK +
Sbjct: 671 ELQFFDSKVSKS---ITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEIN 724
Query: 365 PSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDG 424
+ +++ L H NI+ L G C + L+++++ +L E L
Sbjct: 725 DVNSIPSSEIADMG---KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----- 776
Query: 425 NAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484
W R K+A+G+A+AL +LH C V+ ++ I++ EP L
Sbjct: 777 --LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR--------- 825
Query: 485 TSSSHLTCTDVAGTF--GYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
S L CTD Y+APE ++EK D+Y FG++L+ELL+GK P ++E
Sbjct: 826 LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GV 884
Query: 543 QESLVMWAKPILKDGKVSQLLDPSLDTD---YDNDQIERMVLAATLSISRAPTVRPQINL 599
S+V WA+ D + +DPS+ D N+ +E M LA + + PT RP N
Sbjct: 885 HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATD-PTARPCAND 943
Query: 600 VLKLLQ 605
VLK L+
Sbjct: 944 VLKTLE 949
|
Length = 968 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 56/200 (28%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKI--LKPSEDVLKEFASEIEIITALHHRNIISLFGF 394
+GKG VY+ + +A+K+ L+ +ED +++ EI+ ++ I +G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
+ + L ++ ++ GS + L K D + R V L+YLH E+
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILRE-----VLLGLEYLH---EEGK 119
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSE 514
IH+D+K++NILLS++ + +L+DFG++ L+++ S GT ++APE E
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR--NTFVGTPFWMAPEVIKQSGYDE 177
Query: 515 KIDVYAFGIVLLELLSGKKP 534
K D+++ GI +EL G+ P
Sbjct: 178 KADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 58/232 (25%), Positives = 108/232 (46%), Gaps = 21/232 (9%)
Query: 340 GKGGHSHVYRGCL-PDGKELAVKILK--PSEDVLKEFASEIEIITALHHRNIISLFGFCF 396
G+G VY+ P GK A+K + E+ K+ E++ + + ++ +G +
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQPV 454
++ + +V +++ GSL + L KK G E +A + + LDYLH ++ +
Sbjct: 70 KEGEISIVLEYMDGGSLADLL---KKVG---KIPEPVLAYIARQILKGLDYLHT--KRHI 121
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVA-GTFGYLAPEYFMHGKVS 513
IH+D+K SN+L++ E +++DFG++ L + L + GT Y++PE S
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENT---LDQCNTFVGTVTYMSPERIQGESYS 178
Query: 514 EKIDVYAFGIVLLELLSGKKPINSENPKGQ----ESLVMWAKPILKDGKVSQ 561
D+++ G+ LLE GK P +++ P L + S
Sbjct: 179 YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSP 230
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVKILK---PSEDVLKEFASEIEIITALHHRNIISLFGF 394
+G G VY L G+ +AVK ++ +KE A E++++ L H N++ +G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
+ + ++ S G+LEE L + Y + + E L YLH +
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDEHV--IRVY--TLQLLEGLAYLH---SHGI 120
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS--HLTCTDVAGTFGYLAPEYFMHGKV 512
+H+D+K +NI L + +L DFG A L +++ +AGT Y+APE GK
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 513 SEK---IDVYAFGIVLLELLSGKKP 534
D+++ G V+LE+ +GK+P
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 63/191 (32%), Positives = 104/191 (54%), Gaps = 15/191 (7%)
Query: 353 PDGKELAVKI--LKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410
P GK +AVK L+ +E + K+ E++I+ + I+ +G + + ++ + +++
Sbjct: 24 PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83
Query: 411 GSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD 468
GSL++ L K+ ER K+AV V + L YLH + +IH+DVK SNIL++
Sbjct: 84 GSLDKIL---KEVQGRIP--ERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNS 136
Query: 469 DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLEL 528
+ +L DFG++ L S L T V GT Y+APE S K D+++ G+ L+EL
Sbjct: 137 RGQIKLCDFGVSGQLVNS---LAKTFV-GTSSYMAPERIQGNDYSVKSDIWSLGLSLIEL 192
Query: 529 LSGKKPINSEN 539
+G+ P EN
Sbjct: 193 ATGRFPYPPEN 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 2e-23
Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 31/213 (14%)
Query: 354 DGKELAVKILKPSEDVLKEFASEIE-------IITALHHRNIISLFGFCFED-NNLLLVY 405
GK A+K+LK + + + E+E I++ ++H I+ L + F+ L LV
Sbjct: 17 TGKLYAMKVLKKKKIIKR---KEVEHTLTERNILSRINHPFIVKLH-YAFQTEEKLYLVL 72
Query: 406 DFLSRGSLEENLHGNKKDGNAF--GWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSN 463
++ G L +L + F Y A + AL+YLH+ +I++D+K N
Sbjct: 73 EYAPGGELFSHLSKEGR----FSEERARFY--AAEIVLALEYLHS---LGIIYRDLKPEN 123
Query: 464 ILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGI 523
ILL D +L+DFGLA LS+ S GT YLAPE + + +D ++ G+
Sbjct: 124 ILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGV 181
Query: 524 VLLELLSGKKPINSENPKGQESLVMWAKPILKD 556
+L E+L+GK P +E+ K ++ K ILKD
Sbjct: 182 LLYEMLTGKPPFYAEDRK-----EIYEK-ILKD 208
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 64/226 (28%), Positives = 117/226 (51%), Gaps = 25/226 (11%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILK---PSEDVLKEFASEIEIITALHH---RNIIS 390
L+G+G + VYRG +P G+ +A+KI+ P +DV + E+ +++ L NI
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-SDIQREVALLSQLRQSQPPNITK 66
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE---ALDYLH 447
+G + L ++ ++ GS+ + E+Y ++V + E AL Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIA-------EKY-ISVIIREVLVALKYIH 118
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF 507
VIH+D+K++NIL+++ +L DFG+A+ L+ +SS + GT ++APE
Sbjct: 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGTPYWMAPEVI 173
Query: 508 MHGKVSE-KIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552
GK + K D+++ GI + E+ +G P + + L+ +KP
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP 219
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 69/239 (28%), Positives = 109/239 (45%), Gaps = 43/239 (17%)
Query: 331 SNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSEDVLKEFAS-----EIEIITAL- 383
+F ++G+G S V KE A+KIL + ++KE E E++T L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQ-LIKEKKVKYVKIEKEVLTRLN 59
Query: 384 HHRNIISLFGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDGN-AFGWTERYKVAVGVAE 441
H II L+ + F+D NL V ++ G L + + +K G+ T Y AE
Sbjct: 60 GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFY-----AAE 110
Query: 442 ---ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVA-- 496
AL+YLH+ + +IH+D+K NILL D +++DFG A L +SS + A
Sbjct: 111 ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 497 ----------------GTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
GT Y++PE + D++A G ++ ++L+GK P N
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 332 NFLPEYLVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKEFA----SEIEIITALHHR 386
+F ++GKG V D K++ A+K + + V K +E I+ L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 387 NIISLFGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKV-AVGVAEALD 444
+++L+ + F+D N+ LV D L G L +L K F E+ K + AL+
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLRYHLSQKVK----FS-EEQVKFWICEIVLALE 114
Query: 445 YLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAP 504
YLH + +IH+D+K NILL + ++DF +A+ ++ + T +GT GY+AP
Sbjct: 115 YLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAP 168
Query: 505 EYFMHGKVSEKIDVYAFGIVLLELLSGKKP 534
E S +D ++ G+ E L GK+P
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 339 VGKGGHSHVYRG-----CLPDGKEL-AVKILK--PSEDVLKEFASEIEIITALHHRNIIS 390
+G+G V+ G + KEL AVK LK S D K+F E E++T H NI+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGN----------AFGWTERYKVAVGVA 440
+G C E + ++V++++ G L + L + D ++ ++AV +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 441 EALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD---VAG 497
+ YL Q +H+D+ + N L+ D ++ DFG+ S + TD V G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGM-------SRDVYTTDYYRVGG 182
Query: 498 T----FGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
++ PE M+ K + + DV++FG+VL E+ + GK+P
Sbjct: 183 HTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 16/206 (7%)
Query: 333 FLPEYLVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISL 391
F +G+G + VY+ G+ +A+K++ P E+ L+E EI I+ I+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV--GVAEALDYLHNS 449
+G F++ +L +V ++ GS+ + + K TE A+ + L+YLH+
Sbjct: 64 YGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT-----LTEEEIAAILYQTLKGLEYLHS- 117
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS-TSSSHLTCTDVAGTFGYLAPEYFM 508
IH+D+K+ NILL+++ + +L+DFG++ L+ T + T V GT ++APE
Sbjct: 118 --NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFWMAPEVIQ 172
Query: 509 HGKVSEKIDVYAFGIVLLELLSGKKP 534
+ K D+++ GI +E+ GK P
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 4e-22
Identities = 65/219 (29%), Positives = 113/219 (51%), Gaps = 23/219 (10%)
Query: 332 NFLPEYLVGKG--GHSHVYR----GCLPDGKELAVKILKPSE--DVLKEFASEIEIITAL 383
+++P ++GKG G + +YR L KE+ + L E D L +EI I++ L
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL----NEIVILSLL 56
Query: 384 HHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV--GVAE 441
H NII+ + +DN LL+ ++ + G+L + + ++ G F E + +
Sbjct: 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLF--EEEMVLWYLFQIVS 112
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY 501
A+ Y+H + ++H+D+K+ NI L+ +L DFG++ L + S V GT Y
Sbjct: 113 AVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--AETVVGTPYY 167
Query: 502 LAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
++PE K + K D++A G VL ELL+ K+ ++ NP
Sbjct: 168 MSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 5e-22
Identities = 62/182 (34%), Positives = 100/182 (54%), Gaps = 13/182 (7%)
Query: 355 GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFED--NNLLLVYDFLSR 410
G+++AVK LKP + + + EIEI+ L+H NI+ G C ED N + L+ +FL
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF 470
GSL+E L NK N ++ K AV + + +DYL + + +H+D+ + N+L+ +
Sbjct: 93 GSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEH 146
Query: 471 EPQLSDFGLASWLSTSSSHLTCTDV--AGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLEL 528
+ ++ DFGL + T + T D + F Y APE + K DV++FG+ L EL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYEL 205
Query: 529 LS 530
L+
Sbjct: 206 LT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 1e-21
Identities = 62/217 (28%), Positives = 107/217 (49%), Gaps = 24/217 (11%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVK--ILKPS-----EDVLKEFASEIEIITALHHRNIIS 390
++GKG + VY G G+ +AVK L S E ++ E++++ +L H NI+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY---KVAVGVAEALDYLH 447
G C +DN + + +F+ GS+ L N FG K + + + YLH
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL-------NRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD----VAGTFGYLA 503
N+C V+H+D+K +N++L + +L DFG A L+ H T ++ + GT ++A
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176
Query: 504 PEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
PE K D+++ G + E+ +GK P+ S +
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 22/200 (11%)
Query: 344 HSHVYRGCLPDGKEL--AVKILKPSEDVL--KEFASEIEIITALHHRNIISLFGFCFEDN 399
VY + GKE+ AVK LK KEF E ++ L H I+ L G C +
Sbjct: 12 VKGVYL--MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP 69
Query: 400 NLLLVYDFLSRGSLEENL--HGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHK 457
L+LV + G L + L + A VA + YL + +H+
Sbjct: 70 -LMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE---SKHFVHR 119
Query: 458 DVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF--GYLAPEYFMHGKVSEK 515
D+ + N+LL + + ++SDFG++ L S + T AG + + APE +GK S K
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT-AGRWPLKWYAPECINYGKFSSK 178
Query: 516 IDVYAFGIVLLELLS-GKKP 534
DV+++G+ L E S G KP
Sbjct: 179 SDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 74/283 (26%), Positives = 133/283 (46%), Gaps = 35/283 (12%)
Query: 330 TSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVKIL--------KPSEDVLKEFASEIEII 380
NF E +GKG S VY+ CL DG+ +A+K + K +D LKE I+++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE----IDLL 56
Query: 381 TALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVA 440
L H N+I E+N L +V + G L + KK +K V +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 441 EALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS--TSSSHLTCTDVAGT 498
AL+++H + ++H+D+K +N+ ++ +L D GL + S T+++H + GT
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGT 169
Query: 499 FGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558
Y++PE + K D+++ G +L E+ + + P + + +L K K
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCK------K 219
Query: 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVL 601
+ + P L D+ ++++ +V + I+ P RP I+ VL
Sbjct: 220 IEKCDYPPLPADHYSEELRDLV---SRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 28/207 (13%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFC 395
+G G V+ G ++A+K+++ SED +F E +++ L H N++ L+G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
+ + +V ++++ G L L K W + V EA++YL ++ I
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGT-EWL--LDMCSDVCEAMEYLESNG---FI 122
Query: 456 HKDVKSSNILLSDDFEPQLSDFGLASWL----STSSSHLTCTDVAGT---FGYLAPEYFM 508
H+D+ + N L+ +D ++SDFGLA ++ TSS GT + PE F
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ--------GTKFPVKWAPPEVFD 174
Query: 509 HGKVSEKIDVYAFGIVLLELLS-GKKP 534
+ + S K DV++FG+++ E+ S GK P
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 54/180 (30%), Positives = 87/180 (48%), Gaps = 10/180 (5%)
Query: 359 AVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEEN 416
AVK LK D++ +F E I+ +L H N+I L+G + L++V + GSL +
Sbjct: 27 AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-THPLMMVTELAPLGSLLDR 85
Query: 417 LHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSD 476
L + F + AV +A + YL + IH+D+ + NILL+ D + ++ D
Sbjct: 86 LRKDALG--HFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGD 140
Query: 477 FGLASWLSTSSSHLTCT-DVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
FGL L + H + F + APE S DV+ FG+ L E+ + G++P
Sbjct: 141 FGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 340 GKGGHSHVYRGCLPDGKEL-AVKIL--KPSEDVLKEFASEIEIITALHHRNIISLFGFCF 396
G+G V + L + + A+K + P+ D+ K+ E+EI + I+ +G
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 397 E--DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
+ +++ + ++ GSL+ KK G G K+A V + L YLH + +
Sbjct: 70 DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKI 126
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFG----YLAPEYFMHG 510
IH+D+K SNILL+ + +L DFG++ L S +AGTF Y+APE
Sbjct: 127 IHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--------LAGTFTGTSFYMAPERIQGK 178
Query: 511 KVSEKIDVYAFGIVLLELLSGKKPINSENP 540
S DV++ G+ LLE+ + P E
Sbjct: 179 PYSITSDVWSLGLTLLEVAQNRFPFPPEGE 208
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 55/200 (27%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
+G G V+ G + +++A+K ++ ++F E +++ L H ++ L+G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKD 458
+ + LV++F+ G L + L + F + + V E + YL +S VIH+D
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 459 VKSSNILLSDDFEPQLSDFGLASWL---STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEK 515
+ + N L+ ++ ++SDFG+ ++ +SS T V + +PE F K S K
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK----WSSPEVFSFSKYSSK 181
Query: 516 IDVYAFGIVLLELLS-GKKP 534
DV++FG+++ E+ S GK P
Sbjct: 182 SDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
+G G V+ G + +AVK LKP K+F +E +I+ L H +I L+ C +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKD 458
+ +V + + GSL E L G G A + +A VA + YL Q IH+D
Sbjct: 74 EPIYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128
Query: 459 VKSSNILLSDDFEPQLSDFGLASWLSTS---SSHLTCTDVAGTFGYLAPEYFMHGKVSEK 515
+ + N+L+ ++ +++DFGLA + + + T APE ++ + S K
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT----APEAALYNRFSIK 184
Query: 516 IDVYAFGIVLLELLS-GKKP 534
DV++FGI+L E+++ G+ P
Sbjct: 185 SDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 64/212 (30%), Positives = 108/212 (50%), Gaps = 25/212 (11%)
Query: 336 EYLVGKGGHSHVYRGCL--PDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNII 389
E ++G G V RG L P KE+ A+K LK S+ +F +E I+ H NII
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 390 SLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
L G + ++++ +++ GSL++ L + DG F + + G+A + YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGK-FTVGQLVGMLRGIASGMKYLSEM 125
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFG------YLA 503
+H+D+ + NIL++ + ++SDFGL+ L S + T T G + A
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGGKIPIRWTA 176
Query: 504 PEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
PE + K + DV++FGIV+ E++S G++P
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 32/223 (14%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFC 395
++G+G + VY+ G+ +A+KI+ ED +E E I+ +H NI + +G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG-A 71
Query: 396 F-------EDNNLLLVYDFLSRGS---LEENLH--GNKKDGNAFGWTERYKVAVGVAEAL 443
F D+ L LV + GS L + L G + + R L
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR-----ETLRGL 126
Query: 444 DYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL-STSSSHLTCTDVAGTFGYL 502
YLH + VIH+D+K NILL+ + E +L DFG+++ L ST T GT ++
Sbjct: 127 AYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GTPYWM 180
Query: 503 APEYFMHGKVSE-----KIDVYAFGIVLLELLSGKKPINSENP 540
APE + + + DV++ GI +EL GK P+ +P
Sbjct: 181 APEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP 223
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-20
Identities = 73/284 (25%), Positives = 137/284 (48%), Gaps = 35/284 (12%)
Query: 331 SNFLPEYLVGKGGHSHVYRG-CLPDGKELAVKIL--------KPSEDVLKEFASEIEIIT 381
+NF E +G+G S VYR CL D K +A+K + K +D +KE I+++
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKE----IDLLK 57
Query: 382 ALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE 441
L+H N+I EDN L +V + G L + + KK +K V +
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS--TSSSHLTCTDVAGTF 499
A++++H+ + V+H+D+K +N+ ++ +L D GL + S T+++H + GT
Sbjct: 118 AVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTP 170
Query: 500 GYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559
Y++PE + K D+++ G +L E+ + + P + + +L + K+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLFSLCQ------KI 220
Query: 560 SQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603
Q P L T++ ++++ +V ++ I P RP I V ++
Sbjct: 221 EQCDYPPLPTEHYSEKLRELV---SMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 9e-20
Identities = 60/233 (25%), Positives = 121/233 (51%), Gaps = 30/233 (12%)
Query: 325 ELLSATSNFLPEYLVGKGGHSHVYRGCL--PDGKE----LAVKILKPSE--DVLKEFASE 376
E+ + FL E +G+G VY+G L P+ + +A+K LK + V +EF E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 377 IEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDG 424
E+++ L H NI+ L G C ++ +++++L+ G L E L G++
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 425 NAFGWTERYKVAVGVAEALDYL--HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482
++ ++ +A+ +A ++YL H+ +H+D+ + N L+ + ++SDFGL+
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRD 173
Query: 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
+ ++ + + ++ PE ++GK + + D+++FG+VL E+ S G +P
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 65/209 (31%), Positives = 110/209 (52%), Gaps = 16/209 (7%)
Query: 336 EYLVGKGGHSHVYRGCL--PDGKE--LAVKILKP--SEDVLKEFASEIEIITALHHRNII 389
E ++G G V RG L P +E +A+K LK +E ++F SE I+ H NII
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 390 SLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
L G + ++++ +F+ G+L+ L N DG F + + G+A + YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQN--DGQ-FTVIQLVGMLRGIAAGMKYL--- 122
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAG---TFGYLAPEY 506
E +H+D+ + NIL++ + ++SDFGL+ +L +S T T G + APE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 507 FMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
+ K + DV+++GIV+ E++S G++P
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 62/200 (31%), Positives = 108/200 (54%), Gaps = 20/200 (10%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKE-FASEIEIITALHHRNIISLFGFCFE 397
+G+G V +G G+++AVK +K DV + F E ++T LHH+N++ L G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 398 DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHK 457
N L +V + +S+G+L L + + + ++ VAE ++YL + + ++H+
Sbjct: 71 -NGLYIVMELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLES---KKLVHR 124
Query: 458 DVKSSNILLSDDFEPQLSDFGLASW--LSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEK 515
D+ + NIL+S+D ++SDFGLA + +S L + APE H K S K
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKHKKFSSK 177
Query: 516 IDVYAFGIVLLELLS-GKKP 534
DV+++G++L E+ S G+ P
Sbjct: 178 SDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 75/281 (26%), Positives = 135/281 (48%), Gaps = 35/281 (12%)
Query: 331 SNFLPEYLVGKGGHSHVYRG-CLPDGKELAVKIL--------KPSEDVLKEFASEIEIIT 381
+NF E +G+G S VYR CL DG +A+K + K D +KE I+++
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKE----IDLLK 57
Query: 382 ALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE 441
L+H N+I + EDN L +V + G L + KK +K V +
Sbjct: 58 QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS--TSSSHLTCTDVAGTF 499
AL+++H+ + V+H+D+K +N+ ++ +L D GL + S T+++H + GT
Sbjct: 118 ALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----SLVGTP 170
Query: 500 GYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559
Y++PE + K D+++ G +L E+ + + P + + +L K K+
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCK------KI 220
Query: 560 SQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLV 600
Q P L +D+ ++++ ++V + I+ P RP I V
Sbjct: 221 EQCDYPPLPSDHYSEELRQLV---NMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 56/196 (28%), Positives = 100/196 (51%), Gaps = 7/196 (3%)
Query: 340 GKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDN 399
G G V+ G ++AVK LKP + F E +I+ L H ++ L+ C E+
Sbjct: 15 GAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE 74
Query: 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDV 459
+ +V +++S+GSL + L +G + +A +AE + YL + IH+D+
Sbjct: 75 PIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDL 129
Query: 460 KSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVY 519
+ NIL+ ++ +++DFGLA L + + APE +G+ + K DV+
Sbjct: 130 AARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188
Query: 520 AFGIVLLELLS-GKKP 534
+FGI+L E+++ G+ P
Sbjct: 189 SFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 13/217 (5%)
Query: 355 GKELAVKILKPSEDVLKEFA-SEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413
GK++AVK + + +E +E+ I+ HH N++ ++ + L +V +FL G+L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 414 EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ 473
+ + + + V + V AL YLHN Q VIH+D+KS +ILL+ D +
Sbjct: 107 TDIVTHTRMNEEQIA-----TVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIK 158
Query: 474 LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKK 533
LSDFG + +S + GT ++APE ++D+++ GI+++E++ G+
Sbjct: 159 LSDFGFCAQVSKEVPKR--KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 216
Query: 534 PINSENP-KGQESLVMWAKPILKDG-KVSQLLDPSLD 568
P +E P + + P +KD KVS +L LD
Sbjct: 217 PYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLD 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 59/183 (32%), Positives = 94/183 (51%), Gaps = 19/183 (10%)
Query: 366 SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGN 425
SE+ L++F EI+I++ H NI+ L+ F +N L ++ +F G+L +
Sbjct: 42 SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGAL-----DSIMLEL 96
Query: 426 AFGWTERYKVAVG--VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL-ASW 482
G TE V + EAL++LH+ VIH+D+K+ NILL+ D + +L+DFG+ A
Sbjct: 97 ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKN 153
Query: 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSE-----KIDVYAFGIVLLELLSGKKPINS 537
ST T GT ++APE + K D+++ GI L+EL + P +
Sbjct: 154 KSTLQKRDT---FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210
Query: 538 ENP 540
NP
Sbjct: 211 LNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 21/236 (8%)
Query: 337 YLVGKGGHSHVY---RGCLPDGKELAVKILKPSEDVLKE---FASEIEIITALHHRNIIS 390
+GKG V R DGK L K + KE SE+ I+ L H NI+
Sbjct: 6 ETIGKGSFGTVRKVRR--KSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 391 LFGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHN 448
+ + +N L +V ++ G L + + KK+ +++ + AL HN
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 449 --SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY 506
V+H+D+K +NI L + +L DFGLA L SS GT Y++PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQ 181
Query: 507 FMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562
H EK D+++ G ++ EL + P + N Q L A I K+GK ++
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQL---ASKI-KEGKFRRI 230
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 338 LVGKGGHSHVYRGC---LPD--GKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISL 391
+GKG V L D G+ +AVK L+ S + L++F EIEI+ +L H NI+
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 392 FGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
G C+ NL LV ++L GSL + L ++ + A + + ++YL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLG-- 125
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT--FGYLAPEYF 507
+ +H+D+ + NIL+ + ++ DFGL L + + + F Y APE
Sbjct: 126 -SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESL 183
Query: 508 MHGKVSEKIDVYAFGIVLLELLS 530
K S DV++FG+VL EL +
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 2e-18
Identities = 64/208 (30%), Positives = 109/208 (52%), Gaps = 16/208 (7%)
Query: 336 EYLVGKGGHSHVYRGCL--PDGKE--LAVKILKP--SEDVLKEFASEIEIITALHHRNII 389
+ ++G G V+RG L P KE +A+K LKP +E ++F SE I+ H NII
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 390 SLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
L G + +++ +++ G+L++ L DG F + + G+A + YL +
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLR--DHDGE-FSSYQLVGMLRGIAAGMKYLSD- 125
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFG--YLAPEYF 507
+H+D+ + NIL++ + E ++SDFGL+ L T T G + APE
Sbjct: 126 --MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 508 MHGKVSEKIDVYAFGIVLLELLS-GKKP 534
+ K + DV++FGIV+ E++S G++P
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 54/211 (25%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKE-----FASEIEIITALHHRNIISLF 392
+G+G + VY+ G+ +A+K ++ + KE EI+++ L H NI+ L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENE--KEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 393 GFCFED--NNLLLVYDFLS---RGSLEENLHGNKK--DGNAFGWTERYKVAVGVAEALDY 445
++ +V++++ G L+ K + + ++ + E L Y
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLD---SPEVKFTESQIKCYMKQ------LLEGLQY 115
Query: 446 LHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
LH+ ++H+D+K SNIL+++D +L+DFGLA T + T+ T Y PE
Sbjct: 116 LHS---NGILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITLWYRPPE 171
Query: 506 YFMHGKV-SEKIDVYAFGIVLLELLSGKKPI 535
+ ++D+++ G +L EL G KPI
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCF 396
+G G + VY+ + G+ +A+K++K D + EI ++ H NI++ FG
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEAL---DYLHNSCEQP 453
+ L +V ++ GSL++ + G ++A E L YLH E
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLH---ETG 121
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF---MHG 510
IH+D+K +NILL++D + +L+DFG+++ L+ + + GT ++APE G
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR--KSFIGTPYWMAPEVAAVERKG 179
Query: 511 KVSEKIDVYAFGIVLLELLSGKKP 534
K D++A GI +EL + P
Sbjct: 180 GYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 48/191 (25%), Positives = 97/191 (50%), Gaps = 17/191 (8%)
Query: 358 LAVKILK-PSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEEN 416
+AVK LK P+ K+F E E++T L H +I+ +G C + + L++V++++ G L +
Sbjct: 38 VAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKF 97
Query: 417 LHGNKKDG------------NAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNI 464
L + D G ++ +A +A + YL Q +H+D+ + N
Sbjct: 98 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNC 154
Query: 465 LLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIV 524
L+ + ++ DFG++ + ++ + ++ PE M+ K + + DV++FG++
Sbjct: 155 LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 214
Query: 525 LLELLS-GKKP 534
L E+ + GK+P
Sbjct: 215 LWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 66/214 (30%), Positives = 108/214 (50%), Gaps = 17/214 (7%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFASEIEIITALH-HRNIISLFGFCF 396
+GKG + V++ +G + AVKIL P D+ +E +E I+ AL H N++ +G +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85
Query: 397 EDN-----NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
+ + L LV + + GS+ + + G K G E +A + EAL L +
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM---EEPIIAYILHEALMGLQHLHV 142
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF---- 507
IH+DVK +NILL+ + +L DFG+++ L TS+ T V GT ++APE
Sbjct: 143 NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSV-GTPFWMAPEVIACEQ 200
Query: 508 -MHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
+ + DV++ GI +EL G P+ +P
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKILK---PSEDVLKEFASEIEIITALHHRNIISLFGF 394
+GKG VY+G L E+AVK + P + K F E EI+ H NI+ L G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGV 60
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
C + + +V + + GSL L +K N + ++++ A ++YL +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGL----ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510
IH+D+ + N L+ ++ ++SDFG+ + T S L + T APE +G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWT----APEALNYG 170
Query: 511 KVSEKIDVYAFGIVLLELLSG 531
+ + + DV+++GI+L E S
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 58/197 (29%), Positives = 101/197 (51%), Gaps = 8/197 (4%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
+G G V+ G ++AVK LKP + F E +I+ L H ++ L+ E+
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEE 73
Query: 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKD 458
+ +V +++S+GSL + L +G A +A VA + Y+ IH+D
Sbjct: 74 P-IYIVTEYMSKGSLLDFL--KDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127
Query: 459 VKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDV 518
++S+NIL+ D +++DFGLA L + + + APE ++G+ + K DV
Sbjct: 128 LRSANILVGDGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 519 YAFGIVLLELLS-GKKP 534
++FGI+L EL++ G+ P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 17/214 (7%)
Query: 339 VGKGGHSHVYR-GCLPDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCF 396
+GKG + VY+ DG AVKIL P DV +E +E I+ +L +H N++ +G +
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89
Query: 397 EDNN-----LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
+ + L LV + + GS+ E + G G + G L +LHN+
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-- 147
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM--- 508
+IH+DVK +NILL+ + +L DFG+++ L +S+ L GT ++APE
Sbjct: 148 -RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL--TSTRLRRNTSVGTPFWMAPEVIACEQ 204
Query: 509 --HGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
+ DV++ GI +EL G P+ +P
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 57/217 (26%), Positives = 108/217 (49%), Gaps = 19/217 (8%)
Query: 334 LPEYLVGKGGHSHVYRGCLPDGKELAVKILK--PSEDVLKEFASEIEIITALHHRNIISL 391
L E GK H+Y + + +A+K LK + EF E ++ LHH NI+ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENL-----HGN-----KKDG---NAFGWTERYKVAVG 438
G ++ + +++++L++G L E L H + +DG ++ + +A+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
+A ++YL + +HKD+ + NIL+ + ++SD GL+ + ++ +
Sbjct: 133 IAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 499 FGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
++ PE M+GK S D+++FG+VL E+ S G +P
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 58/213 (27%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 334 LPEYLVGKGGHSHVYRGCLPDGKEL-AVKILK-PSEDVLKEFASEIEIITALHHRNIISL 391
L E GK + Y C K L AVK LK S++ K+F E E++T L H +I+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD------GNA---FGWTERYKVAVGVAEA 442
+G C E + L++V++++ G L + L + D GN ++ +A +A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 443 LDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL 502
+ YL Q +H+D+ + N L+ ++ ++ DFG++ + ++ + ++
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 503 APEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
PE M+ K + + DV++ G+VL E+ + GK+P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 75/254 (29%), Positives = 124/254 (48%), Gaps = 30/254 (11%)
Query: 354 DGKELAVK---ILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDN-NLLLVYDFLS 409
DGK+ +K I K S +E E+ +++ + H NI+ + FE+N NL +V D+
Sbjct: 24 DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ-YQESFEENGNLYIVMDYCE 82
Query: 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD 469
G L + + N + G F + V + AL ++H ++ ++H+D+KS NI L+ D
Sbjct: 83 GGDLYKKI--NAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKD 137
Query: 470 FEPQLSDFGLASWL-STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLEL 528
+L DFG+A L ST TC GT YL+PE + + K D++A G VL E+
Sbjct: 138 GTIKLGDFGIARVLNSTVELARTCI---GTPYYLSPEICENRPYNNKSDIWALGCVLYEM 194
Query: 529 LSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSIS 588
+ K + N K +LV+ K+ + P + + Y D R +++
Sbjct: 195 CTLKHAFEAGNMK---NLVL---------KIIRGSYPPVSSHYSYDL--RNLVSQLF--K 238
Query: 589 RAPTVRPQINLVLK 602
R P RP +N +L+
Sbjct: 239 RNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 7e-18
Identities = 55/200 (27%), Positives = 106/200 (53%), Gaps = 8/200 (4%)
Query: 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+ +G+G V+ G ++A+K LKP + + F E +I+ L H ++ L+
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
E+ + +V +F+ +GSL + L + DG + +A +A+ + Y+ I
Sbjct: 71 SEEP-IYIVTEFMGKGSLLDFL--KEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYI 124
Query: 456 HKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEK 515
H+D++++NIL+ D+ +++DFGLA L + + + APE ++G+ + K
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 516 IDVYAFGIVLLELLS-GKKP 534
DV++FGI+L EL++ G+ P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 7e-18
Identities = 60/212 (28%), Positives = 104/212 (49%), Gaps = 13/212 (6%)
Query: 332 NFLPEYLVGKGGHSHVYR-GCLPDGKELAVKILKPSEDVLKEFAS---EIEIITALHHRN 387
+F +GKG + VY+ L D + A+K + KE EI I+ +++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 388 IISLFGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYL 446
IIS + F D N L +V ++ G L + + KK E +++ + + L L
Sbjct: 61 IIS-YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY 506
H EQ ++H+D+KS+NILL + ++ D G++ L ++ T + GT Y+APE
Sbjct: 120 H---EQKILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQI-GTPHYMAPEV 172
Query: 507 FMHGKVSEKIDVYAFGIVLLELLSGKKPINSE 538
+ S K D+++ G +L E+ + P +
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 8e-18
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 11/212 (5%)
Query: 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVK---ILKPSEDVLKEFASEIEIITALHHRN 387
+F +GKG V++ D + A+K + K + +E E ++ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 388 IISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH 447
II + + L +V ++ G L + L + G + ++ + + L +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLK--MQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF 507
+ + ++H+D+KS N+ L ++ D G+A LS ++ + GT YL+PE
Sbjct: 119 S---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPELC 173
Query: 508 MHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
+EK DV+A G+VL E +GK P ++ N
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 9e-18
Identities = 69/267 (25%), Positives = 129/267 (48%), Gaps = 29/267 (10%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVKI--LKPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+GKG V++G K +A+KI L+ +ED +++ EI +++ + +G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
+D L ++ ++L GS + L D T+ + + + LDYLH+ + I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPGPLDE-----TQIATILREILKGLDYLHS---EKKI 123
Query: 456 HKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEK 515
H+D+K++N+LLS+ E +L+DFG+A L + + + GT ++APE K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 516 IDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQ 575
D+++ GI +EL G+ P + +P L+ P P+L+ +Y +
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------------PTLEGNY-SKP 228
Query: 576 IERMVLAATLSISRAPTVRPQINLVLK 602
++ V A +++ P+ RP +LK
Sbjct: 229 LKEFVEAC---LNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 53/200 (26%), Positives = 103/200 (51%), Gaps = 8/200 (4%)
Query: 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
E +G+G V+ G +A+K LKP + F E +++ L H ++ L+
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
E+ + +V +++S+GSL + L G + G + +A +A + Y+ +
Sbjct: 71 SEE-PIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 124
Query: 456 HKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEK 515
H+D++++NIL+ ++ +++DFGLA L + + + APE ++G+ + K
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 516 IDVYAFGIVLLELLS-GKKP 534
DV++FGI+L EL + G+ P
Sbjct: 184 SDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 49/206 (23%), Positives = 97/206 (47%), Gaps = 21/206 (10%)
Query: 340 GKGGHSHVYRGC-LPDGK----ELAVKILKPSED--VLKEFASEIEIITALHHRNIISLF 392
G G VY+G +P+G+ +A+K+L+ KE E ++ ++ H +++ L
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNA---FGWTERYKVAVGVAEALDYLHNS 449
G C + L+ + G L + + +K + + W V +A+ + YL
Sbjct: 76 GICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLE-- 126
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH 509
E+ ++H+D+ + N+L+ +++DFGLA L ++A E +H
Sbjct: 127 -EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH 185
Query: 510 GKVSEKIDVYAFGIVLLELLS-GKKP 534
+ K DV+++G+ + EL++ G KP
Sbjct: 186 RIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 61/199 (30%), Positives = 105/199 (52%), Gaps = 16/199 (8%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
+GKG V G G ++AVK +K ++ + F +E ++T L H N++ L G E+
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 399 N-NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHK 457
L +V +++++GSL + L + + G K ++ V EA++YL + +H+
Sbjct: 72 KGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHR 126
Query: 458 DVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAG-TFGYLAPEYFMHGKVSEKI 516
D+ + N+L+S+D ++SDFGL S++ D + APE K S K
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKS 180
Query: 517 DVYAFGIVLLELLS-GKKP 534
DV++FGI+L E+ S G+ P
Sbjct: 181 DVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 25/200 (12%)
Query: 355 GKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFE-DNNLLLVYDFLS 409
G A+K++K + ++ + + +E +I++ ++ L+ + F+ NL LV ++L
Sbjct: 18 GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLP 76
Query: 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAE---ALDYLHNSCEQPVIHKDVKSSNILL 466
G L L G + + +AE AL+YLH+ +IH+D+K NIL+
Sbjct: 77 GGDLASLLE-------NVGSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILI 126
Query: 467 SDDFEPQLSDFGLASWLSTSSSHLT------CTDVAGTFGYLAPEYFMHGKVSEKIDVYA 520
+ +L+DFGL+ + GT Y+APE + S+ +D ++
Sbjct: 127 DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWS 186
Query: 521 FGIVLLELLSGKKPINSENP 540
G +L E L G P + E P
Sbjct: 187 LGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 52/194 (26%), Positives = 96/194 (49%), Gaps = 13/194 (6%)
Query: 339 VGKGGHSHVYRGCLPD-GKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFE 397
+G G + VY G +AVK LK ++EF E ++ + H N++ L G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 398 DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHK 457
+ ++ +F++ G+L + L + +A ++ A++YL ++ IH+
Sbjct: 74 EPPFYIITEFMTYGNLLDYLRECNRQ--EVNAVVLLYMATQISSAMEYLE---KKNFIHR 128
Query: 458 DVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT---FGYLAPEYFMHGKVSE 514
D+ + N L+ ++ +++DFGL+ ++ T T AG + APE + K S
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGD----TYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 515 KIDVYAFGIVLLEL 528
K DV+AFG++L E+
Sbjct: 185 KSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 66/234 (28%), Positives = 113/234 (48%), Gaps = 13/234 (5%)
Query: 355 GKELAVKILKPSEDVLKEFA-SEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413
GK +AVK + + +E +E+ I+ H N++ ++ + L +V +FL G+L
Sbjct: 45 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104
Query: 414 EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ 473
+ + + + V + V +AL LH Q VIH+D+KS +ILL+ D +
Sbjct: 105 TDIVTHTRMNEEQIA-----AVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVK 156
Query: 474 LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKK 533
LSDFG + +S + GT ++APE ++D+++ GI+++E++ G+
Sbjct: 157 LSDFGFCAQVSKEVPRR--KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 214
Query: 534 PINSENP-KGQESLVMWAKPILKDG-KVSQLLDPSLDTDYDNDQIERMVLAATL 585
P +E P K + + P LK+ KVS L LD D +R A L
Sbjct: 215 PYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 56/188 (29%), Positives = 99/188 (52%), Gaps = 26/188 (13%)
Query: 357 ELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413
++A+K++K SED EF E +++ L H ++ L+G C + + +V +++S G L
Sbjct: 30 DVAIKMIKEGSMSED---EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86
Query: 414 EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ 473
L ++ G F ++ ++ V E + YL + + IH+D+ + N L+ D +
Sbjct: 87 LNYL---REHGKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVK 140
Query: 474 LSDFGLASWL----STSSSHLTCTDVAGTF--GYLAPEYFMHGKVSEKIDVYAFGIVLLE 527
+SDFGL+ ++ TSS V F + PE ++ K S K DV+AFG+++ E
Sbjct: 141 VSDFGLSRYVLDDEYTSS-------VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWE 193
Query: 528 LLS-GKKP 534
+ S GK P
Sbjct: 194 VYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 4e-17
Identities = 58/204 (28%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFA-SEIEIITALHHRNIISLFGFCF 396
+G+G VY + G+E+A+K + + KE +EI ++ H NI++
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIH 456
+ L +V ++L+ GSL + + D V +AL++LH++ VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSN---QVIH 138
Query: 457 KDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKI 516
+D+KS NILL D +L+DFG + ++ S + + GT ++APE K+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196
Query: 517 DVYAFGIVLLELLSGKKPINSENP 540
D+++ GI+ +E++ G+ P +ENP
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 63/194 (32%), Positives = 99/194 (51%), Gaps = 20/194 (10%)
Query: 352 LPDGKELAVKI--LKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409
+P G +A K+ + V K+ E++I+ I+S +G +NN+ + +F+
Sbjct: 27 IPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD 86
Query: 410 RGSLEENLHGNKKDG----NAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNIL 465
GSL+ KK G G K+AV V E L YL+N ++H+D+K SNIL
Sbjct: 87 CGSLDRIY---KKGGPIPVEILG-----KIAVAVVEGLTYLYN--VHRIMHRDIKPSNIL 136
Query: 466 LSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVL 525
++ + +L DFG++ L S + T V GT Y++PE GK + K DV++ GI +
Sbjct: 137 VNSRGQIKLCDFGVSGELINSIAD---TFV-GTSTYMSPERIQGGKYTVKSDVWSLGISI 192
Query: 526 LELLSGKKPINSEN 539
+EL GK P N
Sbjct: 193 IELALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 5e-17
Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKIL------KPSEDVLKEFASEIEIITALHHRNIIS 390
L+G G VY G L DG AVK + + ++ +K+ EI +++ L H NI+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDGNAFGWTERYKVAVGVAEALDYLHN 448
G E++NL + + + GSL + L +G+ + +T + + L+YLH+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQ------ILLGLEYLHD 120
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM 508
+ +H+D+K +NIL+ + +L+DFG+A + S + G+ ++APE
Sbjct: 121 ---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK---GSPYWMAPEVIA 174
Query: 509 H-GKVSEKIDVYAFGIVLLELLSGKKP 534
G D+++ G +LE+ +GK P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 6/180 (3%)
Query: 361 KILKPSEDVLKEFASEIEIIT-ALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHG 419
K + + + + SE+ II L H NI+ + E++ L +V D + L E+ +
Sbjct: 43 KDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNS 102
Query: 420 NKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479
K+ F + + V + AL YLH E+ ++H+D+ +NI+L +D + ++DFGL
Sbjct: 103 LKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGL 160
Query: 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
A S T V GT Y PE + EK DV+AFG +L ++ + + P S N
Sbjct: 161 AKQKQPESK---LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 60/208 (28%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 339 VGKGGHSHVYRGCLPDGKEL-AVKI--LKPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+GKG VY+G KE+ A+KI L+ +ED +++ EI +++ I +G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE---ALDYLHNSCEQ 452
+ L ++ ++L GS + L G E +A + E LDYLH+ +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLKP--------GPLEETYIATILREILKGLDYLHS---E 120
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
IH+D+K++N+LLS+ + +L+DFG+A L + + + GT ++APE
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 513 SEKIDVYAFGIVLLELLSGKKPINSENP 540
K D+++ GI +EL G+ P + +P
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHP 206
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 7e-17
Identities = 72/271 (26%), Positives = 129/271 (47%), Gaps = 33/271 (12%)
Query: 338 LVGKG--GHSHVYRGCLPDGKELAVKILKPSEDVLKE----FASEIEIITALHHRNIISL 391
+VG+G G H+ R D K + +K + P E + K+ +E +++ L H NII
Sbjct: 7 VVGRGAFGIVHLCRR-KADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
+ ED L++V ++ G+L E + K+ + V + AL ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYI--QKRCNSLLDEDTILHFFVQILLALHHVHT--- 119
Query: 452 QPVIHKDVKSSNILLSD-DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510
+ ++H+D+K+ NILL ++ DFG++ LS+ S T V GT Y++PE
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELCEGK 176
Query: 511 KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570
++K D++A G VL EL S K+ + N +LV+ K+ +
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAAN---LPALVL---------KIMSGTFAPISDR 224
Query: 571 YDNDQIERMVLAATLSISRAPTVRPQINLVL 601
Y D R ++ + L++ P+ RPQ++ ++
Sbjct: 225 YSPDL--RQLILSMLNLD--PSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 9e-17
Identities = 58/204 (28%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFA-SEIEIITALHHRNIISLFGFCF 396
+G+G VY + G+E+A+K + + KE +EI ++ + NI++
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIH 456
+ L +V ++L+ GSL + + D V +ALD+LH++ VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALDFLHSN---QVIH 138
Query: 457 KDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKI 516
+D+KS NILL D +L+DFG + ++ S + + GT ++APE K+
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196
Query: 517 DVYAFGIVLLELLSGKKPINSENP 540
D+++ GI+ +E++ G+ P +ENP
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 52/215 (24%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 339 VGKGGHSHVY----RGCLPDGKEL--AVKILKP-SEDVLKEFASEIEIITALHHRNIISL 391
+G+G V+ LP+ ++ AVK LK SE ++F E E++T L H++I+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGN-----------AFGWTERYKVAVGVA 440
+G C E LL+V++++ G L L + D + +A +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 441 EALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFG 500
+ YL +H+D+ + N L+ ++ DFG++ + ++ +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 501 YLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
++ PE ++ K + + D+++FG+VL E+ + GK+P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 61/213 (28%), Positives = 92/213 (43%), Gaps = 41/213 (19%)
Query: 338 LVGKGGHSHVYRGC--LPDGKELAVKILKPSED---VLKEFASEIEIITALHHRNIISLF 392
+VG+G + V + C G+ +A+K K SED V K E++++ L H NI++L
Sbjct: 8 VVGEGAYGVVLK-CRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE----------A 442
L LV++++ R LE E + A
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLEL--------------LEASPGGLPPDAVRSYIWQLLQA 112
Query: 443 LDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL 502
+ Y H +IH+D+K NIL+S+ +L DFG A L + TD T Y
Sbjct: 113 IAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYR 168
Query: 503 APE----YFMHGKVSEKIDVYAFGIVLLELLSG 531
APE +GK +DV+A G ++ ELL G
Sbjct: 169 APELLVGDTNYGK---PVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 60/215 (27%), Positives = 105/215 (48%), Gaps = 23/215 (10%)
Query: 338 LVGKGGHSHVYRGC--LPDGKELAVK---ILKPSEDVLKEFAS---EIEIITALHHRNII 389
L+G+G VY C + G+ELAVK S + KE + EI+++ L H I+
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 390 SLFGFCFEDNNLLLVY-DFLSRGSLEENL--HGNKKDGNAFGWTERYKVAVGVAEALDYL 446
+G C D+ L ++ +++ GS+++ L +G + +T + + E ++YL
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQ------ILEGVEYL 120
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT-CTDVAGTFGYLAPE 505
H++ ++H+D+K +NIL +L DFG + L T S T V GT +++PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 506 YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
K DV++ G ++E+L+ K P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 61/193 (31%), Positives = 103/193 (53%), Gaps = 22/193 (11%)
Query: 355 GKELAVKILKPSEDV-LKEFA---SEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410
GK A+KIL ++ V LK+ +E I+ ++ H +++L+G +D+NL LV +++
Sbjct: 26 GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85
Query: 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF 470
G L +L + + Y A V AL+YLH+ ++++D+K N+LL D
Sbjct: 86 GELFSHLRKSGRFPE--PVARFY--AAQVVLALEYLHS---LDIVYRDLKPENLLLDSDG 138
Query: 471 EPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLE 527
+++DFG A + T T + GT YLAPE + +GK +D +A GI++ E
Sbjct: 139 YIKITDFGFAKRVKGR----TYT-LCGTPEYLAPEIILSKGYGK---AVDWWALGILIYE 190
Query: 528 LLSGKKPINSENP 540
+L+G P +NP
Sbjct: 191 MLAGYPPFFDDNP 203
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKILK-------PSEDVLKEFASEIEIITALHHRNII 389
+G G S Y+ + G +AVK + E+V++ EI ++ L+H +II
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 390 SLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
+ G ED++ L ++++ GS+ L AF + L YLH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLH-- 120
Query: 450 CEQPVIHKDVKSSNILL-SDDFEPQLSDFGLASWLSTSSSHLTCTD-----VAGTFGYLA 503
E +IH+DVK +N+L+ S +++DFG A+ L+ T + GT ++A
Sbjct: 121 -ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK---GTGAGEFQGQLLGTIAFMA 176
Query: 504 PEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
PE + DV++ G V++E+ + K P N+E
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKILK---PSEDVLKEFASEIEIITALHHRNIISLFGF 394
L+GKG V++G L D +AVK K P E +K F SE I+ H NI+ L G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-FLSEARILKQYDHPNIVKLIGV 60
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
C + + +V + + G L K + + K A+ A + YL + +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLES---KNC 114
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLST---SSSHLTCTDVAGTFGYLAPEYFMHGK 511
IH+D+ + N L+ ++ ++SDFG++ SSS L + T APE +G+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEALNYGR 170
Query: 512 VSEKIDVYAFGIVLLELLS 530
S + DV+++GI+L E S
Sbjct: 171 YSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 3e-16
Identities = 59/213 (27%), Positives = 108/213 (50%), Gaps = 25/213 (11%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKI--LKPSE---------DVLKEFASEIEIITALHH 385
L+GKG + VY + G+ +AVK L + D++K SEIE + L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 386 RNIISLFGFCFEDNNLLLVYDFLSRGSLEENL--HGNKKDGNAFGWTERYKVAVGVAEAL 443
NI+ GF + L + +++ GS+ L +G ++ +TE+ V E L
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ------VLEGL 121
Query: 444 DYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLA 503
YLH+ + ++H+D+K+ N+L+ D ++SDFG++ + + G+ ++A
Sbjct: 122 AYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 504 PE--YFMHGKVSEKIDVYAFGIVLLELLSGKKP 534
PE + S K+D+++ G V+LE+ +G++P
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 53/191 (27%), Positives = 98/191 (51%), Gaps = 19/191 (9%)
Query: 355 GKELAVKILKPSEDVLKE-----FASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409
G+++AVK + D+ K+ +E+ I+ H NI+ ++ + L +V +FL
Sbjct: 44 GRQVAVKKM----DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99
Query: 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD 469
G+L + + + + V + V +AL +LH Q VIH+D+KS +ILL+ D
Sbjct: 100 GGALTDIVTHTRMNEEQIA-----TVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSD 151
Query: 470 FEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELL 529
+LSDFG + +S + GT ++APE ++D+++ GI+++E++
Sbjct: 152 GRVKLSDFGFCAQVSKEVPRR--KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209
Query: 530 SGKKPINSENP 540
G+ P +E P
Sbjct: 210 DGEPPYFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 55/208 (26%), Positives = 107/208 (51%), Gaps = 19/208 (9%)
Query: 339 VGKGGHSHVYRGCLPDGKEL-AVKI--LKPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+GKG V++G +++ A+KI L+ +ED +++ EI +++ + +G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE---ALDYLHNSCEQ 452
+ L ++ ++L GS + L G + +++A + E LDYLH+ +
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRA--------GPFDEFQIATMLKEILKGLDYLHS---E 120
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
IH+D+K++N+LLS+ + +L+DFG+A L + + + GT ++APE
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 513 SEKIDVYAFGIVLLELLSGKKPINSENP 540
K D+++ GI +EL G+ P + +P
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 3e-16
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 20/216 (9%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFC 395
LVG G + VY+G + G+ A+K++ + D +E EI ++ HHRNI + +G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 396 FE------DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
+ D+ L LV +F GS+ + + K GN + + L +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLH-- 128
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH 509
+ VIH+D+K N+LL+++ E +L DFG+++ L + GT ++APE
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIAC 185
Query: 510 GKVSE-----KIDVYAFGIVLLELLSGKKPINSENP 540
+ + K D+++ GI +E+ G P+ +P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 4e-16
Identities = 56/204 (27%), Positives = 104/204 (50%), Gaps = 12/204 (5%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFA-SEIEIITALHHRNIISLFGFCF 396
+G+G VY + G+E+A++ + + KE +EI ++ + NI++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIH 456
+ L +V ++L+ GSL + + D V +AL++LH++ VIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLHSN---QVIH 139
Query: 457 KDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKI 516
+D+KS NILL D +L+DFG + ++ S + + GT ++APE K+
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAPEVVTRKAYGPKV 197
Query: 517 DVYAFGIVLLELLSGKKPINSENP 540
D+++ GI+ +E++ G+ P +ENP
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 30/205 (14%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVKI--LKPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+G G VY+ L + LAVK+ L + ++ K+ SE+EI+ II +G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 396 FEDNNLLLVYDFLSRGSLE------ENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
F +N + + +F+ GSL+ E++ G ++AV V + L YL +
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG--------------RIAVAVVKGLTYLWS- 113
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH 509
++H+DVK SN+L++ + +L DFG+++ L S GT Y+APE
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISG 167
Query: 510 GKVSEKIDVYAFGIVLLELLSGKKP 534
+ DV++ GI +EL G+ P
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 53/194 (27%), Positives = 101/194 (52%), Gaps = 19/194 (9%)
Query: 357 ELAVKILKP--SEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413
++AVK+LK +E L + SE+E++ + H+NII+L G C +D L ++ ++ S+G+L
Sbjct: 52 KVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 111
Query: 414 EENLHGNKKDGNAFGWT------------ERYKVAVGVAEALDYLHNSCEQPVIHKDVKS 461
E L + G + + + A VA ++YL + IH+D+ +
Sbjct: 112 REYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168
Query: 462 SNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAF 521
N+L+++D +++DFGLA + + T+ ++APE + + DV++F
Sbjct: 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228
Query: 522 GIVLLELLS-GKKP 534
G++L E+ + G P
Sbjct: 229 GVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 61/227 (26%), Positives = 116/227 (51%), Gaps = 13/227 (5%)
Query: 355 GKELAVKILKPSEDVLKEFA-SEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413
G+++AVK++ + +E +E+ I+ H+N++ ++ L ++ +FL G+L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 414 EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ 473
+ + + + V V +AL YLH+ Q VIH+D+KS +ILL+ D +
Sbjct: 106 TDIVSQTRLNEEQIA-----TVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVK 157
Query: 474 LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKK 533
LSDFG + +S + GT ++APE ++D+++ GI+++E++ G+
Sbjct: 158 LSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215
Query: 534 PINSENP-KGQESLVMWAKPILKDG-KVSQLLDPSLDTDYDNDQIER 578
P S++P + + L P LK+ K+S +L L+ + ER
Sbjct: 216 PYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 57/200 (28%), Positives = 94/200 (47%), Gaps = 16/200 (8%)
Query: 338 LVGKGGHSHVYRGCL--PDGKELAVKILKPSED---VLKEFASEIEIITALHHRNIISLF 392
LVG+G + V + C G+ +A+K SED V K EI ++ L H N+++L
Sbjct: 8 LVGEGSYGMVMK-CKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
L LV++F+ L++ +K N + K + +++ H+
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQILRGIEFCHS---H 119
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM-HGK 511
+IH+D+K NIL+S +L DFG A L+ TD T Y APE + K
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTK 177
Query: 512 VSEKIDVYAFGIVLLELLSG 531
+D++A G ++ E+L+G
Sbjct: 178 YGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 15/198 (7%)
Query: 355 GKELAVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFE--DNNLLLVYDFLSR 410
G+ +AVK LK + + EI I+ L+H NI+ G C E L L+ +++
Sbjct: 33 GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92
Query: 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF 470
GSL + L +K + A + E + YLH+ Q IH+D+ + N+LL +D
Sbjct: 93 GSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDR 144
Query: 471 EPQLSDFGLASWLSTSSSHLTCTDVAGT--FGYLAPEYFMHGKVSEKIDVYAFGIVLLEL 528
++ DFGLA + + + + F Y A E K S DV++FG+ L EL
Sbjct: 145 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYEL 203
Query: 529 LSGKKPINSENPKGQESL 546
L+ S K +E +
Sbjct: 204 LTHCDSKQSPPKKFEEMI 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 51/198 (25%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
+G G V+ G + ++AVK LKP ++ F E ++ L H ++ L+ ++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKD 458
+ ++ +++++GSL + L + +G + + +AE + Y+ + IH+D
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRD 128
Query: 459 VKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAG-TFGYLAPEYFMHGKVSEKID 517
++++N+L+S+ +++DFGLA + + T + A + APE G + K D
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 518 VYAFGIVLLELLS-GKKP 534
V++FGI+L E+++ GK P
Sbjct: 187 VWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.5 bits (190), Expect = 2e-15
Identities = 56/204 (27%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFA-SEIEIITALHHRNIISLFGFCF 396
+G+G V+ + G+E+A+K + + KE +EI ++ L + NI++
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIH 456
+ L +V ++L+ GSL + + D V +AL++LH VIH
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIA-----AVCRECLQALEFLH---ANQVIH 138
Query: 457 KDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKI 516
+D+KS N+LL D +L+DFG + ++ S + + GT ++APE K+
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKV 196
Query: 517 DVYAFGIVLLELLSGKKPINSENP 540
D+++ GI+ +E++ G+ P +ENP
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 20/216 (9%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFC 395
+VG G + VY+G + G+ A+K++ +ED +E EI ++ HHRNI + +G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 396 FE------DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
+ D+ L LV +F GS+ + + K GNA + + L +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLH-- 138
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM- 508
VIH+D+K N+LL+++ E +L DFG+++ L + GT ++APE
Sbjct: 139 -AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIAC 195
Query: 509 ----HGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
+ D+++ GI +E+ G P+ +P
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-15
Identities = 67/245 (27%), Positives = 113/245 (46%), Gaps = 10/245 (4%)
Query: 333 FLPEYLVGKGGHSHVY---RGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNII 389
++ LVG+ + + RG P K +A ++ E SE+ + A H I+
Sbjct: 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128
Query: 390 SLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
F D+ LLL+ ++ S G L + + K+ F E + + ALD +H+
Sbjct: 129 KHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR 188
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH 509
++H+D+KS+NI L +L DFG + S S S + GT YLAPE +
Sbjct: 189 K---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER 245
Query: 510 GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK----PILKDGKVSQLLDP 565
+ S+K D+++ G++L ELL+ +P + + V++ K P + LLDP
Sbjct: 246 KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDP 305
Query: 566 SLDTD 570
L +
Sbjct: 306 LLSKN 310
|
Length = 478 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 22/195 (11%)
Query: 355 GKELAVKILKPSEDV-LKE---FASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410
A+K++ E + LK+ +E ++ + H II LF + L ++ +++
Sbjct: 26 EHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG 85
Query: 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF 470
G L L + + N+ T + + V AL+YLH+ + ++++D+K NILL +
Sbjct: 86 GELFSYLRNSGRFSNS---TGLFYASEIVC-ALEYLHS---KEIVYRDLKPENILLDKEG 138
Query: 471 EPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLE 527
+L+DFG A L + L C GT YLAPE H K +D +A GI++ E
Sbjct: 139 HIKLTDFGFAKKLRDRTWTL-C----GTPEYLAPEVIQSKGHNKA---VDWWALGILIYE 190
Query: 528 LLSGKKPINSENPKG 542
+L G P +NP G
Sbjct: 191 MLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSED---VLKEFASEIEIITALHHRNIISLFGF 394
+G+G + VY+ G+ +A+K +K + + K EI+++ L+H NII L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER------YKVAVGVAEALDYLHN 448
+L LV++F+ + +L+ KD G E Y++ G L + H
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLYKLIKD-RQRGLPESLIKSYLYQLLQG----LAFCH- 115
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM 508
++H+D+K N+L++ + +L+DFGLA S S T T Y APE +
Sbjct: 116 --SHGILHRDLKPENLLINTEGVLKLADFGLAR--SFGSPVRPYTHYVVTRWYRAPELLL 171
Query: 509 HGKV-SEKIDVYAFGIVLLELLSGK 532
K S +D+++ G + ELLS +
Sbjct: 172 GDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 56/187 (29%), Positives = 93/187 (49%), Gaps = 21/187 (11%)
Query: 357 ELAVKILKPSED--VLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLE 414
++A+K+LK + V E E EI+ L + I+ + G C E L+LV + S G L
Sbjct: 24 DVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLN 82
Query: 415 ENLHGNKKDGNAFGWTE-RYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ 473
+ L G K + E ++V++G + YL + +H+D+ + N+LL + +
Sbjct: 83 KFLSGKKDEITVSNVVELMHQVSMG----MKYLE---GKNFVHRDLAARNVLLVNQHYAK 135
Query: 474 LSDFGLASWLSTSSSHLTCTDVAGTFG-----YLAPEYFMHGKVSEKIDVYAFGIVLLEL 528
+SDFGL+ L S+ A + G + APE K S + DV+++GI + E
Sbjct: 136 ISDFGLSKALGADDSYYK----ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEA 191
Query: 529 LS-GKKP 534
S G+KP
Sbjct: 192 FSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 53/193 (27%), Positives = 100/193 (51%), Gaps = 19/193 (9%)
Query: 358 LAVKILK--PSEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSRGSLE 414
+AVK+LK ++ L + SE+E++ + H+NII+L G C +D L ++ ++ S+G+L
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 415 ENLHGNKKDGNAFGW------------TERYKVAVGVAEALDYLHNSCEQPVIHKDVKSS 462
E L + G + + + A VA ++YL Q IH+D+ +
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAAR 163
Query: 463 NILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFG 522
N+L+++D +++DFGLA + + T+ ++APE + + DV++FG
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 523 IVLLELLS-GKKP 534
++L E+ + G P
Sbjct: 224 VLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 30/270 (11%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEF-ASEIEII--TALHHRNIISLFGF 394
+G+G +Y D + +K + ++ +KE AS+ E+I + H NI++ F
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
E+ L +V ++ G L + + N++ G F + V ++ L ++H ++ +
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRI--NRQRGVLFSEDQILSWFVQISLGLKHIH---DRKI 122
Query: 455 IHKDVKSSNILLSDD-FEPQLSDFGLASWLSTSSS-HLTCTDVAGTFGYLAPEYFMHGKV 512
+H+D+KS NI LS + +L DFG+A L+ S TC GT YL+PE +
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC---VGTPYYLSPEICQNRPY 179
Query: 513 SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYD 572
+ K D+++ G VL EL + K P N LV+ K+ Q + ++
Sbjct: 180 NNKTDIWSLGCVLYELCTLKHPFEGNN---LHQLVL---------KICQGYFAPISPNFS 227
Query: 573 NDQIERMVLAATLSISRAPTVRPQINLVLK 602
D R +++ +S P RP I +LK
Sbjct: 228 RDL--RSLISQLFKVS--PRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 50/187 (26%), Positives = 96/187 (51%), Gaps = 18/187 (9%)
Query: 359 AVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415
AVK+LK E L + SE+E++ + H+NII+L G C ++ L +V ++ + G+L +
Sbjct: 46 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRD 105
Query: 416 NLHGNKKDGNAFGW----------TERYKV--AVGVAEALDYLHNSCEQPVIHKDVKSSN 463
L + G T++ V A VA +++L + IH+D+ + N
Sbjct: 106 FLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARN 162
Query: 464 ILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGI 523
+L+++D +++DFGLA + + T+ ++APE + + DV++FG+
Sbjct: 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 222
Query: 524 VLLELLS 530
+L E+ +
Sbjct: 223 LLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 15/209 (7%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVK--ILKPSEDVLKEFASEIEIITALHHRNIISLFGFCF 396
+G G VY+ + LA I SE+ L+++ EI+I+ + H NI+ L +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIH 456
+NNL ++ +F + G+++ + ++ + V EAL+YLH E +IH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLH---ENKIIH 126
Query: 457 KDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSE-- 514
+D+K+ NIL + D + +L+DFG+++ + + GT ++APE M +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 515 ---KIDVYAFGIVLLELLSGKKPINSENP 540
K DV++ GI L+E+ + P + NP
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFAS-----EIEIITALHHRNIISLF 392
+G+G + VYR G+ +A+K K D ++ EI ++ L H NI+ L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALK--KVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 393 GFCFED--NNLLLVYDFLSR--GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHN 448
+++ LV ++ + SL +N+ F ++ + + + L YLH
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQDLASLLDNMP------TPFSESQVKCLMLQLLRGLQYLHE 126
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM 508
+ +IH+D+K SN+LL+D +++DFGLA + +T V T Y APE +
Sbjct: 127 NF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLL 181
Query: 509 HGKV-SEKIDVYAFGIVLLELLSGKK--PINSE 538
+ ID++A G +L ELL+ K P SE
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 57/223 (25%), Positives = 105/223 (47%), Gaps = 30/223 (13%)
Query: 339 VGKGGHSHVYR----GCLPDGKEL--AVKILK--PSEDVLKEFASEIEIITALHHRNIIS 390
+G+G V++ G LP AVK+LK S D+ +F E ++ H NI+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGN----------------KKDGN--AFGWTER 432
L G C + L++++++ G L E L K N TE+
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 433 YKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492
+A VA + YL E+ +H+D+ + N L+ ++ +++DFGL+ + ++ +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 493 TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
+ A ++ PE + + + + DV+A+G+VL E+ S G +P
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 62/218 (28%), Positives = 109/218 (50%), Gaps = 34/218 (15%)
Query: 336 EYLVGKGGHSHVYRGCLP-DGKEL--AVKILK--PSEDVLKEFASEIEIITAL-HHRNII 389
E ++G+G V R + DG ++ A+K+LK SE+ ++FA E+E++ L HH NII
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 390 SLFGFCFEDNNLLLVYDFLSRGSLEENLHGN----------KKDGNAFGWTER--YKVAV 437
+L G C L + ++ G+L + L + K+ G A T + + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 438 GVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAG 497
VA + YL E+ IH+D+ + N+L+ ++ +++DFGL+ V
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY--------VKK 175
Query: 498 TFG-----YLAPEYFMHGKVSEKIDVYAFGIVLLELLS 530
T G ++A E + + K DV++FG++L E++S
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 51/193 (26%), Positives = 100/193 (51%), Gaps = 19/193 (9%)
Query: 358 LAVKILK--PSEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSRGSLE 414
+AVK+LK +E L + SE+E++ + H+NII+L G C +D L ++ ++ S+G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 415 ENLHGNKKDGNAFGW------------TERYKVAVGVAEALDYLHNSCEQPVIHKDVKSS 462
E L + G + + + VA ++YL Q IH+D+ +
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166
Query: 463 NILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFG 522
N+L++++ +++DFGLA ++ + T+ ++APE + + DV++FG
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226
Query: 523 IVLLELLS-GKKP 534
+++ E+ + G P
Sbjct: 227 VLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 53/176 (30%), Positives = 88/176 (50%), Gaps = 20/176 (11%)
Query: 367 EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNA 426
+D++KE + + L H N I G ++ LV ++ GS + L +KK
Sbjct: 60 QDIIKE----VRFLQQLRHPNTIEYKGCYLREHTAWLVMEY-CLGSASDILEVHKK---P 111
Query: 427 FGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486
E + G + L YLH+ IH+D+K+ NILL++ +L+DFG AS +S +
Sbjct: 112 LQEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168
Query: 487 SSHLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
+S + GT ++APE + G+ K+DV++ GI +EL K P+ + N
Sbjct: 169 NSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 40/105 (38%), Positives = 57/105 (54%), Gaps = 9/105 (8%)
Query: 434 KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCT 493
K+ V + +AL YL + VIH+DVK SNILL +L DFG++ L S + T
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---T 172
Query: 494 DVAGTFGYLAPEYF----MHGKVSEKIDVYAFGIVLLELLSGKKP 534
AG Y+APE + K + DV++ GI L+EL +G+ P
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 52/191 (27%), Positives = 96/191 (50%), Gaps = 26/191 (13%)
Query: 363 LKPSEDVLKEFASEIEIITALHHRN---IISLFGFCFEDNNLLLVYDFLSRGSLEENLHG 419
+KP+ + + E+++ LH N I+ +G + D + + + + GSL++ L
Sbjct: 38 IKPA--IRNQIIRELKV---LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-- 90
Query: 420 NKKDG----NAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLS 475
KK G N G K+++ V L YL + ++H+DVK SNIL++ E +L
Sbjct: 91 -KKAGRIPENILG-----KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLC 142
Query: 476 DFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPI 535
DFG++ L S ++ GT Y++PE + + D+++ G+ L+E+ G+ PI
Sbjct: 143 DFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
Query: 536 NSENPKGQESL 546
+ K E++
Sbjct: 199 PPPDAKELEAM 209
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 54/221 (24%), Positives = 105/221 (47%), Gaps = 27/221 (12%)
Query: 358 LAVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415
+AVKIL+P +++ +F E++I++ L NII L G C +++ L ++ +++ G L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 416 NL----------HGNKKDGNA-----FGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVK 460
L +GN A ++ VA+ +A + YL + +H+D+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLA 165
Query: 461 SSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYA 520
+ N L+ ++ +++DFG++ L + ++A E + GK + DV+A
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 521 FGIVLLELLSGKKPINSENPKGQ---ESLVMWAKPILKDGK 558
FG+ L E+L + E P G+ E ++ A +D
Sbjct: 226 FGVTLWEILM----LCKEQPYGELTDEQVIENAGEFFRDQG 262
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 50/211 (23%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 338 LVGKGGHSHVYRGC-LPDGKEL----AVKIL--KPSEDVLKEFASEIEIITALHHRNIIS 390
L+G G V++G +P+G + A+K + + +E + + +L H I+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
L G C +L LV GSL +++ ++ ++ V +A+ + YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLE--- 126
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510
E ++H+++ + NILL D Q++DFG+A L ++ ++A E + G
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 511 KVSEKIDVYAFGIVLLELLS-GKKPINSENP 540
+ + + DV+++G+ + E++S G +P P
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVK---ILKPSED-------VLKEFASEIEIITALHHR 386
L+G G VY G G+ +AVK + S +L A EI ++ L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 387 NIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE---AL 443
NI+ G + ++L + +++ GS+ L N +G E V V + L
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL-------NNYGAFEETLVRNFVRQILKGL 119
Query: 444 DYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCT----DVAGTF 499
+YLHN + +IH+D+K +NIL+ + ++SDFG++ L +S + G+
Sbjct: 120 NYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 500 GYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKP 534
++APE + K D+++ G +++E+L+GK P
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 39/220 (17%)
Query: 332 NFLPEYLVGKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFAS--------EIEIITA 382
+ +G+G ++ VY+ G+ +A+K +K E KE EI+++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGE--RKEAKDGINFTALREIKLLQE 58
Query: 383 LHHRNIISL---FGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVA--- 436
L H NII L FG +N+ LV++F+ LE+ + KD + A
Sbjct: 59 LKHPNIIGLLDVFG---HKSNINLVFEFME-TDLEKVI----KDKSI-----VLTPADIK 105
Query: 437 ---VGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCT 493
+ L+YLH++ ++H+D+K +N+L++ D +L+DFGLA + + +T
Sbjct: 106 SYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ 162
Query: 494 DVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGK 532
V T Y APE + +D+++ G + ELL
Sbjct: 163 VV--TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 339 VGKGGHSHVYRGC--LPDGKELAVKILKPSEDVLKEFAS----EIEIITALHHRNIISLF 392
+GKGG V C GK A K L ++ E +I+ + R I+SL
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL- 58
Query: 393 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
+ FE ++L LV ++ G L+ +++ + G F A + L++LH
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--FPEARAIFYAAQIICGLEHLHQ--- 113
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
+ ++++D+K N+LL D ++SD GLA L AGT GY+APE
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEV 170
Query: 512 VSEKIDVYAFGIVLLELLSGKKP 534
+D +A G L E+++G+ P
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 57/223 (25%), Positives = 107/223 (47%), Gaps = 21/223 (9%)
Query: 340 GKGGHSHVYRGCLPDGKELAVKIL----KPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
G GG + P G +A K++ KP+ + + E++++ + I+ +G
Sbjct: 16 GNGGVVTKVQH-KPSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKK-DGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
+ D + + + + GSL++ L K+ G KV++ V L YL + +
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLRE--KHQI 125
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSE 514
+H+DVK SNIL++ E +L DFG++ L S ++ GT Y++PE S
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSV 181
Query: 515 KIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557
+ D+++ G+ L+EL G+ PI P +E ++ +P++
Sbjct: 182 QSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIFGRPVVDGE 222
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 61/216 (28%), Positives = 107/216 (49%), Gaps = 29/216 (13%)
Query: 339 VGKGGHSHVYR------GCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLF 392
+G G VY+ G L K + K SE+ L+++ EIEI+ +H I+ L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSC 450
G + D L ++ +F G+++ + + G TE + + EAL YLH+
Sbjct: 76 GAFYWDGKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVICRQMLEALQYLHS-- 128
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD-VAGTFGYLAPEYFMH 509
+IH+D+K+ N+LL+ D + +L+DFG++ + + L D GT ++APE M
Sbjct: 129 -MKIIHRDLKAGNVLLTLDGDIKLADFGVS---AKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 510 GKVSE-----KIDVYAFGIVLLELLSGKKPINSENP 540
+ + K D+++ GI L+E+ + P + NP
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 49/188 (26%), Positives = 100/188 (53%), Gaps = 18/188 (9%)
Query: 358 LAVKILK--PSEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSRGSLE 414
+AVK+LK ++ L + SE+E++ + H+NII+L G C ++ L ++ ++ ++G+L
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 415 ENLHGNKKDG--NAFGWTERYK----------VAVGVAEALDYLHNSCEQPVIHKDVKSS 462
E L + G F T+ + A VA ++YL + + IH+D+ +
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAAR 163
Query: 463 NILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFG 522
N+L+++D +++DFGLA + + ++ ++APE + + DV++FG
Sbjct: 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 523 IVLLELLS 530
I++ E+ +
Sbjct: 224 ILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 7e-14
Identities = 48/190 (25%), Positives = 90/190 (47%), Gaps = 20/190 (10%)
Query: 357 ELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEEN 416
++A+K + ++F E +++ L H ++ L+G C + L +V +F+ G L
Sbjct: 30 KVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCL--- 86
Query: 417 LHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSD 476
L+ ++ + V E ++YL + IH+D+ + N L+S ++SD
Sbjct: 87 LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSD 143
Query: 477 FGLASWL----STSSSHLTCTDVAGTF--GYLAPEYFMHGKVSEKIDVYAFGIVLLELLS 530
FG+ ++ TSSS F + PE F K S K DV++FG+++ E+ +
Sbjct: 144 FGMTRYVLDDEYTSSS-------GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
Query: 531 -GKKPINSEN 539
GK P ++
Sbjct: 197 EGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (178), Expect = 7e-14
Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKE-FAS----EIEIITALHHRNIISLF 392
+G+G + VY+ G+ +A+K ++ + +E S EI ++ L H NI+ L
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHPNIVKLL 64
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHG--NKKDGNAFGWTERY--KVAVGVAEALDYLHN 448
+ L LV+++ + +L +K+ G + + + L Y H
Sbjct: 65 DVIHTERKLYLVFEYC-----DMDLKKYLDKRPG---PLSPNLIKSIMYQLLRGLAYCH- 115
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM 508
++H+D+K NIL++ D +L+DFGLA T +V T Y APE +
Sbjct: 116 --SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT-HEVV-TLWYRAPEILL 171
Query: 509 HGKV-SEKIDVYAFGIVLLELLSGK 532
K S +D+++ G + E+++GK
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 47/197 (23%), Positives = 101/197 (51%), Gaps = 8/197 (4%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
+G G V+ ++AVK +KP ++ F +E ++ L H ++ L ++
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE 73
Query: 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKD 458
+ ++ +F+++GSL + L +G+ + + +AE + ++ ++ IH+D
Sbjct: 74 P-IYIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRD 127
Query: 459 VKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDV 518
++++NIL+S +++DFGLA + + + + APE G + K DV
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 519 YAFGIVLLELLS-GKKP 534
++FGI+L+E+++ G+ P
Sbjct: 187 WSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 26/196 (13%)
Query: 355 GKELAVKILKPSEDVLKEFASEIEIITALHHR-----NIISLFGFCFED-NNLLLVYDFL 408
G A+K+LK S+ + K + ++ A+ + L+ + F+ + L LV ++L
Sbjct: 21 GDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY-YSFQSKDYLYLVMEYL 79
Query: 409 SRG---SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNIL 465
+ G SL + L G +D W ++Y V ++ LH ++ +IH+D+K N+L
Sbjct: 80 NGGDCASLIKTLGGLPED-----WAKQY--IAEVVLGVEDLH---QRGIIHRDIKPENLL 129
Query: 466 LSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVL 525
+ +L+DFGL S + L GT YLAPE + + D ++ G V+
Sbjct: 130 IDQTGHLKLTDFGL------SRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVI 183
Query: 526 LELLSGKKPINSENPK 541
E L G P ++E P
Sbjct: 184 FEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 52/183 (28%), Positives = 99/183 (54%), Gaps = 20/183 (10%)
Query: 357 ELAVKILKPSEDVLKEFA--SEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413
++AVK+LKP+ + A SE++I++ L +H NI++L G C +L++ ++ G L
Sbjct: 67 KVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL 126
Query: 414 EENLHGNKKDGNAFGWTE-----RYKVAVGVAEALDYLHN-SCEQPVIHKDVKSSNILLS 467
L ++ +F E Y+VA G+A +L + +C IH+D+ + N+LL+
Sbjct: 127 LNFLRRKRE---SFLTLEDLLSFSYQVAKGMA----FLASKNC----IHRDLAARNVLLT 175
Query: 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLE 527
++ DFGLA + S+++ + ++APE + + + DV+++GI+L E
Sbjct: 176 HGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE 235
Query: 528 LLS 530
+ S
Sbjct: 236 IFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-14
Identities = 56/216 (25%), Positives = 105/216 (48%), Gaps = 34/216 (15%)
Query: 338 LVGKGGHSHVYRGCLP-DGKEL--AVKILK--PSEDVLKEFASEIEIITAL-HHRNIISL 391
++G+G V + + DG + A+K +K S+D ++FA E+E++ L HH NII+L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNK----------KDGNAFGWTER--YKVAVGV 439
G C L L ++ G+L + L ++ + A + + A V
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 440 AEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF 499
A +DYL ++ IH+D+ + NIL+ +++ +++DFGL+ V T
Sbjct: 122 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VKKTM 170
Query: 500 G-----YLAPEYFMHGKVSEKIDVYAFGIVLLELLS 530
G ++A E + + DV+++G++L E++S
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 61/207 (29%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 336 EYLVGKGGHSHVYRGCL--PDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNII 389
E ++G G V G L P +E+ A+K LK +E ++F SE I+ H NII
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 390 SLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
L G + +++V +++ GSL+ L K DG F + + G+A + YL
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQ-FTVIQLVGMLRGIASGMKYL--- 122
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS-SSHLTCTDVAGTFGYLAPEYFM 508
+ +H+D+ + NIL++ + ++SDFGL+ L + T + APE
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 509 HGKVSEKIDVYAFGIVLLELLS-GKKP 534
+ K + DV+++GIV+ E++S G++P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 18/218 (8%)
Query: 331 SNFLPEYLVGKGGHSHVYRG-----CLPDGKEL-AVKIL--KPSEDVLKEFASEIEIITA 382
SN +G+G V+ G+ L VK L E++ EF E+++
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 383 LHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFG---WTERYKVAVG- 438
L H+N++ L G C E ++ ++ G L++ L K + + KVA+
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 439 -VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAG 497
+A +D+L N+ +H+D+ + N L+S E ++S L+ + S + +
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI- 180
Query: 498 TFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
+LAPE S K DV++FG+++ E+ + G+ P
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 29/232 (12%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILK--PSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+G G + VY+ + G+ A+K++K P ED EI ++ H NI++ FG
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALD---YLHNSCEQ 452
+ L + +F GSL++ H G ++A E L YLH+ +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYH-------VTGPLSESQIAYVSRETLQGLYYLHSKGK- 127
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM---H 509
+H+D+K +NILL+D+ +L+DFG+++ ++ + + GT ++APE
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR--KSFIGTPYWMAPEVAAVERK 183
Query: 510 GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK-----PILKD 556
G ++ D++A GI +EL + P+ +P +L + K P LKD
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHP--MRALFLMTKSNFQPPKLKD 233
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 21/215 (9%)
Query: 333 FLPEYLVGKGGHSHVYRGCLPDGKEL-AVKIL----KPSEDVLKEFASEIEIITALHHRN 387
F+ + +G G VY E+ AVK + K + + ++ E++ + L H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 388 IISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH 447
I G +++ LV ++ GS + L +KK E + G + L YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEY-CLGSASDLLEVHKK---PLQEVEIAAITHGALQGLAYLH 138
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF 507
+ +IH+D+K+ NILL++ + +L+DFG AS S ++S + GT ++APE
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVI 189
Query: 508 M---HGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
+ G+ K+DV++ GI +EL K P+ + N
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 66/232 (28%), Positives = 113/232 (48%), Gaps = 29/232 (12%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILK--PSEDVLKEFASEIEIITALHHRNIISLFGFC 395
VG G + VY+ L G+ AVKI+K P +D EI ++ H NI++ FG
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD-FSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALD---YLHNSCEQ 452
L + ++ GSL++ H G ++A E L YLH+ +
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYH-------VTGPLSELQIAYVCRETLQGLAYLHSKGK- 127
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM---H 509
+H+D+K +NILL+D+ + +L+DFG+A+ ++ + + GT ++APE +
Sbjct: 128 --MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR--KSFIGTPYWMAPEVAAVEKN 183
Query: 510 GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK-----PILKD 556
G ++ D++A GI +EL + P+ +P +L + +K P LKD
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHP--MRALFLMSKSNFQPPKLKD 233
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 48/197 (24%), Positives = 99/197 (50%), Gaps = 8/197 (4%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
+G G V+ G ++A+K LK + F +E ++ L H ++ L+ ++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVTQE 73
Query: 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKD 458
+ ++ +++ GSL + L +G + +A +AE + ++ + IH+D
Sbjct: 74 P-IYIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRD 127
Query: 459 VKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDV 518
++++NIL+S+ +++DFGLA L + + + APE +G + K DV
Sbjct: 128 LRAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 519 YAFGIVLLELLS-GKKP 534
++FGI+L E+++ G+ P
Sbjct: 187 WSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 54/207 (26%), Positives = 101/207 (48%), Gaps = 19/207 (9%)
Query: 338 LVGKGGHSHVYRGC-LPDGKEL----AVKILK----PSEDVLKEFASEIEIITALHHRNI 388
++G G VY+G +P+G+ + A+KIL P +V EF E I+ ++ H ++
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPHL 71
Query: 389 ISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHN 448
+ L G C + LV + G L + +H +K + G V +A+ + YL
Sbjct: 72 VRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDN---IGSQLLLNWCVQIAKGMMYLE- 126
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM 508
E+ ++H+D+ + N+L+ +++DFGLA L ++A E
Sbjct: 127 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 509 HGKVSEKIDVYAFGIVLLELLS-GKKP 534
+ K + + DV+++G+ + EL++ G KP
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 32/225 (14%)
Query: 339 VGKGGHSHVYRG---CLPDGKELAVKILKPSED---VLKEFASEIEIITALHHRNIISLF 392
+G G V +G K +AVKILK + + E E ++ L + I+ +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNK--KDGNAFGWTER-YKVAVGVAEALDYLHNS 449
G C E + +LV + G L + L NK + N TE ++V++G + YL
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNI---TELVHQVSMG----MKYLE-- 112
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFG-----YLAP 504
E +H+D+ + N+LL ++SDFGL+ L ++ A T G + AP
Sbjct: 113 -ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHGKWPVKWYAP 167
Query: 505 EYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVM 548
E + K S K DV++FG+++ E S G+KP + KG E M
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY--KGMKGNEVTQM 210
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 57/217 (26%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 339 VGKGGHSHVYRGCL-PDGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFC 395
+G+G V+ G L D +AVK + + D+ +F E I+ H NI+ L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
+ + +V + + G L + +G E ++ A ++YL + I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL---RTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 456 HKDVKSSNILLSDDFEPQLSDFGL----ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
H+D+ + N L+++ ++SDFG+ + S+ + V T APE +G+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWT----APEALNYGR 172
Query: 512 VSEKIDVYAFGIVLLELLS-GKKPI-NSENPKGQESL 546
S + DV++FGI+L E S G P N N + +E++
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 339 VGKGGHSHVYRGC--LPDGKELAVKILKPSED--VLKEFA-SEIEIITALHHRNIISLFG 393
+G+G + V++ C G+ +A+K SED V+K+ A EI ++ L H N+++L
Sbjct: 9 IGEGSYGVVFK-CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 394 FCFEDNNLLLVYDFLSR---GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
L LV+++ LE+N G + K+ +A+++ H
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH-------LIKKIIWQTLQAVNFCH--- 117
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM-H 509
+ IH+DVK NIL++ + +L DFG A L+ TD T Y APE +
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAPELLVGD 175
Query: 510 GKVSEKIDVYAFGIVLLELLSG 531
+ +DV+A G V ELL+G
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 45/183 (24%), Positives = 89/183 (48%), Gaps = 13/183 (7%)
Query: 358 LAVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415
+AVK+L+ ++ +F EI+I++ L + NII L G C D+ L ++ +++ G L +
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 416 NLHGNK------KDGN--AFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS 467
L + N + +AV +A + YL +H+D+ + N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163
Query: 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLE 527
+ + +++DFG++ L + + ++A E + GK + DV+AFG+ L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 528 LLS 530
+ +
Sbjct: 224 MFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 34/272 (12%)
Query: 339 VGKGGHSHV----YRGCLPDGKELAVKILK---PSEDVLKEFASEIEIITALHHRNIISL 391
VGKG + V +R DGK+ +K L S K E ++++ L H NI++
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 392 F-GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
+ ED L +V F G L L K G + + V +A AL YLH
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLH--- 119
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510
E+ ++H+D+K+ N+ L+ ++ D G+A L + + GT Y++PE F +
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNK 177
Query: 511 KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570
+ K DV+A G + E+ + K N+ K SLV + +GK+ P + D
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNA---KDMNSLVYR----IIEGKL-----PPMPKD 225
Query: 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602
Y + E L AT+ +S+ P RP + +L+
Sbjct: 226 YSPELGE---LIATM-LSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 339 VGKGGHSHVY----RGCLPDGKELAVKILK----PSEDVLKEFASEIEIITALHHRNIIS 390
+G G VY RG D EL V + SE +F E I++ +H+NI+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENL-HGNKKDGNAFGWTER--YKVAVGVAEALDYLH 447
L G FE ++ + ++ G L+ L + T + A VA+ YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQ----LSDFGLASWLSTSSSHLTCTDVAGTFGYLA 503
E IH+D+ + N LL+ P ++DFG+A + +S + ++
Sbjct: 134 ---ENHFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMP 189
Query: 504 PEYFMHGKVSEKIDVYAFGIVLLELLS 530
PE F+ G + K DV++FG++L E+ S
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 7e-13
Identities = 64/242 (26%), Positives = 110/242 (45%), Gaps = 31/242 (12%)
Query: 364 KPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD 423
K S + ++ E+ + L H N I G ++ LV ++ GS + L +KK
Sbjct: 53 KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY-CLGSASDLLEVHKK- 110
Query: 424 GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483
E V G + L YLH+ +IH+DVK+ NILLS+ +L DFG AS +
Sbjct: 111 --PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165
Query: 484 STSSSHLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
+ ++ + GT ++APE + G+ K+DV++ GI +EL K P+ + N
Sbjct: 166 APANXFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN- 218
Query: 541 KGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLV 600
+L ++Q P+L + + ++ V + + + P RP ++
Sbjct: 219 -AMSALY----------HIAQNESPALQSGHWSEYFRNFVDS---CLQKIPQDRPTSEVL 264
Query: 601 LK 602
LK
Sbjct: 265 LK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 22/216 (10%)
Query: 353 PDGKELAVKIL----KPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408
P G +A K++ KP+ + + E++++ + I+ +G + D + + + +
Sbjct: 28 PSGLIMARKLIHLEIKPA--IRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85
Query: 409 SRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL 466
GSL++ L KK G E+ KV++ V + L YL + ++H+DVK SNIL+
Sbjct: 86 DGGSLDQVL---KKAGRI---PEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILV 137
Query: 467 SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLL 526
+ E +L DFG++ L S ++ GT Y++PE S + D+++ G+ L+
Sbjct: 138 NSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLV 193
Query: 527 ELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562
E+ G+ PI P +E +M+ P+ D S+
Sbjct: 194 EMAIGRYPIPP--PDAKELELMFGCPVEGDPAESET 227
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 21/209 (10%)
Query: 338 LVGKGGHSHVYRGC--LPDGKELAVKILK---PSEDVLKEFAS---EIEIITALHHRNII 389
L+G+G VY C + G+ELA K ++ S + KE ++ EI+++ L H I+
Sbjct: 9 LLGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 390 SLFGFCFEDN---NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYL 446
+G C D L + +++ GS+++ L K A + K + E + YL
Sbjct: 68 QYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYL 122
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST-SSSHLTCTDVAGTFGYLAPE 505
H++ ++H+D+K +NIL +L DFG + L T S V GT +++PE
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 506 YFMHGKVSEKIDVYAFGIVLLELLSGKKP 534
K DV++ G ++E+L+ K P
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 34/222 (15%)
Query: 338 LVGKGGHSHVYRGCL--PDGKEL--AVKILKPSEDV--LKEFASEIEIITALHHRNIISL 391
++GKG VY G L DG+++ AVK L D+ +++F E I+ H N++SL
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 392 FGFCFEDNNL-LLVYDFLSRGSL-----EENLHGNKKDGNAFGWTERYKVAVGVAEALDY 445
G C L+V ++ G L E + KD FG + VA+ ++Y
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG--------LQVAKGMEY 113
Query: 446 LHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA------SWLSTSSSHLTCTDVAGTF 499
L + +H+D+ + N +L + F +++DFGLA + S + V
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK--- 167
Query: 500 GYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENP 540
++A E K + K DV++FG++L EL++ G P +
Sbjct: 168 -WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 7e-13
Identities = 54/187 (28%), Positives = 80/187 (42%), Gaps = 25/187 (13%)
Query: 353 PDGKELAVKILKPSEDVLKEFASEIEIITAL---HHRNIISLFGFCFEDNNLLLVYDFLS 409
P K KI+K K F + IE + + N I L+ +L+ D++
Sbjct: 39 PTQKLFVQKIIKA-----KNF-NAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIK 92
Query: 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD 469
G L + L K A E K+ + EAL+ LH +IH D+K N+L D
Sbjct: 93 DGDLFDLLKKEGKLSEA----EVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLY-DR 144
Query: 470 FEPQ--LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLE 527
+ + L D+GL + T S + D GT Y +PE D +A G++ E
Sbjct: 145 AKDRIYLCDYGLCKIIGTPSCY----D--GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYE 198
Query: 528 LLSGKKP 534
LL+GK P
Sbjct: 199 LLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 68/222 (30%), Positives = 113/222 (50%), Gaps = 36/222 (16%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL----AVKILKPSEDV--LKEFA---SEIEIITALHHRNI 388
++GKGG+ V++ G + A+K+LK + V K+ A +E I+ A+ H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 389 ISLFGFCFE-DNNLLLVYDFLSRGSLEENLHGNK---KDGNAFGWTERYKVAVGVAEALD 444
+ L + F+ L L+ ++LS G L +L +D F +E ++ AL+
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE-------ISLALE 114
Query: 445 YLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA--SWLSTSSSHLTCTDVAGTFGYL 502
+LH +Q +I++D+K NILL +L+DFGL S + +H C GT Y+
Sbjct: 115 HLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC----GTIEYM 167
Query: 503 APEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541
APE M HGK +D ++ G ++ ++L+G P +EN K
Sbjct: 168 APEILMRSGHGKA---VDWWSLGALMYDMLTGAPPFTAENRK 206
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 338 LVGKGGHSHVYRGCLPDGK----ELAVKILK--PSEDVLKEFASEIEIITALHHRNIISL 391
+G+G VY+G + +AVK K S V ++F E I+ H +I+ L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
G +N + +V + G L L NK + + ++ AL YL +
Sbjct: 73 IGVI-TENPVWIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLES--- 125
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
+ +H+D+ + N+L+S +L DFGL+ +L S+ + ++APE +
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFRR 184
Query: 512 VSEKIDVYAFGIVLLELLS-GKKP 534
+ DV+ FG+ + E+L G KP
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 8e-13
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 336 EYLVGKGGHSHVYRGCL--PDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNII 389
E ++G G + RGCL P +EL A+ L+ S+ + F +E + H NI+
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 390 SLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
L G N +++V +++S G+L+ L +K + + G+A + YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYL--- 123
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL--APEYF 507
E +HK + + +L++ D ++S F L S T ++G L APE
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 508 MHGKVSEKIDVYAFGIVLLELLS-GKKP 534
+ S DV++FGIV+ E++S G++P
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 25/206 (12%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVKIL--KPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+G G VY+ P G+ A+K++ + V ++ EIEI+ ++H N++
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQP 453
+ + ++ +F+ GSLE E++ VA + + YLH +
Sbjct: 142 DHNGEIQVLLEFMDGGSLE----------GTHIADEQFLADVARQILSGIAYLH---RRH 188
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY----FMH 509
++H+D+K SN+L++ +++DFG++ L+ + C GT Y++PE H
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNH 246
Query: 510 GKVSEKI-DVYAFGIVLLELLSGKKP 534
G D+++ G+ +LE G+ P
Sbjct: 247 GAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 58/229 (25%), Positives = 105/229 (45%), Gaps = 22/229 (9%)
Query: 325 ELLSATSNFLPEYLVGKGGHSHVYRGCL------PDGKELAVKILKPSEDV--LKEFASE 376
E+ +T F+ E +G+ VY+G L + +A+K LK + +EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 377 IEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVA 436
+ + L H NI+ L G ++ L +++ + S L E L + G T+ K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDV-GSTDDDKTV 117
Query: 437 VGVAEALDYLHNSCE----------QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486
E D++H + V+HKD+ + N+L+ D ++SD GL + +
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
+ + +++PE M+GK S D++++G+VL E+ S G +P
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 75/288 (26%), Positives = 120/288 (41%), Gaps = 69/288 (23%)
Query: 338 LVGKGGHSHVYRGC--LPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISL---- 391
++G+GG VY GC GK A+K L +K+ + AL+ R ++SL
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGET-----LALNERIMLSLVSTG 54
Query: 392 ---FGFCFE-----DNNLLLVYDFLSRGSLEENL--HGNKKDGNAFGWTERYKVAVGVAE 441
F C + L + D ++ G L +L HG F E A +
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIIL 108
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY 501
L+++HN + V+++D+K +NILL + ++SD GLA S H + GT GY
Sbjct: 109 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGY 161
Query: 502 LAPEYFMHGKVSE-KIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560
+APE G + D ++ G +L +LL G P K
Sbjct: 162 MAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK------------------- 202
Query: 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK-LLQGD 607
D +I+RM L T+++ + P++ +L+ LLQ D
Sbjct: 203 -----------DKHEIDRMTL--TVNVELPDSFSPELKSLLEGLLQRD 237
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 43/137 (31%), Positives = 74/137 (54%), Gaps = 3/137 (2%)
Query: 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSS 462
LV D+ + G L + + K F E + + V A+ ++H+ + +IH+D+KS+
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSA 172
Query: 463 NILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFG 522
NILL + +L DFG + + + S GT Y+APE + S+K D+++ G
Sbjct: 173 NILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG 232
Query: 523 IVLLELLSGKKPINSEN 539
++L ELL+ K+P + EN
Sbjct: 233 VLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 338 LVGKGGHSHVYRGC----LPDGKE---LAVKILK--PSEDVLKEFASEIEIITALHHRNI 388
+G G VY G L G +AVK L+ ++ KEF E +++ +H NI
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 389 ISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD---GNAFGWTERYKVAVGVAEALDY 445
+ L G C + ++ + + G L L + + E + + VA+ Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 446 LHNSCEQPVIHKDVKSSNILLSD-----DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFG 500
L + IH+D+ + N L+S+ D ++ DFGLA + S + +
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 501 YLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
++APE + GK + + DV++FG+++ E+L+ G++P
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 64/242 (26%), Positives = 110/242 (45%), Gaps = 34/242 (14%)
Query: 332 NFLPEYLVGKGGHSHVY----RGCLPDGKELAVKILKPSEDVLKEFA-----SEIEIITA 382
NF ++G G + V+ G GK A+K+LK + V K +E +++ A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 383 LHHRNIISLFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE 441
+ + + F+ D L L+ D+++ G L +L+ + +V V +AE
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH-------FTESEVRVYIAE 113
Query: 442 ---ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
ALD+LH + +I++D+K NILL + L+DFGL+ GT
Sbjct: 114 IVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA-YSFCGT 169
Query: 499 FGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI 553
Y+APE H K +D ++ G++ ELL+G P + + +S + ++ I
Sbjct: 170 IEYMAPEVIRGGSGGHDKA---VDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SRRI 224
Query: 554 LK 555
LK
Sbjct: 225 LK 226
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 47/199 (23%), Positives = 102/199 (51%), Gaps = 24/199 (12%)
Query: 358 LAVKILK----PSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413
+AVK+LK SE L++ SE ++ ++H ++I L+G C +D LLL+ ++ GSL
Sbjct: 33 VAVKMLKENASSSE--LRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 90
Query: 414 EENLHGNKKDGNAFGWTERYKV----------AVGVAEALDYLHNSC-------EQPVIH 456
L ++K G ++ ++ + A+ + + + + E ++H
Sbjct: 91 RSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVH 150
Query: 457 KDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKI 516
+D+ + N+L+++ + ++SDFGL+ + S++ + ++A E + +
Sbjct: 151 RDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQS 210
Query: 517 DVYAFGIVLLELLS-GKKP 534
DV++FG++L E+++ G P
Sbjct: 211 DVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 338 LVGKGGHSHVYRGCLP-DGKELAVKILKP----SEDVLKEFASEIEIITALHHRNIISLF 392
++GKG V L G+ AVK+LK +D ++ +E I++ + ++
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 393 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
CF+ + L V +F++ G L ++ +++ F A + AL +LH +
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEITSALMFLH---D 114
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
+ +I++D+K N+LL + +L+DFG+ + T + GT Y+APE
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 512 VSEKIDVYAFGIVLLELLSGKKPINSEN 539
+D +A G++L E+L G P +EN
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 30/197 (15%)
Query: 355 GKELAVKILKPSEDVLK-----EFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409
G+ A+K LK E +LK A E I+ L H I+++ ++N + + +F+
Sbjct: 43 GEYYAIKCLKKRE-ILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVV 101
Query: 410 RGSLEENLHGNKK---DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL 466
G L +L + D F E + A +YLH+ + +I++D+K N+LL
Sbjct: 102 GGELFTHLRKAGRFPNDVAKFYHAE-------LVLAFEYLHS---KDIIYRDLKPENLLL 151
Query: 467 SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGI 523
+ +++DFG A + + C GT YLAPE HGK +D + G+
Sbjct: 152 DNKGHVKVTDFGFAKKV-PDRTFTLC----GTPEYLAPEVIQSKGHGKA---VDWWTMGV 203
Query: 524 VLLELLSGKKPINSENP 540
+L E ++G P + P
Sbjct: 204 LLYEFIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 69/256 (26%), Positives = 104/256 (40%), Gaps = 33/256 (12%)
Query: 337 YLVGK----GGHSHVYRGCLPDGKELAVKIL----KPSEDVLKEFASEIEIITALHHRNI 388
L+GK H+ + P +AVK + ED LK EI L H NI
Sbjct: 4 TLIGKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKED-LKLLQQEIITSRQLQHPNI 61
Query: 389 ISLFGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH 447
+ F D+ L +V ++ GS E+ L + +G + V ALDY+H
Sbjct: 62 LPYV-TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIH 118
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFG-----YL 502
+ + IH+ VK+S+ILLS D + LS + + +L
Sbjct: 119 S---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL 175
Query: 503 APEYF---MHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559
+PE + G +EK D+Y+ GI EL +G P + P Q M + + G V
Sbjct: 176 SPEVLQQNLQG-YNEKSDIYSVGITACELANGHVPF-KDMPATQ----MLLEKV--RGTV 227
Query: 560 SQLLDPSLDTDYDNDQ 575
LLD S Y++
Sbjct: 228 PCLLDKSTYPLYEDSM 243
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-12
Identities = 59/192 (30%), Positives = 95/192 (49%), Gaps = 22/192 (11%)
Query: 355 GKELAVKILK----PSEDVLKEFASEIEIITALHHRNIISLF--GFCFEDNNLLLVYDFL 408
G E+A+K+L+ E F E + L+H NI++L G L V++++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS- 467
+L E L DG A E ++ + V +AL HN Q ++H+D+K NI++S
Sbjct: 62 PGRTLREVL---AADG-ALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQ 114
Query: 468 DDFEP--QLSDFGLASWLS----TSSSHLT-CTDVAGTFGYLAPEYFMHGKVSEKIDVYA 520
P ++ DFG+ + L + LT T+V GT Y APE V+ D+YA
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 521 FGIVLLELLSGK 532
+G++ LE L+G+
Sbjct: 175 WGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 66/248 (26%), Positives = 106/248 (42%), Gaps = 39/248 (15%)
Query: 338 LVGKGGHSHVYRGC--LPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISL---- 391
++G+GG VY GC GK A+K L +K+ + AL+ R ++SL
Sbjct: 1 IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGET-----LALNERIMLSLVSTG 54
Query: 392 ---FGFCFE-----DNNLLLVYDFLSRGSLEENL--HGNKKDGNAFGWTERYKVAVGVAE 441
F C + L + D ++ G L +L HG F E A +
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIIL 108
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY 501
L+++HN + V+++D+K +NILL + ++SD GLA S H + GT GY
Sbjct: 109 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGY 161
Query: 502 LAPEYFMHGKVSE-KIDVYAFGIVLLELLSGKKPINSENPKGQ---ESLVMWAKPILKDG 557
+APE G + D ++ G +L +LL G P K + + + + L D
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 221
Query: 558 KVSQLLDP 565
+L
Sbjct: 222 FSPELRSL 229
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 71/308 (23%), Positives = 121/308 (39%), Gaps = 61/308 (19%)
Query: 338 LVGKGGHSHVYRGCLPD-GKELAVKILKPSEDVL--KEFASEIE-IITALHHRNIISLFG 393
+G+G V + G +AVK ++ + D K +++ ++ + I+ +G
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 394 ---------FCFE------DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVG 438
C E D VY+ L + + E + G K+AV
Sbjct: 71 ALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILG--------------KIAVA 115
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
+AL+YL E +IH+DVK SNILL + +L DFG++ L S + T AG
Sbjct: 116 TVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGC 170
Query: 499 FGYLAPEY---FMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPK-GQESLVMWAKPIL 554
Y+APE + DV++ GI L E+ +GK P N Q + V+ P
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDP-- 228
Query: 555 KDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL------LQGDE 608
P L + + V L + + + RP+ +L+ + +
Sbjct: 229 ----------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNV 278
Query: 609 EAANWAKE 616
+ A + +
Sbjct: 279 DVAAYVQR 286
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 52/179 (29%), Positives = 90/179 (50%), Gaps = 16/179 (8%)
Query: 364 KPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD 423
K S + ++ E++ + + H N I G ++ LV ++ GS + L +KK
Sbjct: 63 KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY-CLGSASDLLEVHKK- 120
Query: 424 GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483
E + G + L YLH+ +IH+D+K+ NILL++ + +L+DFG AS
Sbjct: 121 --PLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175
Query: 484 STSSSHLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
S ++S + GT ++APE + G+ K+DV++ GI +EL K P+ + N
Sbjct: 176 SPANSFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 14/210 (6%)
Query: 339 VGKGGHSHVY------RGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLF 392
+GKGG V G L K+L K LK + E I+ +H R I+SL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMV-EKRILAKVHSRFIVSL- 58
Query: 393 GFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
+ F+ +L LV ++ G L +++ ++ F + L++LH +
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---Q 115
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
+ +I++D+K N+LL +D ++SD GLA L S AGT G++APE +
Sbjct: 116 RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEE 173
Query: 512 VSEKIDVYAFGIVLLELLSGKKPINSENPK 541
+D +A G+ L E+++ + P + K
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGPFRARGEK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 6e-12
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 30/207 (14%)
Query: 339 VGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKEFAS--------EIEIITAL-HHRNI 388
+G G VY + EL A+K +K K+F S E++ + L H NI
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK------KKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 389 ISLFGFCFEDNNLLLVYDFLSRGSLEENLHG--NKKDGNAFGWTERYKVAVGVAEALDYL 446
+ L E++ L V++++ E NL+ + G F + + + + L ++
Sbjct: 61 VKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY 506
H H+D+K N+L+S +++DFGLA + + + TD T Y APE
Sbjct: 116 HK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY---TDYVSTRWYRAPEI 169
Query: 507 FMH-GKVSEKIDVYAFGIVLLELLSGK 532
+ S +D++A G ++ EL + +
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 34/216 (15%)
Query: 338 LVGKGGHSHVYRGCL-PDGKEL--AVKILK--PSEDVLKEFASEIEIITAL-HHRNIISL 391
++G+G V + + DG + A+K +K S+D ++FA E+E++ L HH NII+L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNK--KDGNAFGWTER----------YKVAVGV 439
G C L L ++ G+L + L ++ + AF A V
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 440 AEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF 499
A +DYL ++ IH+D+ + NIL+ +++ +++DFGL+ V T
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--------VKKTM 182
Query: 500 G-----YLAPEYFMHGKVSEKIDVYAFGIVLLELLS 530
G ++A E + + DV+++G++L E++S
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 338 LVGKGGHSHVYRGCLPD-GKELAVKILK---PSEDVLKEFAS---EIEIITALHHRNIIS 390
L+G+G VY D G+ELAVK ++ S + KE + EI+++ L H I+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 391 LFGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHN 448
+G + + L + + + GS+++ L K A K + E + YLH+
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS-SHLTCTDVAGTFGYLAPEYF 507
+ ++H+D+K +NIL +L DFG + L T S V GT +++PE
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 508 MHGKVSEKIDVYAFGIVLLELLSGKKP 534
K D+++ G ++E+L+ K P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 49/187 (26%), Positives = 92/187 (49%), Gaps = 24/187 (12%)
Query: 359 AVKILKPSED--VLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEEN 416
AVK+L+P ++F E++I++ L NI L G C D L ++ +++ G L +
Sbjct: 50 AVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQF 109
Query: 417 LH-------GNKKDGNAFGWTERYKVAVGVAEALDYL--HNSCEQPVIHKDVKSSNILLS 467
L G + + ++ +A +A + YL N +H+D+ + N L+
Sbjct: 110 LQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-----FVHRDLATRNCLVG 164
Query: 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGT----FGYLAPEYFMHGKVSEKIDVYAFGI 523
++ +++DFG++ L +S + V G ++A E + GK + K DV+AFG+
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYY----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220
Query: 524 VLLELLS 530
L E+L+
Sbjct: 221 TLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 59/246 (23%), Positives = 100/246 (40%), Gaps = 47/246 (19%)
Query: 331 SNFLPEYLVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKE----FASEIEIITALHH 385
+F ++G+G V+ D ++ A+K+L+ S+ + + +E +I+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 386 RNIISLFGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE--- 441
I+ L+ + F+D +L LV +++ G L L +KD Y +AE
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARFY-----IAELVL 112
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA--------SWLSTSSSHLT-- 491
ALD +H IH+D+K NIL+ D +L+DFGL + SH
Sbjct: 113 ALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 492 -----------------CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKP 534
GT Y+APE + D ++ G++L E+L G P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
Query: 535 INSENP 540
S+
Sbjct: 230 FYSDTL 235
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 40/105 (38%), Positives = 65/105 (61%), Gaps = 9/105 (8%)
Query: 434 KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCT 493
K+AV + +AL+YLH+ VIH+DVK SN+L++ + + +L DFG++ +L S + T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS---VAKT 161
Query: 494 DVAGTFGYLAPEYF---MHGK-VSEKIDVYAFGIVLLELLSGKKP 534
AG Y+APE ++ K K DV++ GI ++EL +G+ P
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 40/206 (19%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 339 VGKGGHSHVYRGCLPD------GKELAVKILKPSEDVLK--EFASEIEIITALHHRNIIS 390
+G+G VY G +A+K + + + + EF +E ++ + +++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD------GNAFGWTERYKVAVGVAEALD 444
L G L+V + +++G L+ L + + + ++A +A+ +
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 445 YLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAP 504
YL + +H+D+ + N ++++D ++ DFG+ + + + ++AP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 505 EYFMHGKVSEKIDVYAFGIVLLELLS 530
E G + K DV++FG+VL E+ +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKIL--KPSEDVLKEFASEIEIITALHHRNIISLFGF 394
++GKG + VY L +A+K + + S V + EI + + L HRNI+ G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV-QPLHEEIALHSYLKHRNIVQYLGS 73
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGN----KKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
E+ + + + GSL L K + + + + E L YLH
Sbjct: 74 DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-----ILEGLKYLH--- 125
Query: 451 EQPVIHKDVKSSNILLSD-DFEPQLSDFGLASWLSTSSSHLTCTDV-AGTFGYLAPEYFM 508
+ ++H+D+K N+L++ ++SDFG + L+ + CT+ GT Y+APE
Sbjct: 126 DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVID 182
Query: 509 HGK--VSEKIDVYAFGIVLLELLSGKKP 534
G D+++ G ++E+ +GK P
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 339 VGKGGHSHVYRGCLPDGKEL-AVKILKPS----EDVLKEFASEIEIITALHHRNIISLFG 393
VG+GG+ V+ D E+ A+K +K S + ++ +E +I+T ++ L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 394 FCFED-NNLLLVYDFLSRG---SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
+ F+D L L +++ G +L NL +D F E + EA+D LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMF-------EAVDALH-- 118
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS-WLSTSSSHLTCTDVAGTFGYLAPEYFM 508
E IH+D+K N L+ +L+DFGL+ ++ ++S V G+ Y+APE
Sbjct: 119 -ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS------VVGSPDYMAPEVLR 171
Query: 509 HGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
+D ++ G +L E L G P + P
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 54/210 (25%), Positives = 102/210 (48%), Gaps = 16/210 (7%)
Query: 338 LVGKGGHSHVYRGCLPDGK-----ELAVKILK--PSEDVLKEFASEIEIITALHHRNIIS 390
L+ +G ++ G L D K E+ VK +K SE + E ++ L H+NI+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72
Query: 391 LFGFCFEDNNLLLV-YDFLSRGSLEENL----HGNKKDGNAFGWTERYKVAVGVAEALDY 445
+ C ED V Y +++ G+L+ L G + A + +A+ +A + Y
Sbjct: 73 ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132
Query: 446 LHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
LH + VIHKD+ + N ++ ++ + +++D L+ L H + ++A E
Sbjct: 133 LHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALE 189
Query: 506 YFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
++ + S DV++FG++L EL++ G+ P
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 51/208 (24%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 338 LVGKGGHSHVYRGC-LPDGKEL----AVKILK--PSEDVLKEFASEIEIITALHHRNIIS 390
++G G VY+G +PDG+ + A+K+L+ S KE E ++ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
L G C + + LV + G L + + NK + G + V +A+ + YL
Sbjct: 74 LLGICLT-STVQLVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLE--- 126
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510
E ++H+D+ + N+L+ +++DFGLA L + ++A E +H
Sbjct: 127 EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 511 KVSEKIDVYAFGIVLLELLS-GKKPINS 537
+ + + DV+++G+ + EL++ G KP +
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 58/227 (25%), Positives = 95/227 (41%), Gaps = 43/227 (18%)
Query: 336 EYLVGKGGHSHVY---RGCLPDGKELAVKILKPSEDVLKEFAS----EIEIITALHHRNI 388
E +G+G + VY R DGKE A+K K ++ + EI ++ L H N+
Sbjct: 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENV 64
Query: 389 ISLFGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEA---- 442
+SL E + + L++D+ E +L K R V + +
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKF-------HRQAKRVSIPPSMVKS 112
Query: 443 --------LDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ----LSDFGLAS-WLSTSSSH 489
+ YLH V+H+D+K +NIL+ + + + D GLA + +
Sbjct: 113 LLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 490 LTCTDVAGTFGYLAPEYFMHGKVSEK-IDVYAFGIVLLELLSGKKPI 535
V T Y APE + + K ID++A G + ELL+ +PI
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 32/220 (14%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKE-----FASEIEIITALHHRNIISL-- 391
+G+G + VY+ D EL V + K D KE EI+I+ L+HRNI++L
Sbjct: 15 IGEGTYGQVYKARDKDTGEL-VALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73
Query: 392 --------FGFCFEDNNLLLVYDFLSR---GSLEENLHGNKKDGNAFGWTERYKVAVGVA 440
F + LV++++ G LE L +D +
Sbjct: 74 IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-------SFMKQLL 126
Query: 441 EALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFG 500
E L+Y H + +H+D+K SNILL++ + +L+DFGLA ++ S V T
Sbjct: 127 EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-TLW 182
Query: 501 YLAPEYFM-HGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
Y PE + + IDV++ G +L EL + KKPI N
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQAN 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 65/231 (28%), Positives = 111/231 (48%), Gaps = 36/231 (15%)
Query: 339 VGKGGHSHVYRGCLPD-GKELAVKILKPSEDVLKEFASEIEIITALHHRNIIS------- 390
+GKG VY+ D + A+K+L E V K+ E+ + RNI+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKK-----EVAHTIGERNILVRTLLDES 55
Query: 391 --LFG--FCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDY 445
+ G F F+ D++L LV D++S G L +L +K+G ++ +A V AL++
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHL---QKEGRFSEDRAKFYIAELVL-ALEH 111
Query: 446 LHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF----GY 501
LH + ++++D+K NILL L DFGL S ++LT TF Y
Sbjct: 112 LH---KYDIVYRDLKPENILLDATGHIALCDFGL------SKANLTDNKTTNTFCGTTEY 162
Query: 502 LAPEYFMHGK-VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK 551
LAPE + K ++ +D ++ G+++ E+ G P +E+ + + + K
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 59/213 (27%), Positives = 101/213 (47%), Gaps = 29/213 (13%)
Query: 338 LVGKGGHSHVYRGCLPD-GKELAVKILK---PSEDVLKEFAS---EIEIITALHHRNIIS 390
L+G+G VY D G+ELAVK + S++ KE + EI+++ L H I+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 391 LFGFCFED---NNLLLVYDFLSRGSLEENLHGNKKDGNAFGW-----TERYKVAVGVAEA 442
+G C D L + +++ GS+++ L A+G T RY + +
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQL-------KAYGALTENVTRRYTRQI--LQG 118
Query: 443 LDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST-SSSHLTCTDVAGTFGY 501
+ YLH++ ++H+D+K +NIL +L DFG + + T S V GT +
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175
Query: 502 LAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKP 534
++PE K DV++ ++E+L+ K P
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 339 VGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIE-----IITALHHRNIISLF 392
+GKG V DGK AVK+L+ + K+ I ++ + H ++ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 393 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
+ F+ + L V D+++ G L +L + F A +A AL YLH
Sbjct: 63 -YSFQTADKLYFVLDYVNGGELFFHLQRERS----FPEPRARFYAAEIASALGYLH---S 114
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
+I++D+K NILL L+DFGL S T + GT YLAPE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQP 172
Query: 512 VSEKIDVYAFGIVLLELLSGKKPINSEN 539
+D + G VL E+L G P S +
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 41/173 (23%), Positives = 81/173 (46%), Gaps = 8/173 (4%)
Query: 356 KELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415
KE+ V L P+E V + E ++++ L H I+ E + ++ ++ L+
Sbjct: 34 KEIPVGELNPNETV--QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDC 91
Query: 416 NLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLS 475
L K G + + + + + Y+H ++ ++H+D+K+ NI L ++ ++
Sbjct: 92 KLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKNNL-LKIG 147
Query: 476 DFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLEL 528
DFG++ L S T GT Y++PE H K D+++ G +L E+
Sbjct: 148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 7e-11
Identities = 52/177 (29%), Positives = 86/177 (48%), Gaps = 34/177 (19%)
Query: 375 SEIEIITALHHRNIISLFGFCFEDNN---LLL-------VYDFL-SRGSLEENLHGNKKD 423
SE EI+ +H I+ L+ F+D +L+ ++ L RG +E
Sbjct: 42 SEKEILEECNHPFIVKLYR-TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE-------- 92
Query: 424 GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483
+T R+ +A V A +YLHN + +I++D+K N+LL + +L DFG A L
Sbjct: 93 -----YTARFYIA-CVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143
Query: 484 STSSSHLT-CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
+ T C GT Y+APE ++ +D ++ GI+L ELL+G+ P ++
Sbjct: 144 KSGQKTWTFC----GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 61/239 (25%), Positives = 110/239 (46%), Gaps = 29/239 (12%)
Query: 332 NFLPEYLVGKGGHSHVY---RGCLPD-GKELAVKILKPSEDVLKEFA-----SEIEIITA 382
NF ++G G + V+ + D GK A+K+L+ + V K +E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 383 LHHRNIISLFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVG-VA 440
+ + + F+ + L L+ D++S G + +L+ + G +
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED-----EVRFYSGEII 115
Query: 441 EALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFG 500
AL++LH + ++++D+K NILL + L+DFGL+ + T + GT
Sbjct: 116 LALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIE 171
Query: 501 YLAPEYFM----HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILK 555
Y+APE HGK +D ++ GI++ ELL+G P E + +S V ++ ILK
Sbjct: 172 YMAPEIIRGKGGHGKA---VDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILK 225
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-10
Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 55/230 (23%)
Query: 355 GKELAVKILKPSEDVLKEFA----SEIEIITALHHRNIISLFGFCFED-NNLLLVYDFLS 409
G A+K L+ SE + KE +E +I+ + ++ L+ + F+D N L L+ ++L
Sbjct: 26 GHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLP 84
Query: 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAE---ALDYLHNSCEQPVIHKDVKSSNILL 466
G + L KKD T Y +AE A+D +H + IH+D+K N+LL
Sbjct: 85 GGDMMTLLM--KKDTFTEEETRFY-----IAETILAIDSIH---KLGYIHRDIKPDNLLL 134
Query: 467 SDDFEPQLSDFGLASWL---------------------STSSSHLTCTDVA--------- 496
+LSDFGL + L S ++ A
Sbjct: 135 DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRA 194
Query: 497 ------GTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
GT Y+APE F+ +++ D ++ G+++ E+L G P S+NP
Sbjct: 195 LAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 338 LVGKGGHSHVYRGCL--PDGKEL--AVKILKP---SEDVLKEFASEIEIITALHHRNIIS 390
++G+G V G L DG +L AVK +K + ++EF SE + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 391 LFGFCFEDNNL------LLVYDFLSRGSLEENLHGNKKDGNAFGWTER--YKVAVGVAEA 442
L G CFE ++L +++ F+ G L L ++ G + K V +A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 443 LDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL 502
++YL N + IH+D+ + N +L +D ++DFGL+ + + + ++
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 503 APEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
A E + K DV+AFG+ + E+ + G+ P
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 355 GKELAVKILKPSEDVL---KEFASEIEIITALHHRNIISLF------GFCFEDNNLLLVY 405
GK++A+K + + DV K E++I+ H NII++ G F+D + +V
Sbjct: 30 GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD--VYVVM 87
Query: 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNIL 465
D L L +H ++ Y++ G L Y+H++ VIH+D+K SN+L
Sbjct: 88 D-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG----LKYIHSAN---VIHRDLKPSNLL 139
Query: 466 LSDDFEPQLSDFGLASWLSTSSSHLT--CTDVAGTFGYLAPE-YFMHGKVSEKIDVYAFG 522
+++D E ++ DFG+A LS+S + T+ T Y APE + + ID+++ G
Sbjct: 140 VNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG 199
Query: 523 IVLLELLSGKKPI-NSENPKGQESLVM 548
+ E+L G++ + +N Q L++
Sbjct: 200 CIFAEML-GRRQLFPGKNYVHQLKLIL 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 19/197 (9%)
Query: 360 VKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFE-DNNLLLVYDFLSRGSLEENLH 418
+++ K S V ++ E ++ + H NI++ F FE D +L +V ++ G L + +
Sbjct: 33 IRLPKSSSAV-EDSRKEAVLLAKMKHPNIVA-FKESFEADGHLYIVMEYCDGGDLMQKIK 90
Query: 419 GNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFG 478
+ G F + V + + ++H E+ V+H+D+KS NI L+ + + +L DFG
Sbjct: 91 LQR--GKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFG 145
Query: 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSE 538
A L++ ++ CT V GT Y+ PE + + + K D+++ G +L EL + K P +
Sbjct: 146 SARLLTSPGAY-ACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
Query: 539 NPKGQESLVMWAKPILK 555
+ W ILK
Sbjct: 204 S---------WKNLILK 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 63/238 (26%), Positives = 93/238 (39%), Gaps = 45/238 (18%)
Query: 338 LVGKGGHSHVYRGCLPD-GKELAVKILKPSEDV----LKEFASEIEIITALHHRNIISLF 392
L+GKG V+ L GK A+K+L E + +K +E EI+ L H + +L+
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTE---RYKVAVGVAEALDYLHNS 449
+ L LV D+ G L L ++ G +E R+ A + AL+YLH
Sbjct: 68 ASFQTETYLCLVMDYCPGGELFRLL--QRQPGKCL--SEEVARFYAAEVLL-ALEYLHL- 121
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT------------------ 491
++++D+K NILL + LSDF L S S
Sbjct: 122 --LGIVYRDLKPENILLHESGHIMLSDFDL-SKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 492 ----CTDVA------GTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
GT Y+APE +D + GI+L E+L G P N
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 31/237 (13%)
Query: 338 LVGKGGHSHVYRGCLP-DGKELAVKILKPS-----EDVLKEFASEIEIITALHHRNIISL 391
++GKG V+ L + A+K LK +DV + + A H + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
+ NL V ++L+ G L ++ K F A + L +LH+
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK----FDLPRATFYAAEIICGLQFLHS--- 114
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLA--SWLSTSSSHLTCTDVAGTFGYLAPEYFMH 509
+ ++++D+K NILL D +++DFG+ + L + + C GT Y+APE +
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC----GTPDYIAPEILLG 170
Query: 510 GKVSEKIDVYAFGIVLLELLSGKKP------------INSENPKGQESLVMWAKPIL 554
K + +D ++FG++L E+L G+ P I +NP L AK IL
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 69/252 (27%), Positives = 108/252 (42%), Gaps = 62/252 (24%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKE----FASEIEIITALHHRNIISLFG 393
LV K HVY A+KIL+ ++ + KE +E +I+ ++ +F
Sbjct: 19 LVQKKDTGHVY----------AMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF- 67
Query: 394 FCFEDN-NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE---ALDYLHNS 449
+ F+D NL L+ +FL G + L KKD T+ Y +AE A+D +H
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLM--KKDTLTEEETQFY-----IAETVLAIDSIH-- 118
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS--------SHLTCTD------- 494
+ IH+D+K N+LL +LSDFGL + L + +H +D
Sbjct: 119 -QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 495 ------------------VAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPIN 536
GT Y+APE FM ++ D ++ G+++ E+L G P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 537 SENPKGQESLVM 548
SE P+ VM
Sbjct: 238 SETPQETYKKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 49/212 (23%), Positives = 102/212 (48%), Gaps = 15/212 (7%)
Query: 331 SNFLPEYLVGKGGHSHVYRGC-LPDGKEL----AVKILK--PSEDVLKEFASEIEIITAL 383
+ F ++G G VY+G +P+G+++ A+K L+ S KE E ++ ++
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 384 HHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEAL 443
+ ++ L G C + + L+ + G L + + +K + G V +A+ +
Sbjct: 67 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGM 122
Query: 444 DYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLA 503
+YL E+ ++H+D+ + N+L+ +++DFGLA L ++A
Sbjct: 123 NYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 504 PEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
E +H + + DV+++G+ + EL++ G KP
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 61/209 (29%), Positives = 108/209 (51%), Gaps = 25/209 (11%)
Query: 353 PDGKEL-AVKILKPSEDVLKE---FASEIEIITALHHRNIISLFGFCFE-DNNLLLVYDF 407
PD +L A+K+LK + +++ E +I+ ++H I+ L + F+ + L L+ DF
Sbjct: 21 PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLH-YAFQTEGKLYLILDF 79
Query: 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE---ALDYLHNSCEQPVIHKDVKSSNI 464
L G L L +TE V +AE ALD+LH+ +I++D+K NI
Sbjct: 80 LRGGDLFTRL------SKEVMFTEE-DVKFYLAELALALDHLHS---LGIIYRDLKPENI 129
Query: 465 LLSDDFEPQLSDFGLA--SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFG 522
LL ++ +L+DFGL+ S ++ C GT Y+APE ++ D ++FG
Sbjct: 130 LLDEEGHIKLTDFGLSKESIDHEKKAYSFC----GTVEYMAPEVVNRRGHTQSADWWSFG 185
Query: 523 IVLLELLSGKKPINSENPKGQESLVMWAK 551
+++ E+L+G P ++ K ++++ AK
Sbjct: 186 VLMFEMLTGSLPFQGKDRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 355 GKELAVKILKP----SEDVLKEFASEIEIITALHHRNIISL-FGFCFEDNNLLLVYDFLS 409
GK A+KILK ++D + +E ++ H + SL + F +D L V ++++
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDR-LCFVMEYVN 78
Query: 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD 469
G L +L + F + ALDYLH+ ++++D+K N++L D
Sbjct: 79 GGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKD 131
Query: 470 FEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELL 529
+++DFGL T ++ T GT YLAPE +D + G+V+ E++
Sbjct: 132 GHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
Query: 530 SGKKPI-NSENPKGQESLVM 548
G+ P N ++ K E ++M
Sbjct: 190 CGRLPFYNQDHEKLFELILM 209
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 61/256 (23%), Positives = 119/256 (46%), Gaps = 40/256 (15%)
Query: 340 GKGGHSHVYRGCL---PD------GKELAV--KILKPSEDVLKEFASEIEIITALHHRNI 388
G+G +++Y+G L D G+E++V K+L F +++ L H+++
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63
Query: 389 ISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHN 448
+ L+G C D N ++V +++ G L+ LH K + + W + VA +A AL YL
Sbjct: 64 VKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSL-HW--KLDVAKQLASALHYLE- 118
Query: 449 SCEQPVIHKDVKSSNILL---SDDFEPQ----LSDFGLASWLSTSSSHLTCTDVAGTFGY 501
++ ++H +V NIL+ + LSD G+ + + + +
Sbjct: 119 --DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE------RIPW 170
Query: 502 LAPEYFMHGKVSEKI--DVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAK----PIL 554
+APE +G+ S I D ++FG LLE+ S G++P+++ + E + P+
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQDQHRLPMP 228
Query: 555 KDGKVSQLLDPSLDTD 570
+++ L++ D
Sbjct: 229 DCAELANLINQCWTYD 244
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 68/252 (26%), Positives = 110/252 (43%), Gaps = 62/252 (24%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEI----EIITALHHRNIISLFG 393
LV K H+Y A+KIL+ ++ + KE + I +I+ ++ +F
Sbjct: 19 LVQKKDTGHIY----------AMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF- 67
Query: 394 FCFEDN-NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE---ALDYLHNS 449
+ F+D NL L+ +FL G + L KKD + T+ Y +AE A+D +H
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLM--KKDTLSEEATQFY-----IAETVLAIDAIH-- 118
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS--------SHLTCTDVA----- 496
+ IH+D+K N+LL +LSDFGL + L + +H +D +
Sbjct: 119 -QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 497 --------------------GTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPIN 536
GT Y+APE FM ++ D ++ G+++ E+L G P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 537 SENPKGQESLVM 548
SE P+ VM
Sbjct: 238 SETPQETYRKVM 249
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 46/184 (25%), Positives = 89/184 (48%), Gaps = 16/184 (8%)
Query: 358 LAVKILKPSEDVLK----EFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413
+AVK+L+ ED K +F EI+I++ L NII L C + L ++ +++ G L
Sbjct: 49 VAVKMLR--EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 414 EENL-------HGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL 466
+ L K D ++ +A +A + YL + +H+D+ + N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLV 163
Query: 467 SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLL 526
++ +++DFG++ L + + +++ E + GK + DV+AFG+ L
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223
Query: 527 ELLS 530
E+L+
Sbjct: 224 EILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 55/209 (26%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILK---PSEDVLKEFASEIEIITALHHRNIISLFGF 394
+G+G + VY+ G+ +A+K ++ +E V EI ++ L+H NI+ L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQ 452
+N L LV++FL + L++ + + G + Y ++ G+A + H+
Sbjct: 68 IHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----FCHS---H 119
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
V+H+D+K N+L++ + +L+DFGLA T V T Y APE + K
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 177
Query: 513 -SEKIDVYAFGIVLLELLSGKK--PINSE 538
S +D+++ G + E+++ + P +SE
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRALFPGDSE 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 6e-10
Identities = 53/198 (26%), Positives = 101/198 (51%), Gaps = 15/198 (7%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFAS--EIEIITALHHRNIISLFGFC 395
+G+G ++ VY+G +GK +A+K+++ E+ F + E ++ L H NI+ L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV-GVAEALDYLHNSCEQPV 454
L LV++++ + + +K G E K+ + + L Y+H ++ +
Sbjct: 73 HTKETLTLVFEYVHTDLCQ---YMDKHPGGLH--PENVKLFLFQLLRGLSYIH---QRYI 124
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVS 513
+H+D+K N+L+SD E +L+DFGLA S SH +V T Y P+ + + S
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVV-TLWYRPPDVLLGSTEYS 182
Query: 514 EKIDVYAFGIVLLELLSG 531
+D++ G + +E++ G
Sbjct: 183 TCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 53/219 (24%), Positives = 103/219 (47%), Gaps = 53/219 (24%)
Query: 339 VGKGGHSHVYRGCLPDGKEL-AVKILK-------PSEDVLKEFASEIEIITALHHRNIIS 390
+G+G ++ VY+G E+ A+K + PS + EI ++ L H NI+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-----REISLMKELKHENIVR 62
Query: 391 LFGFCFEDNNLLLVYDFL------------SRGSLEENLHGNKKDGNAFGWTERYKVAVG 438
L +N L+LV++++ RG+L+ N + F +
Sbjct: 63 LHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKS------FTYQ-------- 108
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW----LSTSSSHLTCTD 494
+ + + + H E V+H+D+K N+L++ E +L+DFGLA ++T S+ +
Sbjct: 109 LLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--- 162
Query: 495 VAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGK 532
T Y AP+ + + S ID+++ G ++ E+++G+
Sbjct: 163 ---TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 48/169 (28%), Positives = 84/169 (49%), Gaps = 18/169 (10%)
Query: 375 SEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYK 434
SE +I+ ++H ++L+G +++ L LV +F+ G L NK+ N G +
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQ 139
Query: 435 VAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD 494
+ + + E L L+ ++++D+K N+LL D +++DFG A + T + L
Sbjct: 140 IVL-IFEYLQSLN------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTL---- 188
Query: 495 VAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
GT Y+APE + HGK + D + GI + E+L G P + P
Sbjct: 189 -CGTPEYIAPEILLNVGHGKAA---DWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 53/212 (25%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 355 GKELAVKILKPSEDVLK-----EFASEIEIITALHHRNIISLFGFCFE-DNNLLLVYDFL 408
GK A+K+LK + V K +E +++ + + + F+ D L L+ D++
Sbjct: 28 GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYI 87
Query: 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE---ALDYLHNSCEQPVIHKDVKSSNIL 465
+ G L +L ++ + E+ +V + E AL++LH + +I++D+K NIL
Sbjct: 88 NGGELFTHLSQRER------FKEQ-EVQIYSGEIVLALEHLH---KLGIIYRDIKLENIL 137
Query: 466 LSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV--SEKIDVYAFGI 523
L + L+DFGL+ GT Y+AP+ G + +D ++ G+
Sbjct: 138 LDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGV 196
Query: 524 VLLELLSGKKPINSENPKGQESLVMWAKPILK 555
++ ELL+G P + K ++ + ++ ILK
Sbjct: 197 LMYELLTGASPFTVDGEKNSQAEI--SRRILK 226
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 10/167 (5%)
Query: 376 EIEIITALHHRNIISLFGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYK 434
E EI+ ++ I++L + FE +L LV ++ G L+ +++ + G Y
Sbjct: 43 EKEILEKVNSPFIVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHY- 100
Query: 435 VAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD 494
+ + + +LH ++++D+K N+LL D +LSD GLA L T T
Sbjct: 101 -SAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153
Query: 495 VAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541
AGT GY+APE S +D +A G + E+++G+ P K
Sbjct: 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 48/170 (28%), Positives = 87/170 (51%), Gaps = 14/170 (8%)
Query: 375 SEIEIITALHHRNIISLFGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY 433
+E +I+ ++ R ++SL + +E + L LV ++ G L+ +++ G A G+ E
Sbjct: 49 NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY---HMGEA-GFEEGR 103
Query: 434 KV--AVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491
V A + L+ LH ++ ++++D+K NILL D ++SD GLA + T
Sbjct: 104 AVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---T 157
Query: 492 CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541
GT GY+APE + + + D +A G +L E+++G+ P K
Sbjct: 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 52/216 (24%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 332 NFLPEYLVGKGGHSHVYRGCLPDGKEL-AVKILKP----SEDVLKEFASEIEIITALHHR 386
+F ++GKG V EL A+KILK +D ++ E ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 387 NIISLFGFCFED-NNLLLVYDFLSRGSLEENLH--GNKKDGNAFGWTERYKVAVGVAEAL 443
++ CF+ + L V ++++ G L ++ G K+ A + +++VG L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAA--EISVG----L 114
Query: 444 DYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLA 503
+LH + +I++D+K N++L + +++DFG+ +T GT Y+A
Sbjct: 115 FFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIA 169
Query: 504 PEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
PE + + +D +A+G++L E+L+G+ P + E+
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSE---DVLKEFASEIEIITALHHRNIISLFG 393
+VG+G + V + + KE+ A+K K SE +V + E++++ L NI+ L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 394 FCFEDNNLLLVYDFLSRGSLE---ENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
L LV++++ + LE E +G + KV + + + +H
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE----------KVRSYIYQLIKAIHWCH 117
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510
+ ++H+D+K N+L+S + +L DFG A LS S+ T+ T Y +PE +
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGA 176
Query: 511 KVSEKIDVYAFGIVLLELLSGK 532
+ +D+++ G +L EL G+
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 1e-09
Identities = 49/162 (30%), Positives = 83/162 (51%), Gaps = 29/162 (17%)
Query: 384 HHRNIISLFGFCFEDNN--LLLVYDFLS-------RGSLEENLHGNKKDGNAFGWTERYK 434
H NI+ L +N+ + LV++++ R ++ E++H +RY
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH------------KRY- 111
Query: 435 VAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC-- 492
+ + +AL Y+H+ VIH+D+K SNILL+ D +L+DFGLA LS +
Sbjct: 112 IMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 493 -TDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGK 532
TD T Y APE + + ++ +D+++ G +L E+L GK
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 18/226 (7%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFAS--EIEIITALHHRNIISL--FGF 394
VG+G + HVY+ DGK+ LK E ++ EI ++ L H N+ISL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 395 CFEDNNLLLVYDFLSRGSLE-ENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
D + L++D+ H K R V + + LD +H
Sbjct: 69 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 128
Query: 454 VIHKDVKSSNILL----SDDFEPQLSDFGLASWLSTSSSHLTCTD-VAGTFGYLAPEYFM 508
V+H+D+K +NIL+ + +++D G A ++ L D V TF Y APE +
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188
Query: 509 HGK-VSEKIDVYAFGIVLLELLSG-------KKPINSENPKGQESL 546
+ ++ ID++A G + ELL+ ++ I + NP + L
Sbjct: 189 GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 1e-09
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 356 KELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNN--LLLVYDFLSRGSL 413
K ++ + LK E + E+ ++ L H+NI+ N L ++ +F G L
Sbjct: 44 KAISYRGLKEREK--SQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDL 101
Query: 414 EENLHGNKKDGNAFGWTERY---KVAVGVAEALDYLHNSCEQP----VIHKDVKSSNILL 466
N+ +K FG E + + + AL Y HN + P V+H+D+K NI L
Sbjct: 102 SRNI---QKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158
Query: 467 SDDFE-----------------PQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH 509
S ++ DFGL+ + S +C GT Y +PE +H
Sbjct: 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCV---GTPYYWSPELLLH 215
Query: 510 GKVS--EKIDVYAFGIVLLELLSGKKPINSEN 539
S +K D++A G ++ EL SGK P + N
Sbjct: 216 ETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247
|
Length = 1021 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 57/209 (27%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKP----SEDVLKEFASEIEIIT-ALHHRNIISL 391
++GKG V L E+ A+K+LK +D + +E I+ A H + +L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 392 FGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
CF+ + L V ++++ G L + ++K F A V AL +LH
Sbjct: 62 HC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFLH--- 113
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510
VI++D+K NILL + +L+DFG+ + +T T GT Y+APE
Sbjct: 114 RHGVIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 511 KVSEKIDVYAFGIVLLELLSGKKPINSEN 539
+ +D +A G+++ E+++G+ P ++N
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 59/226 (26%), Positives = 99/226 (43%), Gaps = 18/226 (7%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFAS--EIEIITALHHRNIISL--FGF 394
VG+G + HVY+ DGK+ LK E ++ EI ++ L H N+I+L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 395 CFEDNNLLLVYDFLSRGSLE-ENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
D + L++D+ H K R V + + LD +H
Sbjct: 69 SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128
Query: 454 VIHKDVKSSNILL----SDDFEPQLSDFGLASWLSTSSSHLTCTD-VAGTFGYLAPEYFM 508
V+H+D+K +NIL+ + +++D G A ++ L D V TF Y APE +
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188
Query: 509 HGK-VSEKIDVYAFGIVLLELLSG-------KKPINSENPKGQESL 546
+ ++ ID++A G + ELL+ ++ I + NP + L
Sbjct: 189 GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 36/106 (33%), Positives = 55/106 (51%), Gaps = 6/106 (5%)
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
+ E L YLH Q +IH+DVK+ NI ++D + + D G A + + + L +AGT
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL---GLAGT 219
Query: 499 FGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQE 544
APE K + K D+++ GIVL E+L+ I + P E
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265
|
Length = 357 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 35/206 (16%)
Query: 355 GKELAVK-ILKP-SEDVL-KEFASEIEIITALHHRNIISL---FGFCFEDNNL---LLVY 405
G+ +A+K I+KP S VL K E++++ L H NIISL F ED LL
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94
Query: 406 DF---LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSS 462
D L+ LE+ F Y++ G L Y+H++ V+H+D+K S
Sbjct: 95 DLHRLLTSRPLEKQ----------FIQYFLYQILRG----LKYVHSA---GVVHRDLKPS 137
Query: 463 NILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAF 521
NIL++++ + ++ DFGLA + T T Y APE + K ++D+++
Sbjct: 138 NILINENCDLKICDFGLA---RIQDPQM--TGYVSTRYYRAPEIMLTWQKYDVEVDIWSA 192
Query: 522 GIVLLELLSGKKPINSENPKGQESLV 547
G + E+L GK ++ Q S++
Sbjct: 193 GCIFAEMLEGKPLFPGKDHVNQFSII 218
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 49/195 (25%), Positives = 91/195 (46%), Gaps = 29/195 (14%)
Query: 353 PDGKELAVKILKP----SEDVLKEFASE---IEIITALHHRNIISLFGFCFE-DNNLLLV 404
G+ A+K LK + D ++ E E + H +++LF CF+ ++++ V
Sbjct: 22 KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFA-CFQTEDHVCFV 80
Query: 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKV--AVGVAEALDYLHNSCEQPVIHKDVKSS 462
++ + G L ++H + ++E V A V L YLH E ++++D+K
Sbjct: 81 MEYAAGGDLMMHIHTDV-------FSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLD 130
Query: 463 NILLSDDFEPQLSDFGLAS---WLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVY 519
N+LL + +++DFGL +S C GT +LAPE + +D +
Sbjct: 131 NLLLDTEGFVKIADFGLCKEGMGFGDRTSTF-C----GTPEFLAPEVLTETSYTRAVDWW 185
Query: 520 AFGIVLLELLSGKKP 534
G+++ E+L G+ P
Sbjct: 186 GLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 56/199 (28%), Positives = 95/199 (47%), Gaps = 23/199 (11%)
Query: 347 VYRG-CLPDGKELAVKILKPSEDVLKEFA----SEIEIITALHHRNIISLFGFCFEDN-- 399
VYR G+ +A+K LK E + F EI I+ L H NI+++ N
Sbjct: 21 VYRARDKKTGEIVALKKLK-MEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD 79
Query: 400 NLLLVYDFLSRG--SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHK 457
+ +V +++ SL E + F +E + + + + +LH + ++H+
Sbjct: 80 KIYMVMEYVEHDLKSLMETMKQP------FLQSEVKCLMLQLLSGVAHLH---DNWILHR 130
Query: 458 DVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV-SEKI 516
D+K+SN+LL++ ++ DFGLA + T V T Y APE + K S I
Sbjct: 131 DLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV--TLWYRAPELLLGAKEYSTAI 188
Query: 517 DVYAFGIVLLELLSGKKPI 535
D+++ G + ELL+ KKP+
Sbjct: 189 DMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 57/221 (25%), Positives = 108/221 (48%), Gaps = 31/221 (14%)
Query: 332 NFLPEYLVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKEFASEIEIITALHHRNIIS 390
NFL ++GKG V EL A+KILK +DV+ + + ++ + + +++
Sbjct: 3 NFL--MVLGKGSFGKVMLAERKGTDELYAIKILK--KDVVIQ---DDDVECTMVEKRVLA 55
Query: 391 LFG---------FCFED-NNLLLVYDFLSRGSLEENLH--GNKKDGNAFGWTERYKVAVG 438
L G CF+ + L V ++++ G L + G K+ +A + A
Sbjct: 56 LSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY------AAE 109
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
+A L +LH+ + +I++D+K N++L + +++DFG+ +T GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGT 164
Query: 499 FGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
Y+APE + + +D +AFG++L E+L+G+ P E+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 15/166 (9%)
Query: 388 IISLFGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYL 446
I+ L + F+D+ L +V +++ G L NL N W Y V ALD +
Sbjct: 105 IVQLH-YAFQDDKYLYMVMEYMPGGDLV-NLMSNYDIPEK--WARFYTAEV--VLALDAI 158
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY 506
H+ IH+DVK N+LL +L+DFG + ++ + C GT Y++PE
Sbjct: 159 HS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD-ANGMVRCDTAVGTPDYISPEV 214
Query: 507 FM----HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVM 548
G + D ++ G+ L E+L G P +++ G S +M
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 10/99 (10%)
Query: 443 LDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL 502
LD+LH +C ++H+D+K NIL++ + +L+DFGLA S + T V T Y
Sbjct: 121 LDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA---RIYSCQMALTPVVVTLWYR 174
Query: 503 APEYFMHGKVSEKIDVYAFGIVLLELLSGKKPI---NSE 538
APE + + +D+++ G + E+ +KP+ NSE
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSE 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVK-ILKPSED--VLKEFASEIEIITALHHRNIISLFGF 394
+G+G + VY+G G+ +A+K I SE+ V EI ++ L H NI+ L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER---YKVAVGVAEALDYLHNSCE 451
+++ L L+++FLS L++ L K + Y++ G+ + H
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGIL----FCH---S 119
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG- 510
+ V+H+D+K N+L+ + +L+DFGLA T V T Y APE +
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGSP 177
Query: 511 KVSEKIDVYAFGIVLLELLSGKKPI 535
+ S +D+++ G + E+ + KKP+
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 43/227 (18%)
Query: 332 NFLPEYLVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKE---------------FAS 375
NFL ++GKG V EL A+KILK +DV+ +
Sbjct: 3 NFL--MVLGKGSFGKVMLAERKGTDELYAIKILK--KDVIIQDDDVECTMVEKRVLALPG 58
Query: 376 EIEIITALHHRNIISLFGFCFED-NNLLLVYDFLSRGSLEENLH--GNKKDGNAFGWTER 432
+ +T LH CF+ + L V ++++ G L ++ G K+ +A +
Sbjct: 59 KPPFLTQLHS---------CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY--- 106
Query: 433 YKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492
A +A L +LH+ + +I++D+K N++L + +++DFG+ + T
Sbjct: 107 ---AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTR 159
Query: 493 TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
T GT Y+APE + + +D +AFG++L E+L+G+ P + E+
Sbjct: 160 T-FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 67/292 (22%), Positives = 127/292 (43%), Gaps = 33/292 (11%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFC 395
+GKG + VY+ P G +A+K ++ E + E++I+ I+ +G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
F + + + +++ GSL++ L+ ++ V + L +L E +I
Sbjct: 69 FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNII 125
Query: 456 HKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEK 515
H+DVK +N+L++ + + +L DFG++ L S L T++ G Y+APE G ++
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAKTNI-GCQSYMAPERIKSGGPNQN 181
Query: 516 I------DVYAFGIVLLELLSGKKPINSE---NPKGQESLVMWAKPILKDGKVSQLLDPS 566
DV++ G+ +LE+ G+ P E N Q S ++ P P+
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------------PT 229
Query: 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQIN--LVLKLLQGDEEAANWAKE 616
L + Y +D + + +R PT + ++K D + A W
Sbjct: 230 LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWVTG 281
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 35/111 (31%), Positives = 58/111 (52%), Gaps = 5/111 (4%)
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
+ ALDYLH+ E+ V+++D+K N++L D +++DFGL T GT
Sbjct: 104 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159
Query: 499 FGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPI-NSENPKGQESLVM 548
YLAPE +D + G+V+ E++ G+ P N ++ K E ++M
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 210
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 53/212 (25%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKEFASEIEII--------TALHHRNI 388
++GKG V L EL AVK+LK + +L++ ++E A H +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLK-KDVILQD--DDVECTMTEKRVLALAGKHPFL 58
Query: 389 ISLFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH 447
L CF+ + L V ++++ G L ++ + + F A + L +LH
Sbjct: 59 TQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLH 113
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF 507
E+ +I++D+K N+LL + +++DFG+ +T + GT Y+APE
Sbjct: 114 ---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEIL 168
Query: 508 MHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
+ +D +A G++L E+L+G+ P ++
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 67/245 (27%), Positives = 112/245 (45%), Gaps = 39/245 (15%)
Query: 339 VGKGGHSHVYRGCLPD-----------GKELAV--KILKPSE-DVLKEFASEIEIITALH 384
+G+G + +Y G L KE+ V K+L PS D+ F ++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 385 HRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALD 444
H++I+ L+G C D ++V +F+ G L+ +H K D W ++KVA +A AL
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-RKSDVLTTPW--KFKVAKQLASALS 119
Query: 445 YLHNSCEQPVIHKDVKSSNILLS-----DDFEP--QLSDFGLASWLSTSSSHLTCTDVAG 497
YL ++ ++H +V + NILL+ + P +LSD G+ T S C +
Sbjct: 120 YLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP---ITVLSRQECVE--- 170
Query: 498 TFGYLAPEYFMHGKV-SEKIDVYAFGIVLLEL-LSGKKPIN----SENPKGQESLVMWAK 551
++APE K S D ++FG L E+ +G+ P+ +E + E M
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVT 230
Query: 552 PILKD 556
P K+
Sbjct: 231 PSCKE 235
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 18/198 (9%)
Query: 340 GKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFAS--EIEIITAL-HHRNIISLFGFC 395
G+G S V + GK A+K +K L++ + EI+ + L H NI+ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVL 67
Query: 396 FE--DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
F+ L LV++ L +L E + G K+ + ++LD++H +
Sbjct: 68 FDRKTGRLALVFE-LMDMNLYELIKGRKR---PLPEKRVKSYMYQLLKSLDHMHRN---G 120
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM-HGKV 512
+ H+D+K NIL+ DD +L+DFG S T+ T Y APE + G
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFGSC---RGIYSKPPYTEYISTRWYRAPECLLTDGYY 176
Query: 513 SEKIDVYAFGIVLLELLS 530
K+D++A G V E+LS
Sbjct: 177 GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 29/101 (28%), Positives = 54/101 (53%), Gaps = 5/101 (4%)
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
+ AL+YLH+ + V+++D+K N++L D +++DFGL + + T GT
Sbjct: 104 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGT 158
Query: 499 FGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
YLAPE +D + G+V+ E++ G+ P +++
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 43/159 (27%), Positives = 78/159 (49%), Gaps = 12/159 (7%)
Query: 376 EIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD-GNAFGWTERYK 434
E+ ++ L H NI++L D +L LV+++L +++L D GN
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-----DKDLKQYMDDCGNIMSMHNVKI 108
Query: 435 VAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD 494
+ L Y H + V+H+D+K N+L+++ E +L+DFGLA S + T ++
Sbjct: 109 FLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSN 163
Query: 495 VAGTFGYLAPEYFM-HGKVSEKIDVYAFGIVLLELLSGK 532
T Y P+ + + S +ID++ G + E+ SG+
Sbjct: 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 339 VGKGGHSHVYR-GCLPDGKELAVKIL---KPSEDVLKEFASEIEIITALHHRNIISLFGF 394
+G+G H V++ G+ +A+K + + + + EI+ + A H ++ L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
+ +LV +++ L E L + + + + + + Y+H + +
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVL---RDEERPLPEAQVKSYMRMLLKGVAYMHAN---GI 120
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG--KV 512
+H+D+K +N+L+S D +++DFGLA S L VA T Y APE ++G K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPE-LLYGARKY 178
Query: 513 SEKIDVYAFGIVLLELLSG 531
+D++A G + ELL+G
Sbjct: 179 DPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 70/288 (24%), Positives = 109/288 (37%), Gaps = 33/288 (11%)
Query: 267 SADTSEDNRSNLDGESGAIVSVEH----DSACPPLSPYNELPKELEGLQERYSSTCRLFS 322
S DT+ D + D E G V H D+ LSP ++ +E E SS+
Sbjct: 34 SKDTTGDKFDDCD-ELGDSDDVTHATDYDADEESLSPQTDVCQEP---CETTSSSDPASV 89
Query: 323 YQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITA 382
+ + S+ P G V+ C G E K++ + K EI+I+
Sbjct: 90 VRMQYNILSSLTP------GSEGEVFV-CTKHGDEQRKKVIVKAVTGGKTPGREIDILKT 142
Query: 383 LHHRNIISLFGFCFEDNNLLLV-----YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV 437
+ HR II+L + + +V D + L + +
Sbjct: 143 ISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLE----------QAITIQR 192
Query: 438 GVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAG 497
+ EAL YLH + +IH+DVK+ NI L + L DFG A L C +G
Sbjct: 193 RLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 498 TFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQES 545
T +PE K D+++ G+VL E+ + + K S
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSS 297
|
Length = 392 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 45/166 (27%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 395 CFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
CF+ + L LV ++++ G L ++ +K R+ A + AL++LH E+
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHA---RF-YAAEICIALNFLH---ERG 116
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVS 513
+I++D+K N+LL D +L+D+G+ T + GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 514 EKIDVYAFGIVLLELLSGKKPIN--SENP--KGQESL--VMWAKPI 553
+D +A G+++ E+++G+ P + ++NP ++ L V+ KPI
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI 220
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 42/204 (20%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 339 VGKGGHSHVY----RGCLPDGKE--LAVKILKPSEDVLK--EFASEIEIITALHHRNIIS 390
+G+G VY +G + D E +A+K + + + + EF +E ++ + +++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHG--NKKDGNAF----GWTERYKVAVGVAEALD 444
L G + L++ + ++RG L+ L + + N + ++A +A+ +
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 445 YLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAP 504
YL+ +H+D+ + N ++++DF ++ DFG+ + + + +++P
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 505 EYFMHGKVSEKIDVYAFGIVLLEL 528
E G + DV++FG+VL E+
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 10/168 (5%)
Query: 375 SEIEIITALHHRNIISLFGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY 433
+E +I+ ++ + +++L + +E + L LV ++ G L+ +++ G E
Sbjct: 49 NEKQILEKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-----FEEE 102
Query: 434 KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCT 493
+ AE L L + + +++D+K NILL D ++SD GLA + S
Sbjct: 103 RALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IR 159
Query: 494 DVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541
GT GY+APE + + + D + G ++ E++ G+ P K
Sbjct: 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 48/147 (32%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 394 FCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
F F+ L LV F++ G L H +++G R+ A + AL+ LH +
Sbjct: 60 FSFQSPEKLYLVLAFINGGEL---FHHLQREGRFDLSRARFYTA-ELLCALENLH---KF 112
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
VI++D+K NILL L DFGL L+ T T GT YLAPE +
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNT-FCGTPEYLAPELLLGHGY 170
Query: 513 SEKIDVYAFGIVLLELLSGKKPINSEN 539
++ +D + G++L E+L+G P EN
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPPFYDEN 197
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 40/151 (26%), Positives = 78/151 (51%), Gaps = 14/151 (9%)
Query: 395 CFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
CF+ ++ L V ++++ G L ++ +K R+ A ++ AL+YLH E+
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA---RFYSA-EISLALNYLH---ERG 116
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVS 513
+I++D+K N+LL + +L+D+G+ T + GT Y+APE
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 514 EKIDVYAFGIVLLELLSGKKPIN----SENP 540
+D +A G+++ E+++G+ P + S+NP
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIVGSSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 46/206 (22%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 339 VGKGGHSHVYRGCLPD------GKELAVKILKPSEDVLK--EFASEIEIITALHHRNIIS 390
+G+G VY G D +AVK + S + + EF +E ++ +++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDG-NAFG-----WTERYKVAVGVAEALD 444
L G + L+V + ++ G L+ L + + N G E ++A +A+ +
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 445 YLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAP 504
YL+ + +H+D+ + N +++ DF ++ DFG+ + + + ++AP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 505 EYFMHGKVSEKIDVYAFGIVLLELLS 530
E G + D+++FG+VL E+ S
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-08
Identities = 29/123 (23%), Positives = 52/123 (42%), Gaps = 5/123 (4%)
Query: 7 VVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVKT-FDSMLSVY 65
++V V ES L WA + G ++ LHV+D S L L++ ++L
Sbjct: 2 ILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAAELAELLEEEARALLEAL 61
Query: 66 EGFCNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSV--SVAKYC 123
V ++ V G + I++ A+ G +++G S+ +R + SVA+
Sbjct: 62 REALAEAGVKVETVVLEGDPAEA-ILEAAEELGADLIVMG-SRGRSGLRRLLLGSVAERV 119
Query: 124 ARK 126
R
Sbjct: 120 LRH 122
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 54/180 (30%), Positives = 80/180 (44%), Gaps = 14/180 (7%)
Query: 362 ILKPSEDVLKEFASEIEIITA-LHHRNIISLFGFCFED-NNLLLVYDFLSRGSLEENLHG 419
ILK E+ K SE ++ + H ++ L F F+ + L V D+++ G L +L
Sbjct: 33 ILKKKEE--KHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQR 89
Query: 420 NKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479
+ F A +A AL YLH+ ++++D+K NILL L+DFGL
Sbjct: 90 ER----CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGL 142
Query: 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
+ T + GT YLAPE +D + G VL E+L G P S N
Sbjct: 143 CK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 21/211 (9%)
Query: 338 LVGKGGHSHVY---RGCLPDGKELAVKILKPSEDVLKEFASEIE-----IITALHHRNII 389
++GKG V R DG AVK+L+ + K+ + I ++ L H ++
Sbjct: 2 VIGKGSFGKVLLAKRKS--DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 390 SLFGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHN 448
L + F+ L V D+++ G L +L + F A VA A+ YLH+
Sbjct: 60 GLH-YSFQTAEKLYFVLDYVNGGELFFHLQRER----CFLEPRARFYAAEVASAIGYLHS 114
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM 508
+I++D+K NILL L+DFGL T + GT YLAPE
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLR 169
Query: 509 HGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
+D + G VL E+L G P S +
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 41/158 (25%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 376 EIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKV 435
E+ ++ L H NI++L + +L LV+++L + L++ L GN+
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL---DDCGNSINMHNVKLF 109
Query: 436 AVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDV 495
+ L+Y H + V+H+D+K N+L+++ E +L+DFGLA S + T ++
Sbjct: 110 LFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNE 164
Query: 496 AGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGK 532
T Y P+ + S +ID++ G + E+ +G+
Sbjct: 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 59/220 (26%), Positives = 103/220 (46%), Gaps = 44/220 (20%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFA----SEIEIITALHHRNIISLF 392
+G+G + V P G ++A+K + P E F EI+I+ H NII +
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT--FCQRTLREIKILRRFKHENIIGIL 69
Query: 393 GF----CFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER----------YKVAV 437
FE N++ +V + + E +L+ K T+ Y++
Sbjct: 70 DIIRPPSFESFNDVYIVQELM-----ETDLYKLIK-------TQHLSNDHIQYFLYQILR 117
Query: 438 GVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL-TCTDVA 496
G L Y+H++ V+H+D+K SN+LL+ + + ++ DFGLA H T+
Sbjct: 118 G----LKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 497 GTFGYLAPEYFMHGK-VSEKIDVYAFGIVLLELLSGKKPI 535
T Y APE ++ K ++ ID+++ G +L E+LS +P+
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 53/202 (26%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVK-ILKPSED--VLKEFASEIEIITALHHRNIISLFGF 394
+G+G + VY+ G+ +A+K I +ED V EI ++ L+H NI+ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
+N L LV++FL L++ + + G + Y + + + Y H+ V
Sbjct: 67 VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQ--LLQGIAYCHS---HRV 120
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK-VS 513
+H+D+K N+L+ + +L+DFGLA T V T Y APE + + S
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGSRQYS 178
Query: 514 EKIDVYAFGIVLLELLSGKKPI 535
+D+++ G + E+++ ++P+
Sbjct: 179 TPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 41/158 (25%), Positives = 77/158 (48%), Gaps = 10/158 (6%)
Query: 376 EIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKV 435
E+ ++ L H NI++L + L LV+++L L++ L GN
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYL---DNCGNLMSMHNVKIF 108
Query: 436 AVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDV 495
+ L Y H ++ ++H+D+K N+L+++ E +L+DFGLA S + T ++
Sbjct: 109 MFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNE 163
Query: 496 AGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGK 532
T Y P+ + + S ID++ G +L E+ +G+
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPS-----EDVLKEFASEIEIITALHHRNIISL 391
++GKG V L E A+K LK +DV + A H + L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
F +L V ++L+ G L ++ + + F A + L +LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR----FDEARARFYAAEIICGLQFLHK--- 114
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
+ +I++D+K N+LL D +++DFG+ + GT Y+APE K
Sbjct: 115 KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTFCGTPDYIAPEILKGQK 172
Query: 512 VSEKIDVYAFGIVLLELLSGKKPINSEN 539
+E +D ++FG++L E+L G+ P + E+
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (133), Expect = 6e-08
Identities = 55/221 (24%), Positives = 93/221 (42%), Gaps = 49/221 (22%)
Query: 338 LVGKGGHSHVYRGCL----PDGKELAVK-ILKPSEDVL--KEFASEIEIITALHHRNIIS 390
+G G + V C G+++A+K I +D++ K EI+++ L H NII
Sbjct: 7 PIGSGAYGVV---CSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIG 63
Query: 391 LFGF-------CFEDNNLLLVYDFL---------SRGSLEENLHGNKKDGNAFGWTERYK 434
L F D + +V + + S L + + +
Sbjct: 64 LLDILRPPSPEDFND--VYIVTELMETDLHKVIKSPQPLTD---------------DHIQ 106
Query: 435 -VAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC- 492
+ L YLH S VIH+D+K SNIL++ + + ++ DFGLA +
Sbjct: 107 YFLYQILRGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 493 TDVAGTFGYLAPEYFMHGK-VSEKIDVYAFGIVLLELLSGK 532
T+ T Y APE + ++ ID+++ G + ELL+ K
Sbjct: 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 47/170 (27%), Positives = 84/170 (49%), Gaps = 14/170 (8%)
Query: 375 SEIEIITALHHRNIISLFGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY 433
+E +I+ ++ R ++SL + +E + L LV ++ G L+ +++ GN G+ E
Sbjct: 49 NEKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNM---GNP-GFDEER 103
Query: 434 KV--AVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491
V A + L+ LH + ++++D+K NILL D ++SD GLA + T
Sbjct: 104 AVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---T 157
Query: 492 CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541
GT GY+APE + + + D + G ++ E++ GK P K
Sbjct: 158 IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 356 KELAVKILKPSEDVLKE----FASEIEIITALHHRNIISLFGFCFEDNNLL-LVYDFLSR 410
K A+K+L E + + F E +I+ + ++ LF + F+D+ L +V +++
Sbjct: 69 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPG 127
Query: 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF 470
G L NL N W Y V +A LD +H+ IH+DVK N+LL
Sbjct: 128 GDLV-NLMSNYDVPEK--WARFYTAEVVLA--LDAIHS---MGFIHRDVKPDNMLLDKSG 179
Query: 471 EPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH----GKVSEKIDVYAFGIVLL 526
+L+DFG ++ + C GT Y++PE G + D ++ G+ L
Sbjct: 180 HLKLADFGTCMKMN-KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 527 ELLSGKKPINSENPKGQESLVM 548
E+L G P +++ G S +M
Sbjct: 239 EMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 17/201 (8%)
Query: 356 KELAVKILKPSEDVLKE----FASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRG 411
K A+K+L E + + F E +I+ + ++ LF +D L +V +++ G
Sbjct: 69 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGG 128
Query: 412 SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE 471
L NL N W + Y V +A LD +H+ +IH+DVK N+LL
Sbjct: 129 DLV-NLMSNYDVPEK--WAKFYTAEVVLA--LDAIHS---MGLIHRDVKPDNMLLDKHGH 180
Query: 472 PQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH----GKVSEKIDVYAFGIVLLE 527
+L+DFG + + + C GT Y++PE G + D ++ G+ L E
Sbjct: 181 LKLADFGTCMKMD-ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFE 239
Query: 528 LLSGKKPINSENPKGQESLVM 548
+L G P +++ G S +M
Sbjct: 240 MLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 54/240 (22%), Positives = 95/240 (39%), Gaps = 46/240 (19%)
Query: 333 FLPEYLVGKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFAS---------------- 375
+L G+G + V + GK +A+K +K E + +
Sbjct: 12 QKGAHL-GEGTYGKVEKAYDTLTGKIVAIKKVKIIE--ISNDVTKDRQLVGMCGIHFTTL 68
Query: 376 -EIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYK 434
E++I+ + H NI+ L E + + LV D ++ L++ + + TE
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR------LTESQV 121
Query: 435 --VAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA------------ 480
+ + + L+ LH +H+D+ +NI ++ +++DFGLA
Sbjct: 122 KCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTL 178
Query: 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSEN 539
S T T T Y APE M K +D+++ G + ELL+GK EN
Sbjct: 179 SKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238
|
Length = 335 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 339 VGKGGHSHVYRGCLPDGKELA----VKILKPSEDVLKEFASEIEIITALHHRNIISLFGF 394
+G+G + V++ + E+ V++ E V EI ++ L H+NI+ L+
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
D L LV+++ +++L K + G + V + + L L V
Sbjct: 68 LHSDKKLTLVFEYC-----DQDL--KKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV-S 513
+H+D+K N+L++ + E +L+DFGLA + V T Y P+ K+ S
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYS 178
Query: 514 EKIDVYAFGIVLLELLSGKKPI 535
ID+++ G + EL + +P+
Sbjct: 179 TSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 56/192 (29%), Positives = 84/192 (43%), Gaps = 16/192 (8%)
Query: 354 DGKELAVKILKP----SEDVLKEFASEIEIITA-LHHRNIISLFGFCFEDNN-LLLVYDF 407
DGK AVK+L+ + K +E ++ + H ++ L + F+ L V DF
Sbjct: 19 DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH-YSFQTTEKLYFVLDF 77
Query: 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS 467
++ G L +L + +F A +A AL YLH+ ++++D+K NILL
Sbjct: 78 VNGGELFFHLQRER----SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLD 130
Query: 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLE 527
L+DFGL S T T GT YLAPE +D + G VL E
Sbjct: 131 SQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYE 188
Query: 528 LLSGKKPINSEN 539
+L G P +
Sbjct: 189 MLYGLPPFYCRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 17/210 (8%)
Query: 339 VGKGGHSHVYRGCLPDG---KELAVKILKPSEDVLKE--FASEIEIITALHHRNIISLFG 393
+G G V G + G ++ VK L+ S V ++ F E + +L H N++ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKK-DGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
C E LLV +F G L+ L +K + T ++A +A L +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF--MHG 510
IH D+ N LL+ D ++ D+GL+ ++T + ++APE +HG
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 511 KV-----SEKIDVYAFGIVLLELLS-GKKP 534
+ +++ +V++ G+ + EL G +P
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 52/193 (26%), Positives = 89/193 (46%), Gaps = 21/193 (10%)
Query: 355 GKELAVKILKPSEDVLK-EFA---SEIEIITALHHRNIISLFGFCFEDNN-LLLVYDFLS 409
GK A+KILK + K E A +E ++ H + +L + F+ ++ L V ++ +
Sbjct: 20 GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYAN 78
Query: 410 RGSLEENLHGNK---KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL 466
G L +L + +D F E + AL YLH V+++D+K N++L
Sbjct: 79 GGELFFHLSRERVFSEDRARFYGAE-------IVSALGYLH---SCDVVYRDLKLENLML 128
Query: 467 SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLL 526
D +++DFGL S T GT YLAPE +D + G+V+
Sbjct: 129 DKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 186
Query: 527 ELLSGKKPINSEN 539
E++ G+ P +++
Sbjct: 187 EMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 51/221 (23%), Positives = 107/221 (48%), Gaps = 31/221 (14%)
Query: 339 VGKGGHSHVYRGC---LPDGKEL-----AVKIL-KPSEDVLKEFASEIEIITALHHRNII 389
+G+G + +++G + D EL +K+L K + + F +++ L H++++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 390 SLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
+G C + ++V +++ GSL+ L KK+ N + + +VA +A AL +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL---KKNKNLINISWKLEVAKQLAWALHFLE-- 117
Query: 450 CEQPVIHKDVKSSNILLSDDFEP--------QLSDFGLASWLSTSSSHLTCTDVAGTFGY 501
++ + H +V + N+LL + + +LSD G+ S + L + +
Sbjct: 118 -DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI------SITVLPKEILLERIPW 170
Query: 502 LAPEYFMHGK-VSEKIDVYAFGIVLLELLSG-KKPINSENP 540
+ PE + + +S D ++FG L E+ SG KP+++ +
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 68/279 (24%), Positives = 113/279 (40%), Gaps = 27/279 (9%)
Query: 339 VGKGGHSHVYRGCLPDGKELA---VKILKPSEDVLKE--FASEIEIITALHHRNIISLFG 393
+G G V G G A VK L+ S ++ F E++ L+H N++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTE-RYKVAVGVAEALDYLHNSCEQ 452
C E LLV +F G L+ L N+ + ++A VA L +LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY------ 506
IH D+ N L+ D ++ D+GLA ++T A +LAPE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 507 -FMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565
+ ++K ++++ G+ + EL + ++ P S K ++++ + +L P
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLSDEQVLKQVVREQDI-KLPKP 233
Query: 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLL 604
LD Y + E M P RP V +LL
Sbjct: 234 QLDLKYSDRWYEVMQFCWL-----DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 48/159 (30%), Positives = 82/159 (51%), Gaps = 18/159 (11%)
Query: 385 HRNIISLFGF--CFEDN-NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE 441
H+NI L+ F N N L +Y+ L L + + + +A + Y++ G
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCG--- 117
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS----SSHLTCTDVAG 497
L Y+H++ V+H+D+K N+L++ D E ++ DFGLA S + + + T+
Sbjct: 118 -LKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM--TEYVA 171
Query: 498 TFGYLAPEYFM-HGKVSEKIDVYAFGIVLLELLSGKKPI 535
T Y APE + ++ IDV++ G +L ELL G+KP+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 44/170 (25%), Positives = 83/170 (48%), Gaps = 14/170 (8%)
Query: 375 SEIEIITALHHRNIISLFGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY 433
+E I+ ++ R ++SL + +E + L LV ++ G L+ +++ GN G+ E+
Sbjct: 49 NEKRILEKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNM---GNP-GFDEQR 103
Query: 434 KV--AVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491
+ A + L+ L + ++++D+K NILL D ++SD GLA + T
Sbjct: 104 AIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---T 157
Query: 492 CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541
GT GY+APE + K + D + G ++ E++ G+ P +
Sbjct: 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-07
Identities = 36/132 (27%), Positives = 54/132 (40%), Gaps = 16/132 (12%)
Query: 6 VVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTIT--ESTGSLLSLVKTF----- 58
V V V D +S+ L WAL +A G I+ +HV IT S+ L + +
Sbjct: 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEED 60
Query: 59 ---DSMLSVYEGFCNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVG------ISKT 109
+L Y FC+ K V + V V K IV+ +G K+++G S
Sbjct: 61 KEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMK 120
Query: 110 HRTIRSSVSVAK 121
+ + SV K
Sbjct: 121 FKKSDVASSVLK 132
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 13/94 (13%)
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY 501
L Y+H S +IH+D+K SNI +++D E ++ DFGLA T T Y
Sbjct: 130 GLKYIH-SAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 181
Query: 502 LAPE---YFMHGKVSEKIDVYAFGIVLLELLSGK 532
APE +MH ++ +D+++ G ++ ELL+GK
Sbjct: 182 RAPEIMLNWMH--YNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 25/211 (11%)
Query: 339 VGKGGHSHVYRGC-LPDGKELA----VKILKPSEDVLKEFASEIEIITALH---HRNIIS 390
+G+G + V++ L +G V++ E + E+ ++ L H N++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 391 LFGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYK-VAVGVAEALD 444
LF C + L LV++ + + L L + G TE K + + LD
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVP---TETIKDMMFQLLRGLD 124
Query: 445 YLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAP 504
+LH+ V+H+D+K NIL++ + +L+DFGLA S + T V T Y AP
Sbjct: 125 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA---RIYSFQMALTSVVVTLWYRAP 178
Query: 505 EYFMHGKVSEKIDVYAFGIVLLELLSGKKPI 535
E + + +D+++ G + E+ +KP+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 33/113 (29%), Positives = 54/113 (47%), Gaps = 16/113 (14%)
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS-------------WLSTSSS 488
AL+YLHN ++H+D+K N+L++ +L+DFGL+ + +
Sbjct: 113 ALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541
V GT Y+APE + + +D +A GI+L E L G P + P+
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 222
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 39/144 (27%), Positives = 71/144 (49%), Gaps = 15/144 (10%)
Query: 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE---ALDYLHNSCEQPVI 455
+L V +FL+ G L H K G + Y+ AE L +LH+ + +I
Sbjct: 69 EHLFFVMEFLNGGDLM--FHIQDK-----GRFDLYRATFYAAEIVCGLQFLHS---KGII 118
Query: 456 HKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEK 515
++D+K N++L D +++DFG+ + + GT Y+APE K +
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLKYTFS 176
Query: 516 IDVYAFGIVLLELLSGKKPINSEN 539
+D ++FG++L E+L G+ P + ++
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 52/182 (28%), Positives = 86/182 (47%), Gaps = 32/182 (17%)
Query: 376 EIEIITALHHRNIISLFGFCFED----NN----LLLVYDFLSRGSLEENLHGNKKDGNA- 426
EI+I+ L H N+++L C N LV++F E +L G + N
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC-----EHDLAGLLSNKNVK 115
Query: 427 FGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486
F +E KV + L Y+H + ++H+D+K++NIL++ D +L+DFGLA S S
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLS 172
Query: 487 ---SSHLTCTDVAGTFGYLAPEYFM----HGKVSEKIDVYAFGIVLLELLSGKKPI---N 536
+ V T Y PE + +G ID++ G ++ E+ + + PI N
Sbjct: 173 KNSKPNRYTNRVV-TLWYRPPELLLGERDYGP---PIDMWGAGCIMAEMWT-RSPIMQGN 227
Query: 537 SE 538
+E
Sbjct: 228 TE 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 30/199 (15%)
Query: 376 EIEIITALHHRNIISLFGF------CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGW 429
E+ ++ ++H+NIISL E ++ LV + + +L + +H + D +
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIH-MELDHERMSY 127
Query: 430 TERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489
Y++ G+ +LH++ +IH+D+K SNI++ D ++ DFGLA T+ ++
Sbjct: 128 L-LYQMLCGIK----HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTN 176
Query: 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMW 549
T T Y APE + E +D+++ G ++ EL+ G S +G + + W
Sbjct: 177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG-----SVIFQGTDHIDQW 231
Query: 550 AKPILKDGKVSQLLDPSLD 568
K I QL PS +
Sbjct: 232 NKVI------EQLGTPSAE 244
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 27/91 (29%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY 501
+ +LH++ +IH+D+K SNI++ D ++ DFGLA T+ + T T Y
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 183
Query: 502 LAPEYFMHGKVSEKIDVYAFGIVLLELLSGK 532
APE + E +D+++ G ++ E++ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 33/96 (34%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA-SWLSTSSSHLTCTDVAGTFG 500
AL Y+H + V H+D+K NIL + D + ++ DFGLA + + + + TD T
Sbjct: 115 ALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 501 YLAPE----YFMHGKVSEKIDVYAFGIVLLELLSGK 532
Y APE +F K + ID+++ G + E+L+GK
Sbjct: 172 YRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 5e-07
Identities = 34/94 (36%), Positives = 57/94 (60%), Gaps = 7/94 (7%)
Query: 443 LDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL 502
L Y+H++ V+H+D+K SN+LL+ + + ++ DFGLA +TS T+ T Y
Sbjct: 121 LKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYR 175
Query: 503 APEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPI 535
APE ++ + + IDV++ G + ELL G+KP+
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 48/216 (22%), Positives = 94/216 (43%), Gaps = 47/216 (21%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKILKPSED-------VLKEFASEIEIITALHHRNII 389
+G+G + VY+ L G+ +A+K ++ L+E A ++ + + H NI+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL-LKQLESFEHPNIV 64
Query: 390 SLFGFC-----FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE--- 441
L C + L LV++ + +++L + + G+
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-----DQDLAT---------YLSKC-PKPGLPPETI 109
Query: 442 ---------ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492
+D+LH+ ++H+D+K NIL++ D + +++DFGLA S +
Sbjct: 110 KDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA---RIYSFEMAL 163
Query: 493 TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLEL 528
T V T Y APE + + +D+++ G + EL
Sbjct: 164 TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKI--LKPSEDVLKEFASEIEIITALHH 385
A +++L +G+G ++ VY+G +G+ +A+K+ +K E V E ++ L H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 386 RNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV---GVAEA 442
NI+ L L V++++ L + + + G Y V + +
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHP------GGLHPYNVRLFMFQLLRG 115
Query: 443 LDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL 502
L Y+H Q ++H+D+K N+L+S E +L+DFGLA S S + V T Y
Sbjct: 116 LAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYR 170
Query: 503 APEYFMHG-KVSEKIDVYAFGIVLLELLSGK 532
P+ + S +D++ G + +E+L G+
Sbjct: 171 PPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-07
Identities = 62/240 (25%), Positives = 95/240 (39%), Gaps = 64/240 (26%)
Query: 354 DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL-LVYDFL 408
GK A+K L SE D L +E +++ ++SL+ + F+D L L+ +FL
Sbjct: 25 TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY-YSFQDAQYLYLIMEFL 83
Query: 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE---ALDYLHNSCEQPVIHKDVKSSNIL 465
G L L K D + T Y +AE A++ +H + IH+D+K NIL
Sbjct: 84 PGGDLMTML--IKYDTFSEDVTRFY-----MAECVLAIEAVH---KLGFIHRDIKPDNIL 133
Query: 466 LSDDFEPQLSDFGLAS-----------------------------------WLSTSSSHL 490
+ +LSDFGL++ L+ SS
Sbjct: 134 IDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQ 193
Query: 491 TCT----------DVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
T GT Y+APE F+ ++ D ++ G ++ E L G P SEN
Sbjct: 194 IATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENS 253
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 48/214 (22%), Positives = 94/214 (43%), Gaps = 21/214 (9%)
Query: 338 LVGKGGHSHVYRGCLP----DGKELAVKILKP----SEDVLKEFASEIEIITALHHRNII 389
++GKG V L +++AVK+LK S D+ +EF E + H N+I
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDI-EEFLREAACMKEFDHPNVI 64
Query: 390 SLFGFCFEDNNL------LLVYDFLSRGSLEENLHGNKKDGNAFGWTER--YKVAVGVAE 441
L G +++ F+ G L L ++ F + + + +A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY 501
++YL + + IH+D+ + N +L+++ ++DFGL+ + + + +
Sbjct: 125 GMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 502 LAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
LA E + DV+AFG+ + E+++ G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 31/103 (30%), Positives = 55/103 (53%), Gaps = 9/103 (8%)
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY 501
AL++LH E+ +I++D+K N+LL + +L+D+G+ T T GT Y
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTST-FCGTPNY 162
Query: 502 LAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPI----NSENP 540
+APE +D +A G+++ E+++G+ P S+NP
Sbjct: 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNP 205
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 64/245 (26%), Positives = 113/245 (46%), Gaps = 25/245 (10%)
Query: 332 NFLPEYLVGKG--GHSHVYRGCLPDGKELAVKILKPSEDVLKE----FASEIEIITALHH 385
+F + LVG+G G V R G A+K++K S + +E F E +I++ +
Sbjct: 2 DFDVKSLVGRGHFGEVQVVRE-KATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 386 RNIISLFGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALD 444
I L + F+D NL LV ++ G L L N+ + + +AE +
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQ----FDEDMAQFYLAELVL 113
Query: 445 YLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAP 504
+H+ + +H+D+K N+L+ +L+DFG A+ L T++ + GT Y+AP
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAP 172
Query: 505 EYFM----HGKVSEKI--DVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILK--- 555
E GK + + D ++ G++ E++ G+ P + + +M + LK
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE 232
Query: 556 DGKVS 560
D KVS
Sbjct: 233 DPKVS 237
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 52/241 (21%), Positives = 100/241 (41%), Gaps = 52/241 (21%)
Query: 328 SATSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVK-ILKPSEDVLKEFA-----SEIEII 380
S ++ +G+G VY+ + G+ +A+K IL +E K+ EI+I+
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE---KDGFPITALREIKIL 61
Query: 381 TALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGN------KKDGNAFGWTERYK 434
L H N++ L + + + R + G+ D + G E
Sbjct: 62 KKLKHPNVVPL---------IDMAVE---RPDKSKRKRGSVYMVTPYMDHDLSGLLENPS 109
Query: 435 VAVGVA----------EALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484
V + + E ++YLH E ++H+D+K++NIL+ + +++DFGLA
Sbjct: 110 VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYD 166
Query: 485 TSSSHLTC---------TDVAGTFGYLAPEYFMHGK-VSEKIDVYAFGIVLLELLSGKKP 534
+ T++ T Y PE + + + +D++ G V E+ + +P
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RP 225
Query: 535 I 535
I
Sbjct: 226 I 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 16/178 (8%)
Query: 366 SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGN 425
+ +++ E+ + +H NI+ DN L +V F++ GS ++ + + DG
Sbjct: 39 TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM 98
Query: 426 AFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485
+ Y + GV +ALDY+H+ +H+ VK+S+IL+S D + LS GL S LS
Sbjct: 99 S-ELAIAY-ILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLS--GLRSNLSM 151
Query: 486 SSS-------HLTCTDVAGTFGYLAPEYFMHG--KVSEKIDVYAFGIVLLELLSGKKP 534
+ H +L+PE K D+Y+ GI EL +G P
Sbjct: 152 INHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 36/132 (27%), Positives = 70/132 (53%), Gaps = 12/132 (9%)
Query: 443 LDYLHNSCEQPVIHKDVKSSNILLS-DDFEPQLSDFGLASWLSTSSSH---LTCTDVAGT 498
L Y+H++ V+H+D+K +N+ ++ +D ++ DFGLA + SH L+ V T
Sbjct: 127 LKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV--T 181
Query: 499 FGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557
Y +P + ++ ID++A G + E+L+GK + Q L++ + P++++
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241
Query: 558 KVSQLL--DPSL 567
++LL PS
Sbjct: 242 DRNELLNVIPSF 253
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 42/200 (21%), Positives = 95/200 (47%), Gaps = 22/200 (11%)
Query: 347 VYRGCLPDGKELAVKILKP----SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL 402
+Y+G + KE+ ++ K + ++ +EI+ + + NI+ ++GF + + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 403 ----LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKD 458
L+ ++ +RG L E L K + + +A+ + L L+ +P +K+
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148
Query: 459 VKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF--MHGKVSEKI 516
+ S + L++++++ ++ GL LS+ +V Y + + + + + K
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFK----NV-NFMVYFSYKMLNDIFSEYTIKD 203
Query: 517 DVYAFGIVLLELLSGKKPIN 536
D+Y+ G+VL E+ +GK P
Sbjct: 204 DIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 338 LVGKGGHSHVYRGCLPDG-KELAVKILKPSEDVLKE-----FASEIEIITALHHRNIISL 391
++G+G V L + K A+KIL E +LK F E +++ ++ I +L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWE-MLKRAETACFREERDVLVNGDNQWITTL 66
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
++NNL LV D+ G L L +K + R+ +A V A+D +H +
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVI-AIDSVH---Q 120
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVA-GTFGYLAPEYFM-- 508
+H+D+K NIL+ + +L+DFG S L + VA GT Y++PE
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 509 ---HGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
GK + D ++ G+ + E+L G+ P +E+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 59/271 (21%), Positives = 108/271 (39%), Gaps = 76/271 (28%)
Query: 339 VGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKEFA----SEIEIITALHHRNIISLFG 393
+G G V D L A+K L+ ++ +++ A +E +I+ + ++ L+
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 394 FCFED-NNLLLVYDFLSRGSL----------EENLHGNKKDGNAFGWTERYKVAVGVAEA 442
+ F+D +NL V D++ G + EE+L R+ +A + A
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-------------ARFYIA-ELTCA 113
Query: 443 LDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS---WLSTSS------------ 487
++ +H IH+D+K NIL+ D +L+DFGL + W S
Sbjct: 114 IESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 488 ------------------------SHLTCT--DVAGTFGYLAPEYFMHGKVSEKIDVYAF 521
H C + GT Y+APE + ++ D ++
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 522 GIVLLELLSGKKPINSENPKG-QESLVMWAK 551
G++L E+L G+ P ++ P Q ++ W
Sbjct: 231 GVILYEMLVGQPPFLADTPAETQLKVINWET 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 32/107 (29%), Positives = 57/107 (53%), Gaps = 7/107 (6%)
Query: 443 LDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS-WLSTSSSHLTCTDVAGTFGY 501
L YLH++ ++H+D+K N+L++ + ++ DFGLA S H+T V T Y
Sbjct: 116 LKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV--TQYY 170
Query: 502 LAPEYFMHGK-VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV 547
APE M + + +D+++ G + ELL + +++P Q L+
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 47/167 (28%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 380 ITALHHRNIISLFGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVG 438
IT LH + F+D N L LV D+ G L L +D Y
Sbjct: 63 ITTLH---------YAFQDENYLYLVMDYYVGGDLL-TLLSKFEDRLPEDMARFY----- 107
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVA-G 497
+AE + +H+ + +H+D+K N+LL + +L+DFG S L + + VA G
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG--SCLKMNQDGTVQSSVAVG 165
Query: 498 TFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
T Y++PE GK + D ++ G+ + E+L G+ P +E+
Sbjct: 166 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 374 ASEIEIITALHHRNIISLFG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER 432
A+E I+ A++H +II L G F + L++ + + +L+ +
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY------KTDLYCYLAAKRNIAICDI 184
Query: 433 YKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492
+ V A+ YLH + +IH+D+K+ NI ++ + L DFG A + +++
Sbjct: 185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN-KY 240
Query: 493 TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGK 532
AGT APE +D+++ GIVL E+ +
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 32/98 (32%), Positives = 56/98 (57%), Gaps = 6/98 (6%)
Query: 439 VAEALDYL-HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAG 497
VA+ +D+L +C IH+DV + N+LL+D ++ DFGLA + S+++ +
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 498 TFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
++APE + + DV+++GI+L E+ S GK P
Sbjct: 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 39/145 (26%), Positives = 70/145 (48%), Gaps = 29/145 (20%)
Query: 348 YRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRN---------IISLFGFCFED 398
+ + K AVK++K ++ + K +++ R+ I+ L+
Sbjct: 24 RKKN--NSKLYAVKVVKKADMINKNMVHQVQA-----ERDALALSKSPFIVHLYYSLQSA 76
Query: 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER---YKVAVGVAEALDYLHNSCEQPVI 455
NN+ LV ++L G ++ LH +G+ + K VA ALDYLH +I
Sbjct: 77 NNVYLVMEYLIGGDVKSLLH-------IYGYFDEEMAVKYISEVALALDYLH---RHGII 126
Query: 456 HKDVKSSNILLSDDFEPQLSDFGLA 480
H+D+K N+L+S++ +L+DFGL+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 52/202 (25%), Positives = 98/202 (48%), Gaps = 25/202 (12%)
Query: 340 GKGGHSHVYRG--CLPDGKELAVKILKPSEDVLKEFAS--EIEIITALHHRNIISLFGFC 395
G+G ++ VY+G L G+ +A+K ++ + F + E ++ L H NI++L
Sbjct: 14 GEGSYATVYKGRSKL-TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 396 FEDNNLLLVYDFLSRGSLEENL--HGNKKDGN---AFGWTERYKVAVGVAEALDYLHNSC 450
L LV+++L L++ + G + F +++ G L Y H
Sbjct: 73 HTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLF----LFQLLRG----LAYCH--- 120
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510
++ V+H+D+K N+L+S+ E +L+DFGLA S S T ++ T Y P+ +
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGS 178
Query: 511 -KVSEKIDVYAFGIVLLELLSG 531
+ S +D++ G + E+ +G
Sbjct: 179 TEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|216006 pfam00582, Usp, Universal stress protein family | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-06
Identities = 29/129 (22%), Positives = 48/129 (37%), Gaps = 8/129 (6%)
Query: 5 KVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVKTFDSMLSV 64
K ++V V ES L WAL + G +I LHV+D S + + +
Sbjct: 3 KRILVAVDGSEESERALEWALELAKRRGAELILLHVIDPEPSGAASEALEEEEEEELEEE 62
Query: 65 YEGFCNLKQVDLKLKVC-----RGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSV-- 117
L V RG + I++ A+ +++G S+ +R +
Sbjct: 63 EAEAEALAAAAEAGGVVVEVVVRGGDPAEAILEVAEEEDADLIVMG-SRGRSGLRRLLLG 121
Query: 118 SVAKYCARK 126
SVA+ R
Sbjct: 122 SVAEKVLRH 130
|
The universal stress protein UspA is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, though UspA lacks ATP-binding activity. Length = 139 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 46/176 (26%), Positives = 77/176 (43%), Gaps = 30/176 (17%)
Query: 376 EIEIITALHHRNIISLFGFCFEDNNLLLVYDFL---------SRGSLEENLHGNKKDGNA 426
EI ++ + H NI+ L + L LV+++L S +N K
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIK----- 105
Query: 427 FGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP-QLSDFGLASWLST 485
T Y++ G+A Y H+ V+H+D+K N+L+ +L+DFGLA
Sbjct: 106 ---TYLYQILRGIA----YCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155
Query: 486 SSSHLTCTDVAGTFGYLAPEYFMHGK-VSEKIDVYAFGIVLLELLSGKK--PINSE 538
T V T Y APE + + S +D+++ G + E+++ K P +SE
Sbjct: 156 PVRTFTHEVV--TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE 209
|
Length = 294 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 3/93 (3%)
Query: 435 VAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD 494
VA + A+DY+H + +IH+D+K+ N+L++ + L DFG A + S S
Sbjct: 265 VARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 495 VAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLE 527
+AGT APE + +D+++ G+V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 51/190 (26%), Positives = 93/190 (48%), Gaps = 28/190 (14%)
Query: 355 GKELAVKIL-KPSEDVL--KEFASEIEIITALHHRNIISLFGF-----CFED-NNLLLVY 405
G +AVK L +P + ++ K E+ ++ + H N+I L E+ N++ LV
Sbjct: 42 GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101
Query: 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNIL 465
+ G+ N+ +K + Y++ G L Y+H++ +IH+D+K SN+
Sbjct: 102 HLM--GADLNNIVKCQKLTDDHVQFLIYQILRG----LKYIHSA---DIIHRDLKPSNLA 152
Query: 466 LSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY---FMHGKVSEKIDVYAFG 522
+++D E ++ DFGLA T T Y APE +MH + +D+++ G
Sbjct: 153 VNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQT--VDIWSVG 205
Query: 523 IVLLELLSGK 532
++ ELL+G+
Sbjct: 206 CIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 54/191 (28%), Positives = 96/191 (50%), Gaps = 30/191 (15%)
Query: 355 GKELAVKIL-KP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNL------LLVY 405
G ++A+K L +P SE K E+ ++ + H N+I L D +L LV
Sbjct: 40 GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99
Query: 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAV-GVAEALDYLHNSCEQPVIHKDVKSSNI 464
F+ G+ L ++K +R + V + + L Y+H + +IH+D+K N+
Sbjct: 100 PFM--GTDLGKLMKHEKLSE-----DRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNL 149
Query: 465 LLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY---FMHGKVSEKIDVYAF 521
+++D E ++ DFGLA + S +T V T Y APE +MH ++ +D+++
Sbjct: 150 AVNEDCELKILDFGLA---RQTDSEMTGYVV--TRWYRAPEVILNWMH--YTQTVDIWSV 202
Query: 522 GIVLLELLSGK 532
G ++ E+L+GK
Sbjct: 203 GCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 57/243 (23%), Positives = 95/243 (39%), Gaps = 34/243 (13%)
Query: 345 SHVYRGCLPDGKELAVKILKPSEDVLKE---FASEIEIITALHHRNIISLFGFCFEDNNL 401
S +Y + VK LK + KE F + + L H NI+ G C E
Sbjct: 14 SEIYTD--TGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPY 70
Query: 402 LLVYDFLSRGSL------EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
LLV+++ G L E+ N + ++A +A + ++H + +
Sbjct: 71 LLVFEYCELGDLKSYLSQEQWHRRNSQL------LLLQRMACEIAAGVTHMH---KHNFL 121
Query: 456 HKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF--MHGKV- 512
H D+ N L+ D ++ D+G+ T D +LAPE HG +
Sbjct: 122 HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLI 181
Query: 513 ----SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568
++ +V+A G+ L EL N+ P S ++KD +V +L P L+
Sbjct: 182 TAEQTKPSNVWALGVTLWELFE-----NAAQPYSHLSDREVLNHVIKDQQV-KLFKPQLE 235
Query: 569 TDY 571
Y
Sbjct: 236 LPY 238
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 13/93 (13%)
Query: 443 LDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL 502
L Y+H++ +IH+D+K SN+ +++D E ++ DFGLA + T T Y
Sbjct: 131 LKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA-----RQADDEMTGYVATRWYR 182
Query: 503 APEY---FMHGKVSEKIDVYAFGIVLLELLSGK 532
APE +MH ++ +D+++ G ++ ELL GK
Sbjct: 183 APEIMLNWMH--YNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 25/223 (11%)
Query: 323 YQELLSATSNFLPE-----YLVGKGGHSHVYRGC-LPDGKELAVKIL-KP--SEDVLKEF 373
Y+E ++ T LPE VG G + V G+++A+K L +P SE K
Sbjct: 2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRA 61
Query: 374 ASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF-LSRGSLEENLHGNKKDGNAFGWTER 432
E+ ++ + H N+I L + DF L ++ +L K G+ +
Sbjct: 62 YRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDL--QKIMGHPLSEDKV 119
Query: 433 YKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492
+ + L Y+H++ +IH+D+K N+ +++D E ++ DFGLA +
Sbjct: 120 QYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLA-----RHADAEM 171
Query: 493 TDVAGTFGYLAPEY---FMHGKVSEKIDVYAFGIVLLELLSGK 532
T T Y APE +MH ++ +D+++ G ++ E+L+GK
Sbjct: 172 TGYVVTRWYRAPEVILNWMH--YNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 29/97 (29%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
VA+ +++L + IH+D+ + NILLS++ ++ DFGLA + ++ D
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 499 FGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
++APE + + DV++FG++L E+ S G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 49/166 (29%), Positives = 80/166 (48%), Gaps = 24/166 (14%)
Query: 380 ITALHHRNIISLFGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVG 438
IT LH + F+D NNL LV D+ G L L +K + R+ +A
Sbjct: 63 ITNLH---------YAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEM 111
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVA-G 497
V A+D +H + +H+D+K N+LL + +L+DFG S L + ++VA G
Sbjct: 112 VL-AIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFG--SCLRLLADGTVQSNVAVG 165
Query: 498 TFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSE 538
T Y++PE G+ + D ++ G+ + E+L G+ P +E
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
VA+ + +L + IH+D+ + NILL+ ++ DFGLA + S+++ +
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 499 FGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
++APE + + + DV+++GI+L E+ S G P
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 36/136 (26%), Positives = 66/136 (48%), Gaps = 15/136 (11%)
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY 501
+ +LH++ +IH+D+K SNI++ D ++ DFGLA T+ + T T Y
Sbjct: 138 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 191
Query: 502 LAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG---- 557
APE + E +D+++ G ++ E++ G G + + W K I + G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF-----PGTDHIDQWNKVIEQLGTPCP 246
Query: 558 KVSQLLDPSLDTDYDN 573
+ + L P++ T +N
Sbjct: 247 EFMKKLQPTVRTYVEN 262
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 53/203 (26%), Positives = 86/203 (42%), Gaps = 25/203 (12%)
Query: 353 PDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFC-FEDNNLLLV--YDFLS 409
P + L K +K + +EI + L+H NI+ + E N ++ YDF
Sbjct: 190 PKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-- 247
Query: 410 RGSLEENLHGNKKDGNAFGWTER------YKVAVGVAEALDYLHNSCEQPVIHKDVKSSN 463
+L+ D AF W +R + + A++Y+H+ + +IH+D+K N
Sbjct: 248 ------DLYSFMYDE-AFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLEN 297
Query: 464 ILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGI 523
I L+ D + L DFG A V GT +PE E D+++ G+
Sbjct: 298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGL 356
Query: 524 VLLELLSGK-KPI--NSENPKGQ 543
+LL++LS PI P Q
Sbjct: 357 ILLDMLSHDFCPIGDGGGKPGKQ 379
|
Length = 501 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 45/232 (19%)
Query: 338 LVGKGGHSHVYRGCLPD-GKELAVKILKPSEDVL------KEFASEIEIITALHHRNIIS 390
L+GKGG VY P + +A+K K ED+ K F E +I L H I+
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALK--KIREDLSENPLLKKRFLREAKIAADLIHPGIVP 66
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENL------------HGNKKDGNAFGWTERYKVAVG 438
++ C + + + ++ +L+ L K AF +
Sbjct: 67 VYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF-----LSIFHK 121
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA---------------SWL 483
+ ++Y+H+ + V+H+D+K NILL E + D+G A
Sbjct: 122 ICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 484 STSSSHLTCT-DVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKP 534
+ S +T + GT Y+APE + SE D+YA G++L ++L+ P
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 52/244 (21%), Positives = 98/244 (40%), Gaps = 63/244 (25%)
Query: 359 AVKILKPSEDVLK----EFASEIEIITALHHRNIISLFGFCFED-NNLLLVYDFLSRGSL 413
A+K L+ + +L+ +E +I+ + ++ L+ + F+D +NL V D++ G +
Sbjct: 30 AMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLY-YSFQDKDNLYFVMDYIPGGDM 88
Query: 414 EENL--HGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE 471
L G + A + AV + + IH+D+K NIL+ D
Sbjct: 89 MSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF---------IHRDIKPDNILIDRDGH 139
Query: 472 PQLSDFGLAS---WLSTS----------------------SSHLTCTD------------ 494
+L+DFGL + W S ++ C D
Sbjct: 140 IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQ 199
Query: 495 --------VAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP-KGQES 545
+ GT Y+APE + ++ D ++ G++L E+L G+ P ++ P + Q
Sbjct: 200 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMK 259
Query: 546 LVMW 549
++ W
Sbjct: 260 VINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 29/97 (29%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
VA +++L + IH+D+ + NILLS++ ++ DFGLA + ++ D
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 499 FGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
++APE + + DV++FG++L E+ S G P
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 27/91 (29%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY 501
+ +LH++ +IH+D+K SNI++ D ++ DFGLA T+ + T T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYY 184
Query: 502 LAPEYFMHGKVSEKIDVYAFGIVLLELLSGK 532
APE + E +D+++ G ++ E++ K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 49/194 (25%), Positives = 83/194 (42%), Gaps = 19/194 (9%)
Query: 353 PDGKELAVKIL---KPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409
P G + V+I +E+ LK +E+ + H NI++ + + L ++ F++
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH-NSCEQPVIHKDVKSSNILLSD 468
GS L +G + G L+YLH N IH+++K+S+IL+S
Sbjct: 83 YGSANSLLKTYFPEG--MSEALIGNILFGALRGLNYLHQNGY----IHRNIKASHILISG 136
Query: 469 DFEPQLSDFG-LASWLSTSSSHLTCTDV----AGTFGYLAPEYF---MHGKVSEKIDVYA 520
D LS L S + D +L+PE ++G + K D+Y+
Sbjct: 137 DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYG-YNVKSDIYS 195
Query: 521 FGIVLLELLSGKKP 534
GI EL +G+ P
Sbjct: 196 VGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 31/91 (34%), Positives = 44/91 (48%), Gaps = 8/91 (8%)
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY 501
ALD LH + ++ +D+ +NILL D QL+ F W S C A Y
Sbjct: 97 ALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDS---CDGEAVENMY 148
Query: 502 LAPEYFMHGKVSEKIDVYAFGIVLLELLSGK 532
APE + +E D ++ G +L ELL+GK
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 45/176 (25%), Positives = 81/176 (46%), Gaps = 27/176 (15%)
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
VA +++L + IH+D+ + NILLS++ ++ DFGLA + ++
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 499 FGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP-----INSENPKGQESLVMWAKP 552
++APE + + DV++FG++L E+ S G P IN E +
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR---------- 289
Query: 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRA-PTVRPQINLVLKLLQGD 607
LKDG +++ P + +I R++LA + PT + ++ LLQ +
Sbjct: 290 -LKDG--TRMRAP----ENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQEN 338
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 44/196 (22%), Positives = 88/196 (44%), Gaps = 18/196 (9%)
Query: 356 KELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDN------NLLLVYDFLS 409
K + + I SE +++F SE + H N++ L G C + + +++ F+
Sbjct: 32 KTMKIAICTRSE--MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMK 89
Query: 410 RGSLEENL-HGNKKDGNAFGWTERY-KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS 467
G L L + D + T+ K +A ++YL + + IH+D+ + N +L+
Sbjct: 90 HGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLN 146
Query: 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLE 527
++ ++DFGL+ + + ++A E + K DV++FG+ + E
Sbjct: 147 ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWE 206
Query: 528 LLS-GKKPI----NSE 538
+ + G+ P NSE
Sbjct: 207 IATRGQTPYPGVENSE 222
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 63/272 (23%), Positives = 111/272 (40%), Gaps = 62/272 (22%)
Query: 331 SNFLPEYLVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKE-----FASEIEIITALH 384
S F+ +G G V C D L A+K L+ +DVL +E +I+
Sbjct: 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLR-KKDVLNRNQVAHVKAERDILAEAD 59
Query: 385 HRNIISLFGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEAL 443
+ ++ L+ + F+D +NL V D++ G + L + R+ +A + A+
Sbjct: 60 NEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA---RFYIA-ELTLAI 114
Query: 444 DYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS---WLSTSS------------- 487
+ +H + IH+D+K NIL+ D +L+DFGL + W S
Sbjct: 115 ESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSM 171
Query: 488 ---------SHLTCTD--------------------VAGTFGYLAPEYFMHGKVSEKIDV 518
S+ C D + GT Y+APE + ++ D
Sbjct: 172 EPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231
Query: 519 YAFGIVLLELLSGKKPINSENP-KGQESLVMW 549
++ G++L E+L G+ P + P + Q ++ W
Sbjct: 232 WSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 23/92 (25%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
VA +++L + +H+D+ + N+L+ + ++ DFGLA + S++++
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 499 FGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS 530
++APE + + DV++FGI+L E+ +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 24/92 (26%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
VA +++L + +H+D+ + N+LL+ ++ DFGLA + S++++
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 499 FGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS 530
++APE + DV+++GI+L E+ S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 46/179 (25%), Positives = 60/179 (33%), Gaps = 39/179 (21%)
Query: 435 VAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD 494
V + AL LH + KS NILL+ D L G ++ + S
Sbjct: 22 VCLQCLGALRELH---------RQAKSGNILLTWDG--LLKLDGSVAFKTPEQS-----R 65
Query: 495 VAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL 554
F APE +EK D+Y+ GI L E L + P N E IL
Sbjct: 66 PDPYFM--APEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE---------LSAIL 114
Query: 555 KDGKVSQLLDPSLDTDYDNDQIERMVLAA-------TLSISRAPTVRPQINLVLKLLQG 606
+ LL+ D + V AA L SR P R N L +
Sbjct: 115 EI-----LLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRA 168
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 31/147 (21%), Positives = 55/147 (37%), Gaps = 15/147 (10%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIIS--LFGFC 395
L+ G + VY D +KI E + E+ I+ L + + +
Sbjct: 5 LLKGGLTNRVYLLGTKDED-YVLKINPSRE-KGADREREVAILQLLARKGLPVPKVLASG 62
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
D L+ +++ +L+E K+D +A +AE L LH +
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSEEEKED-----------IAEQLAELLAKLHQLPLLVLC 111
Query: 456 HKDVKSSNILLSDDFEPQLSDFGLASW 482
H D+ NIL+ D + D+ A +
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 678 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.66 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.6 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 99.57 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.46 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.41 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 99.31 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.23 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.01 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.92 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 98.83 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.81 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.55 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.47 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.42 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 98.4 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.34 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.27 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.21 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.09 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.08 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.04 | |
| COG2205 | 890 | KdpD Osmosensitive K+ channel histidine kinase [Si | 97.93 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.88 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.88 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.86 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.82 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.8 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.74 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.55 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.53 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.49 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.47 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.47 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.39 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.39 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.2 | |
| cd01984 | 86 | AANH_like Adenine nucleotide alpha hydrolases supe | 97.05 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.04 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.73 | |
| PLN02236 | 344 | choline kinase | 96.62 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.57 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.49 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.49 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-59 Score=501.32 Aligned_cols=286 Identities=46% Similarity=0.868 Sum_probs=260.4
Q ss_pred ccccccHHHHHHhhcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHH-HHHHHHHHHHHHhcCCCCeeeEEEEE
Q 041755 317 TCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDV-LKEFASEIEIITALHHRNIISLFGFC 395 (678)
Q Consensus 317 ~~~~f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~ 395 (678)
..+.|++.||..||++|...++||+||||.||+|.+.+|+.||||++...... .++|.+|++++++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56789999999999999999999999999999999999999999998765433 66799999999999999999999999
Q ss_pred EeCC-eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEE
Q 041755 396 FEDN-NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQL 474 (678)
Q Consensus 396 ~~~~-~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL 474 (678)
.+.+ +++||||||++|+|.++|+..... +++|..|++||.++|+||+|||..+..+||||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 599999999999999999976433 8899999999999999999999988889999999999999999999999
Q ss_pred eecccccccCC-CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc
Q 041755 475 SDFGLASWLST-SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI 553 (678)
Q Consensus 475 ~DFGla~~~~~-~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 553 (678)
+|||+|+..+. .....+. ..||++|+||||+..+.++.|+|||||||+|+||+||++|++...+.....++.|+++.
T Consensus 219 sDFGLa~~~~~~~~~~~~~--~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTT--VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCccccceeee--cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 99999987665 3222221 18999999999999999999999999999999999999999877767777899999999
Q ss_pred cccCccccccCCCCC-CCCCH-HHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 554 LKDGKVSQLLDPSLD-TDYDN-DQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 554 ~~~~~~~~l~dp~l~-~~~~~-~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+.++.+.+++||.+. ..+.. +++.+++.+|.+|++.+|..||+|.+|+++|+.
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~ 351 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG 351 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence 999999999999997 66664 789999999999999999999999999999954
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=394.83 Aligned_cols=250 Identities=30% Similarity=0.486 Sum_probs=207.4
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-eEEEEEEcCCCCC
Q 041755 337 YLVGKGGHSHVYRGCLPDGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDN-NLLLVYDFLSRGS 412 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~lV~E~~~~gs 412 (678)
..||.|+||+||+|.+.....||||++.... ...+.|.+|+.+|.+++|||||+++|+|.+.. .+++||||+++|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 3499999999999999443349999998643 23679999999999999999999999999887 7999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeccCCCCCeEecCCC-CcEEeecccccccCCCCCCc
Q 041755 413 LEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP-VIHKDVKSSNILLSDDF-EPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 413 L~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~-iiHrDIKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~ 490 (678)
|.++|+.. ....+++..++.++.+||+||.|||+ ++ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus 127 L~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 127 LSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred HHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 99999874 34689999999999999999999999 77 99999999999999998 99999999998765432 3
Q ss_pred eecccccCCCCCCcchhc--cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFM--HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~--~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
..+...||+.|||||++. ...|+.|+||||||++||||+||+.||....+...... ++....+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~---------------v~~~~~R 264 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA---------------VVVGGLR 264 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH---------------HHhcCCC
Confidence 334478999999999999 56999999999999999999999999987765211111 1111112
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
...+......+..++.+||+.+|..||++.+|+..|+...
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 2222234566777778899999999999999999998644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=373.15 Aligned_cols=243 Identities=26% Similarity=0.449 Sum_probs=205.5
Q ss_pred CceeecccCceEEEEEEeC-CCCEEEEEEeC--CChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-eEEEEEEcCCC
Q 041755 335 PEYLVGKGGHSHVYRGCLP-DGKELAVKILK--PSEDVLKEFASEIEIITALHHRNIISLFGFCFEDN-NLLLVYDFLSR 410 (678)
Q Consensus 335 ~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~lV~E~~~~ 410 (678)
..+.||+|..|+||++.++ +++.+|+|++. .++...+++.+|++++...+|||||.++|.|.... ..+++||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 3567999999999999876 78999999984 45678899999999999999999999999999988 49999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|+.++... +.+++...-+|+.++++||.|||+. ++||||||||+|||++..|++||||||.++.+-..
T Consensus 163 GSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---- 232 (364)
T KOG0581|consen 163 GSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---- 232 (364)
T ss_pred CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence 9999999654 5699999999999999999999962 89999999999999999999999999999987665
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCc--ccccchhhcccccccCccccccC---C
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPK--GQESLVMWAKPILKDGKVSQLLD---P 565 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~--~~~~l~~~~~~~~~~~~~~~l~d---p 565 (678)
.+...+||..|||||.+.++.|+.++||||||++++|+.+|+.||....+. ....+.. .+++ |
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~------------~Iv~~ppP 300 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC------------AIVDEPPP 300 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH------------HHhcCCCC
Confidence 334589999999999999999999999999999999999999999765221 1111111 1111 2
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+... .....+..++..||++||.+||++.++++
T Consensus 301 ~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 301 RLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22222 24455777889999999999999999885
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=388.63 Aligned_cols=245 Identities=27% Similarity=0.449 Sum_probs=206.5
Q ss_pred cCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCC----ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKP----SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
..|...++||+|||+.+|+++. ..|..||+|++.. .....+...+||+|.++|+|||||+++++|.+.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3588889999999999999987 7899999999975 3456778899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
|+|++++|.+++..+ .++.+.+++.++.||+.||.|||+ ++|||||||..|+||+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999999633 679999999999999999999999 9999999999999999999999999999998875
Q ss_pred C-CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 486 S-SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 486 ~-~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
. .... ..+|||.|+|||++.....+..+||||+|||||-||.|++||+..+-++.-+.+. ..+ ..-
T Consensus 171 ~~Erk~---TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik-------~~~---Y~~ 237 (592)
T KOG0575|consen 171 DGERKK---TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIK-------LNE---YSM 237 (592)
T ss_pred cccccc---eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHH-------hcC---ccc
Confidence 4 3333 3799999999999999999999999999999999999999998654322211111 111 011
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
|. ........++..+|+.+|.+||++.+|+.
T Consensus 238 P~-------~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 238 PS-------HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cc-------ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11 11223344557789999999999999994
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-46 Score=366.44 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=213.4
Q ss_pred CCCCceeecccCceEEEEEE-eCCCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEE-EEEeCCe-EEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGC-LPDGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFG-FCFEDNN-LLLVY 405 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~-~~~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g-~~~~~~~-~~lV~ 405 (678)
+|.+.++||+|.||.||++. +.+|..+|.|.+.. +......+..|+.+|++|+|||||++++ -+.+++. +++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 45556779999999999995 56999999998874 3466788999999999999999999998 4555555 89999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ-PVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||.+|+|...+...++.+..+++..+|+++.|++.||.++|+..++ -|+||||||.||+|+.+|.+||+||||++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999998888889999999999999999999999984433 38999999999999999999999999999987
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
...... ...+|||.||+||.+...+|+.|+||||+||++|||+.-++||.+.+- .... ..+..|++..
T Consensus 180 s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~L~-~KI~qgd~~~--- 247 (375)
T KOG0591|consen 180 SKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LSLC-KKIEQGDYPP--- 247 (375)
T ss_pred chhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HHHH-HHHHcCCCCC---
Confidence 755433 357999999999999999999999999999999999999999987632 1111 1223333221
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
-.+......+.+++..|+..||+.||+...++..++
T Consensus 248 -----~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 248 -----LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -----CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 123556778889999999999999999655554443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=368.53 Aligned_cols=250 Identities=27% Similarity=0.404 Sum_probs=201.0
Q ss_pred cCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCCh--------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSE--------DVLKEFASEIEIITALHHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~--------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 401 (678)
+.|...+.||+|+||.|-+|.. ++|+.||||+++... .......+|++||++|+|||||+++++|...+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 4577788999999999999975 489999999997532 1223346999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC---CCcEEeecc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD---FEPQLSDFG 478 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~---~~~kL~DFG 478 (678)
||||||+.||+|.+++-.+ ..+.+..-..++.|++.||.|||+ +||+||||||+||||..+ ..+||+|||
T Consensus 252 YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred EEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccc
Confidence 9999999999999999765 456777778899999999999999 999999999999999766 789999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhccCCC---CccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccc
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV---SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILK 555 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~---s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 555 (678)
+|+..+... .+...+||+.|.|||++.++.+ ..|+|+||+||+||-+|+|.+||....... ++. ..+.
T Consensus 325 lAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~----eQI~ 395 (475)
T KOG0615|consen 325 LAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLK----EQIL 395 (475)
T ss_pred hhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHH----HHHh
Confidence 999887433 3445899999999999987653 347899999999999999999998754332 111 1122
Q ss_pred cCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 556 DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 556 ~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.|.+.. -| ..-....++...++.++|..||++||++.|++.
T Consensus 396 ~G~y~f--~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYAF--GP----LQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCcccc--cC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 222221 01 111233456777889999999999999999885
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=365.10 Aligned_cols=203 Identities=30% Similarity=0.532 Sum_probs=182.6
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
..+|.....||+|.||.||+|+.. +|..||||.+... ....+.+..|+.||+.++|||||.|++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357778888999999999999875 6899999988654 456677889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC------CCcEEeeccc
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD------FEPQLSDFGL 479 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~------~~~kL~DFGl 479 (678)
|||.+|+|.++++.. ..+++.....++.|||.||++||+ ++||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999865 368999999999999999999999 999999999999999875 4589999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcc
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 542 (678)
|+.+...... ...+|++-|||||+++.++|+.|+|+||+|++||++++|+.||....+.+
T Consensus 162 AR~L~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 162 ARFLQPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hhhCCchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 9998865433 34799999999999999999999999999999999999999998766544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=361.36 Aligned_cols=241 Identities=28% Similarity=0.420 Sum_probs=198.9
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...++||+|+||+||.++.. +++.||+|++++.. ...+....|..||..++||+||+|+..|++.+++|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 57889999999999999999754 68999999998643 34677889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+.||.|..+|... ..|++.....++.+|+.||.|||+ ++||||||||+|||||++|+++|+||||++..-.
T Consensus 105 d~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 105 DYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred eccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999999744 568999999999999999999999 9999999999999999999999999999995444
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
.... +..++||+.|||||++.+..|+..+|+||||+++|||++|.+||...+.......+. .. ++ +
T Consensus 178 ~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~------~~-k~-----~ 243 (357)
T KOG0598|consen 178 DGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL------KG-KL-----P 243 (357)
T ss_pred CCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh------cC-cC-----C
Confidence 3222 223799999999999999999999999999999999999999998876433222111 11 10 0
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQ 596 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs 596 (678)
....+ .......++...|..+|++|-.
T Consensus 244 -~~p~~---ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 244 -LPPGY---LSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred -CCCcc---CCHHHHHHHHHHhccCHHHhcC
Confidence 01111 1223444557779999999964
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=373.89 Aligned_cols=249 Identities=25% Similarity=0.449 Sum_probs=207.8
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHH
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 415 (678)
.+.||+|-||.||.|.++....||+|.++......+.|.+|+++|++|+|+|||+|+|+|..++.+|||||||+.|+|.+
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~ 290 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLD 290 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHH
Confidence 45699999999999999777799999999877667889999999999999999999999999889999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceeccc
Q 041755 416 NLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDV 495 (678)
Q Consensus 416 ~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 495 (678)
+|.. ..+..+...+...++.|||+|++||++ +++|||||...|||++++..+||+|||||+...++..... ...
T Consensus 291 yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~-~~~ 364 (468)
T KOG0197|consen 291 YLRT--REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS-EGG 364 (468)
T ss_pred Hhhh--cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeec-CCC
Confidence 9976 245678999999999999999999999 9999999999999999999999999999996555433322 222
Q ss_pred ccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHH
Q 041755 496 AGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDND 574 (678)
Q Consensus 496 ~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~ 574 (678)
.-...|.|||.+..+.++.|+|||||||+||||+| |+.|+......+.... ++.| .+-..+..
T Consensus 365 kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-------le~G---------yRlp~P~~ 428 (468)
T KOG0197|consen 365 KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-------LERG---------YRLPRPEG 428 (468)
T ss_pred CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-------Hhcc---------CcCCCCCC
Confidence 33457999999999999999999999999999999 8999876554332211 1111 12122333
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 575 QIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 575 ~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+...+.+++..||+.+|++|||+..+...|+.
T Consensus 429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 429 CPDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 45566777899999999999999988887764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=364.02 Aligned_cols=251 Identities=27% Similarity=0.382 Sum_probs=207.8
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 402 (678)
..++|..++.||+|.|++|++|+.. .++.||||++.+. +...+-...|-++|.+| .||.|++|+-.|++...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 4468889999999999999999865 7899999998653 23455667899999999 7999999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+|+||+++|+|.++|... +.|++...+.++.+|+.||+|||+ +|||||||||+|||||.+|++||+|||.|+.
T Consensus 151 FvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999865 568999999999999999999999 9999999999999999999999999999999
Q ss_pred cCCCCCC-----------ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcc
Q 041755 483 LSTSSSH-----------LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK 551 (678)
Q Consensus 483 ~~~~~~~-----------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~ 551 (678)
++..... .....++||..|.+||++..+..+..+|+|+|||+||+|+.|.+||.+.++.-...-++.
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~-- 301 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA-- 301 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH--
Confidence 8653222 112458999999999999999999999999999999999999999988765322111110
Q ss_pred cccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 552 PILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 552 ~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
+|-.+...++ +....++...|..||.+|++..+|-+-
T Consensus 302 -----------l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 302 -----------LDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -----------hcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 1111222222 445556677799999999999888763
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=360.62 Aligned_cols=259 Identities=22% Similarity=0.396 Sum_probs=204.1
Q ss_pred hcCCCCceeecccCceEEEEEEe------CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC-C
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL------PDGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFED-N 399 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~------~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~-~ 399 (678)
.++|...+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.++..+ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 35788899999999999999963 23578999999753 24456789999999999 899999999998764 4
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCC--------------------------------------------------------
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKD-------------------------------------------------------- 423 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~-------------------------------------------------------- 423 (678)
.+++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999999999998753210
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceecccccCCCC
Q 041755 424 --GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY 501 (678)
Q Consensus 424 --~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y 501 (678)
..++.+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 2357889999999999999999999 99999999999999999999999999999876443332222334567889
Q ss_pred CCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHH
Q 041755 502 LAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMV 580 (678)
Q Consensus 502 ~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~ 580 (678)
+|||++.+..++.++|||||||+||||++ |..||........ .. ..+..+... .. .......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~~~~~-----~~----~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC----QRLKDGTRM-----RA----PENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH----HHHhcCCCC-----CC----CCCCCHHHH
Confidence 99999999999999999999999999997 9999976443211 00 011111110 01 111234567
Q ss_pred HHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 581 LAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 581 ~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.++..||+.+|.+||++.++++.|+.
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~ 333 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGD 333 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHH
Confidence 78899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=340.54 Aligned_cols=262 Identities=23% Similarity=0.289 Sum_probs=206.3
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
.|....++|+|+||.||+++.+ +|+.||||++..++ ...+-.++|+++|++|+|+|+|.|+++|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4555678999999999999876 69999999997543 3456668999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
|+.. +.+-|..+. ..++.....+++.|++.|+.|+|+ +++|||||||+||||+.+|.+||||||+|+.+....
T Consensus 83 ~dhT-vL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 83 CDHT-VLHELERYP---NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred cchH-HHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 9764 444444332 457889999999999999999999 999999999999999999999999999999887422
Q ss_pred CCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcc--------ccc-ccC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK--------PIL-KDG 557 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~--------~~~-~~~ 557 (678)
. ..++.+.|.+|.|||.+.+ .+|...+||||+||++.||++|.+-|.+.+.-++..++.... .++ .++
T Consensus 156 d--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 D--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred c--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 2 3356789999999999988 689999999999999999999999998877666554443221 111 111
Q ss_pred ccccccCCCCCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 KVSQLLDPSLDTD-----YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ~~~~l~dp~l~~~-----~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+..+.=|..... --+....-++.++..||+.||.+|++-++++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1221111211111 11122346777889999999999999999884
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=353.88 Aligned_cols=262 Identities=24% Similarity=0.332 Sum_probs=202.8
Q ss_pred CCCceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEEEEE
Q 041755 333 FLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFED--NNLLLVYD 406 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~E 406 (678)
|.....||+|+||.||+|+. .+|+.||+|.++.+. .......+||.||++|.||||++|.+...+. ..+|||+|
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFe 198 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFE 198 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEe
Confidence 44455799999999999985 489999999987543 4455668999999999999999999999876 68999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
||++ +|..++.. .+-.|++.++..++.|++.||+|||. ++|+|||||.+|||||.+|.+||+|||||+++...
T Consensus 199 YMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 199 YMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred cccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9955 88888763 34579999999999999999999999 99999999999999999999999999999988765
Q ss_pred CCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC-----cc-
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG-----KV- 559 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~-----~~- 559 (678)
.... .|..+-|++|.|||++.+. .|+.++|+||.||||.||++|++.|.+.+...+...+...-....+. ++
T Consensus 272 ~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 272 GSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 4443 4567789999999999874 69999999999999999999999999877665543332111111110 01
Q ss_pred -ccccCCCCCCC--C---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 560 -SQLLDPSLDTD--Y---DNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 560 -~~l~dp~l~~~--~---~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
...+.|.-... + -.......+.++..+|..||.+|.|+.++|+
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111111100 0 0011234455667778999999999999985
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=346.63 Aligned_cols=263 Identities=22% Similarity=0.357 Sum_probs=204.5
Q ss_pred cCCCCceeecccCceEEEEEEeCC-----------------CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPD-----------------GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISL 391 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~-----------------g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l 391 (678)
++|...+.||+|+||.||++.+.+ +..||+|+++.. ......|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467888999999999999997532 347999999763 3556789999999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCCHHHHhccCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 041755 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKK---------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIH 456 (678)
Q Consensus 392 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~---------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiH 456 (678)
++++.+.+..++||||+++|+|.+++..... ....++|..++.++.||+.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 9999999999999999999999998864321 12357889999999999999999999 89999
Q ss_pred ccCCCCCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc--CCCC
Q 041755 457 KDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS--GKKP 534 (678)
Q Consensus 457 rDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt--G~~P 534 (678)
|||||+|||++.++.+||+|||+++.+.............++..|+|||++..+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999987654433222233456889999999999999999999999999999987 5677
Q ss_pred CCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 535 INSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 535 f~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
|....... ........+....... . . .........+.+++..||+.+|.+||++.+|.+.|+
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~~~-~-~----~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQGRQV-Y-L----FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhccccc-c-c----cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 76543221 1111111111110000 0 0 001122345778889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=327.29 Aligned_cols=198 Identities=27% Similarity=0.453 Sum_probs=181.6
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
.+|...+.||.|+||.|.+++.+ +|..+|+|+++..+ ...+...+|..+|+.+.||++++|++.|.+.+.+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 36777889999999999999876 68899999998754 34566788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||++||.|+.+|+.. ++|++...+.+|.||+.||+|||+ .+|++|||||+|||||.+|.+||+|||+|+.+..
T Consensus 124 eyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 999999999999754 569999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 540 (678)
. +-..+||+.|+|||.+....++.++|+|||||++|||+.|.+||...++
T Consensus 197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 3 2347999999999999999999999999999999999999999998776
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=339.15 Aligned_cols=257 Identities=20% Similarity=0.343 Sum_probs=203.7
Q ss_pred cccccHHHHHHhhcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEE
Q 041755 318 CRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFG 393 (678)
Q Consensus 318 ~~~f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g 393 (678)
.+.++.+++ +......||+|++|.||+|.. +|+.||||.++... ...+.|.+|+.++.+++||||++++|
T Consensus 12 ~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 12 IKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred ceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 344555555 333346799999999999998 78999999997532 33577889999999999999999999
Q ss_pred EEEe----CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC
Q 041755 394 FCFE----DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD 469 (678)
Q Consensus 394 ~~~~----~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~ 469 (678)
++.+ ...+++||||+++|+|.+++... ..++|.....++.+++.||.|||+. .+++||||||+|||++.+
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTEN 159 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCC
Confidence 9977 35789999999999999999643 4688999999999999999999972 478899999999999999
Q ss_pred CCcEEeecccccccCCCCCCceecccccCCCCCCcchhcc--CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccch
Q 041755 470 FEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH--GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV 547 (678)
Q Consensus 470 ~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~ 547 (678)
+.+||+|||+++.+.... ....||..|+|||++.+ +.++.++|||||||++|||++|+.||...........
T Consensus 160 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~- 233 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL- 233 (283)
T ss_pred CcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH-
Confidence 999999999998654322 12468899999999976 6899999999999999999999999986543221111
Q ss_pred hhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 548 MWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 548 ~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+...+ . .+.+ +......+..++..||+.+|.+||++.++++.|+.
T Consensus 234 -----i~~~~-~----~~~~----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~ 278 (283)
T PHA02988 234 -----IINKN-N----SLKL----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278 (283)
T ss_pred -----HHhcC-C----CCCC----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 11110 0 0111 11223456677899999999999999999998863
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=338.51 Aligned_cols=260 Identities=28% Similarity=0.441 Sum_probs=208.4
Q ss_pred cCCCCceeecccCceEEEEEE-eCCCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGC-LPDGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~-~~~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+.|.....||.|..++||+|+ .+.+..||||++.-.+ ...+.+.+|+..++.++||||+.++..|..+..+++||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 467778899999999999996 4578999999997543 4578899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
|.+|++.+.+...-. ..+.+..+..|+.++++||.|||. +|.||||||+.||||+.+|.+||+|||....+....
T Consensus 106 Ma~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999986544 348999999999999999999999 999999999999999999999999999988765533
Q ss_pred CC-cee-cccccCCCCCCcchhcc--CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 488 SH-LTC-TDVAGTFGYLAPEYFMH--GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 488 ~~-~~~-~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
.. ... ...+||++|||||+++. ..|+.|+||||||++.+||.+|..||....+... +.+.. .+....+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~tL-----qn~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLTL-----QNDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHHh-----cCCCCCcc
Confidence 22 111 45789999999999654 5699999999999999999999999986554321 11111 11111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
-..+..+-....-..+.+++..||..||.+|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111112223346778889999999999999999985
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=354.90 Aligned_cols=258 Identities=24% Similarity=0.404 Sum_probs=203.4
Q ss_pred cCCCCceeecccCceEEEEEEe------CCCCEEEEEEeCCCh--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL------PDGKELAVKILKPSE--DVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~------~~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 401 (678)
++|...+.||+|+||.||+|.. .++..||||+++... ...+.+.+|+.++..+ +||||++++++|.+++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 3577788999999999999963 246689999997543 4456788999999999 899999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCC-----------------------------------------------------------
Q 041755 402 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 422 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~----------------------------------------------------------- 422 (678)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999864321
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 423 ------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 423 ------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
....++|..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 11357899999999999999999999 999999999999999999999999999998765433222
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
......++..|+|||++.+..++.++|||||||++|||++ |..||....... .... .+..+.. ...+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~----~~~~~~~--~~~~---- 339 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYK----MIKEGYR--MLSP---- 339 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHH----HHHhCcc--CCCC----
Confidence 2222345678999999999999999999999999999998 888986543221 1111 1111110 0001
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
... ...+..++..||+.+|.+||++.+|+++|+.
T Consensus 340 ~~~---~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 ECA---PSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCC---CHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 111 2356778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=370.64 Aligned_cols=254 Identities=24% Similarity=0.430 Sum_probs=212.5
Q ss_pred CCceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 334 LPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 334 ~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
...+.||+|.||+||+|... +...||||.++... +..++|.+|++++..|+|||||+|+|+|.+++.+|||+
T Consensus 489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvF 568 (774)
T KOG1026|consen 489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVF 568 (774)
T ss_pred eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEE
Confidence 44567999999999999743 34679999998643 57899999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCC------C----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEe
Q 041755 406 DFLSRGSLEENLHGNKK------D----GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLS 475 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~------~----~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~ 475 (678)
|||..|+|.+||..... . ..+++..+.+.||.|||.|+.||-+ +.+|||||-..|+|+.++..+||+
T Consensus 569 EYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKIs 645 (774)
T KOG1026|consen 569 EYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKIS 645 (774)
T ss_pred EecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEec
Confidence 99999999999975431 1 2348899999999999999999999 999999999999999999999999
Q ss_pred ecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhccccc
Q 041755 476 DFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPIL 554 (678)
Q Consensus 476 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~ 554 (678)
||||++-....++........-...||+||.++++++|.++|||||||+|||+++ |+.||.+...++.. ..+
T Consensus 646 DfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI-------e~i 718 (774)
T KOG1026|consen 646 DFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI-------ECI 718 (774)
T ss_pred ccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH-------HHH
Confidence 9999997766554433222334568999999999999999999999999999999 99999887654422 233
Q ss_pred ccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 555 KDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 555 ~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
..|++- ..++.....+..+++.||+.+|.+||+++||-..|+.
T Consensus 719 ~~g~lL---------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 719 RAGQLL---------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred HcCCcc---------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 334331 1244556678888899999999999999999999974
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=335.76 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=200.0
Q ss_pred CCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.|...+.||+|+||.||+|.. .+|+.||+|++.... .....+.+|+.++..++|+||+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 366778999999999999986 479999999986432 234567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++|+|..++.... ...+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 999999998886432 2468999999999999999999999 99999999999999999999999999999876433
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
.. .....||..|+|||++.+..++.++|||||||++|||++|+.||............. . .+....
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~--~-~~~~~~-------- 221 (285)
T cd05631 156 ET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD--R-RVKEDQ-------- 221 (285)
T ss_pred Ce---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH--H-Hhhccc--------
Confidence 22 233579999999999999999999999999999999999999998654321111000 0 000000
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQ-----INLVLK 602 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs-----~~eVl~ 602 (678)
..+.......+..++..||+.+|.+||+ +.++++
T Consensus 222 --~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 --EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0111122345667889999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=346.33 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=201.6
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
..++|....+||+|+||.||+++.+ +|..+|+|++++++ ...+....|-.||....+|+||+|+..|++.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 5578999999999999999999865 79999999998764 456778899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||++||++..+|... ..|++.....++.+++.|+.-||+ .|+|||||||+|+|||..|++||+||||+.-+
T Consensus 219 iMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchh
Confidence 99999999999999643 679999999999999999999999 99999999999999999999999999998543
Q ss_pred CCC----------------------CCC----ce-------------------ecccccCCCCCCcchhccCCCCccceE
Q 041755 484 STS----------------------SSH----LT-------------------CTDVAGTFGYLAPEYFMHGKVSEKIDV 518 (678)
Q Consensus 484 ~~~----------------------~~~----~~-------------------~~~~~Gt~~Y~APE~l~~~~~s~ksDV 518 (678)
... ... .. ....+|||.|+|||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 210 000 00 012579999999999999999999999
Q ss_pred eehhHHHHHHhcCCCCCCCCCCcccc-cchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 041755 519 YAFGIVLLELLSGKKPINSENPKGQE-SLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ 596 (678)
Q Consensus 519 wSlGvvL~eLltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs 596 (678)
||||||+||||.|.+||..+++...- .++.|...+...... +.......+|.+||. ||+.|-.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~--------------~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV--------------DLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC--------------cccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999999998876543 344454322221110 111334445577777 9999976
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=346.13 Aligned_cols=248 Identities=23% Similarity=0.352 Sum_probs=202.9
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC-----h-HHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCe
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS-----E-DVLKEFASEIEIITALH-HRNIISLFGFCFEDNN 400 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~-----~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~ 400 (678)
..++|...+.||+|+||+|+.|... +|..||||++... . ...+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4578899999999999999999754 7899999977643 1 23556678999999999 9999999999999999
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC-CCcEEeeccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD-FEPQLSDFGL 479 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~-~~~kL~DFGl 479 (678)
+++||||+.+|+|.+++.. ..++.+.+..+++.|++.|++|||+ ++|+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999975 2578889999999999999999999 999999999999999999 9999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhccCC-CC-ccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK-VS-EKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 557 (678)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+..... .+ +..+
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~-----~k--i~~~ 238 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY-----RK--IRKG 238 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH-----HH--HhcC
Confidence 99874 1122334579999999999999877 86 7899999999999999999999874322111 11 1111
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 041755 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVL 601 (678)
Q Consensus 558 ~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl 601 (678)
.+. +..... ...+..++..||..+|..|+++.+|+
T Consensus 239 ~~~------~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 EFK------IPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred Ccc------CCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111 111110 34456677999999999999999998
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=343.97 Aligned_cols=251 Identities=24% Similarity=0.336 Sum_probs=204.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||+|... +|+.||||+++... .....+.+|++++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888899999999999999876 68999999997532 34567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999999999999643 468899999999999999999999 9999999999999999999999999999986544
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCccccc-chhhcccccccCccccccC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQES-LVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-l~~~~~~~~~~~~~~~l~d 564 (678)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...... +..|.. .+. .
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~--------~ 219 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-TLQ--------R 219 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-ccc--------C
Confidence 2234679999999999999999999999999999999999999998655432211 111111 000 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
|... .........+..++..||..+|.+||++.++++.
T Consensus 220 ~~~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVYD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1100 0001123446667789999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.24 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=198.1
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--eEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDN--NLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~lV~E 406 (678)
.+|...+.||+|.||.||++... +|...|||.+.... ...+.+.+|+.+|++|+|||||+.+|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45677888999999999999875 48999999886532 22667889999999999999999999854444 6899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC-CCCcEEeecccccccCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD-DFEPQLSDFGLASWLST 485 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~-~~~~kL~DFGla~~~~~ 485 (678)
|+++|+|.+++.... ..+++..+..++.||++||.|||+ ++||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999997642 269999999999999999999998 99999999999999999 79999999999987764
Q ss_pred -CCCCceecccccCCCCCCcchhccCCC-CccceEeehhHHHHHHhcCCCCCCCC-CCcccccchhhcccccccCccccc
Q 041755 486 -SSSHLTCTDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGKKPINSE-NPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 486 -~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~-~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
...........||+.|||||++..+.. ..++|||||||+++||+||+.||... ... .+...+...+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~------~~~~~ig~~~----- 239 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA------EALLLIGRED----- 239 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH------HHHHHHhccC-----
Confidence 111122335789999999999996543 35999999999999999999999763 111 1111111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
.-|.+... ......+++..|+..+|..|||+.++|+-
T Consensus 240 ~~P~ip~~----ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 240 SLPEIPDS----LSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CCCCCCcc----cCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 11222222 22334455699999999999999999974
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=352.43 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=202.8
Q ss_pred cCCCCceeecccCceEEEEEEe------CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL------PDGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~------~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 401 (678)
++|...+.||+|+||.||+|.. .++..||||+++.. ......+.+|+++++.+ +||||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 3677788999999999999873 23468999999753 34456788999999999 899999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCC-----------------------------------------------------------
Q 041755 402 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 422 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~----------------------------------------------------------- 422 (678)
++||||+++|+|.+++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999998854211
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceeccc
Q 041755 423 -------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDV 495 (678)
Q Consensus 423 -------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 495 (678)
...++++.++++++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 11357889999999999999999999 99999999999999999999999999999876543322222223
Q ss_pred ccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHH
Q 041755 496 AGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDND 574 (678)
Q Consensus 496 ~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~ 574 (678)
.++..|+|||++.++.++.++|||||||++|||++ |+.||........ ... ....+ ..+.....
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~----~~~~~-----~~~~~~~~---- 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYK----MVKRG-----YQMSRPDF---- 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHH----HHHcc-----cCccCCCC----
Confidence 45678999999999999999999999999999997 9999976443211 000 01111 00101111
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 575 QIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 575 ~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
....+..++..||+.+|.+||++.+|+++|+.
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~ 371 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 12456777899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=318.70 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=209.8
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.+|...+.||+|.||.||+|+.. +|+.||||.++..+ ......++|++.|+.++|+||+.|+++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35666778999999999999854 79999999998654 235667899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
||+ .+|+..+... ...+.-.++..++.++++||+|||. +.|+||||||.|+|++.+|.+||+|||+|+.+...
T Consensus 82 fm~-tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 994 5899988653 3678889999999999999999999 99999999999999999999999999999998775
Q ss_pred CCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc-------
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK------- 558 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~------- 558 (678)
....+. .+-|.+|.|||.+.+ ..|+..+|+||.||++.||+-|.+-|.+.+.-++...+.-+.....+..
T Consensus 155 ~~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Cccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 544433 367999999999987 4699999999999999999999998888776555443332221111111
Q ss_pred -----cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 559 -----VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 559 -----~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
+...-.+.+..-+ .......+++...++..||.+|+++.|++++
T Consensus 233 pdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111112222212 2233445777889999999999999999874
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=344.41 Aligned_cols=257 Identities=29% Similarity=0.456 Sum_probs=203.9
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.+.+.....||+|.||+||+|.+- | .||||+++. ..+..+.|.+|+..+++-+|-||+-+.|||..... .+|+-
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 344556778999999999999983 3 599999975 45788999999999999999999999999998766 99999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
+|+|-+|..+||... ..|...+.+.||.||++|+.|||. ++|||||||..||||.+++.+||+||||+..-..-
T Consensus 468 wCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred hccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 999999999999654 568888999999999999999999 99999999999999999999999999998653322
Q ss_pred CCCceecccccCCCCCCcchhcc---CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMH---GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
..........|...|||||++.. .+|++.+||||||+|+|||+||..||...+.+ + +.| .-|+-.-..
T Consensus 542 ~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d-q---Iif-----mVGrG~l~p 612 (678)
T KOG0193|consen 542 SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD-Q---IIF-----MVGRGYLMP 612 (678)
T ss_pred ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh-h---eEE-----EecccccCc
Confidence 11222223567889999999864 47899999999999999999999999843322 1 112 112111112
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
|..... .+..+.|.+++..||..++++||.+.+|+..|+..
T Consensus 613 d~s~~~---s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 613 DLSKIR---SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred cchhhh---ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 222221 23345566667999999999999999999977643
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=341.22 Aligned_cols=240 Identities=23% Similarity=0.321 Sum_probs=195.6
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRG 411 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 411 (678)
++||+|+||.||++... +|+.||||+++.. ......+.+|+.++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 7899999999753 234567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCce
Q 041755 412 SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491 (678)
Q Consensus 412 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 491 (678)
+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~ 151 (323)
T cd05571 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--c
Confidence 999998643 468999999999999999999999 9999999999999999999999999999875432211 1
Q ss_pred ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCC
Q 041755 492 CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDY 571 (678)
Q Consensus 492 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~ 571 (678)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+ . .+. ..+..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~------~-~~~------~~~p~-- 216 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------L-MEE------IRFPR-- 216 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH------H-cCC------CCCCC--
Confidence 23467999999999999999999999999999999999999999765432111110 0 000 11111
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041755 572 DNDQIERMVLAATLSISRAPTVRP-----QINLVLK 602 (678)
Q Consensus 572 ~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~ 602 (678)
.....+..++..||+.||.+|| ++.++++
T Consensus 217 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 --TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred --CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 1233466777999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=347.62 Aligned_cols=263 Identities=21% Similarity=0.307 Sum_probs=208.4
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHH--HHHHHHHHhcC-CCCeeeEEEEEEeCC-eEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEF--ASEIEIITALH-HRNIISLFGFCFEDN-NLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~--~~Ei~il~~l~-HpnIv~l~g~~~~~~-~~~lV~ 405 (678)
++|...+.||.|+||.||+|... .|..||||.++..-...++. ++|+.-|++|+ |||||+|.+++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 56777788999999999999854 78999999987543222333 58999999999 999999999999888 999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||| ..+|...+.++ +..|++..++.|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||||+.+..
T Consensus 90 E~M-d~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 90 EFM-DCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred Hhh-hhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc
Confidence 999 56899998765 4789999999999999999999999 9999999999999999999999999999997755
Q ss_pred CCCCceecccccCCCCCCcchhc-cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc-----cccC-c
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFM-HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI-----LKDG-K 558 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~-----~~~~-~ 558 (678)
.. ..|..+.|.+|+|||++. .+-|+.+.|+||+|||++|+.+-++-|.+.++.++...+.....- +.+| .
T Consensus 163 kp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 163 KP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred CC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 43 335678899999999875 577999999999999999999999999987766554333221111 1111 1
Q ss_pred cccccCCCC---CC----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 559 VSQLLDPSL---DT----DYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 559 ~~~l~dp~l---~~----~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
+...+.=.+ .+ ..-.......+.++..|++.||.+|||+.+.++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111111 11 1112245677788899999999999999999974
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.67 Aligned_cols=254 Identities=21% Similarity=0.410 Sum_probs=208.0
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|...+.||+|+||.||+|...++..||+|.+.......+.+.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 46788899999999999999988888999999887665667899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 86 ~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 86 GSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 99999987532 3568899999999999999999999 99999999999999999999999999999876543221
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
......++..|+|||++..+.++.++|||||||++|+|++ |+.||........ .... ..+.. -+.. .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~----~~~~~----~~~~-~ 227 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSAL----QRGYR----MPRM-E 227 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHH----HcCCC----CCCC-C
Confidence 1122446778999999999999999999999999999998 9999975443221 1111 01100 0111 1
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.....+.+++.+|+..+|++||++.++++.|+.
T Consensus 228 ----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 ----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122446778899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=328.85 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=208.1
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
.++|...+.||+|+||.||+|..++++.||+|.++......+.|.+|+.++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 35688889999999999999998788899999998765556779999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+++|.+++.... +..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 85 YGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred CCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 999999996542 3568999999999999999999999 99999999999999999999999999999877633221
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
. .....++..|+|||++.+..++.++||||||+++|||++ |+.||........... +..+ ..
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-------~~~~-~~-------- 222 (261)
T cd05068 160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ-------VDQG-YR-------- 222 (261)
T ss_pred c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------HHcC-CC--------
Confidence 1 111223457999999999999999999999999999999 9999976543211110 0000 00
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
..........+..++.+|++.+|.+||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 00111223567788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=332.70 Aligned_cols=257 Identities=24% Similarity=0.448 Sum_probs=207.2
Q ss_pred cCCCCceeecccCceEEEEEEeCC------CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPD------GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~------g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 402 (678)
++|...+.||+|+||.||+|.... +..||+|.++.. ......|.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357778889999999999997542 257999998753 345677999999999999999999999999888999
Q ss_pred EEEEcCCCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC
Q 041755 403 LVYDFLSRGSLEENLHGNKKD------------GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF 470 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~ 470 (678)
++|||+++|+|.+++...... ...+++..++.++.|++.||.|||+ .+++|+||||+|||+++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 999999999999999754211 1458899999999999999999999 9999999999999999999
Q ss_pred CcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhh
Q 041755 471 EPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMW 549 (678)
Q Consensus 471 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~ 549 (678)
.++|+|||++................+++.|+|||++.++.++.++|||||||++|||++ |..||...........
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~--- 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM--- 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---
Confidence 999999999986644333222334567889999999999999999999999999999998 9999976554321111
Q ss_pred cccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 550 AKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 550 ~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+..+... .........+..++..||+.+|.+||++.+|++.|+.
T Consensus 239 ----i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 ----IRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111 1112234567788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.50 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=204.8
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|...+.||+|+||.||++...++..+|+|.++........|.+|+++++.++||||++++++|.+.+..++||||+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 45777788999999999999988888999999876555557889999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 84 GCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 99999987432 358999999999999999999999 99999999999999999999999999999865433221
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...+.... .... ..+. ....+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i----~~~~--~~~~~~~-- 225 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMI----SRGF--RLYRPKL-- 225 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH----HCCC--CCCCCCC--
Confidence 1122345668999999998899999999999999999999 8999976543211 1111 1110 0111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
....+..++.+||+.+|.+||++.++++.|.
T Consensus 226 -----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 226 -----ASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -----CCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1245778889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=334.45 Aligned_cols=264 Identities=22% Similarity=0.274 Sum_probs=202.4
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|...+.||+|+||.||++... +++.||||+++.. ....+.+.+|++++..++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999876 6889999998753 2345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|++++.+...... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998777655422 2468999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhh-ccc--------ccccC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMW-AKP--------ILKDG 557 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~-~~~--------~~~~~ 557 (678)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.. ..+ .....
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred ccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 222 12235789999999999999999999999999999999999999976543221110000 000 00011
Q ss_pred ccccccCCCCCCCC------CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 KVSQLLDPSLDTDY------DNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ~~~~l~dp~l~~~~------~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.......+...... .......+.+++..||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11111111111100 0112345778889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.72 Aligned_cols=243 Identities=23% Similarity=0.335 Sum_probs=199.7
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||+|... +|+.||||+++... .....+.+|+.++.+++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999875 68999999987532 34567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++.....++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999998643 467899999999999999999999 9999999999999999999999999999987644
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+..... .+..+.+.
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-------~i~~~~~~----- 233 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE-------KILAGRLK----- 233 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH-------HHhcCCcC-----
Confidence 22 13579999999999999999999999999999999999999997654321100 01111110
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQ-----INLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs-----~~eVl~ 602 (678)
+...+ ...+..++..||+.||.+||+ +.+++.
T Consensus 234 -~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 234 -FPNWF----DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -CCCCC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11111 234667889999999999997 566664
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.47 Aligned_cols=253 Identities=21% Similarity=0.328 Sum_probs=202.9
Q ss_pred cCCCCceeecccCceEEEEEEeC----CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP----DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~----~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...+.||+|+||.||+|.+. .+..||+|.++.. ......|.+|+.++.+++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999753 4668999999864 34456789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... ...+++.+++.++.|++.||+|||+ ++++||||||+|||++.++.++++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999998643 2468999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
.... .......++..|+|||.+.++.++.++|||||||++|||++ |+.||........ ... +..+..
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~----~~~~~~---- 226 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKA----VEDGFR---- 226 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHH----HHCCCC----
Confidence 2211 11112345678999999999999999999999999999775 9999976543221 110 111110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.. ........+.+++..||+.+|.+||++.+|++.|..
T Consensus 227 -~~----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 227 -LP----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -CC----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 00 111223457778899999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=330.49 Aligned_cols=258 Identities=17% Similarity=0.356 Sum_probs=204.7
Q ss_pred hhcCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNN 400 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 400 (678)
++++|...+.||+|+||.||+|... .+..||||+++.. .....+|.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999998742 3567999998643 2445678999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEE
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKD------GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQL 474 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL 474 (678)
.++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+ .+++|+||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653221 2346888999999999999999999 89999999999999999999999
Q ss_pred eecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccc
Q 041755 475 SDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPI 553 (678)
Q Consensus 475 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 553 (678)
+|||++................++..|+|||++.++.++.++|||||||++|||++ |..||...........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~------- 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF------- 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------
Confidence 99999986654332222222355788999999999999999999999999999999 7889876543211110
Q ss_pred cccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 554 LKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 554 ~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
...+.... . .......+..++.+||+.+|.+||++.++++.|+
T Consensus 234 ~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCCcCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11111100 0 1112345677889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.50 Aligned_cols=256 Identities=25% Similarity=0.423 Sum_probs=206.1
Q ss_pred cCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 402 (678)
.+|...+.||+|+||.||+|... +++.||||+++... ...+.|.+|+++++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777788999999999999763 34789999987543 35688999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCc
Q 041755 403 LVYDFLSRGSLEENLHGNK----------KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP 472 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~----------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 472 (678)
+||||+++++|.+++.... .....+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 9999999999999997542 123457899999999999999999999 999999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcc
Q 041755 473 QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAK 551 (678)
Q Consensus 473 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 551 (678)
+|+|||++................+++.|+|||++.++.++.++|||||||++|||++ |..||........ ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~-- 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IEC-- 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH--
Confidence 9999999986543322222223456788999999999999999999999999999998 9999976543221 111
Q ss_pred cccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 552 PILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 552 ~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
+..+.... ........+..++..||+.+|.+||++.+|++.|+
T Consensus 237 --~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 --ITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --HHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111111 01122345677889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.61 Aligned_cols=254 Identities=20% Similarity=0.391 Sum_probs=202.9
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCC----EEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGK----ELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~----~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
.+|...+.||+|+||.||+|.+. +|. .||||+++.. ....+.|.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888899999999999999753 344 4899998753 35567899999999999999999999999764 5789
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
|+||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+
T Consensus 86 v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999997532 468899999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
.............++..|+|||++.+..++.++|||||||++|||++ |+.||........... +..+.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~-------~~~~~~--~ 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGER--L 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HhCCCC--C
Confidence 65444333333345678999999999999999999999999999998 9999976433221111 111100 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.. .......+..++..||+.+|..||++.+++..|...
T Consensus 231 ~~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~ 268 (316)
T cd05108 231 PQ-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 268 (316)
T ss_pred CC-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 011123467788999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=335.79 Aligned_cols=240 Identities=24% Similarity=0.310 Sum_probs=193.1
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 041755 339 VGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413 (678)
Q Consensus 339 IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 413 (678)
||+|+||.||+|... +++.||+|+++.. ......+..|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999875 6889999998642 34456788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceec
Q 041755 414 EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCT 493 (678)
Q Consensus 414 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 493 (678)
.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~ 151 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTN 151 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccc
Confidence 9998643 468999999999999999999999 9999999999999999999999999999986433222 123
Q ss_pred ccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCH
Q 041755 494 DVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDN 573 (678)
Q Consensus 494 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~ 573 (678)
...||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+... . ..+...
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~~~~~~~-~------~~~~~~--- 215 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------YRKILQE-P------LRFPDG--- 215 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------HHHHHcC-C------CCCCCc---
Confidence 46799999999999999999999999999999999999999976543211 1111111 0 011111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041755 574 DQIERMVLAATLSISRAPTVRPQINLVLKLL 604 (678)
Q Consensus 574 ~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L 604 (678)
....+..++..||+.+|.+||++..+.++|
T Consensus 216 -~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 216 -FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred -CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 223456677999999999998654444443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=336.63 Aligned_cols=199 Identities=25% Similarity=0.429 Sum_probs=176.3
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|+||.||++... +|..||+|++... ......|.+|++++.+++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 67888999999999999999875 6889999998753 34567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++|+|.+++... ..+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 85 MDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999998643 458899999999999999999997 1369999999999999999999999999988654322
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 539 (678)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 123578999999999999999999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=343.32 Aligned_cols=238 Identities=30% Similarity=0.492 Sum_probs=200.6
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHH
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 415 (678)
..-||.|+.|.||+|++ .++.||||.++.-+ ..+|+-|++|+||||+.+.|+|.....+|+|||||+.|.|..
T Consensus 129 LeWlGSGaQGAVF~Grl-~netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~ 201 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-HNETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYE 201 (904)
T ss_pred hhhhccCcccceeeeec-cCceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHH
Confidence 45699999999999999 66889999876322 257888999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceeccc
Q 041755 416 NLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDV 495 (678)
Q Consensus 416 ~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 495 (678)
.|... ..+.-.....+..+||.|+.|||. +.|||||||.-||||..+..+||+|||.++...... +...+
T Consensus 202 VLka~----~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkMSF 271 (904)
T KOG4721|consen 202 VLKAG----RPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKMSF 271 (904)
T ss_pred HHhcc----CccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhhh---hhhhh
Confidence 99643 567777888999999999999999 999999999999999999999999999998776652 33458
Q ss_pred ccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHH
Q 041755 496 AGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQ 575 (678)
Q Consensus 496 ~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~ 575 (678)
+||..|||||++.+.+.++|+|||||||||||||||..||.+-+. ..+.|. -..+. |..-.+..+
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAIIwG----VGsNs-------L~LpvPstc 336 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAIIWG----VGSNS-------LHLPVPSTC 336 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeEEe----ccCCc-------ccccCcccC
Confidence 999999999999999999999999999999999999999976543 222231 11122 222234455
Q ss_pred HHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 576 IERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 576 ~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
.+-+..++.+||+..|..||++.+|+.-|+
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 677888899999999999999999997765
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=325.37 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=206.1
Q ss_pred cCCCCceeecccCceEEEEEEeCC----CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPD----GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~----g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...+.||+|+||.||+|.+.. ...||||+++.. ......|.+|+.++..++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578889999999999999998642 457999998753 34567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++++|.+++.... ..+++.+++.++.|++.||.|||+ ++|+|+||||+|||+++++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999996532 468999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
............++..|+|||++.+..++.++||||||+++|+|++ |..||....... +... +..+. .
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~----~~~~~----~ 226 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKA----VEDGY----R 226 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHH----HHcCC----C
Confidence 3333333223445678999999999999999999999999999998 999986543221 1111 01100 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.+ ........+.+++..||+.+|.+||++.+|++.|+.
T Consensus 227 ~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~ 264 (266)
T cd05033 227 LP-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264 (266)
T ss_pred CC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 00 011223457788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=336.06 Aligned_cols=243 Identities=24% Similarity=0.321 Sum_probs=199.7
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||+|... +|+.||+|++.... .....+.+|+++++.++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999875 68999999986432 34567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++.....++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999999999998643 468899999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
.. ....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+. .+..
T Consensus 154 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~-------~~~~------ 215 (291)
T cd05612 154 RT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL-------AGKL------ 215 (291)
T ss_pred Cc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCc------
Confidence 21 23578999999999999899999999999999999999999997654322111110 0110
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQ-----INLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs-----~~eVl~ 602 (678)
.+...+ ...+.+++..||+.||.+||+ +.++++
T Consensus 216 ~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 216 EFPRHL----DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CCCccC----CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 011111 234667789999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.70 Aligned_cols=253 Identities=22% Similarity=0.379 Sum_probs=205.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
.+|...+.||+|+||.||+|... .++.||+|+++.+......+.+|++++..++||||+++++++..++..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 35777889999999999999865 58899999998766666789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+++|.+++.... ...+++..++.++.|++.||.|||+ ++++||||||+|||+++++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 86 YGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999986532 3468999999999999999999999 99999999999999999999999999999876543222
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
.. ....++..|+|||++.+..++.++|||||||++|||++ |..||........... +..+ ..+..
T Consensus 161 ~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~-----~~~~~- 226 (263)
T cd05052 161 AH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-------LEKG-----YRMER- 226 (263)
T ss_pred cc-CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHCC-----CCCCC-
Confidence 11 12234668999999999999999999999999999998 9999876443211000 1100 01111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
.......+..++.+||+.+|.+||++.++++.|+
T Consensus 227 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 227 ---PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred ---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 1112345667789999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=354.44 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=203.2
Q ss_pred CCCceeecccCceEEEEEEeC-C-CCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-D-GKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~-g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
|...+.||+|+||.||+|... + +..||+|.+.... .....+.+|+.+++.++||||++++++|..++.++|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 777889999999999999754 3 6788999775433 445667889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+|+|.++|........++++.+...++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999999887544445678999999999999999999999 99999999999999999999999999999876554332
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .+ .+... + +
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~------~~-~~~~~----~-~-- 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ------VL-YGKYD----P-F-- 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HH-hCCCC----C-C--
Confidence 223346799999999999999999999999999999999999999975433211110 00 01111 1 0
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.......+..++..||+.+|..||++.+++.
T Consensus 292 --~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 --PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112245677789999999999999999875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.27 Aligned_cols=245 Identities=27% Similarity=0.397 Sum_probs=205.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|.....||+|.||.||||+.+ +++.||+|.+.+. +...+.+.+|++|++.|+|||||.++++|....++++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777788999999999999876 6889999988653 3557788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+.+ +|+.+|.. ...++++.++.++.+++.||.|||+ ++|+|||+||.||||+.+|++|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9966 99999964 3679999999999999999999999 99999999999999999999999999999988775
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
.. ..+.+.||+-|||||.+.+++|+..+|.||+||++|||.+|++||....- ....+.+..+ |.
T Consensus 154 t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv~~I~~d--------~v 217 (808)
T KOG0597|consen 154 TS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLVKSILKD--------PV 217 (808)
T ss_pred ce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHHHHHhcC--------CC
Confidence 43 34568999999999999999999999999999999999999999975432 1111112211 11
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
. ++......+..+..-.|.+||..|.+..+++.
T Consensus 218 ~---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 218 K---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred C---CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1 11233445566667779999999999998874
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=337.41 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=196.0
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRG 411 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 411 (678)
++||+|+||.||++... +|+.||||+++.. ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999865 7899999999753 244567889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCce
Q 041755 412 SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491 (678)
Q Consensus 412 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 491 (678)
+|..++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~ 151 (328)
T cd05593 81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--T 151 (328)
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--c
Confidence 999888643 468999999999999999999999 9999999999999999999999999999876432221 2
Q ss_pred ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCC
Q 041755 492 CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDY 571 (678)
Q Consensus 492 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~ 571 (678)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+ .. + +..+...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~------~~-~------~~~~p~~~ 218 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LM-E------DIKFPRTL 218 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh------cc-C------CccCCCCC
Confidence 23467999999999999999999999999999999999999999765432211111 00 0 01111112
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041755 572 DNDQIERMVLAATLSISRAPTVRP-----QINLVLKL 603 (678)
Q Consensus 572 ~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~~ 603 (678)
...+..++..||+.+|.+|| ++.++++.
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 219 ----SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 23456677999999999997 78888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=344.48 Aligned_cols=247 Identities=24% Similarity=0.401 Sum_probs=205.8
Q ss_pred CCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCChHH-HHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSEDV-LKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
.|..-..||+|..|.||.+.. .+++.||||++....+. .+-+++|+.+|+.++|+|||.+++.|..++.++.|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 455556799999999999975 47899999999766543 4456799999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+|+|.+.+... .+++.++..|+.+++.||+|||. ++|||||||.+|||++.+|.+||+|||++..+......
T Consensus 354 ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 354 GGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 99999998643 48999999999999999999999 99999999999999999999999999999988765442
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
....+||+.|||||++....|++|+||||||++++||+-|++||..+++-....++. ..|. |.+.
T Consensus 426 --R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------~ng~------P~lk- 490 (550)
T KOG0578|consen 426 --RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNGT------PKLK- 490 (550)
T ss_pred --cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------hcCC------CCcC-
Confidence 234799999999999999999999999999999999999999998766543222221 1111 1111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+.....+.++..+||..|+.+||++.++|+
T Consensus 491 -~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 491 -NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 12222344566679999999999999999996
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=328.15 Aligned_cols=257 Identities=24% Similarity=0.413 Sum_probs=203.9
Q ss_pred cCCCCceeecccCceEEEEEEe-----CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-----PDGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-----~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
++|...+.||+|+||.||+|.. .++..|++|.++.. ......|.+|+++++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567778999999999999974 25678999999743 3455788999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC
Q 041755 404 VYDFLSRGSLEENLHGNKK-------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF 470 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~-------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~ 470 (678)
||||+++++|.+++..... ....+++.+...++.|++.||.|||+ ++++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 9999999999999863321 12357899999999999999999999 9999999999999999999
Q ss_pred CcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhh
Q 041755 471 EPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMW 549 (678)
Q Consensus 471 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~ 549 (678)
.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||...........
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~--- 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM--- 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---
Confidence 999999999987644332222233456778999999998899999999999999999998 9999976543211110
Q ss_pred cccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 550 AKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 550 ~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+..+... .. .......+..++..|++.+|.+||++.+|++.|.+
T Consensus 239 ----~~~~~~~-----~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 ----VRKRQLL-----PC----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcCCcC-----CC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111100 01 11123456778899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=346.75 Aligned_cols=258 Identities=22% Similarity=0.371 Sum_probs=204.6
Q ss_pred cCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS--EDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 401 (678)
++|...++||+|+||.||+|... .+..||||+++.. ....+.|.+|++++.++. ||||++++++|.+.+..
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 46778889999999999999742 2347999999753 344577999999999996 99999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCC-----------------------------------------------------------
Q 041755 402 LLVYDFLSRGSLEENLHGNKK----------------------------------------------------------- 422 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~----------------------------------------------------------- 422 (678)
+|||||+++|+|.++|+....
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 999999999999998865321
Q ss_pred ---------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC
Q 041755 423 ---------------------------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD 469 (678)
Q Consensus 423 ---------------------------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~ 469 (678)
....+++..+..++.|++.||.|||+ .+|+||||||+|||++.+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCC
Confidence 11357889999999999999999999 999999999999999999
Q ss_pred CCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchh
Q 041755 470 FEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVM 548 (678)
Q Consensus 470 ~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~ 548 (678)
+.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||......... ..
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--~~ 351 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--YN 351 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--HH
Confidence 9999999999987654333323333467788999999999999999999999999999997 99998754321110 00
Q ss_pred hcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 549 WAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 549 ~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.+..+. .+. ........+..++..||+.+|.+||++.+|.++|+.
T Consensus 352 ----~~~~~~-----~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~ 396 (400)
T cd05105 352 ----KIKSGY-----RMA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES 396 (400)
T ss_pred ----HHhcCC-----CCC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence 011110 000 111223457778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=329.97 Aligned_cols=259 Identities=24% Similarity=0.413 Sum_probs=207.5
Q ss_pred cCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
.+|...+.||+|+||.||++... ++..+|+|.+... ......+.+|++++.+++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888899999999999999742 3456899988754 4556789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEE
Q 041755 404 VYDFLSRGSLEENLHGNKK---------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQL 474 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~---------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL 474 (678)
||||+++++|.+++..... ....+++.+++.++.|++.||.|||+ ++++||||||+|||+++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 9999999999999864321 22358999999999999999999999 99999999999999999999999
Q ss_pred eecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccc
Q 041755 475 SDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPI 553 (678)
Q Consensus 475 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 553 (678)
+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||........ .. .
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~~----~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IE----C 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----H
Confidence 99999987654333222233456788999999999999999999999999999998 8999876543221 11 0
Q ss_pred cccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 554 LKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 554 ~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
+..+.... .... ....+..++..||+.+|.+||++.+|++.|+...
T Consensus 235 i~~~~~~~-----~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ITQGRVLQ-----RPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHcCCcCC-----CCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 11111110 1111 2235778889999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=340.20 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=203.1
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||+|... +|+.||||+++... .....+..|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999876 68999999997532 34567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999754 468999999999999999999999 9999999999999999999999999999987654
Q ss_pred CC---------------------------CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCC
Q 041755 486 SS---------------------------SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSE 538 (678)
Q Consensus 486 ~~---------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 538 (678)
.. .........||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 33 011223457999999999999999999999999999999999999999865
Q ss_pred CCccccc-chhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHH
Q 041755 539 NPKGQES-LVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ-INLVLKL 603 (678)
Q Consensus 539 ~~~~~~~-l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs-~~eVl~~ 603 (678)
....... +..|... +. -|.. ......+..++..|+. +|.+||+ +.++++.
T Consensus 234 ~~~~~~~~i~~~~~~------~~---~p~~-----~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWKES------LR---FPPD-----PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccCCc------cc---CCCC-----CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 5322111 1111000 00 0000 0023445666788997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=337.35 Aligned_cols=240 Identities=22% Similarity=0.334 Sum_probs=194.8
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRG 411 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 411 (678)
++||+|+||.||++... +|+.||+|+++.. ......+.+|+.++..++||||+++++++...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999864 7899999998753 234567788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCce
Q 041755 412 SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491 (678)
Q Consensus 412 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 491 (678)
+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 151 (323)
T cd05595 81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence 999888643 468999999999999999999999 9999999999999999999999999999875432221 2
Q ss_pred ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCC
Q 041755 492 CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDY 571 (678)
Q Consensus 492 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~ 571 (678)
.....||+.|+|||++.++.++.++|||||||++|||++|+.||...+.......+. . +. ..+...+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~------~-~~------~~~p~~~ 218 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------M-EE------IRFPRTL 218 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh------c-CC------CCCCCCC
Confidence 233679999999999999999999999999999999999999997654322111110 0 00 0111112
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041755 572 DNDQIERMVLAATLSISRAPTVRP-----QINLVLK 602 (678)
Q Consensus 572 ~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~ 602 (678)
...+..++..||+.+|.+|| ++.++++
T Consensus 219 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 ----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ----CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 23456677999999999998 7888775
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=322.62 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=197.6
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHH
Q 041755 338 LVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLE 414 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 414 (678)
.||+|+||.||+|... +|+.||+|.+... ......|.+|+++++.++||||++++++|...+..++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5899999999999875 7899999987643 455678999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceecc
Q 041755 415 ENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD 494 (678)
Q Consensus 415 ~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 494 (678)
+++... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++..............
T Consensus 82 ~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 82 TFLRTE---GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 998643 2468999999999999999999999 9999999999999999999999999999886543221111111
Q ss_pred cccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCH
Q 041755 495 VAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDN 573 (678)
Q Consensus 495 ~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~ 573 (678)
..++..|+|||++.++.++.++||||||+++|||++ |..||............. .+ .......
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-------~~---------~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-------QG---------VRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-------cC---------CCCCCcc
Confidence 233457999999999999999999999999999998 888886544322111110 00 0001111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 574 DQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 574 ~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
.....+..++..||+.+|.+||++.+|+++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 22345777889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=331.38 Aligned_cols=263 Identities=21% Similarity=0.322 Sum_probs=200.1
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|+||.||+|... +++.||+|+++... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888899999999999999865 78999999987432 3345678999999999999999999999998999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
++ |+|.+++... +..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 97 5899888643 2457899999999999999999999 999999999999999999999999999997654322
Q ss_pred CCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccc---------ccccC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP---------ILKDG 557 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~---------~~~~~ 557 (678)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+..... .....
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred c--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 2 1223578999999999865 5689999999999999999999999977654322111110000 00001
Q ss_pred ccccccCCCCCCCCC----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 KVSQLLDPSLDTDYD----NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ~~~~l~dp~l~~~~~----~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+...+.+....... ........+++..||+.+|.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111111111111000 011234567889999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=355.64 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=208.6
Q ss_pred HHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Q 041755 325 ELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDN- 399 (678)
Q Consensus 325 el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~- 399 (678)
++....++|...+.||+|+||+||+|... +|+.||||++... ......+.+|+.++..++|+||+++++.+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34445679999999999999999999754 7999999998643 455677889999999999999999988775432
Q ss_pred -------eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCc
Q 041755 400 -------NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP 472 (678)
Q Consensus 400 -------~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 472 (678)
.+++||||+++|+|.+++.........+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCE
Confidence 3689999999999999997655555679999999999999999999999 999999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccc
Q 041755 473 QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552 (678)
Q Consensus 473 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 552 (678)
||+|||+++.+.............||+.|+|||++.+..++.++|||||||+||||++|+.||...+.... ...
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MHK 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHH
Confidence 99999999876543333333446799999999999999999999999999999999999999976543211 001
Q ss_pred ccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 553 ~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+ .+.. ++ + .......+..++..||+.+|.+||++.+++.
T Consensus 257 ~~-~~~~----~~-~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 257 TL-AGRY----DP-L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred Hh-cCCC----CC-C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 11 1111 11 1 1122345677889999999999999999885
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=314.98 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=206.9
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
.++|..++.||+|-||.||.|+.+ ++-.||+|++..++ +...++.+|++|.+.|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 357889999999999999999875 67889999997654 4467889999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
+||..+|+|...|...+ ...+++...+.+..|+|.||.|+|. ++||||||||+|+|++..+.+||+|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999998543 3568888899999999999999999 999999999999999999999999999987655
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
... ....+||+.|++||+..+...+.++|+|++|++.||++.|.+||........-.-+. -.++.+
T Consensus 176 ~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~----------k~~~~~ 241 (281)
T KOG0580|consen 176 SNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR----------KVDLKF 241 (281)
T ss_pred CCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH----------HccccC
Confidence 322 234789999999999999999999999999999999999999998765322111000 011122
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
| ........+++..|+..+|.+|.+..+|+.
T Consensus 242 p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 242 P-------STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred C-------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 2 222344566779999999999999999885
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=348.34 Aligned_cols=242 Identities=21% Similarity=0.371 Sum_probs=199.5
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 402 (678)
...+|...++||+|.||+|+++..+ +++.+|||+++++ ++..+..+.|..|+.... ||.+++|+.+|+..+++|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3468899999999999999999876 6889999999875 356778888999988876 999999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+||||+.||++..+.+ ...|++.....++..|+.||.|||+ ++|||||||.+|||||.+|++||+||||++-
T Consensus 446 fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999433332 2579999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
...... .+..++||+.|||||++.+..|+..+|+|||||+|||||.|..||.+++.++.-.-+. .+
T Consensus 518 ~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~------~d------ 583 (694)
T KOG0694|consen 518 GMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV------ND------ 583 (694)
T ss_pred cCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh------cC------
Confidence 442222 3345899999999999999999999999999999999999999999877654321111 10
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQI 597 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~ 597 (678)
|+...... ....+.++...|..+|++|..+
T Consensus 584 -~~~yP~~l----s~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 -EVRYPRFL----SKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCCCCcc----cHHHHHHHHHHhccCcccccCC
Confidence 12222222 3344555578899999999887
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=328.70 Aligned_cols=257 Identities=24% Similarity=0.397 Sum_probs=204.4
Q ss_pred CCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
+|...+.||+|+||.||+|... ....+++|.+... ......+.+|+.+++.++||||++++++|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999752 2357899988653 2446789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCC
Q 041755 404 VYDFLSRGSLEENLHGNKK--------------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSN 463 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~N 463 (678)
||||+.+|+|.+++..... ....+++..++.++.|++.||.|||+ .+++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 9999999999999864321 12458899999999999999999998 999999999999
Q ss_pred eEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcc
Q 041755 464 ILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKG 542 (678)
Q Consensus 464 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~ 542 (678)
||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986644332222223456778999999998899999999999999999998 999997654322
Q ss_pred cccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 543 QESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 543 ~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
. ..+. ..+ ............+..++..||+.+|.+||++.++++.|+..
T Consensus 238 ~---~~~~----~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 L---FNLL----KTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred H---HHHH----hCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 1 1111 110 00011112234677888999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=338.80 Aligned_cols=258 Identities=22% Similarity=0.394 Sum_probs=203.8
Q ss_pred cCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe-CCe
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFE-DNN 400 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-~~~ 400 (678)
++|...+.||+|+||.||+|... .++.||+|+++.. ....+.+..|+.++.++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 36788899999999999999632 3578999998753 34456788999999999 79999999998865 457
Q ss_pred EEEEEEcCCCCCHHHHhccCCCC---------------------------------------------------------
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKD--------------------------------------------------------- 423 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~--------------------------------------------------------- 423 (678)
++++|||+++|+|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 89999999999999988643210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCC
Q 041755 424 GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLA 503 (678)
Q Consensus 424 ~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~A 503 (678)
...++|..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++..+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1368999999999999999999999 9999999999999999999999999999987755443333334566788999
Q ss_pred cchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHH
Q 041755 504 PEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLA 582 (678)
Q Consensus 504 PE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~l 582 (678)
||++.+..++.++|||||||+||||++ |..||........ +. ..+..+... .........+..+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~----~~~~~~~~~---------~~~~~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC----RRLKEGTRM---------RAPEYATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH----HHHhccCCC---------CCCccCCHHHHHH
Confidence 999999999999999999999999998 9999975432211 00 011111100 0011223457788
Q ss_pred HHhcccCCCCCCCCHHHHHHHhhc
Q 041755 583 ATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 583 a~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+..||+.+|.+||++.+|++.|+.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~ 332 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGD 332 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHH
Confidence 899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=328.15 Aligned_cols=258 Identities=23% Similarity=0.416 Sum_probs=206.2
Q ss_pred hcCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCe
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNN 400 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 400 (678)
.++|...+.||+|+||.||++... ....+|+|.+... ......+.+|++++.++ +|+||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 356778889999999999999753 2367999998753 34556789999999999 79999999999999999
Q ss_pred EEEEEEcCCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC
Q 041755 401 LLLVYDFLSRGSLEENLHGNK------------KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD 468 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~ 468 (678)
.++||||+++|+|..++.... .....+++..++.++.|++.||.|||+ .+|+||||||+|||++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcC
Confidence 999999999999999986532 234568999999999999999999998 99999999999999999
Q ss_pred CCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccch
Q 041755 469 DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLV 547 (678)
Q Consensus 469 ~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~ 547 (678)
++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~- 246 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL- 246 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH-
Confidence 99999999999987655433222223345678999999999999999999999999999998 9999875433221111
Q ss_pred hhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 548 MWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 548 ~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+..+. ...........+.+++..|+..+|.+|||+.++++.|+.
T Consensus 247 ------~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~ 290 (293)
T cd05053 247 ------LKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290 (293)
T ss_pred ------HHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence 00110 001112223457788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.52 Aligned_cols=248 Identities=34% Similarity=0.571 Sum_probs=194.6
Q ss_pred ceeecccCceEEEEEEeC-----CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 336 EYLVGKGGHSHVYRGCLP-----DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~-----~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
.+.||.|.||.||+|.+. .+..|+||+++.. ....+.|.+|++++.+++||||++++|+|...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 467999999999999875 3678999999753 355789999999999999999999999999888899999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++|+|.++|... ....+++.+++.|+.||+.||.|||+ ++++|+||+++|||++.++.+||+|||++........
T Consensus 84 ~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 999999999865 23578999999999999999999999 8999999999999999999999999999987743333
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
........+...|+|||.+....++.++||||||+++|||++ |+.||...+...... .+ .++...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~------~~-~~~~~~------- 224 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIE------KL-KQGQRL------- 224 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHH------HH-HTTEET-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------cc-cccccc-------
Confidence 222333456788999999999999999999999999999999 789986653322111 11 111110
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLL 604 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L 604 (678)
.........+..++..||..+|.+||++.++++.|
T Consensus 225 --~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 --PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 01112244577788999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=329.00 Aligned_cols=258 Identities=22% Similarity=0.408 Sum_probs=207.5
Q ss_pred cCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
.+|...+.||+|+||.||+|... ++..+++|.++... ...+.|.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999742 35678999987654 445778999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC
Q 041755 404 VYDFLSRGSLEENLHGNKK------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE 471 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~ 471 (678)
||||+++++|.+++..... ....+++..++.++.|++.||.|||+ ++++||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 9999999999999975321 12458999999999999999999999 99999999999999999999
Q ss_pred cEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhc
Q 041755 472 PQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWA 550 (678)
Q Consensus 472 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 550 (678)
++|+|||++................|+..|+|||++.+..++.++|||||||++|||+| |+.||........ ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~-- 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---IE-- 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH--
Confidence 99999999986654332222233567889999999999999999999999999999999 9999876543221 11
Q ss_pred ccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 551 KPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 551 ~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.+..+..... .......+.+++.+||+.+|.+||++.+|+++|+..
T Consensus 237 --~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~ 282 (291)
T cd05094 237 --CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282 (291)
T ss_pred --HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 1111111111 111234577888999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=338.26 Aligned_cols=253 Identities=20% Similarity=0.344 Sum_probs=195.4
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.|...+.||+|+||+||+|... +++.||||+++.. ......+.+|++++..++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5778899999999999999764 6899999999643 2445678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++|+|.+++... ..+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 99999999998643 458899999999999999999999 99999999999999999999999999997643210
Q ss_pred CC---------------------------------------------CceecccccCCCCCCcchhccCCCCccceEeeh
Q 041755 487 SS---------------------------------------------HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAF 521 (678)
Q Consensus 487 ~~---------------------------------------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSl 521 (678)
.. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 000123579999999999999999999999999
Q ss_pred hHHHHHHhcCCCCCCCCCCcccc-cchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 041755 522 GIVLLELLSGKKPINSENPKGQE-SLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLV 600 (678)
Q Consensus 522 GvvL~eLltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eV 600 (678)
||++|||++|+.||....+.... ....|... +. +.+ ...++.+ ...++.- +.|+..+|..||++.++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------~~--~~~--~~~~s~~-~~dli~~-ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENT------LH--IPP--QVKLSPE-AVDLITK-LCCSAEERLGRNGADDI 302 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHccccc------cC--CCC--CCCCCHH-HHHHHHH-HccCcccccCCCCHHHH
Confidence 99999999999999865543211 11111110 00 000 0112222 2222211 23677778889999999
Q ss_pred HHH
Q 041755 601 LKL 603 (678)
Q Consensus 601 l~~ 603 (678)
+..
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=328.70 Aligned_cols=263 Identities=21% Similarity=0.301 Sum_probs=195.3
Q ss_pred cCCCCceeecccCceEEEEEEeC--CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhc---CCCCeeeEEEEEEe-----
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP--DGKELAVKILKPS---EDVLKEFASEIEIITAL---HHRNIISLFGFCFE----- 397 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~--~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~----- 397 (678)
.+|...+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.++..+ .||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 5788999988643 22334566788777766 69999999999852
Q ss_pred CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeec
Q 041755 398 DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDF 477 (678)
Q Consensus 398 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DF 477 (678)
...+++||||+. ++|.+++.... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 356899999995 69999886532 2458999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC
Q 041755 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557 (678)
Q Consensus 478 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 557 (678)
|++....... ......||+.|+|||.+.+..++.++|||||||++|||++|++||...........+..........
T Consensus 155 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 9998765432 2234578999999999999999999999999999999999999998755422111111000000000
Q ss_pred ccc-------cccCCCCCC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 KVS-------QLLDPSLDT---DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ~~~-------~l~dp~l~~---~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+. ..+.+.... ....+....+.+++..||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 001000000 000111234567889999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=337.27 Aligned_cols=246 Identities=28% Similarity=0.468 Sum_probs=208.9
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
.|....+||+|.||.||+|... .++.||+|++.-. +....++.+|+.+|.+++++||.++||.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4555567999999999999875 6889999999754 466788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
.+|++.+.|.. +..+.+....-++++++.||.|||. ++.+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus 94 ~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 94 GGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred cCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999953 3455778888899999999999999 9999999999999999999999999999988766543
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
.. ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+.....+ +.+-.-|.+.
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~ 232 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLD 232 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCccc
Confidence 32 458999999999999988999999999999999999999999988776432222 1222335555
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.+. ..+.+++..||..+|+.||++.++++
T Consensus 233 ~~~S----~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 GDFS----PPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccC----HHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 5433 34667779999999999999999995
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=323.07 Aligned_cols=250 Identities=23% Similarity=0.373 Sum_probs=202.1
Q ss_pred CCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRG 411 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 411 (678)
+|...+.||+|+||.||+|...++..+|+|++.........|.+|+++++.++||||+++++++.+.+..++||||++++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 46677889999999999998877788999998765444467889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCce
Q 041755 412 SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491 (678)
Q Consensus 412 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 491 (678)
+|.+++.... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++........ .
T Consensus 85 ~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~ 157 (256)
T cd05059 85 CLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-S 157 (256)
T ss_pred CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-c
Confidence 9999987432 368999999999999999999999 99999999999999999999999999999866432221 1
Q ss_pred ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 492 CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 492 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
.....++..|+|||++.+..++.++||||||+++|+|++ |+.||......... .. +..+ .....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~----~~~~-----~~~~~--- 222 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---ES----VSAG-----YRLYR--- 222 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---HH----HHcC-----CcCCC---
Confidence 112234557999999999999999999999999999999 89999754432111 00 0000 01111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLKLL 604 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L 604 (678)
.......+..++..||+.+|.+||++.++++.|
T Consensus 223 -~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 -PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred -CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111234577888999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=322.61 Aligned_cols=251 Identities=23% Similarity=0.370 Sum_probs=203.3
Q ss_pred CCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRG 411 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 411 (678)
+|...+.||+|+||.||+|...++..+|+|.++........|.+|+.++.+++||||++++++|.+.+..++||||+.+|
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 56677889999999999998877778999998865544577999999999999999999999999888899999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCce
Q 041755 412 SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491 (678)
Q Consensus 412 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 491 (678)
+|.+++.... ..+++.+++.++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||+++........ .
T Consensus 85 ~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~ 157 (256)
T cd05113 85 CLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-S 157 (256)
T ss_pred cHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-e
Confidence 9999986432 368999999999999999999999 99999999999999999999999999998866443221 1
Q ss_pred ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 492 CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 492 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
.....++..|+|||++.++.++.++|||||||++|+|++ |..||........... . ..+.. +..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~------~-~~~~~-----~~~--- 222 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK------V-SQGLR-----LYR--- 222 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH------H-hcCCC-----CCC---
Confidence 112345678999999998899999999999999999998 9999975543211110 0 11100 000
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
.......+..++..||+.+|.+||++.++++.|+
T Consensus 223 -~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 -PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0112356777889999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=336.39 Aligned_cols=251 Identities=21% Similarity=0.284 Sum_probs=200.1
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||++... +|+.||||+++... ...+.+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999865 78999999997532 35567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999754 2468999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCceecccccCCCCCCcchhc------cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFM------HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 559 (678)
.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........... +......
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~------i~~~~~~ 227 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN------IMNFQRF 227 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHH------HHcCCCc
Confidence 3322 223357999999999986 45678999999999999999999999976543221111 1110000
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 560 SQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 560 ~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
... | . .......+..++..|++ +|.+||++.+++.
T Consensus 228 ~~~--~---~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 LKF--P---E--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cCC--C---C--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 000 0 0 01122345566688887 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=337.25 Aligned_cols=263 Identities=21% Similarity=0.327 Sum_probs=196.1
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----CeEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFED-----NNLL 402 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~~ 402 (678)
+|...+.||+|+||.||+|... +|+.||||+++.. ......+.+|+++++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777889999999999999865 7899999998642 23446788999999999999999999988643 3589
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+||||+. ++|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999994 7898888543 458999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCC-CceecccccCCCCCCcchhcc--CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcc--------
Q 041755 483 LSTSSS-HLTCTDVAGTFGYLAPEYFMH--GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK-------- 551 (678)
Q Consensus 483 ~~~~~~-~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~-------- 551 (678)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 533221 122234679999999999876 678999999999999999999999997654322111100000
Q ss_pred cccccCccccccC---CCCCCCCC---HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 552 PILKDGKVSQLLD---PSLDTDYD---NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 552 ~~~~~~~~~~l~d---p~l~~~~~---~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+........++ +.....+. ......+..++..||+.+|.+||++.++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000000000 00000000 011234567889999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=339.18 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=197.4
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.++..++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47888999999999999999875 6899999999743 234566789999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999999998643 468999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCCCc------------------------------------eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHh
Q 041755 486 SSSHL------------------------------------TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELL 529 (678)
Q Consensus 486 ~~~~~------------------------------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLl 529 (678)
..... .....+||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 21100 011246999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCcccc-cchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC---HHHHHH
Q 041755 530 SGKKPINSENPKGQE-SLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ---INLVLK 602 (678)
Q Consensus 530 tG~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs---~~eVl~ 602 (678)
+|..||...+..... ....|..... +.+. ..+ ...+.+++..|+. +|.+|++ +.+++.
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~~~~~~--------~~~~--~~~----s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINWKETLQ--------FPDE--VPL----SPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCccC--------CCCC--CCC----CHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999866542211 1111110000 0000 011 1234455567776 8999998 888775
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=324.08 Aligned_cols=254 Identities=26% Similarity=0.432 Sum_probs=208.6
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChH-HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSED-VLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
..+|...+.||.|+||.||+|...++..+|+|++..... ....+..|+.+++.++||||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 346777888999999999999988899999999986543 5677899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++|+|.+++.... +..+++..++.++.|++.||.|||+ ++++|+||||+|||+++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999997542 3568999999999999999999999 9999999999999999999999999999987654322
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
.. ....++..|+|||.+.++.++.++||||||+++|+|++ |+.||........ ..... .+ .
T Consensus 160 ~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~~~~----~~---------~ 221 (261)
T cd05148 160 LS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YDQIT----AG---------Y 221 (261)
T ss_pred cc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHHHH----hC---------C
Confidence 21 13446778999999999999999999999999999998 8999976542211 11100 00 0
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
...........+.+++..||+.+|.+||++.++++.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 001112223557788899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=320.89 Aligned_cols=258 Identities=25% Similarity=0.406 Sum_probs=208.6
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC----ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP----SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||+|... +|+.||||.++. .......|.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999865 789999998753 2345667899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++.........+++..++.++.|++.||.|||+ ++++|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886544444568999999999999999999999 9999999999999999999999999999887654
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
.... .....|++.|+|||++.+..++.++|+||||+++|||++|+.||....... ..... . +.... .+
T Consensus 159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~---~-~~~~~-----~~ 226 (267)
T cd08228 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQ---K-IEQCD-----YP 226 (267)
T ss_pred hhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHH---H-HhcCC-----CC
Confidence 3221 123568899999999998889999999999999999999999996543211 11111 0 11100 11
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.. ........+.+++..||+.+|.+||++.+|++.|+.
T Consensus 227 ~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~ 264 (267)
T cd08228 227 PL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264 (267)
T ss_pred CC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHH
Confidence 11 112233557778899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=336.60 Aligned_cols=203 Identities=27% Similarity=0.417 Sum_probs=177.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||+||++... +|+.||||+++.. ......+..|+.++..++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999765 6899999999753 234567788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 999999999999643 468999999999999999999999 9999999999999999999999999999976532
Q ss_pred CCCC---------------------------------ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCC
Q 041755 486 SSSH---------------------------------LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGK 532 (678)
Q Consensus 486 ~~~~---------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~ 532 (678)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0012357999999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 041755 533 KPINSENP 540 (678)
Q Consensus 533 ~Pf~~~~~ 540 (678)
.||....+
T Consensus 234 ~Pf~~~~~ 241 (363)
T cd05628 234 PPFCSETP 241 (363)
T ss_pred CCCCCCCH
Confidence 99986554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.36 Aligned_cols=253 Identities=25% Similarity=0.426 Sum_probs=203.7
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|...+.||+|+||.||+|...++..+|+|.++........|.+|+.++++++|+|++++++++. .+..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 357778899999999999999888889999999875544567999999999999999999999885 4568999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
++|.+++.... ...+++..++.++.+++.||.|||+ ++++||||||+||++++++.++|+|||++..+.......
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 85 GSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 99999997532 2458999999999999999999999 999999999999999999999999999998765432221
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
. ....++..|+|||++.+..++.++||||||+++|+|++ |..||...+.... ... +..+ ...
T Consensus 160 ~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~----~~~~---------~~~ 222 (260)
T cd05070 160 R-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV---LEQ----VERG---------YRM 222 (260)
T ss_pred c-cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH----HHcC---------CCC
Confidence 1 12345678999999998999999999999999999999 8899976443211 111 0000 000
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.........+..++.+|+..+|.+||++.++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111223457788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=324.71 Aligned_cols=246 Identities=24% Similarity=0.354 Sum_probs=196.1
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 041755 339 VGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413 (678)
Q Consensus 339 IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 413 (678)
||+|+||+||++... +|+.||+|++.... ...+.+..|+++++.++||||+++.+++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 78999999986432 2346678899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceec
Q 041755 414 EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCT 493 (678)
Q Consensus 414 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 493 (678)
...+.........+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++..+...... ..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence 98886544445678999999999999999999999 99999999999999999999999999999876543322 22
Q ss_pred ccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCH
Q 041755 494 DVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDN 573 (678)
Q Consensus 494 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~ 573 (678)
...||+.|+|||++.++.++.++|||||||++|||++|+.||.......... ....... .... .+..
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~---------~~~~--~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRIL---------NDSV--TYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHhhc---------ccCC--CCcc
Confidence 3578999999999999999999999999999999999999997543221110 0000011 0000 1111
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041755 574 DQIERMVLAATLSISRAPTVRP-----QINLVLK 602 (678)
Q Consensus 574 ~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~ 602 (678)
.....+..++..||+.+|.+|| ++.++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2234566778999999999999 5566664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=322.65 Aligned_cols=256 Identities=19% Similarity=0.361 Sum_probs=206.0
Q ss_pred cCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 402 (678)
++|...+.||+|+||.||+|... .+..||+|.+.... .....|.+|+.++..++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 57788899999999999999764 24689999987543 44567889999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEee
Q 041755 403 LVYDFLSRGSLEENLHGNKKD------GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSD 476 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~D 476 (678)
+||||+++|+|.+++...... ...++|..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECC
Confidence 999999999999998754321 2357899999999999999999998 9999999999999999999999999
Q ss_pred cccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccc
Q 041755 477 FGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILK 555 (678)
Q Consensus 477 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 555 (678)
||+++.+.............++..|+|||.+.++.++.++|||||||++|||++ |..||...+...... +. .
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~---~~----~ 235 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK---FV----I 235 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH---HH----h
Confidence 999986654332222223456789999999998999999999999999999998 999997654322111 11 1
Q ss_pred cCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 556 DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 556 ~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
.+.... . .......+..++..||+.+|.+||++.++++.|+
T Consensus 236 ~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 DGGHLD-----L----PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCCCCC-----C----CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111110 1 1112356778889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=323.69 Aligned_cols=264 Identities=25% Similarity=0.361 Sum_probs=202.4
Q ss_pred CCceeecccCceEEEEEEe-----CCCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEEE
Q 041755 334 LPEYLVGKGGHSHVYRGCL-----PDGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFED--NNLLLV 404 (678)
Q Consensus 334 ~~~~~IG~G~~g~Vy~g~~-----~~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV 404 (678)
...+.||+|+||+||++.. .++..||+|+++... .....|.+|+++++.++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6778999999999988642 367899999997542 4567889999999999999999999998754 468999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++.. ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++..+.
T Consensus 87 ~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred ecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999864 248999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCce-ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 485 TSSSHLT-CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 485 ~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
....... .....++..|+|||++..+.++.++||||||+++|||++|..||......- .....+.........+.+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL 237 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence 4332211 112345667999999998899999999999999999999999986543211 11111111111111122222
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+..............+..++..||+.+|.+||++.+|+++|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 2222111122334567788899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.35 Aligned_cols=255 Identities=23% Similarity=0.381 Sum_probs=201.3
Q ss_pred CCCceeecccCceEEEEEEeC-C---CCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe-----
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-D---GKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNN----- 400 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~---g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 400 (678)
|...+.||+|+||.||+|... + +..||||+++.. ......+.+|+++++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456788999999999999864 2 367999998753 3456789999999999999999999999876554
Q ss_pred -EEEEEEcCCCCCHHHHhccCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeec
Q 041755 401 -LLLVYDFLSRGSLEENLHGNKK--DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDF 477 (678)
Q Consensus 401 -~~lV~E~~~~gsL~~~L~~~~~--~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DF 477 (678)
.++||||+++|+|..++..... ....+++.....++.|++.||.|||+ .+++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 7999999999999999865332 22468999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhccccccc
Q 041755 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKD 556 (678)
Q Consensus 478 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 556 (678)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... +..+. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~----~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL----RH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----Hc
Confidence 99987654433222222345678999999988899999999999999999999 889986543221 11111 11
Q ss_pred CccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 557 GKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 557 ~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+... . ........+..++..||+.+|.+||++.++++.|+.
T Consensus 231 ~~~~-----~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 231 GNRL-----K----QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred CCCC-----C----CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 1100 0 111234467778899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.54 Aligned_cols=240 Identities=28% Similarity=0.389 Sum_probs=193.3
Q ss_pred eeecccCceEEEEEEe----CCCCEEEEEEeCCCh-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 337 YLVGKGGHSHVYRGCL----PDGKELAVKILKPSE-----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~----~~g~~vAvK~l~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+.||+|+||.||++.. .+++.||||+++... .....+..|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 358899999987432 3345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++|+|.+++... ..+.+..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999998643 457888889999999999999999 999999999999999999999999999987543322
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...... .+. .+.. .+
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~------~~~-~~~~------~~ 219 (323)
T cd05584 155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID------KIL-KGKL------NL 219 (323)
T ss_pred C--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH------HHH-cCCC------CC
Confidence 1 1223579999999999999889999999999999999999999997654321111 011 1110 01
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLK 602 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~ 602 (678)
... ....+..++..||+.+|.+|| ++.++++
T Consensus 220 ~~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 220 PPY----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCC----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111 123466778999999999999 7787765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=317.30 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=209.8
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||+|... +|+.||+|.++.. ....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67888999999999999999876 7999999988632 234678899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++.........+++.+++.++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999987654445678999999999999999999999 9999999999999999999999999999886654
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
..... ....|+..|+|||++.+..++.++|||||||++|+|++|+.||...... +..... .+..+.. .+
T Consensus 159 ~~~~~--~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~~----~~ 227 (267)
T cd08224 159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-KIEKCDY----PP 227 (267)
T ss_pred CCccc--ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHh-hhhcCCC----CC
Confidence 32221 2356889999999999889999999999999999999999999654321 111000 0111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
. ........+..++..||..+|.+||++.+|+++|+.
T Consensus 228 ~----~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~ 264 (267)
T cd08224 228 L----PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE 264 (267)
T ss_pred C----ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence 1 111233456778899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.69 Aligned_cols=253 Identities=23% Similarity=0.409 Sum_probs=204.6
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|...+.||+|+||.||+|...++..||+|+++......+.|.+|+++++.++||||+++++++.+ +..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCC
Confidence 4688889999999999999988777789999998655445678999999999999999999998754 568999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++..+.......
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 85 GSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 99999997532 2467899999999999999999999 999999999999999999999999999998765433221
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
.....++..|+|||++.++.++.++||||||+++|||++ |..||........... +..+. ..
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~-------~~~~~-----~~---- 222 (262)
T cd05071 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------VERGY-----RM---- 222 (262)
T ss_pred -ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH-------HhcCC-----CC----
Confidence 122456778999999999999999999999999999999 8889876543221110 00000 00
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
....+....+.+++..|++.+|.+||++.+++++|+.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 0112234567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=324.69 Aligned_cols=253 Identities=22% Similarity=0.401 Sum_probs=201.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCC----EEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGK----ELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~----~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
.+|...+.||+|+||.||+|.+. +|+ .+++|.+... .....++..|+.++..+.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 35667788999999999999864 454 4788887543 2445778889999999999999999999864 56789
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
++||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+|||+++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999743 2468999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
.............++..|+|||++.++.++.++|||||||++|||++ |+.||.+..+.....+ +..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~~~-- 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL-------LEKGERL-- 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHCCCcC--
Confidence 55443333344567889999999999999999999999999999998 9999976543321111 1111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
..+.. ....+..++..|+..+|..||++.++++.|..
T Consensus 231 ~~~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~ 267 (279)
T cd05111 231 AQPQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267 (279)
T ss_pred CCCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 11111 12345667799999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=335.98 Aligned_cols=244 Identities=23% Similarity=0.319 Sum_probs=198.7
Q ss_pred cCCCCceeecccCceEEEEEEeC-C-CCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-D-GKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~-g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...+.||+|+||.||+|... . +..||+|++... ......+.+|+.++..++||||+++++++.+.+.+++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46888899999999999999754 2 468999998642 23456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 110 ~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999643 468999999999999999999999 999999999999999999999999999998754
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...++...... +. .+..
T Consensus 183 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~------i~-~~~~----- 245 (340)
T PTZ00426 183 TRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK------IL-EGII----- 245 (340)
T ss_pred CCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH------Hh-cCCC-----
Confidence 321 235799999999999998899999999999999999999999986543211110 11 1110
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLKL 603 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~~ 603 (678)
.+....+ ..+..++..||+.+|.+|+ ++.++++.
T Consensus 246 -~~p~~~~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 -YFPKFLD----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -CCCCCCC----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0111112 3355677999999999995 78888754
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=326.50 Aligned_cols=255 Identities=22% Similarity=0.355 Sum_probs=202.1
Q ss_pred CCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
+|...+.||+|+||.||+|... +++.||||+++... .....|.+|+.++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3555677999999999999753 35789999997543 345678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC
Q 041755 404 VYDFLSRGSLEENLHGNK------------KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE 471 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~ 471 (678)
++||+.+++|.+++.... .....+++..++.++.|++.||.|||+ ++|+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 999999999999985321 112458899999999999999999999 99999999999999999999
Q ss_pred cEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhc
Q 041755 472 PQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWA 550 (678)
Q Consensus 472 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~ 550 (678)
+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||...........
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~---- 238 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM---- 238 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----
Confidence 99999999887654333222233456789999999999999999999999999999998 8888876443211111
Q ss_pred ccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 551 KPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 551 ~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
+..+... ....+....+..++..||+.+|.+||++.+|+..|+
T Consensus 239 ---i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 239 ---IRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred ---HHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 1111111 011122344677889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=330.23 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=196.8
Q ss_pred CCCCceeecccCceEEEEEEe----CCCCEEEEEEeCCC-----hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCL----PDGKELAVKILKPS-----EDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNL 401 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~----~~g~~vAvK~l~~~-----~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 401 (678)
+|...+.||+|+||.||++.. .+|+.||+|+++.. ....+.+..|+.++..++ ||||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477788999999999999875 36889999998642 233566788999999994 99999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
++||||+++|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 9999999999999998643 458999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 482 WLSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 482 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
.+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||............ ...+..
T Consensus 154 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~----- 225 (332)
T cd05614 154 EFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILK----- 225 (332)
T ss_pred cccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhc-----
Confidence 654432222 2236799999999999765 4788999999999999999999999754332211111 000110
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~ 602 (678)
.++.+.... ...+..++..||+.+|.+|| ++.++++
T Consensus 226 --~~~~~~~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 --CDPPFPSFI----GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred --CCCCCCCCC----CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 112222222 23456677999999999999 6667765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.85 Aligned_cols=259 Identities=22% Similarity=0.376 Sum_probs=208.6
Q ss_pred hcCCCCceeecccCceEEEEEEeCC-----CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCeE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPD-----GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFE-DNNL 401 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~-----g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~ 401 (678)
.++|...++||+|+||.||+|...+ +..|++|+++.. ......+.+|+.+++.++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999998755 788999998753 3556778999999999999999999999876 4678
Q ss_pred EEEEEcCCCCCHHHHhccCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeec
Q 041755 402 LLVYDFLSRGSLEENLHGNKKD----GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDF 477 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~----~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DF 477 (678)
++++||+++|+|.+++...... +..+++..++.++.|++.||.|||+ .+++||||||+|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998754322 2568999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhccccccc
Q 041755 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKD 556 (678)
Q Consensus 478 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 556 (678)
|+++.+.............++..|+|||++.+..++.++|||||||++|||++ |+.||...++.. +..+. ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYL----KD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHH----Hc
Confidence 99987654433333333456778999999998899999999999999999999 999997654322 11111 11
Q ss_pred CccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 557 GKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 557 ~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
+. .... .......+.+++.+||+.+|++||++.++++.|+..
T Consensus 235 ~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 235 GY-----RLAQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CC-----CCCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 10 0000 111224567788999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=319.62 Aligned_cols=253 Identities=22% Similarity=0.387 Sum_probs=205.1
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|...+.||+|+||.||+|...+++.||+|.+.........|.+|+.+++.++||||+++++++. .+..++||||+.+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMEN 84 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCC
Confidence 467888999999999999999889999999999876555678999999999999999999999874 4578999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
++|.+++.... +..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05067 85 GSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-
Confidence 99999986532 3568999999999999999999998 99999999999999999999999999999876532221
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
......++..|+|||++..+.++.++||||||+++|||++ |+.||...+.... ... +..+ .......
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~-----~~~~~~~ 226 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQN----LERG-----YRMPRPD 226 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHH----HHcC-----CCCCCCC
Confidence 1123456778999999999999999999999999999999 9999976543211 110 0010 0000111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.....+..++..|++.+|.+||++.+++..|+.
T Consensus 227 ----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 ----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 122457778899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=319.46 Aligned_cols=262 Identities=22% Similarity=0.255 Sum_probs=204.0
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChH---HHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSED---VLKEFASEIEIITALHHRNIISLFGFCFED--NNLLLVY 405 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 405 (678)
+|...+.|++|+||.||+|+++ ++..||+|.++.+.+ .--.-++||.+|.+++|||||.+..+.... +..||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4556678999999999999875 788999999987642 223457999999999999999999988643 5799999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
|||+. +|...+...+ .+|...+...++.|+++||+|||. +.|+||||||+|+|+++.|.+||+|||||+.++.
T Consensus 157 e~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99954 8999988654 678999999999999999999999 9999999999999999999999999999999877
Q ss_pred CCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC-------
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG------- 557 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------- 557 (678)
.... .+..+-|.+|.|||++.+. .|+..+|+||+|||+.||+++++-|.+.....+...+........+.
T Consensus 230 p~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 230 PLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred Cccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 5433 4567889999999999875 59999999999999999999999999877665544332211111111
Q ss_pred -------ccccccCCCCCCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 -------KVSQLLDPSLDTDYDND-QIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 -------~~~~l~dp~l~~~~~~~-~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.+..-..+...|... ..+.-..+....|..||.+|-|+++.|+
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11111111222222211 1233444556778999999999999885
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.16 Aligned_cols=263 Identities=22% Similarity=0.354 Sum_probs=206.3
Q ss_pred cCCCCceeecccCceEEEEEEeCC-----------------CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPD-----------------GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISL 391 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~-----------------g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l 391 (678)
.+|...+.||+|+||.||++...+ +..||+|++... ....+.|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 578888999999999999987542 246899998754 3556789999999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCCHHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCe
Q 041755 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNI 464 (678)
Q Consensus 392 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~-------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NI 464 (678)
+++|..++..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence 9999999999999999999999999975431 12368999999999999999999999 9999999999999
Q ss_pred EecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc--CCCCCCCCCCcc
Q 041755 465 LLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS--GKKPINSENPKG 542 (678)
Q Consensus 465 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~~ 542 (678)
+++.++.++|+|||++................++..|+|||++.++.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999986644333222334556789999999998899999999999999999998 677876543211
Q ss_pred cccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 543 QESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 543 ~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
................... ........+.+++..||+.+|.+||++.+|++.|+
T Consensus 242 ---~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 ---VIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1111111111111111000 11112246788889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=342.97 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=201.4
Q ss_pred CCCceeecccCceEEEEEEeC--CC--CE-EEEEEeCC----ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP--DG--KE-LAVKILKP----SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~--~g--~~-vAvK~l~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
-...++||+|+||.||+|.+. ++ .. ||||..+. .+....+|++|.+++++++|||||+++|++.....+++
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i 238 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML 238 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence 344578999999999999865 33 23 89999884 25778999999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
|||+|.||+|.++|.... ..++..++..++.++|.||+|||+ +++|||||-.+|+|++.++.+||+||||++..
T Consensus 239 vmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 999999999999997553 368999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
.. .........-...|+|||.+..+.|+.++|||||||++||+++ |..||.+.........+ ..++ +..
T Consensus 313 ~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI------~~~~-~r~- 382 (474)
T KOG0194|consen 313 SQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKI------VKNG-YRM- 382 (474)
T ss_pred cc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHH------HhcC-ccC-
Confidence 31 1111101123568999999999999999999999999999999 88899876543221111 1111 111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
..+......+..+...||..+|+.||+|.++.+.|+..
T Consensus 383 -------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~ 420 (474)
T KOG0194|consen 383 -------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEAL 420 (474)
T ss_pred -------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHH
Confidence 11112234455555799999999999999999988743
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=320.38 Aligned_cols=255 Identities=20% Similarity=0.334 Sum_probs=198.8
Q ss_pred CCCceeecccCceEEEEEEeCC-CC--EEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------Ce
Q 041755 333 FLPEYLVGKGGHSHVYRGCLPD-GK--ELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFED------NN 400 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~~-g~--~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~ 400 (678)
|...+.||+|+||.||+|...+ +. .+|+|.++.. ......|..|++++..++||||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3456789999999999998754 33 6899988653 45567899999999999999999999988542 24
Q ss_pred EEEEEEcCCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecc
Q 041755 401 LLLVYDFLSRGSLEENLHGNK--KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
.++||||+++|+|.+++.... .....+++.....++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874322 123458999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccC
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDG 557 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~ 557 (678)
+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |+.||........ .. .+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~----~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI---YD----YLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH----HHHcC
Confidence 9987654332222222346778999999999999999999999999999999 8899875433211 00 11111
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 558 ~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.... ........+..++..||+.+|.+||++.++++.|+.
T Consensus 231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 231 NRLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1100 011223456788899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=323.40 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=203.1
Q ss_pred hcCCCCceeecccCceEEEEEEeCC------CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPD------GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~------g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 401 (678)
+++|...+.||+|+||.||+|...+ +..||+|.+... ......|..|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678889999999999999998643 567899988643 34456799999999999999999999999998899
Q ss_pred EEEEEcCCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC---CcEEe
Q 041755 402 LLVYDFLSRGSLEENLHGNKK---DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF---EPQLS 475 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~---~~kL~ 475 (678)
++||||+++++|.+++..... ....++|..+..++.||+.||.|||+ ++++||||||+|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999875432 12358999999999999999999999 8999999999999998765 58999
Q ss_pred ecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhccccc
Q 041755 476 DFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPIL 554 (678)
Q Consensus 476 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~ 554 (678)
|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||........... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~------~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF------VT 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH------HH
Confidence 9999987643322111112334568999999999999999999999999999997 9999976543321111 11
Q ss_pred ccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 555 KDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 555 ~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
..... .........+..++..|++.+|.+||++.+|++.|+
T Consensus 236 ~~~~~----------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGRL----------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCcC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11110 011112345677889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.33 Aligned_cols=242 Identities=23% Similarity=0.331 Sum_probs=194.9
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRG 411 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 411 (678)
+.||+|+||.||++... +|+.||+|+++.. ......+..|++++..++||||+++++++...+.+++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 7899999999753 234567788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCce
Q 041755 412 SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491 (678)
Q Consensus 412 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 491 (678)
+|..++... ..+++..+..++.||+.||.|||+ ..+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (325)
T cd05594 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T 152 (325)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence 999988643 468999999999999999999995 26899999999999999999999999999875432221 1
Q ss_pred ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCC
Q 041755 492 CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDY 571 (678)
Q Consensus 492 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~ 571 (678)
.....||+.|+|||++.++.++.++|||||||++|||++|+.||...........+.. +. ..+...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-------~~------~~~p~~~ 219 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------EE------IRFPRTL 219 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-------CC------CCCCCCC
Confidence 2235799999999999999999999999999999999999999976543221111110 00 0111112
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041755 572 DNDQIERMVLAATLSISRAPTVRP-----QINLVLKL 603 (678)
Q Consensus 572 ~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~~ 603 (678)
...+..++..||+.+|.+|+ ++.++++.
T Consensus 220 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 220 ----SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ----CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 23456677999999999996 88888853
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=328.14 Aligned_cols=264 Identities=20% Similarity=0.325 Sum_probs=197.3
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.++|...+.||+|+||.||+|... +|+.||||+++... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468889999999999999999876 78999999987532 233467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+. ++|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 6888877643 2458889999999999999999999 99999999999999999999999999998754332
Q ss_pred CCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccc-cchhhccc------------
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQE-SLVMWAKP------------ 552 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~l~~~~~~------------ 552 (678)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ....+...
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 157 SH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred Cc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 21 1233568999999999865 45889999999999999999999999764321110 00000000
Q ss_pred --ccccCccccccCCCCCCCCC-HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 553 --ILKDGKVSQLLDPSLDTDYD-NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 553 --~~~~~~~~~l~dp~l~~~~~-~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
......+.......+..... ......+.+++..||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000000000000000 001234567789999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=330.98 Aligned_cols=247 Identities=18% Similarity=0.321 Sum_probs=193.3
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++||+|+||.||++... +++.||||+++.. ......+..|..++..+ +||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999865 6899999999753 23456688999999998 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-- 151 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-- 151 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC--
Confidence 9999888543 468999999999999999999999 9999999999999999999999999999875322111
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcc--cccchhhcccccccCccccccCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG--QESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~--~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+....+..+.+ .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p 225 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIP 225 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCC
Confidence 2234679999999999999999999999999999999999999996432211 11111111111111110 111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCC------HHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQ------INLVLK 602 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs------~~eVl~ 602 (678)
... ...+..++..||+.+|.+||+ +.++++
T Consensus 226 ~~~----~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 RSL----SVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCC----CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 112 234667779999999999997 566663
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=330.27 Aligned_cols=242 Identities=18% Similarity=0.334 Sum_probs=189.7
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++||+|+||.||++... +++.||+|+++.. ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999865 6889999998753 24456678899988877 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|..++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-- 151 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-- 151 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence 9999888543 468999999999999999999999 9999999999999999999999999999875432211
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCccc--ccchhhcccccccCccccccCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQ--ESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~--~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+....+..+.. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~- 224 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI- 224 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC-
Confidence 12346799999999999999999999999999999999999999964221111 0111111111111110 11
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQI 597 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~ 597 (678)
+......+..++..||+.+|.+||+.
T Consensus 225 ---p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 ---PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ---CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11223446677899999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=322.31 Aligned_cols=270 Identities=23% Similarity=0.330 Sum_probs=201.1
Q ss_pred cCCCCceeecccCceEEEEEEe-----CCCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-----PDGKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISLFGFCFE--DNNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-----~~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~ 402 (678)
.+|...+.||+|+||.||++.. .++..||+|.+... ....+.|.+|+++++.++||||+++++++.. ...++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677888999999999999974 25889999998754 3556789999999999999999999998754 34689
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+||||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999999643 2458999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCcee-cccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 483 LSTSSSHLTC-TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 483 ~~~~~~~~~~-~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
.......... ....++..|+|||++.++.++.++|||||||++|||++|..|+......-................+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 7543322211 112334569999999999999999999999999999998877643221100000000000000000001
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.+...............+.+++..||..+|++|||+.+|++.|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 111111111112223457788899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=336.35 Aligned_cols=203 Identities=28% Similarity=0.401 Sum_probs=174.9
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||++... +|+.||||++... ......+.+|++++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999764 7899999998643 234567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999998643 468899999999999999999999 9999999999999999999999999999864321
Q ss_pred CCC------------C---------------------------------ceecccccCCCCCCcchhccCCCCccceEee
Q 041755 486 SSS------------H---------------------------------LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYA 520 (678)
Q Consensus 486 ~~~------------~---------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwS 520 (678)
... . ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 0 0001246999999999999999999999999
Q ss_pred hhHHHHHHhcCCCCCCCCCC
Q 041755 521 FGIVLLELLSGKKPINSENP 540 (678)
Q Consensus 521 lGvvL~eLltG~~Pf~~~~~ 540 (678)
|||++|||++|+.||.....
T Consensus 234 lGvil~elltG~~Pf~~~~~ 253 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENS 253 (377)
T ss_pred cchhhhhhhcCCCCCCCCCH
Confidence 99999999999999976554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=323.11 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=200.6
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
+|...++||+|+||.||++... +++.||+|++.... .....+.+|+.+++.++||||+++++++..++.+++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4677889999999999999864 78999999986532 234567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998886432 2468999999999999999999999 99999999999999999999999999999876433
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
.. .....|++.|+|||++.+..++.++|||||||++|||++|+.||...........+. ..+..+
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~---~~~~~~--------- 220 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---RRVKED--------- 220 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH---HHhhhc---------
Confidence 22 123578999999999999999999999999999999999999997644321110000 000000
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLKL 603 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~~ 603 (678)
...+.......+..++..||+.||.+|| ++.++++.
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 -QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0111122334567788999999999999 77777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=326.48 Aligned_cols=263 Identities=21% Similarity=0.336 Sum_probs=202.6
Q ss_pred cCCCCceeecccCceEEEEEEeCC---------------CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPD---------------GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFG 393 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~---------------g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g 393 (678)
++|...+.||+|+||.||++...+ ...||+|.++.. ......|.+|++++.+++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478888899999999999986532 235899998753 355677999999999999999999999
Q ss_pred EEEeCCeEEEEEEcCCCCCHHHHhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeE
Q 041755 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKK--------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNIL 465 (678)
Q Consensus 394 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~~--------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NIL 465 (678)
++...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+++|+||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 99999999999999999999999864321 11347899999999999999999999 99999999999999
Q ss_pred ecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc--CCCCCCCCCCccc
Q 041755 466 LSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS--GKKPINSENPKGQ 543 (678)
Q Consensus 466 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~~~ 543 (678)
++.++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999987644332222223455778999999999999999999999999999988 5677765443221
Q ss_pred ccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 544 ESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 544 ~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
+........... .... ..........+.+++..||+.+|.+||++.+|++.|+
T Consensus 242 ---~~~~~~~~~~~~-~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 ---IENTGEFFRNQG-RQIY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHhhhhcc-cccc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 110000010000 0000 0001112346888899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=318.84 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=207.8
Q ss_pred cCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||+|.. .+|+.+|||.+... ......|.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677788899999999999985 48999999987642 244578899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++++|.+++.........+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999887543444678999999999999999999999 9999999999999999999999999999887654
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
..... ....|+..|+|||++.+..++.++||||||+++|+|++|..||........ . .... +.....+
T Consensus 159 ~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~---~~~~------~~~~~~~ 226 (267)
T cd08229 159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-S---LCKK------IEQCDYP 226 (267)
T ss_pred CCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-H---Hhhh------hhcCCCC
Confidence 33221 235689999999999998999999999999999999999999975432211 1 1110 0111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.+. .......+..++..||+.+|.+||||.+|++++..
T Consensus 227 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 227 PLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 111 11233456777899999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=328.51 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=202.1
Q ss_pred HHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---------------HHHHHHHHHHHHHHhcCCCCeee
Q 041755 327 LSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---------------DVLKEFASEIEIITALHHRNIIS 390 (678)
Q Consensus 327 ~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---------------~~~~~~~~Ei~il~~l~HpnIv~ 390 (678)
.+..|+|.....||+|.||.|-+|+.. +++.||||++...+ .-.+...+||.||++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 344578999999999999999999864 79999999996421 11357889999999999999999
Q ss_pred EEEEEEe--CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC
Q 041755 391 LFGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD 468 (678)
Q Consensus 391 l~g~~~~--~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~ 468 (678)
|+++..+ .+.+|||+|||..|.+...= .....+.+.+.++++.++..||+|||. ++||||||||+|+||++
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSS 245 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcC
Confidence 9999865 46899999999998875432 222238999999999999999999999 99999999999999999
Q ss_pred CCCcEEeecccccccCCCCCC---ceecccccCCCCCCcchhccCC----CCccceEeehhHHHHHHhcCCCCCCCCCCc
Q 041755 469 DFEPQLSDFGLASWLSTSSSH---LTCTDVAGTFGYLAPEYFMHGK----VSEKIDVYAFGIVLLELLSGKKPINSENPK 541 (678)
Q Consensus 469 ~~~~kL~DFGla~~~~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~ 541 (678)
+|++||+|||.+.....+... ......+||+.|+|||...++. .+.+.||||+||+||-|+.|+.||.++...
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 999999999999877443211 1222368999999999987743 356899999999999999999999875432
Q ss_pred ccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041755 542 GQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLL 604 (678)
Q Consensus 542 ~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L 604 (678)
.. +.++++..+.-....+..+.+..+++.+|.+||+.|-++.+|..-.
T Consensus 326 ~l---------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 EL---------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HH---------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 11 1222222222222234556677788999999999999999987543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=336.82 Aligned_cols=202 Identities=23% Similarity=0.371 Sum_probs=174.3
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
+|...+.||+|+||.||+|... +++.||||++.... .....+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999864 68899999987532 345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++|+|.+++... ..+++.....++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999998643 457889999999999999999999 99999999999999999999999999997533110
Q ss_pred C---------------------------------------------CCceecccccCCCCCCcchhccCCCCccceEeeh
Q 041755 487 S---------------------------------------------SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAF 521 (678)
Q Consensus 487 ~---------------------------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSl 521 (678)
. ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0000123579999999999999999999999999
Q ss_pred hHHHHHHhcCCCCCCCCCC
Q 041755 522 GIVLLELLSGKKPINSENP 540 (678)
Q Consensus 522 GvvL~eLltG~~Pf~~~~~ 540 (678)
||+||||++|+.||...++
T Consensus 235 Gvil~elltG~~Pf~~~~~ 253 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTP 253 (382)
T ss_pred hHHHHHHHhCCCCCCCCCH
Confidence 9999999999999986554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=330.35 Aligned_cols=199 Identities=25% Similarity=0.444 Sum_probs=175.7
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|+||.||++... +|..+|+|++... ......+.+|++++..++||||++++++|.+++.+++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 67888999999999999999876 6889999988653 34567799999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++|+|.+++... ..+++.....++.+++.||.|||+ ..+|+||||||+|||++.++.+||+|||++..+....
T Consensus 85 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 85 MDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 9999999998643 458899999999999999999997 1479999999999999999999999999987654322
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 539 (678)
.....||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 123578999999999998899999999999999999999999997544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=326.29 Aligned_cols=245 Identities=22% Similarity=0.374 Sum_probs=206.5
Q ss_pred CCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
+|...+.||+|.||+|-+|.. ..|+.||||.++.+ ++..-.+.+||+|++.|+||||+.++++|...+..++|||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 445556699999999999975 58999999998754 4667788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|..+|.|.+++... ..+++.+.+.++.||..|+.|+|. ++++|||||.+|||||.++++||+||||+.++...
T Consensus 134 YaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 134 YASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred ecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 99999999999755 569999999999999999999999 99999999999999999999999999999987765
Q ss_pred CCCceecccccCCCCCCcchhccCCCC-ccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVS-EKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
..- +.++|++-|.+||++.+.+|. +.+|-|||||+||-|+.|..||++.+.+.... .+..|.+.+ |
T Consensus 207 kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvr-------QIs~GaYrE---P 273 (668)
T KOG0611|consen 207 KFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVR-------QISRGAYRE---P 273 (668)
T ss_pred cHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHH-------HhhcccccC---C
Confidence 433 348999999999999999884 68999999999999999999999876543211 122233322 1
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLL 604 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L 604 (678)
+......-++.+||..+|++|-|+.+|..-.
T Consensus 274 --------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 --------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred --------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1112233467999999999999999998643
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=328.98 Aligned_cols=241 Identities=24% Similarity=0.335 Sum_probs=193.7
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++||+|+||.||+|... +|+.||||+++.. ......+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36899999999999875 5889999998753 23456678899999876 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|...+... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-- 151 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-- 151 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--
Confidence 9999988643 458899999999999999999999 9999999999999999999999999999875433222
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... +.. +. ......
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~------i~~-~~------~~~p~~ 218 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES------ILH-DD------VLYPVW 218 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH------HHc-CC------CCCCCC
Confidence 12346799999999999999999999999999999999999999986653321110 111 00 001111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCC-------CHHHHHHH
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRP-------QINLVLKL 603 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RP-------s~~eVl~~ 603 (678)
. ...+..++..||+.+|.+|| ++.++++.
T Consensus 219 ~----~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 219 L----SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred C----CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1 23456677999999999999 77777753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=334.79 Aligned_cols=244 Identities=22% Similarity=0.377 Sum_probs=190.5
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
|...+.||+|+||.||+|... +|+.||||++... ......|.+|+++++.++|+||+++++++.+++.+++||||+.
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 334567999999999999865 7899999998643 3456788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+|+|.... ...+..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 156 ~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 156 GGSLEGTH--------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCcccccc--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 99986532 34677888999999999999999 9999999999999999999999999999987643321
Q ss_pred ceecccccCCCCCCcchhcc-----CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 490 LTCTDVAGTFGYLAPEYFMH-----GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
......||..|+|||++.. ...+.++|||||||++|||++|+.||..........+.... .. . ..
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~-~-----~~ 293 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CM-S-----QP 293 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hc-c-----CC
Confidence 1233579999999998743 23456899999999999999999999743322111111000 00 0 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.. .......+..++..||+.+|.+||++.++++
T Consensus 294 ~~~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 PEA----PATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCC----CCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 1122345677789999999999999999986
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=314.88 Aligned_cols=248 Identities=23% Similarity=0.389 Sum_probs=204.3
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+|...+.||+|++|.||+|... +|+.|++|.+.. .......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677889999999999999865 789999998864 235567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++++|.+++.... ...+++..++.++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997542 3578999999999999999999998 999999999999999999999999999988765433
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
... ....|+..|+|||++.++.++.++|||||||++|+|++|+.||...+... .... ...+... .+
T Consensus 156 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~~~~-----~~ 221 (256)
T cd08529 156 NFA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILK----IIRGVFP-----PV 221 (256)
T ss_pred chh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHcCCCC-----CC
Confidence 221 23568899999999999999999999999999999999999997654221 1111 0011111 11
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.......+..++.+||+.+|++||++.++++
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 222 ----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ----ccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1122345777889999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=318.07 Aligned_cols=253 Identities=23% Similarity=0.431 Sum_probs=203.7
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|.....||+|+||.||+|...++..+|+|.+.........|.+|+.+++.++|||++++++++. .+..++||||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 457778899999999999998877778999998876555677899999999999999999999875 4568999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05069 85 GSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence 99999997532 3458999999999999999999999 89999999999999999999999999999876443221
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
......++..|+|||++.++.++.++||||||+++|||++ |+.||........ ..+. ..+ . .+
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~----~~~-~----~~---- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQV----ERG-Y----RM---- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcC-C----CC----
Confidence 1122346778999999998999999999999999999999 8999976543221 1110 000 0 00
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.........+..++.+||+.+|.+||++.+|++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111223457778899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=329.41 Aligned_cols=240 Identities=22% Similarity=0.316 Sum_probs=193.2
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCC-CeeeEEEEEEeCCeEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHR-NIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~Hp-nIv~l~g~~~~~~~~~lV~ 405 (678)
+|...+.||+|+||.||+|... +++.||||+++.. ......+..|.+++..+.|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4777899999999999999865 5789999998753 24456788899999999765 6888999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 999999999998643 458899999999999999999999 9999999999999999999999999999875322
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ . ... +
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------~-~~~------~ 218 (324)
T cd05587 154 GGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI------M-EHN------V 218 (324)
T ss_pred CCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------H-cCC------C
Confidence 221 223467999999999999999999999999999999999999999765432211110 0 000 1
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQI 597 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~ 597 (678)
.+... ....+..++..||+.+|.+||+.
T Consensus 219 ~~~~~----~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 SYPKS----LSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCC----CCHHHHHHHHHHhhcCHHHcCCC
Confidence 11111 22346677899999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.22 Aligned_cols=203 Identities=23% Similarity=0.371 Sum_probs=174.9
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||++... +|+.||||++.... .....+.+|++++..++||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 46888999999999999999865 68999999986432 33566889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++.....++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 999999999999643 457888999999999999999999 9999999999999999999999999999753310
Q ss_pred CC-----------------------------------------CCceecccccCCCCCCcchhccCCCCccceEeehhHH
Q 041755 486 SS-----------------------------------------SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIV 524 (678)
Q Consensus 486 ~~-----------------------------------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvv 524 (678)
.. .........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0001123579999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCC
Q 041755 525 LLELLSGKKPINSENP 540 (678)
Q Consensus 525 L~eLltG~~Pf~~~~~ 540 (678)
+|||++|+.||....+
T Consensus 234 lyell~G~~Pf~~~~~ 249 (376)
T cd05598 234 LYEMLVGQPPFLADTP 249 (376)
T ss_pred eeehhhCCCCCCCCCH
Confidence 9999999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=332.16 Aligned_cols=237 Identities=26% Similarity=0.357 Sum_probs=191.8
Q ss_pred eeecccCceEEEEEEe----CCCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 337 YLVGKGGHSHVYRGCL----PDGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~----~~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
+.||+|+||.||++.. .+|+.||+|+++... .....+..|++++.+++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999864 368999999997532 234567789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+|+|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 99999998643 468999999999999999999999 99999999999999999999999999999865443221
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........... +.. +.. .+..
T Consensus 155 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~------i~~-~~~------~~p~ 219 (318)
T cd05582 155 --AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM------ILK-AKL------GMPQ 219 (318)
T ss_pred --eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH------HHc-CCC------CCCC
Confidence 2246799999999999988899999999999999999999999976543211110 000 000 0111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINL 599 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~e 599 (678)
.....+..++..||+.+|.+||++.+
T Consensus 220 ----~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 ----FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11234566779999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.30 Aligned_cols=258 Identities=25% Similarity=0.425 Sum_probs=203.5
Q ss_pred cCCCCceeecccCceEEEEEEeC--------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP--------DGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDN 399 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~--------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 399 (678)
++|...+.||+|+||.||++... ++..+|+|.++.. ......+..|++++..+ +||||++++++|...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46888899999999999999742 2357999999864 34556788999999999 7999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKK------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS 467 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~ 467 (678)
..++||||+++|+|.+++..... ....+++.++..++.|++.||.|||+ ++++||||||+|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 99999999999999999975432 12358999999999999999999998 9999999999999999
Q ss_pred CCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccc
Q 041755 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESL 546 (678)
Q Consensus 468 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 546 (678)
.++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||...........
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 999999999999986644322211122234568999999999999999999999999999998 8888865432211110
Q ss_pred hhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 547 VMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 547 ~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
+..+.. ..........+..++..||+.+|.+||++.+|++.|+..
T Consensus 255 -------~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 255 -------LKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred -------HHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 111110 011112234566678999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=326.76 Aligned_cols=256 Identities=22% Similarity=0.382 Sum_probs=204.3
Q ss_pred cCCCCceeecccCceEEEEEEe------CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL------PDGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~------~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 401 (678)
++|...+.||+|+||.||+|.. ..+..||||+++.. ....+.+.+|+.+++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4688889999999999999964 13557999998753 34456789999999999 799999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
++||||+++|+|.+++.... ...+++.++..++.|++.||.|||+ ++++|+||||+|||++.++.++|+|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999997532 2348999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccc
Q 041755 482 WLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 482 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
...............++..|+|||++.++.++.++|||||||++|||++ |..||........ +.. .+..+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~----~~~~~~-- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYK----LIKEGY-- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHH----HHHcCC--
Confidence 7654332222223456788999999999999999999999999999998 9999876543211 101 111110
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.+.. .......+.+++..||..+|++||++.++++.|+.
T Consensus 262 ---~~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 262 ---RMAQ----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---cCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0000 11112457778899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=308.03 Aligned_cols=263 Identities=25% Similarity=0.389 Sum_probs=211.0
Q ss_pred hcCCCCceeecccCceEEEEEE-eCCCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----eEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGC-LPDGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDN-----NLL 402 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~-~~~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 402 (678)
.++|.+.+.||+|||+-||.+. ..++..||+|++.... +..+..++|++..++++|||++++++++..+. ..|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4678899999999999999997 4578999999887654 77888999999999999999999999886443 489
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
|+++|...|+|.+.+......+..+++.+.+.|+.++++||.+||... .++.||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999999988777788999999999999999999999822 3499999999999999999999999999886
Q ss_pred cCCCCCC----ce---ecccccCCCCCCcchhc---cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccc
Q 041755 483 LSTSSSH----LT---CTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552 (678)
Q Consensus 483 ~~~~~~~----~~---~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 552 (678)
..-.... .. -.....|..|.|||.+. +...++++|||||||+||+|+.|..||+.....+. ++..
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-SlaL---- 253 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SLAL---- 253 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eEEE----
Confidence 5432111 00 01134688999999995 45678999999999999999999999987654332 2111
Q ss_pred ccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 553 ~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.+..+.+.- ..+....+.+.+++..|++.||.+||++.+++..++.
T Consensus 254 Av~n~q~s~--------P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 254 AVQNAQISI--------PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred eeecccccc--------CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 111112221 1122246778889999999999999999999988753
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=337.30 Aligned_cols=254 Identities=22% Similarity=0.287 Sum_probs=200.0
Q ss_pred HhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 041755 328 SATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 328 ~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 402 (678)
...++|...+.||+|+||.||++... +|+.||+|+++... .....+..|+.+++.++||||+++++++.+++.++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568999999999999999999875 68999999986422 33455788999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+||||+++|+|.+++.. ..+++.....++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999999864 247888888999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCceecccccCCCCCCcchhccC----CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHG----KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+....... +... .
T Consensus 192 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~------i~~~-~ 263 (370)
T cd05596 192 MDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK------IMDH-K 263 (370)
T ss_pred ccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH------HHcC-C
Confidence 6443221 22346799999999998653 478999999999999999999999986543221110 1100 0
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTV--RPQINLVLKL 603 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~--RPs~~eVl~~ 603 (678)
.. + .+.. .......+..++..||+.+|.+ ||++.++++.
T Consensus 264 ~~-~---~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 NS-L---TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred Cc-C---CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 0 0000 0112244556778999988987 9999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=335.60 Aligned_cols=257 Identities=21% Similarity=0.286 Sum_probs=198.0
Q ss_pred HHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 041755 325 ELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDN 399 (678)
Q Consensus 325 el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 399 (678)
++....++|...+.||+|+||.||++... +++.||+|++... ......+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678999999999999999999875 6889999998642 233456789999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
.+|+||||+++|+|.+++.. ..+++.....++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccc
Confidence 99999999999999999853 247888999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhccC----CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccc
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG----KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILK 555 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 555 (678)
+........ .......||+.|+|||++.+. .++.++|||||||+||||++|+.||...+...... .+..
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~------~i~~ 261 (370)
T cd05621 189 CMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS------KIMD 261 (370)
T ss_pred ceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH------HHHh
Confidence 987643222 122346799999999999754 37889999999999999999999997654322111 0111
Q ss_pred cCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCC--CCCCHHHHHHH
Q 041755 556 DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPT--VRPQINLVLKL 603 (678)
Q Consensus 556 ~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~--~RPs~~eVl~~ 603 (678)
.... ..+.. .......+..++..|+..++. .||++.++++.
T Consensus 262 ~~~~-----~~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 262 HKNS-----LNFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCcc-----cCCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0000 00000 011123344455777775544 38899998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=329.83 Aligned_cols=243 Identities=21% Similarity=0.339 Sum_probs=192.5
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHH---HhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEII---TALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il---~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
|...+.||+|+||.||+|... +|+.||||+++... ...+.+.+|++++ ..++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 556788999999999999865 68999999997432 3345566676655 566799999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|...+.. ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988753 358999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .. +.
T Consensus 153 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i------~~-~~------ 217 (324)
T cd05589 153 GFGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI------VN-DE------ 217 (324)
T ss_pred CCCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hh-CC------
Confidence 2211 223467999999999999999999999999999999999999999765432211111 00 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQ-----INLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs-----~~eVl~ 602 (678)
+..... ....+..++..||+.+|.+||+ +.++++
T Consensus 218 ~~~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 VRYPRF----LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCC----CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 011111 1244567789999999999994 555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=336.05 Aligned_cols=250 Identities=26% Similarity=0.344 Sum_probs=211.4
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe-EEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNN-LLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~-~~lV~ 405 (678)
++|...+.||+|+||.++..+.+ +++.|++|.+... +.......+|+.++++++|||||.+.+.+.+++. +++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56778889999999999988765 7889999988643 3445578899999999999999999999999888 99999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
+|++||+|.+.+...+ +..|++..++.++.|++.|+.|||+ +.|+|||||+.|||++.++.+||+|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998764 5789999999999999999999998 9999999999999999999999999999999877
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
..... ..++||+.|+.||++.+.+|..|+|||||||++|||++-+++|...+.......+. ...++|
T Consensus 159 ~~~~a--~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~-----------~~~~~P 225 (426)
T KOG0589|consen 159 EDSLA--STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN-----------RGLYSP 225 (426)
T ss_pred chhhh--heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh-----------hccCCC
Confidence 65222 34799999999999999999999999999999999999999998876543221111 111222
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
. +..+...+..++..|++.+|..||++.++|..
T Consensus 226 l-----p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 L-----PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred C-----CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1 22334456667799999999999999999976
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=328.81 Aligned_cols=240 Identities=22% Similarity=0.319 Sum_probs=193.6
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
+|...+.||+|+||.||+|... +++.||||+++.. ......+..|..++..+ +|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999865 6789999998753 23345677788888877 5899999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 999999999988643 458899999999999999999999 9999999999999999999999999999875432
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
... ......||+.|+|||++.++.++.++|||||||++|||++|+.||...+.......+ . ....
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i------~-~~~~------ 218 (323)
T cd05616 154 DGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------M-EHNV------ 218 (323)
T ss_pred CCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH------H-hCCC------
Confidence 221 223467999999999999999999999999999999999999999765432211111 0 0110
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQI 597 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~ 597 (678)
.+ +......+..++..||+.+|.+|++.
T Consensus 219 ~~----p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 AY----PKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC----CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01 11223456778899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=313.80 Aligned_cols=245 Identities=24% Similarity=0.387 Sum_probs=198.4
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHH
Q 041755 338 LVGKGGHSHVYRGCLPDGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 415 (678)
+||+|+||.||+|...+++.+|+|+++.. ......|.+|++++..++||||++++++|...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 68999999999999888999999998753 3445678999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceeccc
Q 041755 416 NLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDV 495 (678)
Q Consensus 416 ~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 495 (678)
++... ...+.+..++.++.+++.||.|||+ ++++|+||||+||+++.++.+||+|||++.......... ....
T Consensus 82 ~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 154 (250)
T cd05085 82 FLRKK---KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK 154 (250)
T ss_pred HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence 98643 2457899999999999999999998 999999999999999999999999999987654332211 1123
Q ss_pred ccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHH
Q 041755 496 AGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDND 574 (678)
Q Consensus 496 ~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~ 574 (678)
.++..|+|||++.++.++.++||||||+++|+|++ |..||.......... .+..+. .. .....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~-------~~~~~~-----~~----~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE-------QVEKGY-----RM----SCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH-------HHHcCC-----CC----CCCCC
Confidence 44678999999999999999999999999999998 999997543321110 001110 00 11112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 575 QIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 575 ~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
....+..++..|++.+|.+||++.++++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2356778889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=328.44 Aligned_cols=238 Identities=24% Similarity=0.361 Sum_probs=189.4
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++||+|+||.||+|... +++.||||+++... .....+..|..++..+ +||||+++++++..++.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999865 68899999997532 3345566777777654 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|..++... ..+++.....++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~-- 151 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-- 151 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--
Confidence 9999988643 468999999999999999999999 9999999999999999999999999999986533221
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+ .. . .+.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~-~------~~~~~~~ 218 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI------LN-D------RPHFPRW 218 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hc-C------CCCCCCC
Confidence 223467999999999999999999999999999999999999999865432211100 00 0 0111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQINLV 600 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~eV 600 (678)
....+..++..||+.+|.+||++.+.
T Consensus 219 ----~~~~~~~ll~~~l~~~P~~R~~~~~~ 244 (316)
T cd05592 219 ----ISKEAKDCLSKLFERDPTKRLGVDGD 244 (316)
T ss_pred ----CCHHHHHHHHHHccCCHHHcCCChHH
Confidence 12345667799999999999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=323.86 Aligned_cols=261 Identities=21% Similarity=0.302 Sum_probs=203.3
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----eEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDN-----NLLLVY 405 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~lV~ 405 (678)
.|...+++|.|.||.||+|.+. ++..||||..-++.... -+|++||+.+.|||||+|+-+|.... .+.|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 4666789999999999999865 57999999887654322 36999999999999999999886432 356899
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC-CCcEEeecccccccC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD-FEPQLSDFGLASWLS 484 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~-~~~kL~DFGla~~~~ 484 (678)
|||+. +|.+.+......+..++...+.-+..||++||.|||. .+|+||||||.|+|+|.+ |.+||||||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99965 8999887655556778888889999999999999999 999999999999999977 999999999999988
Q ss_pred CCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC------
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG------ 557 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~------ 557 (678)
.+..... ...|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.+...+...+..........
T Consensus 178 ~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 178 KGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred cCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 7766543 456889999999987 469999999999999999999999999877665544333222111111
Q ss_pred -ccccccCCCCCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 -KVSQLLDPSLDTD-----YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 -~~~~l~dp~l~~~-----~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+..+...|.+... +........++++..+|..+|.+|.++.+++.
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 1112222222211 12222345667779999999999999999885
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=316.31 Aligned_cols=253 Identities=24% Similarity=0.327 Sum_probs=193.8
Q ss_pred eecccCceEEEEEEeCC---CCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCC
Q 041755 338 LVGKGGHSHVYRGCLPD---GKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGS 412 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~---g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 412 (678)
.||+|+||.||+|...+ +..+|+|.++... .....|.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999997643 4579999887543 345678899999999999999999999999889999999999999
Q ss_pred HHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCce
Q 041755 413 LEENLHGNKK-DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491 (678)
Q Consensus 413 L~~~L~~~~~-~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 491 (678)
|.+++..... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.+++++|+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999975432 22356788888999999999999999 9999999999999999999999999999976544332222
Q ss_pred ecccccCCCCCCcchhccC-------CCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 492 CTDVAGTFGYLAPEYFMHG-------KVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 492 ~~~~~Gt~~Y~APE~l~~~-------~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
.....|+..|+|||++... .++.++||||||+++|||++ |+.||.......... + ...+......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~----~~~~~~~~~~ 231 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---Y----TVREQQLKLP 231 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---H----HhhcccCCCC
Confidence 2335678899999998642 35789999999999999996 999997644322111 0 0011111222
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
++.+.... ...+..++..|+ .+|.+||++.+|++.|+
T Consensus 232 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 33332222 223455668888 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=361.64 Aligned_cols=255 Identities=24% Similarity=0.422 Sum_probs=208.8
Q ss_pred CCCceeecccCceEEEEEEeC--CCC----EEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP--DGK----ELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~--~g~----~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
....+.||+|.||.||.|... +|. .||||.++.. .+...+|.+|..+|+.++|||||+|+|+|.+....+++
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 345678999999999999754 343 4899999864 67889999999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 405 YDFLSRGSLEENLHGNKK---DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
+|||++|+|..+|...+. ....+...+.+.++.+||+|+.||++ +++|||||..+|+||++...+||+|||||+
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhH
Confidence 999999999999986532 24568889999999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccc
Q 041755 482 WLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 482 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
.+.............-...|||||.++.+.++.|+|||||||+|||++| |..||...+...... ..+++|++.
T Consensus 851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~------~~~~ggRL~ 924 (1025)
T KOG1095|consen 851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL------DVLEGGRLD 924 (1025)
T ss_pred hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH------HHHhCCccC
Confidence 5554433322221122357999999999999999999999999999999 899998765432211 123333221
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.+..+..++.++++.||+.+|++||++..|++.+..
T Consensus 925 ----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~ 960 (1025)
T KOG1095|consen 925 ----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA 960 (1025)
T ss_pred ----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence 234455667788899999999999999999996654
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=346.14 Aligned_cols=263 Identities=18% Similarity=0.287 Sum_probs=194.5
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--------Ce
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED--------NN 400 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--------~~ 400 (678)
..+|...+.||+|+||.||+|... +++.||||++..... ...+|+.+++.++||||+++++++... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ---YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 457889999999999999999864 689999998865432 234799999999999999999987532 24
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC-CcEEeeccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF-EPQLSDFGL 479 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kL~DFGl 479 (678)
+++||||++ ++|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 142 l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecccc
Confidence 679999997 57877775443445678999999999999999999999 9999999999999999664 799999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcc--ccc--
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK--PIL-- 554 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~--~~~-- 554 (678)
++.+...... ....||+.|+|||++.+. .++.++|||||||+||||++|.+||.+.........+.... +..
T Consensus 218 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 218 AKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred chhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 9876543322 235789999999998764 68999999999999999999999998755432111110000 000
Q ss_pred ---ccCccccccCCCC-----CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 555 ---KDGKVSQLLDPSL-----DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 555 ---~~~~~~~l~dp~l-----~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....+..+--|.+ ...+.......+..++..||+.+|.+||++.++++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000010000111 00111112245778889999999999999999884
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=313.14 Aligned_cols=250 Identities=25% Similarity=0.438 Sum_probs=204.4
Q ss_pred eeecccCceEEEEEEeCC----CCEEEEEEeCCChH--HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLPD----GKELAVKILKPSED--VLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~----g~~vAvK~l~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
+.||+|+||.||+|.... +..|++|+++.... ....+.+|++++..++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 368999999999998753 88999999986542 368899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 411 GSLEENLHGNKKD-----GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 411 gsL~~~L~~~~~~-----~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
++|.+++...... ...+++.+++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765222 3678999999999999999999999 9999999999999999999999999999988765
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
...........++..|+|||.+....++.++||||||+++|+|++ |..||........ ... +..+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~----~~~~~~----- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---LEY----LRKGYR----- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH----HHcCCC-----
Confidence 443223334567899999999998899999999999999999999 6999976533211 110 111100
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
. .........+..++..||+.+|.+||++.++++.|+
T Consensus 226 ~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 L----PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred C----CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 011112355777889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=322.91 Aligned_cols=260 Identities=20% Similarity=0.363 Sum_probs=204.8
Q ss_pred hhcCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNN 400 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 400 (678)
..++|...+.||+|+||.||+|... .+..||+|.++... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567888999999999999999643 25589999987543 344568899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEE
Q 041755 401 LLLVYDFLSRGSLEENLHGNKK------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQL 474 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL 474 (678)
.++||||+++|+|.+++..... ....+.+..+..++.|++.||.|||+ ++|+||||||+|||+++++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975321 12345778889999999999999999 99999999999999999999999
Q ss_pred eecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccc
Q 041755 475 SDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPI 553 (678)
Q Consensus 475 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 553 (678)
+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||........ .. ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~---~~---~~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV---LK---FV 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HH
Confidence 99999986654332222222345778999999999999999999999999999998 7889875433211 11 01
Q ss_pred cccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 554 LKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 554 ~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.. +.... . .......+..++..||+.+|.+||++.++++.|+..
T Consensus 235 ~~-~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 MD-GGYLD-----Q----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred Hc-CCCCC-----C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11 11100 0 111235677888999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=320.07 Aligned_cols=253 Identities=26% Similarity=0.435 Sum_probs=200.8
Q ss_pred HhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC------C
Q 041755 328 SATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFED------N 399 (678)
Q Consensus 328 ~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~------~ 399 (678)
.+++.|...+.||+|+||.||+|... +++.||+|++.........+.+|+.++.++ +||||+++++++... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 45677888889999999999999865 688999999976555556788999999998 699999999998753 4
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+ ++|+|+||||+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 6899999999999999987532 3568999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhc-----cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccc
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL 554 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 554 (678)
+........ ......|+..|+|||++. ...++.++|||||||++|||++|+.||............
T Consensus 158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~------- 228 (272)
T cd06637 158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------- 228 (272)
T ss_pred ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-------
Confidence 986543222 123367899999999986 346888999999999999999999999754332211100
Q ss_pred ccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 555 KDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 555 ~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.... .+.+. .......+..++..||..+|.+||++.++++
T Consensus 229 ~~~~-----~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRNP-----APRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcCC-----CCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0000 01111 1112234677889999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=320.16 Aligned_cols=256 Identities=22% Similarity=0.393 Sum_probs=203.0
Q ss_pred cCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
.+|.....||+|+||.||++... ++..+|+|.++.. ......|.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35677788999999999999632 4568999988754 3556789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCc
Q 041755 404 VYDFLSRGSLEENLHGNKK-----------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP 472 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 472 (678)
||||+++|+|.+++..... ....+++..++.++.|++.||.|||+ .+++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999875421 11358999999999999999999999 999999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcc
Q 041755 473 QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAK 551 (678)
Q Consensus 473 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 551 (678)
||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.............
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--- 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT--- 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH---
Confidence 9999999986544322222223345788999999999999999999999999999998 899986544322111110
Q ss_pred cccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 552 PILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 552 ~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
.+.. +.. .......+..++..||+.+|.+||++.+|++.|+
T Consensus 239 ----~~~~-----~~~----~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 ----QGRE-----LER----PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----cCcc-----CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0000 000 0111244667889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=328.47 Aligned_cols=236 Identities=26% Similarity=0.382 Sum_probs=190.6
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++||+|+||.||+|... +++.||||+++.. ......+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 6889999998753 23456778899998877 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-- 151 (320)
T cd05590 81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-- 151 (320)
T ss_pred chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC--
Confidence 9999988643 458899999999999999999999 9999999999999999999999999999875432221
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... +. .+.. .+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~------i~-~~~~------~~~~~ 218 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA------IL-NDEV------VYPTW 218 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH------Hh-cCCC------CCCCC
Confidence 22346799999999999999999999999999999999999999986543221110 11 1110 01111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQIN 598 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~ 598 (678)
....+..++..||+.+|.+||++.
T Consensus 219 ----~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 219 ----LSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred ----CCHHHHHHHHHHcccCHHHCCCCC
Confidence 123456677999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=321.37 Aligned_cols=257 Identities=24% Similarity=0.440 Sum_probs=205.1
Q ss_pred hcCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 401 (678)
.++|...+.||+|+||.||+|... ++..||+|++... ......|.+|+.+++.++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 357888899999999999999753 4678999998753 34567799999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCC
Q 041755 402 LLVYDFLSRGSLEENLHGNK------------------KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSN 463 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~------------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~N 463 (678)
++||||+++|+|.+++.... .....+++.+++.++.|++.||.|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999996432 112357899999999999999999999 999999999999
Q ss_pred eEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcc
Q 041755 464 ILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKG 542 (678)
Q Consensus 464 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~ 542 (678)
||++.++.++|+|||++..+.............++..|+|||.+.++.++.++|||||||++|||++ |..||.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999886543322222222345678999999998999999999999999999998 888986544322
Q ss_pred cccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 543 QESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 543 ~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
. .. .+..+.... ........+.+++.+||+.+|.+||++.++++.|+
T Consensus 241 ~---~~----~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 241 V---IY----YVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred H---HH----HHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1 11 111111110 01112345777889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=325.37 Aligned_cols=258 Identities=24% Similarity=0.410 Sum_probs=204.8
Q ss_pred cCCCCceeecccCceEEEEEEe--------CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL--------PDGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDN 399 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~--------~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 399 (678)
.+|...+.||+|+||.||+|.. .++..||+|.++.. ......+.+|+.+++.+ +||||+++++++....
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 94 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 94 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence 4677788999999999999963 13457999998753 34567889999999999 7999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKK------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS 467 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~ 467 (678)
..++||||+++|+|.+++..... ....+++.++..++.|++.||.|||+ ++++||||||+|||++
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~ 171 (304)
T cd05101 95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVT 171 (304)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEc
Confidence 99999999999999999975422 12457899999999999999999999 9999999999999999
Q ss_pred CCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccc
Q 041755 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESL 546 (678)
Q Consensus 468 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 546 (678)
.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|+|++ |..||..........
T Consensus 172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~- 250 (304)
T cd05101 172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK- 250 (304)
T ss_pred CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH-
Confidence 999999999999987755433322233456778999999999999999999999999999998 788886543221111
Q ss_pred hhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 547 VMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 547 ~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
. +..+... .........+..++..||+.+|.+||++.+|++.|+..
T Consensus 251 -----~-~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 251 -----L-LKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred -----H-HHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 1 1111000 01112234566778999999999999999999999653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=339.34 Aligned_cols=245 Identities=22% Similarity=0.341 Sum_probs=202.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
+-|..++-||.|+.|.|-+|+.. +|+.+|||++... ......+.+||-||+-+.|||+++|++++.+..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 44667788999999999999864 7999999999653 233456778999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|.|+++|-.. +++++.+..+++.||+.|+.|+|. .+|+||||||+|+|||..+++||+|||+|.+-..
T Consensus 92 Eyv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 999999999999653 678999999999999999999999 9999999999999999999999999999987544
Q ss_pred CCCCceecccccCCCCCCcchhccCCC-CccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
+.-- ..-||++.|.|||++++.+| +.++||||+|||||.||||+.||++++-. .+... +..|.++.
T Consensus 165 gklL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LLlK----V~~G~f~M--- 231 (786)
T KOG0588|consen 165 GKLL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLLLK----VQRGVFEM--- 231 (786)
T ss_pred Cccc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHHHH----HHcCcccC---
Confidence 4322 33689999999999999998 46899999999999999999999865432 22221 12222221
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.........++..|+..||..|.|+.+|++
T Consensus 232 -------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 232 -------PSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred -------CCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 1111233445568889999999999999997
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=320.09 Aligned_cols=264 Identities=25% Similarity=0.380 Sum_probs=208.5
Q ss_pred ccHHHHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEE--
Q 041755 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCF-- 396 (678)
Q Consensus 321 f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~-- 396 (678)
+.++.+..+.++|...+.||+|+||.||++... +|+.+|+|+++........+..|+.++..+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 455667778899999999999999999999864 688999999876554556788999999999 6999999999884
Q ss_pred ---eCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcE
Q 041755 397 ---EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ 473 (678)
Q Consensus 397 ---~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~k 473 (678)
.++..++||||+++++|.+++.........+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEE
Confidence 3457899999999999999886543344678999999999999999999999 9999999999999999999999
Q ss_pred EeecccccccCCCCCCceecccccCCCCCCcchhcc-----CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchh
Q 041755 474 LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-----GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVM 548 (678)
Q Consensus 474 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~ 548 (678)
|+|||++........ ......|++.|+|||++.. ..++.++|||||||++|||++|+.||....+... +..
T Consensus 165 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~--~~~ 240 (286)
T cd06638 165 LVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA--LFK 240 (286)
T ss_pred EccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--Hhh
Confidence 999999887644322 1223568999999999853 4578899999999999999999999976543211 000
Q ss_pred hcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 549 WAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 549 ~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
. ..+......++. .....+..++..||+.+|.+||++.++++.
T Consensus 241 ~-----~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 I-----PRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred c-----cccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 000101111111 112346778899999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=322.56 Aligned_cols=263 Identities=20% Similarity=0.332 Sum_probs=202.8
Q ss_pred cCCCCceeecccCceEEEEEEeC-----------------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-----------------DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISL 391 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-----------------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l 391 (678)
++|...+.||+|+||.||++... ++..||+|+++.. ......|.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888899999999999998532 2446899999753 3456789999999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCCHHHHhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCe
Q 041755 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKKD-------GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNI 464 (678)
Q Consensus 392 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~-------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NI 464 (678)
++++...+..++||||+++|+|.+++...... ...+++.+.+.++.|++.||.|||+ .+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 99999999999999999999999998754321 2347889999999999999999999 8999999999999
Q ss_pred EecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc--CCCCCCCCCCcc
Q 041755 465 LLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS--GKKPINSENPKG 542 (678)
Q Consensus 465 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~~ 542 (678)
|++.++.++|+|||++..+.............++..|+|||....+.++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999987644332222222345678999999988999999999999999999998 778886543321
Q ss_pred cccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 543 QESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 543 ~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
. ............ .....+. .......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 242 ~---~~~~~~~~~~~~-~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 V---IENTGEFFRDQG-RQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H---HHHHHHHHhhcc-ccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 100000010000 0000011 1112256778889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=328.03 Aligned_cols=239 Identities=22% Similarity=0.354 Sum_probs=191.1
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHh-cCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITA-LHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
+.||+|+||.||+|... +++.||||+++.. ......+..|..++.. ++||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999875 5789999999753 2334566778888876 4899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++... ..+++.+...++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 9999998643 468899999999999999999999 9999999999999999999999999999875432221
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.. ..+.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------~~~~~~~~ 218 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-------------DNPCYPRW 218 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------CCCCCCcc
Confidence 12235799999999999999999999999999999999999999976543221111110 01111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQIN-LVL 601 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~-eVl 601 (678)
. ...+..++..||+.+|.+||++. +++
T Consensus 219 ~----~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 219 L----TREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred C----CHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1 23456677999999999999997 544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=315.90 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=196.0
Q ss_pred eecccCceEEEEEEe---CCCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 041755 338 LVGKGGHSHVYRGCL---PDGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRG 411 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~---~~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 411 (678)
.||+|+||.||+|.+ .++..+|+|+++.. ....+.|..|+.++..+.||||+++++++. ++..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 36789999998643 345678999999999999999999999885 45779999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCce
Q 041755 412 SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491 (678)
Q Consensus 412 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 491 (678)
+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||.|||++.++.+||+|||++..+........
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999998643 358899999999999999999999 9999999999999999999999999999987654433211
Q ss_pred -ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 492 -CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 492 -~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
.....++..|+|||.+..+.++.++|||||||++|||++ |..||........... +..+.. +....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-------i~~~~~-----~~~~~ 221 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM-------IESGER-----MECPQ 221 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHCCCC-----CCCCC
Confidence 122344678999999988889999999999999999998 9999976543221111 111110 01111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.....+.+++..||+.+|.+||++.+|.+.|+.
T Consensus 222 ----~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 222 ----RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ----CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 123446678899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=320.07 Aligned_cols=253 Identities=21% Similarity=0.388 Sum_probs=201.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCC----EEEEEEeCC--ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGK----ELAVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~----~vAvK~l~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
++|...+.||+|+||.||+|... +|. .||+|+++. .......+.+|+.++..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56778899999999999999753 454 489999864 33556788999999999999999999999975 45789
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
+|||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++.+
T Consensus 86 ~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 86 VTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999998753 2468999999999999999999999 99999999999999999999999999999877
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
.............+++.|+|||.+.++.++.++|||||||++|||++ |..||........ ..+ +..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~----~~~~~~~-- 230 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PDL----LEKGERL-- 230 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH----HHCCCcC--
Confidence 54433322222345678999999999999999999999999999998 8999875433211 111 1111000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.. .......+..++..||+.+|..||++.++++.|+.
T Consensus 231 ---~~----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~ 267 (279)
T cd05109 231 ---PQ----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267 (279)
T ss_pred ---CC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00 11123456678899999999999999999988854
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=315.77 Aligned_cols=255 Identities=24% Similarity=0.427 Sum_probs=207.5
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
.++|...+.||+|+||.||+|..++++.||||.+.......+.+.+|+.++++++||||+++++++......++||||++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 84 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMS 84 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccC
Confidence 35788899999999999999998888899999998766556789999999999999999999999998889999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+++|.+++.... +..+++..+..++.+++.||.|||+ ++++|+||||+||++++++.++|+|||++..+......
T Consensus 85 ~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 85 KGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 999999997532 3468999999999999999999999 99999999999999999999999999999876542211
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
. .....++..|+|||.+.++.++.++||||||+++|+|++ |+.||........ .... .. + +. ...
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~---~~-~-~~----~~~- 225 (261)
T cd05034 160 A-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQV---ER-G-YR----MPR- 225 (261)
T ss_pred h-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---Hc-C-CC----CCC-
Confidence 1 112234678999999999899999999999999999998 9999965433211 1110 00 0 00 000
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.......+.+++.+|++.+|.+||++.++++.|+.
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 226 ---PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11113457778899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=314.26 Aligned_cols=251 Identities=25% Similarity=0.385 Sum_probs=201.6
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE------DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
++|...+.||+|++|.||++... +++.||+|.+.... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57889999999999999999864 68999999886431 234678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+++++|.+.+... ..+++.....++.|++.||.|||+ .+++|+||||+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 99999999999998643 458889999999999999999999 99999999999999999999999999999865
Q ss_pred CCCCCCce-ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSHLT-CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
........ .....|+..|+|||++.+..++.++||||||+++|||++|+.||......... .. .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~---~~~~~----- 223 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FK---IATQP----- 223 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HH---HhccC-----
Confidence 43221111 12356788999999999988999999999999999999999999754332110 00 00000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
..+.+ .......+..++..||..+|.+||++.++++.
T Consensus 224 ~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 TNPQL----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCC----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00111 11223346677899999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=314.21 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=205.1
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|...+.||.|+||.||+|.. .|+.||+|.++......+.+.+|+.++..++|+||+++++++...+..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 5778889999999999999987 589999999987655678899999999999999999999999988999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 85 GSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 99999986542 2368999999999999999999999 9999999999999999999999999999987643221
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
...++..|+|||++..+.++.++||||||+++|||++ |+.||........ .... ..+.. +
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~----~~~~~-----~---- 218 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPHV----EKGYR-----M---- 218 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH----hcCCC-----C----
Confidence 2334678999999998999999999999999999997 9999875533211 1110 00000 0
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.........+..++.+||..+|.+||++.+++++|+.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0011123556778899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=326.65 Aligned_cols=242 Identities=18% Similarity=0.302 Sum_probs=190.5
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++||+|+||.||++... +++.||+|+++.. ......+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999865 6889999999753 23456688999999888 599999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|..++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-- 151 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-- 151 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--
Confidence 9999888543 468999999999999999999999 9999999999999999999999999999875322111
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
......||+.|+|||++.+..++.++|||||||+||||++|+.||.............+....+..... .+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~p~- 224 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RIPR- 224 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CCCC-
Confidence 123467999999999999999999999999999999999999999754322211111111111111100 0111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCH
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQI 597 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~ 597 (678)
.....+..++..||+.+|.+||++
T Consensus 225 ---~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 ---FLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred ---CCCHHHHHHHHHHhccCHHHcCCC
Confidence 112345667799999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.19 Aligned_cols=253 Identities=22% Similarity=0.408 Sum_probs=205.9
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
.+|...+.||+|+||.||+|...++..+|+|.+.........|.+|+++++.++|+||+++++++.+ ...+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 5788889999999999999988788889999998766666789999999999999999999999887 778999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++..........
T Consensus 85 ~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 85 GSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 99999997532 3568899999999999999999999 899999999999999999999999999998765432221
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
.....++..|+|||++..+.++.++|+|||||++|+|++ |+.||...+.... ..+ +..+... + .
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~----~~~~~~~----~-~-- 224 (260)
T cd05073 160 -REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRA----LERGYRM----P-R-- 224 (260)
T ss_pred -ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHH----HhCCCCC----C-C--
Confidence 122345678999999998899999999999999999999 8999976443211 111 1111000 0 0
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.......+..++.+|++.+|.+||++.++++.|+.
T Consensus 225 --~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 --PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11123457778899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=316.53 Aligned_cols=255 Identities=26% Similarity=0.422 Sum_probs=203.8
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CC---CEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DG---KELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g---~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
.++|...+.||+|+||.||+|.+. ++ ..+|+|.++.. ......+.+|++++..++||||+++.+++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888899999999999999865 33 37999998754 3456779999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+++++|.+++... ...+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999998643 2468999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCCCcee-cccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 484 STSSSHLTC-TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 484 ~~~~~~~~~-~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
......... .....+..|+|||++.++.++.++|||||||++|||++ |+.||........ ... +..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~---~~~----i~~~~--- 227 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV---MKA----INDGF--- 227 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH---HHH----HhcCC---
Confidence 543322111 11223457999999998899999999999999999997 9999975443211 110 11110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
..+ ...+....+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 228 -~~~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 228 -RLP-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred -CCC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 000 011223457788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=327.47 Aligned_cols=239 Identities=23% Similarity=0.336 Sum_probs=190.9
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++||+|+||.||+|... +|+.||+|+++... .....+..|..++..+ +||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999875 68999999997532 3345667788888764 899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|..++... ..+++.....++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||+++.......
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN-- 151 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--
Confidence 9999988643 468899999999999999999999 9999999999999999999999999999875322221
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+ ..+ .+.+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~-------~~~------~~~~~~~ 218 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI-------RVD------TPHYPRW 218 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH-------HhC------CCCCCCC
Confidence 223467999999999999999999999999999999999999999765432111100 000 1111111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQIN-LVL 601 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~-eVl 601 (678)
. ...+..++..||+.+|.+||++. +++
T Consensus 219 ~----~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 I----TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred C----CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 23456677999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=323.02 Aligned_cols=256 Identities=24% Similarity=0.372 Sum_probs=200.8
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCC--EEEEEEeCC--ChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGK--ELAVKILKP--SEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~--~vAvK~l~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...++||+|+||.||+|... +|. .+++|.++. .....+.|.+|++++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888899999999999999875 343 478888874 234567899999999999 799999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCc
Q 041755 405 YDFLSRGSLEENLHGNKK------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP 472 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 472 (678)
|||+++|+|.+++..... ....+++..++.++.|++.||+|||+ ++|+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 999999999999965321 12358899999999999999999999 999999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcc
Q 041755 473 QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAK 551 (678)
Q Consensus 473 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 551 (678)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||........ ...
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~---~~~-- 230 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL---YEK-- 230 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH--
Confidence 9999999864322111 111223557999999998899999999999999999997 9999976543221 110
Q ss_pred cccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 552 PILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 552 ~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.. .+ ..+.. .......+.+++..||+.+|.+||++.++++.|....
T Consensus 231 -~~-~~-----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 231 -LP-QG-----YRMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred -Hh-cC-----CCCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 00 00111 1112245677889999999999999999999986443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=318.58 Aligned_cols=245 Identities=24% Similarity=0.291 Sum_probs=193.5
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 041755 339 VGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413 (678)
Q Consensus 339 IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 413 (678)
||+|+||.||++... +|+.||+|++.... .....+..|++++.+++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 69999999986432 2344566799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceec
Q 041755 414 EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCT 493 (678)
Q Consensus 414 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 493 (678)
.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 98886432 2458899999999999999999999 999999999999999999999999999988765432 223
Q ss_pred ccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCH
Q 041755 494 DVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDN 573 (678)
Q Consensus 494 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~ 573 (678)
...||..|+|||++.++.++.++|||||||++|||++|+.||.......... ......+. .. +.. ....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~-~~----~~~-~~~~--- 221 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTLE-DE----VKF-EHQN--- 221 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHHHhhc-cc----ccc-cccc---
Confidence 3578999999999999999999999999999999999999997543321111 00011111 00 000 0011
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 574 DQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 574 ~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
....+..++..||+.+|.+||++.++++.
T Consensus 222 -~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 222 -FTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred -CCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 22346677899999999999999877643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=317.01 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=201.9
Q ss_pred cCCCCceeecccCceEEEEEEeC-CC---CEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DG---KELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g---~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
+.|...+.||+|+||.||+|... +| ..||||+++.. ......|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34677889999999999999864 33 36999998753 45567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... ...+++.+++.++.|++.||.|||+ ++++|+||||+|||++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998643 2468999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCceecccc---cCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccc
Q 041755 485 TSSSHLTCTDVA---GTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 485 ~~~~~~~~~~~~---Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
............ ++..|+|||++.++.++.++|||||||++|||++ |..||....... ...+.. ....+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~---~~~~~- 230 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIE---QDYRL- 230 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHH---cCCcC-
Confidence 433222211111 2457999999999999999999999999999886 999997654321 111110 00000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
....+....+..++..||+.+|.+||++.+|+..|+.
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 231 ---------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred ---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0011223446778899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=337.90 Aligned_cols=257 Identities=22% Similarity=0.390 Sum_probs=202.1
Q ss_pred CCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS--EDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 402 (678)
+|...+.||+|+||.||+|.+. .++.||||+++.. ......+.+|++++.++. ||||++++++|...+..+
T Consensus 38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~ 117 (401)
T cd05107 38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY 117 (401)
T ss_pred HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence 4666788999999999999853 3468999999754 234567899999999997 999999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCCC------------------------------------------------------------
Q 041755 403 LVYDFLSRGSLEENLHGNKK------------------------------------------------------------ 422 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~------------------------------------------------------------ 422 (678)
+||||+++|+|.++++....
T Consensus 118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (401)
T cd05107 118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG 197 (401)
T ss_pred EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence 99999999999999975421
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC
Q 041755 423 ----------------------------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD 468 (678)
Q Consensus 423 ----------------------------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~ 468 (678)
....+++...+.++.|++.||.|||+ .+++||||||+|||+++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICE 274 (401)
T ss_pred hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeC
Confidence 11347888899999999999999998 99999999999999999
Q ss_pred CCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccch
Q 041755 469 DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLV 547 (678)
Q Consensus 469 ~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~ 547 (678)
++.+||+|||+++.+.............++..|+|||.+.++.++.++|||||||++|||++ |+.||......... .
T Consensus 275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~--~ 352 (401)
T cd05107 275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF--Y 352 (401)
T ss_pred CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH--H
Confidence 99999999999986543322222223457889999999999899999999999999999998 88998654321110 0
Q ss_pred hhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 548 MWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 548 ~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
..+..+. .+. ........+.+++..||+.+|..||++.+|++.|+.
T Consensus 353 ----~~~~~~~-----~~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~ 398 (401)
T cd05107 353 ----NAIKRGY-----RMA----KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398 (401)
T ss_pred ----HHHHcCC-----CCC----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 0011110 000 111123457777899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=335.88 Aligned_cols=194 Identities=22% Similarity=0.315 Sum_probs=169.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
++|...+.||+|+||.||++... +++.||+|.... ..+.+|++++++|+||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-----~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~- 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-----GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY- 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-----hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-
Confidence 57999999999999999999865 689999997542 34678999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
.++|..++... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 166 ~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 166 KTDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 47888888543 458899999999999999999999 99999999999999999999999999999754332211
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSE 538 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 538 (678)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 239 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 239 -KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred -ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 223467999999999999999999999999999999999999887543
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=319.83 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=210.4
Q ss_pred cccHHHHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe
Q 041755 320 LFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFE 397 (678)
Q Consensus 320 ~f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~ 397 (678)
.+...++..++++|.....||+|+||.||++... +|+.+|+|++.........+.+|+.++.++ +|||++++++++..
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 3566778888999999999999999999999874 789999999976555556788899999999 79999999999875
Q ss_pred C-----CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCc
Q 041755 398 D-----NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP 472 (678)
Q Consensus 398 ~-----~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 472 (678)
. +.+++||||+++|+|.+++.........+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence 4 35899999999999999887543444678999999999999999999999 899999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccccCCCCCCcchhccCC-----CCccceEeehhHHHHHHhcCCCCCCCCCCcccccch
Q 041755 473 QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK-----VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV 547 (678)
Q Consensus 473 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-----~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~ 547 (678)
||+|||++......... .....|+..|+|||++..+. ++.++|||||||++|||++|+.||....+... +.
T Consensus 168 kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF 243 (291)
T ss_pred EEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence 99999998876543221 12356899999999986543 68899999999999999999999976543211 11
Q ss_pred hhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 548 MWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 548 ~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+. .+....+.+ .......+..++..||+.+|.+||++.++++
T Consensus 244 ~~~-----~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KIP-----RNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHh-----cCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 110 011111111 1122345778889999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=341.00 Aligned_cols=270 Identities=17% Similarity=0.202 Sum_probs=199.3
Q ss_pred ccHHHHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCC------CCeeeEEE
Q 041755 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHH------RNIISLFG 393 (678)
Q Consensus 321 f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~g 393 (678)
+..+++...+++|...++||+|+||+||+|... .++.||||+++........+..|+.++..++| .+++++++
T Consensus 119 ~~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 119 VLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred ecCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 334555566789999999999999999999865 68899999997654445566778888877755 45899999
Q ss_pred EEEeC-CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC--
Q 041755 394 FCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF-- 470 (678)
Q Consensus 394 ~~~~~-~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~-- 470 (678)
++... .++|+|||++ +++|.+++... ..+++..+..|+.||+.||.|||+ ..+||||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~ 271 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTV 271 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcc
Confidence 88754 5789999988 77898888643 468999999999999999999996 14999999999999998765
Q ss_pred --------------CcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCC
Q 041755 471 --------------EPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPIN 536 (678)
Q Consensus 471 --------------~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~ 536 (678)
.+||+|||++..... ..+...||+.|+|||++.+..++.++|||||||+||||++|+.||.
T Consensus 272 ~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 272 VDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred cccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 499999998764322 1234689999999999999999999999999999999999999998
Q ss_pred CCCCcccccchhhc---------ccc--------cc-cCccccccCCC-----CCCCC--CHHHHHHHHHHHHhcccCCC
Q 041755 537 SENPKGQESLVMWA---------KPI--------LK-DGKVSQLLDPS-----LDTDY--DNDQIERMVLAATLSISRAP 591 (678)
Q Consensus 537 ~~~~~~~~~l~~~~---------~~~--------~~-~~~~~~l~dp~-----l~~~~--~~~~~~~l~~la~~Cl~~dP 591 (678)
..+......++... ... +. .+.+....++. ..... .......+.+++..||+.||
T Consensus 347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 75543222111110 000 00 00000000000 00000 00112346688999999999
Q ss_pred CCCCCHHHHHH
Q 041755 592 TVRPQINLVLK 602 (678)
Q Consensus 592 ~~RPs~~eVl~ 602 (678)
.+||++.|+++
T Consensus 427 ~~R~ta~e~L~ 437 (467)
T PTZ00284 427 QKRLNARQMTT 437 (467)
T ss_pred hhCCCHHHHhc
Confidence 99999999986
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=325.54 Aligned_cols=236 Identities=27% Similarity=0.342 Sum_probs=188.0
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIE-IITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++||+|+||+||+|... +|+.||||++.... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999875 78999999986432 23345555655 56789999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|..++... ..+++.....++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 151 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-- 151 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--
Confidence 9999988643 468899999999999999999999 9999999999999999999999999999875432221
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...... .+.. +. ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~------~i~~-~~------~~~~~~ 218 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD------NILN-KP------LRLKPN 218 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH------HHHc-CC------CCCCCC
Confidence 2234679999999999999999999999999999999999999997654321110 0110 00 011111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQIN 598 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~ 598 (678)
. ...+..++..||+.+|.+||++.
T Consensus 219 ~----~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 219 I----SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C----CHHHHHHHHHHhhcCHHhCCCCC
Confidence 1 34466777999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=326.53 Aligned_cols=240 Identities=21% Similarity=0.325 Sum_probs=193.7
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++||+|+||.||+|... +++.||||+++.. ......+..|.+++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 5889999999753 23456678899999888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|..++... ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 151 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-- 151 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence 9999988643 468999999999999999999999 9999999999999999999999999999875322211
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....... +. ... ..+..
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~------i~-~~~------~~~~~- 217 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS------IL-EDE------VRYPR- 217 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH------HH-cCC------CCCCC-
Confidence 12235789999999999999999999999999999999999999976543211110 00 000 01111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCH-----HHHHH
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQI-----NLVLK 602 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~-----~eVl~ 602 (678)
.....+..++..||+.+|.+||++ .++++
T Consensus 218 ---~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 218 ---WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ---cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 122446677899999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.77 Aligned_cols=246 Identities=24% Similarity=0.407 Sum_probs=198.8
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHH
Q 041755 338 LVGKGGHSHVYRGCLPDGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 415 (678)
+||+|+||.||++...+++.||+|+++... .....|.+|+++++++.||||+++++++.+....++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 689999999999998779999999887532 356789999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceeccc
Q 041755 416 NLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDV 495 (678)
Q Consensus 416 ~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 495 (678)
++... ...+++..+..++.+++.||.|||+ ++++||||||+|||++.++.++|+|||++...............
T Consensus 82 ~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 82 FLRKK---KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 98643 2467899999999999999999999 99999999999999999999999999999866432221111122
Q ss_pred ccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHH
Q 041755 496 AGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDND 574 (678)
Q Consensus 496 ~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~ 574 (678)
.++..|+|||++.++.++.++||||||+++|||+| |..||...........+. .+ ........
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-------~~---------~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-------SG---------YRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-------cC---------CCCCCCcc
Confidence 34667999999999999999999999999999999 888887654322111110 00 00001112
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 575 QIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 575 ~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
....+..++..|+..+|.+||++.++++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2345777889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=322.36 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=200.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCC--EEEEEEeCC--ChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGK--ELAVKILKP--SEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~--~vAvK~l~~--~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...+.||+|+||.||+|... +|. .+++|.++. .......|.+|++++.++ +||||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888899999999999999864 454 457777764 235567889999999999 899999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCc
Q 041755 405 YDFLSRGSLEENLHGNKK------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP 472 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 472 (678)
|||+++|+|.+++..... ....+++.+++.++.|++.||.|||+ ++++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 999999999999975421 12468999999999999999999999 999999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcc
Q 041755 473 QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAK 551 (678)
Q Consensus 473 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 551 (678)
||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||........ ....
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~- 236 (303)
T cd05088 164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEKL- 236 (303)
T ss_pred EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HHHH-
Confidence 999999986432111 1111234667999999988889999999999999999998 9999975443211 1100
Q ss_pred cccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 552 PILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 552 ~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
..+ ..... .......+..++.+||+.+|.+||++.+++..|...
T Consensus 237 ---~~~-----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 237 ---PQG-----YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred ---hcC-----CcCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000 00000 111123467788999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.92 Aligned_cols=245 Identities=25% Similarity=0.396 Sum_probs=194.6
Q ss_pred ecccCceEEEEEEeC---CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 041755 339 VGKGGHSHVYRGCLP---DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413 (678)
Q Consensus 339 IG~G~~g~Vy~g~~~---~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 413 (678)
||+|+||.||+|.+. .+..||+|++.... ...+.|.+|+.++++++||||+++++++. .+..++||||+++|+|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence 899999999999753 45679999987543 44577999999999999999999999885 4578999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCce-e
Q 041755 414 EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT-C 492 (678)
Q Consensus 414 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~ 492 (678)
.+++... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++........... .
T Consensus 82 ~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSGK---KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9998643 2468999999999999999999999 9999999999999999999999999999986654332221 1
Q ss_pred cccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCC
Q 041755 493 TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDY 571 (678)
Q Consensus 493 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~ 571 (678)
+...++..|+|||++.+..++.++|||||||++|||++ |..||.......... .+..+.. ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-------~~~~~~~---------~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-------FIEQGKR---------LDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-------HHHCCCC---------CCC
Confidence 11234578999999998889999999999999999996 999997654322111 1111110 011
Q ss_pred CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 572 DNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 572 ~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+......+..++..||..+|++||++.+|.+.|+.
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 11223456677899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=313.30 Aligned_cols=252 Identities=25% Similarity=0.477 Sum_probs=203.7
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
.+|...+.||+|+||.||+|...++..+|+|.++........|.+|++++++++|||++++++++......++||||+.+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 45677789999999999999887788999999876554456789999999999999999999999998999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
++|.+++.... ..+++..++.++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 84 GCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 99999986432 457899999999999999999999 89999999999999999999999999998865433211
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
......++.+|+|||++.++.++.++||||||+++|||++ |+.||........ ... + ..+ .....+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~---~-~~~--~~~~~~~~-- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV---VET---I-NAG--FRLYKPRL-- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---HHH---H-hCC--CCCCCCCC--
Confidence 1112335678999999998999999999999999999998 9999975443211 110 0 110 01111211
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
....+..++.+||+.+|.+||++.++++.|.
T Consensus 226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1356778889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=322.84 Aligned_cols=258 Identities=24% Similarity=0.431 Sum_probs=202.9
Q ss_pred cCCCCceeecccCceEEEEEEeC--------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP--------DGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDN 399 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~--------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 399 (678)
.+|...+.||+|+||.||++... .+..+|+|+++.. ......+.+|++++.++ +||||++++++|...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778889999999999999642 3457999998753 34567789999999999 5999999999999988
Q ss_pred eEEEEEEcCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKK------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS 467 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~ 467 (678)
..++||||+++|+|.+++..... ....+++.++..++.|++.||.|||+ ++++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 99999999999999999975421 22458999999999999999999998 9999999999999999
Q ss_pred CCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccc
Q 041755 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESL 546 (678)
Q Consensus 468 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 546 (678)
.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||...........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 248 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999987654322211112234567999999999999999999999999999999 8899865443221111
Q ss_pred hhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 547 VMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 547 ~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
+..+... .........+..++.+||+.+|.+||++.++++.|+..
T Consensus 249 -------~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~ 293 (314)
T cd05099 249 -------LREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293 (314)
T ss_pred -------HHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111100 01112233566788999999999999999999999743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=312.04 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=200.8
Q ss_pred cCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
++|...+.||+|+||.||+|.. .+|+.||+|++.... .....+.+|+.++.+++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4688889999999999999986 478999999987543 34456789999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++++|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998643 468999999999999999999999 9999999999999999999999999999987643221
Q ss_pred CceecccccCCCCCCcchhc---cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
. .....|+..|+|||.+. ...++.++|||||||++|||++|+.||....+..... .+.. ..+ ..+
T Consensus 162 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~~-----~~~---~~~ 229 (267)
T cd06646 162 K--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMSK-----SNF---QPP 229 (267)
T ss_pred c--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eeec-----CCC---CCC
Confidence 1 12356889999999884 3557889999999999999999999996544322111 0000 000 001
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLL 604 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L 604 (678)
.... .......+.+++..||+.+|.+||++.++++.|
T Consensus 230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1111 111234567788999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=316.08 Aligned_cols=250 Identities=24% Similarity=0.446 Sum_probs=198.3
Q ss_pred eeecccCceEEEEEEeCC-------CCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 337 YLVGKGGHSHVYRGCLPD-------GKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~-------g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+.||+|+||.||+|...+ +..+|||.+.... .....|.+|+.+++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 358999999999998642 3579999886543 4567889999999999999999999999998999999999
Q ss_pred CCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC-----CcEEeeccc
Q 041755 408 LSRGSLEENLHGNKK---DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF-----EPQLSDFGL 479 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~-----~~kL~DFGl 479 (678)
+++++|.+++..... ....+++.++..++.|++.||.|||+ .+++|+||||+|||++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 22457899999999999999999998 8999999999999999887 899999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCc
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
+................++..|+|||++.++.++.++|||||||++|||++ |+.||...+... ..... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~---~~~~~ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV---TAGGR 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH---hcCCc
Confidence 986644332222222355788999999999999999999999999999998 999997543221 11110 00000
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
+ .........+.+++.+||..+|.+||++.+|++.|+
T Consensus 232 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 232 L----------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred c----------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 011122345678889999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.64 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=196.9
Q ss_pred eeecccCceEEEEEEeC--C--CCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP--D--GKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~--~--g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
+.||+|+||.||+|... + +..+|+|.+.... ...+.+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 36899999999999743 2 3689999998654 35678999999999999999999999876 4578999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999753 368999999999999999999998 899999999999999999999999999998775443322
Q ss_pred e-ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 491 T-CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 491 ~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
. .....++..|+|||.+.++.++.++|||||||++|+|++ |..||...+... +..+. ..+...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~----~~~~~~-------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAML----ESGERL-------- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH----HcCCcC--------
Confidence 1 111234567999999999999999999999999999998 999997654321 11111 111000
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.........+.+++.+||..+|.+||++.++++.|+..
T Consensus 218 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 -PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 00111234567788999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=324.32 Aligned_cols=263 Identities=20% Similarity=0.320 Sum_probs=198.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|+||.||+|... +++.||+|.++... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999865 68899999987432 3345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+.+ +|.+++... +..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 964 888887643 2457899999999999999999999 999999999999999999999999999997654322
Q ss_pred CCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc-------
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV------- 559 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~------- 559 (678)
.. .....+|+.|+|||++.+ ..++.++|||||||++|+|+||+.||...+...................+
T Consensus 159 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 KT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred cc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 21 123467999999998865 46899999999999999999999999765543221111110000000000
Q ss_pred --ccccCCCCCCC----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 560 --SQLLDPSLDTD----YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 560 --~~l~dp~l~~~----~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
...-.+..... ........+.+++..||+.+|.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 00011234567889999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=316.04 Aligned_cols=261 Identities=27% Similarity=0.401 Sum_probs=201.9
Q ss_pred cCCCCceeecccCceEEEEEEe-----CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-----PDGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFED--NNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-----~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 401 (678)
..|...+.||+|+||.||++.. .++..||+|.++.. ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467788999999999999973 35789999998754 34557899999999999999999999999775 568
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999998643 2358999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCce-ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcc--------cccchhhccc
Q 041755 482 WLSTSSSHLT-CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG--------QESLVMWAKP 552 (678)
Q Consensus 482 ~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~--------~~~l~~~~~~ 552 (678)
.+........ .....|+..|+|||++.++.++.++|||||||++|||++++.|+....... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 7654332211 123456778999999998899999999999999999999887653321100 0000000000
Q ss_pred ccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 553 ~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.+..+. ...........+.+++..||+.+|.+||++.++++.|+.
T Consensus 238 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 282 (284)
T cd05079 238 VLEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282 (284)
T ss_pred HHHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence 001110 000111234568888999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=326.42 Aligned_cols=239 Identities=26% Similarity=0.323 Sum_probs=189.1
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIE-IITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
+.||+|+||.||+|... +|+.||||++... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36899999999999864 7899999998643 233455666655 46779999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|..++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 151 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-- 151 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--
Confidence 9999888643 468999999999999999999999 9999999999999999999999999999875422211
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
......||+.|+|||++.++.++.++|||||||++|||++|+.||...+...... .+.. +. ..+...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~------~~~~-~~------~~~~~~ 218 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD------NILH-KP------LVLRPG 218 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH------HHHc-CC------ccCCCC
Confidence 2234679999999999999999999999999999999999999997654321110 0111 00 001111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQINLVL 601 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl 601 (678)
....+..++..|++.+|.+||++.+.+
T Consensus 219 ----~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 219 ----ASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred ----CCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 223455677999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=317.53 Aligned_cols=251 Identities=25% Similarity=0.307 Sum_probs=202.1
Q ss_pred CCCCceeecccCceEEEEEEeCC-CCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLPD-GKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~~-g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
+|...+.||.|.-|+||++.+.+ +..+|+|++... .....+...|-+||+.+.||.++.||..+..++..|||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 34455679999999999999864 588999999754 3556777889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
||+||+|...++.+ .+..|++..++.++.+++-||+|||. .|||+|||||+||||.++|++.|+||.|+..+...
T Consensus 158 yCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred cCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999998865 45789999999999999999999999 99999999999999999999999999997654210
Q ss_pred C---------------------------------C---------------------CceecccccCCCCCCcchhccCCC
Q 041755 487 S---------------------------------S---------------------HLTCTDVAGTFGYLAPEYFMHGKV 512 (678)
Q Consensus 487 ~---------------------------------~---------------------~~~~~~~~Gt~~Y~APE~l~~~~~ 512 (678)
. . .......+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 011223689999999999999999
Q ss_pred CccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCC
Q 041755 513 SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPT 592 (678)
Q Consensus 513 s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~ 592 (678)
+.++|+|+|||+|||||.|..||.+.+.+.....+.. ..+.-.......-.+.++|...|.+||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~---------------~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG---------------QPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc---------------CCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 9999999999999999999999988765543221111 1111101112334456677888999999
Q ss_pred CCCC----HHHHHH
Q 041755 593 VRPQ----INLVLK 602 (678)
Q Consensus 593 ~RPs----~~eVl~ 602 (678)
+|-. +.||-+
T Consensus 378 kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKR 391 (459)
T ss_pred hhhccccchHHhhc
Confidence 9987 666653
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=313.50 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=192.8
Q ss_pred eecccCceEEEEEEeCCC---CEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCC
Q 041755 338 LVGKGGHSHVYRGCLPDG---KELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGS 412 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~g---~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 412 (678)
.||+|+||.||+|...++ ..+++|.++.. ....+.|.+|+.+++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975433 35677776643 2456789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCcee
Q 041755 413 LEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492 (678)
Q Consensus 413 L~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 492 (678)
|.+++.........+++...+.++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997654333456778888999999999999999 99999999999999999999999999998653322211122
Q ss_pred cccccCCCCCCcchhcc-------CCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 493 TDVAGTFGYLAPEYFMH-------GKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 493 ~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
....|+..|+|||++.. ..++.++|||||||++|||++ |..||......... ...+ .+....+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~-~~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL------NHVI-KDQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHH-hhcccccCC
Confidence 23568899999998753 245789999999999999997 56787654332110 0111 122233445
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
|.+...++ ..+.+++..|| .+|.+||++.+|++.|.
T Consensus 232 ~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 55544333 34555667888 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=317.78 Aligned_cols=260 Identities=22% Similarity=0.360 Sum_probs=202.4
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|+||.||++... +|..+|+|.++.. ......+.+|++++.+++||||++++++|.+++.+++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888899999999999999865 6888999988653 34566789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++++|.+++... ..+++..+..++.|++.||.|||+ ..+++|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 9999999999643 468899999999999999999997 2589999999999999999999999999987654322
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC----------
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG---------- 557 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~---------- 557 (678)
. ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+..................
T Consensus 155 ~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 155 A----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred c----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 1 23578999999999988889999999999999999999999997544322111111000000000
Q ss_pred -------cccccc-------CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 558 -------KVSQLL-------DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 558 -------~~~~l~-------dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
...++. .|.+.. ......+..++.+||..+|.+||++.+|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 011100 0122347788899999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=309.17 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=204.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
++|...+.||+|+||.||+|... +++.|++|.++.... ...+.+|+++++.++||||+++++++......++++||++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 57888889999999999999876 489999999976544 6789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 82 AGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999998643 3578999999999999999999999 8999999999999999999999999999987654332
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||....+..... ... . ...+.+.
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--~~~-----~-----~~~~~~~- 220 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--MIP-----N-----KPPPTLS- 220 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--hhc-----c-----CCCCCCC-
Confidence 1223568899999999999999999999999999999999999997654322110 000 0 0000010
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+......+..++..||+.+|.+||++.+|++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11122345677889999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=313.94 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=203.1
Q ss_pred cCCCCceeecccCceEEEEEEeC-C---CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-D---GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~---g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
.+|...+.||+|+||.||+|... + +..+|+|.++.. ....+.|.+|+.++.+++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999753 2 347999998753 34567889999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++++|.+++... ...+++.+++.++.|++.||.|||+ ++++||||||+|||++.++.++|+|||++..+.
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999643 2468999999999999999999999 999999999999999999999999999998775
Q ss_pred CCCCCce-ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 485 TSSSHLT-CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 485 ~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
....... .....++..|+|||++.++.++.++||||||+++||+++ |..||........ .... ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----~~~~---- 226 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAI----EEGY---- 226 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHH----hCCC----
Confidence 5432221 112234568999999999999999999999999999886 9999976543221 1111 1110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.+.. .......+..++..|++.+|.+||+|.++++.|+.
T Consensus 227 -~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 227 -RLPA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -cCCC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 0000 11123456778899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.95 Aligned_cols=236 Identities=26% Similarity=0.327 Sum_probs=187.2
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIE-IITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++||+|+||.||+|... +|+.||+|++.... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999875 68999999986432 23345555654 67889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|...+... ..+++.....++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-- 151 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-- 151 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--
Confidence 9999888542 457888999999999999999999 9999999999999999999999999999875322211
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..... ..+.. +. + .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~i~~-~~--------~--~ 214 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY------DNILH-KP--------L--Q 214 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH------HHHhc-CC--------C--C
Confidence 223467999999999999999999999999999999999999999765422110 00110 00 0 0
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQIN 598 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~ 598 (678)
.+......+..++..||+.+|.+||+..
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1112234567788999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=334.85 Aligned_cols=259 Identities=21% Similarity=0.323 Sum_probs=198.6
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----eEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDN-----NLL 402 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 402 (678)
+|...+.||+|+||.||++... +|+.||||++... ....+.+.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999864 7999999998642 245577899999999999999999999998766 789
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+||||+. ++|.+.+.. ...+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 678887743 2468999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
....... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...++......+... +.......
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~g~~~~~~ 228 (372)
T cd07853 153 EEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDL---LGTPSLEA 228 (372)
T ss_pred cccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH---cCCCCHHH
Confidence 5443222 22335689999999998774 4799999999999999999999999876543222111110 00000000
Q ss_pred -----------c----cC-CCCCC--CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 562 -----------L----LD-PSLDT--DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 562 -----------l----~d-p~l~~--~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+ .. +.... .........+..++..||+.||.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0 00 00000 011112345677889999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.89 Aligned_cols=261 Identities=21% Similarity=0.308 Sum_probs=193.2
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhc---CCCCeeeEEEEEEe-----CC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITAL---HHRNIISLFGFCFE-----DN 399 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~-----~~ 399 (678)
+|...+.||+|+||.||+|... +|+.||+|.++... .....+.+|+.++..+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777889999999999999865 68999999987431 2233456777777665 69999999999864 24
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
..++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence 5899999997 58988886532 2458999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCccccc-chhhcccccccCc
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQES-LVMWAKPILKDGK 558 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-l~~~~~~~~~~~~ 558 (678)
+........ .....||..|+|||++.+..++.++|||||||++|+|++|++||.......... ...+.. ......
T Consensus 155 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~-~~~~~~ 230 (288)
T cd07863 155 ARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-LPPEDD 230 (288)
T ss_pred cccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC-CCChhh
Confidence 987654322 223578999999999999999999999999999999999999997654322110 000000 000000
Q ss_pred cc-------cccCCCCCC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 559 VS-------QLLDPSLDT---DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 559 ~~-------~l~dp~l~~---~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+. ..+.+.... ....+..+.+.+++..||+.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 001110000 001122345677889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=314.20 Aligned_cols=247 Identities=24% Similarity=0.399 Sum_probs=193.9
Q ss_pred eecccCceEEEEEEeC-CCC--EEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 041755 338 LVGKGGHSHVYRGCLP-DGK--ELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSRG 411 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~-~g~--~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~g 411 (678)
+||+|+||.||+|.+. +|. .+++|.++.. ......+.+|++++.++ +||||++++++|...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 5899999999999875 444 4688988742 35567889999999999 7999999999999999999999999999
Q ss_pred CHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 412 SLEENLHGNKK------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 412 sL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
+|.+++..... ....+++.+++.++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCC
Confidence 99999875431 12357899999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCc
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
+........ ......+..|+|||++.+..++.++|||||||++|||++ |..||........ ... . ..+.
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~---~-~~~~ 228 (270)
T cd05047 159 SRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEK---L-PQGY 228 (270)
T ss_pred ccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH---HHH---H-hCCC
Confidence 863321111 111233567999999998899999999999999999997 9999965432211 110 0 0000
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
...........+..++..|++.+|.+||++.+++..|+.
T Consensus 229 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~ 267 (270)
T cd05047 229 ---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 267 (270)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence 000011122356788899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=310.97 Aligned_cols=237 Identities=24% Similarity=0.433 Sum_probs=191.4
Q ss_pred eecccCceEEEEEEeCC-C----------CEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 338 LVGKGGHSHVYRGCLPD-G----------KELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~-g----------~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.||+|+||.||+|...+ + ..+++|++.........|.+|+.+++.++||||+++++++.. ...++|||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEE
Confidence 58999999999998754 3 257889887655447889999999999999999999999988 77899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC-------CcEEeeccc
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF-------EPQLSDFGL 479 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~-------~~kL~DFGl 479 (678)
|+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 81 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 81 YVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred cCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999997542 268999999999999999999998 9999999999999999888 799999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhccC--CCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhccccccc
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG--KVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKD 556 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 556 (678)
+...... ....++..|+|||++... .++.++|||||||++|||++ |..||........... +. .
T Consensus 155 a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~--~~-----~ 221 (259)
T cd05037 155 PITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF--YQ-----D 221 (259)
T ss_pred ccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH--Hh-----c
Confidence 9865441 124567789999999876 78999999999999999999 5777765542211111 10 0
Q ss_pred CccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 557 GKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 557 ~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
...... .....+..++..||..+|.+||++.+|++.|+
T Consensus 222 --------~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 --------QHRLPM---PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --------CCCCCC---CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000000 01156778889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=328.45 Aligned_cols=258 Identities=23% Similarity=0.384 Sum_probs=200.3
Q ss_pred cCCCCceeecccCceEEEEEEe------CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC-Ce
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL------PDGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFED-NN 400 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~------~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~-~~ 400 (678)
++|...+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.++.++ +||||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4688889999999999999963 35789999999753 34566788999999999 689999999988654 56
Q ss_pred EEEEEEcCCCCCHHHHhccCCC----------------------------------------------------------
Q 041755 401 LLLVYDFLSRGSLEENLHGNKK---------------------------------------------------------- 422 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 422 (678)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7999999999999999864321
Q ss_pred -----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceeccccc
Q 041755 423 -----DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAG 497 (678)
Q Consensus 423 -----~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~G 497 (678)
....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 01247888999999999999999999 9999999999999999999999999999987644322222223445
Q ss_pred CCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHH
Q 041755 498 TFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQI 576 (678)
Q Consensus 498 t~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~ 576 (678)
+..|+|||.+.+..++.++||||||+++|+|++ |..||........ ... .+..+... ...... .
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~----~~~~~~~~-----~~~~~~----~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR----RLKEGTRM-----RAPDYT----T 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHH----HHhccCCC-----CCCCCC----C
Confidence 678999999999999999999999999999997 9999865432111 000 11111100 001111 2
Q ss_pred HHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 577 ERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 577 ~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
..+..++..||+.+|.+||++.+|++.|+.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~ 338 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 346777899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.95 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=199.2
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-eCCeEEEEEEcCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCF-EDNNLLLVYDFLS 409 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~~~~~lV~E~~~ 409 (678)
.+|...+.||+|+||.||++.. .|..||+|.++... ..+.|.+|+.++++++|+|++++++++. +++..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 4678889999999999999977 57889999987543 3467899999999999999999999865 4467899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+++|.+++.... ...+++..++.++.|++.||.|||+ ++++||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 84 KGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999987532 2458999999999999999999998 999999999999999999999999999987654322
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
....++..|+|||++.+..++.++|||||||++|||++ |+.||....... +... +..+. .+..
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~----~~~~~-----~~~~- 220 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPR----VEKGY-----KMDA- 220 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HhcCC-----CCCC-
Confidence 12344678999999998899999999999999999997 999986543211 1111 11110 0111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.......+..++.+|++.+|.+||++.++++.|+.
T Consensus 221 ---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 221 ---PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11223456677899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.57 Aligned_cols=245 Identities=22% Similarity=0.307 Sum_probs=195.4
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
|...+.||+|+||+||+|... +|+.||+|++.... .....+.+|+++++.++|+||+.+++++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999865 78999999986542 2345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++++|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998886432 2468999999999999999999999 999999999999999999999999999987654322
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
. .....|+..|+|||++.+..++.++|+|||||++|||++|..||............. .. ...+. ...
T Consensus 157 ~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~-~~~~~------~~~ 224 (285)
T cd05632 157 S---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RR-VLETE------EVY 224 (285)
T ss_pred c---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hh-hhccc------ccc
Confidence 1 123578999999999999999999999999999999999999997654322111110 00 00000 011
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHH
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQIN 598 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~ 598 (678)
.. .....+..++..|++.+|.+||++.
T Consensus 225 ~~----~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 225 SA----KFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred Cc----cCCHHHHHHHHHHccCCHhHcCCCc
Confidence 11 1223456777999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.64 Aligned_cols=268 Identities=24% Similarity=0.354 Sum_probs=204.5
Q ss_pred CCCCceeecccCceEEEEEEeC-----CCCEEEEEEeCCChH--HHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-----DGKELAVKILKPSED--VLKEFASEIEIITALHHRNIISLFGFCFE--DNNLL 402 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-----~g~~vAvK~l~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~ 402 (678)
.|...+.||+|+||.||+|... ++..||||+++.... ....|.+|+++++.+.||||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4566788999999999999853 378999999986543 57889999999999999999999999977 56789
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++..
T Consensus 85 lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999997542 358999999999999999999999 9999999999999999999999999999988
Q ss_pred cCCCCCCcee-cccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 483 LSTSSSHLTC-TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 483 ~~~~~~~~~~-~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
.......... ....++..|+|||++.+..++.++||||||+++|||++|+.|+............. ......-..+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHH
Confidence 7643222211 12345667999999998999999999999999999999999986533221110000 000000000111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.+...............+..++.+||+.+|.+||+|.+|+++|+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 111111111111223567788899999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=321.73 Aligned_cols=254 Identities=22% Similarity=0.401 Sum_probs=200.7
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCC----EEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGK----ELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~----~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
++|...+.||+|+||.||+|... +|. .||+|.+.... .....+.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677788999999999999753 444 57999887542 3445788999999999999999999999764 5689
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
++||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+|+||||+|||++.++.+||+|||+++.+
T Consensus 86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccc
Confidence 99999999999998643 2468899999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
.............++..|+|||++.+..++.++|||||||++|||++ |+.||..........+ +..+.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~-------~~~~~~--~ 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-------LEKGER--L 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHCCCC--C
Confidence 54433323333456788999999999999999999999999999997 9999976432221111 111100 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.. .......+..++..||..+|+.||++.++++.|+..
T Consensus 231 ~~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 231 PQ-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 00 011223567788999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=330.58 Aligned_cols=203 Identities=26% Similarity=0.418 Sum_probs=176.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||++... +|+.||||+++.. ......+..|+.++..++||||+++++.+.+.+.+++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999865 6899999999742 234567888999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++.....++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 999999999998643 468999999999999999999999 9999999999999999999999999999875532
Q ss_pred CCCC---------------------------------ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCC
Q 041755 486 SSSH---------------------------------LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGK 532 (678)
Q Consensus 486 ~~~~---------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~ 532 (678)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 0112357999999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 041755 533 KPINSENP 540 (678)
Q Consensus 533 ~Pf~~~~~ 540 (678)
.||....+
T Consensus 234 ~Pf~~~~~ 241 (360)
T cd05627 234 PPFCSETP 241 (360)
T ss_pred CCCCCCCH
Confidence 99987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.13 Aligned_cols=248 Identities=26% Similarity=0.392 Sum_probs=196.9
Q ss_pred CCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
+|...++||+|+||.||+|.. .+++.||+|++... ......|.+|++++.+++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567778999999999999986 47899999998643 345577999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++++|..+. .+++.....++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999996542 36788899999999999999999 999999999999999999999999999998654322
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCccccc-chhhcccccccCccccccCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQES-LVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-l~~~~~~~~~~~~~~~l~dp~l 567 (678)
.....||..|+|||++.+..++.++||||||+++|+|++|+.||.......... ...+...... . ..+.+
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~-----~~~~~ 220 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-E-----DPPVL 220 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-c-----CCCCC
Confidence 223578999999999999999999999999999999999999997543221110 0000000000 0 01111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
.. ......+..++..|++.+|..||++.++++.
T Consensus 221 ~~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 PV---GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CC---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11 1122346677899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=367.55 Aligned_cols=261 Identities=31% Similarity=0.545 Sum_probs=217.5
Q ss_pred hcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
...|...++||+|+||.||+|.. .+|..||||.++..... ...|++++++++||||++++|+|.+.+..++||||+
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 34677888999999999999986 47999999998754321 234688999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++|+|.++++ .++|..+.+|+.|++.||+|||..+..+|+||||||+||+++.++.+++. ||.+......
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 9999999994 37899999999999999999997656899999999999999999988876 6665433221
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
....||+.|+|||++.++.++.++|||||||++|||+||+.||..... ....+..|+...........++|+.+.
T Consensus 836 ----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 910 (968)
T PLN00113 836 ----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIR 910 (968)
T ss_pred ----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcccc
Confidence 123688999999999999999999999999999999999999964332 234566677666666667777888775
Q ss_pred CC--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 569 TD--YDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 569 ~~--~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.. ...+++..+.+++.+||+.+|.+||+|.+|++.|+...
T Consensus 911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~ 952 (968)
T PLN00113 911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952 (968)
T ss_pred CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence 43 34567778889999999999999999999999997543
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=317.58 Aligned_cols=248 Identities=24% Similarity=0.395 Sum_probs=201.7
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
.+|...+.||+|+||.||+|... +++.|++|.+.... .....+.+|+.+++.+.||||+++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888899999999999999854 78999999887543 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++++|.+++.. ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999853 347899999999999999999999 9999999999999999999999999999886543322
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||....+... +..+. ..+. +.+
T Consensus 172 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~----~~~~------~~~- 236 (296)
T cd06654 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIA----TNGT------PEL- 236 (296)
T ss_pred c--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHh----cCCC------CCC-
Confidence 1 1234688999999999988899999999999999999999999976543221 11110 0000 000
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.........+..++.+||..+|..||++.++++
T Consensus 237 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 011122345667889999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=311.02 Aligned_cols=255 Identities=21% Similarity=0.331 Sum_probs=201.4
Q ss_pred HHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 326 LLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 326 l~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
++.+++++.....||+|+||.||+|... ++..|++|.+.... ...+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4456778888889999999999999854 67889999887543 556789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC-CCCcEEeecccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAF--GWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD-DFEPQLSDFGLA 480 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l--~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~-~~~~kL~DFGla 480 (678)
|+||+++++|.+++.... ..+ ++..+..++.|++.||.|||+ .+|+||||||+||+++. ++.++|+|||++
T Consensus 83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 999999999999987432 234 788889999999999999999 99999999999999986 679999999998
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccCC--CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK--VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
......... .....|+..|+|||++..+. ++.++||||||+++|+|++|+.||........ ..+......
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~--- 228 (268)
T cd06624 157 KRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK--- 228 (268)
T ss_pred eecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc---
Confidence 765432221 12346889999999987654 78899999999999999999999965332111 111110000
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+.+ +......+..++.+||+.+|.+||++.+++.
T Consensus 229 ----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 ----IHPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----cCCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 01111 1122345667789999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.01 Aligned_cols=247 Identities=28% Similarity=0.457 Sum_probs=199.0
Q ss_pred eecccCceEEEEEEeCC--CC--EEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 041755 338 LVGKGGHSHVYRGCLPD--GK--ELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRG 411 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~--g~--~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 411 (678)
.||+|++|.||+|.+.+ ++ .||||.+.... ...+.|.+|+.++++++||||+++++++.. ...++||||+++|
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~ 80 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG 80 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence 58999999999998643 33 68999997643 467789999999999999999999999988 8899999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCce
Q 041755 412 SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491 (678)
Q Consensus 412 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 491 (678)
+|.+++..... ..++|...+.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++..+........
T Consensus 81 ~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 81 SLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 99999976432 468999999999999999999999 9999999999999999999999999999988755332222
Q ss_pred e-cccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 492 C-TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 492 ~-~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
. ....++..|+|||++.+..++.++|||||||++|||++ |+.||...+.......+ ...+. ...
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~------~~~~~--~~~------ 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI------DKEGE--RLE------ 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------HhcCC--cCC------
Confidence 1 23457889999999999999999999999999999998 99999754432211100 00000 000
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
........+..++..|++.+|.+||++.++++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 01112345777889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=314.31 Aligned_cols=266 Identities=21% Similarity=0.326 Sum_probs=210.0
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----CC
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFE-----DN 399 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-----~~ 399 (678)
....|...+.||+|+||.|+.+... +|..||||.+.. .....++..+|+.+|+.++|+||+.+++.+.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4456666788999999999999865 789999998862 34667888999999999999999999999865 35
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
..|+|+|+| ..+|...+.. +..+.......++.|+++||.|+|+ .+|+||||||+|+|++.+..+||+||||
T Consensus 100 DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccc
Confidence 799999999 6688888854 3458889999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
|+..........++..+.|.+|.|||++.. ..|+...||||.||+|.||++|++-|.+.+.-.+..++....+...+..
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 998866533344567888999999998754 6799999999999999999999999999887777666654443333222
Q ss_pred ccccc--------C--CCCCC-CCC---HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 559 VSQLL--------D--PSLDT-DYD---NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 559 ~~~l~--------d--p~l~~-~~~---~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+..+- . |.... .+. .......+.+...||..||.+|+|+.|.++
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 22111 0 00000 000 011233455667889999999999999885
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=329.04 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=200.7
Q ss_pred HHHHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 041755 323 YQELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFE 397 (678)
Q Consensus 323 ~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 397 (678)
+.++....++|...+.||+|+||.||++... +++.||+|++... ......+.+|+.++..++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455556789999999999999999999876 6889999998642 2334567889999999999999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeec
Q 041755 398 DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDF 477 (678)
Q Consensus 398 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DF 477 (678)
++.+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999854 247888889999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccCCCCCCcchhccC----CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc
Q 041755 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG----KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI 553 (678)
Q Consensus 478 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 553 (678)
|++........ .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+...... .+
T Consensus 187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i 259 (371)
T cd05622 187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KI 259 (371)
T ss_pred CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH------HH
Confidence 99987654322 122346799999999998753 37899999999999999999999998654322111 11
Q ss_pred cccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHHh
Q 041755 554 LKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTV--RPQINLVLKLL 604 (678)
Q Consensus 554 ~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~--RPs~~eVl~~L 604 (678)
........+.+ .......+..++..||...+.+ ||++.++++..
T Consensus 260 ~~~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 260 MNHKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HcCCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11100000000 0112233555668888744433 78888888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.37 Aligned_cols=240 Identities=22% Similarity=0.327 Sum_probs=192.6
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~ 405 (678)
+|...+.||+|+||.||+|... +|+.||||+++.. ....+.+..|..++..+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677889999999999999865 6899999998753 234566788999998886 577888999999989999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 999999999998643 468999999999999999999999 9999999999999999999999999999875433
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
... ......||+.|+|||++.++.++.++|||||||++|||++|+.||........... +.. +..
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~------i~~-~~~------ 218 (323)
T cd05615 154 DGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS------IME-HNV------ 218 (323)
T ss_pred CCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH------HHh-CCC------
Confidence 221 12235799999999999999999999999999999999999999986543221111 110 110
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQI 597 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~ 597 (678)
.+.. .....+..++..||+.+|.+|++.
T Consensus 219 ~~p~----~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 SYPK----SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCc----cCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111 122345677899999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.56 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=214.3
Q ss_pred CCCceeecccCceEEEEEEeC-CC---CEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DG---KELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g---~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
..++++||.|.||.||+|+++ .| ..||||.++.. +....+|+.|+.||.++.||||++|.|+.......++|.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 355789999999999999976 23 47999999964 5678899999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
||+||+|+.||..+ ...|.+.+...++++||.|+.||-+ .++|||||...|||++.+..+|++||||++.+.++
T Consensus 711 yMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 711 YMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999754 3569999999999999999999999 99999999999999999999999999999988776
Q ss_pred CCC-ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 487 SSH-LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 487 ~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
... +++..-.-...|.|||.+.+.+++.++||||||+||||.++ |..||-+....+..+. ++
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka----------------Ie 848 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA----------------IE 848 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH----------------HH
Confidence 522 22211122467999999999999999999999999999887 9999876554332211 12
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCHh
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEE 609 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~~ 609 (678)
..++-..+.++...+-++++.||+++-.+||.+.+|+..|+....
T Consensus 849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 223333456677888899999999999999999999999976543
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=324.41 Aligned_cols=240 Identities=26% Similarity=0.323 Sum_probs=188.3
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIE-IITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
+.||+|+||.||+|... +++.||+|++.... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999875 67889999987432 22334455544 56789999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++... ..+.+.....++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-- 151 (325)
T cd05602 81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-- 151 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--
Confidence 9999998643 457788888999999999999999 9999999999999999999999999999975432221
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...... .+.. ... .+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------~i~~-~~~------~~~~- 217 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD------NILN-KPL------QLKP- 217 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH------HHHh-CCc------CCCC-
Confidence 2234679999999999999999999999999999999999999997654322100 0000 000 0111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.....+..++..||+.+|.+||++.+.+.
T Consensus 218 ---~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 218 ---NITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred ---CCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 12234566779999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=308.72 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=202.0
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC--ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
+|...+.||+|+||.||++... +++.||+|.++. .....+.+.+|+.+++.++||||+++++++..++.+++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999865 789999998854 2345677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++|+|.+++.... +..+++...+.++.|++.||.|||+ ++++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999886432 3568899999999999999999999 9999999999999999999999999999986644322
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
. .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+...... .+..+.... +.
T Consensus 156 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~-------~~~~~~~~~-----~~ 221 (255)
T cd08219 156 Y--ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL-------KVCQGSYKP-----LP 221 (255)
T ss_pred c--cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH-------HHhcCCCCC-----CC
Confidence 1 123568999999999998899999999999999999999999997644321100 011111111 11
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
. .....+..++..||+.+|.+||++.+++..
T Consensus 222 ~----~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 S----HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred c----ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1 122346677899999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.87 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=190.7
Q ss_pred eecccCceEEEEEEeCC---CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCC
Q 041755 338 LVGKGGHSHVYRGCLPD---GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGS 412 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~---g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 412 (678)
.||+|+||.||+|...+ ...+++|.+... ......|.+|+++++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 457888987643 3455678999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCce
Q 041755 413 LEENLHGNKKD-GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491 (678)
Q Consensus 413 L~~~L~~~~~~-~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 491 (678)
|.+++...... ...+++.....++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764321 2345688889999999999999999 9999999999999999999999999999876443322222
Q ss_pred ecccccCCCCCCcchhcc-------CCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 492 CTDVAGTFGYLAPEYFMH-------GKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 492 ~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
.....++..|+|||++.. ..++.++|||||||++|||++ |..||........ +.. .+.. ....+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~----~~~~-~~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQ----VVRE-QDIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHH----Hhhc-cCccCC
Confidence 223456778999999743 356889999999999999999 7888865432211 000 0111 111222
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
++.+...+ ...+..++..|+ .+|.+||++.+|+++|.
T Consensus 232 ~~~~~~~~----~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLDLKY----SDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcccccC----CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 23232222 233445567787 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=315.43 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=198.6
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.|...++||+|+||.||++... +++.||||.+.... .....+.+|+.++.+++|+||+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3667789999999999999865 78999999886432 334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++++|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999886432 2458999999999999999999999 99999999999999999999999999998765433
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
.. .....||..|+|||++.+..++.++|||||||++|+|++|+.||............ ...... .. ..
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~~--~~----~~ 223 (285)
T cd05630 156 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKE--VQ----EE 223 (285)
T ss_pred cc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhhh--hh----hh
Confidence 22 12357899999999999999999999999999999999999999764322110000 000000 00 01
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQ-----INLVLK 602 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs-----~~eVl~ 602 (678)
... .....+..++..||+.+|.+||+ +.++++
T Consensus 224 ~~~----~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 YSE----KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCc----cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 111 12234667789999999999999 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.67 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=202.7
Q ss_pred CCCCceeecccCceEEEEEEeCC--CCEEEEEEeCC-----------ChHHHHHHHHHHHHHHh-cCCCCeeeEEEEEEe
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLPD--GKELAVKILKP-----------SEDVLKEFASEIEIITA-LHHRNIISLFGFCFE 397 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~~--g~~vAvK~l~~-----------~~~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~ 397 (678)
+|...+.||+|+||.||+|.... ++.+|+|.+.. ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46777889999999999998764 68899998752 12345668889998875 799999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeec
Q 041755 398 DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDF 477 (678)
Q Consensus 398 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DF 477 (678)
++..++||||+++++|.+++.........+++..++.++.|++.||.|||+ ..+++|+||||+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999999886543445678999999999999999999995 267999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC
Q 041755 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557 (678)
Q Consensus 478 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 557 (678)
|++....... ......|+..|+|||++.++.++.++||||||+++|+|++|+.||......... .. +..+
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~------~~-~~~~ 228 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA------TK-IVEA 228 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH------HH-Hhhc
Confidence 9998765433 223457899999999999989999999999999999999999999754322110 00 0111
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 558 ~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
.. .+..... ....+..++.+||+.+|.+||++.+|..+|.
T Consensus 229 ~~----~~~~~~~----~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VY----EPLPEGM----YSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cC----CcCCccc----CCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11 1111111 1245667789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=343.32 Aligned_cols=258 Identities=26% Similarity=0.343 Sum_probs=206.4
Q ss_pred cCCCCceeecccCceEEEEEEeCCC-CEEEEEEeC-CChHHHHHHHHHHHHHHhcC-CCCeeeEEE-EEEeC------Ce
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDG-KELAVKILK-PSEDVLKEFASEIEIITALH-HRNIISLFG-FCFED------NN 400 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g-~~vAvK~l~-~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g-~~~~~------~~ 400 (678)
.++.+.+.|.+|||+.||.|.+..+ ..||+|++- .++...+.+.+||++|+.|+ |+|||.+++ ..... -+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4667788999999999999998765 999999764 46788899999999999998 999999999 33221 25
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
.+|.||||.+|.|-+++..+.. ..|.+.++++|+.++++|+.+||. +..+|||||||-+||||+.+|+.||||||.|
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 7899999999999999986644 349999999999999999999997 4567999999999999999999999999998
Q ss_pred cccCCCC-CCcee------cccccCCCCCCcchh---ccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhc
Q 041755 481 SWLSTSS-SHLTC------TDVAGTFGYLAPEYF---MHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA 550 (678)
Q Consensus 481 ~~~~~~~-~~~~~------~~~~Gt~~Y~APE~l---~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~ 550 (678)
.-..... ..... -...-|+.|+|||++ .+...++|+|||||||+||-|+....||+....-
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--------- 264 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--------- 264 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---------
Confidence 7543322 11000 012358999999987 4567899999999999999999999999864221
Q ss_pred ccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCHhh
Q 041755 551 KPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEA 610 (678)
Q Consensus 551 ~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~~~ 610 (678)
.+..+++ .--....+..+|..+|..||+.+|.+||++-+|++.+......
T Consensus 265 --aIlng~Y--------~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 265 --AILNGNY--------SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred --eEEeccc--------cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1111222 1122346788899999999999999999999999887655443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.14 Aligned_cols=265 Identities=21% Similarity=0.269 Sum_probs=201.5
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCC------eE
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRN-IISLFGFCFEDN------NL 401 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~------~~ 401 (678)
|.....||+|+||+||+|+.. +|+.||+|.++-.. .......+|+-++..|+|+| |+.|++++...+ .+
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 333445899999999999865 78999999987543 24556789999999999999 999999998877 89
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
+||+||+ .-+|..++.........++...+..++.||++||+|||+ ++|+||||||.||||++.|.+||+|||+|+
T Consensus 93 ~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHH
Confidence 9999999 559999997654322356668899999999999999999 999999999999999999999999999999
Q ss_pred ccCCCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 482 WLSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 482 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
...-.... .+..++|..|.|||++.+. .|+...||||+||++.||++++.-|.+.....+...+-.......+..+.
T Consensus 169 a~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 169 AFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 66533322 3457889999999999886 79999999999999999999999998876643322111111111000000
Q ss_pred c---c--cCCCCCCCC-----CH---HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 561 Q---L--LDPSLDTDY-----DN---DQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 561 ~---l--~dp~l~~~~-----~~---~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
. + .++...... .. .......+++..||+.+|..|.++...+..
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 0 000011100 00 111367778899999999999999999874
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=313.26 Aligned_cols=254 Identities=20% Similarity=0.406 Sum_probs=202.7
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCC----EEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGK----ELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~----~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
.+|...+.||+|+||.||+|... +|. .+|+|.++... .....+.+|+.++..++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45677789999999999999864 343 58999887543 456788999999999999999999999987 78899
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999753 2458999999999999999999999 99999999999999999999999999999877
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
.............++..|+|||.+..+.++.++||||||+++|||++ |+.||...........+ ..+.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~~--~ 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL-------EKGER--L 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-------hCCCC--C
Confidence 64433322222334678999999988899999999999999999998 99999765432211111 11100 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
-.+ ......+..++..||..+|..||++.++++.|...
T Consensus 231 ~~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 231 PQP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred CCC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 001 11123466778999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=325.66 Aligned_cols=261 Identities=21% Similarity=0.289 Sum_probs=196.6
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDN----- 399 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----- 399 (678)
..++|...+.||+|+||.||++... +|+.||||++... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999864 6899999998642 345677889999999999999999999986443
Q ss_pred -eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecc
Q 041755 400 -NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 400 -~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
.+|+||||+.+ +|...+. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCC
Confidence 57999999965 6666663 247888999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchh----------
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVM---------- 548 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~---------- 548 (678)
+++...... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.........
T Consensus 169 ~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 997653322 1233578999999999999999999999999999999999999998654321100000
Q ss_pred ----------h--cccccccCccccccCCCCCC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 549 ----------W--AKPILKDGKVSQLLDPSLDT---DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 549 ----------~--~~~~~~~~~~~~l~dp~l~~---~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+ ..+......+.+.+...... .........+.+++..||+.||.+|||+.+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000000011111000000 001111244667889999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=323.19 Aligned_cols=259 Identities=25% Similarity=0.411 Sum_probs=203.9
Q ss_pred cCCCCceeecccCceEEEEEEeC--------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP--------DGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDN 399 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~--------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 399 (678)
.+|...+.||+|+||.||++... .+..||+|+++.. ......+.+|++++.++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35778889999999999999642 1236899988753 34567899999999999 7999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKK------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS 467 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~ 467 (678)
..+++|||+++|+|.+++..... ....++|.++..++.|++.||.|||+ ++++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 99999999999999999875321 22458899999999999999999999 9999999999999999
Q ss_pred CCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccc
Q 041755 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESL 546 (678)
Q Consensus 468 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 546 (678)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999987654332222222344568999999999999999999999999999998 8888865432221110
Q ss_pred hhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 547 VMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 547 ~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
+..+... .........+..++..|++.+|.+||++.++++.|+...
T Consensus 249 -------~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 249 -------LKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred -------HHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1111000 011122345777889999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=309.56 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=200.4
Q ss_pred CCCCceeecccCceEEEEEEeCCCCEEEEEEeCCC-------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPS-------EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
+|...+.||+|+||.||+|...+|+.+|+|.++.. ......+.+|+++++.++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 46778899999999999998888999999988642 13346688999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999643 357899999999999999999999 899999999999999999999999999988653
Q ss_pred CCCC----CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 485 TSSS----HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 485 ~~~~----~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
.... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||...+......... . ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------~--~~ 224 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG-------A--HR 224 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh-------h--cc
Confidence 2111 111123568999999999999899999999999999999999999997543221110000 0 00
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
...+.+.. .....+..++..||+.+|.+||++.++++
T Consensus 225 -~~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 -GLMPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCCCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00111212 22344677889999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=326.50 Aligned_cols=261 Identities=23% Similarity=0.375 Sum_probs=213.3
Q ss_pred CCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 333 FLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
....+.||+|-||.|.++....+..||||++++.. ...++|.+|+++|.+|+||||+.|+|+|..++.+++|+|||++
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 34567899999999999998778999999999864 5678999999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|..+|..+.... +.-.....|+.||+.|++||.+ .++|||||.+.|+|++.++++||+|||+++-+..+....
T Consensus 620 GDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~ 694 (807)
T KOG1094|consen 620 GDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYR 694 (807)
T ss_pred CcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCcee
Confidence 99999998763321 3445556799999999999999 999999999999999999999999999999877766665
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc--CCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS--GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt--G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
.....+-...|||||.+..++++.++|||+||++|||+++ ...||.....+ ..+.-+..++..+.....+
T Consensus 695 vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~l----- 766 (807)
T KOG1094|consen 695 VQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVVL----- 766 (807)
T ss_pred eecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcceec-----
Confidence 5445566789999999999999999999999999999865 78899765432 2222233333332222111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
..+.-+...+.++++.||+.+-.+||+++++...|+.+
T Consensus 767 -~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 -SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11223345677888999999999999999999998754
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=311.55 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=204.9
Q ss_pred HhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC------
Q 041755 328 SATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDN------ 399 (678)
Q Consensus 328 ~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~------ 399 (678)
+.+++|...+.||+|+||.||+|... +++.+++|++.........|.+|+.+++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45789999999999999999999875 678999999987666667899999999999 6999999999997644
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
.+++||||+++++|.+++......+..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999987544334678999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhcc-----CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccc
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-----GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL 554 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 554 (678)
+......... .....|+..|+|||++.. ..++.++|||||||+||+|++|+.||........ +.. ..
T Consensus 160 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~----~~ 231 (275)
T cd06608 160 SAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFK----IP 231 (275)
T ss_pred ceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHH----hh
Confidence 8765432221 223568999999999854 3467899999999999999999999975432211 111 00
Q ss_pred ccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 555 KDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 555 ~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.. +.+. ........+..++.+||..+|.+||++.++++
T Consensus 232 -~~~~-----~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -RNPP-----PTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -ccCC-----CCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0111 1111 11223456778889999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=312.92 Aligned_cols=238 Identities=24% Similarity=0.409 Sum_probs=188.0
Q ss_pred eecccCceEEEEEEeC-------------------------CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeE
Q 041755 338 LVGKGGHSHVYRGCLP-------------------------DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISL 391 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~-------------------------~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l 391 (678)
.||+|+||.||+|.+. ....|++|++.... .....|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5899999999999742 12358999987644 445678899999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC-
Q 041755 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF- 470 (678)
Q Consensus 392 ~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~- 470 (678)
+++|.+....++||||+++|+|..++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence 99999999999999999999999988642 2468899999999999999999998 9999999999999998654
Q ss_pred ------CcEEeecccccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHh-cCCCCCCCCCCcc
Q 041755 471 ------EPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELL-SGKKPINSENPKG 542 (678)
Q Consensus 471 ------~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLl-tG~~Pf~~~~~~~ 542 (678)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||....+..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999987644221 12357888999998876 56899999999999999995 6999997654322
Q ss_pred cccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 543 QESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 543 ~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
....... . ..+.. .....+..++..||+.+|.+||++.+|++.|.
T Consensus 230 ~~~~~~~------~--------~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 KERFYEK------K--------HRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHh------c--------cCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1111000 0 00001 11235777889999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=318.41 Aligned_cols=263 Identities=20% Similarity=0.315 Sum_probs=198.7
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|+||.||+|... +++.||+|.++... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888899999999999999865 68899999986432 3345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+. ++|..++... ...+++..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 96 6898888643 2468899999999999999999999 999999999999999999999999999997654322
Q ss_pred CCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc----
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL---- 562 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l---- 562 (678)
.. .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+...................+..+
T Consensus 159 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 KT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred Cc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 21 1234678999999998654 5788999999999999999999999765543221111100000000001100
Q ss_pred -----cCCCCCCCC----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 563 -----LDPSLDTDY----DNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 563 -----~dp~l~~~~----~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
--+...... .......+.+++..||+.+|.+|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 001111000 0111234567889999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=321.10 Aligned_cols=203 Identities=23% Similarity=0.315 Sum_probs=175.6
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||++... +++.||+|++... ......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999865 6889999998642 233455788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999743 2468899999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCceecccccCCCCCCcchhcc-----CCCCccceEeehhHHHHHHhcCCCCCCCCCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMH-----GKVSEKIDVYAFGIVLLELLSGKKPINSENP 540 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 540 (678)
.... ......||+.|+|||++.+ +.++.++|||||||+||||++|+.||...+.
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 213 (331)
T cd05624 155 DGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL 213 (331)
T ss_pred CCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH
Confidence 3222 1223579999999999875 5688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=319.46 Aligned_cols=202 Identities=25% Similarity=0.359 Sum_probs=174.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||++... +++.||+|++... ....+.|.+|+.++..++|+||+++++++.+++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888899999999999999865 6899999998642 234566889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999642 2468899999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCCceecccccCCCCCCcchhcc-----CCCCccceEeehhHHHHHHhcCCCCCCCCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMH-----GKVSEKIDVYAFGIVLLELLSGKKPINSEN 539 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 539 (678)
.... ......||+.|+|||++.. +.++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 155 DGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 3221 1223569999999999863 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=332.46 Aligned_cols=197 Identities=24% Similarity=0.316 Sum_probs=170.7
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
....|...+.||+|+||.||++... .++.||||.... ..+.+|++++++|+|+||+++++++..++..++|||+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 3557999999999999999999875 588999996432 3467899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+ .++|.+++... ...++|.+++.|+.|++.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+....
T Consensus 242 ~-~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 Y-RSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9 57898888643 2468999999999999999999999 999999999999999999999999999998765433
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINS 537 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 537 (678)
.........||..|+|||++.+..++.++|||||||+||||++|..|+..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 32222346799999999999999999999999999999999998876543
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=311.36 Aligned_cols=247 Identities=26% Similarity=0.423 Sum_probs=202.3
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||.|+||.||+|... +|+.||+|++... ......+.+|+.+++.++|+||+++++++.++..+++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35777888999999999999865 6899999998653 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++++|.+++... .+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998642 68999999999999999999999 999999999999999999999999999998776532
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
.. .....|+..|+|||++.+..++.++||||||+++|+|+||+.||...++..... .+..+ ..+.+
T Consensus 153 ~~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~-------~~~~~-----~~~~~ 218 (274)
T cd06609 153 SK--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF-------LIPKN-----NPPSL 218 (274)
T ss_pred cc--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH-------Hhhhc-----CCCCC
Confidence 21 223568899999999999889999999999999999999999997654321110 00011 11111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
... .....+..++..||..+|.+||++.++++
T Consensus 219 ~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 219 EGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111 02234667789999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=313.41 Aligned_cols=251 Identities=32% Similarity=0.496 Sum_probs=198.5
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHH---HHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDV---LKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
|...+.||+|+||+||++... +++.||+|++...... ......|+.++.+++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 455788999999999999876 5678999999876432 233456999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
.+++|.+++.. ...+++..++.++.|+++||.|||+ .+++|+||||+|||++.++.++|+|||.+..... .
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--N 151 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--T
T ss_pred ccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--c
Confidence 99999999972 2568999999999999999999999 9999999999999999999999999999876422 2
Q ss_pred CceecccccCCCCCCcchhc-cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFM-HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
........+|..|+|||++. +..++.++||||||+++|+|++|..||................ .. ....+..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~---~~----~~~~~~~ 224 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKIL---KR----PLPSSSQ 224 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHH---HT----HHHHHTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcc---cc----ccccccc
Confidence 22334567899999999998 7889999999999999999999999998652211111111000 00 0000000
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
. .......+..++..||+.+|.+||++.++++
T Consensus 225 ~---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 Q---SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp S---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred c---cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0001266778889999999999999999885
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=329.86 Aligned_cols=261 Identities=21% Similarity=0.289 Sum_probs=199.1
Q ss_pred cCCCCceeecccCceEEEEEEeC---CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP---DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~---~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
.+|...+.||+|+||.||++... .++.||+|.+.... .+.+|++++++++||||+++++++......++|||+
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK----TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 46888999999999999998743 46789999887543 345799999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+. ++|.+++.. ...+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++..+....
T Consensus 168 ~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 168 YK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred cC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 95 688888832 2568999999999999999999999 999999999999999999999999999998766544
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccc--------ccC--
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL--------KDG-- 557 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~--------~~~-- 557 (678)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.+................+ ...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 3333345689999999999999999999999999999999999999997654432111000000000 000
Q ss_pred cccc---ccCCCCCCCCC-------HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 558 KVSQ---LLDPSLDTDYD-------NDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 558 ~~~~---l~dp~l~~~~~-------~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
.+.. .+.......+. ......+..++..||..+|.+||++.+++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 00000000000 0112345567799999999999999999864
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=312.04 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=204.8
Q ss_pred cHHHHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe--
Q 041755 322 SYQELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFE-- 397 (678)
Q Consensus 322 ~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~-- 397 (678)
++.++....+.|.....||.|+||.||+|... +++.+|+|++.........+..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 45556667788999999999999999999874 688999999877665667788999999998 69999999999853
Q ss_pred ----CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcE
Q 041755 398 ----DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ 473 (678)
Q Consensus 398 ----~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~k 473 (678)
.+..+++|||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+++|+||||+||++++++.++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence 457899999999999999986543 2457888899999999999999999 9999999999999999999999
Q ss_pred EeecccccccCCCCCCceecccccCCCCCCcchhc-----cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchh
Q 041755 474 LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVM 548 (678)
Q Consensus 474 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~ 548 (678)
|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|..||....+........
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 239 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP 239 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh
Confidence 999999876543221 122357899999999985 3568889999999999999999999997544321111000
Q ss_pred hcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 549 WAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 549 ~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....+.+.. ......+.+++..||+.+|.+||++.++++
T Consensus 240 ------------~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 ------------RNPPPKLKS---KKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ------------hCCCCCCcc---cccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000111111 112345777889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=309.07 Aligned_cols=247 Identities=26% Similarity=0.443 Sum_probs=199.3
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|...+.||+|+||.||+|.. +++.||+|.++... ....+.+|+.+++.++|||++++++++..+ ..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 4577889999999999999875 78889999987543 346788999999999999999999998764 57999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
++|.+++.... ...+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 83 GNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999997542 2468899999999999999999998 999999999999999999999999999987643321
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
.....+..|+|||++.++.++.++|+|||||++|||++ |+.||........... +..+.. .+
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-------~~~~~~---~~----- 217 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-------VEKGYR---ME----- 217 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-------HhCCCC---CC-----
Confidence 12234568999999999999999999999999999997 9999976543221111 111100 00
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
........+..++..||+.+|..||++.++++.|+.
T Consensus 218 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 -PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111223456778899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=325.10 Aligned_cols=261 Identities=21% Similarity=0.272 Sum_probs=197.6
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFED------ 398 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------ 398 (678)
..++|...+.||+|+||.||++... .++.||||++... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999864 6889999998642 34567788999999999999999999988643
Q ss_pred CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecc
Q 041755 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 399 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
...++||||+.+ +|...+. ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999964 6766664 247889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhh---------
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMW--------- 549 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~--------- 549 (678)
+++....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||...+..........
T Consensus 165 ~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9986544321 2335789999999999999999999999999999999999999976543211100000
Q ss_pred -------ccccccc-Ccc-----ccccCCCC-C--CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 550 -------AKPILKD-GKV-----SQLLDPSL-D--TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 550 -------~~~~~~~-~~~-----~~l~dp~l-~--~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....... ... ...+...+ . ..........+.+++..||+.||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0000000 000 00000000 0 0011112345678889999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=308.58 Aligned_cols=237 Identities=24% Similarity=0.463 Sum_probs=188.0
Q ss_pred eecccCceEEEEEEeCC-------------CCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 338 LVGKGGHSHVYRGCLPD-------------GKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~-------------g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
.||+|+||.||+|...+ ...|++|.+.... .....|..|+.++..++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999997532 2358999887654 445678899999999999999999999999889999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC-------cEEee
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE-------PQLSD 476 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~-------~kL~D 476 (678)
||||+++|+|..++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. ++++|
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 82 VEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999888643 2468999999999999999999999 99999999999999987664 89999
Q ss_pred cccccccCCCCCCceecccccCCCCCCcchhc-cCCCCccceEeehhHHHHHHh-cCCCCCCCCCCcccccchhhccccc
Q 041755 477 FGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM-HGKVSEKIDVYAFGIVLLELL-SGKKPINSENPKGQESLVMWAKPIL 554 (678)
Q Consensus 477 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSlGvvL~eLl-tG~~Pf~~~~~~~~~~l~~~~~~~~ 554 (678)
||++...... ....|+..|+|||.+. +..++.++|||||||++|||+ +|..||........... .
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-------~ 222 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-------Y 222 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-------H
Confidence 9998755322 2245788999999887 466899999999999999998 58888765432211100 0
Q ss_pred ccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041755 555 KDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLL 604 (678)
Q Consensus 555 ~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L 604 (678)
.+.. ... ......+..++..||+.+|.+||++.+|++.|
T Consensus 223 -~~~~-~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 -EGQC-MLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -hcCc-cCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000 000 11134567788999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=325.22 Aligned_cols=261 Identities=19% Similarity=0.256 Sum_probs=197.5
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFED------ 398 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------ 398 (678)
..++|...+.||+|+||.||++... .++.||||++... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3468889999999999999999865 6889999998642 34556788999999999999999999987543
Q ss_pred CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecc
Q 041755 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 399 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
...|+||||++ ++|...+. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 35799999996 47777764 247889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhc--------
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA-------- 550 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~-------- 550 (678)
+++....... .....||..|+|||++.+..++.++|||||||++|||++|+.||...+.......+...
T Consensus 172 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9987544321 22357899999999999999999999999999999999999999765432211110000
Q ss_pred --------------ccccccCccccccCCCCC---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 551 --------------KPILKDGKVSQLLDPSLD---TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 551 --------------~~~~~~~~~~~l~dp~l~---~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+....-....++...+. ..........+.+++..||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000111100000 0001112245677889999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=307.87 Aligned_cols=248 Identities=23% Similarity=0.401 Sum_probs=191.2
Q ss_pred eeecccCceEEEEEEeC----CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCeEEEEEEcCC
Q 041755 337 YLVGKGGHSHVYRGCLP----DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFE-DNNLLLVYDFLS 409 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~----~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV~E~~~ 409 (678)
++||+|+||.||+|... ++..+|+|.+... ....+.+.+|+.+++.++||||+++++++.. ++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999753 2457999988542 3456788999999999999999999998764 456899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+|+|.+++.... ..+.+..+..++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999996432 346788889999999999999999 99999999999999999999999999999765432211
Q ss_pred --ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcC-CCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 490 --LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSG-KKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 490 --~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
.......++..|+|||++.+..++.++|||||||++|||++| .+||....... +... ... +. .+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~---~~~-~~-----~~~ 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVY---LLQ-GR-----RLL 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---Hhc-CC-----CCC
Confidence 111234567789999999989999999999999999999995 55665433211 1111 111 10 000
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
... .....+.+++..||+.+|.+||++.+|++.|+.
T Consensus 223 ~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~ 258 (262)
T cd05058 223 QPE----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258 (262)
T ss_pred CCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence 011 112457778899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=310.61 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=195.4
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEI-ITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~i-l~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|...+.||+|+||.||+|... +|+.||+|+++... .....+..|+.+ ++.++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999875 69999999987542 334566667765 566789999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ-PVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
|++ |+|.+++.........+++..++.++.|++.||.|||+ + +++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 78888876544444679999999999999999999998 6 899999999999999999999999999987643
Q ss_pred CCCCceecccccCCCCCCcchhcc----CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMH----GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
... .+...|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... ...+.. ... +
T Consensus 157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~----~~~-~---- 223 (283)
T cd06617 157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQ----VVE-E---- 223 (283)
T ss_pred ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHH----HHh-c----
Confidence 221 123568899999998865 45688999999999999999999999643211 011100 000 0
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+.+.. ......+..++..||..+|.+||++.++++
T Consensus 224 -~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 -PSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -CCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111110 112345777889999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=319.10 Aligned_cols=202 Identities=25% Similarity=0.348 Sum_probs=174.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||++..+ +++.||+|++... ......|..|+.++..++|+||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888899999999999999875 5788999998642 233455788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999743 2468999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCCceecccccCCCCCCcchhc-----cCCCCccceEeehhHHHHHHhcCCCCCCCCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 539 (678)
.... ......||+.|+|||++. .+.++.++|||||||++|||++|+.||...+
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 155 DGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred CCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 3221 223357999999999986 3568899999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=348.69 Aligned_cols=259 Identities=21% Similarity=0.323 Sum_probs=201.4
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...++||+|+||.||+|... +|+.||||+++.. ....+.|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57888999999999999999865 6899999998743 345678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecc
Q 041755 406 DFLSRGSLEENLHGNKK-------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~-------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 12345678889999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCC----------------CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcc
Q 041755 479 LASWLSTSSS----------------HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542 (678)
Q Consensus 479 la~~~~~~~~----------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 542 (678)
+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 011123579999999999999999999999999999999999999997643211
Q ss_pred cccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhhc
Q 041755 543 QESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRP-QINLVLKLLQG 606 (678)
Q Consensus 543 ~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-s~~eVl~~L~~ 606 (678)
. .+... +.+|.-... ..+....+..++.+|++.+|.+|| ++.++++.|+.
T Consensus 239 i----~~~~~---------i~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 I----SYRDV---------ILSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred h----hhhhh---------ccChhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1 00000 001100000 011223466778999999999996 56666666654
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=322.05 Aligned_cols=239 Identities=25% Similarity=0.319 Sum_probs=186.0
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhc---CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 339 VGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITAL---HHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 339 IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
||+|+||.||+|... +|+.||||++.... .....+..|..++..+ .||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999865 68999999986432 2334556677777765 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-- 151 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-- 151 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--
Confidence 9999988643 468999999999999999999999 9999999999999999999999999999875433222
Q ss_pred eecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.......+ ..+.. .+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i-------~~~~~------~~~~ 218 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI-------AFGKV------RFPK 218 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH-------HcCCC------CCCC
Confidence 12346799999999998765 4899999999999999999999999765432211110 01110 0111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQ----INLVLK 602 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs----~~eVl~ 602 (678)
. .....+..++..||+.+|.+||+ +.++++
T Consensus 219 ~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 N---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred c---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1 11234556779999999999985 555554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=306.83 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=204.4
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFE--DNNLLLVY 405 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~ 405 (678)
+|...+.||.|+||.||++... +|+.||+|++... ....+.+..|+++++.++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677789999999999999764 7889999998642 3456778899999999999999999998864 45689999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC--EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||+++++|.+++.........+++..++.++.|++.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999765444567999999999999999999999321 289999999999999999999999999999877
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
...... .....|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+... +... +..+..
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~----~~~~~~---- 227 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASK----IKEGKF---- 227 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHH----HhcCCC----
Confidence 554321 123578999999999999899999999999999999999999997654221 1111 111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
+ .........+..++..|++.+|.+||++.+|++.
T Consensus 228 -~----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -R----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -C----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1 1122234567788899999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.47 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=194.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS------EDVLKEFASEIEIITALHHRNIISLFGFCFE--DNNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~ 401 (678)
.+|...+.||+|+||.||+|... +|+.|++|++... ......+.+|+.+++.++||||+++++++.+ +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47889999999999999999865 6899999988532 1345678899999999999999999998875 3678
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
+++|||+++++|.+++... ..+++...+.++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 9999999999999998643 357899999999999999999998 999999999999999999999999999988
Q ss_pred ccCCCCCC-ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 482 WLSTSSSH-LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 482 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~------~~~~----- 223 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF------KIAT----- 223 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH------HHhc-----
Confidence 65432111 11123568899999999998889999999999999999999999997543211100 0000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....+.+.. .....+..++ .||..+|.+||++.+|++
T Consensus 224 ~~~~~~~~~----~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 QPTNPQLPS----HISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCCCch----hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 001122211 1122233333 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=308.37 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=198.6
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
++|...+.||+|+||.||+|... +++.||+|+++... .....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 35666778999999999999864 68999999987543 34456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++++|.+++... ..+++.+.+.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 89 GGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999998643 468999999999999999999999 8999999999999999999999999999876543221
Q ss_pred CceecccccCCCCCCcchhc---cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
......|+..|+|||++. .+.++.++|||||||++|+|++|..||....+....... .. .... .+
T Consensus 162 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--~~-----~~~~---~~ 229 (267)
T cd06645 162 --KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--TK-----SNFQ---PP 229 (267)
T ss_pred --ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--hc-----cCCC---CC
Confidence 122357899999999984 456889999999999999999999998654432211100 00 0000 01
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..... ......+.+++..||+.+|++||++.+|++
T Consensus 230 ~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 230 KLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11100 011234667889999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.27 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=197.0
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
|...+.||+|+||.||+|... ++..+++|.+... ......+.+|+++++.++||||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 445567999999999999876 5788899998754 45667899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
++|..++... ...+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-- 158 (282)
T cd06643 87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-- 158 (282)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence 9999987642 2468999999999999999999999 9999999999999999999999999999876543221
Q ss_pred eecccccCCCCCCcchhc-----cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 491 TCTDVAGTFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
......||+.|+|||++. +..++.++|||||||++|||++|+.||...++.... ..... +.......+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~-----~~~~~~~~~ 231 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LKIAK-----SEPPTLAQP 231 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HHHhh-----cCCCCCCCc
Confidence 122356899999999984 345788999999999999999999999765432211 11000 000000011
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
......+.+++..||+.+|.+||++.++++
T Consensus 232 -------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 232 -------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111234667789999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=325.45 Aligned_cols=192 Identities=23% Similarity=0.331 Sum_probs=166.0
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
..+|...+.||+|+||.||+|... +++.||+|+.... .+..|+.++++++||||+++++++...+..++||||+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 357999999999999999999875 5788999986543 2346999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
.++|.+++... ...+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 140 -~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 212 (357)
T PHA03209 140 -SSDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA 212 (357)
T ss_pred -CCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc
Confidence 56888888643 3568999999999999999999999 9999999999999999999999999999975433221
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPIN 536 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~ 536 (678)
.....||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 213 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 213 ---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred ---cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 123579999999999999999999999999999999998665553
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=304.26 Aligned_cols=251 Identities=28% Similarity=0.439 Sum_probs=203.6
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC------C---hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEe
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP------S---EDVLKEFASEIEIITALH-HRNIISLFGFCFE 397 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~------~---~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~ 397 (678)
..++|.+..+||.|+.+.|-+.+.+ +|+.+|+|++.. + ....+.-.+|+.||+++. ||||+.|.++|..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 3457788889999999999988765 789999998842 1 134566688999999985 9999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeec
Q 041755 398 DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDF 477 (678)
Q Consensus 398 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DF 477 (678)
+..+++|+|.|+.|.|+++|... ..+++....+|+.|+++|++|||. ++|+||||||+|||+|++.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEecc
Confidence 99999999999999999999643 578999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccCCCCCCcchhcc------CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcc
Q 041755 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH------GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK 551 (678)
Q Consensus 478 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~ 551 (678)
|++..+..+.. ....+||++|+|||.+.. ..|+..+|+|++||+||.||.|.+||-..... . ..
T Consensus 168 GFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-----l--ML 237 (411)
T KOG0599|consen 168 GFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-----L--ML 237 (411)
T ss_pred ceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-----H--HH
Confidence 99999877653 345899999999999854 35788899999999999999999999643211 1 12
Q ss_pred cccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 552 PILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 552 ~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+++.+|++.- -.|.. .+.......++.+||+.||.+|-|+.|+|.
T Consensus 238 R~ImeGkyqF-~speW-----adis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 238 RMIMEGKYQF-RSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHhccccc-CCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 2333343321 11111 122344566779999999999999999885
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.98 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=201.6
Q ss_pred cCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
.+|...+.||+|+||.||+|.. .+|+.||+|.+.... ...+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788899999999999999986 479999999987543 34566889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++++|.+++.. ..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999853 357899999999999999999999 9999999999999999999999999999876544322
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...++...... ....+ . +.+.
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~-~-----~~~~ 236 (297)
T cd06656 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG-T-----PELQ 236 (297)
T ss_pred C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC-C-----CCCC
Confidence 1 1235688999999999999999999999999999999999999976544221110 00000 0 0000
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
........+..++..||+.+|.+||++.++++
T Consensus 237 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 --NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01112234566779999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.90 Aligned_cols=199 Identities=25% Similarity=0.418 Sum_probs=162.8
Q ss_pred ceeecccCceEEEEEEeC---CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEEEEEEcCCC
Q 041755 336 EYLVGKGGHSHVYRGCLP---DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFE--DNNLLLVYDFLSR 410 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~---~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~~ 410 (678)
.+.||+|+||.||+|... +++.||+|.+.... ....+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence 457999999999999854 56789999987543 23456789999999999999999999864 456899999985
Q ss_pred CCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe----cCCCCcEEeeccccc
Q 041755 411 GSLEENLHGNK-----KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL----SDDFEPQLSDFGLAS 481 (678)
Q Consensus 411 gsL~~~L~~~~-----~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl----~~~~~~kL~DFGla~ 481 (678)
++|.+++.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 58887765322 112358999999999999999999999 999999999999999 456789999999998
Q ss_pred ccCCCCCC-ceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCC
Q 041755 482 WLSTSSSH-LTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSEN 539 (678)
Q Consensus 482 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 539 (678)
........ .......||+.|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76543221 122346789999999999774 58999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.13 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=199.7
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCeEEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFE-DNNLLLVYD 406 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV~E 406 (678)
+|...+.||+|++|.||++... +++.||+|.+... ....+.+.+|++++++++|+|++++++.+.. +..+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4777899999999999999865 6789999998643 3455678899999999999999999998764 446899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++++|.+++.... ...+++.+++.++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999987532 3468999999999999999999999 99999999999999999999999999999876443
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
... .....|++.|+|||++.++.++.++||||||+++++|++|+.||...+.... ...+. .+.+ +.
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~-~~~~-----~~ 221 (257)
T cd08223 156 CDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRII-EGKL-----PP 221 (257)
T ss_pred CCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHH-hcCC-----CC
Confidence 221 2235689999999999999999999999999999999999999975442211 00111 1111 11
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+ .......+..++..|++.+|.+||++.++++
T Consensus 222 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 222 M----PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred C----ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1 1122345777889999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.45 Aligned_cols=248 Identities=25% Similarity=0.454 Sum_probs=199.2
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----------DVLKEFASEIEIITALHHRNIISLFGFCFEDNN 400 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 400 (678)
+|.....||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999864 68899999886421 234678899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999999643 458899999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCc----eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccccc
Q 041755 481 SWLSTSSSHL----TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKD 556 (678)
Q Consensus 481 ~~~~~~~~~~----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 556 (678)
+......... ......|+..|+|||.+.++.++.++|||||||++|+|++|+.||........ . .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~-~-------- 222 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--I-F-------- 222 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--H-H--------
Confidence 8765322111 11234688999999999998999999999999999999999999975432110 0 0
Q ss_pred CccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 557 GKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 557 ~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.......+.+.. .....+..++..||+.+|.+||++.+|++
T Consensus 223 -~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 -KIGENASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -HHhccCCCcCCc----ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000111112212 22345667779999999999999999886
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=307.67 Aligned_cols=246 Identities=24% Similarity=0.418 Sum_probs=202.6
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
.|...+.||.|+||.||+|... ++..||+|++... ......+.+|+.+++.+.||||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4566678999999999999865 6889999998643 355678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++|+|.+++.. ..+++.+...++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998853 357889999999999999999998 9999999999999999999999999999987654332
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
. .....++..|+|||++.+..++.++|+|||||++|||++|..||....+....... .. ...
T Consensus 157 ~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------~~---------~~~ 218 (277)
T cd06640 157 K--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------PK---------NNP 218 (277)
T ss_pred c--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------hc---------CCC
Confidence 1 22346888999999999889999999999999999999999999765432211100 00 001
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
..........+..++..||+.+|..||++.+++..
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11223345567788899999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=312.50 Aligned_cols=245 Identities=25% Similarity=0.433 Sum_probs=199.2
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
|...+.||+|+||.||+|... +|..||+|.++.. ....+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 344556999999999999765 6889999998743 3456788999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+++|.+++.. ..+++..++.++.|++.||.|||+ ++++|+||+|+||++++++.++|+|||++..+.....
T Consensus 86 ~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 86 GGSALDLLKP-----GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999998853 358899999999999999999998 9999999999999999999999999999987654321
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....+.... . .+..+ ..+.+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~----~~~~~-----~~~~~~- 222 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---F----LIPKN-----SPPTLE- 222 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---h----hhhcC-----CCCCCC-
Confidence 112346889999999999989999999999999999999999998754432111 0 01111 111121
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
......+..++..||+.+|.+||++.+|++.
T Consensus 223 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 ---GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ---cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1223456778899999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=309.29 Aligned_cols=256 Identities=22% Similarity=0.369 Sum_probs=203.5
Q ss_pred cCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 402 (678)
++|.....||+|+||.||+|... +.+.|++|.+.... .....|.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788889999999999999853 34679999886543 35678999999999999999999999999888999
Q ss_pred EEEEcCCCCCHHHHhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeec
Q 041755 403 LVYDFLSRGSLEENLHGNKKD-----GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDF 477 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~-----~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DF 477 (678)
+||||+++|+|.+++...... ...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999754321 1268999999999999999999998 89999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhccccccc
Q 041755 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKD 556 (678)
Q Consensus 478 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 556 (678)
|++......... ......++..|+|||.+.++.++.++||||||+++|+|++ |..||....... .... ...
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~----~~~ 233 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNR----LQA 233 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHH----HHc
Confidence 998765332221 2223456778999999988889999999999999999999 788986543221 1111 111
Q ss_pred CccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 557 GKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 557 ~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
+.+... ........+..++.+||+.+|.+||++.+++..|.
T Consensus 234 ~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111100 01112345777889999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=351.04 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=199.2
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFED--NNLL 402 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 402 (678)
..++|.....||+|+||.||++... .+..||+|++.. .......|..|+.++.+|+||||++++++|... ..+|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4568999999999999999999875 577899998864 334567889999999999999999999988653 5689
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeeeccCCCCCeEecC----------
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC----EQPVIHKDVKSSNILLSD---------- 468 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~----~~~iiHrDIKp~NILl~~---------- 468 (678)
|||||+++|+|.++|.........+++..++.|+.||+.||.|||+.. ..+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 999999999999999764444457999999999999999999999832 145999999999999964
Q ss_pred -------CCCcEEeecccccccCCCCCCceecccccCCCCCCcchhcc--CCCCccceEeehhHHHHHHhcCCCCCCCCC
Q 041755 469 -------DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH--GKVSEKIDVYAFGIVLLELLSGKKPINSEN 539 (678)
Q Consensus 469 -------~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 539 (678)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||||+||+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 23589999999987644322 123579999999999864 458899999999999999999999997543
Q ss_pred CcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 540 PKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 540 ~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
... .+.. .+..+ +.+.. ......+..++..||+.+|.+||++.+++.
T Consensus 248 ~~~--qli~----~lk~~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 NFS--QLIS----ELKRG-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cHH--HHHH----HHhcC-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 211 1111 01110 11100 011244667789999999999999999984
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=303.24 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=204.2
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+|...++||+|+||.||.+... +++.+++|.+.. +......+.+|++++++++|+||+++++++.+.+.+++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5778899999999999988754 689999998764 345567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++++|.+++.... ...+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997542 3568999999999999999999999 899999999999999999999999999998765443
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.||.......... .+. .+.....
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~------~~~-~~~~~~~----- 221 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV------KIV-QGNYTPV----- 221 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHH-cCCCCCC-----
Confidence 2 1233578999999999988889999999999999999999999997644322111 011 1111110
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLL 604 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L 604 (678)
.......+..++..||+.+|.+||++.++++.+
T Consensus 222 ----~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 222 ----VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ----ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 011234466778999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=302.80 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=205.3
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||.|+||.||+|... ++..+++|++.... .....+.+|+++++.++|+||+++++.+..++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999854 68899999986432 4567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++++|.+++..... ...+++...+.++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975321 2468999999999999999999998 999999999999999999999999999998766543
Q ss_pred CCc--eecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 488 SHL--TCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 488 ~~~--~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
... ......|+..|+|||++... .++.++|+|||||++|+|++|+.||........ +..... . ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~----~------~~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQ----N------DP 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhc----C------CC
Confidence 321 12335689999999999877 789999999999999999999999976543211 111100 0 01
Q ss_pred CCCCCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDY-DNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~-~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.+.... .......+..++..||+.+|.+||++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111111 1122355677889999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.87 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=199.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
++|...+.||+|+||.||+|... +++.|++|++... ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45777889999999999999875 5899999998754 356778999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++++|..++... ...+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999998887543 2468999999999999999999998 9999999999999999999999999999875433221
Q ss_pred CceecccccCCCCCCcchhc-----cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 489 HLTCTDVAGTFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
......++..|+|||++. ...++.++|||||||++|||++|+.||...++... ...+. . ..
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~----~-~~----- 231 (292)
T cd06644 166 --RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIA----K-SE----- 231 (292)
T ss_pred --ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHh----c-CC-----
Confidence 122356889999999985 34578899999999999999999999976543211 11110 0 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+... ........+..++..||..+|.+||++.++++
T Consensus 232 ~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 PPTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CccCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 01110 01122234667789999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=312.18 Aligned_cols=255 Identities=27% Similarity=0.396 Sum_probs=202.9
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|+||+||++... +|+.||+|++... ....+.|.+|++++..++||||+++++++...+.+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45666788999999999999865 6899999987643 35567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++++|.+++... ..+++.....++.+++.||.|||+ ..+++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 9999999988643 468999999999999999999996 2589999999999999999999999999987553322
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCccc-----ccchhhcccccccCccccc
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQ-----ESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~-----~~l~~~~~~~~~~~~~~~l 562 (678)
. ....|+..|+|||++.++.++.++|||||||++|+|++|+.||........ ..+..+....+...
T Consensus 159 ~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 159 A----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred c----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 1 235789999999999888999999999999999999999999986543211 01111111111100
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLL 604 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L 604 (678)
.+.+. .......+..++..|++.+|.+||++.++++..
T Consensus 230 -~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 -PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 01111 111234577788999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=326.20 Aligned_cols=260 Identities=24% Similarity=0.329 Sum_probs=208.7
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-C-----CCeeeEEEEEEeCCeEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALH-H-----RNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~g~~~~~~~~~lV 404 (678)
+|.+..+||+|+||.|.++... +++.||||+++.......+...|+.||..|+ | -|+|++++||...+++|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 7788999999999999999754 6999999999999888888999999999997 4 3999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC--CcEEeecccccc
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF--EPQLSDFGLASW 482 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~--~~kL~DFGla~~ 482 (678)
+|.+ ..+|.++|..++- ..|+...++.++.||+.||.+||. .+|||+||||+||||.+-+ .+||+|||.+..
T Consensus 267 fELL-~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ehhh-hhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 9999 6699999987654 458899999999999999999998 9999999999999997654 699999999987
Q ss_pred cCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccc-----c-
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILK-----D- 556 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~-----~- 556 (678)
...... ...-+..|+|||++.+.+|+.+.||||||||+.||++|.+-|.++++.++...+.....+.. .
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 655332 24557889999999999999999999999999999999988888777665433322111000 0
Q ss_pred CccccccCC--------------------------------CCCC--------CCCHHHHHHHHHHHHhcccCCCCCCCC
Q 041755 557 GKVSQLLDP--------------------------------SLDT--------DYDNDQIERMVLAATLSISRAPTVRPQ 596 (678)
Q Consensus 557 ~~~~~l~dp--------------------------------~l~~--------~~~~~~~~~l~~la~~Cl~~dP~~RPs 596 (678)
.+....++. .... ......-+.+++++..||..||..|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 000011110 0000 011123456788999999999999999
Q ss_pred HHHHHH
Q 041755 597 INLVLK 602 (678)
Q Consensus 597 ~~eVl~ 602 (678)
..+.++
T Consensus 496 p~qal~ 501 (586)
T KOG0667|consen 496 PAQALN 501 (586)
T ss_pred HHHHhc
Confidence 999985
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=309.23 Aligned_cols=263 Identities=24% Similarity=0.304 Sum_probs=200.6
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|.....||+|+||.||+|... +|+.||+|++.... ...+.+.+|++++++++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46788889999999999999876 68999999886432 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++++|..++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99998888776432 358999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccch-hhccc-------ccccC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV-MWAKP-------ILKDG 557 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~-~~~~~-------~~~~~ 557 (678)
... .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||............ ..... .+...
T Consensus 154 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 321 123467889999999876 55789999999999999999999999765432211110 00000 00000
Q ss_pred c-cccccCCCCCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 K-VSQLLDPSLDTDYDN-----DQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ~-~~~l~dp~l~~~~~~-----~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
. ...+..+........ .....+.+++..||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 001111111111110 11345778889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=310.29 Aligned_cols=264 Identities=21% Similarity=0.301 Sum_probs=197.2
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+|...+.||+|++|.||+|... +|..||||.++.. ....+.+.+|+.++..++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4677889999999999999875 6899999998643 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+. ++|.+++.... .+..+++..++.++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 96 68988886532 23568999999999999999999999 999999999999999999999999999997654332
Q ss_pred CCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCccccc-c-hhhccc---ccc----cC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQES-L-VMWAKP---ILK----DG 557 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-l-~~~~~~---~~~----~~ 557 (678)
.. .....+++.|+|||++.+. .++.++|||||||++|+|+||+.||.......... . ..+..+ .+. -.
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 RV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred cc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 11 1234678899999988654 57899999999999999999999997654321100 0 000000 000 00
Q ss_pred ccccccCCCCCCC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 KVSQLLDPSLDTD---YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ~~~~l~dp~l~~~---~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+...++...... ........+.+++..||..||.+||++.+|++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 00012234567889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.04 Aligned_cols=199 Identities=25% Similarity=0.419 Sum_probs=162.4
Q ss_pred ceeecccCceEEEEEEeC---CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEEEEEEcCCC
Q 041755 336 EYLVGKGGHSHVYRGCLP---DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFE--DNNLLLVYDFLSR 410 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~---~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~~ 410 (678)
...||+|+||.||+|... ++..||+|.+.... ....+.+|+++++.++||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 357999999999999864 45789999987543 23457789999999999999999999854 467899999986
Q ss_pred CCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe----cCCCCcEEeeccccc
Q 041755 411 GSLEENLHGNK-----KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL----SDDFEPQLSDFGLAS 481 (678)
Q Consensus 411 gsL~~~L~~~~-----~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl----~~~~~~kL~DFGla~ 481 (678)
++|.+++.... .....+++..++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 57777764321 122358899999999999999999999 999999999999999 566799999999998
Q ss_pred ccCCCCCC-ceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCC
Q 041755 482 WLSTSSSH-LTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSEN 539 (678)
Q Consensus 482 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 539 (678)
........ .......||+.|+|||++.+ ..++.++|||||||++|||+||++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76543221 12234578999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=303.25 Aligned_cols=249 Identities=26% Similarity=0.476 Sum_probs=200.1
Q ss_pred CCceeecccCceEEEEEEeCC-----CCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 334 LPEYLVGKGGHSHVYRGCLPD-----GKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 334 ~~~~~IG~G~~g~Vy~g~~~~-----g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
...+.||.|+||.||++...+ +..||+|+++... ...+.+..|+.++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999998753 4889999997654 267889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++++|.+++..... ..+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999975322 228999999999999999999999 99999999999999999999999999999877654
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
..... ....+++.|+|||.+.+..++.++||||||+++++|++ |+.||........ .... ..+...
T Consensus 157 ~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~----~~~~~~----- 223 (258)
T smart00219 157 DYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LEYL----KKGYRL----- 223 (258)
T ss_pred ccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----hcCCCC-----
Confidence 22221 12347889999999988889999999999999999998 7888875332111 1110 001100
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLL 604 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L 604 (678)
.. .......+..++..|+..+|.+||++.++++.|
T Consensus 224 ~~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PK----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00 111234577788999999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.55 Aligned_cols=255 Identities=21% Similarity=0.360 Sum_probs=199.3
Q ss_pred CCCceeecccCceEEEEEEeC----CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC------
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP----DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDN------ 399 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~----~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 399 (678)
|...+.||+|+||.||+|.+. +|+.||||+++.. ....+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456778999999999999753 4688999998753 345677899999999999999999999886532
Q ss_pred eEEEEEEcCCCCCHHHHhccCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeec
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKK--DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDF 477 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~--~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DF 477 (678)
..++++||+.+|+|.+++..... ....+++...+.++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 24789999999999988754321 22357899999999999999999999 89999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhccccccc
Q 041755 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKD 556 (678)
Q Consensus 478 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~ 556 (678)
|+++...............+++.|++||.+..+.++.++|||||||++|||++ |+.||........ ..+. ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~---~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYL---IKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHH---HcC
Confidence 99987654332222223445678999999998899999999999999999999 8899875543211 1110 010
Q ss_pred CccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 557 GKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 557 ~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.... . .......+..++.+||+.+|.+||++.++++.|+.
T Consensus 232 ~~~~------~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~ 271 (273)
T cd05074 232 NRLK------Q----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL 271 (273)
T ss_pred CcCC------C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0000 0 11223567888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.14 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=199.3
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-----------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-----------DVLKEFASEIEIITALHHRNIISLFGFCFEDN 399 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 399 (678)
+|...+.||.|+||.||+|... +|+.||+|.++... ...+.+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999754 78999999875321 12456888999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999998654 468999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhccCC--CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK--VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 557 (678)
+................|+..|+|||.+.... ++.++|+||||+++|+|++|..||........ +.. .. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~----~~-~~ 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFK----LG-NK 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHH----hh-cc
Confidence 98654433222233457899999999987755 88999999999999999999999964332110 000 00 00
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.....+.+.... .....+..++..||+.+|..||++.+|++
T Consensus 228 ~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 228 RSAPPIPPDVSM----NLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccCCcCCccccc----cCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111111111111 22345666779999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=308.08 Aligned_cols=258 Identities=26% Similarity=0.363 Sum_probs=203.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFED--NNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 405 (678)
++|...+.||.|++|.||++... +++.+|+|.+.... .....+.+|++++++++||||++++++|.+. +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778889999999999999875 68899999987532 4567899999999999999999999998653 4789999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++++|.+++.........+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999876543444668999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCc--ccccchhhcccccccCcccccc
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPK--GQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~--~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
... ....++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ....+..+... .....+-
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~ 229 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELK 229 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhc
Confidence 221 1345788999999999999999999999999999999999999765321 11111111111 0000100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.... ........+..++..||+.+|.+||++.++++
T Consensus 230 -~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 230 -DEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -cCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000 01123456778889999999999999999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=303.05 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=204.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
++|...+.||.|+||.||+|... +++.+++|++.... ...+.+.+|++++++++||||+++++++..++.++++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999865 67899999987543 45678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++++|.+++... ...+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 999999988643 2468899999999999999999998 9999999999999999999999999999886544221
Q ss_pred CceecccccCCCCCCcchhccC---CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHG---KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
......|+..|+|||++... .++.++||||||+++|||++|+.||........... ... . .+-.+
T Consensus 157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~--~~~-----~---~~~~~ 224 (262)
T cd06613 157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL--ISK-----S---NFPPP 224 (262)
T ss_pred --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHh-----c---cCCCc
Confidence 11235688899999999776 889999999999999999999999976543221110 000 0 00001
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+. ........+.+++.+||..+|..||++.+|+.
T Consensus 225 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111 12233456788899999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=305.44 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=200.3
Q ss_pred cCCCCceeecccCceEEEEEEeCC----CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPD----GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~----g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...+.||+|+||.||+|...+ ...|+||..... ....+.|.+|+.+++.+.||||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788899999999999998643 346899988754 3556789999999999999999999999875 567899
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... ...+++..++.++.+++.||.|||+ .+++|+||||+|||++.++.++|+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999653 2358999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
...... .+...++..|+|||.+....++.++||||||+++|||++ |..||......... .+. ..+..
T Consensus 159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~----~~~~~---- 226 (270)
T cd05056 159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRI----ENGER---- 226 (270)
T ss_pred ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHH----HcCCc----
Confidence 442221 222345568999999988889999999999999999986 99999765432211 110 11100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
..... .....+..++.+|+..+|.+||++.++++.|+.
T Consensus 227 -~~~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~ 264 (270)
T cd05056 227 -LPMPP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD 264 (270)
T ss_pred -CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 00111 122356777899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=319.66 Aligned_cols=248 Identities=24% Similarity=0.352 Sum_probs=206.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV 404 (678)
..|...+.||+|.||.||++..+ +|+.+|+|++.... .....+.+|+.||+++. |||||.++++|...+..++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 45666788999999999999876 59999999997543 34568899999999999 99999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC----CCcEEeecccc
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD----FEPQLSDFGLA 480 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~----~~~kL~DFGla 480 (678)
||++.+|.|.+.+... .+++.....++.|++.++.|||+ .+|+||||||+|+|+... +.+|++|||++
T Consensus 115 mEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 9999999999999754 28999999999999999999999 999999999999999643 47999999999
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
..... ......++||+.|+|||.+....|+..+||||+||++|.|++|..||.+.........+ ..+++
T Consensus 187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i-------~~~~~- 255 (382)
T KOG0032|consen 187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI-------LRGDF- 255 (382)
T ss_pred eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH-------HcCCC-
Confidence 98776 22344589999999999999999999999999999999999999999887654332211 11222
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+...+-.......-.++..|+..||..|+++.++++
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1111111122445556679999999999999999998
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=313.69 Aligned_cols=198 Identities=23% Similarity=0.338 Sum_probs=165.5
Q ss_pred ceeeccc--CceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 336 EYLVGKG--GHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 336 ~~~IG~G--~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
..+||+| +|++||++... +|+.||+|+++.. ......+.+|+++++.++||||++++++|..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4579999 78999999764 7899999999753 3445667789999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+|+|.+++.... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.++++|||.+.........
T Consensus 83 ~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 83 YGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999986432 2358999999999999999999999 99999999999999999999999999875443211110
Q ss_pred c-----eecccccCCCCCCcchhcc--CCCCccceEeehhHHHHHHhcCCCCCCCC
Q 041755 490 L-----TCTDVAGTFGYLAPEYFMH--GKVSEKIDVYAFGIVLLELLSGKKPINSE 538 (678)
Q Consensus 490 ~-----~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 538 (678)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0 0112356788999999976 45899999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=311.92 Aligned_cols=248 Identities=23% Similarity=0.384 Sum_probs=201.2
Q ss_pred cCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
.+|...+.||.|+||.||+|.. .+|+.|++|.+.... ...+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688889999999999999975 478999999886433 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++++|.+++.. ..+++.++..++.+++.||.|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998853 358999999999999999999999 9999999999999999999999999999886544322
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
. .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...++........ .. .... +.
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~------~~-~~~~-----~~ 236 (296)
T cd06655 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TN-GTPE-----LQ 236 (296)
T ss_pred c--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hc-CCcc-----cC
Confidence 1 123468899999999999889999999999999999999999997655422211110 00 0000 00
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
........+..++..||..+|.+||++.++++
T Consensus 237 --~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 --NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 01112234666779999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=302.98 Aligned_cols=249 Identities=23% Similarity=0.365 Sum_probs=195.3
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS------EDVLKEFASEIEIITALHHRNIISLFGFCFED--NNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 401 (678)
.+|...++||+|+||.||+|... +|+.||||.+... ....+.+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999865 6899999987532 23456788999999999999999999998763 468
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
++||||+++++|.+++... ..+++.....++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 8999999999999998643 347888899999999999999999 999999999999999999999999999988
Q ss_pred ccCCCCCC-ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 482 WLSTSSSH-LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 482 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
........ .......|+..|+|||.+.+..++.++|||||||++|||++|+.||........ ... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~----~~~~---- 224 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IFK----IATQ---- 224 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HHH----HhcC----
Confidence 65432111 112235689999999999988899999999999999999999999975432111 000 0000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
...+. ........+..++..|+. +|..||++++|++
T Consensus 225 -~~~~~----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 -PTNPV----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCCCC----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 00111 122333445566677874 8999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=302.73 Aligned_cols=246 Identities=24% Similarity=0.414 Sum_probs=199.6
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS------EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
+|...+.||+|+||.||+|... ++..|++|.+... ....+.+.+|+.+++.++|+||+++++++..+..+++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4667788999999999999876 7899999988542 24567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999998643 458899999999999999999999 999999999999999999999999999988764
Q ss_pred CCCCCceecccccCCCCCCcchhccCC-CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGK-VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
... ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||........ ...+. .....
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~----~~~~~---- 220 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKIG----RSKEL---- 220 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHHH----hcccC----
Confidence 433 122356899999999998776 89999999999999999999999976542111 11100 00001
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.+ .......+..++.+||+.+|.+||++.+++.
T Consensus 221 -~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 -PPI----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred -CCc----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111 1112344566779999999999999999885
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=301.00 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=201.4
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+|...+.||+|+||.||++... +|+.||+|.+... ....+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4777889999999999999764 7899999988642 34556889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+.+++|.+++.... ...+++.+++.++.|++.||.|||+ .+++|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999986532 2457899999999999999999999 999999999999999999999999999998654432
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
.. .....|++.|+|||++.++.++.++|+|||||++++|++|+.||......... ...+. +... ..
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~~~-~~~~-----~~ 221 (256)
T cd08218 156 EL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV------LKIIR-GSYP-----PV 221 (256)
T ss_pred hh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH------HHHhc-CCCC-----CC
Confidence 21 12346889999999999999999999999999999999999999754322110 00111 1110 01
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.......+..++..||+.+|.+||++.+|++
T Consensus 222 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 ----SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ----cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1122345677889999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=302.78 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=201.3
Q ss_pred CCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSE-------DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
+|...+.||+|+||.||+|.. .+|+.||+|++.... ...+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477888999999999999986 478999999986421 246788999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC-CcEEeecccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF-EPQLSDFGLASW 482 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kL~DFGla~~ 482 (678)
||||+++++|.+++... .++++..+..++.|++.||.|||+ ++++|+||||+||+++.++ .++|+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 99999999999998643 468899999999999999999999 9999999999999998776 599999999887
Q ss_pred cCCCCCC--ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 483 LSTSSSH--LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 483 ~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
....... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.............. ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~------ 224 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK---IA------ 224 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH---Hh------
Confidence 6543211 111234688999999999888899999999999999999999999975443221111100 00
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
...............+.+++..|+..+|..||++.++++
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 ---SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000011122233456777889999999999999999885
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.79 Aligned_cols=264 Identities=25% Similarity=0.337 Sum_probs=202.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|...+.||+|+||.||+|... +++.||+|+++.. ....+.+.+|+++++.++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999876 6889999998653 2445788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|++++.+..++.. ...+++.+++.++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9988777665532 2458999999999999999999999 99999999999999999999999999999877654
Q ss_pred CCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhh---------ccccccc
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMW---------AKPILKD 556 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~---------~~~~~~~ 556 (678)
... ......++..|+|||++... .++.++||||||+++|+|++|+.||.............. .......
T Consensus 154 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred ccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 331 22335788999999999888 889999999999999999999999975433211100000 0000000
Q ss_pred Ccccc--ccCCCC----CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 557 GKVSQ--LLDPSL----DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 557 ~~~~~--l~dp~l----~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+.. +.+... ...+.......+..++..||..+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 000000 00111112456788889999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=307.88 Aligned_cols=238 Identities=22% Similarity=0.423 Sum_probs=188.6
Q ss_pred eecccCceEEEEEEeCC--------CCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 338 LVGKGGHSHVYRGCLPD--------GKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~--------g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
.||+|+||.||+|.... ...|++|.+.... ...+.|..|+.+++.+.||||+++++++..++..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 58999999999997532 2348888886543 44577889999999999999999999999989999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC--------cEEeecccc
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE--------PQLSDFGLA 480 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~--------~kL~DFGla 480 (678)
++|+|..++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++. ++++|||++
T Consensus 82 ~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 82 KFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999997542 368999999999999999999999 99999999999999988765 599999988
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCC-CCCCCCCCcccccchhhcccccccCc
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGK-KPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~-~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
...... ....++..|+|||++.+. .++.++|||||||++|||++|. .||....+...... ... .
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~~~-~ 221 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------YED-R 221 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------HHc-c
Confidence 654331 224678899999999874 5799999999999999999985 56554332211110 000 0
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
..+ +......+..++..||+.+|.+||++.++++.|+
T Consensus 222 ------~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ------HQL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------ccC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 001 1112245677889999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=306.97 Aligned_cols=251 Identities=23% Similarity=0.399 Sum_probs=199.0
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC--ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
+|...+.||+|+||.||++... +|+.||+|.++. .......+.+|++++.+++||||+++++++...+.+++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5667788999999999999876 789999998864 3345678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++++|..++.... ....+++..+..++.+++.||.|||+ ..+|+|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (286)
T cd06622 82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158 (286)
T ss_pred CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc
Confidence 9999999886531 23478999999999999999999996 15899999999999999999999999999876543221
Q ss_pred CceecccccCCCCCCcchhccCC------CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGK------VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~------~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
....|+..|+|||++.+.. ++.++|||||||++|+|++|+.||............. .+..+.
T Consensus 159 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~---- 226 (286)
T cd06622 159 ----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS----AIVDGD---- 226 (286)
T ss_pred ----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH----HHhhcC----
Confidence 2246888999999985543 5889999999999999999999997543221111000 000011
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.+ .......+..++..||+.+|.+||++.+++.
T Consensus 227 -~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 -PPTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -CCCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0111 1223445667889999999999999999886
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.17 Aligned_cols=250 Identities=27% Similarity=0.395 Sum_probs=200.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
++|...+.||.|+||.||+|... ++..+|+|+++... .....|..|++++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46777788999999999999875 68999999987543 55678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++++|.+++... ...+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999998643 2468999999999999999999999 9999999999999999999999999999876543222
Q ss_pred CceecccccCCCCCCcchhc-----cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 489 HLTCTDVAGTFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
. .....|+..|+|||++. ...++.++||||||+++|||++|+.||........ +..+ ..+..
T Consensus 159 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~~-----~~~~~---- 225 (280)
T cd06611 159 K--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLKI-----LKSEP---- 225 (280)
T ss_pred c--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHHH-----hcCCC----
Confidence 1 22356899999999985 34577899999999999999999999976543211 1111 00100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.+.. .......+.+++..||+.+|.+||++.++++
T Consensus 226 -~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 -PTLDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred -CCcCC--cccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 11100 1111234666779999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=310.70 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=199.7
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|...+.||+|+||.||+|... +++.||+|++.... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46778899999999999999875 58999999886432 345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++++|.++.... ..+++.+++.++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99999888876432 348999999999999999999999 89999999999999999999999999999876443
Q ss_pred CCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccc-cchhhccccc-------ccC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQE-SLVMWAKPIL-------KDG 557 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~l~~~~~~~~-------~~~ 557 (678)
... .....++..|+|||++.+ ..++.++||||||+++|||++|++||......... ....+..... ...
T Consensus 154 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 GEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred ccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 322 223568899999999876 45788999999999999999999999754421110 0000000000 000
Q ss_pred -ccccccCCCCCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 -KVSQLLDPSLDTDY-----DNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 -~~~~l~dp~l~~~~-----~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.......+...... .......+..++..||+.+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000001110000 0112355778889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=320.80 Aligned_cols=259 Identities=20% Similarity=0.255 Sum_probs=194.8
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFED------ 398 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------ 398 (678)
..++|...+.||+|+||.||+|... +++.||||++.... .....+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 4568888999999999999999864 78899999987532 3446678999999999999999999987543
Q ss_pred CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecc
Q 041755 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 399 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
...|++++++ +++|.+++.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCc
Confidence 3578999998 7899887742 358999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccch-hhcc-----
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV-MWAK----- 551 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~-~~~~----- 551 (678)
++....... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+........ ....
T Consensus 164 ~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 164 LARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred cceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 998754421 23578999999999877 56899999999999999999999999764422110000 0000
Q ss_pred --cccccCccccccCCCCCCCCCH-------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 552 --PILKDGKVSQLLDPSLDTDYDN-------DQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 552 --~~~~~~~~~~l~dp~l~~~~~~-------~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+........+. .+...... .....+..++..||+.||.+|||+.+++.
T Consensus 239 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 239 VLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000 00000000 01123567889999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.84 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=201.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||++... .++.|++|.+.... .....+.+|++++..++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999865 67899999987542 34567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++++|.+++... ..+++..+..++.+++.||.|||+ .+++||||||+|||++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 999999999999543 468999999999999999999999 9999999999999999999999999999874211
Q ss_pred CCC-------------CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccc
Q 041755 486 SSS-------------HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552 (678)
Q Consensus 486 ~~~-------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 552 (678)
... ........|+..|+|||++.+..++.++|||||||++|||++|..||.+.........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~------ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ------ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------
Confidence 100 0011124678899999999988999999999999999999999999975433211000
Q ss_pred ccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 553 ~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
... +. ...+.... .....+..++..||+.+|.+||++.++.++|+.
T Consensus 228 ~~~-~~---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VIS-DD---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHh-cc---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000 00 01111111 122346677899999999999998877777764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=308.11 Aligned_cols=263 Identities=21% Similarity=0.299 Sum_probs=196.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|++|.||+|... +++.||||.+.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999875 78999999986432 2234577899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+. ++|.+++.... ..+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 97 59999886432 368899999999999999999999 999999999999999999999999999987543322
Q ss_pred CCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCc-ccccchhhcccccccCcc------
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPK-GQESLVMWAKPILKDGKV------ 559 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~-~~~~l~~~~~~~~~~~~~------ 559 (678)
.. .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||...... ..................
T Consensus 158 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 KT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred cc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 11 122356889999999875 45889999999999999999999999654411 110000000000000000
Q ss_pred ---cccc-----CCCCCCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 560 ---SQLL-----DPSLDTDY-DNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 560 ---~~l~-----dp~l~~~~-~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.... ...+.... .......+.+++..||+.+|.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 00000000 0011245667889999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=299.54 Aligned_cols=247 Identities=25% Similarity=0.385 Sum_probs=200.1
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+|...+.||+|+||.||++... +++.+|+|.+... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778889999999999999764 7889999988643 34567889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC-CCcEEeecccccccCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD-FEPQLSDFGLASWLSTS 486 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~-~~~kL~DFGla~~~~~~ 486 (678)
+++++|.+++.... +..+++..+..++.+++.||.|||+ ++++|+||||+||+++.+ +.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997532 3568999999999999999999999 999999999999999865 46899999999876543
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
... ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+.... ... ... +....
T Consensus 156 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~---~~~-~~~~~----- 220 (256)
T cd08220 156 SKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VLK---IMS-GTFAP----- 220 (256)
T ss_pred ccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HHH---HHh-cCCCC-----
Confidence 322 225689999999999988899999999999999999999999976543221 111 000 01111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+ .......+..++..||+.+|.+||++.+++.
T Consensus 221 ~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 221 I----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred C----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 1112334667789999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=319.05 Aligned_cols=250 Identities=24% Similarity=0.393 Sum_probs=205.2
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeC---CChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILK---PSEDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~---~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 406 (678)
..|...+.||.||.+.||++...+.+.||+|.+. .+.+...-|.+|+.+|.+|+ |.+||+|++|-..++.+|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 4577778899999999999988777888888664 35577889999999999996 9999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|= ..+|...|..... ....| .++.+..|++.|+.++|. .||||.||||.|+|+-. |.+||+|||+|..+..+
T Consensus 441 ~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred cc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 85 6799999976532 33345 677899999999999999 99999999999999976 48999999999999888
Q ss_pred CCCceecccccCCCCCCcchhccC-----------CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccc
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHG-----------KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILK 555 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~-----------~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 555 (678)
.........+||+.||+||.+... +.+.++||||||||||+|+.|+.||..... .|+
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~a----- 580 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QIA----- 580 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HHH-----
Confidence 877777778999999999999543 256799999999999999999999964321 122
Q ss_pred cCccccccCCCCCCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 556 DGKVSQLLDPSLDTDYDND-QIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 556 ~~~~~~l~dp~l~~~~~~~-~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
++..+.||.-.-.|+.- .-..+++++..||+.||.+||++.++|+
T Consensus 581 --Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 --KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 34555566443333221 1122888899999999999999999996
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=302.89 Aligned_cols=246 Identities=25% Similarity=0.440 Sum_probs=199.1
Q ss_pred CCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCeEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPS--EDVLKEFASEIEIITALH---HRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~ 405 (678)
.|...+.||+|+||.||+|.. .+|+.||+|.++.. ......+.+|+.+++.++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466677899999999999986 47899999998653 345677889999999997 999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++++|.+++.. ..+++...+.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999998853 268899999999999999999999 9999999999999999999999999999987755
Q ss_pred CCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
.... .....|+..|+|||++.++ .++.++|||||||++|+|++|+.||........... +... ..
T Consensus 154 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-------~~~~-----~~ 219 (277)
T cd06917 154 NSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML-------IPKS-----KP 219 (277)
T ss_pred Cccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc-------cccC-----CC
Confidence 4322 2235789999999998764 468999999999999999999999976543221110 0000 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.+... .....+..++..||+.+|.+||++.++++
T Consensus 220 ~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 220 PRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 112111 12345667789999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=310.39 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=201.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||++... +++.||+|.+.... ...+.+..|++++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999876 58999999987542 35567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+.+++|.+++... .+..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998643 23578999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCCc---------------------------eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCC
Q 041755 486 SSSHL---------------------------TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSE 538 (678)
Q Consensus 486 ~~~~~---------------------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 538 (678)
..... ......||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 22110 111246889999999999888999999999999999999999999765
Q ss_pred CCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC----HHHHHH
Q 041755 539 NPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ----INLVLK 602 (678)
Q Consensus 539 ~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs----~~eVl~ 602 (678)
+.... +. .+.+..............+.+++..||+.+|.+||+ +.+++.
T Consensus 236 ~~~~~--~~-------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRDET--FS-------------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chHHH--HH-------------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 43211 00 000000000001113456777889999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=296.01 Aligned_cols=250 Identities=26% Similarity=0.401 Sum_probs=205.2
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFED--NNLLLVY 405 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 405 (678)
+|...+.||+|++|.||+|... +++.|++|++.... ...+.+.+|++++++++||||+++++++... +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999876 78999999987543 5678899999999999999999999999988 8899999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998653 378999999999999999999999 9999999999999999999999999999987766
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
...........++..|+|||.+.....+.++||||||+++++|++|..||....... . ..+ ........
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~-~~~--~~~~~~~~------ 222 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--A-ALY--KIGSSGEP------ 222 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--H-HHH--hccccCCC------
Confidence 543212234578999999999998889999999999999999999999997654110 0 011 01100011
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..........+.+++.+|+..+|.+||++.+++.
T Consensus 223 ---~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 ---PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ---cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1111222456777889999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=302.57 Aligned_cols=245 Identities=26% Similarity=0.456 Sum_probs=199.3
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
|...+.||.|+||.||+|... ++..||||++... ......|.+|+.++.+++||||+++++++.+++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 556778999999999999764 7889999998643 3455778899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+++|.+++.. ..+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..+.....
T Consensus 86 ~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 86 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999998853 357899999999999999999998 9999999999999999999999999999876644221
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
......|+..|+|||++.+..++.++|+|||||++|+|++|..||........... +..+. .+.+..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-------~~~~~-----~~~~~~ 223 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-------IPKNN-----PPTLEG 223 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-------HhcCC-----CCCCCc
Confidence 11234688999999999988899999999999999999999999975432211000 01111 011111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
.....+.+++..||+.+|..||++.++++.
T Consensus 224 ----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 ----NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 223446677899999999999999999973
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=305.17 Aligned_cols=263 Identities=21% Similarity=0.311 Sum_probs=200.8
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+|...+.||+|+||.||+|... +|+.||+|++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999865 7899999998653 24457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+ +++|.+++.... ..+++.+++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999986432 568999999999999999999999 999999999999999999999999999998765433
Q ss_pred CCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhh-c-------cccccc-C
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMW-A-------KPILKD-G 557 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~-~-------~~~~~~-~ 557 (678)
.. ......|+..|+|||++.+. .++.++||||||+++|||++|.+||.............. . ++...+ .
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 PR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred CC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 21 12235689999999998654 468999999999999999999888865443211100000 0 000000 0
Q ss_pred ccccccCCCCCC----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 KVSQLLDPSLDT----DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ~~~~l~dp~l~~----~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+..+..+.-.. ....+....+..++..||+.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000000 000122367788889999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=307.17 Aligned_cols=262 Identities=20% Similarity=0.284 Sum_probs=195.0
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+|...+.||+|+||.||+|... +|+.||+|.++... .....+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677789999999999999875 78999999986432 2345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+. ++|.+++... ...+++..++.++.||++||.|||+ ++++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 5888877542 2468999999999999999999999 999999999999999999999999999998654432
Q ss_pred CCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccc-cchhhcccccccC---ccccc
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQE-SLVMWAKPILKDG---KVSQL 562 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~---~~~~l 562 (678)
.. .....+++.|+|||++.+. .++.++|||||||++|+|+||+.||......... ..+.-........ .+...
T Consensus 154 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred CC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 22 1234678999999998765 4789999999999999999999886543321100 0000000000000 00000
Q ss_pred cC----CCCCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 563 LD----PSLDTD-----YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 563 ~d----p~l~~~-----~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+ +..... ........+.+++..||+.+|.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 000000 01112345667889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=302.21 Aligned_cols=252 Identities=26% Similarity=0.421 Sum_probs=201.9
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
+|...+.||.|+||.||++... +++.+|+|++... ......+.+|+++++.++||||+++++++...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5667778999999999999876 6899999998654 355678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++++|.+++.... ..+++.....++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999987542 568899999999999999999997 36899999999999999999999999999876543221
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
. ...|+..|+|||++.+..++.++||||||+++|+|++|+.||........ ............ .-+.+.
T Consensus 157 ~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~------~~~~~~ 225 (265)
T cd06605 157 K----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNE------PPPRLP 225 (265)
T ss_pred h----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcC------CCCCCC
Confidence 1 15688999999999999999999999999999999999999976532111 111111111110 001111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.. .....+..++..||..+|.+||++.+++.
T Consensus 226 ~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 226 SG---KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hh---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11 12344677889999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=306.68 Aligned_cols=266 Identities=18% Similarity=0.253 Sum_probs=196.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCe-----
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALH-HRNIISLFGFCFEDNN----- 400 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~----- 400 (678)
++|...+.||+|+||.||+|... +|+.||||.++... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999865 78999999886432 23467888999999995 6999999999987665
Q ss_pred EEEEEEcCCCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC-CCCcEEeecc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKD-GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD-DFEPQLSDFG 478 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~-~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~-~~~~kL~DFG 478 (678)
.++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 898888654332 4568999999999999999999999 99999999999999998 8999999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccc-cchhhcc-c---
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQE-SLVMWAK-P--- 552 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~l~~~~~-~--- 552 (678)
++..+....... ....+++.|+|||++.+ ..++.++||||||+++|+|++|..||......... ....... +
T Consensus 157 ~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (295)
T cd07837 157 LGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ 234 (295)
T ss_pred cceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 988654322211 22356889999998865 45789999999999999999999999764432110 0000000 0
Q ss_pred ccc-cCcccccc-CCCCC----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 553 ILK-DGKVSQLL-DPSLD----TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 553 ~~~-~~~~~~l~-dp~l~----~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+. ........ -+... ..........+..++..||..+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 00000000 00000 0000122345677889999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=307.80 Aligned_cols=263 Identities=21% Similarity=0.275 Sum_probs=199.2
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE------DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
+|...+.||+|+||.||+|... +|+.||||.++... .....+..|++++..++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677788999999999999865 68999999997542 2345677899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+ +|+|.+++.... ..+++..++.++.||++||.|||+ .+++|+||||+|||++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 999999996432 368999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccch-hhccccccc-----C
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV-MWAKPILKD-----G 557 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~-~~~~~~~~~-----~ 557 (678)
...... ....+++.|+|||++.+ ..++.++|||||||++|||++|.+||............ ......... .
T Consensus 154 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 532221 22456888999999865 46789999999999999999998888654432110000 000000000 0
Q ss_pred ccccccCCCCCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 558 KVSQLLDPSLDTDY-----DNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 558 ~~~~l~dp~l~~~~-----~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
.............. .......+.+++..||+.+|.+||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000 11223567788999999999999999999973
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=305.29 Aligned_cols=243 Identities=27% Similarity=0.383 Sum_probs=199.6
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||++... +++.||+|++.... .....+.+|+++++++.||||+++++++.+++.+++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46788899999999999999865 68999999986532 34567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999998643 468999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
. .....|++.|+|||.+.++..+.++||||||+++|+|++|+.||........... .. .+..
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~-~~~~------ 215 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK------IL-EGKV------ 215 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------Hh-cCCc------
Confidence 4 1235689999999999988899999999999999999999999976542111000 00 1110
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~ 602 (678)
.+... ....+..++..||..+|.+|| ++.++++
T Consensus 216 ~~~~~----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 216 RFPSF----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred cCCcc----CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11111 134566778999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=293.10 Aligned_cols=248 Identities=29% Similarity=0.461 Sum_probs=203.9
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
+|...+.||+|++|.||++... +++.+++|++.... .....+.+|+++++.++|+|++++++++...+..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677789999999999999876 78999999997654 366789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+++|.+++.... ..+++..++.++.|++.||.|||. .+++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987542 468999999999999999999999 9999999999999999999999999999987665432
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
.....|+..|++||++....++.++||||||+++|+|++|+.||...+...... ... ......+.++
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~~~-----~~~~~~~~~~---- 220 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF--KIA-----TNGPPGLRNP---- 220 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH--HHH-----hcCCCCcCcc----
Confidence 234578999999999998889999999999999999999999997653221110 000 0011111110
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
......+..++..||+.+|.+||++.++++
T Consensus 221 ---~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 221 ---EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ---cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111345777889999999999999999885
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=308.90 Aligned_cols=267 Identities=22% Similarity=0.313 Sum_probs=198.6
Q ss_pred CCCCceeecccCceEEEEEEeC---CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP---DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFED--NNLL 402 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~---~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 402 (678)
.|...+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.++..++||||+++++++.+. ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677788999999999999864 47899999997632 3346678899999999999999999999988 7899
Q ss_pred EEEEcCCCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC----CCCcEEeec
Q 041755 403 LVYDFLSRGSLEENLHGNKKD-GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD----DFEPQLSDF 477 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~-~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~----~~~~kL~DF 477 (678)
+||||+.+ +|.+.+...... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 677766543322 2378999999999999999999999 99999999999999999 999999999
Q ss_pred ccccccCCCCC-CceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCccccc-------chh
Q 041755 478 GLASWLSTSSS-HLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQES-------LVM 548 (678)
Q Consensus 478 Gla~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-------l~~ 548 (678)
|++........ ........+|+.|+|||.+.+. .++.++|||||||++|+|++|+.||.......... +..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987654332 2223345789999999988764 57899999999999999999999998655432100 000
Q ss_pred hcccc-----------cccCccccccCCCCCCCCC----H-------HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 549 WAKPI-----------LKDGKVSQLLDPSLDTDYD----N-------DQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 549 ~~~~~-----------~~~~~~~~l~dp~l~~~~~----~-------~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....+ ..-..+....+......+. . .....+..++..||+.+|.+||++.++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 0000000000000001111 0 22345778899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=308.89 Aligned_cols=242 Identities=26% Similarity=0.434 Sum_probs=195.4
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHH
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLE 414 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 414 (678)
..||+|+||.||++... ++..||||.+.... ...+.+.+|+.+++.++||||+++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 46899999999999865 68899999986543 45667889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceecc
Q 041755 415 ENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD 494 (678)
Q Consensus 415 ~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 494 (678)
+++.. ..+++.+++.++.||+.||.|||+ ++|+||||||+||+++.++.++|+|||++......... ...
T Consensus 108 ~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~ 177 (292)
T cd06658 108 DIVTH-----TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKS 177 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--Cce
Confidence 98843 347899999999999999999999 89999999999999999999999999998765433221 123
Q ss_pred cccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHH
Q 041755 495 VAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDND 574 (678)
Q Consensus 495 ~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~ 574 (678)
..|+..|+|||++.+..++.++||||||+++|||++|+.||........... +...+.+.+... ..
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~------------~~~~~~~~~~~~--~~ 243 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR------------IRDNLPPRVKDS--HK 243 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------------HHhcCCCccccc--cc
Confidence 5689999999999988999999999999999999999999976543211110 001111111111 11
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 575 QIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 575 ~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....+..++..|+..+|.+||++.++++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1234556678999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=305.24 Aligned_cols=265 Identities=20% Similarity=0.313 Sum_probs=195.8
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++++|...+.||+|+||.||+|... +|+.||+|++.... .....+.+|+.+++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 5678999999999999999999764 68999999986432 33346788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+. ++|.+++... ...+.+..+..++.|++.||.|||+ .+|+|+||||+|||++.++.++|+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 7777776533 2457888899999999999999999 8999999999999999999999999999876433
Q ss_pred CCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcc-ccccc-------
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK-PILKD------- 556 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~-~~~~~------- 556 (678)
.... .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.............|.. ....+
T Consensus 156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 PSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 2211 1234578999999998764 57889999999999999999999997554321100000000 00000
Q ss_pred ---CccccccCCCCCCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 557 ---GKVSQLLDPSLDTDY-----DNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 557 ---~~~~~l~dp~l~~~~-----~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
............... .......+.+++..|++.+|.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 0011234556779999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.79 Aligned_cols=251 Identities=25% Similarity=0.439 Sum_probs=200.8
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+|...+.||+|+||.||+|... +++.|++|.++... .....+..|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777889999999999999865 78999999987543 3678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++++|.+++... ..+++..++.++.+++.||.|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9999999998643 457899999999999999999999 999999999999999999999999999998765433
Q ss_pred CCce--ecccccCCCCCCcchhccCC---CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 488 SHLT--CTDVAGTFGYLAPEYFMHGK---VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 488 ~~~~--~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
.... .....++..|+|||++.... ++.++||||||+++|+|++|+.||........ .... +..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~----~~~~----- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFH----VGAG----- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHH----HhcC-----
Confidence 2211 11356789999999998766 88999999999999999999999975432111 0000 0000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+.+.... .....+..++..||+.+|.+||++.+++.
T Consensus 223 ~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 HKPPIPDSL--QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCCccc--ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 011111111 11334567789999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.90 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=206.1
Q ss_pred HhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 328 SATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 328 ~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
..+++|...+.||+|+||.||+|... ++..|++|++.........+.+|+++++.++|+|++++++++...+..++|+|
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 45667888889999999999999876 68999999998655556788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++++|.+++.... ..+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999997542 378999999999999999999999 99999999999999999999999999998765433
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
... .....++..|++||++.+..++.++|||||||++|+|++|+.||....+.... ..+. . .......+
T Consensus 170 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~~~~----~-~~~~~~~~-- 238 (286)
T cd06614 170 KSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--FLIT----T-KGIPPLKN-- 238 (286)
T ss_pred hhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHH----h-cCCCCCcc--
Confidence 211 12245788999999999888999999999999999999999999754432111 1100 0 00000000
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.......+..++..|++.+|..||++.+|++
T Consensus 239 -----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 -----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -----hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112345677889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=305.59 Aligned_cols=263 Identities=22% Similarity=0.294 Sum_probs=199.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFED--NNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV 404 (678)
++|...+.||.|+||.||+|... +++.+|+|.++... .....+.+|+.++.+++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46778889999999999999876 68899999987532 2344677899999999999999999999877 889999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+. ++|.+.+.... ..+++..++.++.|++.||.|||+ .+++|+||||+|||++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99996 59998886532 368999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccc-hh---------hc---
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESL-VM---------WA--- 550 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l-~~---------~~--- 550 (678)
..... .....+++.|+|||++.+. .++.++||||||+++|+|++|..||........... .. |.
T Consensus 158 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 53221 2234678899999998764 468999999999999999999999976543211100 00 00
Q ss_pred -ccccccCccccccCCCCCCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 551 -KPILKDGKVSQLLDPSLDTDYDND-QIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 551 -~~~~~~~~~~~l~dp~l~~~~~~~-~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+..............+...+... ....+.+++..||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000011111111111111111 2445667889999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=308.60 Aligned_cols=242 Identities=25% Similarity=0.420 Sum_probs=194.9
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHH
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLE 414 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 414 (678)
..||+|+||.||++... +++.||+|++.... ...+.+.+|+.++..++||||+++++++..++..++||||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 46999999999999865 78999999986533 34567889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceecc
Q 041755 415 ENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD 494 (678)
Q Consensus 415 ~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 494 (678)
.++.. ..+++..++.++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++......... ...
T Consensus 107 ~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~ 176 (297)
T cd06659 107 DIVSQ-----TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKS 176 (297)
T ss_pred HHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccc
Confidence 87743 357899999999999999999999 99999999999999999999999999998765443221 123
Q ss_pred cccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHH
Q 041755 495 VAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDND 574 (678)
Q Consensus 495 ~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~ 574 (678)
..|+..|+|||++.+..++.++|||||||++|||++|+.||....+..... . +..... +.... ...
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~--~-----~~~~~~-----~~~~~--~~~ 242 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK--R-----LRDSPP-----PKLKN--AHK 242 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-----HhccCC-----CCccc--cCC
Confidence 578999999999998899999999999999999999999997544322111 0 000000 00000 001
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 575 QIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 575 ~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....+..++..||+.+|.+||++.++++
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 1234667789999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=319.47 Aligned_cols=242 Identities=27% Similarity=0.411 Sum_probs=200.8
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
|...+.||.|.||.||.|+.. +...||||.+..+ .....+++.|+..|.+++|||+|.+.|||..+...+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 444566999999999999865 6788999998643 35678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
| -|+-.|+|.-.+ .++.+.++..|..+.+.||.|||+ .+.||||||..||||++.|.+||+|||.|....+.
T Consensus 108 C-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 108 C-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred H-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 9 567777775433 578999999999999999999999 99999999999999999999999999999876553
Q ss_pred CCceecccccCCCCCCcchhc---cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
..++|||.|||||++. .|.|+.|+||||||++..||.-.++|+...+......- +- +--.
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH-------IA-----QNes 242 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-------IA-----QNES 242 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH-------HH-----hcCC
Confidence 3478999999999884 58899999999999999999999999887665332111 11 1111
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
|.+. ..+....+..++-.||+.-|.+|||..++++
T Consensus 243 PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2232 3355666778889999999999999988875
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=296.95 Aligned_cols=251 Identities=23% Similarity=0.384 Sum_probs=206.7
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|++|.||+|... +|+.|+||++.... .....+.+|+.++..++|+||+++++++...+.+++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46788899999999999999876 59999999987653 4567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++++|.+++... ..+++..++.++.|+++||.|||+. .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999643 5689999999999999999999962 789999999999999999999999999998765433
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..........+..+.. . . ..+.+
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~-~-----~~~~~ 223 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---D-G-----PPPSL 223 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---c-C-----CCCCC
Confidence 322 23568899999999999999999999999999999999999997664312111111111 0 0 00111
Q ss_pred CCCCCHH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 568 DTDYDND-QIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 568 ~~~~~~~-~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
... ....+..++..||..+|.+||++.++++
T Consensus 224 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 224 ----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ----CcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 111 3456778889999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=303.49 Aligned_cols=249 Identities=24% Similarity=0.389 Sum_probs=201.8
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
++|...+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.++||||++++++|...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888899999999999999754 78899999986433 44567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++++|.+++.. ..+++.++..++.+++.||.|||+ ++++|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999853 247899999999999999999999 9999999999999999999999999999876544332
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
. .....|++.|+|||++.++.++.++||||||+++|+|++|+.||...+........ ...+. +...
T Consensus 171 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~~~------~~~~ 236 (293)
T cd06647 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT------PELQ 236 (293)
T ss_pred c--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcCCC------CCCC
Confidence 2 12346889999999999888999999999999999999999999765442211100 00000 0010
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
........+..++..||..+|.+||++.+++..
T Consensus 237 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 --NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111123346677899999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=299.23 Aligned_cols=246 Identities=24% Similarity=0.356 Sum_probs=201.4
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
+|...+.||.|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999876 68999999986432 456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+.+++|.+++... ..+++.....++.|+++||.|||+ ++++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998643 468899999999999999999999 99999999999999999999999999998876543
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
.. .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||..........+.. .... ..+.
T Consensus 154 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~------~~~~ 220 (258)
T cd05578 154 TL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----KQET------ADVL 220 (258)
T ss_pred cc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH----Hhcc------cccc
Confidence 21 223568899999999998889999999999999999999999998765421111111 0000 0011
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCH--HHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQI--NLVL 601 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~--~eVl 601 (678)
.+......+..++..||+.+|.+||++ .+++
T Consensus 221 ----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 221 ----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ----CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111122567778899999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=303.98 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=196.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
..|...+.||+|+||.||+|... +|+.||+|++... ......+.+|+++++.++||||++++++|...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777788999999999999865 6899999988532 244567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+. |+|.+.+... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9996 6777776532 2468999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCCceecccccCCCCCCcchhc---cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
. ....|+..|+|||++. .+.++.++||||||+++|||++|+.||...+.........+ +.
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~-------~~---- 230 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------ND---- 230 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-------CC----
Confidence 2 1246788999999874 45688999999999999999999999976543221110000 00
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
.+.+. .......+..++..||..+|.+||++.+|+..
T Consensus 231 -~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 -SPTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CCCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01111 11233457788899999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=297.38 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=204.7
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+|...+.||+|+||.||++... +|+.+++|.+... ......+.+|+++++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999755 7889999998753 34456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++++|.+++......+..+++..++.++.+++.||.|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999987644445678999999999999999999999 999999999999999999999999999998776541
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
. ....|+..|++||++.+..++.++|+||||+++|+|++|+.||...+....... ...+.+.
T Consensus 158 ~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~------- 219 (256)
T cd08530 158 A----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYK-------VQRGKYP------- 219 (256)
T ss_pred c----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HhcCCCC-------
Confidence 1 224678999999999999999999999999999999999999976543211110 0111111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.........+..++..|++.+|.+||++.++++
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 --PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred --CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111233455788889999999999999999885
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=319.53 Aligned_cols=253 Identities=22% Similarity=0.378 Sum_probs=214.4
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
+....++||-|-||.||.|.++ -...||||.++.+.-..++|+.|..+|+.++|||+|+|+|+|..+..+|+|+|||..
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 4556778999999999999886 467899999998888889999999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.++|.+.. ...++-...+.++.||..|++||.. +++|||||...|+|+.++..+|++||||++++..+....
T Consensus 348 GNLLdYLRecn--r~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 348 GNLLDYLRECN--RSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred ccHHHHHHHhc--hhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 99999998653 3556777788999999999999998 999999999999999999999999999999886554332
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
. ....-..-|.|||-+.+..++.|+|||+|||+|||+.| |-.||.+.+-. .+..++...++-
T Consensus 423 H-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS----------------qVY~LLEkgyRM 485 (1157)
T KOG4278|consen 423 H-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QVYGLLEKGYRM 485 (1157)
T ss_pred c-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH----------------HHHHHHhccccc
Confidence 2 11233567999999999999999999999999999998 88888764321 223334444444
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+-++.+...+.++++.||+.+|.+||++.|+-+.|+.
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 4556677788889999999999999999999988774
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.51 Aligned_cols=264 Identities=20% Similarity=0.304 Sum_probs=198.8
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
+|...+.||.|++|.||+|... +|..||||+++... .....+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5778899999999999999875 68999999987542 33466788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
+ ++|.+++..... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 D-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred C-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 7 488888764422 3468999999999999999999999 8999999999999999999999999999976544322
Q ss_pred CceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc------cc
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV------SQ 561 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~------~~ 561 (678)
. .....++..|++||++.+. .++.++|||||||++|+|++|+.||...+.......+.-.........+ ..
T Consensus 156 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 T--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred c--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1 1234678899999998664 5688999999999999999999999865543211100000000000000 00
Q ss_pred ccCCCCC------CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 562 LLDPSLD------TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 562 l~dp~l~------~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+...... ..........+.+++..|++.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0000112345677889999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=304.79 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=196.6
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+|...+.||.|++|.||+|... +|+.||||.++... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778889999999999999865 78999999886432 3346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+. ++|..++.... +..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 68988886532 3568999999999999999999999 999999999999999999999999999988664432
Q ss_pred CCceecccccCCCCCCcchhccCC-CCccceEeehhHHHHHHhcCCCCCCCCCCcccc-cchhhcccccc-------c--
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGK-VSEKIDVYAFGIVLLELLSGKKPINSENPKGQE-SLVMWAKPILK-------D-- 556 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~l~~~~~~~~~-------~-- 556 (678)
.. .....++..|+|||++.+.. ++.++||||||+++|||+||+.||......... ....+...... .
T Consensus 155 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 RT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 22 12345788999999887644 688999999999999999999999764432110 00000000000 0
Q ss_pred ---CccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 557 ---GKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 557 ---~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+.......+... .......+.+++..||+.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000000 0011234567789999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.51 Aligned_cols=248 Identities=24% Similarity=0.391 Sum_probs=199.8
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+|...+.||+|+||.||+|... +|..+|+|.+... ....+.+.+|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778889999999999999875 6899999998643 23456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC-CcEEeecccccccCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF-EPQLSDFGLASWLSTS 486 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kL~DFGla~~~~~~ 486 (678)
+++++|.+++.... +..+++..+..++.|++.||.|||+ .+++|+||||+||++++++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999987532 2467999999999999999999999 9999999999999999886 4699999999876543
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
... .....|++.|+|||++.+..++.++|+||||+++|||++|..||...+.... ...... +.. .+.
T Consensus 156 ~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-~~~----~~~ 222 (257)
T cd08225 156 MEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL------VLKICQ-GYF----API 222 (257)
T ss_pred ccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHhc-ccC----CCC
Confidence 221 1234689999999999988999999999999999999999999975432211 111111 111 110
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.. .....+.+++.+|+..+|.+||++.++++
T Consensus 223 -~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 -SP----NFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -CC----CCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11 12235777789999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=300.03 Aligned_cols=246 Identities=25% Similarity=0.396 Sum_probs=198.5
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
|...+.||+|++|.||++... +++.+++|++.... ...+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444578999999999999864 78999999886433 4456788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
++|.+++.. ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++.........
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~- 171 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR- 171 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc-
Confidence 999999864 357899999999999999999999 99999999999999999999999999998765443221
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...++........ .+. .+.+..
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~-------~~~-----~~~~~~- 237 (285)
T cd06648 172 -RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR-------DNL-----PPKLKN- 237 (285)
T ss_pred -cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH-------hcC-----CCCCcc-
Confidence 123568999999999998889999999999999999999999997654322111110 000 011111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.......+..++..||+.+|.+||++.++++
T Consensus 238 -~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 -LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1112245777889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.63 Aligned_cols=261 Identities=20% Similarity=0.268 Sum_probs=199.1
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFED------ 398 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------ 398 (678)
..++|...+.||+|+||.||+|... +|+.||||++.. .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999865 789999999863 234456788999999999999999999988643
Q ss_pred CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecc
Q 041755 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 399 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
...|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999995 588887752 27889999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccch-h---------
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV-M--------- 548 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~-~--------- 548 (678)
++........ .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+ .
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9987654322 22356889999999999999999999999999999999999999765432110000 0
Q ss_pred ----------hcc--cccccCccccccCCCCC----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 549 ----------WAK--PILKDGKVSQLLDPSLD----TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 549 ----------~~~--~~~~~~~~~~l~dp~l~----~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.. +......+.+++...+. ..........+.+++..||+.||.+||++.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 00000011111111111 1111123455678889999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=296.02 Aligned_cols=241 Identities=24% Similarity=0.345 Sum_probs=194.5
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 041755 339 VGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413 (678)
Q Consensus 339 IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 413 (678)
||.|+||.||++... +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999875 5899999998643 24457799999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceec
Q 041755 414 EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCT 493 (678)
Q Consensus 414 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 493 (678)
.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 9999653 358899999999999999999999 999999999999999999999999999998775543 112
Q ss_pred ccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCH
Q 041755 494 DVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDN 573 (678)
Q Consensus 494 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~ 573 (678)
...|+..|++||++....++.++|+||||+++|+|++|..||........... .. ..+......+..
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~---------~~~~~~~~~~~~ 217 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY----ND---------ILKGNGKLEFPN 217 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH----HH---------HhccCCCCCCCc
Confidence 35689999999999888899999999999999999999999976542111100 00 000000111111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041755 574 DQIERMVLAATLSISRAPTVRPQ-----INLVLK 602 (678)
Q Consensus 574 ~~~~~l~~la~~Cl~~dP~~RPs-----~~eVl~ 602 (678)
.....+..++..||+.+|.+||+ +.++++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 12345777889999999999999 555554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.66 Aligned_cols=262 Identities=22% Similarity=0.305 Sum_probs=195.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-------
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDN------- 399 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------- 399 (678)
++|...+.||+|+||.||+|... +|+.||||.+... ......+.+|+.++++++||||++++++|....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 57888999999999999999865 6899999988542 223445678999999999999999999987643
Q ss_pred -eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecc
Q 041755 400 -NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 400 -~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
..++||||+. ++|.+.+... ...+++.+++.++.|++.||.|||+ ++++|+||||+|||++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCC
Confidence 4599999995 5888877542 2468999999999999999999999 899999999999999999999999999
Q ss_pred cccccCCCCCC--ceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccc
Q 041755 479 LASWLSTSSSH--LTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILK 555 (678)
Q Consensus 479 la~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 555 (678)
++......... .......++..|+|||++.+. .++.++||||||+++|||++|+.||...+.......+......+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99876543221 112234678899999998764 478899999999999999999999976654322211111100000
Q ss_pred cC------------------ccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 556 DG------------------KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 556 ~~------------------~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.. .....+...+.... ....+.+++..||+.+|.+||++.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYV---KDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhccccc---CCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 00000000000000 1234567889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.73 Aligned_cols=244 Identities=23% Similarity=0.412 Sum_probs=206.5
Q ss_pred eeecccCceEEEEEEeC--CCC--EEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP--DGK--ELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~--~g~--~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++||+|.||.|++|.+. +|+ .||||+++.+. ....+|++|+.+|.+|+|||+++|||+..+ ....||||.++.
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELapl 194 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPL 194 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhccc
Confidence 45899999999999875 455 57999998764 468999999999999999999999999987 678999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+.|+.. ....|.......++.|||.|+.||.. +++|||||-..|+||-..-.+||+||||.+-++.....+
T Consensus 195 GSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 195 GSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred chHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 9999999873 33678888889999999999999999 999999999999999999999999999999998877666
Q ss_pred eecc-cccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 491 TCTD-VAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 491 ~~~~-~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
.+.. ..-.+.|+|||.+.+.+++-++|||+|||+||||+| |+.||-+..... +-+.+|..-.
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD~~er 333 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNIDAGER 333 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhcccccc
Confidence 5543 234568999999999999999999999999999999 889997765422 1122332222
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
-.-...+.+++..++..||..+|.+||++..|.+
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 2234566788999999999999999999999974
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.72 Aligned_cols=262 Identities=22% Similarity=0.296 Sum_probs=198.7
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEEEEE
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFED--NNLLLVYD 406 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~E 406 (678)
|...+.||.|+||.||+|... +|+.+|+|++... ......+.+|+++++.++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999875 5899999999764 23456788999999999999999999999887 78999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|++ ++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+|||+++++.++|+|||++......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 997 4888888643 2468999999999999999999999 89999999999999999999999999999877554
Q ss_pred CCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccc----
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQ---- 561 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~---- 561 (678)
... ..+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.......+..............
T Consensus 154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Ccc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 321 1223467889999998765 4578999999999999999999999976554221111110000000000000
Q ss_pred ----------ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 562 ----------LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 562 ----------l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.....+...+.......+.+++..||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000011112456788899999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=313.29 Aligned_cols=263 Identities=20% Similarity=0.318 Sum_probs=197.6
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----Ce
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFED-----NN 400 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 400 (678)
.+++|...+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999864 7899999998642 24556788999999999999999999987654 35
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
.++|+||+. ++|...+.. ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccce
Confidence 899999996 588877743 358999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCc-eecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccccc--
Q 041755 481 SWLSTSSSHL-TCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKD-- 556 (678)
Q Consensus 481 ~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~-- 556 (678)
.......... ......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+...... .....+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~---~~~~~~~~~~ 230 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN---LILGVLGTPS 230 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCC
Confidence 8764432211 1223578999999998755 568999999999999999999999997543221100 00000000
Q ss_pred -CccccccCCC-------C--CCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 557 -GKVSQLLDPS-------L--DTDYD-----NDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 557 -~~~~~l~dp~-------l--~~~~~-----~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
..+..+.+.. + ..... ......+..++..||+.+|.+||++.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 0 00000 1123457788899999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=301.94 Aligned_cols=254 Identities=26% Similarity=0.376 Sum_probs=193.5
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+|.....||+|+||.||++... +|+.||+|.+... ......+.+|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445567999999999999865 6899999998653 245667889999999996 99999999999998899999999
Q ss_pred CCCCCHHHHhcc-CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 408 LSRGSLEENLHG-NKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 408 ~~~gsL~~~L~~-~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
+. ++|.++... .......+++.....++.+++.||+|||+ ..+++||||||+|||++.++.++|+|||++......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 455543321 11123568999999999999999999997 148999999999999999999999999999765443
Q ss_pred CCCceecccccCCCCCCcchhccC---CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHG---KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
... ....|++.|+|||++.+. .++.++|||||||++|||++|+.||...... ...+ ..... +.
T Consensus 162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~----~~~~~-~~----- 227 (288)
T cd06616 162 IAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-FDQL----TQVVK-GD----- 227 (288)
T ss_pred Ccc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-HHHH----hhhcC-CC-----
Confidence 221 234689999999999776 6899999999999999999999999754310 0000 00000 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.+...........+..++..||+.+|.+||++.+|++
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111211111223445778889999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.86 Aligned_cols=261 Identities=20% Similarity=0.295 Sum_probs=196.8
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
|...+.||.|++|.||+|... +|..||+|++.... .....+.+|+++++.++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 556788999999999999865 79999999986532 33467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
+++|.+++..... ..+++..++.++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 -DLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred -CcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5799998865432 468999999999999999999999 8999999999999999999999999999976543322
Q ss_pred CceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccc-cchhhcccccc---------cC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQE-SLVMWAKPILK---------DG 557 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~l~~~~~~~~~---------~~ 557 (678)
.. ....+++.|+|||++.++ .++.++||||||+++|+|++|+.||......... ....+...... .+
T Consensus 155 ~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 TY--THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred cc--CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 11 223568899999988664 5789999999999999999999999765432110 00000000000 00
Q ss_pred ---ccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 ---KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ---~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.....+... .........+.+++.+|++.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000000 001112245778889999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=301.89 Aligned_cols=264 Identities=19% Similarity=0.285 Sum_probs=196.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|.....||+|++|.||+|... +|+.||+|.+... ......+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888899999999999999875 7899999988643 2344678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC-CCCcEEeecccccccCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD-DFEPQLSDFGLASWLST 485 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~-~~~~kL~DFGla~~~~~ 485 (678)
|++ ++|.+++.... ...+++...+.++.||+.||.|||+ ++++|+||||+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 58888775432 2346788888999999999999999 99999999999999985 55799999999986544
Q ss_pred CCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhh--ccc---ccccC-c
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMW--AKP---ILKDG-K 558 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~--~~~---~~~~~-~ 558 (678)
.... .+...|++.|+|||++.+. .++.++|||||||++|+|+||+.||.............. ..+ .+... .
T Consensus 156 ~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 PVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred Cccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 3221 1234678999999998664 578999999999999999999999976543221110000 000 00000 0
Q ss_pred cccccC--CCCCC----CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 559 VSQLLD--PSLDT----DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 559 ~~~l~d--p~l~~----~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+..... +.... .........+.+++.+|++.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 00000 001112344677889999999999999999986
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=291.90 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=205.3
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+|...+.||.|+||.||++... ++..|++|++... ......+.+|+++++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999875 6899999998753 25567789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++++|.+++......+..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997654345779999999999999999999999 899999999999999999999999999998765543
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
. ......|++.|+|||.+....++.++|+||||+++++|++|+.||........ .. ... .+... .+
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~---~~~-~~~~~-----~~ 223 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL---AL---KIL-KGQYP-----PI 223 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH---HH---HHh-cCCCC-----CC
Confidence 1 22235789999999999998999999999999999999999999975542211 00 000 01111 11
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.. .....+..++..||..+|.+||++.++++
T Consensus 224 ~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 PS----QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CC----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11 22345677789999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=297.83 Aligned_cols=258 Identities=24% Similarity=0.289 Sum_probs=193.0
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeC--CeEEEEEE
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALH-HRNIISLFGFCFED--NNLLLVYD 406 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~--~~~~lV~E 406 (678)
|...+.||+|+||.||+|... +++.||+|+++.. ........+|+.++.++. |||++++++++.+. +.+++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456778999999999999864 7899999998753 222334567999999986 99999999999987 88999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+. |+|.+.+.... ..++|.+++.++.|++.||.|||+ .+++||||||+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 68888876432 468999999999999999999999 99999999999999999 99999999999876543
Q ss_pred CCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccch---------hhccccccc
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV---------MWAKPILKD 556 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~---------~~~~~~~~~ 556 (678)
... ....++..|+|||++.. +.++.++|||||||++|||++|..||...+........ .|.. ....
T Consensus 153 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 228 (282)
T cd07831 153 PPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK-KFRK 228 (282)
T ss_pred CCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHH-hhcc
Confidence 222 23467899999997654 55788999999999999999999999765432210000 0000 0000
Q ss_pred CccccccCCCCCCC----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 557 GKVSQLLDPSLDTD----YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 557 ~~~~~l~dp~l~~~----~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
........+..... ........+.+++..||+.+|.+||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000000 01123466788889999999999999999885
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.12 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=196.6
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFED--NNLLL 403 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~l 403 (678)
.++|...+.||+|+||.||+|... +|+.||+|+++... .....+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467889999999999999999875 68999999986432 2234567899999999999999999998765 56899
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+. ++|.+++.... ..+++.+++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 58888886432 568999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc--------c
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI--------L 554 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~--------~ 554 (678)
...... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+...... +
T Consensus 159 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 543221 122356888999999865 45789999999999999999999999765543221111100000 0
Q ss_pred ccCccccccC--CCCCCCCC---HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 555 KDGKVSQLLD--PSLDTDYD---NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 555 ~~~~~~~l~d--p~l~~~~~---~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
........+. ........ ......+..++..||+.||++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 00000000 001344567889999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=302.58 Aligned_cols=244 Identities=26% Similarity=0.404 Sum_probs=194.3
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
|...+.||+|+||.||+|... +|..||+|++... ......+.+|+++++.++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 555678999999999999864 6899999998642 24456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+. |+|.+.+... ...+++.++..++.+++.||.|||+ .+|+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 96 5787777532 2468999999999999999999999 99999999999999999999999999998754332
Q ss_pred CCceecccccCCCCCCcchhc---cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
....|++.|+|||++. .+.++.++|||||||++|||++|+.||.......... .+ ...+ .
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~----~~~~-~----- 241 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HI----AQNE-S----- 241 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--HH----Hhcc-C-----
Confidence 2346889999999974 4678999999999999999999999987543221111 00 0000 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLL 604 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L 604 (678)
+... .......+..++..||+.+|.+||++.+|++.+
T Consensus 242 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 242 PTLQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CCCC---CccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0010 112234567788999999999999999999743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=298.33 Aligned_cols=241 Identities=23% Similarity=0.317 Sum_probs=186.2
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHH---hcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 338 LVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIIT---ALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~---~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
+||+|+||.||++... +|+.+|+|.+.... .....+.+|..++. ...||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999864 68999999886432 22233445544443 3479999999999999899999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+|||+++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~- 152 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc-
Confidence 99999988643 468999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
....||..|+|||.+.+ ..++.++|||||||++|+|++|+.||..........+... . ......+.
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---~-------~~~~~~~~ 219 (279)
T cd05633 153 ---HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---T-------LTVNVELP 219 (279)
T ss_pred ---cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH---h-------hcCCcCCc
Confidence 22468999999999874 4589999999999999999999999976543221111100 0 00111121
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLKL 603 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~~ 603 (678)
......+..++..||+.+|.+|| ++.++++.
T Consensus 220 ----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 220 ----DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ----cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 12234566777999999999999 59888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=327.90 Aligned_cols=201 Identities=20% Similarity=0.234 Sum_probs=161.5
Q ss_pred hcCCCCceeecccCceEEEEEEeC--CCCEEEE------------------EEeCCChHHHHHHHHHHHHHHhcCCCCee
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP--DGKELAV------------------KILKPSEDVLKEFASEIEIITALHHRNII 389 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~--~g~~vAv------------------K~l~~~~~~~~~~~~Ei~il~~l~HpnIv 389 (678)
.++|...+.||+|+||+||++... .+...++ |.++........+.+|++++.+++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998643 2222222 22223334556788999999999999999
Q ss_pred eEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC
Q 041755 390 SLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD 468 (678)
Q Consensus 390 ~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~-~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~ 468 (678)
++++++...+..|+|++++ .++|.+++..... ........+...|+.||+.||.|||+ ++||||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence 9999999999999999998 5677777654321 11223456677899999999999999 99999999999999999
Q ss_pred CCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCC
Q 041755 469 DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPI 535 (678)
Q Consensus 469 ~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf 535 (678)
++.+||+|||+++.+....... .....||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9999999999998775433222 22367999999999999999999999999999999999987543
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.10 Aligned_cols=265 Identities=23% Similarity=0.300 Sum_probs=197.8
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC--CeE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITAL-HHRNIISLFGFCFED--NNL 401 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~--~~~ 401 (678)
..++|...+.||+|+||.||+|... +|+.+|||.+.. .......+.+|+.++.++ +||||++++++|... ..+
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888889999999999999875 688999998753 224456678899999999 999999999998653 468
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
++||||+. ++|..++... .+.|..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999996 5998888532 67899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCC---ceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC
Q 041755 482 WLSTSSSH---LTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557 (678)
Q Consensus 482 ~~~~~~~~---~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 557 (678)
........ .......||..|+|||++.+ ..++.++||||||+++|+|++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 76543322 22234578999999998765 457889999999999999999999997654322111111100000000
Q ss_pred --------ccccccCCCCCC------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 --------KVSQLLDPSLDT------DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 --------~~~~l~dp~l~~------~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....+++..... .........+..++..||+.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 000011100000 000112345778889999999999999999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=295.97 Aligned_cols=240 Identities=23% Similarity=0.304 Sum_probs=189.7
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 041755 339 VGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413 (678)
Q Consensus 339 IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 413 (678)
||+|+||+||++... +|+.||+|++.... .....+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999754 78999999986432 3345678899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceec
Q 041755 414 EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCT 493 (678)
Q Consensus 414 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 493 (678)
.+++..... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~ 152 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IK 152 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cc
Confidence 999875432 468999999999999999999999 9999999999999999999999999999886644221 12
Q ss_pred ccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCH
Q 041755 494 DVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDN 573 (678)
Q Consensus 494 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~ 573 (678)
...++..|+|||++.++.++.++|||||||++|+|++|+.||............. ... ... ...+ ..
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~-----~~~--~~~~----~~ 219 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRT-----LEM--AVEY----PD 219 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hcc-----ccc--cccC----Cc
Confidence 3467889999999998889999999999999999999999997654321111000 000 000 0011 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHH
Q 041755 574 DQIERMVLAATLSISRAPTVRPQINL 599 (678)
Q Consensus 574 ~~~~~l~~la~~Cl~~dP~~RPs~~e 599 (678)
.....+..++..||+.+|.+||+..+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCc
Confidence 12344667789999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=316.61 Aligned_cols=243 Identities=22% Similarity=0.365 Sum_probs=198.1
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHH
Q 041755 338 LVGKGGHSHVYRGCLP-DGKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 415 (678)
+||+|.||+||-|++. +...+|||.+... ....+-+..||.+.++|+|.|||+++|.|.+++.+-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999876 4567899988643 3556778899999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec-CCCCcEEeecccccccCCCCCCcee
Q 041755 416 NLHGNKKDGNAF--GWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS-DDFEPQLSDFGLASWLSTSSSHLTC 492 (678)
Q Consensus 416 ~L~~~~~~~~~l--~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~ 492 (678)
.|...- +++ .+...-.+..||++||.|||. +.|||||||-+|||++ -.|.+||+|||.++.+..-.. .+
T Consensus 662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP--~T 733 (1226)
T KOG4279|consen 662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP--CT 733 (1226)
T ss_pred HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCc--cc
Confidence 997432 455 778888999999999999999 9999999999999996 568999999999987654322 22
Q ss_pred cccccCCCCCCcchhccCC--CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 493 TDVAGTFGYLAPEYFMHGK--VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 493 ~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
..+.||..|||||++..|+ |+.++|||||||++.||.||++||........ . +++-|-+. .-..
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---A-----MFkVGmyK------vHP~ 799 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---A-----MFKVGMYK------VHPP 799 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---h-----hhhhccee------cCCC
Confidence 3478999999999998764 88899999999999999999999965432211 1 11111111 1123
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.+.......++++|+..+|.+||++.++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 34555667777889999999999999999985
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=293.00 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=195.7
Q ss_pred cCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|.....||+|.|+.||+... .+|+.+|+|+++.. ....+++.+|+.|-..|+||||++|.+.+.+....|||+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 4566667899999999999754 47999999988643 2456788899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC---CCCcEEeeccccccc
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD---DFEPQLSDFGLASWL 483 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~---~~~~kL~DFGla~~~ 483 (678)
+|.|++|..-+-.+ ..+++...-.++.||+++|.|+|. ++|||||+||.|+||-. .--+||+|||+|..+
T Consensus 91 ~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred cccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999997666432 456788888999999999999999 99999999999999953 345899999999988
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
..+.. -...+|||+|||||++...+|+..+|||+.||+||-||.|++||.+++....-.. +..|.+. +
T Consensus 164 ~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~-------I~~g~yd--~ 231 (355)
T KOG0033|consen 164 NDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQ-------IKAGAYD--Y 231 (355)
T ss_pred CCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHH-------HhccccC--C
Confidence 73322 2347899999999999999999999999999999999999999987543221110 1111111 1
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
++..- ....+....++.+||..||.+|.|+.|.|+
T Consensus 232 ~~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 PSPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CCccc----CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11000 011223344568999999999999998874
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.52 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=196.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS------EDVLKEFASEIEIITALHHRNIISLFGFCFED--NNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 401 (678)
.+|...+.||+|+||.||+|... +|+.||+|++... ......|.+|++++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999864 6899999987432 24456888999999999999999999998764 468
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
++|+||+++++|.+++... ..+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 8999999999999998643 357899999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCC-CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 482 WLSTSSS-HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 482 ~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||........ .... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~----~~~---- 224 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IFKI----ATQ---- 224 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HHHH----HcC----
Confidence 6533211 1112235689999999999988899999999999999999999999975432211 1110 000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
-..+.+ +......+..++..|+. +|..||+..+++.
T Consensus 225 -~~~~~~----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 -PTKPML----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -CCCCCC----CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 001111 22223456667789998 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=300.76 Aligned_cols=265 Identities=23% Similarity=0.328 Sum_probs=197.3
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDN----- 399 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----- 399 (678)
..++|...+.||+|+||.||+|... +|+.||+|+++... .....+.+|+++++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 4578889999999999999999876 68999999986432 33456788999999999999999999987654
Q ss_pred -----eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEE
Q 041755 400 -----NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQL 474 (678)
Q Consensus 400 -----~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL 474 (678)
.+++|+||+++ +|...+... ...+++..++.++.|++.||.|||+ .+|+|+||||+||++++++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence 78999999975 777776543 2468999999999999999999999 99999999999999999999999
Q ss_pred eecccccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhh-cc-
Q 041755 475 SDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMW-AK- 551 (678)
Q Consensus 475 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~-~~- 551 (678)
+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.. ..
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS 236 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999999876543321 1122356788999998865 3578999999999999999999999975443211100000 00
Q ss_pred ------cccccCccccccCC------CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 552 ------PILKDGKVSQLLDP------SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 552 ------~~~~~~~~~~l~dp------~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.+.........++ .+...+. .....+.+++..||+.+|.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-FIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CChhhcccccccccccccccccccccchhhhcC-CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00000000000000 0000000 11345778889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=294.93 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=197.2
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 041755 339 VGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413 (678)
Q Consensus 339 IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 413 (678)
||.|+||.||++... +|+.+++|++.... .....+.+|++++.+++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999876 59999999987543 4567789999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC-----
Q 041755 414 EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS----- 488 (678)
Q Consensus 414 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~----- 488 (678)
.+++... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999653 368999999999999999999999 9999999999999999999999999999886544321
Q ss_pred -CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 489 -HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 489 -~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
........++..|+|||.+.....+.++||||||+++|+|++|..||........... .. .+... .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~------~~-~~~~~------~ 220 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN------IL-NGKIE------W 220 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH------Hh-cCCcC------C
Confidence 1122335688899999999988899999999999999999999999976543221110 00 01110 0
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
.. .......+..++..||+.+|..||++..+.+.|+
T Consensus 221 ~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 221 PE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred Cc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00 0001355677889999999999999977766664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=288.81 Aligned_cols=246 Identities=28% Similarity=0.456 Sum_probs=202.2
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+|...+.||+|++|.||++... +++.|++|.+.... .....+.+|++++++++|||++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999865 68899999987643 4667899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998643 468999999999999999999998 999999999999999999999999999998776543
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
.. .....|+..|+|||++.+..++.++|||+||+++|+|++|+.||....... ..|... . .. .+.+
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~~~~~~--~-~~-----~~~~ 219 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----ALFRIV--Q-DD-----HPPL 219 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----HHHHHh--c-cC-----CCCC
Confidence 32 223568999999999988888999999999999999999999997543211 111100 0 00 0111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.......+..++..||..+|++||++.+++.
T Consensus 220 ----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 220 ----PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1112345667789999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=292.21 Aligned_cols=259 Identities=21% Similarity=0.303 Sum_probs=195.2
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhc---CCCCeeeEEEEEEeCCe-----
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITAL---HHRNIISLFGFCFEDNN----- 400 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~~~----- 400 (678)
|...+.||+|+||.||+|... +++.||+|+++.. ......+.+|+.++.++ .||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 556788999999999999976 5899999999743 23345567788877766 59999999999988776
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
.+++|||+. ++|.+++..... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 999999996 589888865322 358999999999999999999999 89999999999999999999999999999
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc-
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV- 559 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~- 559 (678)
..+...... ....++..|+|||++.+..++.++|||||||++|||++|.+||.......... .+.......+..
T Consensus 155 ~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD--KIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH--HHHHHcCCCChHh
Confidence 876443221 22457889999999999999999999999999999999999997654322110 000000000000
Q ss_pred --------ccccCCCCCC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 560 --------SQLLDPSLDT---DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 560 --------~~l~dp~l~~---~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
...+...... ....+....+..++..||+.+|.+||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 011122355677889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.52 Aligned_cols=265 Identities=22% Similarity=0.322 Sum_probs=199.4
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCeE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFE----DNNL 401 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~ 401 (678)
.++|...+.||+|+||.||+|... +|+.||+|++.... .....+.+|+.+++.++||||+++++++.. ...+
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 368888999999999999999865 69999999987532 345677889999999999999999998753 3568
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
++||||+. |+|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 6898888543 458999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCC--ceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccc------
Q 041755 482 WLSTSSSH--LTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP------ 552 (678)
Q Consensus 482 ~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~------ 552 (678)
........ .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...+.......+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 76443221 11123578999999999866 4689999999999999999999999976543221111000000
Q ss_pred --ccccCccccccCCCC-CCCC-----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 553 --ILKDGKVSQLLDPSL-DTDY-----DNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 553 --~~~~~~~~~l~dp~l-~~~~-----~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
......+...++..- .... .......+..++..||+.+|.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000011111111000 0000 0122456788889999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=308.72 Aligned_cols=263 Identities=21% Similarity=0.307 Sum_probs=198.1
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----Ce
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFED-----NN 400 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 400 (678)
.++|...+.||+|+||.||+|... +|+.||||.+... ......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467888999999999999999864 6899999998642 23456778899999999999999999988644 35
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
.++||||+. ++|.+++... ..+++.....++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 899999995 7898888532 468999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcc--------
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK-------- 551 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~-------- 551 (678)
........ ......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||...+............
T Consensus 156 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKGD--FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCcc--cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 87654321 1223567899999998865 468999999999999999999999997653221111000000
Q ss_pred cccccCcccccc-------CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 552 PILKDGKVSQLL-------DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 552 ~~~~~~~~~~l~-------dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
..+..+.....+ ++.+... .......+.+++.+||+.+|.+||++.++++-
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARL-FPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHH-cccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000001111000 0000000 11223557788899999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=297.06 Aligned_cols=261 Identities=20% Similarity=0.283 Sum_probs=199.7
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
|...+.||.|++|.||+|... +|+.+++|.++... .....+.+|+++++.++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456678999999999999875 78999999987542 34677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++ +|..++.... ..+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 64 8888876432 468999999999999999999999 9999999999999999999999999999987755431
Q ss_pred CceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC---
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD--- 564 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d--- 564 (678)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+......................+.+
T Consensus 154 --~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 154 --PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred --cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 12235678899999999876 789999999999999999999999976543221110000000000000000000
Q ss_pred ------CCCC----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 ------PSLD----TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 ------p~l~----~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+... ..........+..++..||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0011223456778899999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=295.29 Aligned_cols=204 Identities=25% Similarity=0.357 Sum_probs=180.3
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...++||+|.||+|.+++.+ .|+.||||+++.. ++....-+.|-++|...+||.+..|...|+..+++|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 56777888999999999999865 7999999999863 455666788999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||..||.|+-+|... ..|++...+.+..+|+.||.|||+ ++||+||||.+|+|||.+|++||+||||++---
T Consensus 248 eyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 248 EYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc-
Confidence 999999999888653 568888888899999999999999 999999999999999999999999999987432
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCccc
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQ 543 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~ 543 (678)
....++...+||+.|+|||++....|...+|+|.+||++|||++|+.||...+....
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL 376 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL 376 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH
Confidence 223344568999999999999999999999999999999999999999987665443
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=299.19 Aligned_cols=258 Identities=16% Similarity=0.207 Sum_probs=184.6
Q ss_pred cCCCCceeecccCceEEEEEEeCC----CCEEEEEEeCCChH-H-----------HHHHHHHHHHHHhcCCCCeeeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPD----GKELAVKILKPSED-V-----------LKEFASEIEIITALHHRNIISLFGF 394 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~----g~~vAvK~l~~~~~-~-----------~~~~~~Ei~il~~l~HpnIv~l~g~ 394 (678)
++|...++||+|+||.||+|...+ +..+|+|+...... . ......++..+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578889999999999999998654 45677776432211 0 1122334445566789999999998
Q ss_pred EEeCC----eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC
Q 041755 395 CFEDN----NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF 470 (678)
Q Consensus 395 ~~~~~----~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~ 470 (678)
+.... ..+++++++. .++.+.+... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCC
Confidence 76543 3467788773 4666665432 235788889999999999999999 9999999999999999999
Q ss_pred CcEEeecccccccCCCCCC-----ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCccccc
Q 041755 471 EPQLSDFGLASWLSTSSSH-----LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQES 545 (678)
Q Consensus 471 ~~kL~DFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~ 545 (678)
.++|+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~- 242 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL- 242 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH-
Confidence 9999999999876432211 1112346999999999999999999999999999999999999999866332211
Q ss_pred chhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 546 LVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 546 l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
+...+ .+.+..+..+.+... ...+.+.+++..|+..+|.+||++.++++.|+
T Consensus 243 -~~~~~----~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 243 -IHAAK----CDFIKRLHEGKIKIK---NANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred -HHHhH----HHHHHHhhhhhhccC---CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 10000 000011111111111 11345667789999999999999999999873
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=308.31 Aligned_cols=267 Identities=21% Similarity=0.334 Sum_probs=198.0
Q ss_pred ccHHHHHHhh----cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEE
Q 041755 321 FSYQELLSAT----SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLF 392 (678)
Q Consensus 321 f~~~el~~~t----~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~ 392 (678)
|+.+|+.+++ ++|...+.||+|+||.||+|... +|+.||||++... ......+.+|+.+++.++||||++++
T Consensus 1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 80 (342)
T cd07879 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80 (342)
T ss_pred CchhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchh
Confidence 4455655554 78999999999999999999864 7899999998642 23446688999999999999999999
Q ss_pred EEEEeC------CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe
Q 041755 393 GFCFED------NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL 466 (678)
Q Consensus 393 g~~~~~------~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl 466 (678)
+++... ...++|+||+. .+|...+. ..+++..+..++.|++.||.|||+ .+++||||||+|||+
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll 150 (342)
T cd07879 81 DVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAV 150 (342)
T ss_pred heecccccCCCCceEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEE
Confidence 998654 35699999995 47766552 358899999999999999999999 999999999999999
Q ss_pred cCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCccccc
Q 041755 467 SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQES 545 (678)
Q Consensus 467 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~ 545 (678)
+.++.++|+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+......
T Consensus 151 ~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~ 225 (342)
T cd07879 151 NEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 225 (342)
T ss_pred CCCCCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999988653321 23467889999999876 468899999999999999999999998654322111
Q ss_pred chhhcccc--------cccCccccccC--CCC-CCCCC---HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 546 LVMWAKPI--------LKDGKVSQLLD--PSL-DTDYD---NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 546 l~~~~~~~--------~~~~~~~~l~d--p~l-~~~~~---~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+...... +........+. +.. ..... ......+.+++..||+.+|.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 226 QILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11110000 00000000000 000 00000 011235678889999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.94 Aligned_cols=243 Identities=21% Similarity=0.281 Sum_probs=189.7
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEI-ITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~i-l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
+.||+|+||.||+|... +|+.||||+++... .....+..|..+ ...+.|||++++++++.+++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 35899999999999864 68999999987532 223344555544 4456899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 9999998643 458899999999999999999999 9999999999999999999999999999875433
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||...+........ ..+... ..+..
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~--~~~~~--- 216 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI-------LSRRIN--WPEEV--- 216 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HhcccC--CCCcc---
Confidence 12356889999999998888999999999999999999999999765432211100 000000 00001
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
.......+..++..||+.+|.+||++..+.++|.
T Consensus 217 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 -KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred -cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1122355778889999999999998877766654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=300.70 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=192.7
Q ss_pred eeccc--CceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 041755 338 LVGKG--GHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRG 411 (678)
Q Consensus 338 ~IG~G--~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 411 (678)
.||+| +||+||++... +|+.||||++... ....+.+.+|+.+++.++||||++++++|..++..++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 35666 99999999864 7999999998743 344578889999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc-
Q 041755 412 SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL- 490 (678)
Q Consensus 412 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~- 490 (678)
+|.+++..... ..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++++|||.+..........
T Consensus 85 ~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 85 SANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999875432 358899999999999999999998 999999999999999999999999998654332211110
Q ss_pred ----eecccccCCCCCCcchhccC--CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccc-------cc---
Q 041755 491 ----TCTDVAGTFGYLAPEYFMHG--KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP-------IL--- 554 (678)
Q Consensus 491 ----~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~-------~~--- 554 (678)
......++..|+|||++.++ .++.++|||||||++|||++|+.||................+ ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 00112356679999999764 478999999999999999999999976542211100000000 00
Q ss_pred -----------c---------cCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 555 -----------K---------DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 555 -----------~---------~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
. .+......+..+...........+..++..||+.+|.+|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 00000111111122222334567888999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=301.22 Aligned_cols=245 Identities=19% Similarity=0.339 Sum_probs=205.3
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
=|..++.||+|-|..|-+|+.- .|..||||++... .-....+.+|++.|+-++|||||+||++......+|||.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3556667999999999999754 8999999999754 34567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe-cCCCCcEEeecccccccCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL-SDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl-~~~~~~kL~DFGla~~~~~~ 486 (678)
=.+|+|++++... ...+.+....+++.||+.|+.|+|+ ..+|||||||+||.+ ..-|-+||+|||++..+.++
T Consensus 99 GD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999754 3568899999999999999999999 899999999999976 56688999999999887765
Q ss_pred CCCceecccccCCCCCCcchhccCCCC-ccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVS-EKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
..- +..+|++.|-|||++.+..|+ +++||||||||||.|++|+.||...+..+....+ +|-
T Consensus 173 ~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------------mDC 234 (864)
T KOG4717|consen 173 KKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------------MDC 234 (864)
T ss_pred chh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---------------hcc
Confidence 543 347899999999999999987 5799999999999999999999876654332222 222
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+. .+......+..++..||..||.+|-+.++|+.
T Consensus 235 KYt--vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 KYT--VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccc--CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 221 23344566778889999999999999999874
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=297.34 Aligned_cols=257 Identities=25% Similarity=0.293 Sum_probs=191.8
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHH
Q 041755 338 LVGKGGHSHVYRGCLPDGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLE 414 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 414 (678)
.+|.|+++.||++.. +|+.||||+++.. ......+.+|+++++.++||||+++++++.+.+..+++|||+++|+|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 345556666666655 7999999998643 355678999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC-----C
Q 041755 415 ENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS-----H 489 (678)
Q Consensus 415 ~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~-----~ 489 (678)
+++.... ...+++.....++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||.+..+..... .
T Consensus 88 ~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 88 DLLKTHF--PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 9997542 2458899999999999999999999 9999999999999999999999999999876543211 1
Q ss_pred ceecccccCCCCCCcchhcc--CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhc----ccccccC------
Q 041755 490 LTCTDVAGTFGYLAPEYFMH--GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA----KPILKDG------ 557 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~----~~~~~~~------ 557 (678)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||........ +.... ...+...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhc
Confidence 11223457889999999876 3588999999999999999999999976432211 00000 0000000
Q ss_pred -cccc----ccCCCCC----CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 -KVSQ----LLDPSLD----TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 -~~~~----l~dp~l~----~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.... ..++... ..........+..++..||+.+|.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 1111111 1112223356777889999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=308.19 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=206.8
Q ss_pred CCCceeecccCceEEEEEEeC---CC--CEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP---DG--KELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~---~g--~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
....++||.|-||.||+|... .| -.||||.-+.+ .+..+.|+.|.-+++++.|||||+|+|+|.+. ..++||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 345678999999999999743 23 35789988763 35678999999999999999999999999874 679999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
|.++-|.|..+|..++ ..++......++.||+.||.|||+ ..+|||||...|||+...-.+||+||||++++.+
T Consensus 470 EL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred ecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 9999999999998653 578888999999999999999999 9999999999999999999999999999999988
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
....... ...-..-|||||.+....++.++|||.|||++||++. |.+||.+-...+. .-.++.|.-
T Consensus 544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-------I~~iEnGeR----- 610 (974)
T KOG4257|consen 544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-------IGHIENGER----- 610 (974)
T ss_pred cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-------EEEecCCCC-----
Confidence 6654433 2334567999999999999999999999999999987 9999986543321 112333321
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
...++.+...+..+...||..+|.+||.+.++...|...
T Consensus 611 ----lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 611 ----LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred ----CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 112344556677888999999999999999999888754
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=292.50 Aligned_cols=240 Identities=23% Similarity=0.324 Sum_probs=186.1
Q ss_pred eecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHH---HHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 338 LVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIE---IITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~---il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
+||+|+||.||++... +|+.||+|++.... .....+..|.. ++....||||+.+++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999864 68999999886432 22223444444 4444679999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+|+|.+++... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~- 152 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP- 152 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC-
Confidence 99999988532 468999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
....|+..|+|||++.++ .++.++|||||||++|||++|+.||............. . . ....+.+.
T Consensus 153 ---~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~---~------~~~~~~~~ 219 (278)
T cd05606 153 ---HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-M---T------LTMAVELP 219 (278)
T ss_pred ---cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-H---h------hccCCCCC
Confidence 234689999999999755 68999999999999999999999997653322111100 0 0 00111121
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLK 602 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~ 602 (678)
.. ....+..++..|+..+|.+|| ++.++++
T Consensus 220 ~~----~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 220 DS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred Cc----CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 11 134566777999999999999 8989875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.15 Aligned_cols=261 Identities=21% Similarity=0.299 Sum_probs=196.9
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
|...+.||+|+||.||+|... +++.|+||.+.... .......+|+..+.+++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 556788999999999999875 58899999986532 22334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
+|+|.+++.... +..+++.++..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889999887542 3568999999999999999999999 9999999999999999999999999999986654322
Q ss_pred CceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccch----------hhcccccccC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV----------MWAKPILKDG 557 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~----------~~~~~~~~~~ 557 (678)
. ....|+..|+|||++.. ..++.++|+||||++++||++|+.||............ .|........
T Consensus 155 ~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 Y---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred c---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 1 23568889999998854 45789999999999999999999999765432211000 0100000000
Q ss_pred ccccccCCCCCC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 KVSQLLDPSLDT---DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ~~~~l~dp~l~~---~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+...+...... .........+..++..||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 011000000000 000111356788899999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=294.53 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=202.3
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...+.||+|+||.||+|... +|+.||+|++... ......+.+|++++.++. ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999875 7999999998752 344577889999999999 99999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++++|.+++... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999643 369999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCC------------------ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccc
Q 041755 485 TSSSH------------------LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESL 546 (678)
Q Consensus 485 ~~~~~------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l 546 (678)
..... .......|+..|+|||.+....++.++||||||+++++|++|+.||........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--- 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--- 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---
Confidence 43321 112235678999999999988899999999999999999999999976542110
Q ss_pred hhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCH----HHHHH
Q 041755 547 VMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQI----NLVLK 602 (678)
Q Consensus 547 ~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~----~eVl~ 602 (678)
.. ... . ....+.......+..++..||+.+|.+||++ .++++
T Consensus 231 ~~---~~~-~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQ---KIL-K----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH---HHH-h----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00 000 0 0001111224557788899999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=299.86 Aligned_cols=265 Identities=18% Similarity=0.283 Sum_probs=195.9
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC------
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDN------ 399 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 399 (678)
.++|...+.||+|+||.||+|... +++.+|||++.... .....+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999865 68999999885421 22346778999999999999999999875433
Q ss_pred --eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeec
Q 041755 400 --NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDF 477 (678)
Q Consensus 400 --~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DF 477 (678)
.+++||||+. ++|...+... ...+++..+..++.|+++||.|||+ .+|+|+||||+|||+++++.++|+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcC
Confidence 4699999996 4677777542 2468999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCC---------ceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccch
Q 041755 478 GLASWLSTSSSH---------LTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV 547 (678)
Q Consensus 478 Gla~~~~~~~~~---------~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~ 547 (678)
|++......... ...+...|++.|+|||++.+. .++.++|||||||++|||++|+.||...+.......+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999866443221 112335678899999988654 5889999999999999999999999765543211111
Q ss_pred hhcccccccC------ccccc--------cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 548 MWAKPILKDG------KVSQL--------LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 548 ~~~~~~~~~~------~~~~l--------~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.......... .+... ..+.+...+ ......+.+++..||+.+|.+||++.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1000000000 00000 001000000 111256778899999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.45 Aligned_cols=251 Identities=26% Similarity=0.424 Sum_probs=193.8
Q ss_pred cCCCCceeecccCceEEEEEEeCC-CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPD-GKELAVKILKPS--EDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~-g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|...+.||+|+||.||+|..++ |+.||||+++.. ......+..|+.++..+. ||||++++++|.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567788999999999999999864 899999998753 244566777888777775 9999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+. ++|.+.+... ...+++..+..++.|++.||.|||+ ..+|+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 984 5777766432 2478999999999999999999996 158999999999999999999999999998766443
Q ss_pred CCCceecccccCCCCCCcchhccCC----CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGK----VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
... ....++..|+|||++.... ++.++||||||+++|+|++|+.||...... .+.+.. .+... .
T Consensus 169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~----~~~~~-~--- 236 (296)
T cd06618 169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTK----ILQEE-P--- 236 (296)
T ss_pred Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHH----HhcCC-C---
Confidence 222 2245788999999987543 789999999999999999999999653221 111111 11110 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
+.+.. .......+..++..||+.+|.+||++.++++.
T Consensus 237 --~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 --PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred --CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 00123457778899999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.63 Aligned_cols=202 Identities=25% Similarity=0.350 Sum_probs=180.8
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
.+.|..-++||+||||.||-.... +|+.||+|.+... +....-.++|-.||.+++.+.||.|-..|...+.+|||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 367888999999999999988654 7999999988543 24455678899999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
+..|.||+|.-+|.... +..|+++....++.+|+.||++||+ .+||+||+||+|||||+.|+++|+|.|||.-++
T Consensus 264 LtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999887653 3679999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 539 (678)
.+.... ..+||.||||||+++++.|+...|+|||||+||||+.|+.||....
T Consensus 339 ~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 339 EGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred CCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 765443 3589999999999999999999999999999999999999997543
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.21 Aligned_cols=246 Identities=26% Similarity=0.458 Sum_probs=192.9
Q ss_pred eeecccCceEEEEEEeC-CCCEEE---EEEe--CCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe--EEEEEEcC
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELA---VKIL--KPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNN--LLLVYDFL 408 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vA---vK~l--~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~--~~lV~E~~ 408 (678)
.+||+|+|-+||+|.+. +|..|| ||+- ..+....+.|..|+.+|+.|+||||++++.++.+..+ ..+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 35999999999999875 688886 3322 2345667899999999999999999999999987654 88999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC-CCcEEeecccccccCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD-FEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~-~~~kL~DFGla~~~~~~~ 487 (678)
..|+|..|+.+.+ .+.......|+.||++||.|||+ ...+|||||||.+||+|+.+ |.+||+|+|||.......
T Consensus 126 TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 126 TSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred cCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999997664 46778999999999999999997 45799999999999999865 899999999999876543
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
. ..+.|||.|||||++. ..|++.+||||||++|+||+|+.+||..-....+ +...+..-++...+..+-|
T Consensus 201 a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ--IYKKV~SGiKP~sl~kV~d--- 270 (632)
T KOG0584|consen 201 A----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ--IYKKVTSGIKPAALSKVKD--- 270 (632)
T ss_pred c----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH--HHHHHHcCCCHHHhhccCC---
Confidence 2 3479999999999986 7899999999999999999999999964332221 1111111111112222222
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH--HhhcC
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK--LLQGD 607 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~--~L~~~ 607 (678)
. .+.+++-.||.. ..+||++.|+|+ +|..+
T Consensus 271 ------P---evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 271 ------P---EVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ------H---HHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 2 244566899998 999999999995 45443
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=302.95 Aligned_cols=264 Identities=22% Similarity=0.273 Sum_probs=194.8
Q ss_pred cCCC-CceeecccCceEEEEEEeC-CCCEEEEEEeCCChHH---------------HHHHHHHHHHHHhcCCCCeeeEEE
Q 041755 331 SNFL-PEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDV---------------LKEFASEIEIITALHHRNIISLFG 393 (678)
Q Consensus 331 ~~f~-~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~---------------~~~~~~Ei~il~~l~HpnIv~l~g 393 (678)
++|. ..+.||.|+||.||+|... +|+.||||+++..... ...+.+|+++++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 3567999999999999865 7899999998643211 125789999999999999999999
Q ss_pred EEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcE
Q 041755 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ 473 (678)
Q Consensus 394 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~k 473 (678)
++..++..++||||+. |+|.+++... ..+++.....++.|++.||.|||+ .+++|+||||+|||++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEE
Confidence 9999999999999996 6899888532 458899999999999999999999 9999999999999999999999
Q ss_pred EeecccccccCCCCC------------CceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCC
Q 041755 474 LSDFGLASWLSTSSS------------HLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENP 540 (678)
Q Consensus 474 L~DFGla~~~~~~~~------------~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 540 (678)
|+|||++........ ........+++.|+|||++.+. .++.++|||||||++|||++|+.||...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999987652110 1111224568899999998764 468999999999999999999999986654
Q ss_pred cccccchhhcccccccCccccc--------cCCCCCCC---CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 541 KGQESLVMWAKPILKDGKVSQL--------LDPSLDTD---YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 541 ~~~~~l~~~~~~~~~~~~~~~l--------~dp~l~~~---~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
......+...........+... +.+..... ........+.+++..||+.+|.+||++.+++.
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 3211100000000000000000 00000000 00112345677889999999999999999986
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=295.36 Aligned_cols=242 Identities=26% Similarity=0.411 Sum_probs=194.5
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHH
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLE 414 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 414 (678)
..||+|+||.||++... +|..||||.+.... .....+.+|+.+++.++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 46899999999999874 78999999886433 45667899999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceecc
Q 041755 415 ENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD 494 (678)
Q Consensus 415 ~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 494 (678)
+++.. ..+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......... ...
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~~~ 175 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKS 175 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--ccc
Confidence 98743 347899999999999999999999 89999999999999999999999999998766443221 123
Q ss_pred cccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHH
Q 041755 495 VAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDND 574 (678)
Q Consensus 495 ~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~ 574 (678)
..|++.|+|||++.+..++.++|+||||+++|+|++|..||............. . .+.+.+.. ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~-------~-----~~~~~~~~--~~~ 241 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------D-----NLPPKLKN--LHK 241 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------h-----hCCcccCC--ccc
Confidence 568999999999988889999999999999999999999997643321111000 0 01111110 001
Q ss_pred HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 575 QIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 575 ~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....+..++.+||+.+|.+||++.++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 1234566779999999999999999886
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=295.09 Aligned_cols=242 Identities=26% Similarity=0.426 Sum_probs=192.4
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
|...+.||+|+||.||+|... +|..|++|++... ......+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555677999999999999864 6889999998632 24456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+. |+|.+.+... ...+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 6787777532 2468999999999999999999999 9999999999999999999999999999864322
Q ss_pred CCceecccccCCCCCCcchhc---cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
.....|+..|+|||++. .+.++.++|||||||++|+|++|..||...+......... . ...
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~------~-~~~----- 237 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------Q-NDS----- 237 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH------h-cCC-----
Confidence 12356899999999984 4668899999999999999999999997654322111000 0 001
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+... .......+..++..||+.+|.+||++.+++.
T Consensus 238 ~~~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 238 PTLQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 1111234667789999999999999999995
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=293.76 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=199.0
Q ss_pred CCCCceeecccCceEEEEEEe----CCCCEEEEEEeCCCh-----HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCL----PDGKELAVKILKPSE-----DVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~----~~g~~vAvK~l~~~~-----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 401 (678)
+|...+.||+|+||.||++.. .+++.||||+++... ...+.+..|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 466778999999999999874 357899999987432 3456788999999999 599999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
++||||+++|+|.+++... ..+++.....++.|+++||.|||+ .+++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 9999999999999998642 458899999999999999999998 999999999999999999999999999988
Q ss_pred ccCCCCCCceecccccCCCCCCcchhccCC--CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc
Q 041755 482 WLSTSSSHLTCTDVAGTFGYLAPEYFMHGK--VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559 (678)
Q Consensus 482 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 559 (678)
......... .....|+..|+|||.+.+.. .+.++||||||+++|||++|..||......... ..........
T Consensus 154 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~~~~--- 227 (288)
T cd05583 154 EFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRILKS--- 227 (288)
T ss_pred ccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHHHcc---
Confidence 765432221 12356899999999987765 788999999999999999999999654322111 0111111110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 560 SQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 560 ~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.+.....+ ...+..++..||+.+|..|||+.++.+.|+.
T Consensus 228 ----~~~~~~~~----~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ----KPPFPKTM----SAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----CCCCCccc----CHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11111111 2345667799999999999999999888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=292.66 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=194.6
Q ss_pred CCCCceeecccCceEEEEEEe----CCCCEEEEEEeCCCh-----HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCL----PDGKELAVKILKPSE-----DVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~----~~g~~vAvK~l~~~~-----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 401 (678)
+|...+.||+|+||.||++.. .+|..||+|+++... ...+.+..|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999975 378999999987532 2346788899999999 599999999999998999
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
++||||+++++|.+++... ..+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 9999999999999998643 457889999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCceecccccCCCCCCcchhccC--CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc
Q 041755 482 WLSTSSSHLTCTDVAGTFGYLAPEYFMHG--KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559 (678)
Q Consensus 482 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 559 (678)
........ ......|+..|+|||++..+ .++.++||||||+++|+|++|+.||........ ...+.......
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~--- 227 (290)
T cd05613 154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS--- 227 (290)
T ss_pred eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc---
Confidence 76443222 11235689999999998753 468899999999999999999999975332211 11111111110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041755 560 SQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLK 602 (678)
Q Consensus 560 ~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~ 602 (678)
.+. +.......+..++..||+.+|.+|| ++.+++.
T Consensus 228 ----~~~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 228 ----EPP----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----CCC----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 011 1112234566788999999999997 5566654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=295.91 Aligned_cols=243 Identities=28% Similarity=0.409 Sum_probs=193.1
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCC----ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP----SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
|...+.||+|+||.||+|... ++..+|+|.+.. .......+.+|+++++.++|+|++++++++...+..++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 555667999999999999865 688999998853 234456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+. |+|.+.+... ...+++.++..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||++......
T Consensus 97 ~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 97 CL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred cC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 96 6888777533 2458899999999999999999999 99999999999999999999999999998765432
Q ss_pred CCceecccccCCCCCCcchhc---cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
....|++.|+|||++. .+.++.++|||||||++|+|++|..||.......... .+. .+..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~-----~~~~----- 231 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIA-----QNES----- 231 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--HHh-----hcCC-----
Confidence 2346889999999984 3568889999999999999999999986543221110 000 0000
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
+... .......+..++.+||+.+|.+||++.++++.
T Consensus 232 ~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 232 PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred CCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 1111 11223446677899999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=290.88 Aligned_cols=249 Identities=21% Similarity=0.378 Sum_probs=195.7
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC------ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP------SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~------~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
+|...+.||+|+||.||++... .+..+++|+++. .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4777889999999999999764 345566666543 123345677899999999999999999999998999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++++|.+++......+..+++..++.++.|++.||.|||+ .+++|+||||+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999987654445679999999999999999999999 99999999999999976 569999999988764
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
.... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||....... . ..... .+. .
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~---~---~~~~~-~~~-----~ 222 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS---V---VLRIV-EGP-----T 222 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---H---HHHHH-cCC-----C
Confidence 4322 1123568899999999988889999999999999999999999996433211 0 00010 011 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.+ .......+..++.+||+.+|.+||++.++++
T Consensus 223 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PSL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111 1223345677889999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=313.40 Aligned_cols=201 Identities=30% Similarity=0.467 Sum_probs=173.3
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------CeEEE
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFED------NNLLL 403 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~~~l 403 (678)
|.....||+||||.||+|+.+ .|+.||||.++.. ....+...+|+++|++|+|||||+++++-.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445567999999999999954 7999999999763 24456778999999999999999999876543 35689
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec--CCC--CcEEeeccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS--DDF--EPQLSDFGL 479 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~--~~~--~~kL~DFGl 479 (678)
|||||.+|+|...|... .+...+++.+.+.+...++.||.|||. ++|+||||||.||++- ++| .-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999765 445679999999999999999999998 9999999999999984 334 369999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCC
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENP 540 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 540 (678)
|+-++++. .++.++||..|++||++.. +.|+..+|.|||||++|+..||..||.....
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 99887765 4456899999999999984 8899999999999999999999999976543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=292.90 Aligned_cols=245 Identities=23% Similarity=0.360 Sum_probs=205.2
Q ss_pred CceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 041755 335 PEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413 (678)
Q Consensus 335 ~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 413 (678)
+...||+|.||.||++..+ .|+.+|||.+... ...++++.|+.|+.+...|++|++||.|.....+++|||||..|++
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 3456899999999999865 7999999998654 4567899999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceec
Q 041755 414 EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCT 493 (678)
Q Consensus 414 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 493 (678)
.+.+..+ +.++.+.++..++...+.||+|||. ..-||||||..||||+.+|++||+|||.|..+.+... ...
T Consensus 116 SDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--KRN 187 (502)
T KOG0574|consen 116 SDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--KRN 187 (502)
T ss_pred HHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--hhC
Confidence 9999754 3689999999999999999999999 7889999999999999999999999999987755322 123
Q ss_pred ccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCH
Q 041755 494 DVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDN 573 (678)
Q Consensus 494 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~ 573 (678)
.+.||+.|||||++..-.|+.++||||||++..||.-|++||.+..+....-. +.... -|.+ .-++
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------IPT~P-----PPTF--~KPE 253 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------IPTKP-----PPTF--KKPE 253 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------ccCCC-----CCCC--CChH
Confidence 47899999999999999999999999999999999999999987765432111 11100 0111 1234
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 574 DQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 574 ~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.....+..++..||-..|++|-|+-++++
T Consensus 254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 254 EWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 55667888889999999999999988775
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=328.89 Aligned_cols=253 Identities=27% Similarity=0.456 Sum_probs=192.5
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-------
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFED------- 398 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------- 398 (678)
-.++|....+||+||||.||+++.+ ||+.||||++.-. ......+.+|+.+|++|+|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3456777788999999999999977 9999999988654 56677889999999999999999998654320
Q ss_pred --------------------------------------------------------------------------------
Q 041755 399 -------------------------------------------------------------------------------- 398 (678)
Q Consensus 399 -------------------------------------------------------------------------------- 398 (678)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 041755 399 --------------------------------NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYL 446 (678)
Q Consensus 399 --------------------------------~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yL 446 (678)
..+|+-||||+..+|.+++..+.... .-...|+++.+|++||.|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHH
Confidence 11578899999888888886543211 4567899999999999999
Q ss_pred HhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC----------------CCCCCceecccccCCCCCCcchhccC
Q 041755 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS----------------TSSSHLTCTDVAGTFGYLAPEYFMHG 510 (678)
Q Consensus 447 H~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~----------------~~~~~~~~~~~~Gt~~Y~APE~l~~~ 510 (678)
|+ +|||||||||.||+|++++.+||+|||+|.... .+......|..+||.-|+|||++.+.
T Consensus 714 H~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred Hh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99 999999999999999999999999999998721 11222244567999999999999764
Q ss_pred ---CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcc
Q 041755 511 ---KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSI 587 (678)
Q Consensus 511 ---~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl 587 (678)
.|+.|+|+|||||||+||+. ||...- +....+ .-++.|.+..- .++..+....=..++.+++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL----~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASIL----TNLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHH----HhcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 49999999999999999986 454321 111111 12233433332 1223333444455678999
Q ss_pred cCCCCCCCCHHHHHH
Q 041755 588 SRAPTVRPQINLVLK 602 (678)
Q Consensus 588 ~~dP~~RPs~~eVl~ 602 (678)
+.||.+|||+.++|.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999985
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.36 Aligned_cols=263 Identities=21% Similarity=0.281 Sum_probs=200.6
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----eEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDN-----NLL 402 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 402 (678)
+|...+.||.|+||.||+|... +|+.||||++... ....+.+.+|+++++.++||||+++++++...+ .+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777889999999999999875 5899999998753 345677899999999999999999999998765 789
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+||||+. ++|.+++... ..+++..++.++.+++.||.|||+ .+|+|+||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 5888888543 378999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCC-ceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc-------
Q 041755 483 LSTSSSH-LTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI------- 553 (678)
Q Consensus 483 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~------- 553 (678)
....... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||...+.......+.-....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 7654311 112335688999999999887 7899999999999999999999999776542211111100000
Q ss_pred -cccCccccccCCCC-CCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 554 -LKDGKVSQLLDPSL-DTD-----YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 554 -~~~~~~~~l~dp~l-~~~-----~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.........+...- ... ........+..++.+||+.+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00000000100000 000 00112345677889999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=304.12 Aligned_cols=270 Identities=20% Similarity=0.266 Sum_probs=202.0
Q ss_pred ccccHHHHHHhhcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEE
Q 041755 319 RLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGF 394 (678)
Q Consensus 319 ~~f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~ 394 (678)
+.....++..++++|...+.||+|+||.||+|.. .+|+.||+|+++... ...+.+.+|++++.+++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 4455667778889999999999999999999975 478999999987532 335678899999999999999999998
Q ss_pred EEeC------CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC
Q 041755 395 CFED------NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD 468 (678)
Q Consensus 395 ~~~~------~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~ 468 (678)
+... ...+++++++ +++|.+.+.. ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~ 155 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 155 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcC
Confidence 8643 3468888887 7899887753 358999999999999999999999 99999999999999999
Q ss_pred CCCcEEeecccccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccch
Q 041755 469 DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV 547 (678)
Q Consensus 469 ~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~ 547 (678)
++.+||+|||++...... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+
T Consensus 156 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~ 230 (345)
T cd07877 156 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230 (345)
T ss_pred CCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999998865332 123567899999999866 56889999999999999999999999754432111100
Q ss_pred -hhcc-------cccccCccc---cccCCCCCCCCC---HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 548 -MWAK-------PILKDGKVS---QLLDPSLDTDYD---NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 548 -~~~~-------~~~~~~~~~---~l~dp~l~~~~~---~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.... ..+...... ..+.......+. ......+.+++..|++.+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000 000000000 000000000000 011335678889999999999999998885
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=306.07 Aligned_cols=248 Identities=25% Similarity=0.417 Sum_probs=200.8
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
-+..|.....||+|.|+.|.+|... .|..||||++.+.. .....+.+|++++..|+|||||+|+.+......+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467888899999999999999865 79999999997642 4455689999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+.+|.++++|... ..+.+.....++.|+.+|++|||+ +.|+|||||++||||+.+.++||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999755 345557888899999999999999 999999999999999999999999999999876
Q ss_pred CCCCCceecccccCCCCCCcchhccCCC-CccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
.... ....+|++.|.|||++++..| ++.+|+||+|++||-|+.|..||++.+-+....-+. -|++.
T Consensus 207 ~~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl-------~gk~r--- 273 (596)
T KOG0586|consen 207 YGLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL-------RGKYR--- 273 (596)
T ss_pred cccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe-------eeeec---
Confidence 4332 345899999999999998776 578999999999999999999998765433211110 01110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
+. .+- ...+-.++...|-.+|.+|+++.++.+-
T Consensus 274 ---Ip-~~m---s~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 274 ---IP-FYM---SCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ---cc-cee---echhHHHHHHhhccCccccCCHHHhhhh
Confidence 00 011 1123334466788899999999998863
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=286.74 Aligned_cols=249 Identities=23% Similarity=0.264 Sum_probs=190.4
Q ss_pred HHHHHhhcCCCCceee--cccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 041755 324 QELLSATSNFLPEYLV--GKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDN 399 (678)
Q Consensus 324 ~el~~~t~~f~~~~~I--G~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 399 (678)
.++....++|...+.+ |+|+||.||++... +|..+|+|++....... .|+.....+ +||||+++++++...+
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 3444455666666666 99999999999864 78899999987532111 122222222 6999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC-CcEEeecc
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF-EPQLSDFG 478 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kL~DFG 478 (678)
..++||||+++++|.+++... ..+++.+++.++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 999999999999999999643 378999999999999999999999 8999999999999999998 99999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
++....... ...|+..|+|||++.+..++.++||||||+++|||++|+.||........ ....+....
T Consensus 156 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~----- 223 (267)
T PHA03390 156 LCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ----- 223 (267)
T ss_pred cceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh-----
Confidence 988664322 24688999999999999999999999999999999999999975433211 111111100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ-INLVLK 602 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs-~~eVl~ 602 (678)
.... .........+..++..||+.+|.+||+ +.++++
T Consensus 224 -----~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 -----QKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -----cccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 001122345677779999999999996 688874
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=298.86 Aligned_cols=262 Identities=21% Similarity=0.284 Sum_probs=191.9
Q ss_pred CCCCceeecccCceEEEEEEeC-C--CCEEEEEEeCCC---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC----Ce
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-D--GKELAVKILKPS---EDVLKEFASEIEIITAL-HHRNIISLFGFCFED----NN 400 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~--g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~----~~ 400 (678)
+|...+.||+|+||.||++... . +..||||++... ....+.+.+|++++.++ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4677889999999999999865 3 789999988642 23456788999999999 599999999976432 45
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
.++++||+. ++|.+.+.. ...+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788899885 689988853 2468999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCC--ceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC
Q 041755 481 SWLSTSSSH--LTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557 (678)
Q Consensus 481 ~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 557 (678)
+.+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..................
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 876543221 11223578999999998765 468999999999999999999999997654221110000000000000
Q ss_pred ccccccC---------------CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 KVSQLLD---------------PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ~~~~l~d---------------p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+..+.+ ..+. .........+..++..||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 0000 000011345777889999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.06 Aligned_cols=264 Identities=21% Similarity=0.332 Sum_probs=193.9
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC---------
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFED--------- 398 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--------- 398 (678)
.++|...+.||.|+||.||+|... +|+.||+|.+.... ...+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368888999999999999999865 68999999886543 4557788999999999999999999876543
Q ss_pred -----CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec-CCCCc
Q 041755 399 -----NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS-DDFEP 472 (678)
Q Consensus 399 -----~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~-~~~~~ 472 (678)
...++||||+. ++|.+++.. ..+++...+.++.||+.||.|||+ .+|+||||||+|||++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceE
Confidence 35799999996 589888743 358899999999999999999999 9999999999999997 45678
Q ss_pred EEeecccccccCCCCCCc-eecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhc
Q 041755 473 QLSDFGLASWLSTSSSHL-TCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA 550 (678)
Q Consensus 473 kL~DFGla~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~ 550 (678)
+|+|||++..+....... ......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||...++..........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 999999998654322111 1122467889999998754 56788999999999999999999999765432221111111
Q ss_pred ccccccCccccccC--------CCCCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 551 KPILKDGKVSQLLD--------PSLDTDYD-----NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 551 ~~~~~~~~~~~l~d--------p~l~~~~~-----~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+...........+ ........ ......+.+++..||+.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 11111000000000 00000000 012245667889999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=299.62 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=197.7
Q ss_pred HHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCe
Q 041755 326 LLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFE-DNN 400 (678)
Q Consensus 326 l~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~ 400 (678)
+..++++|...+.||.|+||.||++... +|+.||||++... ....+.+..|++++..++||||++++++|.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3457889999999999999999999865 7999999987532 2345678899999999999999999999865 567
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
.++|+||+ +++|..++.. ..+++.....++.|++.||.|||+ .+|+||||||+|||+++++.++|+|||++
T Consensus 85 ~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccc
Confidence 89999998 6689888753 357888889999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccc-hh--------hc
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESL-VM--------WA 550 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l-~~--------~~ 550 (678)
....... ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||........... .. +.
T Consensus 156 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 230 (328)
T cd07856 156 RIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230 (328)
T ss_pred cccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 7543321 22467889999998766 5689999999999999999999999976543111000 00 00
Q ss_pred ccccccCccccccCCC-CCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 551 KPILKDGKVSQLLDPS-LDTDYDN-----DQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 551 ~~~~~~~~~~~l~dp~-l~~~~~~-----~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....... ..+++... ....... .....+..++..||+.+|.+||++.+++.
T Consensus 231 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 231 NTICSEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred Hhccchh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 00000000 0000011 12356777889999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=287.73 Aligned_cols=260 Identities=21% Similarity=0.319 Sum_probs=198.1
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
|.....||+|+||.||+|... +++.||+|++... ....+.+..|+.+++.++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 445678999999999999876 5999999998764 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
. ++|.+++.... ..+++..++.++.+++.||.|||+ .+|+|+||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 59999997532 468999999999999999999999 9999999999999999999999999999987654322
Q ss_pred CceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccch----------hhcc--ccc-
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV----------MWAK--PIL- 554 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~----------~~~~--~~~- 554 (678)
. .....++..|+|||++... .++.++|||||||++|||++|+.||...........+ .|.. ...
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 T--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred c--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 1 1224567889999999776 7899999999999999999999999765432110000 0000 000
Q ss_pred ccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 555 KDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 555 ~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....+.......... ........+.+++..||..+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000000 00111346788889999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=299.34 Aligned_cols=261 Identities=20% Similarity=0.285 Sum_probs=195.8
Q ss_pred HhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----
Q 041755 328 SATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDN---- 399 (678)
Q Consensus 328 ~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~---- 399 (678)
...++|...+.||+|+||.||+|... +|..||||++... ......+.+|+.+++.++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 35678989999999999999999754 7999999998542 334567889999999999999999999987543
Q ss_pred --eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeec
Q 041755 400 --NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDF 477 (678)
Q Consensus 400 --~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DF 477 (678)
..++||||+ +++|.+++.. ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeec
Confidence 458999999 7799888752 358999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccch-hhcc----
Q 041755 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV-MWAK---- 551 (678)
Q Consensus 478 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~-~~~~---- 551 (678)
|++....... ....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+........ ....
T Consensus 163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 163 GLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9998654322 23467899999999876 45889999999999999999999999765432110000 0000
Q ss_pred ---cccccCccccccC--CCCC-C---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 552 ---PILKDGKVSQLLD--PSLD-T---DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 552 ---~~~~~~~~~~l~d--p~l~-~---~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+.......... +... . .........+..++..|++.+|.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000 0000 0 000111234667889999999999999999885
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=301.95 Aligned_cols=260 Identities=20% Similarity=0.297 Sum_probs=197.3
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe----
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNN---- 400 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~---- 400 (678)
..++|.....||+|+||.||+|... +++.||||++... ....+.+.+|+.+++.+.||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578989999999999999999875 6889999998642 2345677889999999999999999998765544
Q ss_pred --EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecc
Q 041755 401 --LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 401 --~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
.++|+||+ +++|.+++.. ..+++..++.++.|+++||.|||+ .+|+||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 6799998853 358999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccc--
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILK-- 555 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~-- 555 (678)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+........
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 99866432 123467889999999865 4678999999999999999999999976543221110000000000
Q ss_pred ------cCccccccCC---CCCCCCC---HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 556 ------DGKVSQLLDP---SLDTDYD---NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 556 ------~~~~~~l~dp---~l~~~~~---~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
......++.. .....+. ......+.+++..||+.+|.+||++.+|++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000 0000000 012456778889999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=307.37 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=199.8
Q ss_pred CCCCceeecccCceEEEEEEeCC-CCEEEEEEeCC-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLPD-GKELAVKILKP-SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~~-g~~vAvK~l~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
.|.+...||-|+||+||+|..++ +-..|-|++.. ++...++|+-||+||....||+||+|++.|+..+.+++..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 34455678999999999998764 44456787754 55778999999999999999999999999998899999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
||-++..+-. -+..+.+.++..++.|++.||.|||+ +.|||||||..|||++-+|.++|+|||.+..... ..
T Consensus 113 GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~ 184 (1187)
T KOG0579|consen 113 GGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR 184 (1187)
T ss_pred CchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence 9999888764 34679999999999999999999999 9999999999999999999999999999764322 11
Q ss_pred ceecccccCCCCCCcchhcc-----CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 490 LTCTDVAGTFGYLAPEYFMH-----GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
.....+.||+.|||||+.+. .+|+.++||||||++|.||..+.+|....++... ++..++ .....++.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--llKiaK-----SePPTLlq 257 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAK-----SEPPTLLQ 257 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HHHHhh-----cCCCcccC
Confidence 22345789999999998864 5799999999999999999999999876655321 111111 11111221
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+......+..+...||..||..||++.++++
T Consensus 258 -------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 -------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred -------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2233455677789999999999999999885
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=279.87 Aligned_cols=235 Identities=29% Similarity=0.389 Sum_probs=192.0
Q ss_pred ecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 041755 339 VGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL 413 (678)
Q Consensus 339 IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 413 (678)
||.|+||.||++... +++.+|+|+++... .....+..|+.+++.++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999875 58999999987542 3566889999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceec
Q 041755 414 EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCT 493 (678)
Q Consensus 414 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 493 (678)
.+++... ..+++...+.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTN 151 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC--ccc
Confidence 9999643 358999999999999999999999 9999999999999999999999999999887654321 123
Q ss_pred ccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCH
Q 041755 494 DVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDN 573 (678)
Q Consensus 494 ~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~ 573 (678)
...|+..|++||.+.+...+.++|+||||+++|+|++|+.||....... .... ... +. .. ++.
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~---~~~-~~------~~----~~~ 214 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYEK---ILK-DP------LR----FPE 214 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHH---Hhc-CC------CC----CCC
Confidence 3568899999999998889999999999999999999999997544211 1111 000 00 00 111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHH
Q 041755 574 DQIERMVLAATLSISRAPTVRPQINL 599 (678)
Q Consensus 574 ~~~~~l~~la~~Cl~~dP~~RPs~~e 599 (678)
.....+..++..||..+|..||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11345677889999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=278.25 Aligned_cols=260 Identities=26% Similarity=0.405 Sum_probs=200.3
Q ss_pred ceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 041755 336 EYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLVYDFLSRG 411 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~g 411 (678)
...||.|..|.|++.+.. .|..+|||.+... .+..++++..+.++..-+ +|+||+.+|||..+....+.||.|. .
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence 345899999999999865 6899999999753 466788889998887766 9999999999999988899999983 3
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCce
Q 041755 412 SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491 (678)
Q Consensus 412 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 491 (678)
.++.+|... ..++++.-.-++...+..||.||.. .++|||||+||+|||+|+.|++||||||++..+-+...+.
T Consensus 176 C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht- 249 (391)
T KOG0983|consen 176 CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT- 249 (391)
T ss_pred HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccccc-
Confidence 445555432 2578988888999999999999998 5899999999999999999999999999999887665543
Q ss_pred ecccccCCCCCCcchhcc---CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 492 CTDVAGTFGYLAPEYFMH---GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 492 ~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
.-.|-+.|||||.+.- ..|+.++||||||+.|+||.||+.||.+.+.+- +.+.. ++.+ .-|.|.
T Consensus 250 --rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-e~ltk----vln~------ePP~L~ 316 (391)
T KOG0983|consen 250 --RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-EVLTK----VLNE------EPPLLP 316 (391)
T ss_pred --cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-HHHHH----HHhc------CCCCCC
Confidence 3578999999999853 468899999999999999999999998754321 11111 1110 113333
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH--hh---c-CHhhhhHHHhh
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL--LQ---G-DEEAANWAKEQ 617 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~--L~---~-~~~~~~~~~~~ 617 (678)
... .....+.+++..||+.|+.+||...++++. .. . ..++..|..+.
T Consensus 317 ~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV 369 (391)
T KOG0983|consen 317 GHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDV 369 (391)
T ss_pred ccc--CcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHH
Confidence 211 134456777799999999999999999863 11 1 23456786554
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=292.26 Aligned_cols=261 Identities=26% Similarity=0.414 Sum_probs=197.8
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHh--cCCCCeeeEEEEEEeCC----eEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITA--LHHRNIISLFGFCFEDN----NLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~~----~~~lV~E~~~~ 410 (678)
.+||+|.||.||+|.+ +++.||||++.. +....|.+|-+|.+. |+|+||++++++-..+. .++||++|.++
T Consensus 216 eli~~Grfg~V~KaqL-~~~~VAVKifp~--~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQL-DNRLVAVKIFPE--QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred HHhhcCccceeehhhc-cCceeEEEecCH--HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 4589999999999999 559999999974 455778888888775 68999999999876655 79999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC------EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~------~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|+|.++|..+ .++|....+|+..+++||+|||+.. +.+|+|||||..|||+.+|++..|+|||||..+.
T Consensus 293 GsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~ 367 (534)
T KOG3653|consen 293 GSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLE 367 (534)
T ss_pred CcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEec
Confidence 9999999754 6899999999999999999999844 4679999999999999999999999999999998
Q ss_pred CCCCCceecccccCCCCCCcchhccCC-CC-----ccceEeehhHHHHHHhcCCCCCCC-CCCcccccchhhc--ccccc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGK-VS-----EKIDVYAFGIVLLELLSGKKPINS-ENPKGQESLVMWA--KPILK 555 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s-----~ksDVwSlGvvL~eLltG~~Pf~~-~~~~~~~~l~~~~--~~~~~ 555 (678)
.+......-..+||..|||||++.+.. +. .+.||||+|.|||||++.-.-+.. ..+.-+.-+.... .|.++
T Consensus 368 p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e 447 (534)
T KOG3653|consen 368 PGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLE 447 (534)
T ss_pred CCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHH
Confidence 776665555689999999999997642 22 269999999999999997665532 1111110000000 00000
Q ss_pred c---CccccccCCCCCCC-CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 556 D---GKVSQLLDPSLDTD-YDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 556 ~---~~~~~l~dp~l~~~-~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
+ --+.+-..|.+... .....+.-+.+.+-.||..||+.|.|+.=|-+.+.
T Consensus 448 ~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~ 501 (534)
T KOG3653|consen 448 EMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMA 501 (534)
T ss_pred HHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence 0 01111122333221 12244667778889999999999999988877664
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=316.40 Aligned_cols=144 Identities=30% Similarity=0.456 Sum_probs=131.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||+|... +++.||||+++.. ......+..|+.++..++||||+++++++...+.+||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999876 6899999999753 244577889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
||+.+++|.+++... ..+++...+.|+.||+.||.|||. .+||||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998643 357889999999999999999999 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-34 Score=327.34 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=200.4
Q ss_pred HHHhhcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 041755 326 LLSATSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 326 l~~~t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 401 (678)
+...+-+|....+||.|.||.||.|.. ++|...|+|-++... ...+.+.+|+.++..|+|||+|+++|+-...+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 444556788889999999999999975 478999999876432 4567788999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
++.||||.+|+|.+.+... ...++.....+..|++.||.|||+ .|||||||||.||||+.+|.+|++|||.|.
T Consensus 1310 ~IFMEyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeeccccee
Confidence 9999999999999999643 345666667788999999999999 999999999999999999999999999999
Q ss_pred ccCCCCC--CceecccccCCCCCCcchhccCC---CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccccc
Q 041755 482 WLSTSSS--HLTCTDVAGTFGYLAPEYFMHGK---VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKD 556 (678)
Q Consensus 482 ~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 556 (678)
.+..... ........||+.|||||.+.+.. -..+.||||||||++||+||+.||...+..-+ +++- .-.
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a---IMy~---V~~ 1456 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA---IMYH---VAA 1456 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---HHhH---Hhc
Confidence 8765421 12234578999999999997643 45689999999999999999999976544311 1111 111
Q ss_pred CccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 557 GKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 557 ~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
|. -|.+. ......=..++-+||..||..|=++.|+++.
T Consensus 1457 gh-----~Pq~P----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 GH-----KPQIP----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred cC-----CCCCc----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 11 12221 1122223345689999999999777777664
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-33 Score=289.82 Aligned_cols=241 Identities=22% Similarity=0.335 Sum_probs=192.7
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 404 (678)
.+|....+||+|+||+|.+|..+ ....||||+++.+ .+..+--+.|-++|.-. +-|.+++|..+|+.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 47888899999999999999765 4578999999864 23334445677777655 478999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+.+|+|-.+++.. ..+-+.....+|.+||-||-+||+ ++||+||||.+|||||.+|++||+|||+++---
T Consensus 429 MEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccc
Confidence 9999999999998754 456777888999999999999999 999999999999999999999999999987432
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
. ...++...+||+.|+|||++.+.+|+..+|+|||||+||||+.|++||++++..+.-..++ +
T Consensus 502 ~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~---------------e 564 (683)
T KOG0696|consen 502 F--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM---------------E 564 (683)
T ss_pred c--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---------------H
Confidence 2 2234456899999999999999999999999999999999999999999987654322221 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQI 597 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~ 597 (678)
.. ..|+.......+.++..-|...|.+|...
T Consensus 565 hn--vsyPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 565 HN--VSYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred cc--CcCcccccHHHHHHHHHHhhcCCccccCC
Confidence 11 11222333445556667788999999643
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-33 Score=319.18 Aligned_cols=208 Identities=25% Similarity=0.345 Sum_probs=182.5
Q ss_pred HHHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 041755 324 QELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFED 398 (678)
Q Consensus 324 ~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 398 (678)
.++.-..++|.+.++||+|+||.|..++.+ .++.||+|+++..+ ....-|..|-.+|..-+.+-|+.|+..|.++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 345555678999999999999999999875 68899999997632 3345688899999999999999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecc
Q 041755 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 399 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
+++|||||||+||+|..+|... ..+++.-.+.++..|+-||.-||+ .|+|||||||+|||||..|++||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999754 268999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhcc-----CCCCccceEeehhHHHHHHhcCCCCCCCCC
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-----GKVSEKIDVYAFGIVLLELLSGKKPINSEN 539 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 539 (678)
.+..+..+.. ..+...+|||-|++||++.. +.|+..+|+||+||++||||.|..||..++
T Consensus 221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 9988775433 34455799999999999952 678999999999999999999999998654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=290.59 Aligned_cols=242 Identities=22% Similarity=0.383 Sum_probs=191.9
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
-|...+.||-|+||.|.+++.. +...||+|.+++.+ ........|-.||.....+-||+|+..|.+.+++|+|||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 3677778999999999999754 45678999997643 445667789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc---
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL--- 483 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~--- 483 (678)
|++||++-.+|... ..|++...+.++.++..|+++.|. .|+|||||||+|||||.+|++||+||||+.-+
T Consensus 710 YIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceec
Confidence 99999999998754 568899999999999999999999 99999999999999999999999999997532
Q ss_pred CCC-----CCC--------------------------------ceecccccCCCCCCcchhccCCCCccceEeehhHHHH
Q 041755 484 STS-----SSH--------------------------------LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLL 526 (678)
Q Consensus 484 ~~~-----~~~--------------------------------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~ 526 (678)
.+. ..+ ...-..+||+.|+|||++....++.-+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 110 000 0011257999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCcccc-cchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCC
Q 041755 527 ELLSGKKPINSENPKGQE-SLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRP 595 (678)
Q Consensus 527 eLltG~~Pf~~~~~~~~~-~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP 595 (678)
||+.|+.||....+.+.. .++.| ...++--..+....+...-+ ..+|+. ++.|.
T Consensus 863 em~~g~~pf~~~tp~~tq~kv~nw----------~~~l~~~~~~~ls~e~~~li---~kLc~s--ad~RL 917 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGETQYKVINW----------RNFLHIPYQGNLSKEALDLI---QKLCCS--ADSRL 917 (1034)
T ss_pred HHhhCCCCccCCCCCcceeeeeeh----------hhccccccccccCHHHHHHH---HHHhcC--hhhhh
Confidence 999999999988776543 33333 33344444455555544433 355654 44443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=307.84 Aligned_cols=254 Identities=26% Similarity=0.448 Sum_probs=202.8
Q ss_pred CCceeecccCceEEEEEEeC----C----CCEEEEEEeCCCh--HHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEE
Q 041755 334 LPEYLVGKGGHSHVYRGCLP----D----GKELAVKILKPSE--DVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 334 ~~~~~IG~G~~g~Vy~g~~~----~----g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 402 (678)
...+.||+|.||.|++|... . ...||||.++... ...+.+..|++++..+. |+||+.|+|+|...+.++
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 34458999999999999743 1 4578999998643 56788999999999985 999999999999989999
Q ss_pred EEEEcCCCCCHHHHhccCC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC
Q 041755 403 LVYDFLSRGSLEENLHGNK---K-------DG--NAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF 470 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~---~-------~~--~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~ 470 (678)
+|+||+..|+|.++|...+ . .. ..+...+.+.++.|||.|++||++ .++|||||-..|||+..+.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCCC
Confidence 9999999999999998765 0 01 238899999999999999999999 9999999999999999999
Q ss_pred CcEEeecccccccCCCCCCceecccccCC--CCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccch
Q 041755 471 EPQLSDFGLASWLSTSSSHLTCTDVAGTF--GYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLV 547 (678)
Q Consensus 471 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~--~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~ 547 (678)
.+||+|||+|+.......... ..-.|+. .|||||.+....|+.|+|||||||+||||+| |..||.+... ...+.
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~~~l~ 532 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--TEELL 532 (609)
T ss_pred EEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--HHHHH
Confidence 999999999997655443321 1122323 4999999999999999999999999999999 8899876221 11111
Q ss_pred hhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 548 MWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 548 ~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
. .+++|... ..+..+...+..+++.||+.+|.+||++.++++.|+.
T Consensus 533 ~----~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 533 E----FLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred H----HHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 1 23333211 1233335567778899999999999999999999976
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=302.74 Aligned_cols=251 Identities=22% Similarity=0.388 Sum_probs=209.7
Q ss_pred CCceeecccCceEEEEEEe-CCC----CEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 334 LPEYLVGKGGHSHVYRGCL-PDG----KELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 334 ~~~~~IG~G~~g~Vy~g~~-~~g----~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
...++||+|+||+||+|.+ ++| .+||||++... .....+|+.|+-+|.+|.|||+++|+|+|.... +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3467899999999999975 344 46899988653 466789999999999999999999999998765 889999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
||+.|+|.++++..+ ..+..+..+.|..|||+||.|||. ++++||||-..|||+..-..+||.|||+++.+...
T Consensus 778 ~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999998654 678899999999999999999998 99999999999999999999999999999999887
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
...+......-.+.|||-|.+....|+.++|||||||++|||+| |..|+.+....+..++. +.|.
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-------e~ge------- 917 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-------EKGE------- 917 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-------hccc-------
Confidence 77666555555678999999999999999999999999999999 99999877654433322 2221
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
+-..++....++..++..||..|+..||+++++...+...
T Consensus 918 --RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 918 --RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred --cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 1111333455677778999999999999999998776543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=272.46 Aligned_cols=220 Identities=22% Similarity=0.199 Sum_probs=176.0
Q ss_pred cCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccC
Q 041755 342 GGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGN 420 (678)
Q Consensus 342 G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~ 420 (678)
|.||.||++... +|+.||+|.++... .+..|...+....||||+++++++.+.+..++||||+++|+|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 899999999875 78999999997643 2334555566677999999999999999999999999999999998643
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceecccccCCC
Q 041755 421 KKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFG 500 (678)
Q Consensus 421 ~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~ 500 (678)
..+++.....++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++....... ....++..
T Consensus 80 ----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 80 ----LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred ----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 358999999999999999999999 999999999999999999999999999886654321 22355778
Q ss_pred CCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHH
Q 041755 501 YLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMV 580 (678)
Q Consensus 501 Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~ 580 (678)
|+|||++.++.++.++||||||+++|||++|+.|+........ ......+... ....+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-----------------~~~~~~~~~~----~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-----------------THTTLNIPEW----VSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-----------------cccccCCccc----CCHHHH
Confidence 9999999888899999999999999999999988753211100 0000011111 123466
Q ss_pred HHHHhcccCCCCCCCCHH
Q 041755 581 LAATLSISRAPTVRPQIN 598 (678)
Q Consensus 581 ~la~~Cl~~dP~~RPs~~ 598 (678)
.++..|++.||.+||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 677999999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-33 Score=276.49 Aligned_cols=252 Identities=26% Similarity=0.313 Sum_probs=194.0
Q ss_pred ceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCCC
Q 041755 336 EYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSRG 411 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~g 411 (678)
...||.|.||+|++-..+ .|+..|||.++.. +...++++.|.+...+- ++||||+++|.+..++..++.||.| ..
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 356999999999998765 7999999999753 45678899999876554 6999999999999999999999999 45
Q ss_pred CHHHHhcc-CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 412 SLEENLHG-NKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 412 sL~~~L~~-~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
||+.+... +......+++.-.-.|....+.||.||.. ...||||||||+||||+..|.+||||||++..+..+..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA-- 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA-- 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--
Confidence 66544321 11233568888888899999999999997 47899999999999999999999999999887655332
Q ss_pred eecccccCCCCCCcchhcc--CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMH--GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
.+...|-..|||||.+.. ..|+.++||||||++|||+.||+.|+...+.. -+.+. ....|....++.+.-
T Consensus 224 -kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-feql~-----~Vv~gdpp~l~~~~~- 295 (361)
T KOG1006|consen 224 -KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-FEQLC-----QVVIGDPPILLFDKE- 295 (361)
T ss_pred -hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-HHHHH-----HHHcCCCCeecCccc-
Confidence 234678899999999854 45899999999999999999999999765431 11111 111222222221111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
..+....|...+..|+..|-.+||...+++++
T Consensus 296 ---~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 296 ---CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ---ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22345667888899999999999999998764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=295.81 Aligned_cols=258 Identities=24% Similarity=0.404 Sum_probs=214.9
Q ss_pred HHHHHhhcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEe----
Q 041755 324 QELLSATSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSEDVLKEFASEIEIITALH-HRNIISLFGFCFE---- 397 (678)
Q Consensus 324 ~el~~~t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~---- 397 (678)
+.+..-++.|.+...||+|.+|+||+++. ++|+..|+|++.+..+..+++..|.+||+.+. |||++.++|++..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 33444567788889999999999999985 47999999999998888888889999999884 9999999999964
Q ss_pred -CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEee
Q 041755 398 -DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSD 476 (678)
Q Consensus 398 -~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~D 476 (678)
++.++||||||.+||..|++.+.. +..+.|..+..|+++++.||.+||+ +.+||||||-.||||+.++.+||+|
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEee
Confidence 468999999999999999998765 6789999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCceecccccCCCCCCcchhccC-----CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcc
Q 041755 477 FGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-----KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK 551 (678)
Q Consensus 477 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~ 551 (678)
||++..+..... ......||+.|||||++... .|+..+|+||||++..||--|.+|+.+..+.-..-
T Consensus 167 FGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF------ 238 (953)
T KOG0587|consen 167 FGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF------ 238 (953)
T ss_pred eeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc------
Confidence 999987654322 22347899999999999653 46778999999999999999999998766532111
Q ss_pred cccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 552 PILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 552 ~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.. +|-....-.....+.+.+++..||..|-..||++.++++
T Consensus 239 -~IpR-------NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 -LIPR-------NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -cCCC-------CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1111 122222335567788999999999999999999999885
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=273.50 Aligned_cols=207 Identities=26% Similarity=0.410 Sum_probs=174.0
Q ss_pred cCCCCceeecccCceEEEEEEeC---C--CCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP---D--GKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFE-DNNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~---~--g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~ 401 (678)
..|.....||+|+||.||+|... + .+.+|||.++... .......+|+.+++.++||||+.|..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46777888999999999999532 2 3479999997543 334667899999999999999999999987 7789
Q ss_pred EEEEEcCCCCCHHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC----CCcEEee
Q 041755 402 LLVYDFLSRGSLEENLHGNK-KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD----FEPQLSD 476 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~-~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~----~~~kL~D 476 (678)
+|++||.+. +|...++-.+ .....++-..+..|+.||+.|+.|||+ +-|+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999955 8888776433 223578888999999999999999999 889999999999999887 8999999
Q ss_pred cccccccCCCCCCc-eecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCc
Q 041755 477 FGLASWLSTSSSHL-TCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPK 541 (678)
Q Consensus 477 FGla~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~ 541 (678)
||+++.+...-... ....++-|++|.|||.+.+. .|+.+.|||+.|||+.||+|-.+-|.+...+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k 246 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEK 246 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhh
Confidence 99999886653333 44567889999999999875 6899999999999999999999999775443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=279.82 Aligned_cols=254 Identities=27% Similarity=0.453 Sum_probs=195.1
Q ss_pred CCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCC--------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-eCCeE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPS--------EDVLKEFASEIEIITALHHRNIISLFGFCF-EDNNL 401 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~--------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~-~~~~~ 401 (678)
+|...++||+|||+.||+|.+ ...+.||||+-... +...+...+|..|.+.|.||.||++|+|+. +.+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 466677899999999999974 46788999986432 234677889999999999999999999985 55679
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC---CCCcEEeecc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD---DFEPQLSDFG 478 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~---~~~~kL~DFG 478 (678)
|-|.|||+|.+|+-+|... ..+++.+.+.|+.||+.||.||.. ...+|||-||||.||||-+ .|.+||+|||
T Consensus 544 CTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred eeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 9999999999999999644 578999999999999999999986 3578999999999999954 4789999999
Q ss_pred cccccCCCCCCc-----eecccccCCCCCCcchhccC----CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhh
Q 041755 479 LASWLSTSSSHL-----TCTDVAGTFGYLAPEYFMHG----KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMW 549 (678)
Q Consensus 479 la~~~~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~ 549 (678)
|++.+..+.... .+....||.+|++||.|.-+ +.+.|+||||.|||+|+.+.|+.||...... ..++.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--QdILq- 695 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QDILQ- 695 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HHHHh-
Confidence 999987654431 12346899999999998654 4788999999999999999999999865432 12221
Q ss_pred cccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 041755 550 AKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVL 601 (678)
Q Consensus 550 ~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl 601 (678)
...++....+.--..|.+ ......++.+||+...++|-...++.
T Consensus 696 eNTIlkAtEVqFP~KPvV--------sseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 ENTILKATEVQFPPKPVV--------SSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhchhcceeccCCCCCcc--------CHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 112222222221111211 12234456999999999998776655
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=264.24 Aligned_cols=237 Identities=28% Similarity=0.406 Sum_probs=192.1
Q ss_pred CceEEEEEEeC-CCCEEEEEEeCCCh-HH-HHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHhcc
Q 041755 343 GHSHVYRGCLP-DGKELAVKILKPSE-DV-LKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHG 419 (678)
Q Consensus 343 ~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~ 419 (678)
+||.||+|... +|+.+|+|++.... .. .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999876 58999999997643 22 68899999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceecccccCC
Q 041755 420 NKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF 499 (678)
Q Consensus 420 ~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~ 499 (678)
.. .+++..++.++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 32 38899999999999999999999 899999999999999999999999999998776543 223456889
Q ss_pred CCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHH
Q 041755 500 GYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERM 579 (678)
Q Consensus 500 ~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l 579 (678)
.|++||.+....++.++|||+||+++++|++|..||...... .....+. ..+.... ..........+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~----~~~~~~~-------~~~~~~~~~~~ 217 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKI----GKPKPPF-------PPPEWKISPEA 217 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHH----hccCCCC-------ccccccCCHHH
Confidence 999999999888999999999999999999999999763211 1111111 1111000 00000023567
Q ss_pred HHHHHhcccCCCCCCCCHHHHHH
Q 041755 580 VLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 580 ~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..++.+|+..+|.+||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 77889999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=266.98 Aligned_cols=249 Identities=23% Similarity=0.312 Sum_probs=192.9
Q ss_pred hhcCCCCc-eeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe----CCeE
Q 041755 329 ATSNFLPE-YLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFE----DNNL 401 (678)
Q Consensus 329 ~t~~f~~~-~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~----~~~~ 401 (678)
.|++|... .+||-|-.|+|.....+ +|+.+|+|++..+.. ..+|+++.-.. .|||||.++++|.. ...+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K----ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK----ARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH----HHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 44566543 57999999999887654 789999999976543 45788876555 59999999999854 3568
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC---CCCcEEeecc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD---DFEPQLSDFG 478 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~---~~~~kL~DFG 478 (678)
.+|||+|+||.|+..+..+. ...|.+.+.-.|+.||+.|+.|||+ .+|.||||||+|+|... |-.+||+|||
T Consensus 135 LiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccc
Confidence 89999999999999998754 3679999999999999999999999 99999999999999964 4568999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
+|+.-.. .......+-|+.|.|||++...+|+...|+||+||++|-||+|.+||....... .+-- .+..+..|.
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-ispg--Mk~rI~~gq 283 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPG--MKRRIRTGQ 283 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-CChh--HHhHhhccC
Confidence 9986543 223344678999999999999999999999999999999999999998754311 0000 111111111
Q ss_pred cccccCCCCCCCCCH---HH-HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 559 VSQLLDPSLDTDYDN---DQ-IERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~---~~-~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+ .|+. ++ .+....+++..|+.+|.+|-|+.+++.
T Consensus 284 y----------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 Y----------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred c----------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1 1222 22 234445678889999999999999984
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=274.56 Aligned_cols=264 Identities=27% Similarity=0.387 Sum_probs=201.7
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHh--cCCCCeeeEEEEEEeCC----eEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITA--LHHRNIISLFGFCFEDN----NLLL 403 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~~----~~~l 403 (678)
..+....+.||+|.||.||+|.+ -|..||||++...+ ...+.+|.+|.+. |+|+||+.+++.-..++ .++|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred hheeEEEEEecCccccceeeccc-cCCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 34566678899999999999998 78999999997543 3567888888875 69999999998765443 6899
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeccCCCCCeEecCCCCcEEeecc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS-----CEQPVIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-----~~~~iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
|.+|.++|||+|+|.. ..++-...++++..+|.||++||.. .+..|.|||||+.|||+..++.+.|+|+|
T Consensus 287 vTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred eeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999975 4678899999999999999999962 24679999999999999999999999999
Q ss_pred cccccCCCCCC--ceecccccCCCCCCcchhccCC----C-C-ccceEeehhHHHHHHhcC----------CCCCCCCCC
Q 041755 479 LASWLSTSSSH--LTCTDVAGTFGYLAPEYFMHGK----V-S-EKIDVYAFGIVLLELLSG----------KKPINSENP 540 (678)
Q Consensus 479 la~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~~----~-s-~ksDVwSlGvvL~eLltG----------~~Pf~~~~~ 540 (678)
||-........ ...+..+||-.|||||++.... + + ..+||||||.|+||+... +.||.+..+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 99877655332 2334578999999999996532 1 2 259999999999998753 356655433
Q ss_pred cccccchhhcccccccCccccccCCCCC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 541 KGQESLVMWAKPILKDGKVSQLLDPSLD-TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 541 ~~~~~l~~~~~~~~~~~~~~~l~dp~l~-~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.+...-.+ ....- .+-+.|.+. .+.+.+.+..|.+++..||..+|..|-|+--|-+.|...
T Consensus 442 ~DPs~eeM--rkVVC----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l 503 (513)
T KOG2052|consen 442 SDPSFEEM--RKVVC----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL 503 (513)
T ss_pred CCCCHHHH--hccee----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence 22211000 00000 011223332 234567889999999999999999999999888887643
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=268.17 Aligned_cols=265 Identities=23% Similarity=0.374 Sum_probs=194.7
Q ss_pred cHHHHHHhhcCCCCceeecccCceEEEEEE-eCCCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeC
Q 041755 322 SYQELLSATSNFLPEYLVGKGGHSHVYRGC-LPDGKELAVKILKPSE-DVLKEFASEIEIITALH-HRNIISLFGFCFED 398 (678)
Q Consensus 322 ~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~-~~~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~ 398 (678)
.++++.+.|+ .+||+|+|+.|-.+. +.+|.+||||++.+.. ....+..+|++++.+.+ |+||++|++||.++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3566666554 359999999998775 5689999999997654 56788899999999986 99999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC---cEEe
Q 041755 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE---PQLS 475 (678)
Q Consensus 399 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~---~kL~ 475 (678)
..+|||||-|.||+|..+++.+ ..|.+.+..++...|+.||.|||+ +||.||||||+|||...-.. +|||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeee
Confidence 9999999999999999999865 468999999999999999999999 99999999999999976554 7999
Q ss_pred ecccccccCCC--C---CCceecccccCCCCCCcchhc-----cCCCCccceEeehhHHHHHHhcCCCCCCCCCCccccc
Q 041755 476 DFGLASWLSTS--S---SHLTCTDVAGTFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQES 545 (678)
Q Consensus 476 DFGla~~~~~~--~---~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~ 545 (678)
||.|..-.... - +.......+|+..|||||+.. ...|+.+.|.||||||||-||+|.+||.+.....-
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC-- 299 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC-- 299 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--
Confidence 99886543211 1 111223468999999999863 24588899999999999999999999977543210
Q ss_pred chhhcccccccCccccccCCCCCC--CCCHHHHH----HHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 546 LVMWAKPILKDGKVSQLLDPSLDT--DYDNDQIE----RMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 546 l~~~~~~~~~~~~~~~l~dp~l~~--~~~~~~~~----~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
-|...-.-..--..++...-.+ +|++.+.. ....++...+-.++..|-++.+++.
T Consensus 300 --GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 --GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred --CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0111000000000111111111 12222221 2223445567789999999888875
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=280.58 Aligned_cols=244 Identities=23% Similarity=0.352 Sum_probs=190.9
Q ss_pred CceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 335 PEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 335 ~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
.+++||.|-||+||-|+.. +|+.||||++.+- ......+.+|+.||.+++||.||.|.-.|...+..+.|||-+ +
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~ 646 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H 646 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence 3678999999999999864 8999999998642 344577889999999999999999999999999999999999 5
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC---CCcEEeecccccccCCCC
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD---FEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~---~~~kL~DFGla~~~~~~~ 487 (678)
|+..+.+... ....+++..-..+..||+.||.|||. ++|+|+||||+||||.+. -++||||||+|+.++...
T Consensus 647 GDMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 647 GDMLEMILSS--EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred chHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 5555554432 34678988889999999999999999 999999999999999643 479999999999988765
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
.. ..++||+.|+|||++.+..|...-|+||.||++|--|+|..||+.+.... ..++-+.-+.....+.
T Consensus 722 FR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQIQNAaFMyPp~PW~------- 789 (888)
T KOG4236|consen 722 FR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQIQNAAFMYPPNPWS------- 789 (888)
T ss_pred hh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHhhccccccCCCchh-------
Confidence 43 34899999999999999999999999999999999999999997543211 1122122111111111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.....++++...|+..-++|-+...-+.
T Consensus 790 ------eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 790 ------EISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ------hcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 11223445556667777778888776553
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=289.59 Aligned_cols=241 Identities=24% Similarity=0.332 Sum_probs=199.0
Q ss_pred cCCCCceeecccCceEEEEEEeCCCC-EEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGK-ELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~-~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
.++.....||-||||.|-+.+.+... .+|+|++++. ....+....|-.||...+.|.||+||.-|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34455567999999999999876433 3899998753 345677889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
|-|-||.|+..|..+ +.|+......++..+++|++|||. ++||+|||||+|+||+.+|-+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999999999654 568888889999999999999999 9999999999999999999999999999999877
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
+...- .++||+.|.|||++.+...+..+|.||||+++|||++|.+||.+.++...-+++.... ..+
T Consensus 573 g~KTw---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi--------d~i--- 638 (732)
T KOG0614|consen 573 GRKTW---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI--------DKI--- 638 (732)
T ss_pred CCcee---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh--------hhh---
Confidence 65443 3799999999999999999999999999999999999999999988765444433211 111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQ 596 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs 596 (678)
.++....+....++...++.+|.+|..
T Consensus 639 ----~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 ----EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ----hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 112222334555667778889999975
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=288.62 Aligned_cols=239 Identities=26% Similarity=0.347 Sum_probs=189.1
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+..|.....+|.|+|+.|-++... +++..++|++.... .+-.+|+.++... +||||+++.+.+.++.+.|+|||.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~---~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA---DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc---cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 556777777999999999888654 78899999997542 2234577666555 699999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe-cCCCCcEEeecccccccCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL-SDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl-~~~~~~kL~DFGla~~~~~~ 486 (678)
+.++-|.+.+...+ .+. .++..|+.+|+.|+.|||. +|||||||||+|||+ ++.++++|+|||.++.....
T Consensus 398 l~g~ell~ri~~~~----~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 398 LDGGELLRRIRSKP----EFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ccccHHHHHHHhcc----hhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99998888775432 223 7777899999999999999 999999999999999 68999999999999877664
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
+...+-|..|.|||++....|++.+||||||++||+||+|+.||...... .. ....+..+.+.
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~e----i~~~i~~~~~s------ 532 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IE----IHTRIQMPKFS------ 532 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HH----HHHhhcCCccc------
Confidence 23346689999999999999999999999999999999999999765433 11 11112222222
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.........++..||+.+|.+||+|.++..
T Consensus 533 ------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 ------ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ------cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 112233444568999999999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=294.93 Aligned_cols=261 Identities=18% Similarity=0.230 Sum_probs=168.8
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-C----CCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEE------EEe
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-D----GKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGF------CFE 397 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~----g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~------~~~ 397 (678)
..++|...+.||+|+||.||+|.+. + +..||||++...... +.+..| .+....+.++..++.. +..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 4578999999999999999999875 4 789999988643211 111111 1122222222222211 245
Q ss_pred CCeEEEEEEcCCCCCHHHHhccCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 041755 398 DNNLLLVYDFLSRGSLEENLHGNKKD----------------GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKS 461 (678)
Q Consensus 398 ~~~~~lV~E~~~~gsL~~~L~~~~~~----------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp 461 (678)
+...++||||+.+++|.+++...... +....+..+..++.|++.||.|||+ ++|+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCH
Confidence 56799999999999999988643210 0111234456799999999999999 9999999999
Q ss_pred CCeEecC-CCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccC----------------------CCCccceE
Q 041755 462 SNILLSD-DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG----------------------KVSEKIDV 518 (678)
Q Consensus 462 ~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----------------------~~s~ksDV 518 (678)
+|||++. ++.+||+|||+|+.+...... ......||+.|+|||.+... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999986 579999999999866443222 22346789999999966332 23456799
Q ss_pred eehhHHHHHHhcCCCCCCCCCCc-------ccccchhhcccccccCccccccCCCCCCCCC--HHHHHHHHHHHHhcccC
Q 041755 519 YAFGIVLLELLSGKKPINSENPK-------GQESLVMWAKPILKDGKVSQLLDPSLDTDYD--NDQIERMVLAATLSISR 589 (678)
Q Consensus 519 wSlGvvL~eLltG~~Pf~~~~~~-------~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~--~~~~~~l~~la~~Cl~~ 589 (678)
|||||+||||+++..|+...... ....+..|...... ...+.+...+. ........+++..||+.
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP------RASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc------ccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999977665422100 00011111111000 00000000000 00112334688999999
Q ss_pred CCCCCCCHHHHHH
Q 041755 590 APTVRPQINLVLK 602 (678)
Q Consensus 590 dP~~RPs~~eVl~ 602 (678)
||.+|||+.++++
T Consensus 437 dP~kR~ta~e~L~ 449 (566)
T PLN03225 437 KGRQRISAKAALA 449 (566)
T ss_pred CcccCCCHHHHhC
Confidence 9999999999996
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=244.44 Aligned_cols=211 Identities=22% Similarity=0.343 Sum_probs=173.7
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
|..-+.||+|.||+||+|+.. .+..||+|.++-++ .......+|+-+++.|+|+|||+|+++...++.+.||+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 334456999999999999865 68899999987543 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
..+|..+... -++.++-+....++.|+++||.++|+ +++.|||+||.|.||+.+|++||+|||+++.++-...
T Consensus 84 -dqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 84 -DQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred -hHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 4578777653 34568888899999999999999999 9999999999999999999999999999998765433
Q ss_pred CceecccccCCCCCCcchhccCC-CCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhccc
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGK-VSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKP 552 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 552 (678)
... ..+-|.+|.+|.++.+.+ |+...|+||-||++.||.. |++-|.+.+-..+..-+.|...
T Consensus 157 cys--aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg 220 (292)
T KOG0662|consen 157 CYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220 (292)
T ss_pred eee--ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhC
Confidence 222 345699999999998754 7999999999999999987 6666776665554444444433
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=266.81 Aligned_cols=263 Identities=24% Similarity=0.374 Sum_probs=193.6
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--------CCe
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFE--------DNN 400 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------~~~ 400 (678)
|....+||+|.||.||+|+.. .|+.||+|++-. .+..-...++|+.+|..|+|+|++.|++.|.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 444567999999999999764 688899886532 12334556899999999999999999998853 235
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
+||||++|+. +|...|... ...++..++.+++.++..||.|+|. ..|+|||+|+.|+||+.+|.+||+|||++
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 8999999954 888888643 2578999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCC--CceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhh--------
Q 041755 481 SWLSTSSS--HLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMW-------- 549 (678)
Q Consensus 481 ~~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~-------- 549 (678)
+.+..... ....+..+-|.+|++||.+.+ ..|+++.|||.-||++.||+||.+-|.+.....+..++..
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 87755432 233455677999999999876 5699999999999999999999999987766544433321
Q ss_pred cccccccCcccccc--CCCCCCCCC--HHHHH------HHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 550 AKPILKDGKVSQLL--DPSLDTDYD--NDQIE------RMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 550 ~~~~~~~~~~~~l~--dp~l~~~~~--~~~~~------~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+|-..+-.+.+-+ .|...+.+. .+.++ ..+.++-.++..||.+||++.+++.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11111111111111 111111110 01111 2334445668999999999999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=269.02 Aligned_cols=260 Identities=20% Similarity=0.292 Sum_probs=203.4
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCC--C----CeeeEEEEEEeCCeEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHH--R----NIISLFGFCFEDNNLL 402 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~H--p----nIv~l~g~~~~~~~~~ 402 (678)
+++|.+...+|+|.||.|....+. .+..||||+++.-....+..+-|+++|.++.+ | -++.+.++|.-.++.|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiC 167 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHIC 167 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceE
Confidence 678888999999999999998754 47899999999877777788899999999943 2 3788889999999999
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC--------------
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD-------------- 468 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~-------------- 468 (678)
+|+|.+ |-|+.++|..+.. .+++...++.|+.|+++++.|||+ .+++|.||||+|||+.+
T Consensus 168 ivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 168 IVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence 999998 6699999976533 678999999999999999999999 99999999999999842
Q ss_pred ------CCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcc
Q 041755 469 ------DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542 (678)
Q Consensus 469 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 542 (678)
+..++|+|||.|..-.... ..++.|..|.|||++.+-.++.++||||+||||.||.||..-|...+..+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3458999999998654432 34677999999999999999999999999999999999999997655322
Q ss_pred cccchhh----------------cccccccCcc-----------ccccCCCCC----CCCCHHHHHHHHHHHHhcccCCC
Q 041755 543 QESLVMW----------------AKPILKDGKV-----------SQLLDPSLD----TDYDNDQIERMVLAATLSISRAP 591 (678)
Q Consensus 543 ~~~l~~~----------------~~~~~~~~~~-----------~~l~dp~l~----~~~~~~~~~~l~~la~~Cl~~dP 591 (678)
.+.+. +...+..|.+ ...+++... -.....+...+++++..+|..||
T Consensus 317 --HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 317 --HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred --HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 11110 0001111111 111111110 01233456679999999999999
Q ss_pred CCCCCHHHHHH
Q 041755 592 TVRPQINLVLK 602 (678)
Q Consensus 592 ~~RPs~~eVl~ 602 (678)
.+|+|+.|++.
T Consensus 395 ~~RiTl~EAL~ 405 (415)
T KOG0671|consen 395 ARRITLREALS 405 (415)
T ss_pred cccccHHHHhc
Confidence 99999999885
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=282.92 Aligned_cols=205 Identities=20% Similarity=0.290 Sum_probs=156.3
Q ss_pred hhcCCCCceeecccCceEEEEEEe-----------------CCCCEEEEEEeCCCh-HHHHH--------------HHHH
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCL-----------------PDGKELAVKILKPSE-DVLKE--------------FASE 376 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~-----------------~~g~~vAvK~l~~~~-~~~~~--------------~~~E 376 (678)
..++|...++||+|+||.||+|.+ .+++.||||.++... ...++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999963 245789999987543 22233 3346
Q ss_pred HHHHHhcCCCCe-----eeEEEEEEe--------CCeEEEEEEcCCCCCHHHHhccCCC--------------------C
Q 041755 377 IEIITALHHRNI-----ISLFGFCFE--------DNNLLLVYDFLSRGSLEENLHGNKK--------------------D 423 (678)
Q Consensus 377 i~il~~l~HpnI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~L~~~~~--------------------~ 423 (678)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++|+.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777876654 677887753 3568999999999999999875321 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCC
Q 041755 424 GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLA 503 (678)
Q Consensus 424 ~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~A 503 (678)
...++|..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......... ......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 1235678899999999999999999 89999999999999999999999999999765443221 1112345889999
Q ss_pred cchhccCCC----------------------CccceEeehhHHHHHHhcCCC-CCCC
Q 041755 504 PEYFMHGKV----------------------SEKIDVYAFGIVLLELLSGKK-PINS 537 (678)
Q Consensus 504 PE~l~~~~~----------------------s~ksDVwSlGvvL~eLltG~~-Pf~~ 537 (678)
||.+..... ..+.||||+||++|+|++|.. ||..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 998854321 235799999999999999875 7653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=259.45 Aligned_cols=199 Identities=20% Similarity=0.362 Sum_probs=171.1
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC----ChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP----SEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~----~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 403 (678)
.++|...++||+|.|.+|..+++. +.+.||+|++++ +.+...-...|-.+..+. +||.+|.|..+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357888999999999999999876 678899999874 223334445666666665 69999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
|.||+++|+|--++... ..++++..+.+..+|.-||.|||+ +|||+||||.+|+|||..|++||+|+|+++.-
T Consensus 329 vieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC
Confidence 99999999998777654 458999999999999999999999 99999999999999999999999999998753
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCC
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINS 537 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 537 (678)
-.. ..++...+||+.|+|||++.+..|...+|+|+|||+++||+.|+.||+.
T Consensus 402 l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 402 LGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 221 1223358999999999999999999999999999999999999999974
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=259.52 Aligned_cols=263 Identities=24% Similarity=0.363 Sum_probs=214.0
Q ss_pred HHHHHhhcCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 041755 324 QELLSATSNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFC 395 (678)
Q Consensus 324 ~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 395 (678)
.+|.....++....++-+|.||.||+|.+. +.+.|.+|.++.. +-....++.|--++..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 344444456777778899999999999643 4456788888753 35567789999999999999999999999
Q ss_pred EeC-CeEEEEEEcCCCCCHHHHhccCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC
Q 041755 396 FED-NNLLLVYDFLSRGSLEENLHGNK----KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF 470 (678)
Q Consensus 396 ~~~-~~~~lV~E~~~~gsL~~~L~~~~----~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~ 470 (678)
.++ ...+.+|.++.-|+|..+|...+ ...+.+.-.+...++.|++.|++|||+ .+|||.||...|.+||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhhe
Confidence 765 57888999999999999998322 223557778889999999999999999 9999999999999999999
Q ss_pred CcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhh
Q 041755 471 EPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMW 549 (678)
Q Consensus 471 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~ 549 (678)
++||+|=.+++-+.+.+.+......-....||+||.+.+..|+..+|||||||+||||+| |+.|+-..+|.+.+..+
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl-- 511 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL-- 511 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH--
Confidence 999999999998877776655555555678999999999999999999999999999999 99999887776544322
Q ss_pred cccccccC-ccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 550 AKPILKDG-KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 550 ~~~~~~~~-~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
++| ++.+ +.++...+..++..||+..|++||++++++.-|..
T Consensus 512 -----kdGyRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 512 -----KDGYRLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -----hccceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 222 2221 23345667788899999999999999999988864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=243.33 Aligned_cols=198 Identities=28% Similarity=0.406 Sum_probs=168.3
Q ss_pred CceeecccCceEEEEEEeC-CCCEEEEEEeCC--ChHHHHHHHHHHHHHHh-cCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 335 PEYLVGKGGHSHVYRGCLP-DGKELAVKILKP--SEDVLKEFASEIEIITA-LHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 335 ~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~--~~~~~~~~~~Ei~il~~-l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
....||+|+||.|-+-++. +|+..|+|.++. ..+..++.++|+.+..+ ..+|.+|.++|........++.||.| .
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~ 128 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-D 128 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-h
Confidence 3456899999999887754 899999999874 45667888899988665 46999999999999889999999999 5
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
.||..+....-..+..+++...=+|+..+.+||.|||+ ...+||||+||+||||+.+|++|+||||++..+.++-..
T Consensus 129 tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk- 205 (282)
T KOG0984|consen 129 TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK- 205 (282)
T ss_pred hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH-
Confidence 68887766555667889999999999999999999998 488999999999999999999999999999887654322
Q ss_pred eecccccCCCCCCcchhcc----CCCCccceEeehhHHHHHHhcCCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMH----GKVSEKIDVYAFGIVLLELLSGKKPINSE 538 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 538 (678)
+-..|-..|+|||.+.. ..|+.|+||||||+.+.||.+++.||...
T Consensus 206 --t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 206 --TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred --HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 22467889999999854 36899999999999999999999999764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=237.31 Aligned_cols=209 Identities=34% Similarity=0.604 Sum_probs=184.1
Q ss_pred ecccCceEEEEEEeCC-CCEEEEEEeCCChH--HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHH
Q 041755 339 VGKGGHSHVYRGCLPD-GKELAVKILKPSED--VLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415 (678)
Q Consensus 339 IG~G~~g~Vy~g~~~~-g~~vAvK~l~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 415 (678)
||+|.+|.||++...+ |+.+++|++..... ....+.+|++++..+.|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998754 89999999986643 46789999999999999999999999999899999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC-CCCcEEeecccccccCCCCCCceecc
Q 041755 416 NLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD-DFEPQLSDFGLASWLSTSSSHLTCTD 494 (678)
Q Consensus 416 ~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~ 494 (678)
++.... ..+++..++.++.+++++|.|||+ .+++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 986432 468899999999999999999999 89999999999999999 89999999999987655332 1223
Q ss_pred cccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCH
Q 041755 495 VAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDN 573 (678)
Q Consensus 495 ~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~ 573 (678)
..+...|++||.+... ..+.+.|+|+||+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 5678899999999887 888999999999999999
Q ss_pred HHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 574 DQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 574 ~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 557778899999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=281.85 Aligned_cols=247 Identities=25% Similarity=0.423 Sum_probs=186.4
Q ss_pred CCCceeecccCceE-EEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 333 FLPEYLVGKGGHSH-VYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 333 f~~~~~IG~G~~g~-Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
|...+++|.|+.|+ ||+|.. +|+.||||.+-. +...-..+|+..|+.- .|||||++++.-.+...+|+..|.| .
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~--e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE--EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-A 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh--HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-h
Confidence 34445589999875 699988 889999998753 2333456899999887 4999999999888889999999999 6
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC---C--CCcEEeecccccccCC
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD---D--FEPQLSDFGLASWLST 485 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~---~--~~~kL~DFGla~~~~~ 485 (678)
.+|.+++...........-...+.+..|++.||++||+ .+||||||||.||||+. + ..++|+|||+++.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 79999997631111111214457788999999999999 99999999999999976 3 4689999999999877
Q ss_pred CCCCce-ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcC-CCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 486 SSSHLT-CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSG-KKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 486 ~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
+..... .....||-||+|||++....-+.++||||||||+|+.++| ..||+...... .+++. ..-.+..
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NIl~------~~~~L~~-- 734 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANILT------GNYTLVH-- 734 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhhhc------Cccceee--
Confidence 654433 3457899999999999998888899999999999999995 89998654321 11111 0001111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.. ..+. ...+++..|++.+|..||++.+|+.
T Consensus 735 ---L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 ---LEP--LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ---ecc--CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111 1111 4456678999999999999999983
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=268.32 Aligned_cols=290 Identities=26% Similarity=0.299 Sum_probs=222.6
Q ss_pred hhhHHhhhhhccCccccccHHHHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHh
Q 041755 304 PKELEGLQERYSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITA 382 (678)
Q Consensus 304 ~~~l~~l~~~~~~~~~~f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~ 382 (678)
+.+...|...+...-..|++.--+...++|.+....|+|-|++|.+|... -|..||||+++.++...+.=+.|++||.+
T Consensus 405 ~~~~~~L~DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkK 484 (752)
T KOG0670|consen 405 PRVNPGLQDNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKK 484 (752)
T ss_pred cccCCccccCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHH
Confidence 44445566666555555555444445678999999999999999999865 58899999999999888888999999999
Q ss_pred cCC------CCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 041755 383 LHH------RNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIH 456 (678)
Q Consensus 383 l~H------pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiH 456 (678)
|+. -|+++|+..|...+++|||+|-+ .-+|.+.|..... +..|....+..++.|++-||..|.. -+|+|
T Consensus 485 L~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~---c~vlH 559 (752)
T KOG0670|consen 485 LNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK---CGVLH 559 (752)
T ss_pred hhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh---cCeee
Confidence 963 48999999999999999999988 5689999987643 3557788899999999999999999 89999
Q ss_pred ccCCCCCeEecCC-CCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCC
Q 041755 457 KDVKSSNILLSDD-FEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPI 535 (678)
Q Consensus 457 rDIKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf 535 (678)
.||||+|||+++. ..+||||||.|........ +...-+..|.|||++.+-+|+...|+||.||+||||.||+-.|
T Consensus 560 aDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlF 635 (752)
T KOG0670|consen 560 ADIKPDNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILF 635 (752)
T ss_pred cccCccceEeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceec
Confidence 9999999999976 4689999999987765432 2334566899999999999999999999999999999999999
Q ss_pred CCCCCcccccchhhcc-----cccccC-ccccccCCCCC--------------------------------C--CCC---
Q 041755 536 NSENPKGQESLVMWAK-----PILKDG-KVSQLLDPSLD--------------------------------T--DYD--- 572 (678)
Q Consensus 536 ~~~~~~~~~~l~~~~~-----~~~~~~-~~~~l~dp~l~--------------------------------~--~~~--- 572 (678)
.+........+.+..+ .++..| ...+.||..++ . .++
T Consensus 636 pG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq 715 (752)
T KOG0670|consen 636 PGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQ 715 (752)
T ss_pred CCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchh
Confidence 8765544333333222 222222 11222222211 0 122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 573 NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 573 ~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
...+..+..+.-.|+..||.+|-+.++.|+
T Consensus 716 ~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 716 PKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 233456666788999999999999998875
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-30 Score=251.91 Aligned_cols=207 Identities=24% Similarity=0.401 Sum_probs=171.3
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-----eEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDN-----NLL 402 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-----~~~ 402 (678)
+..+++.||.|+||.||...++ +|+.||.|.+..- -...+.+.+|+.+|..++|.|++..++...-.+ ++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4567888999999999998875 8999999988642 245688999999999999999999888765432 467
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
.|+|.| ..+|...+- ....++-..+.-+..||++||.|||+ .+|.||||||.|.|++.|..+||||||+|+.
T Consensus 134 V~TELm-QSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHH-Hhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccc
Confidence 788888 456766664 33567778888899999999999999 9999999999999999999999999999997
Q ss_pred cCCCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccch
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV 547 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~ 547 (678)
...+... .++..+-|..|.|||++++. .|+...||||.||++.||+..+--|...++..+..++
T Consensus 206 ee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI 270 (449)
T KOG0664|consen 206 WDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI 270 (449)
T ss_pred cchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH
Confidence 6654433 34456679999999999985 6999999999999999999999999877776554443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=251.63 Aligned_cols=284 Identities=19% Similarity=0.310 Sum_probs=212.4
Q ss_pred HhhhhhccCccccccHHHHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcC--
Q 041755 308 EGLQERYSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALH-- 384 (678)
Q Consensus 308 ~~l~~~~~~~~~~f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-- 384 (678)
|...+...+.++....-+... .++|...++||.|-|++||++.+. +.+.||+|+.+......+..+.||++|++++
T Consensus 56 E~~~dY~kGGYHpV~IGD~F~-~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~ 134 (590)
T KOG1290|consen 56 EDPEDYRKGGYHPVRIGDVFN-GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREG 134 (590)
T ss_pred cChhhhhcCCCceeecccccc-CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhc
Confidence 444455566777766666542 368999999999999999999764 6788999999988888888999999999984
Q ss_pred ---C---CCeeeEEEEEE----eCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 041755 385 ---H---RNIISLFGFCF----EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454 (678)
Q Consensus 385 ---H---pnIv~l~g~~~----~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~i 454 (678)
| .+||+|+++|. .+.+.|||+|++ |.+|..+|..... ..++...+.+|+.||+.||.|||.. -+|
T Consensus 135 Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~e--cgI 209 (590)
T KOG1290|consen 135 DPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRE--CGI 209 (590)
T ss_pred CCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHh--cCc
Confidence 2 47999999996 456899999999 7788888876543 5578899999999999999999995 589
Q ss_pred eeccCCCCCeEecCC-----------C-----------------------------------------------------
Q 041755 455 IHKDVKSSNILLSDD-----------F----------------------------------------------------- 470 (678)
Q Consensus 455 iHrDIKp~NILl~~~-----------~----------------------------------------------------- 470 (678)
||.||||+||||..+ +
T Consensus 210 IHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~ 289 (590)
T KOG1290|consen 210 IHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLA 289 (590)
T ss_pred cccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhc
Confidence 999999999998310 0
Q ss_pred --------------------------------------------------------------------------------
Q 041755 471 -------------------------------------------------------------------------------- 470 (678)
Q Consensus 471 -------------------------------------------------------------------------------- 470 (678)
T Consensus 290 ~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~ 369 (590)
T KOG1290|consen 290 GLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPS 369 (590)
T ss_pred ccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcC
Confidence
Q ss_pred ----------------------CcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHH
Q 041755 471 ----------------------EPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLEL 528 (678)
Q Consensus 471 ----------------------~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eL 528 (678)
.+||+|||-|.|.... .+...-|..|+|||++.+..|++.+|||||+|+++||
T Consensus 370 s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FEL 444 (590)
T KOG1290|consen 370 SPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFEL 444 (590)
T ss_pred CccccccccccCCCCCCCccceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHh
Confidence 0244444444443221 1223457789999999999999999999999999999
Q ss_pred hcCCCCCCCCCCcc---ccc--------chhhcccccccCccc-cccCCC-----------------CC--CCCCHHHHH
Q 041755 529 LSGKKPINSENPKG---QES--------LVMWAKPILKDGKVS-QLLDPS-----------------LD--TDYDNDQIE 577 (678)
Q Consensus 529 ltG~~Pf~~~~~~~---~~~--------l~~~~~~~~~~~~~~-~l~dp~-----------------l~--~~~~~~~~~ 577 (678)
+||..-|+...... .+. +-..-..+...|+.. ++++.. |. -.+..++..
T Consensus 445 aTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~ 524 (590)
T KOG1290|consen 445 ATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQ 524 (590)
T ss_pred hcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHH
Confidence 99999987544332 111 111122233333322 222211 11 246778889
Q ss_pred HHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 578 RMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 578 ~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+..+..-||+.+|++|||+.+.++
T Consensus 525 ~fsdFL~PmLef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 525 QFSDFLSPMLEFDPEKRPTAAQCLK 549 (590)
T ss_pred HHHHHHHHHHhcCccccccHHHHhc
Confidence 9999999999999999999999885
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=261.85 Aligned_cols=196 Identities=24% Similarity=0.364 Sum_probs=169.7
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHH---------HHHHHHHHHHHHhcC---CCCeeeEEEEEEe
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDV---------LKEFASEIEIITALH---HRNIISLFGFCFE 397 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~---------~~~~~~Ei~il~~l~---HpnIv~l~g~~~~ 397 (678)
.+|...+.+|.|+||.|+.+..+ +...|+||.+.+.+-. .-..-.||.||..|+ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46888889999999999999876 5678999988765422 223556999999998 9999999999999
Q ss_pred CCeEEEEEEcC-CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEee
Q 041755 398 DNNLLLVYDFL-SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSD 476 (678)
Q Consensus 398 ~~~~~lV~E~~-~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~D 476 (678)
++.+||+||-. ++-+|++++... ..+.+.+..-|+.|++.|+++||+ .+|||||||-+|+.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEee
Confidence 99999999976 455899998643 578999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCceecccccCCCCCCcchhccCCCC-ccceEeehhHHHHHHhcCCCCCCC
Q 041755 477 FGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVS-EKIDVYAFGIVLLELLSGKKPINS 537 (678)
Q Consensus 477 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~ 537 (678)
||.|.....+.. ..++||.+|.|||++.+.+|- ..-|||++|++||.++....||..
T Consensus 714 fgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999887655432 347899999999999988874 568999999999999999999863
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=235.82 Aligned_cols=198 Identities=33% Similarity=0.504 Sum_probs=173.0
Q ss_pred CCCceeecccCceEEEEEEeCC-CCEEEEEEeCCCh-H-HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 333 FLPEYLVGKGGHSHVYRGCLPD-GKELAVKILKPSE-D-VLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~~-g~~vAvK~l~~~~-~-~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
|...+.||.|++|.||++...+ ++.+++|.+.... . ..+.+.+|++.+..++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999998864 8999999998654 2 57789999999999999999999999999899999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+++|.+++..... .+++...+.++.+++.+|.|||+ .+++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999875421 17899999999999999999999 89999999999999999999999999999877654311
Q ss_pred ceecccccCCCCCCcchh-ccCCCCccceEeehhHHHHHHhcCCCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYF-MHGKVSEKIDVYAFGIVLLELLSGKKPINS 537 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 537 (678)
......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12235678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=234.25 Aligned_cols=257 Identities=21% Similarity=0.326 Sum_probs=191.5
Q ss_pred hcCCCCceeecccCceEEEEEE-eCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeC--CeEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFASEIEIITALH-HRNIISLFGFCFED--NNLLLVY 405 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~-~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~--~~~~lV~ 405 (678)
.++|...+.+|+|.|+.||.|. ..+...++||++++-+ .+.+.+|+.||..|. ||||+.|++...+. ....||+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 3577788899999999999997 3478899999999754 467889999999998 99999999998654 5678999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC-CCcEEeecccccccC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD-FEPQLSDFGLASWLS 484 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~-~~~kL~DFGla~~~~ 484 (678)
||+.+.+..... +.+....+..++.+++.||.|+|+ +||+|||+||.|++||.. -.++|+|+|||.++.
T Consensus 115 E~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 115 EYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 999887776655 346677888899999999999999 999999999999999975 469999999999887
Q ss_pred CCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccccc------C
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKD------G 557 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~------~ 557 (678)
++.... ..+.+..|-.||.+.. ..|+..-|+|||||+|..|+..+.||..... ....++..++-+-.+ +
T Consensus 185 p~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 185 PGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHH
Confidence 654322 2355677889999865 6689999999999999999999999864332 222333332211111 0
Q ss_pred ccccccCCCCCC---CCC------------HH-HHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 KVSQLLDPSLDT---DYD------------ND-QIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ~~~~l~dp~l~~---~~~------------~~-~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
++.--+||.+.. ... .. .....+.++-..|+.|..+|||+.|.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111123333221 000 00 0133445556778999999999998764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-27 Score=258.39 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=201.7
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
.+|.....+|.|.||.|||+++. .+...|+|+++-.. +...-..+|+-+++..+||||+.++|-+...+.+++.||||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 46777788999999999999875 78999999998643 45566778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
.+|+|.+..+.. .++.+.++..+.++.++||.|||+ .+-+|||||-.|||+++.|.+|++|||.+..+...-
T Consensus 95 gggslQdiy~~T----gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 95 GGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred CCCcccceeeec----ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh-
Confidence 999999988754 678999999999999999999999 899999999999999999999999999987665422
Q ss_pred CceecccccCCCCCCcchh---ccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 489 HLTCTDVAGTFGYLAPEYF---MHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l---~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
.....+.||+.|||||+. ..+.|..++|||++|+...||---++|.....+.. .+.+..+..+.. |
T Consensus 167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~LmTkS~~qp--------p 235 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALFLMTKSGFQP--------P 235 (829)
T ss_pred -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHHHhhccCCCC--------C
Confidence 223457899999999986 45789999999999999999988888876654432 111111111111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.. .....+.+-+++..|+..+|.+||++..++.
T Consensus 236 ~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111 1223445666778999999999999876653
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-27 Score=235.86 Aligned_cols=258 Identities=21% Similarity=0.267 Sum_probs=191.1
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------Ce
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFED------NN 400 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~ 400 (678)
.+|.....+|.|.- .|..+.+. .++.||+|.+.. .....++..+|..++..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666677888888 66666543 689999997743 224456778999999999999999999998643 35
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
.|+||||| .++|...++. .++-.....|+.|++.|+.|||+ .+|+||||||+||++..++.+||.|||+|
T Consensus 96 ~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhh
Confidence 79999999 6688887762 35677888999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccc--------
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP-------- 552 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~-------- 552 (678)
+..... ..++..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+.+.-.+-..+.....
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 865443 456678899999999999988899999999999999999999999886554332211110000
Q ss_pred --------cccc------Ccccccc-CCCCCCC--CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 553 --------ILKD------GKVSQLL-DPSLDTD--YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 553 --------~~~~------~~~~~l~-dp~l~~~--~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+. -.+.+++ |...... .+.-...-.-.++..||-.+|++|-++.++|.
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0000 0111111 1111111 11111223344668999999999999999885
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-26 Score=272.21 Aligned_cols=196 Identities=18% Similarity=0.254 Sum_probs=139.8
Q ss_pred hcCC-CCeeeEEEEE-------EeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 041755 382 ALHH-RNIISLFGFC-------FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453 (678)
Q Consensus 382 ~l~H-pnIv~l~g~~-------~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~ 453 (678)
.++| +||++++++| .+...+++++||+ +++|.++|... ...+++.+++.++.||++||.|||+ ++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHS---QG 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 3455 5888888877 3334678889987 66999999642 3568999999999999999999999 99
Q ss_pred eeeccCCCCCeEecC-------------------CCCcEEeecccccccCCCCC--------------CceecccccCCC
Q 041755 454 VIHKDVKSSNILLSD-------------------DFEPQLSDFGLASWLSTSSS--------------HLTCTDVAGTFG 500 (678)
Q Consensus 454 iiHrDIKp~NILl~~-------------------~~~~kL~DFGla~~~~~~~~--------------~~~~~~~~Gt~~ 500 (678)
|+||||||+||||+. ++.+||+|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 44566667776654221000 000112468999
Q ss_pred CCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHH
Q 041755 501 YLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMV 580 (678)
Q Consensus 501 Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~ 580 (678)
|+|||++.+..++.++|||||||+||||++|..|+..... ....... ..+.+.. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~---------~~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH---------RVLPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH---------hhcChhh-----hhcCHHHH
Confidence 9999999999999999999999999999999888753211 0000000 0111111 01122345
Q ss_pred HHHHhcccCCCCCCCCHHHHHH
Q 041755 581 LAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 581 ~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.++..||+.+|.+||+|.+|++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 6678999999999999999985
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=220.97 Aligned_cols=253 Identities=22% Similarity=0.354 Sum_probs=184.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-CCCeeeEEEE-EEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALH-HRNIISLFGF-CFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~-~~~~~~~~lV~E~ 407 (678)
+.|.+.+.||+|.||.+-++... ..+.+++|-+.......++|.+|...--.|. |.||+.-+++ |...+.+++++||
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 56778889999999999999876 5778999998877778899999998766664 8999988765 4555678899999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec--CCCCcEEeecccccccCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS--DDFEPQLSDFGLASWLST 485 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~--~~~~~kL~DFGla~~~~~ 485 (678)
++.|+|...+.. ..+.+....+++.|++.||.|+|+ +++||||||.+||||- +...+||||||+.+..+.
T Consensus 104 aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 104 APRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred CccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999998854 346778888999999999999999 9999999999999993 345799999999876543
Q ss_pred CCCCceecccccCCCCCCcchhccC-----CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHG-----KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
. .....-+..|.+||..... ...+.+|||.||++++.++||..||.......+ ....|.. +..+...
T Consensus 176 t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y~~~~~--w~~rk~~ 247 (378)
T KOG1345|consen 176 T-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PYWEWEQ--WLKRKNP 247 (378)
T ss_pred e-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hHHHHHH--HhcccCc
Confidence 2 1223446789999987542 246789999999999999999999984433222 2222221 1221111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
.+ |..-..+.+. ..+|. ..-+..++++|-.+.++.++-.
T Consensus 248 ~~--P~~F~~fs~~-a~r~F---kk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 248 AL--PKKFNPFSEK-ALRLF---KKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred cC--chhhcccCHH-HHHHH---HHhcCCcccccchhHHHHHHHH
Confidence 10 1111122222 22232 5668888999976666666543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-25 Score=230.69 Aligned_cols=200 Identities=25% Similarity=0.393 Sum_probs=164.4
Q ss_pred hhcCCCCceeecccCceEEEEEEeC----CCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP----DGKELAVKILKPSEDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~----~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~l 403 (678)
..+.|...++||+|.|++||++.+. ..+.||+|.+.... ....+.+|+++|..+. +.||+++.+++..++..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 3456888999999999999999753 46789999886432 2345789999999996 8999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC-CCcEEeecccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD-FEPQLSDFGLASW 482 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~-~~~kL~DFGla~~ 482 (678)
|+||+++.+..+++. .++..++..++..++.||.++|. +|||||||||+|+|.+.. +.-.|+|||||.+
T Consensus 113 vlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHH
Confidence 999999999888884 35678889999999999999999 999999999999999854 5678999999984
Q ss_pred cCCCC------C--------------------------Cce----------ecccccCCCCCCcchhcc-CCCCccceEe
Q 041755 483 LSTSS------S--------------------------HLT----------CTDVAGTFGYLAPEYFMH-GKVSEKIDVY 519 (678)
Q Consensus 483 ~~~~~------~--------------------------~~~----------~~~~~Gt~~Y~APE~l~~-~~~s~ksDVw 519 (678)
..... . ... .....||+||.|||++.. +..+.++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 21100 0 000 012469999999999865 5678999999
Q ss_pred ehhHHHHHHhcCCCCCCCCC
Q 041755 520 AFGIVLLELLSGKKPINSEN 539 (678)
Q Consensus 520 SlGvvL~eLltG~~Pf~~~~ 539 (678)
|.|||++-+++++.||....
T Consensus 263 s~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred eccceeehhhccccccccCc
Confidence 99999999999999996543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=207.22 Aligned_cols=166 Identities=27% Similarity=0.257 Sum_probs=124.8
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++... +..++|.+++.++.|++.||.|||+ ++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc---
Confidence 7899999643 3569999999999999999999998 55 999999999999999 99988764422
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+..+...... .++.-. .
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~-------~~~~~~-~ 130 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPA-------DDPRDR-S 130 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhcc-------CCcccc-c
Confidence 2689999999999999999999999999999999999999965432111 11111100000 000000 0
Q ss_pred CCHHHH--HHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 571 YDNDQI--ERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 571 ~~~~~~--~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
...... ..+.+++..||..+|.+||++.++++.+..
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~ 168 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA 168 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence 111122 258889999999999999999999987753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=223.44 Aligned_cols=165 Identities=20% Similarity=0.183 Sum_probs=130.1
Q ss_pred hhcCCCCceeecccCceEEEEEEeC--CCCEEEEEEeCCC------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP--DGKELAVKILKPS------EDVLKEFASEIEIITALHHRNIISLFGFCFEDNN 400 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~--~g~~vAvK~l~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 400 (678)
..++|...+.||+|+||+||+|... +++.||||++... ......|.+|+++|.+++|+|+++.+.. .+.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~ 92 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGK 92 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCC
Confidence 3467888999999999999999764 5778899986532 2345678999999999999999853322 245
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccC-CCCCeEecCCCCcEEeeccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDV-KSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDI-Kp~NILl~~~~~~kL~DFGl 479 (678)
.++||||+++++|... . . .. ...++.++++||.|||+ ++|+|||| ||+|||++.++.+||+|||+
T Consensus 93 ~~LVmE~~~G~~L~~~-~---~----~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-R---P----HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred cEEEEEccCCCCHHHh-C---c----cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 7999999999999632 1 1 01 14578899999999999 99999999 99999999999999999999
Q ss_pred ccccCCCCCCce------ecccccCCCCCCcchhccC
Q 041755 480 ASWLSTSSSHLT------CTDVAGTFGYLAPEYFMHG 510 (678)
Q Consensus 480 a~~~~~~~~~~~------~~~~~Gt~~Y~APE~l~~~ 510 (678)
|+.+........ .+...+++.|+|||++...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 997765432211 1357889999999998653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-21 Score=203.22 Aligned_cols=260 Identities=28% Similarity=0.415 Sum_probs=196.4
Q ss_pred CCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCC-CeeeEEEEEEeCCeEEEEEEc
Q 041755 333 FLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE----DVLKEFASEIEIITALHHR-NIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~Hp-nIv~l~g~~~~~~~~~lV~E~ 407 (678)
|.....||.|+||.||++... ..+++|.+.... .....|.+|+.++..+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556778999999999999876 889999987543 2578899999999999988 799999999777778999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC-CcEEeecccccccCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF-EPQLSDFGLASWLSTS 486 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kL~DFGla~~~~~~ 486 (678)
+.++++.+++...... ..+.......++.|++.++.|+|. .+++|||+||+||+++..+ .++++|||++......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999766543211 368889999999999999999999 8999999999999999998 7999999999866554
Q ss_pred CCCc----eecccccCCCCCCcchhcc---CCCCccceEeehhHHHHHHhcCCCCCCCCCCc-ccccchhhcccccccCc
Q 041755 487 SSHL----TCTDVAGTFGYLAPEYFMH---GKVSEKIDVYAFGIVLLELLSGKKPINSENPK-GQESLVMWAKPILKDGK 558 (678)
Q Consensus 487 ~~~~----~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~-~~~~l~~~~~~~~~~~~ 558 (678)
.... ......||..|+|||.+.+ ..++...|+|++|++++++++|..||...... ........ +....
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~----~~~~~ 231 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI----ILELP 231 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH----HHhcC
Confidence 3321 2345789999999999987 57889999999999999999999997655431 00000000 00000
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
.. .................+..++..|+..+|..|.++.+....
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 000001100002223456667788899999999999887754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.2e-22 Score=211.79 Aligned_cols=259 Identities=22% Similarity=0.238 Sum_probs=191.1
Q ss_pred CCCCceeecccCceEEEEEEeCCC--CEEEEEEeCCCh-HHHHHHHHHHHHHHhcCC----CCeeeEEEEE-EeCCeEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLPDG--KELAVKILKPSE-DVLKEFASEIEIITALHH----RNIISLFGFC-FEDNNLLL 403 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~~g--~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~H----pnIv~l~g~~-~~~~~~~l 403 (678)
+|...+.||+|+||.||.+..... ..+|+|+..... .....+..|+.++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999987543 478999876532 112267789999988873 6899999988 47778899
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC-----CCcEEeecc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD-----FEPQLSDFG 478 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~-----~~~kL~DFG 478 (678)
||+.+ +.+|.++..... ...|+......|+.|++.+|.+||+ .|++||||||+|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 889999875543 4679999999999999999999999 999999999999999865 468999999
Q ss_pred ccc--ccCCCCC----Cce--ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhc
Q 041755 479 LAS--WLSTSSS----HLT--CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA 550 (678)
Q Consensus 479 la~--~~~~~~~----~~~--~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~ 550 (678)
+++ .+..... ... .....||..|.++....+...+.+.|+||++.++.||+.|..||.............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~-- 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE-- 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH--
Confidence 998 3322211 111 123569999999999999999999999999999999999999996544322111000
Q ss_pred ccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 551 KPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 551 ~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.. ........ .......+...+. ..+-..+...+|....+...|+...
T Consensus 251 -~~----~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 251 -KD----PRKLLTDR--FGDLKPEEFAKIL---EYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred -HH----hhhhcccc--ccCCChHHHHHHH---HHhhccCCcCCCCHHHHHHHHHHHH
Confidence 00 00011111 1112233333333 3334478999999999999876543
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-21 Score=179.92 Aligned_cols=133 Identities=29% Similarity=0.393 Sum_probs=111.4
Q ss_pred EEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCC--CCcCc---h-----hhhhhHHHHHHHHHHhhhhccCCe
Q 041755 6 VVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTIT--ESTGS---L-----LSLVKTFDSMLSVYEGFCNLKQVD 75 (678)
Q Consensus 6 ~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~--~~~~~---~-----~~~~~~~~~~l~~~~~~C~~k~v~ 75 (678)
+|+||+|+|+.|++||+||++.+...|+.|++|||.+++. ..... . ....+...++|+++...|...++.
T Consensus 1 ~ILVavD~S~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 80 (146)
T cd01989 1 SVAVAVDKDKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKLEVASAYKQEEDKEAKELLLPYRCFCSRKGVQ 80 (146)
T ss_pred CEEEEecCccccHHHHHHHHHhccCCCCcEEEEEeccCcccCCCCccchHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 5899999999999999999999888899999999987643 11000 0 111234458899999999888999
Q ss_pred EEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCccc---cccCcchhhHhhhcCCCceEEEEEeCC
Q 041755 76 LKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRT---IRSSVSVAKYCARKLSKNFGVFAVENG 139 (678)
Q Consensus 76 ~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~---~r~~~svs~yc~~~ap~~c~V~~v~~~ 139 (678)
++..++.||++.++|+++|++.+||+||||+|+++.+ +.| +||++||++++|++|+|++|++|
T Consensus 81 ~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~g-ssva~~Vi~~a~~~c~Vlvv~~~ 146 (146)
T cd01989 81 CEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKK-SDVASSVLKEAPDFCTVYVVSKG 146 (146)
T ss_pred EEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccC-CchhHHHHhcCCCCceEEEEeCc
Confidence 9999999789999999999999999999999998653 333 47999999999999999999997
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.2e-22 Score=226.75 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=187.0
Q ss_pred CCceeecccCceEEEEEEe-CCCCEEEEEEeC----CCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 334 LPEYLVGKGGHSHVYRGCL-PDGKELAVKILK----PSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 334 ~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~----~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
....++|.|.+|.|+.... ......+.|.++ +.. .....+..|+.+-..|+|||++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3567899999997776643 234444444332 322 22333777888889999999998888777766666669
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
|||++ +|+.++... ..+.-.++..++.|++.|+.|||+ .||.|||+|++|++++.+|.+||+|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 999998643 357778888999999999999999 9999999999999999999999999999987655
Q ss_pred CCCC--ceecccccCCCCCCcchhccCCCCc-cceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 486 SSSH--LTCTDVAGTFGYLAPEYFMHGKVSE-KIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 486 ~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~-ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
.... .....++|+-.|+|||.+....|.+ ..||||.|+++..|++|+.||.......... ........
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---------~~~~~~~~ 543 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---------KTNNYSDQ 543 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---------hhhccccc
Confidence 4443 4455689999999999999999986 5899999999999999999997654432211 00000000
Q ss_pred cCCCCCC-CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 563 LDPSLDT-DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 563 ~dp~l~~-~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+-.... ........+...++.++|+.+|.+|-+|.+|++
T Consensus 544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000000 111233445666778999999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.1e-20 Score=186.61 Aligned_cols=138 Identities=18% Similarity=0.215 Sum_probs=108.1
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChH---H-------HHHH-----------------HHHHHHHHhcCCCCe
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSED---V-------LKEF-----------------ASEIEIITALHHRNI 388 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~---~-------~~~~-----------------~~Ei~il~~l~HpnI 388 (678)
...||+|+||.||+|...+|+.||||+++.+.. . ...| ..|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999999999988899999999975421 0 1122 349999999988776
Q ss_pred eeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeeccCCCCCeEec
Q 041755 389 ISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYL-HNSCEQPVIHKDVKSSNILLS 467 (678)
Q Consensus 389 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yL-H~~~~~~iiHrDIKp~NILl~ 467 (678)
.....+... ..+|||||++++++...+.. ...+++.....++.|++.+|.|| |+ .+|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE
Confidence 443333222 23899999988877654321 24688899999999999999999 67 8999999999999998
Q ss_pred CCCCcEEeeccccccc
Q 041755 468 DDFEPQLSDFGLASWL 483 (678)
Q Consensus 468 ~~~~~kL~DFGla~~~ 483 (678)
++.++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=190.17 Aligned_cols=202 Identities=21% Similarity=0.311 Sum_probs=170.1
Q ss_pred cCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSEDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
-+|.+.++||+|.||..+.|.. -+++.||||.-.. +....++..|.+..+.|. .++|...+.|..++.+-.||+|.+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 3788999999999999999973 4899999996532 223345667888888775 799999999999998889999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC-----CCcEEeeccccccc
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD-----FEPQLSDFGLASWL 483 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~-----~~~kL~DFGla~~~ 483 (678)
|-+|+|++.- .+..|+...+.-+|.|++.-++|+|. +.+|+|||||+|+||..- ..+.|+|||+|+.+
T Consensus 107 -GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8899988763 34679999999999999999999999 999999999999999643 35899999999988
Q ss_pred CCCCCCc-----eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCC
Q 041755 484 STSSSHL-----TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540 (678)
Q Consensus 484 ~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 540 (678)
.+..+.. ......||..||+--...+...+...|+-|||-|+++.|-|..||.+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 6543321 12346799999999999999999999999999999999999999987644
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.2e-21 Score=223.46 Aligned_cols=252 Identities=21% Similarity=0.224 Sum_probs=180.6
Q ss_pred CCCCceeecccCceEEEEEEeCCCCEEEEEEeCC-Ch-HHHHHH---HHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKP-SE-DVLKEF---ASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~-~~-~~~~~~---~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
+|...+.||.+.|=+|.+|++++|. |+||++-. +. -....| +.|++ ...++|||.+++..+-..+.-.|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5667778999999999999998888 89998843 32 223334 44444 556789999999888766677788989
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC--
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS-- 484 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~-- 484 (678)
|+ ..+|.|.|.. ++.+...+..-|+.|++.||.-+|. .||+|+|||.+||||+.-+-+.|+||--.+...
T Consensus 102 yv-khnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YV-KHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HH-hhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 98 4488888753 3567888888899999999999999 999999999999999999999999997765432
Q ss_pred CCC---CCceecccccCCCCCCcchhccC----------C-CCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhh
Q 041755 485 TSS---SHLTCTDVAGTFGYLAPEYFMHG----------K-VSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMW 549 (678)
Q Consensus 485 ~~~---~~~~~~~~~Gt~~Y~APE~l~~~----------~-~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~ 549 (678)
.+. .......-..-.+|+|||.|..+ . ++++.||||+||++.||++ |++||... .+..|
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~aY 247 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLAY 247 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHhH
Confidence 111 11111112233579999998542 2 6789999999999999998 78888532 11111
Q ss_pred cccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCHh
Q 041755 550 AKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEE 609 (678)
Q Consensus 550 ~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~~ 609 (678)
-..- ....+.++. .- . -..+..+++.|++.||..|-++++.|+.-.|..-
T Consensus 248 r~~~--~~~~e~~Le----~I-e---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F 297 (1431)
T KOG1240|consen 248 RSGN--ADDPEQLLE----KI-E---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF 297 (1431)
T ss_pred hccC--ccCHHHHHH----hC-c---CccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence 1000 000111110 00 0 1145567799999999999999999998777643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-21 Score=193.24 Aligned_cols=243 Identities=20% Similarity=0.410 Sum_probs=184.8
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHH
Q 041755 338 LVGKGGHSHVYRGCLPDGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLE 414 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 414 (678)
+|.+.-.|..|+|++ .|..+++|+++..+ ....+|..|.-.|+-+.||||++++|.|....++.++..||+.|+|.
T Consensus 197 kl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly 275 (448)
T KOG0195|consen 197 KLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY 275 (448)
T ss_pred hhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence 467778899999999 56677788886533 45577889999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCee-eccCCCCCeEecCCCCcEEeecccccccCCCCCCceec
Q 041755 415 ENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI-HKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCT 493 (678)
Q Consensus 415 ~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~ii-HrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 493 (678)
..||+.. +-.++-.+..+++..+|+|+.|||+. .++| ---|....+++|++.+++|+= +-+++ .....
T Consensus 276 nvlhe~t--~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarism-ad~kf------sfqe~ 344 (448)
T KOG0195|consen 276 NVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF------SFQEV 344 (448)
T ss_pred HHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheec-cccee------eeecc
Confidence 9999753 35567788899999999999999984 3444 346889999999999988851 11111 11111
Q ss_pred ccccCCCCCCcchhccCCCC---ccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 494 DVAGTFGYLAPEYFMHGKVS---EKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 494 ~~~Gt~~Y~APE~l~~~~~s---~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
...-.+.|++||.++..+-+ ..+|+|||.++||||.|...||....+.+-...+. ++ | ++..
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-----le-g---------lrv~ 409 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-----LE-G---------LRVH 409 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-----hc-c---------cccc
Confidence 22346789999999876543 47999999999999999999998776643221111 11 1 1122
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.++.....|..++.-|+..||.+||.+..|+-+|+..
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 2333345577777999999999999999999988753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=189.17 Aligned_cols=169 Identities=14% Similarity=0.177 Sum_probs=133.4
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh----HHHHH------HHHHHHHHHhcCCCCeeeEEEEEEeC-
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE----DVLKE------FASEIEIITALHHRNIISLFGFCFED- 398 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~----~~~~~------~~~Ei~il~~l~HpnIv~l~g~~~~~- 398 (678)
.++|...+++|.|+||.||.... ++..+|||++++.. ..... |.+|+..+.++.|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 57899999999999999999755 67789999997532 22233 57899999999999999999886533
Q ss_pred -------CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC
Q 041755 399 -------NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE 471 (678)
Q Consensus 399 -------~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~ 471 (678)
+..+|||||++|.+|.+... ++. ....+++.+|..||. .|++|||+||+||+++.++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-
Confidence 35799999999999987732 222 245699999999999 9999999999999999998
Q ss_pred cEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHh
Q 041755 472 PQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELL 529 (678)
Q Consensus 472 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLl 529 (678)
++|+|||........... ..++....+..++|+|+||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987654221111 11455666778999999999987653
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-20 Score=181.48 Aligned_cols=189 Identities=15% Similarity=0.080 Sum_probs=144.5
Q ss_pred CCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHH-----HHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEc
Q 041755 334 LPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLK-----EFASEIEIITALH-HRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 334 ~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~-----~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
.+...|++|+||+||.+.. .+.+++.+.+........ .|.+|+++|.+|. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999998766 788888888876554333 5789999999995 5889999886 356999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccC-CCCCeEecCCCCcEEeecccccccCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDV-KSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDI-Kp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
+.+.+|...+.. . ...++.|++.+|.++|. .||+|||| ||+|||++.++.++|+|||+|......
T Consensus 80 I~G~~L~~~~~~----------~-~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR----------G-DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh----------h-hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999998654321 1 13477899999999999 99999999 799999999999999999999865543
Q ss_pred CCC---ce--------ecccccCCCCCCcchhccC-CCC-ccceEeehhHHHHHHhcCCCCCCCCCCc
Q 041755 487 SSH---LT--------CTDVAGTFGYLAPEYFMHG-KVS-EKIDVYAFGIVLLELLSGKKPINSENPK 541 (678)
Q Consensus 487 ~~~---~~--------~~~~~Gt~~Y~APE~l~~~-~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~ 541 (678)
... .. ......++.|++|+...-- ..+ ...++++.|+.+|.++|++.|+-.+.+.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 211 00 0113467888888754321 223 5679999999999999999987665543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-20 Score=183.71 Aligned_cols=205 Identities=22% Similarity=0.300 Sum_probs=170.6
Q ss_pred hcCCCCceeecccCceEEEEEE-eCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCCeEEEEEEc
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFASEIEIITALHH-RNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~-~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E~ 407 (678)
.++|...+.||.|+||.+|.|. ..+|..||||+-.... ...++..|..+...|++ ..|..+.-|..+...-.||||.
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL 92 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL 92 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence 4688999999999999999997 4589999999875432 23456789999999985 6777778888888888999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC---CCcEEeecccccccC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD---FEPQLSDFGLASWLS 484 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~---~~~kL~DFGla~~~~ 484 (678)
+ +-+|++.+.-.. ..|+..+.+-++-|++.-++|+|. +++|||||||+|+|+.-+ ..+.|+|||||+.+-
T Consensus 93 L-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 93 L-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred c-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 8 889999886432 568889999999999999999999 999999999999999643 568999999999876
Q ss_pred CCCCCc-----eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcc
Q 041755 485 TSSSHL-----TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542 (678)
Q Consensus 485 ~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 542 (678)
+..+.. ......||..|.+--...+-..+...|+-|+|.+|..+.-|..||.+..+..
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 543321 2334789999999888877788899999999999999999999998866543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.8e-19 Score=178.01 Aligned_cols=141 Identities=24% Similarity=0.245 Sum_probs=111.0
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChH---------------------------HHHHHHHHHHHHHhcCCCCe
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSED---------------------------VLKEFASEIEIITALHHRNI 388 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~---------------------------~~~~~~~Ei~il~~l~HpnI 388 (678)
...||+|+||.||+|...+|+.||||++++... ....+..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 457999999999999987899999999875421 01223578999999999987
Q ss_pred eeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC
Q 041755 389 ISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD 468 (678)
Q Consensus 389 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~ 468 (678)
.....+.... .+|||||++++++...... ...++..+...++.+++.+|.+||. ..+|+||||||+|||++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 5544443332 4899999988865443221 1346778889999999999999997 37999999999999999
Q ss_pred CCCcEEeecccccccCC
Q 041755 469 DFEPQLSDFGLASWLST 485 (678)
Q Consensus 469 ~~~~kL~DFGla~~~~~ 485 (678)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999986644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.7e-19 Score=204.82 Aligned_cols=250 Identities=19% Similarity=0.220 Sum_probs=182.5
Q ss_pred HHHhhcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCeEE
Q 041755 326 LLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALH---HRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 326 l~~~t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~ 402 (678)
+..-...|.+.+.||+|+||+||+|...+|+.||+|+-++...+ +|.--.+++.+|+ -+.|..+..++.-.+..+
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW--EFYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce--eeeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 33344568888999999999999999888999999999875432 1211223344444 234445555555566779
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec-------CCCCcEEe
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS-------DDFEPQLS 475 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~-------~~~~~kL~ 475 (678)
||+||.+.|+|.+++. ....++|.....++.|++.-+++||. .+|||+||||+|.||. ++.-++|+
T Consensus 771 lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEE
Confidence 9999999999999997 34678999999999999999999999 9999999999999994 23458999
Q ss_pred ecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccc
Q 041755 476 DFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILK 555 (678)
Q Consensus 476 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 555 (678)
|||.+.-+..-........+++|-++-.+|+..+..+++.+|.|.|.-+++-||.|++.- ..
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~~ 905 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------VK 905 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------hc
Confidence 999987654433334555678999999999999999999999999999999999998642 01
Q ss_pred cCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 556 DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 556 ~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+| ....++..+...+..+...+++... |..+-..=|...++...|++
T Consensus 906 ~g-~~~~~~~~~~Ry~~~~~W~~~F~~l---LN~~~~~~p~l~~lr~~~~~ 952 (974)
T KOG1166|consen 906 NG-SSWMVKTNFPRYWKRDMWNKFFDLL---LNPDCDTLPNLQELRTELEE 952 (974)
T ss_pred CC-cceeccccchhhhhHHHHHHHHHHH---hCcCcccchhHHHHHHHHHH
Confidence 11 1112222233334455566666554 44333334666666666654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=180.38 Aligned_cols=232 Identities=22% Similarity=0.301 Sum_probs=148.7
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCC----ChHHHHHHHHHHHHHHhcCC-----------CCeeeEEEEE-
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP----SEDVLKEFASEIEIITALHH-----------RNIISLFGFC- 395 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~----~~~~~~~~~~Ei~il~~l~H-----------pnIv~l~g~~- 395 (678)
+.....||.|+++.||.+.+. +|+.+|+|++.. .....+.+.+|.-.+..+.+ ..++++--.-
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345678999999999999986 589999998742 23456777777655554332 1222221111
Q ss_pred -------EeCC--------eEEEEEEcCCCCCHHHHhc---cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 041755 396 -------FEDN--------NLLLVYDFLSRGSLEENLH---GNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHK 457 (678)
Q Consensus 396 -------~~~~--------~~~lV~E~~~~gsL~~~L~---~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHr 457 (678)
.... +.+++|+-+ .++|.+++. ........+....+..+..|+++.+++||. .|++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 1111 346788877 668877653 222222334566677888999999999999 999999
Q ss_pred cCCCCCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccC--------CCCccceEeehhHHHHHHh
Q 041755 458 DVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG--------KVSEKIDVYAFGIVLLELL 529 (678)
Q Consensus 458 DIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--------~~s~ksDVwSlGvvL~eLl 529 (678)
||||+|+|++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|.|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999887755442211 2345779999977442 4788999999999999999
Q ss_pred cCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCC
Q 041755 530 SGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVR 594 (678)
Q Consensus 530 tG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~R 594 (678)
+|+.||....+...... .+.... +..+.+..++...|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~~-------------------~f~~C~--~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW-------------------DFSRCR--DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG-------------------GGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc-------------------cchhcC--CcCHHHHHHHHHHccCCcccC
Confidence 99999987644322111 111111 344556667788899999887
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.5e-19 Score=191.94 Aligned_cols=215 Identities=24% Similarity=0.406 Sum_probs=161.7
Q ss_pred HHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccC
Q 041755 380 ITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDV 459 (678)
Q Consensus 380 l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDI 459 (678)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....++|.....+...|+.||.|||+. ....|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence 3568899999999999999999999999999999999975 346789999999999999999999982 23399999
Q ss_pred CCCCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccC-------CCCccceEeehhHHHHHHhcCC
Q 041755 460 KSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-------KVSEKIDVYAFGIVLLELLSGK 532 (678)
Q Consensus 460 Kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-------~~s~ksDVwSlGvvL~eLltG~ 532 (678)
++.|.++|..+.+||+|||+.................-..-|.|||.+... ..+.+.||||||++++|+++..
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998876531111111112235569999998763 1467899999999999999999
Q ss_pred CCCCCCCCccc-ccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 533 KPINSENPKGQ-ESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 533 ~Pf~~~~~~~~-~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.||........ ..++.+.+. .-...+-|.+.... +....+..++..||..+|..||++..|-..++.
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred CccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 99987443322 122222111 11222333332211 223368888999999999999999998876654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.7e-20 Score=200.96 Aligned_cols=185 Identities=28% Similarity=0.367 Sum_probs=157.6
Q ss_pred eecccCceEEEEEE----eCCCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 338 LVGKGGHSHVYRGC----LPDGKELAVKILKPSE---DVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~----~~~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
.+|+|.||.|++.+ .+.|..+|+|+++... ........|..++...+ ||.++++...+..+..++++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999864 3357889999987532 11125567888888887 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+|.|...+... ..+.+.....+...++-+++++|+ .+|+|||+|++||+++.+|++++.|||+.+..-....
T Consensus 81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 99999888543 456777778888999999999999 9999999999999999999999999999986544322
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINS 537 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 537 (678)
.+||..|||||++. ......|+||||++++||+||..||..
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999998 567789999999999999999999986
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.7e-18 Score=168.51 Aligned_cols=136 Identities=20% Similarity=0.239 Sum_probs=105.4
Q ss_pred CCCceeecccCceEEEEEEeCCCCEEEEEEeCCC-hHHHHHHHHHHHHHHhc-----CCCCeeeEEEEEEeCC---e-EE
Q 041755 333 FLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPS-EDVLKEFASEIEIITAL-----HHRNIISLFGFCFEDN---N-LL 402 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l-----~HpnIv~l~g~~~~~~---~-~~ 402 (678)
.....+||+|+||.||. ...++.. +||++... ....+.+.+|+.++..+ .||||++++|++.++. . +.
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567899999999996 2224444 79988754 23456789999999999 5799999999998863 3 33
Q ss_pred EEEEc--CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeeeccCCCCCeEecC----CCCcEEe
Q 041755 403 LVYDF--LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEAL-DYLHNSCEQPVIHKDVKSSNILLSD----DFEPQLS 475 (678)
Q Consensus 403 lV~E~--~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL-~yLH~~~~~~iiHrDIKp~NILl~~----~~~~kL~ 475 (678)
+|+|| +.+|+|.+++... .+++. ..++.+++.++ +|||+ ++|+||||||+|||++. ++.++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 5579999999542 25544 35577888777 99999 99999999999999974 3479999
Q ss_pred ecccc
Q 041755 476 DFGLA 480 (678)
Q Consensus 476 DFGla 480 (678)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=169.51 Aligned_cols=144 Identities=19% Similarity=0.174 Sum_probs=112.0
Q ss_pred hcCCCCceeecccCceEEEEEE--eCCCCEEEEEEeCCChH-------------------------HHHHHHHHHHHHHh
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGC--LPDGKELAVKILKPSED-------------------------VLKEFASEIEIITA 382 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~--~~~g~~vAvK~l~~~~~-------------------------~~~~~~~Ei~il~~ 382 (678)
..-|.....||+|+||.||+|. ..+|+.||||+++.... ....+..|+.++.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3357778899999999999998 56899999999874320 11335689999999
Q ss_pred cCCC--CeeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eeeccC
Q 041755 383 LHHR--NIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP-VIHKDV 459 (678)
Q Consensus 383 l~Hp--nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~-iiHrDI 459 (678)
+.+. .+.+++++ ...++||||+++++|...+.. ...+...+...++.|++.+|.+||+ .+ |+||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Di 175 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDL 175 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCC
Confidence 9763 34444443 234899999999888765422 1235556678899999999999999 88 999999
Q ss_pred CCCCeEecCCCCcEEeecccccccCC
Q 041755 460 KSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 460 Kp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+||+++ ++.++|+|||++.....
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccCC
Confidence 99999999 88999999999875443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.6e-17 Score=162.55 Aligned_cols=145 Identities=19% Similarity=0.190 Sum_probs=114.1
Q ss_pred HHHHHhhcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChH-----------------------HHHHHHHHHHHH
Q 041755 324 QELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSED-----------------------VLKEFASEIEII 380 (678)
Q Consensus 324 ~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~-----------------------~~~~~~~Ei~il 380 (678)
.++......|...+.||+|+||.||++...+|+.||||+++.+.. ....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 455555555788899999999999999988899999998764320 112367789999
Q ss_pred HhcCCCC--eeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeecc
Q 041755 381 TALHHRN--IISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKD 458 (678)
Q Consensus 381 ~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrD 458 (678)
..+.|++ +...++. ...++||||+++++|...... .....++.+++.++.++|. .+|+|||
T Consensus 88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~---~gi~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK---HGIIHGD 150 (198)
T ss_pred HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH---CCCCcCC
Confidence 9998874 4444442 345899999999998765421 2345788999999999999 9999999
Q ss_pred CCCCCeEecCCCCcEEeecccccccCC
Q 041755 459 VKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 459 IKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
|||+||++++++.++|+|||++.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999865544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4e-17 Score=163.31 Aligned_cols=133 Identities=23% Similarity=0.397 Sum_probs=113.8
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCCh---------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 337 YLVGKGGHSHVYRGCLPDGKELAVKILKPSE---------DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+.||+|++|.||+|.. +|..+++|+..+.. .....+.+|+.++..+.|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 77889999865421 1234678899999999999998887777777788999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+++++|.+.+... .+ .+..++.+++.+|.+||+ .+++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998532 12 788999999999999999 9999999999999999 78999999998875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.2e-17 Score=160.50 Aligned_cols=129 Identities=20% Similarity=0.368 Sum_probs=107.3
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEeCCC-----h----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 338 LVGKGGHSHVYRGCLPDGKELAVKILKPS-----E----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~-----~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
+||+|+||.||+|.. +|..+++|+.... . .....+.+|++++..+.|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 6789999986432 1 12366788999999999987666555666666779999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
++++|.+.+.... . .++.+++.+|.+||+ .+++|+|++|.||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875321 0 789999999999999 9999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.5e-17 Score=183.32 Aligned_cols=140 Identities=18% Similarity=0.315 Sum_probs=114.1
Q ss_pred HHhhcCCCCceeecccCceEEEEEEeCCCCEEEEEEe-CC---Ch-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 041755 327 LSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKIL-KP---SE-----DVLKEFASEIEIITALHHRNIISLFGFCFE 397 (678)
Q Consensus 327 ~~~t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l-~~---~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 397 (678)
......|...++||+|+||.||+|.+.+ ..+++|+. .. .. .....+.+|++++..++|++++....++..
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 3344556778899999999999998744 34444432 11 11 224568899999999999999988888877
Q ss_pred CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeec
Q 041755 398 DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDF 477 (678)
Q Consensus 398 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DF 477 (678)
....++||||+++++|.+++. ....++.+++.+|.|||+ .+++||||||+|||+ .++.++|+||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeC
Confidence 777899999999999999884 346789999999999999 999999999999999 6789999999
Q ss_pred cccccc
Q 041755 478 GLASWL 483 (678)
Q Consensus 478 Gla~~~ 483 (678)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 998753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.9e-17 Score=166.63 Aligned_cols=194 Identities=24% Similarity=0.291 Sum_probs=132.3
Q ss_pred CCCCeeeEEEEEEe---------------------------CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHH
Q 041755 384 HHRNIISLFGFCFE---------------------------DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVA 436 (678)
Q Consensus 384 ~HpnIv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia 436 (678)
+|||||+++++|.+ +..+|+||.-+ ..+|..++..+. .+-....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-----CchHHHHHHH
Confidence 59999999998753 23589999877 458999986432 2334455688
Q ss_pred HHHHHHHHHHHhcCCCCeeeccCCCCCeEe--cCCC--CcEEeecccccccCCCC----CCceecccccCCCCCCcchhc
Q 041755 437 VGVAEALDYLHNSCEQPVIHKDVKSSNILL--SDDF--EPQLSDFGLASWLSTSS----SHLTCTDVAGTFGYLAPEYFM 508 (678)
Q Consensus 437 ~qia~aL~yLH~~~~~~iiHrDIKp~NILl--~~~~--~~kL~DFGla~~~~~~~----~~~~~~~~~Gt~~Y~APE~l~ 508 (678)
.|+++|+.|||. +||.|||+|++|||| |+++ .+.|+|||.+--..... ......+.-|...-||||++.
T Consensus 348 aQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 999999999999 999999999999998 4554 36789999875432211 111222346788899999986
Q ss_pred cCC------CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHH
Q 041755 509 HGK------VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLA 582 (678)
Q Consensus 509 ~~~------~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~l 582 (678)
..+ .-.|.|.|+.|-+.||+++...||...... .+....+.+--=|.+....+. .+.++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-----------~L~~r~Yqe~qLPalp~~vpp----~~rql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-----------LLDTRTYQESQLPALPSRVPP----VARQL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-----------eechhhhhhhhCCCCcccCCh----HHHHH
Confidence 532 135899999999999999999999863211 111111222111223222222 23445
Q ss_pred HHhcccCCCCCCCCHHHHH
Q 041755 583 ATLSISRAPTVRPQINLVL 601 (678)
Q Consensus 583 a~~Cl~~dP~~RPs~~eVl 601 (678)
+...|+.+|.+||+..-..
T Consensus 490 V~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred HHHHhcCCccccCCccHHH
Confidence 5667999999999864433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.6e-17 Score=185.90 Aligned_cols=212 Identities=25% Similarity=0.331 Sum_probs=144.3
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
++|...++|..|+||.||..+++ ..+.+|+|+=+ .....+. |+.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~lilRn------ilt~a~npfvv-------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QNLILRN------ILTFAGNPFVV-------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccc-cchhhhc------cccccCCccee--------------------
Confidence 57888999999999999999876 46778885433 2211111 33333444444
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC--
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS-- 487 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~-- 487 (678)
|+-...+.. .++++. +++.+++|||+ .+|+|||+||+|.||+.-|++|++|||+.+......
T Consensus 136 -gDc~tllk~----~g~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 -GDCATLLKN----IGPLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred -chhhhhccc----CCCCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 333333322 123332 22788999999 999999999999999999999999999987642211
Q ss_pred -----------CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccccc
Q 041755 488 -----------SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKD 556 (678)
Q Consensus 488 -----------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 556 (678)
.......++||+.|+|||++....|...+|+|++|+|+||.+-|..||.++.+++....+. .+
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi------sd 273 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI------SD 273 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh------hh
Confidence 1112234789999999999999999999999999999999999999999987765322111 10
Q ss_pred CccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHH
Q 041755 557 GKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINL 599 (678)
Q Consensus 557 ~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~e 599 (678)
.-++.+. ++.......+++.+.|+.+|..|--...
T Consensus 274 --~i~wpE~------dea~p~Ea~dli~~LL~qnp~~Rlgt~g 308 (1205)
T KOG0606|consen 274 --DIEWPEE------DEALPPEAQDLIEQLLRQNPLCRLGTGG 308 (1205)
T ss_pred --hcccccc------CcCCCHHHHHHHHHHHHhChHhhcccch
Confidence 0001110 1122233445567779999999954443
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.1e-16 Score=144.47 Aligned_cols=128 Identities=20% Similarity=0.174 Sum_probs=93.7
Q ss_pred cEEEEEEcCCh--hhHHHHHHHHhhccCCCCeEEEEEeecCCCCCc-----Cchh----hhhhHHHHHHHHHHhhhhccC
Q 041755 5 KVVVVGVKFDG--ESRELLTWALVKVAQPGDRIIALHVLDTITEST-----GSLL----SLVKTFDSMLSVYEGFCNLKQ 73 (678)
Q Consensus 5 r~I~VavD~s~--~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~-----~~~~----~~~~~~~~~l~~~~~~C~~k~ 73 (678)
++|+|++|+|+ .|..||+||+.- ++.+..|++|||.++..... .... ...+...+.|+.+.......+
T Consensus 3 ~~ILv~vD~S~~~~s~~al~~A~~l-a~~~~~l~llhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 81 (142)
T PRK15456 3 KTIIMPVDVFEMELSDKAVRHAEFL-AQDDGVIHLLHVLPGSASLSLHRFAADVRRFEEHLQHEAEERLQTMVSHFTIDP 81 (142)
T ss_pred ccEEEeccCCchhHHHHHHHHHHHH-HhcCCeEEEEEEecCcccccccccccchhhHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 78999999984 799999999975 44467999999998753100 0000 011122244555554444456
Q ss_pred CeEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEe
Q 041755 74 VDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVE 137 (678)
Q Consensus 74 v~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~ 137 (678)
++++.++.. |++.+.|+++|++.+||++|||+||++ ..+. .||++.+++++++ |||++|+
T Consensus 82 ~~v~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~~-~~~~llGS~a~~v~~~a~--~pVLvV~ 142 (142)
T PRK15456 82 SRIKQHVRF-GSVRDEVNELAEELGADVVVIGSRNPS-ISTHLLGSNASSVIRHAN--LPVLVVR 142 (142)
T ss_pred cceEEEEcC-CChHHHHHHHHhhcCCCEEEEcCCCCC-ccceecCccHHHHHHcCC--CCEEEeC
Confidence 788888887 899999999999999999999999974 2221 3599999999996 7888774
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.6e-17 Score=177.64 Aligned_cols=234 Identities=24% Similarity=0.327 Sum_probs=154.4
Q ss_pred eecccCceEEEEEEeCCC----CEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEE-------EEEe-----CCe
Q 041755 338 LVGKGGHSHVYRGCLPDG----KELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFG-------FCFE-----DNN 400 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~g----~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g-------~~~~-----~~~ 400 (678)
-.+.++++.++.++..++ ..+.-+....+. .......+++-.+....|-+..-+.+ .... ...
T Consensus 251 ~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~ 330 (516)
T KOG1033|consen 251 SSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVY 330 (516)
T ss_pred cccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccccccc
Confidence 345555555555443222 233444444333 33344445555444444333322222 1111 235
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
+|+.|++|...+|.++|.+.+ .....++.....++.|++.|+.| ++.+|+|+||.||+...+.++||.|||+.
T Consensus 331 lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 789999999999999997553 34567888999999999999999 68999999999999999999999999998
Q ss_pred cccCCCC----CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccc
Q 041755 481 SWLSTSS----SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILK 555 (678)
Q Consensus 481 ~~~~~~~----~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 555 (678)
....... .....+...||..||+||.+.+..|+.|+||||||++|+||++ =..+|+-.. +..-+.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhhh
Confidence 8776554 2233455789999999999999999999999999999999988 333332111 111223
Q ss_pred cCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 041755 556 DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQI 597 (678)
Q Consensus 556 ~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~ 597 (678)
+|.+. |....+++ ++ ..+..+++...|.+||++
T Consensus 474 ~g~ip----~~~~~d~p-~e----~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 474 DGIIP----PEFLQDYP-EE----YTLLQQLLSPSPEERPSA 506 (516)
T ss_pred cCCCC----hHHhhcCc-HH----HHHHHHhcCCCcccCchH
Confidence 33322 11111111 11 124477899999999943
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.3e-15 Score=141.34 Aligned_cols=129 Identities=16% Similarity=0.141 Sum_probs=94.7
Q ss_pred cEEEEEEcCChh--hHHHHHHHHhhccCCCCeEEEEEeecCCCC-C--c----Cch---hhhhhHHHHHHHHHHhhhhcc
Q 041755 5 KVVVVGVKFDGE--SRELLTWALVKVAQPGDRIIALHVLDTITE-S--T----GSL---LSLVKTFDSMLSVYEGFCNLK 72 (678)
Q Consensus 5 r~I~VavD~s~~--S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~-~--~----~~~---~~~~~~~~~~l~~~~~~C~~k 72 (678)
++|+|++|+|+. +.+||+||++...+.|..|++|||.++... . . ... ....+...+.|..+...+...
T Consensus 3 ~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 82 (144)
T PRK15005 3 RTILVPIDISDSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYASLGLAYSAELPAMDDLKAEAKSQLEEIIKKFKLP 82 (144)
T ss_pred ccEEEecCCCchhHHHHHHHHHHHHHhccCCeEEEEEEEccCcccccccccccccchHHHHHHHHHHHHHHHHHHHhCCC
Confidence 689999999998 589999999988888999999999976431 0 0 000 011122224444444444445
Q ss_pred CCeEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEe
Q 041755 73 QVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVE 137 (678)
Q Consensus 73 ~v~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~ 137 (678)
++.++..+.. |++.+.|+++|++.++|++|||+|+. ...+. .||++.++++|+| |||++|+
T Consensus 83 ~~~~~~~v~~-G~p~~~I~~~a~~~~~DLIV~Gs~~~-~~~~~llGS~a~~vl~~a~--cpVlvVr 144 (144)
T PRK15005 83 TDRVHVHVEE-GSPKDRILELAKKIPADMIIIASHRP-DITTYLLGSNAAAVVRHAE--CSVLVVR 144 (144)
T ss_pred CCceEEEEeC-CCHHHHHHHHHHHcCCCEEEEeCCCC-CchheeecchHHHHHHhCC--CCEEEeC
Confidence 6778888887 89999999999999999999999853 22221 3599999999997 7777763
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-15 Score=140.39 Aligned_cols=135 Identities=22% Similarity=0.228 Sum_probs=114.6
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCC--CCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHH--RNIISLFGFCFEDNNLLLVYDFLSRGSL 413 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL 413 (678)
.+.||+|.++.||++...+ ..+++|+...... ...+.+|+.++..++| .+++++++++...+..+++|||+.++.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 4679999999999998744 7899999876543 5678899999999987 5899999988877889999999988766
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 414 EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 414 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
... +......++.+++++|.+||.....+++|+|++|.|||++..+.++++|||++...
T Consensus 81 ~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 81 DEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 543 45667788999999999999855568999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=142.24 Aligned_cols=131 Identities=13% Similarity=0.143 Sum_probs=94.8
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCC---CCc--Cchhhhh-hHHHHHHHHHHhhhhccCCeEE
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTIT---EST--GSLLSLV-KTFDSMLSVYEGFCNLKQVDLK 77 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~---~~~--~~~~~~~-~~~~~~l~~~~~~C~~k~v~~~ 77 (678)
-++|+||+|+|+.|..||+||+......|..|++|||.++.. .+. ....... +........++.++...++.+.
T Consensus 3 ~~~ILvavD~S~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 82 (144)
T PRK15118 3 YKHILIAVDLSPESKVLVEKAVSMARPYNAKVSLIHVDVNYSDLYTGLIDVNLGDMQKRISEETHHALTELSTNAGYPIT 82 (144)
T ss_pred ceEEEEEccCChhHHHHHHHHHHHHHhhCCEEEEEEEccChhhhhhhhhhcchHHHHHHHHHHHHHHHHHHHHhCCCCce
Confidence 479999999999999999999998777789999999954321 000 0000001 1112333444555556677776
Q ss_pred EEEEECCchhHHHHHHHHhcCCcEEEEccCCCccccccCcchhhHhhhcCCCceEEEEEeC
Q 041755 78 LKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAKYCARKLSKNFGVFAVEN 138 (678)
Q Consensus 78 ~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~~~svs~yc~~~ap~~c~V~~v~~ 138 (678)
..+++.|++.++|+++|++.++|++|||+|+..... .+||+.++++|++ |||++|+.
T Consensus 83 ~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~~~~~~~--lgSva~~v~~~a~--~pVLvv~~ 139 (144)
T PRK15118 83 ETLSGSGDLGQVLVDAIKKYDMDLVVCGHHQDFWSK--LMSSARQLINTVH--VDMLIVPL 139 (144)
T ss_pred EEEEEecCHHHHHHHHHHHhCCCEEEEeCcccHHHH--HHHHHHHHHhhCC--CCEEEecC
Confidence 666666999999999999999999999999752111 3499999999997 78888864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.8e-15 Score=148.44 Aligned_cols=137 Identities=21% Similarity=0.268 Sum_probs=99.1
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChH---HHHH----------------------HHHHHHHHHhcCCCC--e
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSED---VLKE----------------------FASEIEIITALHHRN--I 388 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~---~~~~----------------------~~~Ei~il~~l~Hpn--I 388 (678)
.+.||+|+||+||+|...+|+.||||++++... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 457999999999999988899999999875321 1111 135666666665443 4
Q ss_pred eeEEEEEEeCCeEEEEEEcCCCCCHHHH-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec
Q 041755 389 ISLFGFCFEDNNLLLVYDFLSRGSLEEN-LHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS 467 (678)
Q Consensus 389 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~ 467 (678)
.+.+++ ...++||||++++.+... +... . .. .+...++.+++.++.++|. ..+|+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~----~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R----LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-h----hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE
Confidence 444443 245999999998554321 1111 0 01 5667899999999999996 37899999999999999
Q ss_pred CCCCcEEeecccccccCC
Q 041755 468 DDFEPQLSDFGLASWLST 485 (678)
Q Consensus 468 ~~~~~kL~DFGla~~~~~ 485 (678)
++.++|+|||.+.....
T Consensus 150 -~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 -DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred -CCcEEEEECcccccccC
Confidence 89999999999875433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.7e-14 Score=132.00 Aligned_cols=122 Identities=16% Similarity=0.107 Sum_probs=96.1
Q ss_pred EEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCCcCchhhhhhHHHHHHHHHHhhhhccCCeEEEEEEECCc
Q 041755 6 VVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLKQVDLKLKVCRGTS 85 (678)
Q Consensus 6 ~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~v~~~~~v~~~~d 85 (678)
+|+|+||+++.|++||+||.....+.+..|++|||.++... .......+.++.+...++..+++ ..++.+++
T Consensus 1 ~Ilv~vd~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~~------~~~~~~~~~l~~~~~~~~~~~~~--~~~~~~~~ 72 (124)
T cd01987 1 RILVCISGGPNAERLIRRAARLADRLKAPWYVVYVETPRLN------RLSEAERRRLAEALRLAEELGAE--VVTLPGDD 72 (124)
T ss_pred CEEEEECCCcchHHHHHHHHHHHHHhCCCEEEEEEecCccc------cCCHHHHHHHHHHHHHHHHcCCE--EEEEeCCc
Confidence 58999999999999999999888788999999999975321 12233356677777777766664 45667799
Q ss_pred hhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEE
Q 041755 86 VKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAV 136 (678)
Q Consensus 86 ~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v 136 (678)
+.++|+++++++++|+||||+++++.+.+. .||+++++++++ .+|+|++|
T Consensus 73 ~~~~I~~~~~~~~~dllviG~~~~~~~~~~~~Gs~~~~v~~~a-~~~~v~v~ 123 (124)
T cd01987 73 VAEAIVEFAREHNVTQIVVGKSRRSRWRELFRGSLVDRLLRRA-GNIDVHIV 123 (124)
T ss_pred HHHHHHHHHHHcCCCEEEeCCCCCchHHHHhcccHHHHHHHhC-CCCeEEEe
Confidence 999999999999999999999998433321 349999999999 34777665
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.2e-14 Score=146.89 Aligned_cols=135 Identities=15% Similarity=0.146 Sum_probs=105.9
Q ss_pred ceeec-ccCceEEEEEEeCCCCEEEEEEeCCCh--------------HHHHHHHHHHHHHHhcCCCCe--eeEEEEEEeC
Q 041755 336 EYLVG-KGGHSHVYRGCLPDGKELAVKILKPSE--------------DVLKEFASEIEIITALHHRNI--ISLFGFCFED 398 (678)
Q Consensus 336 ~~~IG-~G~~g~Vy~g~~~~g~~vAvK~l~~~~--------------~~~~~~~~Ei~il~~l~HpnI--v~l~g~~~~~ 398 (678)
..+|| .||.|+||.... ++..++||.+.... .....+.+|++++..|.|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 899999999987 47789999874311 223567889999999998875 6777765443
Q ss_pred C----eEEEEEEcCCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcE
Q 041755 399 N----NLLLVYDFLSR-GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ 473 (678)
Q Consensus 399 ~----~~~lV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~k 473 (678)
. ..++||||+++ .+|.+++.. ..++.. .+.+++.+|.+||+ .||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 689888753 234443 35789999999999 9999999999999999999999
Q ss_pred Eeeccccccc
Q 041755 474 LSDFGLASWL 483 (678)
Q Consensus 474 L~DFGla~~~ 483 (678)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999988753
|
|
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.2e-14 Score=133.51 Aligned_cols=132 Identities=20% Similarity=0.114 Sum_probs=94.6
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCCcCchhhhhh---HHH---HHHHHHHhhhhccCCeEE
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVK---TFD---SMLSVYEGFCNLKQVDLK 77 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~~~~~~~~~---~~~---~~l~~~~~~C~~k~v~~~ 77 (678)
-++|+|++|+++.+.+||+||+..+...++.|++|||.+.............. ... .........+...+....
T Consensus 2 ~~~Ilv~~d~~~~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (140)
T PF00582_consen 2 YKRILVAIDGSEESRRALRFALELAKRSGAEITLLHVIPPPPQYSFSAAEDEESEEEAEEEEQARQAEAEEAEAEGGIVI 81 (140)
T ss_dssp TSEEEEEESSSHHHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSEE
T ss_pred CCEEEEEECCCHHHHHHHHHHHHHHHhhCCeEEEEEeeccccccccccccccccccccchhhhhhhHHHHHHhhhcccee
Confidence 47999999999999999999999888899999999999875411000000000 000 111111134445556666
Q ss_pred EEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEe
Q 041755 78 LKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVE 137 (678)
Q Consensus 78 ~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~ 137 (678)
...+..|++.+.|++++++.++|+||||++++++..+. .+|++++|++++| |||++|+
T Consensus 82 ~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~gs~~~~l~~~~~--~pVlvv~ 140 (140)
T PF00582_consen 82 EVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLFGSVAEKLLRHAP--CPVLVVP 140 (140)
T ss_dssp EEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSSHHHHHHHHHHTS--SEEEEEE
T ss_pred EEEEEeeccchhhhhccccccceeEEEeccCCCCccCCCcCCHHHHHHHcCC--CCEEEeC
Confidence 66666699999999999999999999999996433332 3599999999997 7777774
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.9e-14 Score=128.36 Aligned_cols=130 Identities=18% Similarity=0.159 Sum_probs=104.9
Q ss_pred EEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCCc-CchhhhhhHHHHHHHHHHhhhhccCCeEEEEEEECC
Q 041755 6 VVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITEST-GSLLSLVKTFDSMLSVYEGFCNLKQVDLKLKVCRGT 84 (678)
Q Consensus 6 ~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~-~~~~~~~~~~~~~l~~~~~~C~~k~v~~~~~v~~~~ 84 (678)
+|+|+||+++.+..||+||..-....+..|+++||.+++.... .......+...+.+..+..++...++.++..+..+|
T Consensus 1 ~ILv~vd~s~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 80 (132)
T cd01988 1 RILVPVANPNTARDLLELAAALARAQNGEIIPLNVIEVPNHSSPSQLEVNVQRARKLLRQAERIAASLGVPVHTIIRIDH 80 (132)
T ss_pred CEEEecCCchhHHHHHHHHHHHhhcCCCeEEEEEEEecCCCCCcchhHHHHHHHHHHHHHHHHHhhhcCCceEEEEEecC
Confidence 5999999999999999999998888888999999998653111 111122334458888888888888999999988889
Q ss_pred chhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEe
Q 041755 85 SVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVE 137 (678)
Q Consensus 85 d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~ 137 (678)
++.+.|++.++..++|+||||+++++...+. .+|++++++++++ |||++|+
T Consensus 81 ~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~lGs~~~~v~~~~~--~pvlvv~ 132 (132)
T cd01988 81 DIASGILRTAKERQADLIIMGWHGSTSLRDRLFGGVIDQVLESAP--CDVAVVK 132 (132)
T ss_pred CHHHHHHHHHHhcCCCEEEEecCCCCCccceecCchHHHHHhcCC--CCEEEeC
Confidence 9999999999999999999999998533111 3499999999997 8888774
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=9.1e-16 Score=175.65 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=184.2
Q ss_pred CCCceeecccCceEEEEEEeC--CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEE
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP--DGKELAVKILKPS---EDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~--~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E 406 (678)
|...+.||+|.|+.|-..... ....+|+|.+... .........|..+-..+. |+|++.+++...+.+..+++.+
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 334445899999999887653 3345666665432 344555566888888887 9999999999999999999999
Q ss_pred cCCCCCHHHHh-ccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeeeccCCCCCeEecCCC-CcEEeeccccccc
Q 041755 407 FLSRGSLEENL-HGNKKDGNAFGWTERYKVAVGVAEALDYLH-NSCEQPVIHKDVKSSNILLSDDF-EPQLSDFGLASWL 483 (678)
Q Consensus 407 ~~~~gsL~~~L-~~~~~~~~~l~~~~~~~ia~qia~aL~yLH-~~~~~~iiHrDIKp~NILl~~~~-~~kL~DFGla~~~ 483 (678)
|..++++.+.+ +.. ....+......++.|+..+|.|+| . .++.||||||+|.+++..+ .++++|||+|..+
T Consensus 102 ~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccccccccccccCC---ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999888 322 123455566778999999999999 6 8999999999999999999 9999999999988
Q ss_pred CC-CCCCceeccccc-CCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 484 ST-SSSHLTCTDVAG-TFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 484 ~~-~~~~~~~~~~~G-t~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
.. ..........+| ++.|.|||.+.+. ...+..|+||.|+++.-+++|..|+......... ...|.... +...
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~---~~~~ 251 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK---GRFT 251 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc---cccc
Confidence 87 555555566788 9999999999874 4567899999999999999999998765543321 11111100 0000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
. ..-. ........+...++..+|..|.+.+++..
T Consensus 252 ~----~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 252 Q----LPWN----SISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c----Cccc----cCChhhhhcccccccCCchhccccccccc
Confidence 0 0001 11122333446667788999998887653
|
|
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.1e-14 Score=133.88 Aligned_cols=127 Identities=16% Similarity=0.110 Sum_probs=92.0
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCC---Cc--Cc---h-hhhhhHHHHHHHHHHhhhhccCC
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITE---ST--GS---L-LSLVKTFDSMLSVYEGFCNLKQV 74 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~---~~--~~---~-~~~~~~~~~~l~~~~~~C~~k~v 74 (678)
-++|+||||+|+.|..||+||+......+..|++|||.++... .. .. . ....+...+.|..+...+. ..
T Consensus 3 ~k~ILvavD~S~~s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~--~~ 80 (142)
T PRK09982 3 YKHIGVAISGNEEDALLVNKALELARHNDAHLTLIHIDDGLSELYPGIYFPATEDILQLLKNKSDNKLYKLTKNIQ--WP 80 (142)
T ss_pred ceEEEEEecCCcchHHHHHHHHHHHHHhCCeEEEEEEccCcchhchhhhccchHHHHHHHHHHHHHHHHHHHHhcC--CC
Confidence 4789999999999999999999988889999999999875430 00 00 0 0111122244555444332 34
Q ss_pred eEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCccccccCcchhhHhhhcCCCceEEEEEe
Q 041755 75 DLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAKYCARKLSKNFGVFAVE 137 (678)
Q Consensus 75 ~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~~~svs~yc~~~ap~~c~V~~v~ 137 (678)
.++..+.. |++++.|+++|++.+||++|||+| ++..-+-. +|++.+++|++ |||++|+
T Consensus 81 ~~~~~v~~-G~p~~~I~~~A~~~~aDLIVmG~~-~~~~~~~~-~va~~V~~~s~--~pVLvv~ 138 (142)
T PRK09982 81 KTKLRIER-GEMPETLLEIMQKEQCDLLVCGHH-HSFINRLM-PAYRGMINKMS--ADLLIVP 138 (142)
T ss_pred cceEEEEe-cCHHHHHHHHHHHcCCCEEEEeCC-hhHHHHHH-HHHHHHHhcCC--CCEEEec
Confidence 56677777 999999999999999999999986 43222222 59999999996 8888875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.3e-14 Score=154.67 Aligned_cols=141 Identities=22% Similarity=0.298 Sum_probs=100.5
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChH-H----------------------------------------HHHHH
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSED-V----------------------------------------LKEFA 374 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~-~----------------------------------------~~~~~ 374 (678)
.+.||.|++|+||+|++.+|+.||||+.+++-. . .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999999987520 0 00244
Q ss_pred HHHHHHHhcC----CCCeeeEEEEEE-eCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 041755 375 SEIEIITALH----HRNIISLFGFCF-EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE-ALDYLHN 448 (678)
Q Consensus 375 ~Ei~il~~l~----HpnIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~-aL~yLH~ 448 (678)
+|...+.++. |.+-+.+-.++. .....+|||||++|++|.+....... .+ .+..++..++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHh
Confidence 5555555552 333333323332 23456999999999999887643211 11 23456666666 4678887
Q ss_pred cCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 449 ~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
.|++|+|+||.||+++.++.++|+|||++..++.
T Consensus 276 ---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 ---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999876643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.9e-13 Score=126.83 Aligned_cols=131 Identities=15% Similarity=0.096 Sum_probs=95.6
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCC-CCc--Cch-hhhhhHH-HHHHHHHHhhhhccCCeEEE
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTIT-EST--GSL-LSLVKTF-DSMLSVYEGFCNLKQVDLKL 78 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~-~~~--~~~-~~~~~~~-~~~l~~~~~~C~~k~v~~~~ 78 (678)
-++|+|++|+|..+..||++|+.-..+.|..|+++||.+++. ... ... ....+.. .+....++.++...++..+.
T Consensus 3 ~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 82 (142)
T PRK10116 3 YSNILVAVAVTPESQQLLAKAVSIARPVNGKISLITLASDPEMYNQFAAPMLEDLRSVMQEETQSFLDKLIQDADYPIEK 82 (142)
T ss_pred CceEEEEccCCcchHHHHHHHHHHHHHhCCEEEEEEEccCcccchhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCCCeEE
Confidence 479999999999999999999998877789999999986543 100 000 0111111 12223344455556776665
Q ss_pred EEEECCchhHHHHHHHHhcCCcEEEEccCCCccccccCcchhhHhhhcCCCceEEEEEe
Q 041755 79 KVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAKYCARKLSKNFGVFAVE 137 (678)
Q Consensus 79 ~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~~~svs~yc~~~ap~~c~V~~v~ 137 (678)
.+++.|++.+.|+++|++.++|+||||+|+++..-+- .|++.+++++++ |||++|.
T Consensus 83 ~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~-~s~a~~v~~~~~--~pVLvv~ 138 (142)
T PRK10116 83 TFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSRA-SCSAKRVIASSE--VDVLLVP 138 (142)
T ss_pred EEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHHH-HHHHHHHHhcCC--CCEEEEe
Confidence 5666699999999999999999999999997544332 489999999996 7788775
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=9.4e-14 Score=156.33 Aligned_cols=189 Identities=18% Similarity=0.170 Sum_probs=113.7
Q ss_pred CcceeccCCCCCCCCCCCCCChhhHHhhhhhccCccccccHHHHHHh------------hcCCCCceeecccCceEEEEE
Q 041755 283 GAIVSVEHDSACPPLSPYNELPKELEGLQERYSSTCRLFSYQELLSA------------TSNFLPEYLVGKGGHSHVYRG 350 (678)
Q Consensus 283 ~~~~~~~~~~~~~p~~~~~~~~~~l~~l~~~~~~~~~~f~~~el~~~------------t~~f~~~~~IG~G~~g~Vy~g 350 (678)
...+++++-.++-|.-...++.+++..+++. ...|+++++... ...|.. ..||.|++|+||+|
T Consensus 64 p~fIKlGQ~LStR~DllP~~~~~eL~~Lqd~----vpp~~~~~~~~~ie~elG~~~~~~F~~fd~-~PlasaSiaQVh~A 138 (537)
T PRK04750 64 PIFVKFGQMLSTRRDLFPPDIADELALLQDR----VPPFDGALARAIIEKALGGPVEEWFDDFDI-KPLASASIAQVHFA 138 (537)
T ss_pred cHHHHHHHHHHcCcccCCHHHHHHHHHHHcC----CCCCCHHHHHHHHHHHhCCCHHHHHHhcCh-hhhcCCCccEEEEE
Confidence 3445555543332221122344555555543 445555543322 235666 68999999999999
Q ss_pred EeCC-CCEEEEEEeCCChH-----------------------------------HHH------HHHHHHHHHHhcC----
Q 041755 351 CLPD-GKELAVKILKPSED-----------------------------------VLK------EFASEIEIITALH---- 384 (678)
Q Consensus 351 ~~~~-g~~vAvK~l~~~~~-----------------------------------~~~------~~~~Ei~il~~l~---- 384 (678)
.+.+ |+.||||+++++-. ..+ +|.+|+..+.+++
T Consensus 139 ~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~ 218 (537)
T PRK04750 139 RLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMREAANASQLRRNFE 218 (537)
T ss_pred EECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHHHHHHHHHHHHHcc
Confidence 9987 99999999986520 011 1344444444442
Q ss_pred CCCeeeEEEEEEe-CCeEEEEEEcCCCCCHHHH--hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 041755 385 HRNIISLFGFCFE-DNNLLLVYDFLSRGSLEEN--LHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKS 461 (678)
Q Consensus 385 HpnIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~--L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp 461 (678)
+.+.+.+-.++.+ ....+|||||+.|+.+.+. +.........+.......++.|+ +. .|++|+|+||
T Consensus 219 ~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~---~GffHaDpHP 288 (537)
T PRK04750 219 DSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FR---DGFFHADMHP 288 (537)
T ss_pred CCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------Hh---CCeeeCCCCh
Confidence 4444443333332 3456899999999999774 22111110112222222223332 33 8999999999
Q ss_pred CCeEecCCC----CcEEeecccccccCCC
Q 041755 462 SNILLSDDF----EPQLSDFGLASWLSTS 486 (678)
Q Consensus 462 ~NILl~~~~----~~kL~DFGla~~~~~~ 486 (678)
.||+++.++ .++++|||++..++..
T Consensus 289 GNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 289 GNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 999999988 9999999999877543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.6e-13 Score=140.25 Aligned_cols=203 Identities=22% Similarity=0.325 Sum_probs=143.4
Q ss_pred HHHHhcCCCCeeeEEEEEEeC-----CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 041755 378 EIITALHHRNIISLFGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452 (678)
Q Consensus 378 ~il~~l~HpnIv~l~g~~~~~-----~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~ 452 (678)
.-|-++.|.||++++.|+.+. ....++.|||..|+|..+|.+.++....+......+++.||+.||.|||+ |+.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence 345567799999999988543 45789999999999999999887777888888889999999999999996 678
Q ss_pred CeeeccCCCCCeEecCCCCcEEeecccccccCCC---CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHh
Q 041755 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS---SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELL 529 (678)
Q Consensus 453 ~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~---~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLl 529 (678)
+|+|+++..+-|++..+|-+|+.-- -....... ..........|.++|.+||+-.....+..+|||+||+..+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999999988887421 10000000 0000011134678999999887778888999999999999998
Q ss_pred cCCCC-CCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 530 SGKKP-INSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 530 tG~~P-f~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
-+..- -+.......+..+.-+...+++|. + ...+..|++..|+.||+|.+++.
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~~len~l---------q-----------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVIIGLENGL---------Q-----------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceeehhhhhhhheeeccCcc---------c-----------cCcCcccccCCCCCCcchhhhhc
Confidence 87643 333222111111111111111111 1 12347899999999999998773
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.9e-12 Score=134.11 Aligned_cols=134 Identities=13% Similarity=0.091 Sum_probs=102.0
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCC-C--C---cCchh----hhhhHHHHHHHHHHhhhhccC
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTIT-E--S---TGSLL----SLVKTFDSMLSVYEGFCNLKQ 73 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~-~--~---~~~~~----~~~~~~~~~l~~~~~~C~~k~ 73 (678)
-++|+|++|+|+.+..||+||+.-....+..|++|||.+... . . ..... ...+...+.|+.+...+...+
T Consensus 3 ~~~ILv~~D~s~~~~~al~~a~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 82 (305)
T PRK11175 3 YQNILVVIDPNQDDQPALRRAVYLAQRNGGKITAFLPIYDFSYEMTTLLSPDEREAMRQGVISQRTAWIREQAKPYLDAG 82 (305)
T ss_pred cceEEEEcCCCccccHHHHHHHHHHHhcCCCEEEEEeccCchhhhhcccchhHHHHHHHHHHHHHHHHHHHHHHHHhhcC
Confidence 478999999999999999999998777788999999975432 0 0 00000 011122355666666666778
Q ss_pred CeEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeCC
Q 041755 74 VDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVENG 139 (678)
Q Consensus 74 v~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~~ 139 (678)
+.++..+.++|++.++|+++|++.++|+||||+++.++..+. .||++..+++++| |||++|+.+
T Consensus 83 ~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~gs~~~~l~~~~~--~pvlvv~~~ 147 (305)
T PRK11175 83 IPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIFTPTDWHLLRKCP--CPVLMVKDQ 147 (305)
T ss_pred CceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhccChhHHHHHhcCC--CCEEEeccc
Confidence 999998887799999999999999999999999987432221 2499999999996 888888753
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=4.5e-12 Score=121.93 Aligned_cols=130 Identities=22% Similarity=0.202 Sum_probs=96.5
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeee-EEEEEEeCCeEEEEEEcCCCCCHHH
Q 041755 337 YLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIIS-LFGFCFEDNNLLLVYDFLSRGSLEE 415 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~-l~g~~~~~~~~~lV~E~~~~gsL~~ 415 (678)
+.|+.|.++.||++.. .|..|++|+..........+..|+.++..+.+.++++ ++.+. ....++||||+++.++..
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcccc
Confidence 4688999999999887 4788999998665433345678999999987655544 44433 234589999999987754
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 416 NLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC--EQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 416 ~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
.. .....++.+++++|..||... ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 30 011345678999999999822 12369999999999999 66899999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.7e-11 Score=109.99 Aligned_cols=128 Identities=22% Similarity=0.228 Sum_probs=101.6
Q ss_pred EEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCCc-CchhhhhhHHHHHHHHHHhhhhccCCeEEEEEEECC
Q 041755 6 VVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITEST-GSLLSLVKTFDSMLSVYEGFCNLKQVDLKLKVCRGT 84 (678)
Q Consensus 6 ~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~-~~~~~~~~~~~~~l~~~~~~C~~k~v~~~~~v~~~~ 84 (678)
+|+|++|.++.++.+|+||++.+...+..|.+|||.++..... ...........+.|..+...|...++.+...+.. |
T Consensus 1 ~ilv~i~~~~~~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~ 79 (130)
T cd00293 1 RILVAVDGSEESERALRWAARLARRLGAELVLLHVVDPPPSSAAELAELLEEEARALLEALREALAEAGVKVETVVLE-G 79 (130)
T ss_pred CEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCCCCcchhHHHHHHHHHHHHHHHHHHHHhcCCCceEEEEec-C
Confidence 5899999999999999999999998899999999987542110 0011233445688889888888889999988887 7
Q ss_pred chhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEE
Q 041755 85 SVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAV 136 (678)
Q Consensus 85 d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v 136 (678)
++.+.|+++++..++|+||||++++....+. .++++++.+++++ |||++|
T Consensus 80 ~~~~~i~~~~~~~~~dlvvig~~~~~~~~~~~~~~~~~~ll~~~~--~pvliv 130 (130)
T cd00293 80 DPAEAILEAAEELGADLIVMGSRGRSGLRRLLLGSVAERVLRHAP--CPVLVV 130 (130)
T ss_pred CCHHHHHHHHHHcCCCEEEEcCCCCCccceeeeccHHHHHHhCCC--CCEEeC
Confidence 7799999999999999999999987543211 3599999999975 676654
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.23 E-value=5.9e-11 Score=125.83 Aligned_cols=133 Identities=13% Similarity=0.086 Sum_probs=92.0
Q ss_pred CcEEEEEEcCChhh-------HHHHHHHHhhccCC-CCeEEEEEeecCCCCC-c-----CchhhhhhHH-HHHHHHHHhh
Q 041755 4 GKVVVVGVKFDGES-------RELLTWALVKVAQP-GDRIIALHVLDTITES-T-----GSLLSLVKTF-DSMLSVYEGF 68 (678)
Q Consensus 4 ~r~I~VavD~s~~S-------~~AL~WAl~~~~~~-gd~vvlvhV~~~~~~~-~-----~~~~~~~~~~-~~~l~~~~~~ 68 (678)
.++|+||+|+++.+ ..||++|+.-.... +..|++|||++..... . .......+.. .+....++.+
T Consensus 152 ~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 231 (305)
T PRK11175 152 GGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIAIELPEFDPSVYNDAIRGQHLLAMKAL 231 (305)
T ss_pred CCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhccccccccchhhHHHHHHHHHHHHHHHH
Confidence 47899999998753 67999999877665 8899999998754310 0 0000011111 1223334444
Q ss_pred hhccCCeEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeC
Q 041755 69 CNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVEN 138 (678)
Q Consensus 69 C~~k~v~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~ 138 (678)
....++..+..++..|++.+.|+++|++.+||+||||++++++..+. .||++.++++++| |||++|+.
T Consensus 232 ~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~llGS~a~~v~~~~~--~pVLvv~~ 300 (305)
T PRK11175 232 RQKFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAAFLGNTAEHVIDHLN--CDLLAIKP 300 (305)
T ss_pred HHHhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcceeecchHHHHHhcCC--CCEEEEcC
Confidence 44456665434444599999999999999999999999988544332 3599999999997 88888864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=9.9e-12 Score=137.09 Aligned_cols=247 Identities=21% Similarity=0.247 Sum_probs=177.9
Q ss_pred CCCCceeecc--cCceEEEEEEe---CCCCEEEEEEeCC--C-hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEE
Q 041755 332 NFLPEYLVGK--GGHSHVYRGCL---PDGKELAVKILKP--S-EDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 332 ~f~~~~~IG~--G~~g~Vy~g~~---~~g~~vAvK~l~~--~-~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 402 (678)
.|.....+|. |.+|.||.+.. .++..+|+|.-+. . ......=.+|+.....++ |+|.++.+..+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556677899 99999999975 3688899997432 1 122233346666666665 999999888898989999
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeeeccCCCCCeEecCC-CCcEEeec
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE----ALDYLHNSCEQPVIHKDVKSSNILLSDD-FEPQLSDF 477 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~----aL~yLH~~~~~~iiHrDIKp~NILl~~~-~~~kL~DF 477 (678)
+-.|++ +.+|..+.+... ..++....+.+..+... ||.++|+ .+++|-|+||.||++..+ ...+++||
T Consensus 195 iqtE~~-~~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeccc-cchhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCc
Confidence 999988 578888876532 34677778888888888 9999999 999999999999999999 88999999
Q ss_pred ccccccCCCCCCce---ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccc
Q 041755 478 GLASWLSTSSSHLT---CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL 554 (678)
Q Consensus 478 Gla~~~~~~~~~~~---~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 554 (678)
|+...+........ .....|...|++||.. .+.++...|+|++|.++++-.++-.+...... ..|.. +
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~--~ 338 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQ--L 338 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCC------CCccc--c
Confidence 99998876542221 1223677889999976 56788999999999999999988765533211 11211 1
Q ss_pred ccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 555 KDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 555 ~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+ .+. +..++...-..++..+..++++.+|..|++.+.+..
T Consensus 339 r-----~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 R-----QGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c-----ccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1 111 111111111223333668889999999999887764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.8e-10 Score=115.38 Aligned_cols=141 Identities=19% Similarity=0.264 Sum_probs=111.3
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCChH--HHHHHHHHHHHHHhcCC--CCeeeEEEEEEeC---CeEEEEEEcCC
Q 041755 337 YLVGKGGHSHVYRGCLPDGKELAVKILKPSED--VLKEFASEIEIITALHH--RNIISLFGFCFED---NNLLLVYDFLS 409 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~--~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~---~~~~lV~E~~~ 409 (678)
..||.|.++.||++...+|..+++|+...... ....+..|++++..+.+ .++.+++.++.+. +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999887778999999875442 45678899999999976 3457777777653 25689999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC--------------------------------------- 450 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--------------------------------------- 450 (678)
+.++.+.+.. ..++..++..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9888765531 24677788888899999999998521
Q ss_pred --------------CCCeeeccCCCCCeEecC--CCCcEEeecccccc
Q 041755 451 --------------EQPVIHKDVKSSNILLSD--DFEPQLSDFGLASW 482 (678)
Q Consensus 451 --------------~~~iiHrDIKp~NILl~~--~~~~kL~DFGla~~ 482 (678)
...++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=5e-10 Score=110.58 Aligned_cols=134 Identities=16% Similarity=0.175 Sum_probs=97.3
Q ss_pred eeecccCceEEEEEEeCC-------CCEEEEEEeCCC-------------h----------HHHHHHH----HHHHHHHh
Q 041755 337 YLVGKGGHSHVYRGCLPD-------GKELAVKILKPS-------------E----------DVLKEFA----SEIEIITA 382 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~-------g~~vAvK~l~~~-------------~----------~~~~~~~----~Ei~il~~ 382 (678)
..||.|--+.||.|...+ +..+|||+.+.+ + ...+.+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 479999987531 0 0122333 79999999
Q ss_pred cCC--CCeeeEEEEEEeCCeEEEEEEcCCCCCHHH-HhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeeecc
Q 041755 383 LHH--RNIISLFGFCFEDNNLLLVYDFLSRGSLEE-NLHGNKKDGNAFGWTERYKVAVGVAEALDYL-HNSCEQPVIHKD 458 (678)
Q Consensus 383 l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~-~L~~~~~~~~~l~~~~~~~ia~qia~aL~yL-H~~~~~~iiHrD 458 (678)
+.. -++..++++ ..-+|||||+.++.+.. .+.. ..++..+...+..+++.+|..| |. .++||+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence 863 456666654 34489999997653322 2211 2244455667889999999999 77 8999999
Q ss_pred CCCCCeEecCCCCcEEeeccccccc
Q 041755 459 VKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 459 IKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
|++.|||+++ +.+.|+|||.+...
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeC
Confidence 9999999974 68999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.3e-09 Score=100.71 Aligned_cols=133 Identities=20% Similarity=0.173 Sum_probs=101.2
Q ss_pred CCcEEEEEEc-CChhhHHHHHHHHhhccCCCCeEEEEEeecCCCC-CcCc----h-------hhhhhHHHHHHHHHHhhh
Q 041755 3 QGKVVVVGVK-FDGESRELLTWALVKVAQPGDRIIALHVLDTITE-STGS----L-------LSLVKTFDSMLSVYEGFC 69 (678)
Q Consensus 3 ~~r~I~VavD-~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~-~~~~----~-------~~~~~~~~~~l~~~~~~C 69 (678)
..++|++++| +++.+..|+.+|+......+..+.++||.+.... .... . ........+.+..++..-
T Consensus 4 ~~~~il~~~d~~s~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (154)
T COG0589 4 MYKKILVAVDVGSEAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALADAPIPLSEEELEEEAEELLAEAKALA 83 (154)
T ss_pred ccceEEEEeCCCCHHHHHHHHHHHHHHHhcCCeEEEEEEecccccccccccccccchhhhhHHHHHHHHHHHHHHHHHHH
Confidence 4579999999 9999999999999999988999999999876541 0000 0 111223346666666666
Q ss_pred hccCCeE-EEEEEECCch-hHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeC
Q 041755 70 NLKQVDL-KLKVCRGTSV-KKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVEN 138 (678)
Q Consensus 70 ~~k~v~~-~~~v~~~~d~-~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~ 138 (678)
...++.. +..+.. |++ ...|++.+...++|++|||++++++..+. .|||+.+++++++ |||++|+.
T Consensus 84 ~~~~~~~~~~~~~~-g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~~llGsvs~~v~~~~~--~pVlvv~~ 152 (154)
T COG0589 84 EAAGVPVVETEVVE-GSPSAEEILELAEEEDADLIVVGSRGRSGLSRLLLGSVAEKVLRHAP--CPVLVVRS 152 (154)
T ss_pred HHcCCCeeEEEEec-CCCcHHHHHHHHHHhCCCEEEECCCCCccccceeeehhHHHHHhcCC--CCEEEEcc
Confidence 6777774 777777 777 79999999999999999999987544431 3599999999996 88888763
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.9e-09 Score=103.54 Aligned_cols=129 Identities=22% Similarity=0.322 Sum_probs=99.7
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEeCCC----h-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 338 LVGKGGHSHVYRGCLPDGKELAVKILKPS----E-----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~----~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
++++|+-+.+|.+.+ -|..+++|.-.+. + -....-.+|+.++.+++--.|.-.+-+..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 578999999999866 4555777754321 1 12455678999999997655555555556667779999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
++-.|.+.+... +..++..+-.-+.-||. .+|+|+||.++||++..+. +.++||||+..
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 998998888643 24566777777888999 9999999999999998875 99999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.1e-10 Score=126.75 Aligned_cols=248 Identities=21% Similarity=0.205 Sum_probs=169.7
Q ss_pred HHhhcCCCCceeecccCceEEEEEEe--CCCCEEEEEEeCCCh-H-HHHHH-HHHHHHHHhc-CCCCeeeEEEEEEeCCe
Q 041755 327 LSATSNFLPEYLVGKGGHSHVYRGCL--PDGKELAVKILKPSE-D-VLKEF-ASEIEIITAL-HHRNIISLFGFCFEDNN 400 (678)
Q Consensus 327 ~~~t~~f~~~~~IG~G~~g~Vy~g~~--~~g~~vAvK~l~~~~-~-~~~~~-~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 400 (678)
.-.+.+|.....||.|.|+.|+.... .++..|++|.+...- . ..+.| ..|+-+...+ .|.+++.+...+.+..+
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 33456788888999999999998753 368899999876532 1 11112 3455555555 48889988887877788
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC-CCcEEeeccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD-FEPQLSDFGL 479 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~-~~~kL~DFGl 479 (678)
.|+--||+.++++...+. ....+....++++..|++.++.++|+ +.++|+|+||+||++..+ +..++.|||.
T Consensus 341 ~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred ccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccc
Confidence 889999999999877662 22456777889999999999999998 999999999999999886 7889999999
Q ss_pred ccccCCCCCCceecccccCCCC-CCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGY-LAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y-~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
+..+..... ....++..| .+|+......+..+.|+|+||.-+.+.+++..--... ..|.. +..|.
T Consensus 414 ~t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~~~--i~~~~ 479 (524)
T KOG0601|consen 414 WTRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------VQSLT--IRSGD 479 (524)
T ss_pred ccccceecc----cccccccccccchhhccccccccccccccccccccccccCcccCccc--------cccee--eeccc
Confidence 864222111 111223334 3566666677889999999999999999987532211 11110 11111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
+ +.+.+. ...+..++..++..++..||.+.+......
T Consensus 480 ~-----p~~~~~-----~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 480 T-----PNLPGL-----KLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred c-----cCCCch-----HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1 111111 123334445668889999998887765443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.2e-09 Score=100.11 Aligned_cols=141 Identities=22% Similarity=0.290 Sum_probs=105.1
Q ss_pred CceeecccCceEEEEEEeCCCCEEEEEEeCCC---------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 335 PEYLVGKGGHSHVYRGCLPDGKELAVKILKPS---------EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 335 ~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~---------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
...+|-+|+-+.|+++.. .|+...||.-.+. .-..++..+|+++|.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456789999999999987 7888888854321 123566788999999987555555445555656668999
Q ss_pred EcCCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC---CcEEeeccccc
Q 041755 406 DFLSR-GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF---EPQLSDFGLAS 481 (678)
Q Consensus 406 E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~---~~kL~DFGla~ 481 (678)
||+++ .++.+++...-. ..........++..|-+.+.-||. ++|||+||..+||+|..++ .+.|+|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 377888765432 222223336788889999999999 9999999999999997655 35899999975
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.6e-09 Score=119.21 Aligned_cols=165 Identities=23% Similarity=0.298 Sum_probs=122.7
Q ss_pred eCCCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHH
Q 041755 352 LPDGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWT 430 (678)
Q Consensus 352 ~~~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~ 430 (678)
..+|.+|.|...+... .......+-++.|+.|+||||++++..+.+.+..|||+|-+. .|..++... ...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 3478888888776433 344556778899999999999999999999999999999873 455555422 234
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccC
Q 041755 431 ERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510 (678)
Q Consensus 431 ~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~ 510 (678)
...--+.||+.||.|||+ +.+++|++|.-+-|+++..|..||++|.++........ ......--..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 455577899999999997 37899999999999999999999999988764433221 00111112346677654322
Q ss_pred CCCccceEeehhHHHHHHhcC
Q 041755 511 KVSEKIDVYAFGIVLLELLSG 531 (678)
Q Consensus 511 ~~s~ksDVwSlGvvL~eLltG 531 (678)
. -..|.|-|||+++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 456999999999999999
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.5e-10 Score=132.03 Aligned_cols=203 Identities=24% Similarity=0.321 Sum_probs=139.3
Q ss_pred CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChH----HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSED----VLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
|...+-+-.|.++.++.+.-. .|...++|+...... ..+....+-.++-.-++|.++...--+.-....+||++|
T Consensus 806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~ 885 (1205)
T KOG0606|consen 806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHY 885 (1205)
T ss_pred ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHH
Confidence 344445667777777766432 344444444432221 122222232333333455555444444456788999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+.+++|...|+... ..+..-.......+..+++|||. ..++|+|++|.|+|+..++..+++|||+....+...
T Consensus 886 ~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 886 LNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hccCCchhhhhcCC----CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccccccc
Confidence 99999999998543 23333445566778889999998 669999999999999999999999998544332110
Q ss_pred --------C----------------C-----ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCC
Q 041755 488 --------S----------------H-----LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSE 538 (678)
Q Consensus 488 --------~----------------~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 538 (678)
. . .......||+.|++||.+.+.......|+|++|++++|.++|.+||+..
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 0 0112357999999999999999999999999999999999999999987
Q ss_pred CCcc
Q 041755 539 NPKG 542 (678)
Q Consensus 539 ~~~~ 542 (678)
.+..
T Consensus 1039 tpq~ 1042 (1205)
T KOG0606|consen 1039 TPQQ 1042 (1205)
T ss_pred chhh
Confidence 7654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=4e-08 Score=102.14 Aligned_cols=140 Identities=19% Similarity=0.154 Sum_probs=101.7
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCCh--HHHH----------HHHHHHHHHHhcCCC--CeeeEEEEEEe-----
Q 041755 337 YLVGKGGHSHVYRGCLPDGKELAVKILKPSE--DVLK----------EFASEIEIITALHHR--NIISLFGFCFE----- 397 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~--~~~~----------~~~~Ei~il~~l~Hp--nIv~l~g~~~~----- 397 (678)
.++-......|++..+ +|+.|.||...... ...+ .+.+|...+..|... ....++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3455555556777766 78899999875432 1222 377899998888533 33344445432
Q ss_pred CCeEEEEEEcCCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC-------C
Q 041755 398 DNNLLLVYDFLSRG-SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD-------D 469 (678)
Q Consensus 398 ~~~~~lV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~-------~ 469 (678)
....+||+|++++. +|.+++.... ....+...+..++.+++..+.-||. .||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCC
Confidence 23578999999886 8988875321 1344567778899999999999999 99999999999999975 4
Q ss_pred CCcEEeecccccc
Q 041755 470 FEPQLSDFGLASW 482 (678)
Q Consensus 470 ~~~kL~DFGla~~ 482 (678)
+.+.|+||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6789999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.6e-08 Score=97.99 Aligned_cols=124 Identities=23% Similarity=0.337 Sum_probs=81.7
Q ss_pred EEEEEEeCCCCEEEEEEeCCCh---------------------------HHHHHHHHHHHHHHhcCCC--CeeeEEEEEE
Q 041755 346 HVYRGCLPDGKELAVKILKPSE---------------------------DVLKEFASEIEIITALHHR--NIISLFGFCF 396 (678)
Q Consensus 346 ~Vy~g~~~~g~~vAvK~l~~~~---------------------------~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~ 396 (678)
.||.|...+|..+|||+.+... .......+|.+.|.++..- ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899998899999999975320 1134467899999999865 45666644
Q ss_pred eCCeEEEEEEcCC--CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeeeccCCCCCeEecCCCCcE
Q 041755 397 EDNNLLLVYDFLS--RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDY-LHNSCEQPVIHKDVKSSNILLSDDFEPQ 473 (678)
Q Consensus 397 ~~~~~~lV~E~~~--~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~y-LH~~~~~~iiHrDIKp~NILl~~~~~~k 473 (678)
..+ +|||||++ +..+..+.... +.......++.+++..+.. +|. .|++|+||.+.|||++++ .+.
T Consensus 79 ~~~--~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 NRN--VIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ETT--EEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEE
T ss_pred eCC--EEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEE
Confidence 233 89999998 54444332211 1123345677777775555 467 899999999999999988 999
Q ss_pred Eeeccccccc
Q 041755 474 LSDFGLASWL 483 (678)
Q Consensus 474 L~DFGla~~~ 483 (678)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.9e-08 Score=106.65 Aligned_cols=105 Identities=10% Similarity=0.096 Sum_probs=82.4
Q ss_pred CCcEEEEEEcCChhhHHHHHHHHhhccCC--CCeEEEEEeecCCCCCcCchhhhhhHHHHHHHHHHhhhhc------cCC
Q 041755 3 QGKVVVVGVKFDGESRELLTWALVKVAQP--GDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNL------KQV 74 (678)
Q Consensus 3 ~~r~I~VavD~s~~S~~AL~WAl~~~~~~--gd~vvlvhV~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~------k~v 74 (678)
.-++|+|+||+|+.|++||+.|++..... +..|++|||.+....... .....+..+++++.++..+.. .+|
T Consensus 4 ~ykkILVavDGSe~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~~~-~~~~~~~~eelle~~~~~~~~~l~~~~~gV 82 (357)
T PRK12652 4 AANRLLVPVADSVTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVDPE-GQDELAAAEELLERVEVWATEDLGDDASSV 82 (357)
T ss_pred ccCeEEEEeCCCHHHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccccc-hhHHHHHHHHHHHHHHHHHHHhhhcccCCC
Confidence 35799999999999999999999988664 589999999876431111 112223344677777777655 489
Q ss_pred eEEEEEEEC-------CchhHHHHHHHHhcCCcEEEEccCC
Q 041755 75 DLKLKVCRG-------TSVKKIIVKEAKSYGEAKVIVGISK 108 (678)
Q Consensus 75 ~~~~~v~~~-------~d~~~~l~~~a~~~~a~~LVlG~~~ 108 (678)
+++.+++.+ |++.+.|+++|++.++|++|||-.-
T Consensus 83 ~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~~ 123 (357)
T PRK12652 83 TIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPEY 123 (357)
T ss_pred ceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCCC
Confidence 999999875 8999999999999999999999873
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.3e-08 Score=114.19 Aligned_cols=191 Identities=21% Similarity=0.267 Sum_probs=118.1
Q ss_pred CCcceeccCCCCCCCCCCCCCChhhHHhhhhhccCccccccHHHHHHh------------hcCCCCceeecccCceEEEE
Q 041755 282 SGAIVSVEHDSACPPLSPYNELPKELEGLQERYSSTCRLFSYQELLSA------------TSNFLPEYLVGKGGHSHVYR 349 (678)
Q Consensus 282 ~~~~~~~~~~~~~~p~~~~~~~~~~l~~l~~~~~~~~~~f~~~el~~~------------t~~f~~~~~IG~G~~g~Vy~ 349 (678)
....+++++-.++-|.-...+..+++..++++ +..|++++.... ...|.. ..|+.++-|+||+
T Consensus 69 GPtfIK~GQ~LStR~Dl~p~e~~~eL~~LQD~----vpp~~~~~~~~iie~eLG~~iee~F~eF~~-~PiAsASIaQVH~ 143 (517)
T COG0661 69 GPTFIKLGQILSTRPDLVPPEYAEELAKLQDR----VPPFPFEEAERIIEEELGRPIEELFSEFEP-EPIASASIAQVHR 143 (517)
T ss_pred CCchhhhhhHHhcCccccCHHHHHHHHHhhcC----CCCCCHHHHHHHHHHHhCCCHHHHHHHcCC-CchhhhhHhhhee
Confidence 45667777765555544434445566665554 445555543222 233433 5799999999999
Q ss_pred EEeCCCCEEEEEEeCCChH-------------------------------HH----------HHHHHHHHHHHhcC----
Q 041755 350 GCLPDGKELAVKILKPSED-------------------------------VL----------KEFASEIEIITALH---- 384 (678)
Q Consensus 350 g~~~~g~~vAvK~l~~~~~-------------------------------~~----------~~~~~Ei~il~~l~---- 384 (678)
|.+.+|+.||||+.+|+-. .. -++.+|..-+.+++
T Consensus 144 A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~ 223 (517)
T COG0661 144 AVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRREAANAERFRENFK 223 (517)
T ss_pred EEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHcC
Confidence 9999999999999987510 00 11334444444442
Q ss_pred -CCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHH-HHHHHhcCCCCeeeccCCCC
Q 041755 385 -HRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEA-LDYLHNSCEQPVIHKDVKSS 462 (678)
Q Consensus 385 -HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~a-L~yLH~~~~~~iiHrDIKp~ 462 (678)
.+++.--.=|..-.+..+|+|||++|-.+.+...-.. ..++ +..++..++++ +..+-. .|++|.|..|.
T Consensus 224 ~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d---~k~ia~~~~~~f~~q~~~---dgffHaDpHpG 294 (517)
T COG0661 224 DDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGID---RKELAELLVRAFLRQLLR---DGFFHADPHPG 294 (517)
T ss_pred CCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh---cCccccCCCcc
Confidence 2333322222222356699999999988887743221 1233 22333333332 222222 78999999999
Q ss_pred CeEecCCCCcEEeecccccccCCC
Q 041755 463 NILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 463 NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
||+++.+|.+.+.|||+...++..
T Consensus 295 Ni~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 295 NILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999998877653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.4e-08 Score=108.40 Aligned_cols=169 Identities=20% Similarity=0.295 Sum_probs=129.5
Q ss_pred ceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEE----eCCeEEEEEEcCCC-CCHHHH
Q 041755 344 HSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCF----EDNNLLLVYDFLSR-GSLEEN 416 (678)
Q Consensus 344 ~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~----~~~~~~lV~E~~~~-gsL~~~ 416 (678)
..+.|++..+ ||..|++|++...+ +.......-+++++++.|+|+|++.+++. .+..++|||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4678998765 89999999995433 12223345678999999999999999886 34578999999986 577776
Q ss_pred hccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 417 LHGNKK-----------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 417 L~~~~~-----------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
...... .+...++...|.++.|+..||.++|+ .|+.-+-|.|.+||++.+..++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 554322 23456889999999999999999999 8998899999999999999999998888766554
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKP 534 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~P 534 (678)
+.. |.+.. -.+-|.=.||.+++.|.||..-
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 331 11111 1256888899999999999653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.2e-07 Score=91.82 Aligned_cols=132 Identities=19% Similarity=0.221 Sum_probs=93.9
Q ss_pred CCceeecccCceEEEEEEeCCCCEEEEEEeCCCh-----------------------HHHHHHHHHHHHHHhcCCC--Ce
Q 041755 334 LPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE-----------------------DVLKEFASEIEIITALHHR--NI 388 (678)
Q Consensus 334 ~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~-----------------------~~~~~~~~Ei~il~~l~Hp--nI 388 (678)
.....||-|.-+.||.|..++|.++|||.-+... -......+|+++|.+|... .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4467899999999999999999999999764321 1134467899999999755 67
Q ss_pred eeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC
Q 041755 389 ISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD 468 (678)
Q Consensus 389 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~ 468 (678)
.+.+++ +.-.+||||+++-.|...-- .-...-.++..|++-+.-+-. .||||+|+.+-|||+++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence 777765 45589999998865544321 111122233333333333334 89999999999999999
Q ss_pred CCCcEEeeccccc
Q 041755 469 DFEPQLSDFGLAS 481 (678)
Q Consensus 469 ~~~~kL~DFGla~ 481 (678)
+|.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999995443
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.8e-07 Score=100.87 Aligned_cols=189 Identities=21% Similarity=0.299 Sum_probs=116.7
Q ss_pred CcceeccCCCCCCCCCCCCCChhhHHhhhhhccCccccccHHHHHHhh------------cCCCCceeecccCceEEEEE
Q 041755 283 GAIVSVEHDSACPPLSPYNELPKELEGLQERYSSTCRLFSYQELLSAT------------SNFLPEYLVGKGGHSHVYRG 350 (678)
Q Consensus 283 ~~~~~~~~~~~~~p~~~~~~~~~~l~~l~~~~~~~~~~f~~~el~~~t------------~~f~~~~~IG~G~~g~Vy~g 350 (678)
+..+++++..++-|.- +|++.-.........|..|+++|+.... ..|. ...||.-..|+||+|
T Consensus 106 g~yIKlGQ~lst~~dl----lP~Eyv~~L~~LqD~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~-~~piaaASlaQVhrA 180 (538)
T KOG1235|consen 106 GTYIKLGQHLSTRPDL----LPKEYVKTLSELQDQAPPFPWEEAFKIFEEELGAPIEDIFSEFD-EEPIAAASLAQVHRA 180 (538)
T ss_pred CeEEEechhhcccccc----CcHHHHHHHHHHhccCCCCCHHHHHHHHHHHhCCCHHHHHHhcC-cchhhhcchhheEEE
Confidence 5667777765544422 3344333334444566778887765443 2343 346999999999999
Q ss_pred EeCCCCEEEEEEeCCChH--------------------------------HHH------HHHHHHHHHH----hcCCCC-
Q 041755 351 CLPDGKELAVKILKPSED--------------------------------VLK------EFASEIEIIT----ALHHRN- 387 (678)
Q Consensus 351 ~~~~g~~vAvK~l~~~~~--------------------------------~~~------~~~~Ei~il~----~l~Hpn- 387 (678)
++++|+.||||+-+++-. ..+ +|.+|.+-.. .+.|-+
T Consensus 181 ~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~ 260 (538)
T KOG1235|consen 181 RLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSL 260 (538)
T ss_pred EecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhccc
Confidence 999999999999876410 011 1444444332 234555
Q ss_pred -----eeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 041755 388 -----IISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSS 462 (678)
Q Consensus 388 -----Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~ 462 (678)
|.+++-.+ ....+|+||||+|..+.+.-.-.. ..++-.. ++..+.++ |++.....|++|.|-.|.
T Consensus 261 ~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~---~gi~~~~---i~~~l~~~--~~~qIf~~GffHaDPHPG 330 (538)
T KOG1235|consen 261 LTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDK---RGISPHD---ILNKLVEA--YLEQIFKTGFFHADPHPG 330 (538)
T ss_pred ccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHH---cCCCHHH---HHHHHHHH--HHHHHHhcCCccCCCCCC
Confidence 33333222 246799999999987765533211 2233333 33333332 333333378999999999
Q ss_pred CeEecC----CCCcEEeecccccccCCC
Q 041755 463 NILLSD----DFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 463 NILl~~----~~~~kL~DFGla~~~~~~ 486 (678)
||+++. ++.+.+-|||+...+...
T Consensus 331 Nilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 331 NILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred cEEEecCCCCCccEEEEcccccccccHH
Confidence 999984 678999999998866543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.3e-06 Score=86.74 Aligned_cols=137 Identities=18% Similarity=0.114 Sum_probs=103.2
Q ss_pred ecccCceEEEEEEeCCCCEEEEEEeCCC-------hHHHHHHHHHHHHHHhcCCC--CeeeEEEEEEeC-----CeEEEE
Q 041755 339 VGKGGHSHVYRGCLPDGKELAVKILKPS-------EDVLKEFASEIEIITALHHR--NIISLFGFCFED-----NNLLLV 404 (678)
Q Consensus 339 IG~G~~g~Vy~g~~~~g~~vAvK~l~~~-------~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~~~-----~~~~lV 404 (678)
-|+||.+-|++-.. +|+.+-+|.-... ......|.+|+..|.+|..- .+.++. ++... -..+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 57899999999776 5667899976421 22467899999999998632 244444 33211 246899
Q ss_pred EEcCCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC--cEEeeccccc
Q 041755 405 YDFLSR-GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE--PQLSDFGLAS 481 (678)
Q Consensus 405 ~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~--~kL~DFGla~ 481 (678)
+|-+.+ -+|.+++..... .+.+..++..++.+++..+.-||+ .|+.|+|+-+.|||++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998754 488888854322 355777888999999999999999 99999999999999986666 9999997655
Q ss_pred c
Q 041755 482 W 482 (678)
Q Consensus 482 ~ 482 (678)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2e-06 Score=91.67 Aligned_cols=195 Identities=16% Similarity=0.200 Sum_probs=125.8
Q ss_pred CCceeecccCceEEEEEEeCCCCEEEEEEeCC-ChHHHHHHHHHHHHHHhc-CCCCeeeEEEEE------Ee-CCeEEEE
Q 041755 334 LPEYLVGKGGHSHVYRGCLPDGKELAVKILKP-SEDVLKEFASEIEIITAL-HHRNIISLFGFC------FE-DNNLLLV 404 (678)
Q Consensus 334 ~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~------~~-~~~~~lV 404 (678)
...+.||+||-+.+|-.- .-..-+-|++.. ......+. +..|... .||-+-.-+.+= -+ +....+.
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 345679999999999532 212224466643 22221111 1222222 344322201110 11 1225677
Q ss_pred EEcCCCCC-HHHHhcc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 405 YDFLSRGS-LEENLHG--NKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 405 ~E~~~~gs-L~~~L~~--~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
|+.+.+.. ...++.- ++..-....|....+.+..++.+...||. .|.+-+|+.++|+|+.+++.+.|.|-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEccccee
Confidence 77776642 2222221 12233557899999999999999999999 999999999999999999999999865444
Q ss_pred ccCCCCCCceecccccCCCCCCcchhc-----cCCCCccceEeehhHHHHHHhcC-CCCCCCCC
Q 041755 482 WLSTSSSHLTCTDVAGTFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSG-KKPINSEN 539 (678)
Q Consensus 482 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~ 539 (678)
...++.. ..-.+|...|.+||... +..-+...|-|.||+++++||.| +.||.+..
T Consensus 166 i~~ng~~---~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 166 INANGTL---HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred eccCCce---EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 3322221 12257899999999764 33456789999999999999886 99997643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=8.8e-08 Score=107.64 Aligned_cols=153 Identities=20% Similarity=0.346 Sum_probs=99.3
Q ss_pred HHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCcee-------cccccCCCCCCcchhc
Q 041755 436 AVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC-------TDVAGTFGYLAPEYFM 508 (678)
Q Consensus 436 a~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~-------~~~~Gt~~Y~APE~l~ 508 (678)
+.+++.||.|+|. ..++||+.|.|++|.++.++..||+.|+.+............ --..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455599999998 488999999999999999999999999987654432111000 0123456799999999
Q ss_pred cCCCCccceEeehhHHHHHHhcCCCC-CCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcc
Q 041755 509 HGKVSEKIDVYAFGIVLLELLSGKKP-INSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSI 587 (678)
Q Consensus 509 ~~~~s~ksDVwSlGvvL~eLltG~~P-f~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl 587 (678)
+...+.++|+|||||++|-+..|..+ +........ + ......+..-...+.......+.+-+...+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~-----~--------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS-----Y--------SFSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcch-----h--------hhhhcccccccccccccCcHHHHHHHHHHh
Confidence 98899999999999999999955554 333221110 0 011111111111111122223333346668
Q ss_pred cCCCCCCCCHHHHHHH
Q 041755 588 SRAPTVRPQINLVLKL 603 (678)
Q Consensus 588 ~~dP~~RPs~~eVl~~ 603 (678)
..++.-||++.++...
T Consensus 250 ~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLSI 265 (700)
T ss_pred cCCcccCcchhhhhcc
Confidence 9999999988877654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.6e-06 Score=86.84 Aligned_cols=123 Identities=18% Similarity=0.148 Sum_probs=90.0
Q ss_pred CCCEEEEEEeCCC--h------HHHHHHHHHHHHHHhcCC--CCeeeEEEEEEeC----CeEEEEEEcCCCC-CHHHHhc
Q 041755 354 DGKELAVKILKPS--E------DVLKEFASEIEIITALHH--RNIISLFGFCFED----NNLLLVYDFLSRG-SLEENLH 418 (678)
Q Consensus 354 ~g~~vAvK~l~~~--~------~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~----~~~~lV~E~~~~g-sL~~~L~ 418 (678)
.++.+-+|.+... . -....+.+|...+..|.. =.+.+.+++.... ...+||+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 4566777653211 1 123457788888887753 2345555655542 2458999999885 7999886
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC---CcEEeeccccccc
Q 041755 419 GNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF---EPQLSDFGLASWL 483 (678)
Q Consensus 419 ~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~---~~kL~DFGla~~~ 483 (678)
... ..+......++.+++..+.-||. .||+|+|+++.|||++.+. .+.|+||+-++..
T Consensus 111 ~~~----~~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWE----QLDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhc----ccchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 532 14556778899999999999999 9999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.6e-06 Score=103.23 Aligned_cols=126 Identities=16% Similarity=0.103 Sum_probs=98.7
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCCcCchhhhhhHHHHHHHHHHhhhhccCCeEEEEEEEC
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLKQVDLKLKVCRG 83 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~v~~~~~v~~~ 83 (678)
+.+|+|+|+.++.+..++++|.+-..+-+..+++|||..+.. .. .......-+..+..+|++.|.+ ..++.|
T Consensus 250 ~eriLV~v~~~~~~~~lIr~~~rlA~~~~a~~~~l~V~~~~~---~~---~~~~~~~~l~~~~~lA~~lGa~--~~~~~~ 321 (895)
T PRK10490 250 RDAILLCIGHNTGSEKLVRTAARLAARLGSVWHAVYVETPRL---HR---LPEKKRRAILSALRLAQELGAE--TATLSD 321 (895)
T ss_pred CCeEEEEECCCcchHHHHHHHHHHHHhcCCCEEEEEEecCCc---Cc---CCHHHHHHHHHHHHHHHHcCCE--EEEEeC
Confidence 467999999999999999999999999999999999986531 01 1111222233333577776666 557788
Q ss_pred CchhHHHHHHHHhcCCcEEEEccCCCccccccCcchhhHhhhcCCCceEEEEEeCC
Q 041755 84 TSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAKYCARKLSKNFGVFAVENG 139 (678)
Q Consensus 84 ~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~~~svs~yc~~~ap~~c~V~~v~~~ 139 (678)
+|+.++|+++|+..+|+.+|||.+++++.|+. +|+++.+++.++ ...|.+|...
T Consensus 322 ~dva~~i~~~A~~~~vt~IViG~s~~~~~~~~-~s~~~~l~r~~~-~idi~iv~~~ 375 (895)
T PRK10490 322 PAEEKAVLRYAREHNLGKIIIGRRASRRWWRR-ESFADRLARLGP-DLDLVIVALD 375 (895)
T ss_pred CCHHHHHHHHHHHhCCCEEEECCCCCCCCccC-CCHHHHHHHhCC-CCCEEEEeCC
Confidence 99999999999999999999999988765432 599999999997 8889988543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.34 E-value=6.6e-06 Score=83.62 Aligned_cols=139 Identities=17% Similarity=0.261 Sum_probs=85.8
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCC--eeeEEEEEEeCCeEEEEEEcCCCCC-H
Q 041755 337 YLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRN--IISLFGFCFEDNNLLLVYDFLSRGS-L 413 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gs-L 413 (678)
..||+|..+.||+. .|..+++|...+.. ......+|.+++..+..-. +.+.++++...+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999983 35568889887643 2234578999999986443 4667777777777889999998863 2
Q ss_pred HHH---------------------hccCCCCCCCCCHHHHHH-HHHH----------HHH-HHHHHHh-cCCCCeeeccC
Q 041755 414 EEN---------------------LHGNKKDGNAFGWTERYK-VAVG----------VAE-ALDYLHN-SCEQPVIHKDV 459 (678)
Q Consensus 414 ~~~---------------------L~~~~~~~~~l~~~~~~~-ia~q----------ia~-aL~yLH~-~~~~~iiHrDI 459 (678)
... ||.-......+ ..+.. +..+ +.. ...+|.. .....++|+|+
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l--~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTF--QSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcH--HHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 111 12110011111 11100 0000 001 1222221 11245789999
Q ss_pred CCCCeEecCCCCcEEeecccccc
Q 041755 460 KSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 460 Kp~NILl~~~~~~kL~DFGla~~ 482 (678)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999988 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.4e-05 Score=80.78 Aligned_cols=152 Identities=24% Similarity=0.262 Sum_probs=98.9
Q ss_pred ccHHHHHHhhcCCCCcee---ecccCceEEEEEEeCCCCEEEEEEeCCChHH-------------------------HHH
Q 041755 321 FSYQELLSATSNFLPEYL---VGKGGHSHVYRGCLPDGKELAVKILKPSEDV-------------------------LKE 372 (678)
Q Consensus 321 f~~~el~~~t~~f~~~~~---IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~-------------------------~~~ 372 (678)
.+.+.|....++.....+ |..|--+.||+|...++..+|||+++..... ..-
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 344555555555555544 5567778999999888999999998753211 011
Q ss_pred HHHHHHHHHhcC--CCCeeeEEEEEEeCCeEEEEEEcCCCCCH-HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 041755 373 FASEIEIITALH--HRNIISLFGFCFEDNNLLLVYDFLSRGSL-EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449 (678)
Q Consensus 373 ~~~Ei~il~~l~--HpnIv~l~g~~~~~~~~~lV~E~~~~gsL-~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~ 449 (678)
...|+.-|.++. +-.+.+-+++. +-.|||||+....+ .=.|. ...+...+...+..++++.+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~- 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYK- 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHH-
Confidence 245777777774 44455555554 23899999954311 01111 1122222455666777777766654
Q ss_pred CCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 450 ~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
..++||+||..-|||+. ++.+.|+|||-|....
T Consensus 185 -~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 -EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 37899999999999999 8899999999876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.1e-05 Score=81.06 Aligned_cols=144 Identities=21% Similarity=0.298 Sum_probs=86.5
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCC--CeeeEEEEEEe---CCeEEEEEEcCCCC
Q 041755 337 YLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHR--NIISLFGFCFE---DNNLLLVYDFLSRG 411 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~~~~---~~~~~lV~E~~~~g 411 (678)
+.|+.|..+.||+....+ ..+++|+.... .....+..|..++..|... .+.+++.++.. ....+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 568999999999998866 69999998765 5567778899998888533 34566664433 23578999999988
Q ss_pred CHHH----------------H---hccCCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHHh--
Q 041755 412 SLEE----------------N---LHGNKKDGNAFGWTER---------YKV------------AVGVAE-ALDYLHN-- 448 (678)
Q Consensus 412 sL~~----------------~---L~~~~~~~~~l~~~~~---------~~i------------a~qia~-aL~yLH~-- 448 (678)
.+.. . |+........+.+... ... ...+.. .+..++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 7776 1 1111111111111110 000 111222 2333332
Q ss_pred --cCCCCeeeccCCCCCeEec-CCCCcEEeecccccc
Q 041755 449 --SCEQPVIHKDVKSSNILLS-DDFEPQLSDFGLASW 482 (678)
Q Consensus 449 --~~~~~iiHrDIKp~NILl~-~~~~~kL~DFGla~~ 482 (678)
.....++|+|+.|.|||++ +++.+.|+||+.+.+
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1346799999999999999 556668999987654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.09 E-value=5.4e-07 Score=100.30 Aligned_cols=183 Identities=20% Similarity=0.176 Sum_probs=133.2
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCCeEEEEEEcCCCC-CHH
Q 041755 337 YLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRN-IISLFGFCFEDNNLLLVYDFLSRG-SLE 414 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~E~~~~g-sL~ 414 (678)
+-+++|++++++|.+..-.+....+.+... ....-++++|.+++||| .+..++-+..++...++++++..+ +-.
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~ 323 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSA 323 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCcccc
Confidence 346899999999987544455556666543 34456889999999999 777777777777889999999877 221
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceecc
Q 041755 415 ENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD 494 (678)
Q Consensus 415 ~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 494 (678)
.... .....+...+...+...-.++|+|||+ ..-+|+| |||..+ +..++.||+....+.... ....
T Consensus 324 ~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t 389 (829)
T KOG0576|consen 324 LEMT---VSEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRT 389 (829)
T ss_pred ccCC---hhhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---cccc
Confidence 1110 111223334445566667788999997 4458888 887776 588999999988776644 2334
Q ss_pred cccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCC
Q 041755 495 VAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINS 537 (678)
Q Consensus 495 ~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~ 537 (678)
..+|+.++|||..+.+.+..+.|+|++|+--.+|--|-+|-..
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 6799999999999999999999999999877777777776543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.2e-05 Score=76.55 Aligned_cols=136 Identities=16% Similarity=0.165 Sum_probs=88.9
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh----HHHHHH------HHHHHHHHhcC---CCCeeeEEEEE-
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE----DVLKEF------ASEIEIITALH---HRNIISLFGFC- 395 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~----~~~~~~------~~Ei~il~~l~---HpnIv~l~g~~- 395 (678)
.++|...+++-......|.+-.. +|+.+++|..++.. .....| .+++..+..+. --....++-+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 35677777777777777877666 78999999887532 111212 22333333332 22222222222
Q ss_pred ----EeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC
Q 041755 396 ----FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE 471 (678)
Q Consensus 396 ----~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~ 471 (678)
.-....+|+|||++|..|.+... ++. .++..+.+++.-||. .|+.|+|+.|.|+++++++
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-
Confidence 12235579999999988766542 221 245667788999999 9999999999999999664
Q ss_pred cEEeecccccc
Q 041755 472 PQLSDFGLASW 482 (678)
Q Consensus 472 ~kL~DFGla~~ 482 (678)
++++||+..+.
T Consensus 173 i~iID~~~k~~ 183 (229)
T PF06176_consen 173 IRIIDTQGKRM 183 (229)
T ss_pred EEEEECccccc
Confidence 99999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.3e-05 Score=79.09 Aligned_cols=105 Identities=22% Similarity=0.201 Sum_probs=83.5
Q ss_pred HHHHHHHHhcCC-CCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 041755 374 ASEIEIITALHH-RNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452 (678)
Q Consensus 374 ~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~ 452 (678)
..|.-++..+.+ +++.+++|+|- .++|.||...+++...-. .-..-...+|..|.+||.++++.+.+|+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888899986 69999999993 278999998776643200 001112358999999999999999999987666
Q ss_pred CeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 453 ~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
.+.-.|++++|+-++++|.+|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 7889999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.04 E-value=5.6e-05 Score=77.43 Aligned_cols=141 Identities=19% Similarity=0.151 Sum_probs=85.3
Q ss_pred ecccCc-eEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHH
Q 041755 339 VGKGGH-SHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLVYDFLSRGSLEEN 416 (678)
Q Consensus 339 IG~G~~-g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~ 416 (678)
|-.|.+ ..||+... ++..+.||+..... ...+.+|++++..+. +--+.+++++....+..++|||+++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDG-KNPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcC-CCCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 344445 78999876 45788999886543 345667898888874 34456777777666667999999998777543
Q ss_pred h-------------------ccCCCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----cCC
Q 041755 417 L-------------------HGNKKDGNAFGW--TERYKVAV--------------------GVAEALDYLHN----SCE 451 (678)
Q Consensus 417 L-------------------~~~~~~~~~l~~--~~~~~ia~--------------------qia~aL~yLH~----~~~ 451 (678)
. |.......++.. ..+..... .+...+..|-. ...
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 2 211111111110 00000000 01111222211 112
Q ss_pred CCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 452 ~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
..++|+|+.|.|||++++..+.|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 4589999999999999987788999987653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2205 KdpD Osmosensitive K+ channel histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.0001 Score=84.67 Aligned_cols=134 Identities=19% Similarity=0.122 Sum_probs=101.8
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCCcCchhhhhhHHHHHHHHHHhhhhccCCeEEEEEEEC
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLKQVDLKLKVCRG 83 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~v~~~~~v~~~ 83 (678)
+.+|+|+|+.++.|-..++||-+-.-+.+...++|||-.+.. ....+.....|+....+|++ ..-+.+++.|
T Consensus 248 ~e~ilvcI~~~~~~e~liR~a~RlA~~~~a~~~av~v~~~~~------~~~~~~~~~~l~~~~~Lae~--lGae~~~l~~ 319 (890)
T COG2205 248 RERILVCISGSPGSEKLIRRAARLASRLHAKWTAVYVETPEL------HRLSEKEARRLHENLRLAEE--LGAEIVTLYG 319 (890)
T ss_pred cceEEEEECCCCchHHHHHHHHHHHHHhCCCeEEEEEecccc------ccccHHHHHHHHHHHHHHHH--hCCeEEEEeC
Confidence 468999999999999999999998889999999999987642 11111222334444445544 3446788889
Q ss_pred CchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeCCeeeeecc
Q 041755 84 TSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVENGKIVFQRE 146 (678)
Q Consensus 84 ~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~~k~~~~r~ 146 (678)
+|+.++|.++|+.++++.+|||.+.+++..+- .+|+.++.+++++ ...|.+|..+.....|+
T Consensus 320 ~dv~~~i~~ya~~~~~TkiViG~~~~~rw~~~~~~~l~~~L~~~~~-~idv~ii~~~~~~~~~~ 382 (890)
T COG2205 320 GDVAKAIARYAREHNATKIVIGRSRRSRWRRLFKGSLADRLAREAP-GIDVHIVALDAPPDKRP 382 (890)
T ss_pred CcHHHHHHHHHHHcCCeeEEeCCCcchHHHHHhcccHHHHHHhcCC-CceEEEeeCCCCccccc
Confidence 99999999999999999999999987544321 3599999999987 88888887765544443
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00024 Score=70.56 Aligned_cols=131 Identities=23% Similarity=0.403 Sum_probs=95.8
Q ss_pred CceeecccCceEEEEEEeCCCCEEEEEEeCCCh-----------------HHHHHHHHHHHHHHhcC------CCCeeeE
Q 041755 335 PEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE-----------------DVLKEFASEIEIITALH------HRNIISL 391 (678)
Q Consensus 335 ~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~-----------------~~~~~~~~Ei~il~~l~------HpnIv~l 391 (678)
....||+|+.=.||. .++.....||+..+.. ...+++.+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 345799999999995 6667778999987654 33567788888777776 7899999
Q ss_pred EEEEEeCCeEEEEEEcCCC------CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeE
Q 041755 392 FGFCFEDNNLLLVYDFLSR------GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNIL 465 (678)
Q Consensus 392 ~g~~~~~~~~~lV~E~~~~------gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NIL 465 (678)
+|+...+-.+.+|+|.+.+ -+|.+++.. ..++. ... ..+-+-..||-. ..|+.+|++|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~---~~L~~f~~~l~~---~~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELR---QALDEFKRYLLD---HHIVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHH---HHHHHHHHHHHH---cCCeecCCCcccEE
Confidence 9999999899999998643 267788743 23444 333 333344556666 88999999999999
Q ss_pred ecCCC----CcEEee-ccc
Q 041755 466 LSDDF----EPQLSD-FGL 479 (678)
Q Consensus 466 l~~~~----~~kL~D-FGl 479 (678)
+.... .+.|+| ||-
T Consensus 151 ~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EEecCCCceEEEEEeCCCC
Confidence 96432 577887 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.0002 Score=70.83 Aligned_cols=134 Identities=20% Similarity=0.324 Sum_probs=95.5
Q ss_pred CccccccHHHHHHhhcCCCCceeecccCc-eEEEEEEeCCCCEEEEEEeCC---C------------h-------HHHHH
Q 041755 316 STCRLFSYQELLSATSNFLPEYLVGKGGH-SHVYRGCLPDGKELAVKILKP---S------------E-------DVLKE 372 (678)
Q Consensus 316 ~~~~~f~~~el~~~t~~f~~~~~IG~G~~-g~Vy~g~~~~g~~vAvK~l~~---~------------~-------~~~~~ 372 (678)
+..+.|+. -+.++.....||.|.- |.||++.. +|+.||+|+++. . . .....
T Consensus 27 PKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P 100 (207)
T PF13095_consen 27 PKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP 100 (207)
T ss_pred CCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence 44455665 2267888889999999 99999988 788999999421 0 0 12345
Q ss_pred HHHHHHHHHhcC---CCCe--eeEEEEEEeC------------------CeEEEEEEcCCCCCHHHHhccCCCCCCCCCH
Q 041755 373 FASEIEIITALH---HRNI--ISLFGFCFED------------------NNLLLVYDFLSRGSLEENLHGNKKDGNAFGW 429 (678)
Q Consensus 373 ~~~Ei~il~~l~---HpnI--v~l~g~~~~~------------------~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~ 429 (678)
|..|.+...+|+ +.++ ++.+||..-. ..+.+|.||.+... .+.
T Consensus 101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~- 166 (207)
T PF13095_consen 101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ- 166 (207)
T ss_pred HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc-
Confidence 888888877775 4466 8899987422 12467888775532 111
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 430 TERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 430 ~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
..-+.+|.+-|..+|. .||+-+|+++.|.. .-+|+|||.+
T Consensus 167 ---~~~~~~~~~dl~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 ---IRDIPQMLRDLKILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ---hhHHHHHHHHHHHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 2235567777888998 99999999999986 4589999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00015 Score=87.40 Aligned_cols=77 Identities=14% Similarity=0.342 Sum_probs=56.6
Q ss_pred ceeecccCceEEEEEEeCCC---CEEEEEEeCCCh--HHHHHHHHHHHHHHhcC-CCCe--eeEEEEEEeC---CeEEEE
Q 041755 336 EYLVGKGGHSHVYRGCLPDG---KELAVKILKPSE--DVLKEFASEIEIITALH-HRNI--ISLFGFCFED---NNLLLV 404 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g---~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~-HpnI--v~l~g~~~~~---~~~~lV 404 (678)
...|+.|.+..+|+....++ ..+++|+..... .....+.+|+++++.+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45688999999999876554 467888765432 22346789999999996 6665 7778887654 457899
Q ss_pred EEcCCCCC
Q 041755 405 YDFLSRGS 412 (678)
Q Consensus 405 ~E~~~~gs 412 (678)
|||+++..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00016 Score=73.46 Aligned_cols=141 Identities=18% Similarity=0.297 Sum_probs=82.2
Q ss_pred eeecccCceEEEEEEeCC--CCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCeEEEEEEcCCCCCH
Q 041755 337 YLVGKGGHSHVYRGCLPD--GKELAVKILKPSEDVLKEFASEIEIITALHHRNI-ISLFGFCFEDNNLLLVYDFLSRGSL 413 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~--g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~~gsL 413 (678)
+.|..|-...+|+....+ +..|++|+........-.-.+|+.++..+...++ .++++.+ + + .+||||+++.++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-~-~--~~l~e~i~G~~l 79 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-Q-N--GLIYEFIPGRTL 79 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-C-C--cEEEEeeCCCcC
Confidence 456778888999987654 6789999876543322233478888888864333 3444433 2 2 479999988665
Q ss_pred HH-----------------HhccCCCCC--------CCCCHHHHHHHHH----------------------HHHHHHHHH
Q 041755 414 EE-----------------NLHGNKKDG--------NAFGWTERYKVAV----------------------GVAEALDYL 446 (678)
Q Consensus 414 ~~-----------------~L~~~~~~~--------~~l~~~~~~~ia~----------------------qia~aL~yL 446 (678)
.. .+|...... ....|.....+.. .+...+..|
T Consensus 80 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 159 (235)
T cd05157 80 EPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWL 159 (235)
T ss_pred CHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHH
Confidence 21 122211111 1111222212211 111111111
Q ss_pred ----Hh-cCCCCeeeccCCCCCeEecC-CCCcEEeeccccc
Q 041755 447 ----HN-SCEQPVIHKDVKSSNILLSD-DFEPQLSDFGLAS 481 (678)
Q Consensus 447 ----H~-~~~~~iiHrDIKp~NILl~~-~~~~kL~DFGla~ 481 (678)
-. .....++|+|+.+.|||+++ ++.+.|+||..|.
T Consensus 160 ~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 160 KELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 11 12356999999999999998 5789999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00013 Score=74.42 Aligned_cols=141 Identities=18% Similarity=0.207 Sum_probs=78.2
Q ss_pred eeecccCce-EEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCC---CeeeEEEEEEeC---CeEEEEEEcCC
Q 041755 337 YLVGKGGHS-HVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHR---NIISLFGFCFED---NNLLLVYDFLS 409 (678)
Q Consensus 337 ~~IG~G~~g-~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~~~~---~~~~lV~E~~~ 409 (678)
..|+.||.. .||+. +..+++|+.+.. .....+.+|.+++..|... -+..+++..... ...+++|++++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~-~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA-GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc-chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457877776 58974 245788876543 2345788899999888632 334444443321 23488999998
Q ss_pred CCCHHHH------------------hccCCCCCCCC-------------CHHHHH--HHH-------HHHHHH-HH-HHH
Q 041755 410 RGSLEEN------------------LHGNKKDGNAF-------------GWTERY--KVA-------VGVAEA-LD-YLH 447 (678)
Q Consensus 410 ~gsL~~~------------------L~~~~~~~~~l-------------~~~~~~--~ia-------~qia~a-L~-yLH 447 (678)
|.++.+. ||......... .|.... .+. .+.+.. +. +++
T Consensus 78 G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 157 (235)
T cd05155 78 GETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAALR 157 (235)
T ss_pred CCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHhc
Confidence 8665321 22211110000 111110 000 011111 11 111
Q ss_pred h--cCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 448 N--SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 448 ~--~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
. .....++|+|+.+.|||++++...-|+||+.+..
T Consensus 158 ~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 158 APWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 1 1234589999999999999776667999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.0002 Score=68.95 Aligned_cols=128 Identities=22% Similarity=0.264 Sum_probs=89.3
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHH
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 415 (678)
.+.||+|++|.||+|.+ .|..+|+|+-+.+ .....+..|+++|..+.--++.+=+-++-+ -.+.|||+.|-.|.+
T Consensus 27 ~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~d-s~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~L~~ 101 (201)
T COG2112 27 EKELAKGTTSVVYLGEW-RGGEVALKVRRRD-SPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhcccccEEEEeec-cCceEEEEEecCC-cchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcchhh
Confidence 45699999999999988 5568999987754 334678899999999987776654433322 255699998877776
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCC-CCCeEecCCCCcEEeecccccc
Q 041755 416 NLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVK-SSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 416 ~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIK-p~NILl~~~~~~kL~DFGla~~ 482 (678)
.-... . .+-...+++.-.-|-. .||-|..|. |...+|-.++.+.|+||.-|..
T Consensus 102 ~~~~~-------~----rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIGG-------D----RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcc-------c----HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 65321 1 2233455565444444 889999986 4545555555999999998874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.001 Score=70.45 Aligned_cols=76 Identities=9% Similarity=0.047 Sum_probs=56.3
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCC---CCeeeEEEEEEeC---CeEEEEEEcCC
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHH---RNIISLFGFCFED---NNLLLVYDFLS 409 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~~---~~~~lV~E~~~ 409 (678)
...||.|..+.||+....++ .+++|..+.. .....|..|.+.|+.|.- -.+.+++++|..+ +..+||||+++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~-~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARSF-STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEeccc-ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 45699999999999876555 4777875531 123468899999998853 3677888887543 56899999998
Q ss_pred CCCH
Q 041755 410 RGSL 413 (678)
Q Consensus 410 ~gsL 413 (678)
++++
T Consensus 97 G~~~ 100 (297)
T PRK10593 97 GVSV 100 (297)
T ss_pred CEec
Confidence 8754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0008 Score=69.50 Aligned_cols=138 Identities=17% Similarity=0.185 Sum_probs=80.2
Q ss_pred ecccCceEEEEEEeCCCCEEEEEEeCCChHHH-HHHHHHHHHHHhcCCCCe-eeEEEEEEeCCeEEEEEEcCCCCCHHH-
Q 041755 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVL-KEFASEIEIITALHHRNI-ISLFGFCFEDNNLLLVYDFLSRGSLEE- 415 (678)
Q Consensus 339 IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~-~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~~gsL~~- 415 (678)
+..|-.+.+|+... +|..+++|+........ -...+|.+++..+....+ .+++.++ . -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 45677789998764 67789999865433221 235778999998864433 3344433 2 278999998866532
Q ss_pred ----------------HhccCCCCCCCCCHHHH-HHHHHHH---------HHHHHHHHh-----cCCCCeeeccCCCCCe
Q 041755 416 ----------------NLHGNKKDGNAFGWTER-YKVAVGV---------AEALDYLHN-----SCEQPVIHKDVKSSNI 464 (678)
Q Consensus 416 ----------------~L~~~~~~~~~l~~~~~-~~ia~qi---------a~aL~yLH~-----~~~~~iiHrDIKp~NI 464 (678)
.||.....+.+++...+ ..+..++ ...+..+-. .....++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 12322222222222211 1111111 111222211 1124589999999999
Q ss_pred EecCCCCcEEeecccccc
Q 041755 465 LLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 465 Ll~~~~~~kL~DFGla~~ 482 (678)
++++++ +.|+||+.+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999887 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.00051 Score=72.39 Aligned_cols=143 Identities=16% Similarity=0.173 Sum_probs=84.5
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCC--eeeEEEE------EEeCCeEEEEEEc
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRN--IISLFGF------CFEDNNLLLVYDF 407 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~------~~~~~~~~lV~E~ 407 (678)
...|..|....+|+....+ ..+++|+.... .......|++++..|.+.+ +.+++.. ...++..++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~--~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV--SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC--ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 3457778778999987644 57899988752 2344566788777775332 3444331 1223456899999
Q ss_pred CCCCCHHH--------------HhccCCC-------CCCCCCHHHHHH----------HHHHHHHHHHHHHh----cCCC
Q 041755 408 LSRGSLEE--------------NLHGNKK-------DGNAFGWTERYK----------VAVGVAEALDYLHN----SCEQ 452 (678)
Q Consensus 408 ~~~gsL~~--------------~L~~~~~-------~~~~l~~~~~~~----------ia~qia~aL~yLH~----~~~~ 452 (678)
++|..+.. .||.... ......|..... ....+..++.++.. ....
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 98865421 1121100 001123322210 11122334444442 2235
Q ss_pred CeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 453 PVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 453 ~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
+++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 79999999999999998778899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0014 Score=72.01 Aligned_cols=74 Identities=20% Similarity=0.184 Sum_probs=54.0
Q ss_pred eeecccCceEEEEEEeCCC-CEEEEEEeCCC--------hHHHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCeEEEE
Q 041755 337 YLVGKGGHSHVYRGCLPDG-KELAVKILKPS--------EDVLKEFASEIEIITALH---HRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~g-~~vAvK~l~~~--------~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV 404 (678)
+.||-|.+..||++...+| +.|+||.-.+. ......+..|.+.|..+. ..++.+++.+.. +..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 4689999999999998777 58999985421 123456777888888763 345677776633 456899
Q ss_pred EEcCCCCC
Q 041755 405 YDFLSRGS 412 (678)
Q Consensus 405 ~E~~~~gs 412 (678)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00067 Score=71.84 Aligned_cols=140 Identities=24% Similarity=0.329 Sum_probs=83.8
Q ss_pred eecccCceEEEEEEeCC-------CCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCee-eEEEEEEeCCeEEEEEEcCC
Q 041755 338 LVGKGGHSHVYRGCLPD-------GKELAVKILKPSEDVLKEFASEIEIITALHHRNII-SLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~-------g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~lV~E~~~ 409 (678)
.|..|-...+|+....+ ++.+++|+............+|.+++..+...++. ++++++. + .+|+||++
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i~ 80 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFIP 80 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC-C---CchhheeC
Confidence 45566667999987655 58899999876543334567888888888643333 4555543 2 46899998
Q ss_pred CCCHHHH-----------------hccCCCCC--C---CC--CHHHHHH--------------------------HHHHH
Q 041755 410 RGSLEEN-----------------LHGNKKDG--N---AF--GWTERYK--------------------------VAVGV 439 (678)
Q Consensus 410 ~gsL~~~-----------------L~~~~~~~--~---~l--~~~~~~~--------------------------ia~qi 439 (678)
|.++... ||...... . .. -|..... +...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 8665321 22211110 0 11 1111111 11122
Q ss_pred HHHHHHHHh------cCCCCeeeccCCCCCeEecCC----CCcEEeeccccc
Q 041755 440 AEALDYLHN------SCEQPVIHKDVKSSNILLSDD----FEPQLSDFGLAS 481 (678)
Q Consensus 440 a~aL~yLH~------~~~~~iiHrDIKp~NILl~~~----~~~kL~DFGla~ 481 (678)
...+.+|-. .....++|+|+.+.|||++++ +.+.|+||..|.
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 222334432 134678999999999999985 889999998775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0019 Score=68.88 Aligned_cols=141 Identities=18% Similarity=0.224 Sum_probs=75.6
Q ss_pred eecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-----CCCeeeEE-E--EEEeCCeEEEEEEcCC
Q 041755 338 LVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALH-----HRNIISLF-G--FCFEDNNLLLVYDFLS 409 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~-g--~~~~~~~~~lV~E~~~ 409 (678)
.|+.|....+|+....+| .+++|++.... ......|+.++..|. .|.+++-. | +..-.+..+++++|++
T Consensus 29 ~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~--~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~ 105 (319)
T PRK05231 29 GIAEGIENSNFFLTTTQG-EYVLTLFERLT--AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLE 105 (319)
T ss_pred hhccccccceEEEEeCCC-cEEEEEeccCC--hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecC
Confidence 466777789999877555 68899875211 122334555555543 23333210 0 1122456789999998
Q ss_pred CCCHH-----------H---HhccCCCC-------CCCCCH-HHHHHHH-------------HHHHHHHHHHHhc----C
Q 041755 410 RGSLE-----------E---NLHGNKKD-------GNAFGW-TERYKVA-------------VGVAEALDYLHNS----C 450 (678)
Q Consensus 410 ~gsL~-----------~---~L~~~~~~-------~~~l~~-~~~~~ia-------------~qia~aL~yLH~~----~ 450 (678)
|..+. . .+|..... ...+.| .....-. ..+...+..+... .
T Consensus 106 G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l 185 (319)
T PRK05231 106 GKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPAL 185 (319)
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccC
Confidence 86431 1 12211100 011112 2211111 1111122333211 3
Q ss_pred CCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 451 ~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
..++||+|+.|.|||++.+...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 4689999999999999977666899998764
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0021 Score=68.34 Aligned_cols=143 Identities=18% Similarity=0.200 Sum_probs=81.4
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCC--eeeEEEE------EEeCCeEEEEEEcC
Q 041755 337 YLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRN--IISLFGF------CFEDNNLLLVYDFL 408 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~------~~~~~~~~lV~E~~ 408 (678)
..++.|....+|+....+| .+++|+...... ......|++++..|.... +.+++.. ....+..+++++|+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~-~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRVK-AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCCC-HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 4567777789999876555 578898765321 223445667777764222 3333331 11235678999999
Q ss_pred CCCCHH--------------HHhccCCCC----C----CCCCHHHHHH------------HHHHHHHHHHHHHh----cC
Q 041755 409 SRGSLE--------------ENLHGNKKD----G----NAFGWTERYK------------VAVGVAEALDYLHN----SC 450 (678)
Q Consensus 409 ~~gsL~--------------~~L~~~~~~----~----~~l~~~~~~~------------ia~qia~aL~yLH~----~~ 450 (678)
+|..+. -.+|..... . ..-.|..... ....+...++++.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 875431 112211110 0 0012221110 01123334555542 23
Q ss_pred CCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 451 ~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4789999999999999998877899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0011 Score=79.32 Aligned_cols=195 Identities=17% Similarity=0.154 Sum_probs=130.5
Q ss_pred HHHHHHHHhcCCCCeeeEEEEEEeCCeEE----EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 041755 374 ASEIEIITALHHRNIISLFGFCFEDNNLL----LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449 (678)
Q Consensus 374 ~~Ei~il~~l~HpnIv~l~g~~~~~~~~~----lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~ 449 (678)
..|++.+..+.|+|++.++.|-.+..... +..+++..-++...+... ..++....+.+..++.+||.|+|.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~h~- 304 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYLHS- 304 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHHHH-
Confidence 44667788889999999999987764333 334677777887777532 567888888899999999999998
Q ss_pred CCCCeeeccCCCC---CeEecCCCCcEEe--ecccccccCCCCCCceecccccCCCCCCcchhccCCCCc--cceEeehh
Q 041755 450 CEQPVIHKDVKSS---NILLSDDFEPQLS--DFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSE--KIDVYAFG 522 (678)
Q Consensus 450 ~~~~iiHrDIKp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~--ksDVwSlG 522 (678)
....|.-+..+ +-..+..+...++ ||+..+.++....... ..-+..|.+||......+.. ..|+|.+|
T Consensus 305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred --hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHH
Confidence 44444433333 4444556667766 8888877665433221 22355688888877665554 47999999
Q ss_pred HHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 523 IVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 523 vvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.++..+..|..+-.... ..-+.+...... .+..+...|+..++.+|++..+++.
T Consensus 380 ll~~~~~~~~~i~~~~~----------------------~~~~~l~~~~~~----~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKSA----------------------VPVSLLDVLSTS----ELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHhhhhhcCccccccc----------------------chhhhhccccch----hhhhhhhhhcchhhhhccchhhhhh
Confidence 99999999876532111 000111111111 2444557889999999999999887
Q ss_pred Hh
Q 041755 603 LL 604 (678)
Q Consensus 603 ~L 604 (678)
..
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 53
|
|
| >cd01984 AANH_like Adenine nucleotide alpha hydrolases superfamily including N type ATP PPases, ATP sulphurylases Universal Stress Response protein and electron transfer flavoprotein (ETF) | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.002 Score=54.67 Aligned_cols=82 Identities=20% Similarity=0.211 Sum_probs=64.1
Q ss_pred EEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCCcCchhhhhhHHHHHHHHHHhhhhccCCeEEEEEEECCch
Q 041755 7 VVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLKQVDLKLKVCRGTSV 86 (678)
Q Consensus 7 I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~v~~~~~v~~~~d~ 86 (678)
|+|+++++..|..+|.||.... +.+..++++|+- ..
T Consensus 1 ilv~~sgg~dS~~~l~~~~~~~-~~~~~~~~~~~~-------------------------------------------~~ 36 (86)
T cd01984 1 ILVALSGGLDSSVLLHLAKRLK-SGGPEVVALVVV-------------------------------------------AF 36 (86)
T ss_pred CEEEeeCCHHHHHHHHHHHHHH-hcCCCEEEEEeH-------------------------------------------HH
Confidence 6899999999999999999876 556677777773 44
Q ss_pred hHHHHHHHHhcCCcEEEEccCCCcccccc-Cc-chhhHhhhcCCCceEEE
Q 041755 87 KKIIVKEAKSYGEAKVIVGISKTHRTIRS-SV-SVAKYCARKLSKNFGVF 134 (678)
Q Consensus 87 ~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~-svs~yc~~~ap~~c~V~ 134 (678)
.+.+.+.+++.+++++++|.++....-.. .+ +++.++.+.++ |+|+
T Consensus 37 ~~~~~~~a~~~~~~~Iv~G~~~~d~~~~~~~~~~~~~~~~~~~~--~~vl 84 (86)
T cd01984 37 VRILKRLAAEEGADVIILGHNADDVAGRRLGASANVLVVIKGAG--IPVL 84 (86)
T ss_pred HHHHHHHHHHcCCCEEEEcCCchhhhhhccCchhhhhhcccccC--Ccee
Confidence 66788899999999999999987322211 23 78899998886 6665
|
The domain forms a apha/beta/apha fold which binds to Adenosine nucleotide. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.00041 Score=72.58 Aligned_cols=144 Identities=19% Similarity=0.195 Sum_probs=96.2
Q ss_pred ccHHHHHHhhc---CCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChH-----------------------HHHHHH
Q 041755 321 FSYQELLSATS---NFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSED-----------------------VLKEFA 374 (678)
Q Consensus 321 f~~~el~~~t~---~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~-----------------------~~~~~~ 374 (678)
+.|--|....+ -++..+.||-|.-+-||.+-..+|++.++|+-+-... ..-...
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 44444444433 3677889999999999999998999999996542210 112245
Q ss_pred HHHHHHHhcCC-C-CeeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 041755 375 SEIEIITALHH-R-NIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452 (678)
Q Consensus 375 ~Ei~il~~l~H-p-nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~ 452 (678)
+|+..|+.|.. . -+.+.++++ ..++|||++.+-.|...-+- ..-.+++ ..+..-+--|-. .
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly---~~lm~~Iv~la~---~ 221 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRHV-------EDPPTLY---DDLMGLIVRLAN---H 221 (465)
T ss_pred HHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeeec-------CChHHHH---HHHHHHHHHHHH---c
Confidence 68888888853 2 344555543 55899999988776544321 1222222 222233334444 8
Q ss_pred CeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 453 PVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 453 ~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
|+||+|..-=||++++++.++++||--..
T Consensus 222 GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 222 GLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred CceecccchheeEEecCCCEEEeechHhh
Confidence 99999999999999999999999996543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.015 Score=60.88 Aligned_cols=70 Identities=17% Similarity=0.112 Sum_probs=41.6
Q ss_pred ecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCC--CC-eeeEEEEEEeCCeEEEEEEcCCCCCH
Q 041755 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHH--RN-IISLFGFCFEDNNLLLVYDFLSRGSL 413 (678)
Q Consensus 339 IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~H--pn-Iv~l~g~~~~~~~~~lV~E~~~~gsL 413 (678)
.+.|-...||.....+|..+++|.-+. ........+|.++|..|.. |- +.+++.. .. -+++|+++.|..+
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~--~~--~~~~y~~i~G~p~ 91 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRR-PDVSERAAAEKRVLALVRKHLPVQVPDWRVH--TP--ELIAYPKLPGVPA 91 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCC-HHHHHHHHHHHHHHHHHHhcCCCCCCceeee--cC--ceEEEeccCCCcc
Confidence 345555667766545788999998753 3344567889999998853 21 1222211 11 2566777766443
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.017 Score=62.48 Aligned_cols=140 Identities=17% Similarity=0.262 Sum_probs=82.0
Q ss_pred eecccCceEEEEEEeCC-----CCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCee-eEEEEEEeCCeEEEEEEcCCCC
Q 041755 338 LVGKGGHSHVYRGCLPD-----GKELAVKILKPSEDVLKEFASEIEIITALHHRNII-SLFGFCFEDNNLLLVYDFLSRG 411 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~~-----g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~lV~E~~~~g 411 (678)
.|-.|-...+|+....+ ++.|++|+........-.-.+|+.++..+..-++. ++++++.. ..|++|+++.
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~efi~g~ 118 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEFIHAR 118 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECC----ceEEEeeCCC
Confidence 44457778999986532 36899998875432222236788888888654444 44555432 2589999776
Q ss_pred CHHHH-----------------hccCCCCCC--CCCHHHHHHHHHHH-----------------HHHHHHHHh-----cC
Q 041755 412 SLEEN-----------------LHGNKKDGN--AFGWTERYKVAVGV-----------------AEALDYLHN-----SC 450 (678)
Q Consensus 412 sL~~~-----------------L~~~~~~~~--~l~~~~~~~ia~qi-----------------a~aL~yLH~-----~~ 450 (678)
+|... +|....... ...|....++..++ ...+..|.. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 65321 232211111 22233333333221 111222221 22
Q ss_pred CCCeeeccCCCCCeEecC-CCCcEEeeccccc
Q 041755 451 EQPVIHKDVKSSNILLSD-DFEPQLSDFGLAS 481 (678)
Q Consensus 451 ~~~iiHrDIKp~NILl~~-~~~~kL~DFGla~ 481 (678)
...++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 346899999999999986 4689999998765
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.00025 Score=86.13 Aligned_cols=161 Identities=11% Similarity=-0.029 Sum_probs=115.8
Q ss_pred HHHHHHHHHhcCCCCeeeEEEEEE--eCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 041755 373 FASEIEIITALHHRNIISLFGFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450 (678)
Q Consensus 373 ~~~Ei~il~~l~HpnIv~l~g~~~--~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~ 450 (678)
...|...++...|+++.....=.. +....+.+++|+..|.+++.+.........+...-......+......-+|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 345555666678988876554332 233568899999999999998766554455544444444444355555555422
Q ss_pred --CCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHH
Q 041755 451 --EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLEL 528 (678)
Q Consensus 451 --~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eL 528 (678)
..-.+|+++|+-|.+|..+..+|++++|+.+...+.... .....+++.|+.|++...-.++.++|+|..|+-+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 244789999999999999999999999999843332211 1235678889999999888999999999999999999
Q ss_pred hcCCCCC
Q 041755 529 LSGKKPI 535 (678)
Q Consensus 529 ltG~~Pf 535 (678)
..|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 9888876
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.062 Score=56.85 Aligned_cols=30 Identities=33% Similarity=0.403 Sum_probs=25.9
Q ss_pred CCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 451 ~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 367999999999999998 578999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.022 Score=60.94 Aligned_cols=137 Identities=21% Similarity=0.293 Sum_probs=91.7
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCC--------------------------hHHHHH-HHHHHHHHHhcCCCCe
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPS--------------------------EDVLKE-FASEIEIITALHHRNI 388 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~--------------------------~~~~~~-~~~Ei~il~~l~HpnI 388 (678)
..+|..|.-+.||.+...+|..+|||+++.+ ....+. ...|++-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4578889999999999889999999997632 011122 2357888888865443
Q ss_pred eeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC
Q 041755 389 ISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD 468 (678)
Q Consensus 389 v~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~ 468 (678)
.-.--.... .-+|||+|+....-. ..+-....++...+..+-.+++.-+.-|.+. -++||.||.--|+|+-+
T Consensus 229 P~PePIlLk--~hVLVM~FlGrdgw~----aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Lyhd 300 (520)
T KOG2270|consen 229 PCPEPILLK--NHVLVMEFLGRDGWA----APKLKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLYHD 300 (520)
T ss_pred CCCCceeee--cceEeeeeccCCCCc----CcccccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheEEC
Confidence 322222222 238999999532111 0111123456666777778888888888764 57999999999998754
Q ss_pred CCCcEEeeccccc
Q 041755 469 DFEPQLSDFGLAS 481 (678)
Q Consensus 469 ~~~~kL~DFGla~ 481 (678)
|.+.|+|.+-+.
T Consensus 301 -G~lyiIDVSQSV 312 (520)
T KOG2270|consen 301 -GKLYIIDVSQSV 312 (520)
T ss_pred -CEEEEEEccccc
Confidence 589999987654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 678 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-56 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-31 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-24 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-21 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-18 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-17 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-15 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-15 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-15 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-13 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-13 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-12 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-12 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-12 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 9e-12 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 9e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-11 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-11 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 8e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 9e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 9e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-07 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 8e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 3e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 9e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-05 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 678 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-131 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-121 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-110 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-71 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-57 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-57 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-55 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 6e-55 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 5e-54 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-51 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 3e-49 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 1e-48 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-48 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 6e-47 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 1e-46 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 3e-46 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-45 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 4e-45 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-36 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 6e-36 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-34 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-33 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-33 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 5e-33 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-32 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 2e-32 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 3e-32 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-31 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-31 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-31 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 5e-31 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 1e-30 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-30 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 1e-30 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-30 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 7e-30 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 7e-30 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-29 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 2e-29 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 3e-29 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-29 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 4e-29 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-28 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 3e-28 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-28 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 9e-28 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-27 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-27 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-27 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-27 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-27 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-27 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-27 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 4e-27 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 5e-27 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 6e-27 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 6e-27 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 6e-27 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 7e-27 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 9e-27 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-26 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-26 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 1e-26 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-26 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-26 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-26 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-26 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 2e-26 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-26 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 2e-26 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-26 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-26 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-26 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-26 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 3e-26 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-26 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-26 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-26 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-26 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 4e-26 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 4e-26 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-26 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-26 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-26 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 6e-26 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 8e-26 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-25 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-25 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-25 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-25 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-25 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-25 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-25 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-25 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-25 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-25 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-25 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-25 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 4e-25 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-25 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 6e-25 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 6e-25 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 7e-25 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 7e-25 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 8e-25 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 8e-25 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-24 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-24 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-24 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-24 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-24 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 2e-24 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 2e-24 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-24 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-24 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-24 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 5e-24 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 5e-24 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 6e-24 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 6e-24 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 9e-24 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 9e-24 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-23 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 1e-23 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 1e-23 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 2e-23 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-23 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 4e-23 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-23 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 8e-23 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 8e-23 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-22 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-22 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 7e-22 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 7e-22 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 8e-22 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-21 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 1e-21 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 1e-21 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 1e-21 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 1e-21 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-21 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-21 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 4e-21 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 5e-21 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 6e-21 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 8e-21 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 9e-21 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-20 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 4e-20 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 9e-20 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-19 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-19 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 9e-19 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-18 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 5e-18 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-17 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 1e-17 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 5e-17 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 7e-17 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-16 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 2e-16 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 3e-16 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 9e-16 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-15 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-15 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 4e-15 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 6e-15 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-14 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 2e-14 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 3e-14 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 5e-14 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 6e-14 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 6e-14 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 8e-14 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 8e-14 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 9e-14 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-13 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-13 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 3e-13 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 5e-13 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 6e-13 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 8e-13 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 8e-13 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 9e-13 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 9e-13 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 9e-13 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-12 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-12 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-12 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-12 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-12 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 2e-12 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-12 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 3e-12 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-12 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 5e-12 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 9e-12 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 1e-11 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-11 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 4e-11 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-11 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 4e-11 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 5e-11 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 6e-11 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 7e-11 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 7e-11 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 9e-11 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 9e-11 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-10 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-10 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-10 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-10 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 5e-10 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 5e-10 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 6e-10 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-09 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 1e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-06 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-04 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-09 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 4e-09 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-05 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-09 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 6e-09 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 7e-09 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-08 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 6e-07 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 9e-07 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-06 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-06 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 5e-06 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 2e-04 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 3e-04 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 3e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 387 bits (997), Expect = e-131
Identities = 114/314 (36%), Positives = 186/314 (59%), Gaps = 5/314 (1%)
Query: 308 EGLQERYSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE 367
E E + + FS +EL A+ NF + ++G+GG VY+G L DG +AVK LK
Sbjct: 7 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER 66
Query: 368 D--VLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGN 425
+F +E+E+I+ HRN++ L GFC LLVY +++ GS+ L +
Sbjct: 67 TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 426 AFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485
W +R ++A+G A L YLH+ C+ +IH+DVK++NILL ++FE + DFGLA +
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
Query: 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQES 545
+H+T T V GT G++APEY GK SEK DV+ +G++LLEL++G++ + +
Sbjct: 187 KDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 546 --LVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603
L+ W K +LK+ K+ L+D L +Y ++++E+++ A L +P RP+++ V+++
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 604 LQGDEEAANWAKEQ 617
L+GD A W + Q
Sbjct: 306 LEGDGLAERWEEWQ 319
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 363 bits (935), Expect = e-121
Identities = 101/302 (33%), Positives = 171/302 (56%), Gaps = 9/302 (2%)
Query: 315 SSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKP-SEDVLKEF 373
+L AT+NF ++L+G G VY+G L DG ++A+K P S ++EF
Sbjct: 23 PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82
Query: 374 ASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY 433
+EIE ++ H +++SL GFC E N ++L+Y ++ G+L+ +L+G+ + W +R
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 434 KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA-SWLSTSSSHLTC 492
++ +G A L YLH +IH+DVKS NILL ++F P+++DFG++ +HL+
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS- 198
Query: 493 TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552
T V GT GY+ PEYF+ G+++EK DVY+FG+VL E+L + I P+ +L WA
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD---EE 609
+G++ Q++DP+L + + + A ++ + RP + VL L+ +E
Sbjct: 259 SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318
Query: 610 AA 611
+
Sbjct: 319 SV 320
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 334 bits (858), Expect = e-110
Identities = 93/312 (29%), Positives = 159/312 (50%), Gaps = 23/312 (7%)
Query: 312 ERYSSTCRLFSYQELLSATSNFLPEY------LVGKGGHSHVYRGCLPDGKELAVKILKP 365
E + FS+ EL + T+NF +G+GG VY+G + + +AVK L
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 366 SEDV-----LKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGN 420
D+ ++F EI+++ H N++ L GF + ++L LVY ++ GSL + L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC- 123
Query: 421 KKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480
W R K+A G A +++LH E IH+D+KS+NILL + F ++SDFGLA
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 481 SWLST-SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
+ + +T + + GT Y+APE + G+++ K D+Y+FG+VLLE+++G ++
Sbjct: 181 RASEKFAQTVMT-SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR 238
Query: 540 PKGQESLVMWAKPILKD-GKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQIN 598
+ L+ + I + + +D ++ D D+ +E M A+ + RP I
Sbjct: 239 E--PQLLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIK 295
Query: 599 LVLKLLQGDEEA 610
V +LLQ +
Sbjct: 296 KVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-71
Identities = 68/319 (21%), Positives = 114/319 (35%), Gaps = 28/319 (8%)
Query: 309 GLQERYSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSED 368
G + S+ + L + + +G V++ + +AVKI +
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDK 60
Query: 369 VLKEFASEIEIITALHHRNIISLFGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDG 424
+ E+ + + H NI+ G + L L+ F +GSL + L N
Sbjct: 61 QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS- 119
Query: 425 NAFGWTERYKVAVGVAEALDYLH-------NSCEQPVIHKDVKSSNILLSDDFEPQLSDF 477
W E +A +A L YLH + + + H+D+KS N+LL ++ ++DF
Sbjct: 120 ----WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175
Query: 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-----KVSEKIDVYAFGIVLLELLSGK 532
GLA S GT Y+APE +ID+YA G+VL EL S
Sbjct: 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 533 KPINSENPKGQESL--VMWAKPILKDGK---VSQLLDPSLDTDYDNDQIERMVLA-ATLS 586
+ + + P L+D + V + P L + M+
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295
Query: 587 ISRAPTVRPQINLVLKLLQ 605
R V + +
Sbjct: 296 WDHDAEARLSAGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-57
Identities = 65/199 (32%), Positives = 107/199 (53%), Gaps = 8/199 (4%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILK---PSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+G G V+R G ++AVKIL + + EF E+ I+ L H NI+ G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
+ NL +V ++LSRGSL LH R +A VA+ ++YLH + P++
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIV 161
Query: 456 HKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEK 515
H+++KS N+L+ + ++ DFGL+ +++ L+ AGT ++APE +EK
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 516 IDVYAFGIVLLELLSGKKP 534
DVY+FG++L EL + ++P
Sbjct: 220 SDVYSFGVILWELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-57
Identities = 59/197 (29%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
VG+G V + K++A+K ++ SE K F E+ ++ ++H NI+ L+G C
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQIE-SESERKAFIVELRQLSRVNHPNIVKLYGACL-- 71
Query: 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKD 458
N + LV ++ GSL LHG + + + ++ + YLH+ + +IH+D
Sbjct: 72 NPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 459 VKSSNILLSDDFE-PQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKID 517
+K N+LL ++ DFG A + T T+ G+ ++APE F SEK D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 518 VYAFGIVLLELLSGKKP 534
V+++GI+L E+++ +KP
Sbjct: 186 VFSWGIILWEVITRRKP 202
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-55
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 23/209 (11%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSED-----VLKEFASEIEIITALHHRNIISLFG 393
+G GG VYR G E+AVK + D ++ E ++ L H NII+L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
C ++ NL LV +F G L L G + AV +A ++YLH+ P
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGKRIP-----PDILVNWAVQIARGMNYLHDEAIVP 128
Query: 454 VIHKDVKSSNILLSDDFEPQ--------LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
+IH+D+KSSNIL+ E ++DFGLA ++ AG + ++APE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPE 184
Query: 506 YFMHGKVSEKIDVYAFGIVLLELLSGKKP 534
S+ DV+++G++L ELL+G+ P
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 190 bits (483), Expect = 6e-55
Identities = 62/320 (19%), Positives = 113/320 (35%), Gaps = 43/320 (13%)
Query: 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEI- 379
+ E N L+G+G + VY+G L D + +AVK+ + + F +E I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIY 59
Query: 380 -ITALHHRNIISLFGFCFEDN-----NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY 433
+ + H NI LLV ++ GSL + L + D W
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WVSSC 114
Query: 434 KVAVGVAEALDYLHNSCEQ------PVIHKDVKSSNILLSDDFEPQLSDFGLA------S 481
++A V L YLH + + H+D+ S N+L+ +D +SDFGL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 482 WLSTSSSHLTCTDVAGTFGYLAPEYFM-------HGKVSEKIDVYAFGIVLLELLSGKKP 534
+ GT Y+APE +++D+YA G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 535 INSENPKGQESL----VMWAKPILKDGK---VSQLLDPSLDTDYDNDQIERMVLAATLSI 587
+ + + + P +D + + P + + + L T+
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 588 --SRAPTVRPQINLVLKLLQ 605
+ R + +
Sbjct: 295 CWDQDAEARLTAQXAEERMA 314
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 5e-54
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 27/212 (12%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSED--------VLKEFASEIEIITALHHRNII 389
+GKGG V++G + D +A+K L + +EF E+ I++ L+H NI+
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 390 SLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
L+G N +V +F+ G L L W+ + ++ + +A ++Y+ +
Sbjct: 87 KLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHP---IKWSVKLRLMLDIALGIEYMQ-N 140
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQ-----LSDFGLASWLSTSSSHLTCTDVAGTFGYLAP 504
P++H+D++S NI L E ++DFGL+ S + + G F ++AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV-----SGLLGNFQWMAP 195
Query: 505 EYFM--HGKVSEKIDVYAFGIVLLELLSGKKP 534
E +EK D Y+F ++L +L+G+ P
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-51
Identities = 37/204 (18%), Positives = 83/204 (40%), Gaps = 19/204 (9%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFC 395
+ + +++G G ++ VK+LK S ++F E + H N++ + G C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 396 FE--DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
+ L+ ++ GSL LH + ++ K A+ +A + +LH + E
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLH-TLEPL 133
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH---G 510
+ + S ++++ +D ++S + ++APE
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADV-------KFSFQSPGRMYAPAWVAPEALQKKPED 186
Query: 511 KVSEKIDVYAFGIVLLELLSGKKP 534
D+++F ++L EL++ + P
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVP 210
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-48
Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 18/218 (8%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFC 395
+G G VY+G ++AVK+L + L+ F +E+ ++ H NI+ G+
Sbjct: 32 IGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
L +V + SL +LH F + +A A +DYLH + +I
Sbjct: 90 TAPQ-LAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 456 HKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE---YFMHGKV 512
H+D+KS+NI L +D ++ DFGLA+ S S ++G+ ++APE
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 513 SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA 550
S + DVYAFGIVL EL++G+ P ++ N + Q ++
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM 237
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-48
Identities = 50/217 (23%), Positives = 88/217 (40%), Gaps = 24/217 (11%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFC 395
+GKG VY G E+A++++ +ED LK F E+ H N++ G C
Sbjct: 41 IGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
+L ++ +L + K + ++A + + + YLH + ++
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 456 HKDVKSSNILLSDDFEPQLSDFGLA---SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
HKD+KS N+ D+ + ++DFGL L G +LAPE
Sbjct: 153 HKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 513 ---------SEKIDVYAFGIVLLELLSGKKPINSENP 540
S+ DV+A G + EL + + P ++
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 6e-47
Identities = 50/210 (23%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKIL-KPSEDVLKEFASEIEIITALHHRNIISLFGFCF 396
+GKG + G+ + +K L + E+ + F E++++ L H N++ G +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIH 456
+D L + +++ G+L + + + W++R A +A + YLH +IH
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIH 131
Query: 457 KDVKSSNILLSDDFEPQLSDFGLA------------SWLSTSSSHLTCTDVAGTFGYLAP 504
+D+ S N L+ ++ ++DFGLA V G ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 505 EYFMHGKVSEKIDVYAFGIVLLELLSGKKP 534
E EK+DV++FGIVL E++
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-46
Identities = 62/291 (21%), Positives = 112/291 (38%), Gaps = 30/291 (10%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFE 397
+GKG + V+ G G+++AVK+ +E+ +EI + H NI+ +
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 398 DN----NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS---- 449
L L+ D+ GSL + L D K+A L +LH
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKSTTLD-----AKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 450 -CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH--LTCTDVAGTFGYLAPE- 505
+ + H+D+KS NIL+ + ++D GLA + ++ + GT Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
Query: 506 -----YFMHGKVSEKIDVYAFGIVLLELLSGKKPINS----ENPKGQESLVMWAKPILKD 556
H + D+Y+FG++L E+ + P + +++
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 557 GKVSQLLDPSLDTDYDNDQIERMVLAATLS--ISRAPTVRPQINLVLKLLQ 605
+ L PS + +D+ R + ++ + P R V K L
Sbjct: 278 IVCIKKLRPSFPNRWSSDECLR-QMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 69/295 (23%), Positives = 112/295 (37%), Gaps = 57/295 (19%)
Query: 269 DTSEDNRSNLDGESGAIVSVEHDS----ACPPLSPYNELPKELEGLQERYSSTCRLFSYQ 324
D S D +G + + + + + PL + + + LQE
Sbjct: 2 DPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIV-LQES----------- 49
Query: 325 ELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEI--ITA 382
+GKG V+RG G+E+AVKI E+ + + E EI
Sbjct: 50 --------------IGKGRFGEVWRGKW-RGEEVAVKIFSSREE--RSWFREAEIYQTVM 92
Query: 383 LHHRNIISLFGFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVG 438
L H NI+ +DN L LV D+ GSL + L+ K+A+
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALS 147
Query: 439 VAEALDYLH-----NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH--LT 491
A L +LH + + H+D+KS NIL+ + ++D GLA +++ +
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 492 CTDVAGTFGYLAPE------YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
GT Y+APE H + ++ D+YA G+V E+
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-45
Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 27/222 (12%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEI--ITALHHRNIISLFGFC 395
VGKG + V+RG G+ +AVKI ++ K + E E+ L H NI+
Sbjct: 15 CVGKGRYGEVWRGSW-QGENVAVKIFSSRDE--KSWFRETELYNTVMLRHENILGFIASD 71
Query: 396 ----FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH---- 447
L L+ + GSL + L D ++ + +A L +LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLD-----TVSCLRIVLSIASGLAHLHIEIF 126
Query: 448 -NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH--LTCTDVAGTFGYLAP 504
+ + H+D+KS NIL+ + + ++D GLA S S++ + GT Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 505 E------YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
E +++D++AFG+VL E+
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 19/222 (8%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVK-ILKPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+G+GG S+V L DG A+K IL + +E E ++ +H NI+ L +C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 396 FEDNN----LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
+ L+ F RG+L + K GN + + +G+ L+ +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---A 152
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS----TSSSHLTCTDVA---GTFGYLAP 504
+ H+D+K +NILL D+ +P L D G + S LT D A T Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 505 EYF---MHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQ 543
E F H + E+ DV++ G VL ++ G+ P + KG
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 65/299 (21%), Positives = 120/299 (40%), Gaps = 30/299 (10%)
Query: 331 SNFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILK----PSEDVLKEFASEIEIITALHH 385
+NF E +G+G S VYR CL DG +A+K ++ + EI+++ L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 386 RNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEAL 443
N+I + EDN L +V + G L + KK ER K V + AL
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI--PERTVWKYFVQLCSAL 149
Query: 444 DYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLA 503
+++H + V+H+D+K +N+ ++ +L D GL + S+ ++ + GT Y++
Sbjct: 150 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMS 204
Query: 504 PEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563
PE + K D+++ G +L E+ + + P + SL ++ L
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCK----KIEQCDYPPLP 259
Query: 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEAANWAKEQVSASE 622
+ + I+ P RP + + + +
Sbjct: 260 SDHYSEEL-RQLVNMC-------INPDPEKRPDVT---YVYDVAKRMHACTASSLEHHH 307
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 64/298 (21%), Positives = 122/298 (40%), Gaps = 57/298 (19%)
Query: 328 SATSNFLPEY----LVGKGGHSHVYRG-CLPDGKELAVKIL-KPSEDVLKEFASEIEIIT 381
+ F ++ L+G GG V++ DGK +K + +E +E ++ +
Sbjct: 4 TVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALA 59
Query: 382 ALHHRNIISLFGFCFED-----------------NNLLLVYDFLSRGSLEENLHGNKKDG 424
L H NI+ G C++ L + +F +G+LE+ + K+ G
Sbjct: 60 KLDHVNIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRG 116
Query: 425 NAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484
++ + + +DY+H + +I++D+K SNI L D + ++ DFGL + L
Sbjct: 117 EKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173
Query: 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQE 544
GT Y++PE +++D+YA G++L ELL
Sbjct: 174 NDGKRTR---SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETS 225
Query: 545 SLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602
L+DG +S + D ++++ +S+ P RP + +L+
Sbjct: 226 KFFT----DLRDGIISDIFDKKE-----KTLLQKL-------LSKKPEDRPNTSEILR 267
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 15/211 (7%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKIL---KPSEDVLKEFASEIEIITALHHRNIISLFG 393
+G+G DG++ +K + + S +E E+ ++ + H NI+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCE 451
E+ +L +V D+ G L + + N + G F E V + AL ++H +
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLF--QEDQILDWFVQICLALKHVH---D 143
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
+ ++H+D+KS NI L+ D QL DFG+A L+ S+ L GT YL+PE +
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARA-CIGTPYYLSPEICENKP 201
Query: 512 VSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
+ K D++A G VL EL + K + + K
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-33
Identities = 55/215 (25%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKIL---KPSEDVLKEFASEIEIITALHHRNIISLFG 393
+G+G VY+G E+A L K ++ + F E E++ L H NI+ +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 394 FCF----EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
++LV + ++ G+L+ L K + + L +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLH-T 147
Query: 450 CEQPVIHKDVKSSNILLS-DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM 508
P+IH+D+K NI ++ ++ D GLA+ S V GT ++APE +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMY- 202
Query: 509 HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQ 543
K E +DVYAFG+ +LE+ + + P + Q
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 237
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 54/209 (25%), Positives = 82/209 (39%), Gaps = 15/209 (7%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLF 392
LVG+GG VY + +A+K++ + E L +++ +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
F D L + ++ L L + + + ALD H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAH---AA 153
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVA-GTFGYLAPEYFMHGK 511
H+DVK NIL+S D L DFG+AS +T+ LT GT Y+APE F
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 512 VSEKIDVYAFGIVLLELLSGKKPINSENP 540
+ + D+YA VL E L+G P +
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQGDQL 240
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 15/209 (7%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLF 392
+G GG S VY ++A+K + E+ LK F E+ + L H+NI+S+
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
ED+ LV +++ +L E + + + + + H +
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD-VAGTFGYLAPEYFMHGK 511
++H+D+K NIL+ + ++ DFG+A + S + LT T+ V GT Y +PE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 512 VSEKIDVYAFGIVLLELLSGKKPINSENP 540
E D+Y+ GIVL E+L G+ P N E
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETA 217
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 61/302 (20%), Positives = 123/302 (40%), Gaps = 57/302 (18%)
Query: 333 FLPEY----LVGKGGHSHVYRG-CLPDGKELAVKI--LKPSEDVLKEFASEIEIITALHH 385
+L ++ +G+GG V+ D A+K L E ++ E++ + L H
Sbjct: 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 62
Query: 386 RNIISLFGFCFEDNN------------LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY 433
I+ F E N L + + +L++ ++ + +
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCL 121
Query: 434 KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT-- 491
+ + +AEA+++LH + ++H+D+K SNI + D ++ DFGL + + T
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 492 --------CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQ 543
T GT Y++PE S K+D+++ G++L ELL P +++
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---- 231
Query: 544 ESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQ---IERMVLAATLSISRAPTVRPQINLV 600
E + +++ K P L T + ++ M +S +P RP+ +
Sbjct: 232 ERVRTLTD--VRNLKF-----PPLFTQKYPCEYVMVQDM-------LSPSPMERPEAINI 277
Query: 601 LK 602
++
Sbjct: 278 IE 279
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 64/286 (22%), Positives = 116/286 (40%), Gaps = 30/286 (10%)
Query: 328 SATSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVKIL---KPSEDVLKEFASEIEIITAL 383
S ++ Y +G G + + DGK L K L +E + SE+ ++ L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 384 HHRNIISLFG-FCFEDNNLL-LVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGV 439
H NI+ + N L +V ++ G L + K+ E + +V +
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL--DEEFVLRVMTQL 120
Query: 440 AEALDYLH--NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAG 497
AL H + V+H+D+K +N+ L +L DFGLA L+ + T V G
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKTFV-G 178
Query: 498 TFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557
T Y++PE +EK D+++ G +L EL + P + + Q+ L
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAG--------- 226
Query: 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603
K+ + + Y ++ ++ L++ RP + +L+
Sbjct: 227 KIREGKFRRIPYRYSDEL--NEIITRMLNLK--DYHRPSVEEILEN 268
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 58/213 (27%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLF 392
++G GG S V+ L D +++AVK+L+ F E + AL+H I++++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 393 GFCFEDNNLL----LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHN 448
+ +V +++ +L + +H +V +AL++ H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSH- 133
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD-VAGTFGYLAPEYF 507
+ +IH+DVK +NI++S ++ DFG+A ++ S + +T T V GT YL+PE
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 508 MHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
V + DVY+ G VL E+L+G+ P ++P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 48/194 (24%), Positives = 85/194 (43%), Gaps = 14/194 (7%)
Query: 347 VYRGCL-PDGKELAVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403
V+ G L D +AVK + D+ +F E I+ H NI+ L G C + + +
Sbjct: 130 VFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189
Query: 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSN 463
V + + G L + +G ++ A ++YL + IH+D+ + N
Sbjct: 190 VMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARN 243
Query: 464 ILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY--LAPEYFMHGKVSEKIDVYAF 521
L+++ ++SDFG++ + + APE +G+ S + DV++F
Sbjct: 244 CLVTEKNVLKISDFGMSREEADGV--YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF 301
Query: 522 GIVLLELLS-GKKP 534
GI+L E S G P
Sbjct: 302 GILLWETFSLGASP 315
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 4e-31
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 22/217 (10%)
Query: 339 VGKGGHS--HVYRG-CLPDGKELAVKIL---KPSEDVLKEFASEIEIITALHHRNIISLF 392
+GKG V P G+ + V+ + S +++ E+ + +H NI+
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV--GVAEALDYLHNSC 450
DN L +V F++ GS ++ + + DG E + GV +ALDY+H
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDG----MNELAIAYILQGVLKALDYIH--- 145
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS-----SSHLTCTDVAGTFGYLAPE 505
+H+ VK+S+IL+S D + LS + + H +L+PE
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 506 YFMHGKV--SEKIDVYAFGIVLLELLSGKKPINSENP 540
K D+Y+ GI EL +G P
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 25/252 (9%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLF 392
+GKG +VY LA+K+L ++ V + E+EI + L H NI+ L+
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
G+ + + L+ ++ G++ L K F +A AL Y H +
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCH---SK 128
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
VIH+D+K N+LL E +++DFG + +S C GT YL PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGRMH 184
Query: 513 SEKIDVYAFGIVLLELLSGKKPINSENP--------KGQESLVMWAKPILKDGKVSQLLD 564
EK+D+++ G++ E L GK P + + + + + +D +S+LL
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-LISRLLK 243
Query: 565 PSLDTDYDNDQI 576
+ ++
Sbjct: 244 HNPSQRPMLREV 255
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKI--LKPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+GKG V++G K +A+KI L+ +ED +++ EI +++ + +G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV--GVAEALDYLHNSCEQP 453
+D L ++ ++L GS + L E + + + LDYLH+ +
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLHS---EK 139
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLS-TSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
IH+D+K++N+LLS+ E +L+DFG+A L+ T T GT ++APE
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPEVIKQSAY 196
Query: 513 SEKIDVYAFGIVLLELLSGKKPINSENP 540
K D+++ GI +EL G+ P + +P
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHP 224
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 14/213 (6%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKI--LKPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+G G + V C P +++A+K L+ + + E EI+ ++ HH NI+S +
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGW--TERYKVAV--GVAEALDYLHNSCE 451
+ L LV LS GS+ + + G E + V E L+YLH
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK--- 139
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC---TDVAGTFGYLAPEYFM 508
IH+DVK+ NILL +D Q++DFG++++L+T GT ++APE
Sbjct: 140 NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 509 HGKV-SEKIDVYAFGIVLLELLSGKKPINSENP 540
+ K D+++FGI +EL +G P + P
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 340 GKGGHSHVYRG-CLPDGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGF 394
GKG + VYR + G E+A+K++ +++ +E++I L H +I+ L+
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN- 78
Query: 395 CFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
FED N + LV + G + L K F E + + YLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQIITGMLYLH---SHG 132
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS--HLTCTDVAGTFGYLAPEYFMHGK 511
++H+D+ SN+LL+ + +++DFGLA+ L + C GT Y++PE
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC----GTPNYISPEIATRSA 188
Query: 512 VSEKIDVYAFGIVLLELLSGKKPINSEN 539
+ DV++ G + LL G+ P +++
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFDTDT 216
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 46/213 (21%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 332 NFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIIS 390
+F P+ ++G G + + D +++AVK + P + E++++ H N+I
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP--ECFSFADREVQLLRESDEHPNVIR 82
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
F + + + L +L+E + ++ A E + L +LH
Sbjct: 83 YFCTEKDRQFQYIAIE-LCAATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLH--- 135
Query: 451 EQPVIHKDVKSSNILLSDDFEPQ-----LSDFGLASWLSTSSSHLTC-TDVAGTFGYLAP 504
++H+D+K NIL+S +SDFGL L+ + + V GT G++AP
Sbjct: 136 SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 505 EYF---MHGKVSEKIDVYAFGIVLLELLSGKKP 534
E + +D+++ G V ++S
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 72/330 (21%), Positives = 118/330 (35%), Gaps = 46/330 (13%)
Query: 289 EHDSACPPLSPYNELPKELEGLQERY-------SSTCRLFSYQELLSATSNFLPEY---- 337
H S+ L N + + LQ R S T + Y S F +
Sbjct: 5 HHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPS-RPESFFQQSFQRLS 63
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFAS---EIEIITAL-HHRNIISLF 392
+G G + V++ DG+ AVK K+ A E+ + H + L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
E L L + SL+++ + G + + + AL +LH Q
Sbjct: 124 QAWEEGGILYLQTEL-CGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLH---SQ 176
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
++H DVK +NI L +L DFGL L T+ + G Y+APE + G
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAPE-LLQGSY 232
Query: 513 SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYD 572
DV++ G+ +LE+ + P G E W + L+ G + L ++
Sbjct: 233 GTAADVFSLGLTILEVACNMEL-----PHGGEG---WQQ--LRQGYLPPEFTAGLSSEL- 281
Query: 573 NDQIERMVLAATLSISRAPTVRPQINLVLK 602
+ M + P +R +L
Sbjct: 282 RSVLVMM-------LEPDPKLRATAEALLA 304
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 72/320 (22%), Positives = 119/320 (37%), Gaps = 45/320 (14%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVK-ILKPSEDVLKEFASEIEIITAL-HHRNIISLFGF 394
++ +GG + VY + G+E A+K +L E+ + E+ + L H NI+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 395 CF-------EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH 447
L+ L +G L E L + K+ A+ ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVA----------G 497
+ P+IH+D+K N+LLS+ +L DFG A+ +S +
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 498 TFGYLAPE---YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL 554
T Y PE + + + EK D++A G +L L + P I+
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----------IV 262
Query: 555 KDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEAANWA 614
GK S + T + + I M L ++ P R I V+ LQ A N
Sbjct: 263 N-GKYSIPPHDTQYTVF-HSLIRAM-----LQVN--PEERLSIAEVVHQLQEIAAARNVN 313
Query: 615 KEQVSASEELDSIDGEASPT 634
+ +E L+ G S T
Sbjct: 314 PKSP-ITELLEQNGGYGSAT 332
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 55/246 (22%), Positives = 104/246 (42%), Gaps = 17/246 (6%)
Query: 339 VGKGGHSHVYRGCL-PDGKELAVKI--LKPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+G G V++ P G +A K+ L+ + + E++++ + I+ +G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQP 453
+ D + + + + GSL++ L K E+ KV++ V + L YL +
Sbjct: 101 YSDGEISICMEHMDGGSLDQVL----KKAGRIP--EQILGKVSIAVIKGLTYLRE--KHK 152
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVS 513
++H+DVK SNIL++ E +L DFG++ L S GT Y++PE S
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYS 208
Query: 514 EKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDN 573
+ D+++ G+ L+E+ G+ PI + K E + + P +
Sbjct: 209 VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268
Query: 574 DQIERM 579
Sbjct: 269 MDSRPP 274
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 64/306 (20%), Positives = 121/306 (39%), Gaps = 58/306 (18%)
Query: 331 SNFLPEY----LVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITALHH 385
+ ++ ++G+G V + D + A+K ++ +E+ L SE+ ++ +L+H
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH 61
Query: 386 RNIISLFGFCFEDNN-------------LLLVYDFLSRGSLEENLHGNKKDGNAFGWTER 432
+ ++ + E N L + ++ G+L + + + E
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEY 118
Query: 433 YKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492
+++ + EAL Y+H Q +IH+D+K NI + + ++ DFGLA + S L
Sbjct: 119 WRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 493 ------------TDVAGTFGYLAPEYFM-HGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
T GT Y+A E G +EKID+Y+ GI+ E++
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST----- 230
Query: 540 PKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQ---IERMVLAATLSISRAPTVRPQ 596
G E + + K L+ + P D + + I + I P RP
Sbjct: 231 --GMERVNILKK--LRSVSIE--FPPDFDDNKMKVEKKIIRLL-------IDHDPNKRPG 277
Query: 597 INLVLK 602
+L
Sbjct: 278 ARTLLN 283
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILK----PSEDVLKEFASEIEIITALHHRNIISLF 392
+GKGG + + + A KI+ ++ + EI I +L H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 393 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTE---RYKVAVGVAEALDYLHN 448
G FED + + +V + R SL E K TE RY + + YLH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELHKRRKA------LTEPEARYYL-RQIVLGCQYLHR 133
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL--TCTDVAGTFGYLAPEY 506
VIH+D+K N+ L++D E ++ DFGLA+ + C GT Y+APE
Sbjct: 134 ---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEV 186
Query: 507 FMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
S ++DV++ G ++ LL GK P +
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-29
Identities = 66/330 (20%), Positives = 114/330 (34%), Gaps = 73/330 (22%)
Query: 280 GESGAIVSVEHDSACPPL-SPYNELPKELEG--LQERYSSTCRLFSYQELLSATSNFLPE 336
G S + + CP SPY+ LP+ G + +Y E+
Sbjct: 45 GRSDSETKGASEGWCPYCGSPYSFLPQLNPGDIVAGQY----------EVKG-------- 86
Query: 337 YLVGKGGHSHVYRG--CLPDGKELAVKILKPSED--VLKEFASEIEIITALHHRNIISLF 392
+ GG +Y +G+ + +K L S D +E + + + H +I+ +F
Sbjct: 87 -CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 393 GFCFEDNNLL------LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYL 446
F E + +V +++ SL+ + E + + AL YL
Sbjct: 146 NF-VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYL 198
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY 506
H +++ D+K NI+L+++ + +L D G S +++ + GT G+ APE
Sbjct: 199 H---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY------LYGTPGFQAPEI 248
Query: 507 FMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566
+ D+Y G L L N G DP
Sbjct: 249 VR-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------LPEDDPV 290
Query: 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQ 596
L T D R++ A P R
Sbjct: 291 LKT---YDSYGRLLRRAI---DPDPRQRFT 314
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 26/213 (12%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILK----PSEDVLKEFASEIEIITALHHRNIISLF 392
+GKGG + + + A KI+ ++ + EI I +L H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 393 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTE---RYKVAVGVAEALDYLHN 448
G FED + + +V + R SL E K TE RY + + YLH
Sbjct: 108 G-FFEDNDFVFVVLELCRRRSLLELHKRRKA------LTEPEARYYL-RQIVLGCQYLHR 159
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL--TCTDVAGTFGYLAPEY 506
VIH+D+K N+ L++D E ++ DFGLA+ + C GT Y+APE
Sbjct: 160 ---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC----GTPNYIAPEV 212
Query: 507 FMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
S ++DV++ G ++ LL GK P +
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 25/213 (11%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKIL---KPSEDVLKEFASEIEIITAL--HHRNIISLF 392
+G GG S V++ + A+K + + L + +EI + L H II L+
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
+ D + +V + L L K ER + EA+ +H +
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIH---QH 146
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM---- 508
++H D+K +N L+ D +L DFG+A+ + ++ + GT Y+ PE
Sbjct: 147 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 509 -------HGKVSEKIDVYAFGIVLLELLSGKKP 534
K+S K DV++ G +L + GK P
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 61/240 (25%), Positives = 109/240 (45%), Gaps = 17/240 (7%)
Query: 307 LEGLQERYSSTCRLFSYQELLSA---TSNFLPEYLVGKGGHSHVYRGC-LPDGKELAVKI 362
LE +Q R +L E F +G+G + VY+ G+ +A+K
Sbjct: 2 LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ 61
Query: 363 LKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKK 422
+ D L+E EI I+ +++ +G F++ +L +V ++ GS+ + + K
Sbjct: 62 VPVESD-LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK 120
Query: 423 DGNAFGWTERYKVAV--GVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480
TE + + L+YLH IH+D+K+ NILL+ + +L+DFG+A
Sbjct: 121 -----TLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVA 172
Query: 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
L+ + + V GT ++APE + D+++ GI +E+ GK P +P
Sbjct: 173 GQLTDTMAKR--NTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP 230
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-28
Identities = 65/245 (26%), Positives = 109/245 (44%), Gaps = 27/245 (11%)
Query: 326 LLSATSNFLPEY----LVGKGGHSHVYRG-CLPDGKELAVKILK----PSEDVLKEFASE 376
+ +T+ F Y ++GKG V G+E AVK++ + + E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 377 IEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--K 434
++++ L H NI+ L+ F + LV + + G L + + K+ ++E +
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR------FSEVDAAR 130
Query: 435 VAVGVAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWLSTSSSHLT 491
+ V + Y+H + ++H+D+K N+LL S D ++ DFGL++ S
Sbjct: 131 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---K 184
Query: 492 CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK 551
D GT Y+APE HG EK DV++ G++L LLSG P N N V K
Sbjct: 185 MKDKIGTAYYIAPEVL-HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK 243
Query: 552 PILKD 556
+
Sbjct: 244 YTFEL 248
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 9e-28
Identities = 27/243 (11%), Positives = 58/243 (23%), Gaps = 43/243 (17%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKIL----KPSEDVLKEFASEIEIITALHHRNIISLF 392
+ G S V+ + ++ A+K+ + S L+ L +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 393 GFC--------------------------FEDNNLLLVYDFL--SRGSLEENLHGNKKDG 424
+ N LL+ L L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 425 NAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484
G + + + L + ++H N+ + D L D +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245
Query: 485 TSSSHLTCTDVAGTFGYLAPEYFMHGK--VSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
T + Y E+ + ++ + G+ + + P P
Sbjct: 246 T-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 543 QES 545
+ S
Sbjct: 301 KGS 303
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 25/213 (11%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKIL---KPSEDVLKEFASEIEIITAL--HHRNIISLF 392
+G GG S V++ + A+K + + L + +EI + L H II L+
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
+ D + +V + L L K ER + EA+ +H +
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIH---QH 127
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM---- 508
++H D+K +N L+ D +L DFG+A+ + ++ + GT Y+ PE
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 509 -------HGKVSEKIDVYAFGIVLLELLSGKKP 534
K+S K DV++ G +L + GK P
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLF 392
+GKG +VY + +A+K+L S+ V + EIEI + L H NI+ ++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
+ + + L+ +F RG L + L + + F +A+AL Y H E+
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEELADALHYCH---ER 133
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
VIH+D+K N+L+ E +++DFG + + C GT YL PE
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC----GTLDYLPPEMIEGKTH 189
Query: 513 SEKIDVYAFGIVLLELLSGKKPINSENP 540
EK+D++ G++ E L G P +S +
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFDSPSH 217
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-27
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 26/230 (11%)
Query: 326 LLSATSNFLPEY----LVGKGGHSHVYRG-CLPDGKELAVKIL---KPSEDVLKEFASEI 377
+ S + Y +G G + V E A+KI+ S + E+
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 378 EIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KV 435
++ L H NI+ L+ F + N LV + G L + + K + E +
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK------FNEVDAAVI 141
Query: 436 AVGVAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWLSTSSSHLTC 492
V + YLH + ++H+D+K N+LL D ++ DFGL++
Sbjct: 142 IKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KM 195
Query: 493 TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
+ GT Y+APE K EK DV++ G++L LL+G P + +
Sbjct: 196 KERLGTAYYIAPEVL-RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 43/256 (16%), Positives = 87/256 (33%), Gaps = 29/256 (11%)
Query: 303 LPKELEGLQERYSSTCRLFSYQ---ELLSATSNFLPEYLVGKGGHSHVYRGC------LP 353
L K + + C+L + + E + +L+G+G + VY
Sbjct: 34 LSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK 93
Query: 354 DGKELAVKILKPSEDVLKEF---ASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410
+ ++ +K+ KP+ EF +E + + + N +LV + S
Sbjct: 94 NKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSY 151
Query: 411 GSLEENLHGNKK-DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD 469
G+L ++ K A+ + ++ +H + +IH D+K N +L +
Sbjct: 152 GTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNG 208
Query: 470 FEP-----------QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDV 518
F L D G + + T T G+ E + + +ID
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY 268
Query: 519 YAFGIVLLELLSGKKP 534
+ + +L G
Sbjct: 269 FGVAATVYCMLFGTYM 284
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 22/207 (10%)
Query: 340 GKGGHSHVYRGCL--PDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNIISLFG 393
G G V G L P +++ A+K LK +E ++F SE I+ H NII L G
Sbjct: 58 GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG 117
Query: 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
++V +++ GSL+ L + F + + GV + YL +
Sbjct: 118 VVTRGRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLS---DLG 171
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFM 508
+H+D+ + N+L+ + ++SDFGL+ L T G + APE
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD----AAYTTTGGKIPIRWTAPEAIA 227
Query: 509 HGKVSEKIDVYAFGIVLLELLS-GKKP 534
S DV++FG+V+ E+L+ G++P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 56/208 (26%), Positives = 85/208 (40%), Gaps = 16/208 (7%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCF 396
VG+G V+R G + AVK + E E E+ L I+ L+G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVE---ELVACAGLSSPRIVPLYGAVR 120
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIH 456
E + + + L GSL + + K E L+YLH + ++H
Sbjct: 121 EGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLH---TRRILH 173
Query: 457 KDVKSSNILLSDD-FEPQLSDFGLA---SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
DVK+ N+LLS D L DFG A S LT + GT ++APE M
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 513 SEKIDVYAFGIVLLELLSGKKPINSENP 540
K+D+++ ++L +L+G P
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHPWTQYFR 261
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVK-ILKPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
++GKG + VY G L + +A+K I + + EI + L H+NI+ G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVA---EALDYLHNSCEQ 452
E+ + + + + GSL L + E+ + E L YLH +
Sbjct: 89 SENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQT-IGFYTKQILEGLKYLH---DN 141
Query: 453 PVIHKDVKSSNILL-SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
++H+D+K N+L+ + ++SDFG + L+ + GT Y+APE G
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT--ETFTGTLQYMAPEIIDKGP 199
Query: 512 V--SEKIDVYAFGIVLLELLSGKKP 534
+ D+++ G ++E+ +GK P
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 45/196 (22%), Positives = 94/196 (47%), Gaps = 15/196 (7%)
Query: 347 VYRGCL-PDGKEL----AVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDN 399
VY+G P+G+++ A+K L+ S KE E ++ ++ + ++ L G C
Sbjct: 31 VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90
Query: 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDV 459
+ L+ + G L + + +K + G V +A+ ++YL ++ ++H+D+
Sbjct: 91 -VQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLE---DRRLVHRDL 143
Query: 460 KSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVY 519
+ N+L+ +++DFGLA L ++A E +H + + DV+
Sbjct: 144 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVW 203
Query: 520 AFGIVLLELLS-GKKP 534
++G+ + EL++ G KP
Sbjct: 204 SYGVTVWELMTFGSKP 219
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGF 394
++G+G ++V+RG G A+K+ + E E++ L+H+NI+ LF
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 395 CFED---NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNS 449
E+ + +L+ +F GSL L ++ NA+G E V V +++L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQ----LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
E ++H+++K NI+ + Q L+DFG A L + GT YL P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185
Query: 506 YF--------MHGKVSEKIDVYAFGIVLLELLSGKKP 534
+ K +D+++ G+ +G P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 6e-27
Identities = 48/190 (25%), Positives = 94/190 (49%), Gaps = 8/190 (4%)
Query: 347 VYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405
VY G +AVK LK ++EF E ++ + H N++ L G C + ++
Sbjct: 236 VYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295
Query: 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNIL 465
+F++ G+L + L + + +A ++ A++YL ++ IH+++ + N L
Sbjct: 296 EFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCL 350
Query: 466 LSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVL 525
+ ++ +++DFGL+ + T ++ + APE + K S K DV+AFG++L
Sbjct: 351 VGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 409
Query: 526 LELLS-GKKP 534
E+ + G P
Sbjct: 410 WEIATYGMSP 419
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 56/229 (24%), Positives = 104/229 (45%), Gaps = 25/229 (10%)
Query: 325 ELLSATSNFLPEY---------LVGKGGHSHVYRGCL--PDGKEL--AVKILKP--SEDV 369
EL+ A + + ++G+G VY G L DGK++ AVK L
Sbjct: 10 ELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE 69
Query: 370 LKEFASEIEIITALHHRNIISLFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFG 428
+ +F +E I+ H N++SL G C + + L+V ++ G L + + + +
Sbjct: 70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPT 126
Query: 429 WTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488
+ + VA+ + YL + +H+D+ + N +L + F +++DFGLA +
Sbjct: 127 VKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183
Query: 489 HLTCTDVAGTF--GYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
+ ++A E K + K DV++FG++L EL++ G P
Sbjct: 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 19/199 (9%)
Query: 347 VYRGCL--PDGKEL--AVKILKP----SEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
V RG P GK + AVK LKP + + +F E+ + +L HRN+I L+G
Sbjct: 34 VRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93
Query: 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKD 458
+ +V + GSL + L ++ F + AV VAE + YL + IH+D
Sbjct: 94 P-MKMVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLE---SKRFIHRD 146
Query: 459 VKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY--LAPEYFMHGKVSEKI 516
+ + N+LL+ ++ DFGL L + H + + APE S
Sbjct: 147 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-HRKVPFAWCAPESLKTRTFSHAS 205
Query: 517 DVYAFGIVLLELLS-GKKP 534
D + FG+ L E+ + G++P
Sbjct: 206 DTWMFGVTLWEMFTYGQEP 224
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-27
Identities = 51/196 (26%), Positives = 100/196 (51%), Gaps = 8/196 (4%)
Query: 340 GKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDN 399
G+G V+ G +A+K LKP + F E +++ L H ++ L+ E+
Sbjct: 193 GQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE- 251
Query: 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDV 459
+ +V +++S+GSL + L G G + +A +A + Y+ +H+D+
Sbjct: 252 PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 306
Query: 460 KSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVY 519
+++NIL+ ++ +++DFGLA + + + + APE ++G+ + K DV+
Sbjct: 307 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 520 AFGIVLLELLS-GKKP 534
+FGI+L EL + G+ P
Sbjct: 366 SFGILLTELTTKGRVP 381
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-27
Identities = 61/241 (25%), Positives = 98/241 (40%), Gaps = 37/241 (15%)
Query: 326 LLSATSNFLPEY----LVGKGGHSHVYRG-CLPDGKELAVKILK--------------PS 366
+ Y +G G + V E A+K++K
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 367 EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNA 426
E +E +EI ++ +L H NII LF + LV +F G L E + K
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---- 142
Query: 427 FGWTERY--KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLAS 481
+ E + + + YLH + ++H+D+K NILL + ++ DFGL+S
Sbjct: 143 --FDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 482 WLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541
+ S D GT Y+APE K +EK DV++ G+++ LL G P +N +
Sbjct: 198 FFSKDY---KLRDRLGTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253
Query: 542 G 542
Sbjct: 254 D 254
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 334 LPEYLVGKGGHSHVYRGCL-PDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNI 388
+ + +G G V +G K++ A+K+LK + +E E +I+ L + I
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 389 ISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHN 448
+ L G C + L+LV + G L + L + ++ V+ + YL
Sbjct: 73 VRLIGVC-QAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL-- 126
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF--GYLAPEY 506
E+ +H+D+ + N+LL + ++SDFGL+ L S+ T AG + + APE
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPEC 184
Query: 507 FMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
K S + DV+++G+ + E LS G+KP
Sbjct: 185 INFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 52/191 (27%), Positives = 90/191 (47%), Gaps = 12/191 (6%)
Query: 347 VYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406
V G ++AVK++K EF E + + L H ++ +G C ++ + +V +
Sbjct: 24 VKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83
Query: 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL 466
++S G L L + G ++ ++ V E + +L IH+D+ + N L+
Sbjct: 84 YISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLV 137
Query: 467 SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY--LAPEYFMHGKVSEKIDVYAFGIV 524
D ++SDFG+ ++ + V F APE F + K S K DV+AFGI+
Sbjct: 138 DRDLCVKVSDFGMTRYVLDDQ---YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGIL 194
Query: 525 LLELLS-GKKP 534
+ E+ S GK P
Sbjct: 195 MWEVFSLGKMP 205
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-26
Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 26/234 (11%)
Query: 322 SYQELLSATSNFLPEY----LVGKGGHSHVYRG-CLPDGKELAVKIL---KPSEDVLKEF 373
S +E L F Y ++GKG V + +E AVK++
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 374 ASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY 433
E+E++ L H NI+ LF + ++ +V + + G L + + K+ ++E
Sbjct: 69 LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHD 122
Query: 434 --KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWLSTSSS 488
++ V + Y+H + ++H+D+K NILL D + ++ DFGL++ ++
Sbjct: 123 AARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT- 178
Query: 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
D GT Y+APE G EK DV++ G++L LLSG P +N
Sbjct: 179 --KMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 58/235 (24%), Positives = 109/235 (46%), Gaps = 20/235 (8%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVKI--LKPSEDVLKEFASEIEII-TALHHRNIISLFGF 394
+G+G + V + +P G+ +AVK + K +++I + ++ +G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQ 452
F + ++ + + + SL++ G E K+AV + +AL++LH+ +
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTIP--EDILGKIAVSIVKALEHLHS--KL 129
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE----YFM 508
VIH+DVK SN+L++ + ++ DFG++ +L + AG Y+APE
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINPELN 186
Query: 509 HGKVSEKIDVYAFGIVLLELLSGKKPINS-ENPKGQ-ESLVMWAKPILKDGKVSQ 561
S K D+++ GI ++EL + P +S P Q + +V P L K S
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSA 241
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKI--LKPSEDVLKEFASEIEII-TALHHRNIISLFGF 394
+G+G + V + P G+ +AVK E K+ +++++ + I+ +G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQ 452
F + + + + +S S ++ + E K+ + +AL++L
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLDD-VIPEEILGKITLATVKALNHLKE--NL 145
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
+IH+D+K SNILL +L DFG++ L S + T AG Y+APE
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSAS 202
Query: 513 ----SEKIDVYAFGIVLLELLSGKKPINSENP 540
+ DV++ GI L EL +G+ P N
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 62/232 (26%), Positives = 105/232 (45%), Gaps = 23/232 (9%)
Query: 324 QELLSATSNFLPEYLVGK----GGHSHVYRGC-LPDGKELAVKIL---KPSEDVLKEFAS 375
+E L ++ + G V+ G E +K + + + ++ +
Sbjct: 11 RENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM-EQIEA 69
Query: 376 EIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY-- 433
EIE++ +L H NII +F + +N+ +V + G L E + + G A +E Y
Sbjct: 70 EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKAL--SEGYVA 127
Query: 434 KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWLSTSSSHL 490
++ + AL Y H Q V+HKD+K NIL S ++ DFGLA +
Sbjct: 128 ELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--- 181
Query: 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
T+ AGT Y+APE F V+ K D+++ G+V+ LL+G P + +
Sbjct: 182 HSTNAAGTALYMAPEVF-KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE 232
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 49/213 (23%), Positives = 86/213 (40%), Gaps = 25/213 (11%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKIL---KPSEDVLKEFASEIEIITALHH--RNIISLF 392
+G GG S V++ + A+K + + L + +EI + L II L+
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
+ D + +V + L L K ER + EA+ +H +
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIH---QH 174
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM---- 508
++H D+K +N L+ D +L DFG+A+ + ++ + G Y+ PE
Sbjct: 175 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233
Query: 509 -------HGKVSEKIDVYAFGIVLLELLSGKKP 534
K+S K DV++ G +L + GK P
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 57/212 (26%), Positives = 108/212 (50%), Gaps = 21/212 (9%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKP-SEDVLKEFASEIEIITALHHRNIISLFGFCF 396
+G G VY+ G A K+++ SE+ L+++ EIEI+ H I+ L G +
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV--GVAEALDYLHNSCEQPV 454
D L ++ +F G+++ + + G TE V + EAL++LH+ + +
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHS---KRI 138
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLS-TSSSHLTCTDVAGTFGYLAPEYFMHGKVS 513
IH+D+K+ N+L++ + + +L+DFG+++ T + GT ++APE M +
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEVVMCETMK 195
Query: 514 E-----KIDVYAFGIVLLELLSGKKPINSENP 540
+ K D+++ GI L+E+ + P + NP
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-26
Identities = 51/196 (26%), Positives = 100/196 (51%), Gaps = 8/196 (4%)
Query: 340 GKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDN 399
G+G V+ G +A+K LKP + F E +++ L H ++ L+ E+
Sbjct: 276 GQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE- 334
Query: 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDV 459
+ +V +++S+GSL + L G G + +A +A + Y+ +H+D+
Sbjct: 335 PIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 389
Query: 460 KSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVY 519
+++NIL+ ++ +++DFGLA + + + + APE ++G+ + K DV+
Sbjct: 390 RAANILVGENLVCKVADFGLARLI-EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 520 AFGIVLLELLS-GKKP 534
+FGI+L EL + G+ P
Sbjct: 449 SFGILLTELTTKGRVP 464
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-26
Identities = 58/192 (30%), Positives = 96/192 (50%), Gaps = 18/192 (9%)
Query: 347 VYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDN-NLLLVY 405
V G G ++AVK +K + F +E ++T L H N++ L G E+ L +V
Sbjct: 209 VMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266
Query: 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNIL 465
+++++GSL + L + G K ++ V EA++YL +H+D+ + N+L
Sbjct: 267 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVL 321
Query: 466 LSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY--LAPEYFMHGKVSEKIDVYAFGI 523
+S+D ++SDFGL S++ G APE K S K DV++FGI
Sbjct: 322 VSEDNVAKVSDFGLTKEASSTQD-------TGKLPVKWTAPEALREKKFSTKSDVWSFGI 374
Query: 524 VLLELLS-GKKP 534
+L E+ S G+ P
Sbjct: 375 LLWEIYSFGRVP 386
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 340 GKGGHSHVYRGCL--PDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNIISLFG 393
G G V G L P KE+ A+K LK +E ++F E I+ H NII L G
Sbjct: 54 GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113
Query: 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
+ +++V +++ GSL+ L +K F + + G+A + YL +
Sbjct: 114 VVTKSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLS---DMG 167
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFM 508
+H+D+ + NIL++ + ++SDFGL L G + +PE
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE----AAYTTRGGKIPIRWTSPEAIA 223
Query: 509 HGKVSEKIDVYAFGIVLLELLS-GKKP 534
+ K + DV+++GIVL E++S G++P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKI--LKPSEDVLKEFASEIEIITALH-HRNIISLFGF 394
+G G V++ G +AVK +++ K +++++ H I+ FG
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQ 452
+ ++ + + + + + K+ ER K+ V + +AL YL +
Sbjct: 93 FITNTDVFIAMELMGTCAEKLK----KRMQGPIP--ERILGKMTVAIVKALYYLKE--KH 144
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
VIH+DVK SNILL + + +L DFG++ L AG Y+APE
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDP 201
Query: 513 SE-----KIDVYAFGIVLLELLSGKKPINSENP 540
++ + DV++ GI L+EL +G+ P +
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 69/249 (27%), Positives = 114/249 (45%), Gaps = 41/249 (16%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFG--- 393
VG G + VY+G + G+ A+K++ + D +E EI ++ HHRNI + +G
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 394 ---FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV--GVAEALDYLHN 448
D+ L LV +F GS+ + + K GN E + + + L +LH
Sbjct: 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTL--KEEWIAYICREILRGLSHLH- 146
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS-TSSSHLTCTDVAGTFGYLAPEYF 507
+ VIH+D+K N+LL+++ E +L DFG+++ L T T GT ++APE
Sbjct: 147 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVI 201
Query: 508 MHGKVSE-----KIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA--------KPIL 554
+ + K D+++ GI +E+ G P+ +P M A P L
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFLIPRNPAPRL 254
Query: 555 KDGKVSQLL 563
K K S+
Sbjct: 255 KSKKWSKKF 263
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 51/202 (25%), Positives = 86/202 (42%), Gaps = 24/202 (11%)
Query: 347 VYRGC---LPDGKEL--AVKILKP-SEDVLKEFASEIEIITALHHRNIISLFGFCFED-- 398
V L D AVK L+ D ++F EI+I+ ALH I+ G +
Sbjct: 39 VELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98
Query: 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKD 458
+L LV ++L G L + L ++ + + + + ++YL + +H+D
Sbjct: 99 QSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRD 152
Query: 459 VKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFMHGKVS 513
+ + NIL+ + +++DFGLA L + G APE S
Sbjct: 153 LAARNILVESEAHVKIADFGLAKLLPLDKDYYV----VREPGQSPIFWYAPESLSDNIFS 208
Query: 514 EKIDVYAFGIVLLELLS-GKKP 534
+ DV++FG+VL EL + K
Sbjct: 209 RQSDVWSFGVVLYELFTYCDKS 230
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 65/296 (21%), Positives = 115/296 (38%), Gaps = 32/296 (10%)
Query: 262 HKQNHSADTSEDNRSNLDGESGAIVSVEHDSACPPLSPYNELPKELEGLQERYSSTCRLF 321
H +H + L + S Y + E Q + L
Sbjct: 10 HHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLS 69
Query: 322 SYQ-ELLSATSNFLPEY---------LVGKGGHSHVYRGCL--PDGKEL--AVKILKP-- 365
+ EL+ A + + ++G+G VY G L DGK++ AVK L
Sbjct: 70 ALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 129
Query: 366 SEDVLKEFASEIEIITALHHRNIISLFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDG 424
+ +F +E I+ H N++SL G C + + L+V ++ G L + +
Sbjct: 130 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN- 188
Query: 425 NAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484
+ + VA+ + +L + +H+D+ + N +L + F +++DFGLA +
Sbjct: 189 --PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243
Query: 485 TSSSHLTCTDVAGTFGYL-----APEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
T L A E K + K DV++FG++L EL++ G P
Sbjct: 244 DKEFDSV---HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 23/201 (11%)
Query: 347 VYRGCL--PDGKEL---AVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDN 399
VY+G L GK+ A+K LK +E +F E I+ H NII L G +
Sbjct: 60 VYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119
Query: 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDV 459
++++ +++ G+L++ L ++ F + + G+A + YL +H+D+
Sbjct: 120 PMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDL 173
Query: 460 KSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFMHGKVSE 514
+ NIL++ + ++SDFGL+ L + G + APE + K +
Sbjct: 174 AARNILVNSNLVCKVSDFGLSRVLEDDPE----ATYTTSGGKIPIRWTAPEAISYRKFTS 229
Query: 515 KIDVYAFGIVLLELLS-GKKP 534
DV++FGIV+ E+++ G++P
Sbjct: 230 ASDVWSFGIVMWEVMTYGERP 250
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 54/304 (17%), Positives = 110/304 (36%), Gaps = 57/304 (18%)
Query: 328 SATSNFLPEY----LVGKGGHSHVYRG-CLPDGKELAVKILK---PSEDVLKEFASEIEI 379
S + E+ +G G V++ DG A+K K + E+
Sbjct: 4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYA 63
Query: 380 ITAL-HHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVG 438
L H +++ F ED+++L+ ++ + GSL + + N + + F E + +
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ-------------------LSDFGL 479
V L Y+H ++H D+K SNI +S P + D G
Sbjct: 124 VGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGKKPINSE 538
+ +S+ G +LA E K D++A + ++ + +
Sbjct: 181 VTRISSPQV------EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234
Query: 539 NPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQIN 598
+ W + ++ G++ ++ P + + + ++ M I P RP
Sbjct: 235 D--------QWHE--IRQGRLPRI--PQVLSQEFTELLKVM-------IHPDPERRPSAM 275
Query: 599 LVLK 602
++K
Sbjct: 276 ALVK 279
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 23/231 (9%)
Query: 347 VYRGC---LPDGKEL--AVKILKP-SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNN 400
V L D AVK L+ +E+ L++F EIEI+ +L H NI+ G C+
Sbjct: 26 VEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85
Query: 401 --LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKD 458
L L+ ++L GSL + L +K+ + + + + ++YL + IH+D
Sbjct: 86 RNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG---TKRYIHRD 139
Query: 459 VKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFMHGKVS 513
+ + NIL+ ++ ++ DFGL L G APE K S
Sbjct: 140 LATRNILVENENRVKIGDFGLTKVLPQDKEFFK----VKEPGESPIFWYAPESLTESKFS 195
Query: 514 EKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564
DV++FG+VL EL + + S + + + + + +LL
Sbjct: 196 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 52/192 (27%), Positives = 94/192 (48%), Gaps = 14/192 (7%)
Query: 347 VYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406
V+ G + ++A+K ++ ++F E E++ L H ++ L+G C E + LV +
Sbjct: 24 VHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83
Query: 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL 466
F+ G L + L + F + + V E + YL E VIH+D+ + N L+
Sbjct: 84 FMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRDLAARNCLV 137
Query: 467 SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT---FGYLAPEYFMHGKVSEKIDVYAFGI 523
++ ++SDFG+ ++ T GT + +PE F + S K DV++FG+
Sbjct: 138 GENQVIKVSDFGMTRFVLDD----QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGV 193
Query: 524 VLLELLS-GKKP 534
++ E+ S GK P
Sbjct: 194 LMWEVFSEGKIP 205
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 58/231 (25%), Positives = 100/231 (43%), Gaps = 23/231 (9%)
Query: 347 VYRGC---LPDGKEL--AVKILKP-SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNN 400
V L D AVK L+ +E+ L++F EIEI+ +L H NI+ G C+
Sbjct: 57 VEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116
Query: 401 --LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKD 458
L L+ ++L GSL + L +K+ + + + + ++YL + IH+D
Sbjct: 117 RNLKLIMEYLPYGSLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLG---TKRYIHRD 170
Query: 459 VKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFMHGKVS 513
+ + NIL+ ++ ++ DFGL L + G APE K S
Sbjct: 171 LATRNILVENENRVKIGDFGLTKVLPQDKEYYK----VKEPGESPIFWYAPESLTESKFS 226
Query: 514 EKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564
DV++FG+VL EL + + S + + + + + +LL
Sbjct: 227 VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-26
Identities = 47/195 (24%), Positives = 99/195 (50%), Gaps = 20/195 (10%)
Query: 347 VYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406
V+ ++AVK +KP ++ F +E ++ L H ++ L ++ + ++ +
Sbjct: 204 VWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITE 262
Query: 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL 466
F+++GSL + L + +G+ + + +AE + ++ ++ IH+D++++NIL+
Sbjct: 263 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILV 317
Query: 467 SDDFEPQLSDFGLASWLS----TSSSHLTCTDVAGTFGY--LAPEYFMHGKVSEKIDVYA 520
S +++DFGLA + T+ F APE G + K DV++
Sbjct: 318 SASLVCKIADFGLARVIEDNEYTAREG-------AKFPIKWTAPEAINFGSFTIKSDVWS 370
Query: 521 FGIVLLELLS-GKKP 534
FGI+L+E+++ G+ P
Sbjct: 371 FGILLMEIVTYGRIP 385
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 30/238 (12%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKIL----KPSEDVLKEFASEIEIITALHHRNIISLFG 393
+G G VY + + + +A+K + K S + ++ E+ + L H N I G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV--GVAEALDYLHNSCE 451
++ LV ++ GS + L +KK E AV G + L YLH+
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHS--- 172
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
+IH+DVK+ NILLS+ +L DFG AS ++ ++S GT ++APE +
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILAMD 226
Query: 512 VSE---KIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK---PILKDGKVSQLL 563
+ K+DV++ GI +EL K P+ + N +L A+ P L+ G S+
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNESPALQSGHWSEYF 282
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 18/199 (9%)
Query: 340 GKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDN 399
GKG V G G ++AVK +K + F +E ++T L H N++ L G E+
Sbjct: 30 GKGEFGDVMLGDY-RGNKVAVKCIKNDATA-QAFLAEASVMTQLRHSNLVQLLGVIVEEK 87
Query: 400 -NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKD 458
L +V +++++GSL + L + G K ++ V EA++YL +H+D
Sbjct: 88 GGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142
Query: 459 VKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY--LAPEYFMHGKVSEKI 516
+ + N+L+S+D ++SDFGL S++ G APE K S K
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKEASSTQD-------TGKLPVKWTAPEALREKKFSTKS 195
Query: 517 DVYAFGIVLLELLS-GKKP 534
DV++FGI+L E+ S G+ P
Sbjct: 196 DVWSFGILLWEIYSFGRVP 214
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 57/203 (28%), Positives = 85/203 (41%), Gaps = 27/203 (13%)
Query: 347 VYRGCL---PDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFED- 398
V C DG AVK LK + EI+I+ L+H +II G C +
Sbjct: 47 VSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106
Query: 399 -NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHK 457
+L LV +++ GSL + L + G + A + E + YLH Q IH+
Sbjct: 107 AASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLH---AQHYIHR 158
Query: 458 DVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFMHGKV 512
D+ + N+LL +D ++ DFGLA + + G APE K
Sbjct: 159 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAPECLKEYKF 214
Query: 513 SEKIDVYAFGIVLLELLS-GKKP 534
DV++FG+ L ELL+
Sbjct: 215 YYASDVWSFGVTLYELLTHCDSS 237
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-26
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKE-FASEIEIITALHHRNIISLFGFCF 396
+G+G VY + G+E+A++ + + KE +EI ++ + NI++
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQPV 454
+ L +V ++L+ GSL + + E V +AL++LH+ V
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHS---NQV 137
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSE 514
IH+D+KS NILL D +L+DFG + ++ S + + GT ++APE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGP 195
Query: 515 KIDVYAFGIVLLELLSGKKPINSENP 540
K+D+++ GI+ +E++ G+ P +ENP
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENP 221
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 28/215 (13%)
Query: 340 GKGGHSHVYRGCL--PDGKEL--AVKILKP---SEDVLKEFASEIEIITALHHRNIISLF 392
G+G V G L DG L AVK +K S+ ++EF SE + H N+I L
Sbjct: 43 GEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLL 102
Query: 393 GFCFEDN-----NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER--YKVAVGVAEALDY 445
G C E + +++ F+ G L L ++ + + K V +A ++Y
Sbjct: 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEY 162
Query: 446 LHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL--- 502
L + +H+D+ + N +L DD ++DFGL+ + + + G +
Sbjct: 163 L---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY-----RQGRIAKMPVK 214
Query: 503 --APEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
A E + K DV+AFG+ + E+ + G P
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 347 VYRGCLP-----DGKELAVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDN 399
V G+++AVK LKP + + + EIEI+ L+H NI+ G C ED
Sbjct: 37 VELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96
Query: 400 N--LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHK 457
+ L+ +FL GSL+E L K+ N ++ K AV + + +DYL + +H+
Sbjct: 97 GNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHR 150
Query: 458 DVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFMHGKV 512
D+ + N+L+ + + ++ DFGL + T + T APE M K
Sbjct: 151 DLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----VKDDRDSPVFWYAPECLMQSKF 206
Query: 513 SEKIDVYAFGIVLLELLS-GKKPINSENPKGQE 544
DV++FG+ L ELL+ + +
Sbjct: 207 YIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 71/327 (21%), Positives = 130/327 (39%), Gaps = 20/327 (6%)
Query: 216 DGWPFLRRVLLPKHQDPEKTSAKKTSLIQWVLRLPSRYTSAVVYPDHKQNHSADTSEDNR 275
+G F L ++ K L + + S P + S T +
Sbjct: 225 EGTKFDTLWQLVEYLK-LKADGLIYCLKEACPNSSASNASGAAAPTLPAHPSTLTHP--Q 281
Query: 276 SNLDGESGAIVSVEHDSACPPLSPYNELPKELEGLQERYSSTCRLFSYQELLSATSNFLP 335
+D + + E P +P + + +S L + L + +
Sbjct: 282 RRIDTLNSDGYTPEPARITSPDK-PRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA 340
Query: 336 EYLVGKGGHSHVYRGCL-PDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNIIS 390
+ +G G V +G K++ A+K+LK + +E E +I+ L + I+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
L G C + L+LV + G L + L + ++ V+ + YL
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY--LAPEYFM 508
E+ +H+++ + N+LL + ++SDFGL+ L S+ T AG + APE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT-ARSAGKWPLKWYAPECIN 512
Query: 509 HGKVSEKIDVYAFGIVLLELLS-GKKP 534
K S + DV+++G+ + E LS G+KP
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 47/258 (18%), Positives = 106/258 (41%), Gaps = 35/258 (13%)
Query: 310 LQERYSSTCRLFSYQELLSATSNFLPEYLV----GKGGHSHVYRGCLPDGKELAVKILK- 364
+++ S+ L + + ++ +Y + +G + + C D K A+K +
Sbjct: 6 MKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIIL-CEKDNKFYALKKYEK 64
Query: 365 -----------------PSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407
+ +F +E++IIT + + ++ G + + ++Y++
Sbjct: 65 SLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEY 124
Query: 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAV----GVAEALDYLHNSCEQPVIHKDVKSSN 463
+ S+ + + +V V + Y+HN E+ + H+DVK SN
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSN 182
Query: 464 ILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV--SEKIDVYAF 521
IL+ + +LSDFG + ++ + GT+ ++ PE+F + K+D+++
Sbjct: 183 ILMDKNGRVKLSDFGESEYMVDKKIKGSR----GTYEFMPPEFFSNESSYNGAKVDIWSL 238
Query: 522 GIVLLELLSGKKPINSEN 539
GI L + P + +
Sbjct: 239 GICLYVMFYNVVPFSLKI 256
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 55/266 (20%), Positives = 92/266 (34%), Gaps = 56/266 (21%)
Query: 330 TSNFLPEY----LVGKGGHSHVYRGC-LPDGKELAVKILK------PSEDVLKEFASEIE 378
+Y +G+G + V A+KI+ + ++ +E+
Sbjct: 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 379 IITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSL------------------------- 413
++ LHH NI L+ ++ + LV + G L
Sbjct: 81 LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 414 ---------EENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQPVIHKDVKSS 462
++ F E+ + + AL YLH Q + H+D+K
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPE 197
Query: 463 NILLS--DDFEPQLSDFGLASWLSTSSSH--LTCTDVAGTFGYLAPE--YFMHGKVSEKI 516
N L S FE +L DFGL+ ++ T AGT ++APE + K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 517 DVYAFGIVLLELLSGKKPINSENPKG 542
D ++ G++L LL G P N
Sbjct: 258 DAWSAGVLLHLLLMGAVPFPGVNDAD 283
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 58/214 (27%), Positives = 85/214 (39%), Gaps = 19/214 (8%)
Query: 340 GKGGHSHVYRGC-LPDGKELAVKI-----LKPSEDVLKE-FASEIEIITALHHRNIISLF 392
GKG S V R G++ AVKI S + E E I L H +I+ L
Sbjct: 33 GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSC 450
D L +V++F+ L + G + +E + EAL Y H
Sbjct: 93 ETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY--SEAVASHYMRQILEALRYCH--- 147
Query: 451 EQPVIHKDVKSSNILLSDDFEPQ---LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF 507
+ +IH+DVK +LL+ L FG+A L S GT ++APE
Sbjct: 148 DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHFMAPEVV 205
Query: 508 MHGKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541
+ +DV+ G++L LLSG P +
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLPFYGTKER 239
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 50/198 (25%), Positives = 96/198 (48%), Gaps = 26/198 (13%)
Query: 347 VYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406
V G ++A+K++K EF E +++ L H ++ L+G C + + ++ +
Sbjct: 40 VKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99
Query: 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL 466
+++ G L L ++ + F + ++ V EA++YL + +H+D+ + N L+
Sbjct: 100 YMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLV 153
Query: 467 SDDFEPQLSDFGLASWLS----TSSSHLTCTDVAGTFGYL-----APEYFMHGKVSEKID 517
+D ++SDFGL+ ++ TSS PE M+ K S K D
Sbjct: 154 NDQGVVKVSDFGLSRYVLDDEYTSSVG----------SKFPVRWSPPEVLMYSKFSSKSD 203
Query: 518 VYAFGIVLLELLS-GKKP 534
++AFG+++ E+ S GK P
Sbjct: 204 IWAFGVLMWEIYSLGKMP 221
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 45/196 (22%), Positives = 94/196 (47%), Gaps = 15/196 (7%)
Query: 347 VYRGCL-PDGKEL----AVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDN 399
VY+G P+G+++ A+K L+ S KE E ++ ++ + ++ L G C
Sbjct: 31 VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 89
Query: 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDV 459
+ L+ + G L + + +K + G V +A+ ++YL ++ ++H+D+
Sbjct: 90 TVQLITQLMPFGCLLDYVREHKDN---IGSQYLLNWCVQIAKGMNYLE---DRRLVHRDL 143
Query: 460 KSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVY 519
+ N+L+ +++DFGLA L ++A E +H + + DV+
Sbjct: 144 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVW 203
Query: 520 AFGIVLLELLS-GKKP 534
++G+ + EL++ G KP
Sbjct: 204 SYGVTVWELMTFGSKP 219
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 52/217 (23%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKIL--KPSEDVLKEFASEIEIITALHHRNIISLFGF 394
++G+G ++V+RG G A+K+ + E E++ L+H+NI+ LF
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 395 CFED---NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNS 449
E+ + +L+ +F GSL L ++ NA+G E V V +++L
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQ----LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
E ++H+++K NI+ + Q L+DFG A L + GT YL P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPD 185
Query: 506 YF--------MHGKVSEKIDVYAFGIVLLELLSGKKP 534
+ K +D+++ G+ +G P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 61/233 (26%), Positives = 108/233 (46%), Gaps = 28/233 (12%)
Query: 324 QELLSATSNFLPEY----LVGKGGHSHVYRGC-LPDGKELAVKILK----PSEDVLKEFA 374
+E L F Y ++GKG V + +E AVK++ ++D
Sbjct: 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT-STIL 69
Query: 375 SEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY- 433
E+E++ L H NI+ LF + ++ +V + + G L + + K+ ++E
Sbjct: 70 REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR------FSEHDA 123
Query: 434 -KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWLSTSSSH 489
++ V + Y+H + ++H+D+K NILL D + ++ DFGL++ ++
Sbjct: 124 ARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-- 178
Query: 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
D GT Y+APE + G EK DV++ G++L LLSG P +N
Sbjct: 179 -KMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 26/223 (11%)
Query: 324 QELLSATSNFLPEYLV----GKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFASEIE 378
Q+L + F Y V G G +S R E AVKI+ S+ E EIE
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE---EIE 67
Query: 379 II-TALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KV 435
I+ H NII+L + + +V + + G L + + K ++ER V
Sbjct: 68 ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF------FSEREASAV 121
Query: 436 AVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ----LSDFGLASWLSTSSSHLT 491
+ + ++YLH Q V+H+D+K SNIL D+ + DFG A L + L
Sbjct: 122 LFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 492 CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKP 534
T ++APE D+++ G++L +L+G P
Sbjct: 179 --TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 49/198 (24%), Positives = 95/198 (47%), Gaps = 26/198 (13%)
Query: 347 VYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406
V+ G ++AVK LK F +E ++ L H+ ++ L+ ++ + ++ +
Sbjct: 29 VWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITE 87
Query: 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL 466
++ GSL + L G + +A +AE + ++ E+ IH+D++++NIL+
Sbjct: 88 YMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILV 142
Query: 467 SDDFEPQLSDFGLASWLS----TSSSHLTCTDVAGTFGYL-----APEYFMHGKVSEKID 517
SD +++DFGLA + T+ APE +G + K D
Sbjct: 143 SDTLSCKIADFGLARLIEDNEYTAREG----------AKFPIKWTAPEAINYGTFTIKSD 192
Query: 518 VYAFGIVLLELLS-GKKP 534
V++FGI+L E+++ G+ P
Sbjct: 193 VWSFGILLTEIVTHGRIP 210
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 43/204 (21%), Positives = 91/204 (44%), Gaps = 24/204 (11%)
Query: 347 VYRGCLPDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL 402
V +G + D E A+K + S EF +E ++ + +++ L G + L
Sbjct: 45 VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104
Query: 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTER------YKVAVGVAEALDYLHNSCEQPVIH 456
++ + ++RG L+ L + ++A +A+ + YL+ +H
Sbjct: 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVH 161
Query: 457 KDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFMHGK 511
+D+ + N ++++DF ++ DFG+ + + + G G L +PE G
Sbjct: 162 RDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGV 216
Query: 512 VSEKIDVYAFGIVLLELLS-GKKP 534
+ DV++FG+VL E+ + ++P
Sbjct: 217 FTTYSDVWSFGVVLWEIATLAEQP 240
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 53/197 (26%), Positives = 90/197 (45%), Gaps = 18/197 (9%)
Query: 347 VYRGCLPDGKEL---AVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNN 400
V +G K + AVKILK + E +E ++ L + I+ + G C E +
Sbjct: 33 VKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91
Query: 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVK 460
+LV + G L + L N+ ++ V+ + YL E +H+D+
Sbjct: 92 WMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLA 144
Query: 461 SSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF--GYLAPEYFMHGKVSEKIDV 518
+ N+LL ++SDFGL+ L ++ G + + APE + K S K DV
Sbjct: 145 ARNVLLVTQHYAKISDFGLSKALRADENYYK-AQTHGKWPVKWYAPECINYYKFSSKSDV 203
Query: 519 YAFGIVLLELLS-GKKP 534
++FG+++ E S G+KP
Sbjct: 204 WSFGVLMWEAFSYGQKP 220
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 29/216 (13%)
Query: 340 GKGGHSHVYRGCL--PDGKEL--AVKILKP---SEDVLKEFASEIEIITALHHRNIISLF 392
GKG V L DG + AVK+LK + ++EF E + H ++ L
Sbjct: 32 GKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLV 91
Query: 393 GFCFED------NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER--YKVAVGVAEALD 444
G +++ F+ G L L ++ N F + + V +A ++
Sbjct: 92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151
Query: 445 YLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-- 502
YL + IH+D+ + N +L++D ++DFGL+ + + + G L
Sbjct: 152 YLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-----RQGCASKLPV 203
Query: 503 ---APEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
A E + DV+AFG+ + E+++ G+ P
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 340 GKGGHSHVYRGCLPDGK-ELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
G G + VY G +AVK LK ++EF E ++ + H N++ L G C +
Sbjct: 22 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81
Query: 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKD 458
++ +F++ G+L + L + + +A ++ A++YL ++ IH+D
Sbjct: 82 PPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 459 VKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFMHGKVS 513
+ + N L+ ++ +++DFGL+ ++ T A APE + K S
Sbjct: 137 LAARNCLVGENHLVKVADFGLSRLMTGD------TYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 514 EKIDVYAFGIVLLELLS-GKKP 534
K DV+AFG++L E+ + G P
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP 212
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-25
Identities = 60/272 (22%), Positives = 107/272 (39%), Gaps = 33/272 (12%)
Query: 295 PPLSPYNELPKELEGLQERYSSTCRLFSYQE-LLSATSNFLPEYLV-----GKGGHSHVY 348
PP P LP F + L + + +Y V G G + V
Sbjct: 20 PPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVL 79
Query: 349 RG-CLPDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFED-----NNL 401
+ ++ A+K+L+ +E +E+ +I+ + +E+ L
Sbjct: 80 QIFNKRTQEKFALKMLQDCPKARRE----VELHWRASQCPHIVRIVDV-YENLYAGRKCL 134
Query: 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQPVIHKDV 459
L+V + L G L + + AF TER ++ + EA+ YLH + H+DV
Sbjct: 135 LIVMECLDGGELFSRIQ--DRGDQAF--TEREASEIMKSIGEAIQYLH---SINIAHRDV 187
Query: 460 KSSNILLSDDFEP---QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKI 516
K N+L + +L+DFG A ++ + + T T Y+APE K +
Sbjct: 188 KPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSC 244
Query: 517 DVYAFGIVLLELLSGKKPINSENPKGQESLVM 548
D+++ G+++ LL G P S + +
Sbjct: 245 DMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-25
Identities = 52/230 (22%), Positives = 93/230 (40%), Gaps = 32/230 (13%)
Query: 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNII 389
+ + E ++G G V G+ +AVK + D EI+++T H N+I
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI--DFCDIALMEIKLLTESDDHPNVI 72
Query: 390 SLFGFCFEDNNLLLVYDFLSRGSLE---ENLHGNKKDGNAFGWTERYKVAVGVAEALDYL 446
+ D L + + L +L+ E+ + + ++ + +A + +L
Sbjct: 73 RYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQ-------------LSDFGLASWLST--SSSHLT 491
H +IH+D+K NIL+S +SDFGL L + SS
Sbjct: 132 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 492 CTDVAGTFGYLAPEYFM-------HGKVSEKIDVYAFGIVLLELLSGKKP 534
+ +GT G+ APE +++ ID+++ G V +LS K
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 52/253 (20%), Positives = 100/253 (39%), Gaps = 33/253 (13%)
Query: 313 RYSSTCRLFSYQELLSATSNFLPEYLV-----GKGGHSHVYRG-CLPDGKELAVKILKPS 366
+ S+ +Q +Y + G G + V G++ A+K+L S
Sbjct: 6 HHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS 65
Query: 367 EDVLKEFASEIEIITAL-HHRNIISLFGFCFED-----NNLLLVYDFLSRGSLEENLHGN 420
+E ++ +I+ + +E+ LL++ + + G L +
Sbjct: 66 PKARQE----VDHHWQASGGPHIVCILDV-YENMHHGKRCLLIIMECMEGGELFSRIQ-- 118
Query: 421 KKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLS 475
++ AF TER ++ + A+ +LH + H+DVK N+L D +L+
Sbjct: 119 ERGDQAF--TEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLT 173
Query: 476 DFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPI 535
DFG A + ++ C T Y+APE K + D+++ G+++ LL G P
Sbjct: 174 DFGFAKETTQNALQTPC----YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229
Query: 536 NSENPKGQESLVM 548
S + +
Sbjct: 230 YSNTGQAISPGMK 242
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 55/207 (26%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKI--LKPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+G+G V G+++AVK+ L+ + + +E+ I+ H N++ ++
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQP 453
L ++ +FL G+L + + + E V V +AL YLH Q
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLHA---QG 161
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVS 513
VIH+D+KS +ILL+ D +LSDFG + +S + GT ++APE +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYWMAPEVISRSLYA 219
Query: 514 EKIDVYAFGIVLLELLSGKKPINSENP 540
++D+++ GI+++E++ G+ P S++P
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSP 246
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 26/227 (11%)
Query: 328 SATSNFLPEY----LVGKGGHSHVYRG-CLPDGKELAVK-ILKPSEDVLKEFASEIEIIT 381
S + Y +G+G V A K I K + + F EIEI+
Sbjct: 2 STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61
Query: 382 ALHHRNIISLFGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVG 438
+L H NII L+ FED ++ LV + + G L E + + + E ++
Sbjct: 62 SLDHPNIIRLYET-FEDNTDIYLVMELCTGGELFERVVHKRV------FRESDAARIMKD 114
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWLSTSSSHLTCTDV 495
V A+ Y H + V H+D+K N L S D +L DFGLA+
Sbjct: 115 VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTK 168
Query: 496 AGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
GT Y++P+ G + D ++ G+++ LL G P ++
Sbjct: 169 VGTPYYVSPQVL-EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE 214
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 30/256 (11%), Positives = 75/256 (29%), Gaps = 54/256 (21%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKIL----KPSEDVLKEFASEI--------------- 377
++G+ G+ V + +P + +K+ E+
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 378 ----------EIITALHHRNIISLFGFC--FEDNNLLLVYDFL--SRGSLEENLHGNKKD 423
+++ + +I + + +Y + + + E L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 424 GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483
+ R ++ + V L LH+ ++H ++ +I+L L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 484 STSSSHLTCTDVAGTFGYLAPEYFMH-----------GKVSEKIDVYAFGIVLLELLSGK 532
+ + G+ PE ++ D +A G+V+ +
Sbjct: 257 GAR------VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 533 KPINSENPKGQESLVM 548
PI + G +
Sbjct: 311 LPITKDAALGGSEWIF 326
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 47/196 (23%), Positives = 96/196 (48%), Gaps = 15/196 (7%)
Query: 347 VYRGCL-PDGKEL----AVKILK--PSEDVLKEFASEIEIITALHHRNIISLFGFCFEDN 399
V++G P+G+ + +K+++ + + I +L H +I+ L G C +
Sbjct: 29 VHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS 88
Query: 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDV 459
L LV +L GSL +++ ++ G V +A+ + YL E ++H+++
Sbjct: 89 -LQLVTQYLPLGSLLDHVRQHRGA---LGPQLLLNWGVQIAKGMYYLE---EHGMVHRNL 141
Query: 460 KSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVY 519
+ N+LL + Q++DFG+A L L ++ ++A E GK + + DV+
Sbjct: 142 AARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVW 201
Query: 520 AFGIVLLELLS-GKKP 534
++G+ + EL++ G +P
Sbjct: 202 SYGVTVWELMTFGAEP 217
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 50/213 (23%), Positives = 98/213 (46%), Gaps = 33/213 (15%)
Query: 347 VYRG----CLPDGKEL--AVKILKP-SEDVLKEFASEIEIITALHHRNIISLFGFCFEDN 399
V+ P ++ AVK LK + K+F E E++T L H +I+ +G C + +
Sbjct: 31 VFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 90
Query: 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY------------KVAVGVAEALDYLH 447
L++V++++ G L + L + D + +A +A + YL
Sbjct: 91 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 150
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL----- 502
Q +H+D+ + N L+ + ++ DFG++ + ++ + G L
Sbjct: 151 ---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWM 202
Query: 503 APEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
PE M+ K + + DV++FG++L E+ + GK+P
Sbjct: 203 PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 29/244 (11%), Positives = 66/244 (27%), Gaps = 43/244 (17%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKIL----KPSEDVLKEFASEIEII----------TA 382
++G+ G+ V + +P + +K+ E+ + A
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 383 LHHRNIISLFGFCFEDN-----------------NLLLVYDFL--SRGSLEENLHGNKKD 423
H I F + + +Y + + + E L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 424 GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483
+ R ++ + V L LH ++H ++ +I+L L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 484 STSSSHLTCTDVAGTFGYLAPE-----YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSE 538
S+ A ++ D + G+ + + P +
Sbjct: 262 GASAV-SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 539 NPKG 542
G
Sbjct: 321 AALG 324
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 29/225 (12%)
Query: 330 TSNFLPEY-------LVGKGGHSHVYRGC-LPDGKELAVK-ILKPSEDVLKEFASEIEII 380
S F Y +G+G S + + AVK I K E ++ EI +
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITAL 59
Query: 381 TAL-HHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAV 437
H NI+ L + + LV + L+ G L E + K ++E +
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH------FSETEASYIMR 113
Query: 438 GVAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWLSTSSSHLTCTD 494
+ A+ ++H + V+H+D+K N+L +D+ E ++ DFG A + L
Sbjct: 114 KLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK--T 168
Query: 495 VAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
T Y APE E D+++ G++L +LSG+ P S +
Sbjct: 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 62/271 (22%), Positives = 110/271 (40%), Gaps = 37/271 (13%)
Query: 281 ESGAIVSVEHDSACPPLSPYNELPKELEGLQERYSSTCRLFSYQELLSATSNFLPEYLV- 339
G+ V ++D P ++ Y++ +++ + + Q + + Y +
Sbjct: 9 HHGSKVRGKYDG--PKINDYDKFYEDIW----------KKYVPQPVEVKQGSVYDYYDIL 56
Query: 340 ---GKGGHSHVYRGCL--PDGKELAVKILKPSEDVLKE-FASEIEIITALHHRNIISLFG 393
G G V+R C+ G+ K + + K +EI I+ LHH +I+L
Sbjct: 57 EELGSGAFGVVHR-CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 115
Query: 394 FCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV--GVAEALDYLHNSC 450
FED ++L+ +FLS G L + + + +E + E L ++H
Sbjct: 116 A-FEDKYEMVLILEFLSGGELFDRI---AAEDYKM--SEAEVINYMRQACEGLKHMH--- 166
Query: 451 EQPVIHKDVKSSNILLSDDFEPQL--SDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM 508
E ++H D+K NI+ + DFGLA+ L+ T + APE
Sbjct: 167 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFAAPEIVD 223
Query: 509 HGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
V D++A G++ LLSG P E+
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 47/213 (22%), Positives = 90/213 (42%), Gaps = 43/213 (20%)
Query: 347 VYRGCLPDGKEL--------AVKILKP-SEDVLKEFASEIEIITALHHRNIISLFGFCFE 397
+++G + + +K+L + + F +++ L H++++ +G C
Sbjct: 24 IFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83
Query: 398 DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHK 457
+ +LV +F+ GSL+ L KK+ N + +VA +A A+ +L E +IH
Sbjct: 84 GDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHG 137
Query: 458 DVKSSNILLSDDFEPQ--------LSDFGLASWLSTSSSHLTCTDVAGTFGY------LA 503
+V + NILL + + + LSD G++ + +
Sbjct: 138 NVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------------ILQERIPWVP 185
Query: 504 PEYFMHGKV-SEKIDVYAFGIVLLELLS-GKKP 534
PE + K + D ++FG L E+ S G KP
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 26/225 (11%)
Query: 330 TSNFLPEYLV----GKGGHSHVYRGC-LPDGKELAVK-ILKPSEDVLKEFASEIEIITAL 383
T+N ++ G G S V+ GK A+K I K +EI ++ +
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI 63
Query: 384 HHRNIISLFGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVA 440
H NI++L +E + LV +S G L + + +TE+ V V
Sbjct: 64 KHENIVTLEDI-YESTTHYYLVMQLVSGGELFDRILERGV------YTEKDASLVIQQVL 116
Query: 441 EALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWLSTSSSHLTCTDVAG 497
A+ YLH E ++H+D+K N+L ++ + ++DFGL+ + G
Sbjct: 117 SAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACG 169
Query: 498 TFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
T GY+APE S+ +D ++ G++ LL G P E
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK 214
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 49/197 (24%), Positives = 88/197 (44%), Gaps = 19/197 (9%)
Query: 347 VYRGCL--PDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNN 400
V++G P+ L A+K K S+ V ++F E + H +I+ L G +N
Sbjct: 31 VHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENP 89
Query: 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVK 460
+ ++ + + G L L K A ++ AL YL + +H+D+
Sbjct: 90 VWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLE---SKRFVHRDIA 143
Query: 461 SSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF--GYLAPEYFMHGKVSEKIDV 518
+ N+L+S + +L DFGL+ ++ S+ G ++APE + + DV
Sbjct: 144 ARNVLVSSNDCVKLGDFGLSRYMEDST---YYKASKGKLPIKWMAPESINFRRFTSASDV 200
Query: 519 YAFGIVLLELLS-GKKP 534
+ FG+ + E+L G KP
Sbjct: 201 WMFGVCMWEILMHGVKP 217
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 53/214 (24%), Positives = 90/214 (42%), Gaps = 34/214 (15%)
Query: 347 VYRG----CLPDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
VY+G P + A+K LK + +EF E + L H N++ L G +D
Sbjct: 25 VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 84
Query: 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY------------KVAVGVAEALDYL 446
L +++ + S G L E L + + + +A ++YL
Sbjct: 85 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 144
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL---- 502
V+HKD+ + N+L+ D ++SD GL + + + L
Sbjct: 145 S---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY-----KLLGNSLLPIRW 196
Query: 503 -APEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
APE M+GK S D++++G+VL E+ S G +P
Sbjct: 197 MAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 16/205 (7%)
Query: 340 GKGGHSHVYRGCLPDGKEL----AVKILKP--SEDVLKEFASEIEIITALHHRNIISLFG 393
GKG VY G D + A+K L ++ F E ++ L+H N+++L G
Sbjct: 30 GKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIG 89
Query: 394 FCF-EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
+ ++ ++ G L + + + + + VA ++YL EQ
Sbjct: 90 IMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRNPTVKDLISFGLQVARGMEYLA---EQ 143
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF--GYLAPEYFMHG 510
+H+D+ + N +L + F +++DFGLA + + + A E
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTY 203
Query: 511 KVSEKIDVYAFGIVLLELLS-GKKP 534
+ + K DV++FG++L ELL+ G P
Sbjct: 204 RFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 36/238 (15%)
Query: 329 ATSNFLPEYLV----GKGGHSHVYRGC-LPDGKELAVKILKPS----------EDVLKEF 373
+T F Y G+G S V R P KE AVKI+ + +++ +
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 374 ASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER 432
E++I+ + H NII L + LV+D + +G L + L +E+
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT------LSEK 124
Query: 433 Y--KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490
K+ + E + LH + ++H+D+K NILL DD +L+DFG + L
Sbjct: 125 ETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--- 178
Query: 491 TCTDVAGTFGYLAPE------YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
+V GT YLAPE H +++D+++ G+++ LL+G P
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 71/302 (23%), Positives = 117/302 (38%), Gaps = 37/302 (12%)
Query: 262 HKQNHSAD----------TSEDNRSNLDGESGAIVSVEHDSACPPLSPYNELPKELEGLQ 311
H +HS+ S N + D SG + E S K L
Sbjct: 4 HHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALA 63
Query: 312 ERYSSTCRLFSYQELLSATSNFLPEYLV------GKGGHSHVYRGCL--PDGKELAVK-I 362
+ F ++ + + Y V G G V++ C G +LA K I
Sbjct: 64 VDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHK-CEETATGLKLAAKII 122
Query: 363 LKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED-NNLLLVYDFLSRGSLEENLHGNK 421
+E +EI ++ L H N+I L+ FE N+++LV +++ G L + +
Sbjct: 123 KTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRI---I 178
Query: 422 KDGNAFGWTERYKVAV--GVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQL--SDF 477
+ TE + + E + ++H + ++H D+K NIL + Q+ DF
Sbjct: 179 DESYNL--TELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDF 233
Query: 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINS 537
GLA GT +LAPE + VS D+++ G++ LLSG P
Sbjct: 234 GLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290
Query: 538 EN 539
+N
Sbjct: 291 DN 292
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-24
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 23/215 (10%)
Query: 340 GKGGHSHVYRGC-LPDGKELAVKIL--KPSEDVLKEFASEIEIITALHHRNIISLF---- 392
G GG +V R G+++A+K + S + + EI+I+ L+H N++S
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 393 --GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHN 448
++ LL ++ G L + L+ + N G E + ++ AL YLH
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLN---QFENCCGLKEGPIRTLLSDISSALRYLH- 138
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQ---LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
E +IH+D+K NI+L + + D G A L CT+ GT YLAPE
Sbjct: 139 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPE 193
Query: 506 YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540
K + +D ++FG + E ++G +P
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 16/209 (7%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFE 397
+G+G V+R K K +K EI I+ HRNI+ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 398 DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVG--VAEALDYLHNSCEQPVI 455
L+++++F+S + E + ER V+ V EAL +LH +
Sbjct: 73 MEELVMIFEFISGLDIFERI---NTSAFEL--NEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 456 HKDVKSSNILLSDDFEPQL--SDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVS 513
H D++ NI+ + +FG A L + + Y APE H VS
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVS 181
Query: 514 EKIDVYAFGIVLLELLSGKKPINSENPKG 542
D+++ G ++ LLSG P +E +
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQ 210
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 62/251 (24%), Positives = 103/251 (41%), Gaps = 40/251 (15%)
Query: 316 STCRLFSYQELLSA-----TSNFLPEYLV----GKGGHSHVYRGC-LPDGKELAVKILKP 365
S ++F + +L EY++ G G V K++A++I+
Sbjct: 111 SRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISK 170
Query: 366 S---------EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEEN 416
D +EIEI+ L+H II + F F+ + +V + + G L +
Sbjct: 171 RKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDK 229
Query: 417 LHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ- 473
+ GNK+ E + A+ YLH E +IH+D+K N+LLS E
Sbjct: 230 VVGNKR------LKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCL 280
Query: 474 --LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE---YFMHGKVSEKIDVYAFGIVLLEL 528
++DFG + L +S + GT YLAPE + +D ++ G++L
Sbjct: 281 IKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 337
Query: 529 LSGKKPINSEN 539
LSG P +
Sbjct: 338 LSGYPPFSEHR 348
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 36/214 (16%)
Query: 347 VYRG----CLPDGKEL--AVKILKP-SEDVLKEFASEIEIITALHHRNIISLFGFCFEDN 399
V+ LP+ ++ AVK LK SE ++F E E++T L H++I+ FG C E
Sbjct: 57 VFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116
Query: 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYK-----------VAVGVAEALDYLHN 448
LL+V++++ G L L + D E VA VA + YL
Sbjct: 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA- 175
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDV--AGTFGYL---- 502
+H+D+ + N L+ ++ DFG+ S + TD G L
Sbjct: 176 --GLHFVHRDLATRNCLVGQGLVVKIGDFGM-------SRDIYSTDYYRVGGRTMLPIRW 226
Query: 503 -APEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
PE ++ K + + DV++FG+VL E+ + GK+P
Sbjct: 227 MPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 48/200 (24%), Positives = 88/200 (44%), Gaps = 25/200 (12%)
Query: 347 VYRGCL--PDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNN 400
VY G G+++ AVK K + D ++F SE I+ L H +I+ L G E+
Sbjct: 28 VYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EEEP 86
Query: 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVK 460
++ + G L L +++ N+ ++ + +A+ YL +H+D+
Sbjct: 87 TWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIA 140
Query: 461 SSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFMHGKVSEK 515
NIL++ +L DFGL+ ++ + L +PE + +
Sbjct: 141 VRNILVASPECVKLGDFGLSRYIEDEDY------YKASVTRLPIKWMSPESINFRRFTTA 194
Query: 516 IDVYAFGIVLLELLS-GKKP 534
DV+ F + + E+LS GK+P
Sbjct: 195 SDVWMFAVCMWEILSFGKQP 214
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 25/226 (11%)
Query: 330 TSNFLPEYLV----GKGGHSHVYRGC-LPDGKELAVKIL---KPSEDVLKEFASEIEIIT 381
++ F Y V GKG S V R G E A KI+ K S ++ E I
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 382 ALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGV 439
L H NI+ L E++ LV+D ++ G L E++ + ++E +
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHCIQQI 114
Query: 440 AEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ---LSDFGLASWLSTSSSHLTCTDVA 496
E++ Y H ++H+++K N+LL+ + L+DFGLA ++ S A
Sbjct: 115 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFA 168
Query: 497 GTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
GT GYL+PE S+ +D++A G++L LL G P E+
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 25/200 (12%)
Query: 347 VYRGCL--PDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNN 400
V++G P+ + A+K K S+ V ++F E + H +I+ L G +N
Sbjct: 406 VHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENP 464
Query: 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVK 460
+ ++ + + G L L K + A ++ AL YL + +H+D+
Sbjct: 465 VWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIA 518
Query: 461 SSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFMHGKVSEK 515
+ N+L+S + +L DFGL+ ++ S+ + G L APE + +
Sbjct: 519 ARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESINFRRFTSA 572
Query: 516 IDVYAFGIVLLELLS-GKKP 534
DV+ FG+ + E+L G KP
Sbjct: 573 SDVWMFGVCMWEILMHGVKP 592
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-23
Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 24/226 (10%)
Query: 330 TSNFLPEY----LVGKGGHSHVYRGC-LPDGKELAVKIL---KPSEDVLKEFASEIEIIT 381
+ F EY +GKG S V R + G+E A I+ K S ++ E I
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 382 ALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGV 439
L H NI+ L E+ + L++D ++ G L E++ + ++E +
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY------YSEADASHCIQQI 119
Query: 440 AEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWLSTSSSHLTCTDVA 496
EA+ + H + V+H+++K N+LL +L+DFGLA + A
Sbjct: 120 LEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF--GFA 174
Query: 497 GTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
GT GYL+PE + +D++A G++L LL G P E+
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR 220
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 71/306 (23%), Positives = 121/306 (39%), Gaps = 38/306 (12%)
Query: 260 PDHKQNHSADTSEDNRSNLDGESGAIVSVEHDSACPPLSPYNELPKELEGLQERYSSTCR 319
+ H + + + R S + + PK E L +
Sbjct: 22 ARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPED 81
Query: 320 LFSYQELLSATSNFLPEY----LVGKGGHSHVYRGC-LPDGKELAVKILK---------P 365
+A F +Y ++G+G S V R G E AVKI++
Sbjct: 82 EL---PDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQ 138
Query: 366 SEDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDG 424
E+V + E I+ + H +II+L + + LV+D + +G L + L
Sbjct: 139 LEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA-- 196
Query: 425 NAFGWTERY--KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482
+E+ + + EA+ +LH ++H+D+K NILL D+ + +LSDFG +
Sbjct: 197 ----LSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249
Query: 483 LSTSSSHLTCTDVAGTFGYLAPE------YFMHGKVSEKIDVYAFGIVLLELLSGKKPIN 536
L ++ GT GYLAPE H +++D++A G++L LL+G P
Sbjct: 250 LEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW 306
Query: 537 SENPKG 542
Sbjct: 307 HRRQIL 312
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-23
Identities = 65/284 (22%), Positives = 111/284 (39%), Gaps = 38/284 (13%)
Query: 262 HKQNHSADTSEDNRSNLDGESGAIVSVEHDSACPPLSPYNELPKELEGLQERYSSTCRLF 321
H +HS+ + ++ + + Y + L + +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFE------ 56
Query: 322 SYQELLSATSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEII 380
+ L G+G S VYR K A+K+LK + D K +EI ++
Sbjct: 57 -VESEL------------GRGATSIVYRCKQKGTQKPYALKVLKKTVDK-KIVRTEIGVL 102
Query: 381 TALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVG 438
L H NII L + LV + ++ G L + + ++ER
Sbjct: 103 LRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY------YSERDAADAVKQ 156
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWLSTSSSHLTCTDV 495
+ EA+ YLH E ++H+D+K N+L + D +++DFGL+ + V
Sbjct: 157 ILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTV 210
Query: 496 AGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
GT GY APE ++D+++ GI+ LL G +P E
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-23
Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 19/211 (9%)
Query: 339 VGKGGHSHVYRGCL--PDGKELAVKILKPSEDVLKE-FASEIEIITALHHRNIISLFGFC 395
+G G V+R G A K + + KE EI+ ++ L H +++L
Sbjct: 165 LGTGAFGVVHR-VTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVG--VAEALDYLHNSCEQP 453
+DN ++++Y+F+S G L E + + +E V V + L ++H E
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKV--ADEHNK---MSEDEAVEYMRQVCKGLCHMH---ENN 275
Query: 454 VIHKDVKSSNILLSDDFEPQL--SDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
+H D+K NI+ + +L DFGL + L S GT + APE
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKP 332
Query: 512 VSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
V D+++ G++ LLSG P EN
Sbjct: 333 VGYYTDMWSVGVLSYILLSGLSPFGGENDDE 363
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 65/230 (28%), Positives = 106/230 (46%), Gaps = 25/230 (10%)
Query: 326 LLSATSNFLPEYLV----GKGGHSHVYRGC-LPDGKELAVKIL---KPSEDVLKEFASEI 377
+++A++ F Y V GKG S V R G E A KI+ K S ++ E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 378 EIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KV 435
I L H NI+ L E++ LV+D ++ G L E++ + ++E
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF------YSEADASHC 133
Query: 436 AVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ---LSDFGLASWLSTSSSHLTC 492
+ E++ Y H ++H+++K N+LL+ + L+DFGLA ++ S
Sbjct: 134 IQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AW 187
Query: 493 TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
AGT GYL+PE S+ +D++A G++L LL G P E+
Sbjct: 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 237
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 65/269 (24%), Positives = 114/269 (42%), Gaps = 38/269 (14%)
Query: 328 SATSNF-----LPEYLVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKE-FASEIEII 380
S + F L E ++G+G H+ V L +E AVKI++ ++ E+E++
Sbjct: 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEML 64
Query: 381 TAL-HHRNIISLFGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVA 436
HRN++ L F FE+ + LV++ + GS+ ++H + + E V
Sbjct: 65 YQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRRH------FNELEASVVV 117
Query: 437 VGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP---QLSDFGLASWLSTSSSHLTC- 492
VA ALD+LHN + + H+D+K NIL + ++ DF L S + +
Sbjct: 118 QDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 493 ----TDVAGTFGYLAPE-----YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQ 543
G+ Y+APE ++ D+++ G++L LLSG P
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC---- 230
Query: 544 ESLVMWAKPILKDGKVSQLLDPSLDTDYD 572
S W + + L + + Y+
Sbjct: 231 GSDCGWDRGEACPACQNMLFESIQEGKYE 259
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 347 VYRGCL-PDGKEL--AVKILKP--SEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNN 400
V + + DG + A+K +K S+D ++FA E+E++ L HH NII+L G C
Sbjct: 41 VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100
Query: 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY------------KVAVGVAEALDYLHN 448
L L ++ G+L + L ++ + A VA +DYL
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL-- 158
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD--VAGTFGYL---- 502
++ IH+D+ + NIL+ +++ +++DFGL+ + V T G L
Sbjct: 159 -SQKQFIHRDLAARNILVGENYVAKIADFGLSR----------GQEVYVKKTMGRLPVRW 207
Query: 503 -APEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
A E + + DV+++G++L E++S G P
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 51/218 (23%), Positives = 94/218 (43%), Gaps = 28/218 (12%)
Query: 340 GKGGHSHVYRGCL--PDGKELAVKILK-------PSEDVLKEFASEIEIITALHHRNIIS 390
G G + V + C G E A K +K +E E+ I+ + H N+I+
Sbjct: 21 GSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVG--VAEALDYLHN 448
L +++L+ + +S G L + L + + +E + + + ++YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL---AQKES---LSEEEATSFIKQILDGVNYLH- 132
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQ----LSDFGLASWLSTSSSHLTCTDVAGTFGYLAP 504
+ + H D+K NI+L D P L DFGLA + ++ GT ++AP
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAP 187
Query: 505 EYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
E + + + D+++ G++ LLSG P + +
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-22
Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 28/215 (13%)
Query: 340 GKGGHSHVYRG----CLPDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNIISL 391
G G VY G D L AVK L SE +F E II+ +H+NI+
Sbjct: 39 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNK---KDGNAFGWTERYKVAVGVAEALDYLHN 448
G + ++ + ++ G L+ L + ++ + VA +A YL
Sbjct: 99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE- 157
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQL---SDFGLASWLSTSSSHLTCTDVAGTFGYL--- 502
E IH+D+ + N LL+ ++ DFG+A + +S G L
Sbjct: 158 --ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAMLPVK 210
Query: 503 --APEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
PE FM G + K D ++FG++L E+ S G P
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 51/224 (22%), Positives = 92/224 (41%), Gaps = 46/224 (20%)
Query: 347 VYRG----CLPDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
V++ LP AVK+LK S D+ +F E ++ + NI+ L G C
Sbjct: 63 VFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122
Query: 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--------------------KVAVG 438
+ L++++++ G L E L +A
Sbjct: 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 182
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD--VA 496
VA + YL E+ +H+D+ + N L+ ++ +++DFGL S ++ D A
Sbjct: 183 VAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGL-------SRNIYSADYYKA 232
Query: 497 GTFGYL-----APEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
+ PE + + + + DV+A+G+VL E+ S G +P
Sbjct: 233 DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 33/220 (15%)
Query: 340 GKGGHSHVYRGCLPDGKEL------AVKILKP--SEDVLKEFASEIEIITAL-HHRNIIS 390
G G V + AVK+LK D + SE++I++ L H NI++
Sbjct: 55 GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 114
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY----------KVAVGVA 440
L G C +L++ ++ G L L + + VA
Sbjct: 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA 174
Query: 441 EALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFG 500
+ + +L + IH+DV + N+LL++ ++ DFGLA + S++ +
Sbjct: 175 QGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY-----IVKGNA 226
Query: 501 YL-----APEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
L APE + + DV+++GI+L E+ S G P
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 48/250 (19%), Positives = 101/250 (40%), Gaps = 38/250 (15%)
Query: 366 SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGN 425
S + + +I + +N + L + + +L++ +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLE 159
Query: 426 AFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA----- 480
+ + +AEA+++LH+ + ++H+D+K SNI + D ++ DFGL
Sbjct: 160 DREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 481 -----SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPI 535
+ L+ ++ T T GT Y++PE S K+D+++ G++L ELL
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST- 275
Query: 536 NSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQ---IERMVLAATLSISRAPT 592
E + + +++ K P L T + ++ M +S +PT
Sbjct: 276 ------QMERVRIITD--VRNLKF-----PLLFTQKYPQEHMMVQDM-------LSPSPT 315
Query: 593 VRPQINLVLK 602
RP+ +++
Sbjct: 316 ERPEATDIIE 325
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 26/217 (11%)
Query: 340 GKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFAS-------EIEIITALHHRNIISL 391
G G + V + GKE A K +K E+ I+ + H NII+L
Sbjct: 14 GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVG--VAEALDYLHNS 449
+++L+ + +S G L + L + + TE + + + YLH
Sbjct: 74 HDIFENKTDVVLILELVSGGELFDFL---AEKES---LTEDEATQFLKQILDGVHYLH-- 125
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQ----LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
+ + H D+K NI+L D P L DFG+A + + ++ GT ++APE
Sbjct: 126 -SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVAPE 181
Query: 506 YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
+ + + D+++ G++ LLSG P E +
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE 218
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 54/208 (25%), Positives = 87/208 (41%), Gaps = 28/208 (13%)
Query: 347 VYRG----CLPDGKEL--AVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
VY G D L AVK L SE +F E II+ +H+NI+ G +
Sbjct: 87 VYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146
Query: 399 NNLLLVYDFLSRGSLEENLHGNKK---DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
++ + ++ G L+ L + ++ + VA +A YL E I
Sbjct: 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFI 203
Query: 456 HKDVKSSNILLSDDFEPQL---SDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYF 507
H+D+ + N LL+ ++ DFG+A + + + G L PE F
Sbjct: 204 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-----RKGGCAMLPVKWMPPEAF 258
Query: 508 MHGKVSEKIDVYAFGIVLLELLS-GKKP 534
M G + K D ++FG++L E+ S G P
Sbjct: 259 MEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 340 GKGGHSHVYRGC-LPDGKELAVKILKPS---------EDVLKEFASEIEIITALHHRNII 389
G G V K++A+KI+ D +EIEI+ L+H II
Sbjct: 19 GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78
Query: 390 SLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLH 447
+ F F+ + +V + + G L + + GNK+ E + A+ YLH
Sbjct: 79 KIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR------LKEATCKLYFYQMLLAVQYLH 131
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQ---LSDFGLASWLSTSSSHLTCTDVAGTFGYLAP 504
E +IH+D+K N+LLS E ++DFG + L +S + GT YLAP
Sbjct: 132 ---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAP 185
Query: 505 E---YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
E + +D ++ G++L LSG P +
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 52/218 (23%), Positives = 94/218 (43%), Gaps = 28/218 (12%)
Query: 340 GKGGHSHVYRGCL--PDGKELAVKILK-------PSEDVLKEFASEIEIITALHHRNIIS 390
G G + V + C G E A K +K +E E+ I+ + H NII+
Sbjct: 21 GSGQFAIVKK-CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVG--VAEALDYLHN 448
L +++L+ + +S G L + L + + +E + + + ++YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL---AQKES---LSEEEATSFIKQILDGVNYLH- 132
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQ----LSDFGLASWLSTSSSHLTCTDVAGTFGYLAP 504
+ + H D+K NI+L D P L DFGLA + ++ GT ++AP
Sbjct: 133 --TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAP 187
Query: 505 EYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
E + + + D+++ G++ LLSG P + +
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 225
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 49/219 (22%), Positives = 93/219 (42%), Gaps = 30/219 (13%)
Query: 340 GKGGHSHVYRGCL--PDGKELAVKILKPSEDVLKEFAS-------EIEIITALHHRNIIS 390
G G + V + C G + A K +K E+ I+ + H N+I+
Sbjct: 20 GSGQFAVVKK-CREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 391 LFGFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVG--VAEALDYLH 447
L +E+ +++L+ + ++ G L + L + + TE + + YLH
Sbjct: 79 LHEV-YENKTDVILILELVAGGELFDFL---AEKES---LTEEEATEFLKQILNGVYYLH 131
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQ----LSDFGLASWLSTSSSHLTCTDVAGTFGYLA 503
+ H D+K NI+L D P+ + DFGLA + + ++ GT ++A
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVA 185
Query: 504 PEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
PE + + + D+++ G++ LLSG P + +
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 224
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 53/248 (21%), Positives = 105/248 (42%), Gaps = 27/248 (10%)
Query: 311 QERYSSTCRLFSYQELLSATSNFLPEYLV-----GKGGHSHVYRG-CLPDGKELAVKIL- 363
+SS L + + NF Y++ G+G + V + G+E A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 364 --KPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFED-NNLLLVYDFLSRGSLEENLHG 419
+ +D E EI ++ +I+L +E+ + ++L+ ++ + G +
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV-YENTSEIILILEYAAGGEIFSLCL- 121
Query: 420 NKKDGNAFGWTERYKVAV--GVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ---L 474
+ +E + + + E + YLH + ++H D+K NILLS + +
Sbjct: 122 -PELAEMV--SENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKI 175
Query: 475 SDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKP 534
DFG++ + + ++ GT YLAPE + ++ D++ GI+ LL+ P
Sbjct: 176 VDFGMSRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
Query: 535 INSENPKG 542
E+ +
Sbjct: 233 FVGEDNQE 240
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 52/197 (26%), Positives = 97/197 (49%), Gaps = 29/197 (14%)
Query: 359 AVKILKP--SEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415
AVK+LK +E L + SE+E++ + H+NII+L G C +D L ++ ++ S+G+L E
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 176
Query: 416 NLHGNKKDGNAFGWTERY------------KVAVGVAEALDYLHNSCEQPVIHKDVKSSN 463
L + G + + +A ++YL Q IH+D+ + N
Sbjct: 177 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARN 233
Query: 464 ILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFMHGKVSEKIDV 518
+L++++ +++DFGLA ++ + T G L APE + + DV
Sbjct: 234 VLVTENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDV 288
Query: 519 YAFGIVLLELLS-GKKP 534
++FG+++ E+ + G P
Sbjct: 289 WSFGVLMWEIFTLGGSP 305
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 8e-21
Identities = 51/197 (25%), Positives = 97/197 (49%), Gaps = 29/197 (14%)
Query: 359 AVKILKP--SEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSRGSL-- 413
AVK+LK +E L + SE+E++ + H+NII+L G C +D L ++ ++ S+G+L
Sbjct: 71 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 414 ----------EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSN 463
E + N+ + + +A ++YL Q IH+D+ + N
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARN 187
Query: 464 ILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFMHGKVSEKIDV 518
+L++++ +++DFGLA ++ + T G L APE + + DV
Sbjct: 188 VLVTENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDV 242
Query: 519 YAFGIVLLELLS-GKKP 534
++FG+++ E+ + G P
Sbjct: 243 WSFGVLMWEIFTLGGSP 259
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 9e-21
Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 42/222 (18%)
Query: 347 VYRGCLPDGKEL------AVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
V + K AVK+LK S L++ SE ++ ++H ++I L+G C +D
Sbjct: 39 VVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98
Query: 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--------------------KVAVG 438
LLL+ ++ GSL L ++K G + + A
Sbjct: 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
+++ + YL E ++H+D+ + NIL+++ + ++SDFGL+ + S+ V +
Sbjct: 159 ISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY-----VKRS 210
Query: 499 FGYL-----APEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
G + A E + + DV++FG++L E+++ G P
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 31/210 (14%), Positives = 61/210 (29%), Gaps = 47/210 (22%)
Query: 338 LVGKGGHSHVYRGCLPD---GKELAVKILKPS----EDVLKEFASEIEIITALHHRNIIS 390
G ++ D +++A+ + P +DVL+E S ++ + +
Sbjct: 38 FHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
+ L+V +++ GSL+E + + +A A D H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAH--- 146
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510
V S + +S D G V +
Sbjct: 147 RAGVALSIDHPSRVRVSID--------GDV--------------VLAYPATMPD------ 178
Query: 511 KVSEKIDVYAFGIVLLELLSGKKPINSENP 540
+ + D+ G L LL + P+
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLPEAGV 207
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 55/197 (27%), Positives = 98/197 (49%), Gaps = 29/197 (14%)
Query: 359 AVKILKP--SEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415
AVK+LK +E L + SE+E++ + H+NII+L G C +D L ++ ++ S+G+L E
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 416 NLHGNKKDGNAFGWTERY------------KVAVGVAEALDYLHNSCEQPVIHKDVKSSN 463
L + G + + + A VA ++YL + IH+D+ + N
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN 221
Query: 464 ILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFMHGKVSEKIDV 518
+L+++D +++DFGLA + + T G L APE + + DV
Sbjct: 222 VLVTEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDV 276
Query: 519 YAFGIVLLELLS-GKKP 534
++FG++L E+ + G P
Sbjct: 277 WSFGVLLWEIFTLGGSP 293
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 50/216 (23%), Positives = 91/216 (42%), Gaps = 36/216 (16%)
Query: 347 VYRGCLPDGKEL------AVKILKP--SEDVLKEFASEIEIITAL-HHRNIISLFGFCFE 397
V + AVK+LK + + SE++I+ + HH N+++L G C +
Sbjct: 43 VIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102
Query: 398 DNN-LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY------------KVAVGVAEALD 444
L+++ +F G+L L + + + + VA+ ++
Sbjct: 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGME 162
Query: 445 YLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-- 502
+L + IH+D+ + NILLS+ ++ DFGLA + + V L
Sbjct: 163 FLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPL 214
Query: 503 ---APEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
APE + + DV++FG++L E+ S G P
Sbjct: 215 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 50/199 (25%), Positives = 86/199 (43%), Gaps = 31/199 (15%)
Query: 359 AVKILKP--SEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415
AVK+LKP + SE+++++ L +H NI++L G C L++ ++ G L
Sbjct: 57 AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116
Query: 416 NLHGNKKDGNAFGWTER--------------YKVAVGVAEALDYLHNSCEQPVIHKDVKS 461
L + + + VA+ + +L + IH+D+ +
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAA 173
Query: 462 SNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFMHGKVSEKI 516
NILL+ ++ DFGLA + S++ V L APE + + +
Sbjct: 174 RNILLTHGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFES 228
Query: 517 DVYAFGIVLLELLS-GKKP 534
DV+++GI L EL S G P
Sbjct: 229 DVWSYGIFLWELFSLGSSP 247
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 38/223 (17%)
Query: 338 LVGKGGHSHVYRGCL-PDGKELAVKILKPSEDV-LKEFA---SEIEIITALHHRNIISLF 392
++G+G S V +E A+KIL+ + + E ++++ L H + L+
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 393 GFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKV---------AVGVAEA 442
F F+D+ L + G L + + + A
Sbjct: 97 -FTFQDDEKLYFGLSYAKNGEL-------------LKYIRKIGSFDETCTRFYTAEIVSA 142
Query: 443 LDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL 502
L+YLH + +IH+D+K NILL++D Q++DFG A LS S GT Y+
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 503 APEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
+PE K S D++A G ++ +L++G P + N
Sbjct: 200 SPELLTEKSACKSS---DLWALGCIIYQLVAGLPPFRAGNEYL 239
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 49/204 (24%), Positives = 90/204 (44%), Gaps = 36/204 (17%)
Query: 359 AVKILKP--SEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415
AVK+LK + SE++++T L H NI++L G C + L++++ G L
Sbjct: 79 AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138
Query: 416 NLHGNKKDGNAFGWTERYK-------------------VAVGVAEALDYLHNSCEQPVIH 456
L ++ + + A VA+ +++L + +H
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVH 195
Query: 457 KDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL-----APEYFMHGK 511
+D+ + N+L++ ++ DFGLA + + S++ V L APE G
Sbjct: 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNY-----VVRGNARLPVKWMAPESLFEGI 250
Query: 512 VSEKIDVYAFGIVLLELLS-GKKP 534
+ K DV+++GI+L E+ S G P
Sbjct: 251 YTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 49/220 (22%), Positives = 88/220 (40%), Gaps = 44/220 (20%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKILK-------PSEDVLKEFASEIEIITALHHR--N 387
L+G GG VY G + D +A+K ++ E+ ++ +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 388 IISLFGFCFEDNNLLLV----------YDFL-SRGSLEENLHGNKKDGNAFGWTERYKVA 436
+I L + ++ +L+ +DF+ RG+L+E
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE--------------LARSFF 155
Query: 437 VGVAEALDYLHNSCEQPVIHKDVKSSNILL-SDDFEPQLSDFGLASWLSTSSSHLTCTDV 495
V EA+ + HN V+H+D+K NIL+ + E +L DFG + L +
Sbjct: 156 WQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD--- 209
Query: 496 AGTFGYLAPEYFMHGK-VSEKIDVYAFGIVLLELLSGKKP 534
GT Y PE+ + + V++ GI+L +++ G P
Sbjct: 210 -GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 47/222 (21%), Positives = 84/222 (37%), Gaps = 46/222 (20%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKILK-------PSEDVLKEFASEIEIITALH----H 385
L+GKGG V+ G L D ++A+K++ E+ ++ + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 386 RNIISLFGFCFEDNNLLLV----------YDFL-SRGSLEENLHGNKKDGNAFGWTERYK 434
+I L + +LV +D++ +G L E
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG--------------PSRC 143
Query: 435 VAVGVAEALDYLHNSCEQPVIHKDVKSSNILL-SDDFEPQLSDFGLASWLSTSSSHLTCT 493
V A+ + H+ + V+H+D+K NIL+ +L DFG + L
Sbjct: 144 FFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 494 DVAGTFGYLAPEYFMHGK-VSEKIDVYAFGIVLLELLSGKKP 534
GT Y PE+ + + V++ GI+L +++ G P
Sbjct: 200 ---GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 57/222 (25%), Positives = 101/222 (45%), Gaps = 49/222 (22%)
Query: 340 GKGGHSHVYRGC-LPDGKELAVKIL---KPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
GKG + V + G+E+A+KI+ + + L++ E+ I+ L+H NI+ LF
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 396 FEDNNLLLV---------YDFL-SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDY 445
+ L L+ +D+L + G ++E E + A+ Y
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLVAHGRMKEK--------------EARSKFRQIVSAVQY 129
Query: 446 LHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW------LSTSSSHLTCTDVAGTF 499
H ++H+D+K+ N+LL D +++DFG ++ L C G
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-----C----GAP 177
Query: 500 GYLAPEYFMHGKVSE--KIDVYAFGIVLLELLSGKKPINSEN 539
Y APE F GK + ++DV++ G++L L+SG P + +N
Sbjct: 178 PYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 46/221 (20%), Positives = 84/221 (38%), Gaps = 48/221 (21%)
Query: 340 GKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFE 397
G G + V + ++ A+K+L+ + E+E+ +I+ + +E
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCPHIVRIVDV-YE 81
Query: 398 D-----NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALDYLHNSC 450
+ LL+V + L G L + + AF TER ++ + EA+ YLH
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAF--TEREASEIMKSIGEAIQYLH--- 134
Query: 451 EQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF 507
+ H+DVK N+L + +L+DFG A E
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFG-----------------------FAKE-T 170
Query: 508 MHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVM 548
K + D+++ G+++ LL G P S + +
Sbjct: 171 TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 211
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 5e-17
Identities = 57/246 (23%), Positives = 95/246 (38%), Gaps = 31/246 (12%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKE----FASEIEIITALHHRNIISLF 392
++G+G S V + ++ A+KI+ + + + F E +++ R I L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 393 GFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDGNAFG--WTERYKVAVGVAE---ALDYL 446
F F+D L LV ++ G L L K G Y +AE A+D +
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLL---SKFGERIPAEMARFY-----LAEIVMAIDSV 178
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY 506
H +H+D+K NILL +L+DFG L + + V GT YL+PE
Sbjct: 179 H---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEI 234
Query: 507 FMHGKVSEKIDVY-------AFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559
Y A G+ E+ G+ P +++ ++ K L V
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV 294
Query: 560 SQLLDP 565
+ +
Sbjct: 295 DEGVPE 300
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 51/220 (23%), Positives = 89/220 (40%), Gaps = 32/220 (14%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKILK-----PSEDVLKEFASEIEIITALHHRNIISL 391
L+G+G + V AVKILK + EI+++ L H+N+I L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 392 FGFCF--EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVA--------E 441
+ E + +V ++ G E + V A +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE-----------MLDSVPEKRFPVCQAHGYFCQLID 120
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY 501
L+YLH+ Q ++HKD+K N+LL+ ++S G+A L ++ TC G+ +
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 502 LAPEYFMHGKVSE--KIDVYAFGIVLLELLSGKKPINSEN 539
PE K+D+++ G+ L + +G P +N
Sbjct: 178 QPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 46/219 (21%)
Query: 340 GKGGHSHVYRG-CLPDGKELAVKILK---------PSEDVLKEFASEIEIITALHHRNII 389
G G V+ KE+ VK +K + L + EI I++ + H NII
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 390 SLFGFCFEDNNLLLV----------YDFL-SRGSLEENLHGNKKDGNAFGWTERYKVAVG 438
+ LV + F+ L+E +
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP--------------LASYIFRQ 138
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS-HLTCTDVAG 497
+ A+ YL +IH+D+K NI++++DF +L DFG A++L + C G
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC----G 191
Query: 498 TFGYLAPEYFMHGK--VSEKIDVYAFGIVLLELLSGKKP 534
T Y APE M G ++++++ G+ L L+ + P
Sbjct: 192 TIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 58/239 (24%), Positives = 93/239 (38%), Gaps = 51/239 (21%)
Query: 337 YLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKE----FASEIEIITALHHRNIISLF 392
LV VY A+K+L E + + F E +I+ + ++ LF
Sbjct: 86 QLVRHKSTRKVY----------AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 393 GFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE--------AL 443
+ F+D+ L +V +++ G L Y V A AL
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWARFYTAEVVLAL 181
Query: 444 DYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLA 503
D +H IH+DVK N+LL +L+DFG ++ T V GT Y++
Sbjct: 182 DAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYIS 237
Query: 504 PE-------YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILK 555
PE +G+ D ++ G+ L E+L G P +++ G S +M K L
Sbjct: 238 PEVLKSQGGDGYYGRE---CDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 293
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 40/216 (18%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDV-LKEFA---SEIEIITALHHRNIISLF 392
+GKG V D K++ A+K + + V E E++I+ L H +++L+
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 393 GFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER----YKVAVGVAE---ALD 444
+ F+D ++ +V D L G L +L N F E + + E ALD
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHLQQNVH----F--KEETVKLF-----ICELVMALD 129
Query: 445 YLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAP 504
YL Q +IH+D+K NILL + ++DF +A+ L + T +AGT Y+AP
Sbjct: 130 YLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT---MAGTKPYMAP 183
Query: 505 EYFM------HGKVSEKIDVYAFGIVLLELLSGKKP 534
E F + +D ++ G+ ELL G++P
Sbjct: 184 EMFSSRKGAGYSFA---VDWWSLGVTAYELLRGRRP 216
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 9e-16
Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 18/213 (8%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKEFA-----SEIEIITALHHRNIISL 391
++G+GG V+ + +L A K L + + K E +I+ +H R I+SL
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLN-KKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 392 FGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKV--AVGVAEALDYLHN 448
+ FE +L LV ++ G + +++ +D F E + + L++LH
Sbjct: 251 A-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF--QEPRAIFYTAQIVSGLEHLH- 306
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM 508
++ +I++D+K N+LL DD ++SD GLA + T AGT G++APE +
Sbjct: 307 --QRNIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKG-YAGTPGFMAPELLL 362
Query: 509 HGKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541
+ +D +A G+ L E+++ + P + K
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEK 395
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 31/209 (14%)
Query: 344 HSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFE------ 397
+ R P G A +++ EI I+ L H N++ L E
Sbjct: 54 QAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLV----EVLDDPN 109
Query: 398 DNNLLLVYDFLSRGSL-EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIH 456
+++L +V++ +++G + E + A + + ++YLH Q +IH
Sbjct: 110 EDHLYMVFELVNQGPVMEVPTLKPLSEDQAR------FYFQDLIKGIEYLHY---QKIIH 160
Query: 457 KDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM------HG 510
+D+K SN+L+ +D +++DFG+++ S + L+ T GT ++APE G
Sbjct: 161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT--VGTPAFMAPESLSETRKIFSG 218
Query: 511 KVSEKIDVYAFGIVLLELLSGKKPINSEN 539
K +DV+A G+ L + G+ P E
Sbjct: 219 K---ALDVWAMGVTLYCFVFGQCPFMDER 244
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDV-LKEFA---SEIEIITALHHRNIISLF 392
+G G V + A+KIL + V LK+ +E I+ A++ ++ L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 393 GFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
F F+DN NL +V ++++ G + +L + R+ A + +YLH
Sbjct: 108 -FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP---HARFYAA-QIVLTFEYLH---S 159
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM--- 508
+I++D+K N+L+ Q++DFG A + + L C GT LAPE +
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL-C----GTPEALAPEIILSKG 214
Query: 509 HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542
+ K +D +A G+++ E+ +G P ++ P
Sbjct: 215 YNKA---VDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 58/237 (24%), Positives = 101/237 (42%), Gaps = 35/237 (14%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKE----FASEIEIITALHHRNIISLF 392
++G+G V L + ++ A+KIL E + + F E +++ + I +L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 393 GFCFED-NNLLLVYDFLSRGSLEENLHGNKKDGNAF--GWTERYKVAVGVAE---ALDYL 446
+ F+D NNL LV D+ G L L K + Y +AE A+D +
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFY-----LAEMVIAIDSV 191
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY 506
H +H+D+K NIL+ + +L+DFG L + + V GT Y++PE
Sbjct: 192 HQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEI 247
Query: 507 FM--------HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILK 555
+G D ++ G+ + E+L G+ P +E+ +M K +
Sbjct: 248 LQAMEGGKGRYGPE---CDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 54/228 (23%), Positives = 105/228 (46%), Gaps = 23/228 (10%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKE------FASEIEIITALHHRNIIS 390
++GKGG V + ++ A K L+ + +K+ +E +I+ ++ R ++S
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLE--KKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 391 LFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
L + +E + L LV ++ G L+ +++ + G Y A + L+ LH
Sbjct: 249 LA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY--AAEICCGLEDLH-- 303
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT-CTDVAGTFGYLAPEYFM 508
+ ++++D+K NILL D ++SD GLA + + GT GY+APE
Sbjct: 304 -RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV----GTVGYMAPEVVK 358
Query: 509 HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKD 556
+ + + D +A G +L E+++G+ P K + V + +
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL--VKEV 404
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 28/222 (12%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKEFASE---------IEIITALHHRN 387
++G+GG VY D ++ A+K L + +K E + +++
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLD--KKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 388 IISLFGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKV-AVGVAEALDY 445
I+ + + F L + D ++ G L +L + F + A + L++
Sbjct: 254 IVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGV----FS-EADMRFYAAEIILGLEH 307
Query: 446 LHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
+H + V+++D+K +NILL + ++SD GLA S H + GT GY+APE
Sbjct: 308 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPE 360
Query: 506 YFMHGKVSEK-IDVYAFGIVLLELLSGKKPINSENPKGQESL 546
G + D ++ G +L +LL G P K + +
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 51/212 (24%), Positives = 94/212 (44%), Gaps = 20/212 (9%)
Query: 339 VGKGGHSHVYRGC---LPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
VG+G + HVY+ D K+ A+K ++ + EI ++ L H N+ISL
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE-GTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 396 FE--DNNLLLVYDFLS---RGSLEENLHGNKKDGNA-FGWTERYKVAVGVAEALDYLHNS 449
D + L++D+ ++ + + + + + YLH +
Sbjct: 88 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQ----LSDFGLASWLSTSSSHLT-CTDVAGTFGYLAP 504
V+H+D+K +NIL+ + + ++D G A ++ L V TF Y AP
Sbjct: 148 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 505 EYFMHGKV-SEKIDVYAFGIVLLELLSGKKPI 535
E + + ++ ID++A G + ELL+ +PI
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLT-SEPI 235
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVK-ILKPSEDVLKE-FAS----EIEIITALHHRNIISL 391
+G+G + VY+ + +A+K I K+ EI+++ L H NII L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
+N+ LV+DF+ LE + K + + + + L+YLH
Sbjct: 78 LDAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 132
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
++H+D+K +N+LL ++ +L+DFGLA + + T V T Y APE +
Sbjct: 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV--TRWYRAPELLFGAR 188
Query: 512 V-SEKIDVYAFGIVLLELLSGK 532
+ +D++A G +L ELL
Sbjct: 189 MYGVGVDMWAVGCILAELLLRV 210
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 36/203 (17%)
Query: 354 DGKELAVKILKPSEDV-LKEFA---SEIEIITALHHRNIISLFGFCFEDN-NLLLVYDFL 408
+G+ A+K+LK V LK+ E +++ + H II ++ F+D + ++ D++
Sbjct: 30 NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW-GTFQDAQQIFMIMDYI 88
Query: 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVG---VAE---ALDYLHNSCEQPVIHKDVKSS 462
G L L +K R+ V AE AL+YLH + +I++D+K
Sbjct: 89 EGGELFSLL---RKSQ-------RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPE 135
Query: 463 NILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVY 519
NILL + +++DFG A ++ + L C GT Y+APE + K ID +
Sbjct: 136 NILLDKNGHIKITDFGFAKYVPDVTYTL-C----GTPDYIAPEVVSTKPYNKS---IDWW 187
Query: 520 AFGIVLLELLSGKKPINSENPKG 542
+FGI++ E+L+G P N
Sbjct: 188 SFGILIYEMLAGYTPFYDSNTMK 210
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 340 GKGGHSHVYRGC-LPDGKELAVKILK----PSEDVLKEFASEIEIITALHHRNIISLFGF 394
G G V G G ++AVKIL S DV+ + EI+ + H +II L+
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 395 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
+ +V +++S G L + + HG ++ A R ++ + A+DY H
Sbjct: 80 ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA-----R-RLFQQILSAVDYCHRHM-- 131
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS-HLTCTDVAGTFGYLAPEYFMHGK 511
V+H+D+K N+LL +++DFGL++ +S +C G+ Y APE G+
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----GSPNYAAPEVIS-GR 185
Query: 512 --VSEKIDVYAFGIVLLELLSGKKPINSEN 539
++D+++ G++L LL G P + E+
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDEH 215
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 6e-14
Identities = 47/204 (23%), Positives = 91/204 (44%), Gaps = 18/204 (8%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKE-FAS----EIEIITALHHRNIISLF 392
+G+G + V++ + +A+K ++ +D E S EI ++ L H+NI+ L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLH 67
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
D L LV++F + L++ + + L + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-DLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCH---SR 120
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
V+H+D+K N+L++ + E +L++FGLA + V T Y P+ K+
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKL 178
Query: 513 -SEKIDVYAFGIVLLELLSGKKPI 535
S ID+++ G + EL + +P+
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPL 202
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 8e-14
Identities = 40/161 (24%), Positives = 74/161 (45%), Gaps = 11/161 (6%)
Query: 376 EIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS---RGSLEENLHGNKKDGNAFGWTER 432
EI ++ L H NI+ L+ +N L LV++F+ + ++
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDS--RTVGNTPRGLELNLV 110
Query: 433 YKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492
+ + L + H E ++H+D+K N+L++ + +L DFGLA + +
Sbjct: 111 KYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167
Query: 493 TDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGK 532
V T Y AP+ M + S ID+++ G +L E+++GK
Sbjct: 168 EVV--TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 8e-14
Identities = 55/259 (21%), Positives = 107/259 (41%), Gaps = 35/259 (13%)
Query: 292 SACPPLSPYNELPKELEGLQERYSSTCRLFSYQELLSATSNFLPEY----LVGKGGHSHV 347
+ C ++ + S F E+ +T L Y +G G V
Sbjct: 19 AFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIV 78
Query: 348 YRG-CLPDGKELAVK-ILKPSEDVLKEFAS----EIEIITALHHRNIISLF------GFC 395
+ +A+K + +P ++ A E+ ++ ++H+NIISL
Sbjct: 79 CAAYDAVLDRNVAIKKLSRPFQNQT--HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 396 FEDNNLLLVYDFLSRGSLEENLHG--NKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
E ++ LV + ++ NL + + Y++ G + +LH++
Sbjct: 137 EEFQDVYLVMEL-----MDANLCQVIQMELDHERMSYLLYQMLCG----IKHLHSAG--- 184
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVS 513
+IH+D+K SNI++ D ++ DFGLA + +S + T T Y APE +
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMM-TPYVVTRYYRAPEVILGMGYK 241
Query: 514 EKIDVYAFGIVLLELLSGK 532
E +D+++ G ++ E++ K
Sbjct: 242 ENVDIWSVGCIMGEMVRHK 260
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 46/220 (20%), Positives = 91/220 (41%), Gaps = 38/220 (17%)
Query: 338 LVGKGGHSHVYRGC--LPDGKELAVKILKPSEDVLKEFASEIEIITALH----------- 384
+G G S V+ + + +A+KI++ + + EI+++ ++
Sbjct: 26 KLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 385 HRNIISLFG-FCFEDNN---LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVG 438
+I+ L F + N +++V++ L ENL K G Y +++
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVLG-----ENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 439 VAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ------LSDFGLASWLSTSSSHLTC 492
+ LDY+H C +IH D+K N+L+ P+ ++D G A W
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----YDEHY 192
Query: 493 TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGK 532
T+ T Y +PE + D+++ ++ EL++G
Sbjct: 193 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 52/200 (26%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKE-FAS----EIEIITALHHRNIISLFG 393
VG+G + VY+ G+ +A+K ++ + E S EI ++ LHH NI+SL
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
+ L LV++F+ + L++ L ++ ++ + + + H +
Sbjct: 87 VIHSERCLTLVFEFMEK-DLKKVL---DENKTGLQDSQIKIYLYQLLRGVAHCH---QHR 139
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV- 512
++H+D+K N+L++ D +L+DFGLA T V T Y AP+ M K
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV--TLWYRAPDVLMGSKKY 197
Query: 513 SEKIDVYAFGIVLLELLSGK 532
S +D+++ G + E+++GK
Sbjct: 198 STSVDIWSIGCIFAEMITGK 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 52/199 (26%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 339 VGKGGHSHVYRGCLPDGKEL-AVK--ILKPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+G+G ++ VY+G L A+K L+ E E+ ++ L H NI++L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKD-GNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
+ +L LV+++L +++L D GN + L Y H Q V
Sbjct: 70 HTEKSLTLVFEYL-----DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKV 121
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV-S 513
+H+D+K N+L+++ E +L+DFGLA S + V T Y P+ + S
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDYS 179
Query: 514 EKIDVYAFGIVLLELLSGK 532
+ID++ G + E+ +G+
Sbjct: 180 TQIDMWGVGCIFYEMATGR 198
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVL--KEFAS---EIEIITALHHRNIISL 391
L+GKG V A+KILK E ++ E A E ++ H + +L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILK-KEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 392 FGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKV-AVGVAEALDYLHNS 449
+ F+ + L V ++ + G L +L + F +R + + ALDYLH+
Sbjct: 214 K-YSFQTHDRLCFVMEYANGGELFFHLSRERV----FS-EDRARFYGAEIVSALDYLHS- 266
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH 509
E+ V+++D+K N++L D +++DFGL T GT YLAPE
Sbjct: 267 -EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKT-FCGTPEYLAPEVLED 323
Query: 510 GKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
+D + G+V+ E++ G+ P +++
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 49/214 (22%), Positives = 80/214 (37%), Gaps = 34/214 (15%)
Query: 340 GKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
G G + +AVK ++ + + EI +L H NI+
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTP 88
Query: 399 NNLLLVYDFLSRGSLEENL--HGNKKDGNAFGWTERYK----VAVGVAEALDYLHNSCEQ 452
+L ++ ++ S G L E + G + A R+ ++ + Y H+
Sbjct: 89 THLAIIMEYASGGELYERICNAGRFSEDEA-----RFFFQQLLS-----GVSYCHS---M 135
Query: 453 PVIHKDVKSSNILLSDDFEPQL--SDFGLASWLSTSSS-HLTCTDVAGTFGYLAPEYFM- 508
+ H+D+K N LL P+L DFG + S T GT Y+APE +
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV----GTPAYIAPEVLLR 191
Query: 509 ---HGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
GK DV++ G+ L +L G P
Sbjct: 192 QEYDGK---IADVWSCGVTLYVMLVGAYPFEDPE 222
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 49/222 (22%)
Query: 340 GKGGHSHVYRGC-LPDGKELAVKILK----PSEDVLKEFASEIEIITALHHRNIISLFGF 394
G+G V +++A+K + D+ EI + L H +II L+
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77
Query: 395 CFEDNNLLLV--------YDFL-SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDY 445
++++V +D++ + + E+ E + + A++Y
Sbjct: 78 ITTPTDIVMVIEYAGGELFDYIVEKKRMTED--------------EGRRFFQQIICAIEY 123
Query: 446 LHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW------LSTSSSHLTCTDVAGTF 499
H ++H+D+K N+LL D+ +++DFGL++ L TS C G+
Sbjct: 124 CHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-----C----GSP 171
Query: 500 GYLAPEYFMHGK--VSEKIDVYAFGIVLLELLSGKKPINSEN 539
Y APE GK ++DV++ GIVL +L G+ P + E
Sbjct: 172 NYAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 9e-13
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKE-FAS----EIEIITALHHRNIISLF 392
+G+G + V++ G+ +A+K SED EI ++ L H N+++L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESED--DPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
L LV+++ ++ L + + +A+++ H +
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCH---KH 121
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
IH+DVK NIL++ +L DFG A L+ S + +VA T Y +PE +
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD-EVA-TRWYRSPELLVGDTQ 179
Query: 513 -SEKIDVYAFGIVLLELLSGK 532
+DV+A G V ELLSG
Sbjct: 180 YGPPVDVWAIGCVFAELLSGV 200
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 338 LVGKGGHSHVYRGC--LPDGKELAVKILKPSEDVLKEFASEIEIITALHHR------NII 389
L+GKG V + + + +A+KI+K + L + E+ ++ ++ I+
Sbjct: 61 LIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119
Query: 390 SLFG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHN 448
L F F N+L LV++ LS +L + L G + T ++ A + AL +L
Sbjct: 120 HLKRHFMFR-NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKF--AQQMCTALLFLAT 175
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQ--LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY 506
E +IH D+K NILL + + DFG S+ + Y +PE
Sbjct: 176 P-ELSIIHCDLKPENILLCNPKRSAIKIVDFG-----SSCQLGQRIYQYIQSRFYRSPEV 229
Query: 507 FMHGKVSEKIDVYAFGIVLLELLSGK 532
+ ID+++ G +L+E+ +G+
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 9e-13
Identities = 41/206 (19%), Positives = 82/206 (39%), Gaps = 24/206 (11%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKE-FAS----EIEIITALHHRNIISLF 392
+G+G + VY+ + +A+K ++ + +E E+ ++ L HRNII L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
++ L L++++ E +L + +++ H +
Sbjct: 100 SVIHHNHRLHLIFEYA-----ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SR 151
Query: 453 PVIHKDVKSSNILLSDDFEPQ-----LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF 507
+H+D+K N+LLS + + DFGLA T + T Y PE
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII--TLWYRPPEIL 209
Query: 508 MHGKV-SEKIDVYAFGIVLLELLSGK 532
+ + S +D+++ + E+L
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 51/200 (25%), Positives = 94/200 (47%), Gaps = 17/200 (8%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKE-FAS----EIEIITALHHRNIISLFG 393
+G+G + VY+ G+ A+K ++ ++ E S EI I+ L H NI+ L+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
L+LV++ L + L++ L + + + + Y H ++
Sbjct: 68 VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCH---DRR 120
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV- 512
V+H+D+K N+L++ + E +++DFGLA T V T Y AP+ M K
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMGSKKY 178
Query: 513 SEKIDVYAFGIVLLELLSGK 532
S ID+++ G + E+++G
Sbjct: 179 STTIDIWSVGCIFAEMVNGT 198
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 47/207 (22%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVK-ILKPSEDVL--KEFASEIEIITALHHRNIISLF-- 392
+G G V + +A+K + +P ++ K E+ ++ ++H+NII L
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 393 ------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV-GVAEALDY 445
F+D + +V + + + NL + ER + + + +
Sbjct: 93 FTPQKSLEEFQD--VYIVMELM-----DANLCQVIQME---LDHERMSYLLYQMLCGIKH 142
Query: 446 LHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
LH++ +IH+D+K SNI++ D ++ DFGLA + +S + T T Y APE
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMM-TPYVVTRYYRAPE 196
Query: 506 YFMHGKVSEKIDVYAFGIVLLELLSGK 532
+ E +D+++ G ++ E++ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 31/211 (14%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGF 394
+G+G + V + +AVKI+ D + EI I L+H N++ +G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 395 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDGNAFGWTERYK----VAVGVAEALDYLHN 448
E N L ++ S G L + + + +A + +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMA-----GVVYLHG 123
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS----HLTCTDVAGTFGYLAP 504
+ H+D+K N+LL + ++SDFGLA+ ++ + C GT Y+AP
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAP 176
Query: 505 EYFMHGK-VSEKIDVYAFGIVLLELLSGKKP 534
E + +E +DV++ GIVL +L+G+ P
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKE-FAS----EIEIITALHHRNIISLF 392
VG+G + V + G+ +A+K S+D + EI+++ L H N+++L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDD--DKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGN-KKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
C + LV++F+ + + + + N + K + + + H
Sbjct: 91 EVCKKKKRWYLVFEFV-----DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---S 142
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
+IH+D+K NIL+S +L DFG A L+ +VA T Y APE +
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD-EVA-TRWYRAPELLVGDV 200
Query: 512 V-SEKIDVYAFGIVLLELLSGK 532
+ +DV+A G ++ E+ G+
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGE 222
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 38/222 (17%)
Query: 338 LVGKGGHSHVY---RGCLPDGKEL-AVKILKPSEDVLKEFA---SEIEIITALHHRNIIS 390
++G+G V+ + D ++L A+K+LK + +++ E +I+ ++H I+
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 391 LFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER----YKVAVGVAE---A 442
L + F+ + L L+ DFL G L L F TE Y +AE A
Sbjct: 91 LH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVM----F--TEEDVKFY-----LAELALA 138
Query: 443 LDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYL 502
LD+LH +I++D+K NILL ++ +L+DFGL S S + GT Y+
Sbjct: 139 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGL-SKESIDHEKKAYS-FCGTVEYM 193
Query: 503 APEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541
APE H + D ++FG+++ E+L+G P ++ K
Sbjct: 194 APEVVNRRGHTQS---ADWWSFGVLMFEMLTGTLPFQGKDRK 232
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 55/224 (24%), Positives = 103/224 (45%), Gaps = 38/224 (16%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKE-FAS----EIEIITALHHRNIISLF 392
+G+G V++ G+++A+K + + KE F EI+I+ L H N+++L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLI 82
Query: 393 GFCFED--------NNLLLVYDFLSR--GSLEENLHGNKKDGNAFGWTERYKVAVGVAEA 442
C ++ LV+DF L N+ F +E +V +
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK------FTLSEIKRVMQMLLNG 136
Query: 443 LDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA----SWLSTSSSHLTCTDVAGT 498
L Y+H + ++H+D+K++N+L++ D +L+DFGLA ++ + T V T
Sbjct: 137 LYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV--T 191
Query: 499 FGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGKKPI---NSE 538
Y PE + + ID++ G ++ E+ + + PI N+E
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTE 234
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 44/226 (19%)
Query: 338 LVGKGGHSHVY---RGCLPDGKEL-AVKILKPSEDVLKEFASEIE-------IITALHHR 386
++GKGG+ V+ + + ++ A+K+LK + ++ A + I+ + H
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK--KAMIVRNAKDTAHTKAERNILEEVKHP 81
Query: 387 NIISLFGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDGNAFGWTER----YKVAVGVAE 441
I+ L + F+ L L+ ++LS G L L F E Y +AE
Sbjct: 82 FIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGI----F--MEDTACFY-----LAE 129
Query: 442 ---ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGT 498
AL +LH ++ +I++D+K NI+L+ +L+DFGL S +T T GT
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGL-CKESIHDGTVTHT-FCGT 184
Query: 499 FGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541
Y+APE M H + +D ++ G ++ ++L+G P EN K
Sbjct: 185 IEYMAPEILMRSGHNRA---VDWWSLGALMYDMLTGAPPFTGENRK 227
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 338 LVGKGGHSHVYRGC--LPDGKELAVKILKPSEDVLKEFASEIEIITALHHR------NII 389
++GKG V + + +A+K+++ + ++ A EI I+ L + N+I
Sbjct: 104 VIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 390 SLFG-FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHN 448
+ F F N++ + ++ LS +L E + NK G F K A + + LD LH
Sbjct: 163 HMLENFTFR-NHICMTFELLSM-NLYELIKKNKFQG--FSLPLVRKFAHSILQCLDALH- 217
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQ--LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY 506
+ +IH D+K NILL + DFG + + T + F Y APE
Sbjct: 218 --KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY----TYIQSRF-YRAPEV 270
Query: 507 FMHGKVSEKIDVYAFGIVLLELLSGK 532
+ + ID+++ G +L ELL+G
Sbjct: 271 ILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 56/227 (24%), Positives = 97/227 (42%), Gaps = 58/227 (25%)
Query: 340 GKGGHSHVYRGC-LPDGKELAVKILK----PSEDVLKEFASEIEIITALHHRNIISLFGF 394
G G V G G ++AVKIL S DV+ + EI+ + H +II L+
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 395 CFEDNNLLLV---------YDFL-SRGSLEENLHGNKKDGNAFGWTERYKVAVG----VA 440
+++ +V +D++ G L+E K + +
Sbjct: 85 ISTPSDIFMVMEYVSGGELFDYICKNGRLDE------------------KESRRLFQQIL 126
Query: 441 EALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW------LSTSSSHLTCTD 494
+DY H V+H+D+K N+LL +++DFGL++ L TS C
Sbjct: 127 SGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-----C-- 176
Query: 495 VAGTFGYLAPEYFMHGKVSE--KIDVYAFGIVLLELLSGKKPINSEN 539
G+ Y APE G++ ++D+++ G++L LL G P + ++
Sbjct: 177 --GSPNYAAPEVIS-GRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVL--KEFAS---EIEIITALHHRNIISL 391
L+GKG V A+KIL+ E ++ E A E ++ H + +L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILR-KEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 392 FGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER----YKVAVGVAEALDYL 446
+ F+ + L V ++ + G L +L + F TE Y + AL+YL
Sbjct: 71 K-YAFQTHDRLCFVMEYANGGELFFHLSRERV----F--TEERARFY--GAEIVSALEYL 121
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF-G---YL 502
H + V+++D+K N++L D +++DFGL ++ TF G YL
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGL------CKEGISDGATMKTFCGTPEYL 172
Query: 503 APEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
APE +G+ +D + G+V+ E++ G+ P +++
Sbjct: 173 APEVLEDNDYGRA---VDWWGLGVVMYEMMCGRLPFYNQD 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 55/214 (25%), Positives = 94/214 (43%), Gaps = 37/214 (17%)
Query: 338 LVGKGGHSHVYRGC-LPDGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGF 394
+G+G + V + +AVKI+ D + EI I L+H N++ +G
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 395 CFEDNNLLLVYDFLSRGSLEENL--HGNKKDGNAFGWTERYK----VAVGVAEALDYLHN 448
E N L ++ S G L + + + +A + +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQLMA-----GVVYLHG 123
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS----HLTCTDVAGTFGYLAP 504
+ H+D+K N+LL + ++SDFGLA+ ++ + C GT Y+AP
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC----GTLPYVAP 176
Query: 505 EYFM----HGKVSEKIDVYAFGIVLLELLSGKKP 534
E H + +DV++ GIVL +L+G+ P
Sbjct: 177 ELLKRREFHAE---PVDVWSCGIVLTAMLAGELP 207
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 49/221 (22%), Positives = 100/221 (45%), Gaps = 40/221 (18%)
Query: 330 TSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVK-ILKPSEDVLKEFAS----EIEIITAL 383
++ VG G + V G+++A+K + +P + + FA E+ ++ +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI--FAKRAYRELLLLKHM 80
Query: 384 HHRNIISLF------GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDGNAFGWTERY 433
H N+I L + LV F+ + +L + E+
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSE-------EKI 128
Query: 434 KVAV-GVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492
+ V + + L Y+H++ V+H+D+K N+ +++D E ++ DFGLA + + +T
Sbjct: 129 QYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEMT- 181
Query: 493 TDVAGTFGYLAPEYFM-HGKVSEKIDVYAFGIVLLELLSGK 532
V T Y APE + ++ +D+++ G ++ E+L+GK
Sbjct: 182 GYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 74/372 (19%), Positives = 140/372 (37%), Gaps = 42/372 (11%)
Query: 191 DNSLALVPVQSDNSLVVRESPRSKQDGWPFLRRVLLPKHQDPEKTSAKKTSLIQWVLRLP 250
D + L + S +++ K P + ++ +K + W L
Sbjct: 194 DPYVKLKLIPDPKSESKQKTKTIKSSLNPEWNETFRFQLKESDKDRRLSVEIWDWDLTSR 253
Query: 251 SRYTSAV-VYPDHKQNHSADTSEDNRSNLDGESGAI-VSVEHDSACPPLSPYNELPKELE 308
+ + ++ Q D S +GE + V E L E K +
Sbjct: 254 NDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQ 313
Query: 309 GLQERYSSTCRLFSYQELLSATSNFLPE-----YLVGKGGHSHVYRGCLPDGKEL-AVKI 362
G + T S + ++GKG V EL AVKI
Sbjct: 314 GTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKI 373
Query: 363 LKPSEDVLKEFASEIE--------IITALHHRNIISLFGFCFE-DNNLLLVYDFLSRGSL 413
LK + V+++ ++E + + L CF+ + L V ++++ G L
Sbjct: 374 LK-KDVVIQD--DDVECTMVEKRVLALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDL 429
Query: 414 EENLHGNKKDGNAFGWTERYKV--AVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE 471
++ + F E + V A +A L +L + +I++D+K N++L +
Sbjct: 430 MYHIQQVGR----F--KEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGH 480
Query: 472 PQLSDFGLASWLSTSSSHLTCTDVAGTF-G---YLAPEYFMHGKVSEKIDVYAFGIVLLE 527
+++DFG+ ++ TF G Y+APE + + +D +AFG++L E
Sbjct: 481 IKIADFGM------CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 534
Query: 528 LLSGKKPINSEN 539
+L+G+ P E+
Sbjct: 535 MLAGQAPFEGED 546
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 59/244 (24%), Positives = 107/244 (43%), Gaps = 48/244 (19%)
Query: 338 LVGKGGHSHVY---RGCLPDGKEL-AVKILKPSEDVLKEFASEIE--------IITALHH 385
++G G + V+ + D +L A+K+LK + + + A E +
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK--KATIVQKAKTTEHTRTERQVLEHIRQS 118
Query: 386 RNIISLFGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER----YKVAVGVA 440
+++L + F+ L L+ D+++ G L +L ++ F TE Y V
Sbjct: 119 PFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRER----F--TEHEVQIY-----VG 166
Query: 441 E---ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAG 497
E AL++LH + +I++D+K NILL + L+DFGL+ + G
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCG 222
Query: 498 TFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552
T Y+AP+ H K +D ++ G+++ ELL+G P + K ++ +
Sbjct: 223 TIEYMAPDIVRGGDSGHDKA---VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR-- 277
Query: 553 ILKD 556
ILK
Sbjct: 278 ILKS 281
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 46/222 (20%), Positives = 85/222 (38%), Gaps = 30/222 (13%)
Query: 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVK-ILKPSEDVLKE--FAS---------EI 377
S + + + G + V G +G +A+K + D + EI
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 378 EIITALHHRNIISLF-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER 432
++ HH NI+ L + L LV + + +L D +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQH 135
Query: 433 YKVAV-GVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT 491
+ + + L LH V+H+D+ NILL+D+ + + DF LA + ++
Sbjct: 136 IQYFMYHILLGLHVLH-EAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANK-- 190
Query: 492 CTDVAGTFGYLAPEYFM-HGKVSEKIDVYAFGIVLLELLSGK 532
T Y APE M ++ +D+++ G V+ E+ + K
Sbjct: 191 -THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 330 TSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVK-ILKPSEDVLKEFASEIEIITALHHRN 387
++ ++G G VY+ G+ +A+K +L+ +E ++I+ L H N
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCN 108
Query: 388 IISLFGF------CFEDNNLLLVYDFLSRGSLEENLH----GNKKDGNAFGWTE----RY 433
I+ L F ++ L LV D++ E ++ + Y
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 434 KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL-SDDFEPQLSDFGLASWLSTSSSHLTC 492
++ +A Y+H+ + H+D+K N+LL D +L DFG A L +
Sbjct: 164 QLFRSLA----YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--- 213
Query: 493 TDVAGTFGYLAPEYFMHG--KVSEKIDVYAFGIVLLELLSGKKPI 535
+ Y APE + G + IDV++ G VL ELL G +PI
Sbjct: 214 VSYICSRYYRAPE-LIFGATDYTSSIDVWSAGCVLAELLLG-QPI 256
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 5e-11
Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 35/221 (15%)
Query: 330 TSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFAS----EIEIITALH 384
+ +G+G + V + +A+K + P E + EI+I+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQT--YCQRTLREIKILLRFR 83
Query: 385 HRNIISLF-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER------Y 433
H NII + + ++ +V D + E +L+ K + + Y
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHL---SNDHICYFLY 135
Query: 434 KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC- 492
++ G L Y+H S V+H+D+K SN+LL+ + ++ DFGLA H
Sbjct: 136 QILRG----LKYIH-SAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 493 TDVAGTFGYLAPEYFM-HGKVSEKIDVYAFGIVLLELLSGK 532
T+ T Y APE + ++ ID+++ G +L E+LS +
Sbjct: 189 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 35/210 (16%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVK-ILKPSEDVL--KEFASEIEIITALHHRNIISLF-- 392
VG G + V G +AVK + +P + ++ K E+ ++ + H N+I L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 393 ----GFCFEDNNLLLVYDFLSRGSLEENLH----GNKKDGNAFGWTERYKVAV-GVAEAL 443
E N++ LV + +L+ K + + + + L
Sbjct: 97 FTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLT------DDHVQFLIYQILRGL 145
Query: 444 DYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLA 503
Y+H S + +IH+D+K SN+ +++D E ++ DFGLA ++ + T T Y A
Sbjct: 146 KYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEM--TGYVATRWYRA 197
Query: 504 PEYFM-HGKVSEKIDVYAFGIVLLELLSGK 532
PE + ++ +D+++ G ++ ELL+G+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 50/226 (22%), Positives = 91/226 (40%), Gaps = 36/226 (15%)
Query: 330 TSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVK-ILKPSEDVLKEFASEIEIITALHHRN 387
F E + G+G V G G +A+K +++ +E ++ + LHH N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLHHPN 80
Query: 388 IISLFGF-------CFEDNNLLLVYDFLSRGSLEENLH----GNKKDGNAFGWTE----R 432
I+ L + D L +V +++ + LH + A
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 433 YKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL-SDDFEPQLSDFGLASWLSTSSSHLT 491
+++ + LH V H+D+K N+L+ D +L DFG A LS S +
Sbjct: 136 FQLIRSIG----CLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-- 188
Query: 492 CTD-VAGTFGYLAPEY-FMHGKVSEKIDVYAFGIVLLELLSGKKPI 535
+ + Y APE F + + +D+++ G + E++ G +PI
Sbjct: 189 -VAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 7e-11
Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 45/225 (20%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKEFASEIE--------IITALHHRNI 388
++GKG V + AVK+L+ + +LK+ E + ++ + H +
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQ-KKAILKK--KEEKHIMSERNVLLKNVKHPFL 101
Query: 389 ISLFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER----YKVAVGVAEAL 443
+ L F F+ + L V D+++ G L +L + F E Y A +A AL
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRERC----F--LEPRARFY--AAEIASAL 152
Query: 444 DYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF-G-- 500
YLH ++++D+K NILL L+DFGL ++ TF G
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGL------CKENIEHNSTTSTFCGTP 203
Query: 501 -YLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541
YLAPE + + +D + G VL E+L G P S N
Sbjct: 204 EYLAPEVLHKQPYDRT---VDWWCLGAVLYEMLYGLPPFYSRNTA 245
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 9e-11
Identities = 58/220 (26%), Positives = 106/220 (48%), Gaps = 39/220 (17%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKEFASEIE--------IITALHHRNI 388
++GKG V + + +L AVK+LK + +L++ ++E + A +H +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLK-KDVILQD--DDVECTMTEKRILSLARNHPFL 86
Query: 389 ISLFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKV-AVGVAEALDYL 446
LF CF+ + L V +F++ G L ++ +++ F R + A + AL +L
Sbjct: 87 TQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FD-EARARFYAAEIISALMFL 140
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF-G---YL 502
H ++ +I++D+K N+LL + +L+DFG+ + TF G Y+
Sbjct: 141 H---DKGIIYRDLKLDNVLLDHEGHCKLADFGM------CKEGICNGVTTATFCGTPDYI 191
Query: 503 APEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
APE +G +D +A G++L E+L G P +EN
Sbjct: 192 APEILQEMLYGPA---VDWWAMGVLLYEMLCGHAPFEAEN 228
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 48/214 (22%), Positives = 91/214 (42%), Gaps = 42/214 (19%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVK-ILKPSEDVLKEFASEIEIITALHHRNIISLFGFCF- 396
+G G V++ L + E+A+K +L+ +E ++I+ + H N++ L F +
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE----LQIMRIVKHPNVVDLKAFFYS 103
Query: 397 -----EDNNLLLVYDFLSRGSLEENLH----GNKKDGNAFGWTE----RYKVAVGVAEAL 443
++ L LV +++ E ++ K Y++ +A
Sbjct: 104 NGDKKDEVFLNLVLEYV-----PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA--- 155
Query: 444 DYLHNSCEQPVIHKDVKSSNILL-SDDFEPQLSDFGLASWLS--TSSSHLTCTDVAGTFG 500
Y+H+ + H+D+K N+LL +L DFG A L + C+
Sbjct: 156 -YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY----- 206
Query: 501 YLAPEYFMHG--KVSEKIDVYAFGIVLLELLSGK 532
Y APE + G + ID+++ G V+ EL+ G+
Sbjct: 207 YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVK-ILKPSEDVL--KEFASEIEIITALHHRNIISLF-- 392
VG G + V G ++A+K + +P + L K E+ ++ + H N+I L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 393 ------GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYL 446
F D LV F+ +L K ++ V + + L Y+
Sbjct: 93 FTPDETLDDFTD--FYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLV-YQMLKGLRYI 144
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY 506
H + +IH+D+K N+ +++D E ++ DFGLA + S +T V T Y APE
Sbjct: 145 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMT-GYVV-TRWYRAPEV 196
Query: 507 FM-HGKVSEKIDVYAFGIVLLELLSGK 532
+ + ++ +D+++ G ++ E+++GK
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 46/207 (22%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCF 396
+G+G +S V+ + + +++ VKILKP + K+ EI+I+ L NII+L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK--KKIKREIKILENLRGGPNIITLAD-IV 100
Query: 397 ED---NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE---ALDYLHNSC 450
+D LV++ + + + Y + + E ALDY H
Sbjct: 101 KDPVSRTPALVFEHV----NNTDFK------QLYQTLTDYDIRFYMYEILKALDYCH--- 147
Query: 451 EQPVIHKDVKSSNILL-SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH 509
++H+DVK N+++ + + +L D+GLA + + + + PE +
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVD 204
Query: 510 GKV-SEKIDVYAFGIVLLELLSGKKPI 535
++ +D+++ G +L ++ K+P
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 39/222 (17%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKEFASEIEII--------TALHHRNI 388
++GKG V+ + A+K LK + VL + ++E A H +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLMD--DDVECTMVEKRVLSLAWEHPFL 80
Query: 389 ISLFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER----YKVAVGVAEAL 443
+F F+ NL V ++L+ G L ++ K F Y A + L
Sbjct: 81 THMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHK----F--DLSRATFY--AAEIILGL 131
Query: 444 DYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF-G-- 500
+LH + ++++D+K NILL D +++DFG+ ++ TF G
Sbjct: 132 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGM------CKENMLGDAKTNTFCGTP 182
Query: 501 -YLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541
Y+APE + K + +D ++FG++L E+L G+ P + ++ +
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 224
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 61.0 bits (149), Expect = 3e-10
Identities = 45/211 (21%), Positives = 85/211 (40%), Gaps = 28/211 (13%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILK--PSEDVLKEFAS----EIEIITALH---HRNI 388
+G G + VY+ G +A+K ++ E+ ++ L H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 389 ISLF-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAE 441
+ L + + LV++ + +++L G +
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHV-----DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY 501
LD+LH +C ++H+D+K NIL++ +L+DFGLA S + T V T Y
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA---RIYSYQMALTPVVVTLWY 185
Query: 502 LAPEYFMHGKVSEKIDVYAFGIVLLELLSGK 532
APE + + +D+++ G + E+ K
Sbjct: 186 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 39/220 (17%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKEFASEIE--------IITALHHRNI 388
++GKG V EL AVKILK + V+++ ++E + +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILK-KDVVIQD--DDVECTMVEKRVLALPGKPPFL 83
Query: 389 ISLFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER----YKVAVGVAEAL 443
L CF+ + L V ++++ G L ++ + F E Y A +A L
Sbjct: 84 TQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR----F--KEPHAVFY--AAEIAIGL 134
Query: 444 DYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF-G-- 500
+L + +I++D+K N++L + +++DFG+ ++ TF G
Sbjct: 135 FFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGM------CKENIWDGVTTKTFCGTP 185
Query: 501 -YLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539
Y+APE + + +D +AFG++L E+L+G+ P E+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 54/218 (24%), Positives = 101/218 (46%), Gaps = 45/218 (20%)
Query: 338 LVGKGGHSHVYRGCLPDGKEL-AVKILKPSEDVLKEFASEIE--------IITALHHRNI 388
++G+G ++ V L + A+K++K E V + +I+ A +H +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVK-KELVNDD--EDIDWVQTEKHVFEQASNHPFL 72
Query: 389 ISLFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER----YKVAVGVAE-- 441
+ L CF+ ++ L V ++++ G L ++ +K E Y AE
Sbjct: 73 VGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRK----L--PEEHARFY-----SAEIS 120
Query: 442 -ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF- 499
AL+YLH E+ +I++D+K N+LL + +L+D+G+ L D TF
Sbjct: 121 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM------CKEGLRPGDTTSTFC 171
Query: 500 G---YLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKP 534
G Y+APE +D +A G+++ E+++G+ P
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 59/264 (22%), Positives = 116/264 (43%), Gaps = 38/264 (14%)
Query: 289 EHDSACPPLSPYNELPKELEGLQERYSSTCRLFSYQELLSAT-SNFLPEYL--VGKGGHS 345
HD P G++E + S + S +F + L +G+G ++
Sbjct: 9 HHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDF--DLLRVIGRGSYA 66
Query: 346 HVYRGCLPDGKEL-AVKILKPSEDVLKEFASEIE--------IITALHHRNIISLFGFCF 396
V L + A++++K E V + +I+ A +H ++ L CF
Sbjct: 67 KVLLVRLKKTDRIYAMRVVK-KELVNDD--EDIDWVQTEKHVFEQASNHPFLVGLH-SCF 122
Query: 397 E-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKV-AVGVAEALDYLHNSCEQPV 454
+ ++ L V ++++ G L ++ +K E + + ++ AL+YLH E+ +
Sbjct: 123 QTESRLFFVIEYVNGGDLMFHMQRQRK----LP-EEHARFYSAEISLALNYLH---ERGI 174
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF-G---YLAPEYFMHG 510
I++D+K N+LL + +L+D+G+ L D TF G Y+APE
Sbjct: 175 IYRDLKLDNVLLDSEGHIKLTDYGM------CKEGLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 511 KVSEKIDVYAFGIVLLELLSGKKP 534
+D +A G+++ E+++G+ P
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 54/231 (23%), Positives = 100/231 (43%), Gaps = 48/231 (20%)
Query: 330 TSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFAS----EIEIITALH 384
+S+F + L+G+G + V P G+ +A+K ++P + L FA EI+I+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL--FALRTLREIKILKHFK 67
Query: 385 HRNIISLF-----GFCFEDNNLLLVYDF--------LSRGSLEENLHGNKKDGNAFGWTE 431
H NII++F N + ++ + +S L + +
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD---------------D 112
Query: 432 RYKVAV-GVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490
+ + A+ LH VIH+D+K SN+L++ + + ++ DFGLA + S++
Sbjct: 113 HIQYFIYQTLRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169
Query: 491 TCTDVAGTFG--------YLAPEYFM-HGKVSEKIDVYAFGIVLLELLSGK 532
+ + Y APE + K S +DV++ G +L EL +
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 40/167 (23%), Positives = 73/167 (43%), Gaps = 21/167 (12%)
Query: 376 EIEIITALH---HRNIISLF-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAF 427
E+ ++ L H N++ LF + L LV++ + +++L
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-----DQDLTTYLDKVPEP 115
Query: 428 GWTERY--KVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485
G + + LD+LH+ V+H+D+K NIL++ + +L+DFGLA
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA---RI 169
Query: 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGK 532
S + T V T Y APE + + +D+++ G + E+ K
Sbjct: 170 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 2e-09
Identities = 71/534 (13%), Positives = 144/534 (26%), Gaps = 154/534 (28%)
Query: 220 FLRRVLLPKHQD---PEKTSAKKTSLIQWVLRL-PSRYTSAVVYPDHKQNH----SADTS 271
+ +L + D K + T + W L V + N+ S +
Sbjct: 41 MPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKT 100
Query: 272 EDNRSNLDGESGAIVSVEHDSAC---PPLSPYN-ELPKELEGLQERYSSTCRLFSYQELL 327
E + ++ + D + YN + L++ LL
Sbjct: 101 EQRQPSMMTRM---YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQA------------LL 145
Query: 328 SATSNFLPEYLV--GKGGHSHVYRGCLPDGKE-LAVKILKPSEDVLKEFASEIEIITALH 384
+ ++ G G GK +A+ + S V + +I +
Sbjct: 146 ELRPA---KNVLIDGVLG-------S---GKTWVALDVCL-SYKVQCKMDFKIFWLN--- 188
Query: 385 HRNIISLFGFCFEDNNLL---------LVYDFLSRG----SLEENLHGNKKDGNAFGWTE 431
C +L + ++ SR +++ +H + + ++
Sbjct: 189 -------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK 241
Query: 432 RYKVA------VGVAEALDYLHNSCEQPVIHKDVKSSNIL------------LSDDFEPQ 473
Y+ V A+A + + SC+ + + + ++ L S P
Sbjct: 242 PYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD 301
Query: 474 LSDFGLASWLSTSSSHL---TCTD---VAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLE 527
L +L L T + + ++ ++
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII-- 359
Query: 528 LLSGKKPINSENPKGQESL-------------------VMWAKPILKDGK--VSQLLDPS 566
+ +N P + ++W I D V++L S
Sbjct: 360 ----ESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYS 415
Query: 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEAANWAK--EQVSASEEL 624
L +E+ +T+SI P I L LK ++ + E A + + +
Sbjct: 416 L--------VEKQPKESTISI-------PSIYLELK-VKLENEYALHRSIVDHYNIPKTF 459
Query: 625 DSIDGEASPTN-------IQSHLNLALLDLDDDSVSAGSTQQIISVEDYLQGRW 671
DS D P I HL +L R+
Sbjct: 460 DS-DDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFR----------MVFLDFRF 502
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 2e-06
Identities = 56/385 (14%), Positives = 115/385 (29%), Gaps = 77/385 (20%)
Query: 13 FDGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLK 72
F+ + LLT +V D + A + L T D + S+ + + +
Sbjct: 262 FNLSCKILLTTRFKQVT---DFLSAATTTHISLDHHSMTL----TPDEVKSLLLKYLDCR 314
Query: 73 QVDLKLKVCRGTS-VKKII---VKEAKSYGEAKVIVGISKTHRTIRSSVSVAK-YCARKL 127
DL +V II +++ + + V K I SS++V + RK+
Sbjct: 315 PQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
Query: 128 SKNFGVFAVENGKIVFQREGTHNLQDDNVKVT--------VDDADDVPGECTNCDSRTQS 179
VF + + D N +
Sbjct: 375 FDRLSVF------------------PPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSL 416
Query: 180 CEELARDETVVDNSLALVPVQSDNSLVVRESPRSKQDGWPFLRRVLLPKHQDPEKTSAKK 239
E+ ++ T+ S+ L + K + L R ++ + P+ +
Sbjct: 417 VEKQPKESTISIPSIYL-------------ELKVKLENEYALHRSIVDHYNIPKTFDSDD 463
Query: 240 TSLIQWVLRLPSRYT-SAVVYPDH--KQNHSADTSEDNRSNLDGE--SGAIVSVEHD-SA 293
+Y S + + H H + LD I HD +A
Sbjct: 464 LIPPYL-----DQYFYSHIGH--HLKNIEHPERMTLFRMVFLDFRFLEQKI---RHDSTA 513
Query: 294 CPPLSPYNELPKELEGLQERYSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLP 353
++L+ + Y+ L++A +FLP+ ++
Sbjct: 514 WNASGSILNTLQQLKFYKPYICDNDP--KYERLVNAILDFLPKI------EENLICS--K 563
Query: 354 DGKELAVKILKPSEDVLKEFASEIE 378
L + ++ E + +E +++
Sbjct: 564 YTDLLRIALMAEDEAIFEEAHKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 1e-04
Identities = 50/354 (14%), Positives = 93/354 (26%), Gaps = 108/354 (30%)
Query: 342 GGHSHVYRGCLPDGKELAVKIL--KPSEDVLKEFAS--EIEIITALHHRNIISLFGF-CF 396
G H + Y+ L ++ V K +D+ K S EI+ I +L F
Sbjct: 12 GEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTL 71
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI- 455
+V F+ L N + + + + QP +
Sbjct: 72 LSKQEEMVQKFVE-EVLRIN----------YKF---------LMSPI---KTEQRQPSMM 108
Query: 456 -------HKDVKSSNILLSDDFEPQLSDF-GLASWLSTSSSHLTCTDVAGTFGYLAPEYF 507
+ + N + + +L + L L +
Sbjct: 109 TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPA----------KNV----L 154
Query: 508 MHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567
+ G G SGK + A + KV +D
Sbjct: 155 IDGV---------LG-------SGK-----------TWV---ALDVCLSYKVQCKMD--- 181
Query: 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLL-QGDEEAANWAKEQVSASEELDS 626
+I L++ + + ++ KLL Q D + + + + S
Sbjct: 182 ------FKI------FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHS 229
Query: 627 IDGEASPTNIQSHLNLALLDLDD-------DSVSAGS----TQQIISVEDYLQG 669
I E LL L + ++ + T + V D+L
Sbjct: 230 IQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSA 283
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 50/245 (20%), Positives = 85/245 (34%), Gaps = 53/245 (21%)
Query: 330 TSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFAS-EIEIITALHHRN 387
+ + +G G V + GK A+K K +D + + E++I+ L H N
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK--KVLQD--PRYKNRELDIMKVLDHVN 61
Query: 388 IISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER--------------- 432
II L + + + + N + +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 433 ---YKVAVGVAE-------------------ALDYLHNSCEQPVIHKDVKSSNILL-SDD 469
+KV A+ ++H+ + H+D+K N+L+ S D
Sbjct: 122 DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKD 178
Query: 470 FEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG--KVSEKIDVYAFGIVLLE 527
+L DFG A L S + Y APE M G + + ID+++ G V E
Sbjct: 179 NTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPE-LMLGATEYTPSIDLWSIGCVFGE 234
Query: 528 LLSGK 532
L+ GK
Sbjct: 235 LILGK 239
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 4e-09
Identities = 29/100 (29%), Positives = 53/100 (53%), Gaps = 4/100 (4%)
Query: 436 AVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDV 495
+ VA+ +++L + IH+D+ + NILLS+ ++ DFGLA + ++ D
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 496 AGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKP 534
++APE + + DV++FG++L E+ S G P
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 22/98 (22%), Positives = 44/98 (44%), Gaps = 10/98 (10%)
Query: 340 GKGGHSHVYRGCL------PDGKELAVKILKP--SEDVLKEFASEIEIITAL-HHRNIIS 390
G+G V + +AVK+LK + + SE++I+ + HH N+++
Sbjct: 31 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90
Query: 391 LFGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKDGNAF 427
L G C + L+++ +F G+L L + + +
Sbjct: 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 45/175 (25%), Positives = 83/175 (47%), Gaps = 28/175 (16%)
Query: 376 EIEIITALHHRNIISLF--------------GFCFEDNNLLLVYDFLSRGSLEENLHGNK 421
EI+II L H NI+ +F G E N++ +V +++ E +L
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVL 112
Query: 422 KDGNAFGWTERYKVAV-GVAEALDYLHNSCEQPVIHKDVKSSNILL-SDDFEPQLSDFGL 479
+ G E ++ + + L Y+H S V+H+D+K +N+ + ++D ++ DFGL
Sbjct: 113 EQGPLL--EEHARLFMYQLLRGLKYIH-SAN--VLHRDLKPANLFINTEDLVLKIGDFGL 167
Query: 480 ASWLSTSSSHLTC-TDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGK 532
A + SH ++ T Y +P + ++ ID++A G + E+L+GK
Sbjct: 168 ARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 45/268 (16%), Positives = 90/268 (33%), Gaps = 76/268 (28%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFASEIEIITALHH-------RNIIS 390
+G G S V+ + K +A+K++K +E + EI ++ ++ + R ++
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104
Query: 391 LFGFCFE-----DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEAL 443
F+ ++ +V++ L +L N G K+ V + L
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVLG-----HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGL 159
Query: 444 DYLHNSCEQPVIHKDVKSSNILL------------------------------------- 466
DYLH C +IH D+K NILL
Sbjct: 160 DYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 467 ------------SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSE 514
++ + +++D G A W+ + T Y + E + +
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNT 272
Query: 515 KIDVYAFGIVLLELLSGKKPINSENPKG 542
D+++ + EL +G + +
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEE 300
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 51/249 (20%), Positives = 100/249 (40%), Gaps = 54/249 (21%)
Query: 330 TSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVK-ILKPSEDVLKEFAS----EIEIITAL 383
N++ ++L+G+G + +VY K +A+K + + ED++ EI I+ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI--DCKRILREITILNRL 82
Query: 384 HHRNIISLF-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER------ 432
II L+ + + L +V + + +L K TE
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFL--TEEHIKTIL 135
Query: 433 YKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492
Y + +G +++H +IH+D+K +N LL+ D ++ DFGLA +++
Sbjct: 136 YNLLLG----ENFIH-ESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 493 TDVAGTFG--------------------YLAPEYFM-HGKVSEKIDVYAFGIVLLELLSG 531
D+ Y APE + ++ ID+++ G + ELL+
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248
Query: 532 KKPINSENP 540
+ ++
Sbjct: 249 LQSHINDPT 257
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 50/257 (19%), Positives = 100/257 (38%), Gaps = 59/257 (22%)
Query: 330 TSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVK-ILKPSEDVLKEFAS----EIEIITAL 383
+ +L+G G + HV + + +A+K IL+ ED++ EI I+ L
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI--DCKRILREIAILNRL 109
Query: 384 HHRNIISLF-----GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER------ 432
+H +++ + + + L +V + + + + TE
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYL--TELHIKTLL 162
Query: 433 YKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492
Y + VG + Y+H S ++H+D+K +N L++ D ++ DFGLA + + +
Sbjct: 163 YNLLVG----VKYVH-SAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 493 TDVAGTFG-------------------------YLAPEYFMHGKV-SEKIDVYAFGIVLL 526
++ Y APE + + +E IDV++ G +
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275
Query: 527 ELLSGKKPINSENPKGQ 543
ELL+ K + +
Sbjct: 276 ELLNMIKENVAYHADRG 292
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 48/223 (21%), Positives = 86/223 (38%), Gaps = 36/223 (16%)
Query: 338 LVGKGGHSHVYRGC--LPDGKELAVKILKPSEDVLKEFASEIEIITAL-----HHRNIIS 390
+G G V C + + K AVK+++ + + E +I+ + ++ NI+
Sbjct: 42 KMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 391 LFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
G F +++ L+++ L SL E + N +G F + + + +AL+YL
Sbjct: 101 YHG-KFMYYDHMCLIFEPLGP-SLYEIITRNNYNG--FHIEDIKLYCIEILKALNYLR-- 154
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVA--------GTFG- 500
+ + H D+K NILL D + + TF
Sbjct: 155 -KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS 213
Query: 501 -----------YLAPEYFMHGKVSEKIDVYAFGIVLLELLSGK 532
Y APE ++ D+++FG VL EL +G
Sbjct: 214 DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 46/223 (20%), Positives = 87/223 (39%), Gaps = 40/223 (17%)
Query: 338 LVGKGGHSHVYRGCL---PDGKELAVKILKPSEDVLKEFASEIEIITALHHR------NI 388
+G+G V C+ G+ +AVKI+K + + SEI+++ L+
Sbjct: 21 TLGEGAFGKVVE-CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 389 ISLFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH 447
+ + FE ++ +V++ L S + + N F K+A + +++++LH
Sbjct: 80 VQMLE-WFEHHGHICIVFELLGL-STYDFIKENGFLP--FRLDHIRKMAYQICKSVNFLH 135
Query: 448 NSCEQPVIHKDVKSSNILLSD-DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFG------ 500
+ H D+K NIL D+ + + + + D FG
Sbjct: 136 ---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD----FGSATYDD 188
Query: 501 -----------YLAPEYFMHGKVSEKIDVYAFGIVLLELLSGK 532
Y APE + S+ DV++ G +L+E G
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 44/224 (19%), Positives = 80/224 (35%), Gaps = 42/224 (18%)
Query: 338 LVGKGGHSHVYRGC--LPDGKEL-AVKILKPSEDVLKEFASEIEIITALHHR------NI 388
+G+G V C GK A+KI++ + EI ++ + +
Sbjct: 26 NLGEGTFGKVVE-CLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 389 ISLFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH 447
+ + F ++ + ++ L + + E L N + +A + AL +LH
Sbjct: 85 VLMSD-WFNFHGHMCIAFELLGK-NTFEFLKENNFQP--YPLPHVRHMAYQLCHALRFLH 140
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQ-------------------LSDFGLASWLSTSSS 488
E + H D+K NIL + ++DFG S +
Sbjct: 141 ---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-----SATFD 192
Query: 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGK 532
H T + T Y PE + ++ DV++ G +L E G
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 2e-06
Identities = 29/196 (14%), Positives = 49/196 (25%), Gaps = 46/196 (23%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVL---------KEFASEIEIITALH----- 384
+G+G V++ D +A+KI+ L +E EI I L
Sbjct: 28 IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 385 ----HRNIISLFGFCF----EDNNLLLVYDFLSRGSLEENLHGNKKDGNAF--------- 427
I L LL +D + N + +
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 428 ------------GWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLS 475
+ + +L S H+D+ N+LL +L
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLH 204
Query: 476 DFGLASWLSTSSSHLT 491
+ S L
Sbjct: 205 YTLNGKSSTIPSCGLQ 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 60/248 (24%), Positives = 99/248 (39%), Gaps = 72/248 (29%)
Query: 330 TSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVK-ILKPSEDVLKEFAS----EIEIITAL 383
+ +GKG + V++ G+ +AVK I ++ A EI I+T L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST--DAQRTFREIMILTEL 65
Query: 384 H-HRNIISLFGFCFEDNN--LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVA 440
H NI++L DN+ + LV+D++ E +LH AV A
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLH-----------------AVIRA 103
Query: 441 EALD----------------YLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484
L+ YLH S ++H+D+K SNILL+ + +++DFGL+
Sbjct: 104 NILEPVHKQYVVYQLIKVIKYLH-SGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160
Query: 485 TSSSHLTCTDVAGTFG-------------------YLAPEYFM-HGKVSEKIDVYAFGIV 524
++ Y APE + K ++ ID+++ G +
Sbjct: 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220
Query: 525 LLELLSGK 532
L E+L GK
Sbjct: 221 LGEILCGK 228
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 Length = 175 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 25/154 (16%), Positives = 49/154 (31%), Gaps = 30/154 (19%)
Query: 1 GGQGKVVVVGV---------KFDGESRELLTWALVKVAQPGD---RIIALHVLDTITEST 48
G + V+V V + W L K+ + +I+ LHV +
Sbjct: 2 GSEPTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGF 61
Query: 49 GSLLS--------------LVKTFDSMLSVYEGFCNLKQVDLKLKVCRGTSVKKIIVKEA 94
+ S +L + C+ V + + G K +I +E
Sbjct: 62 DDVDSIYASPEDFRDMRQSNKAKGLHLLEFFVNKCHEIGVGCEAWIKTG-DPKDVICQEV 120
Query: 95 KSYGEAKVIVGISKTHRTIRSSV--SVAKYCARK 126
K ++VG S+ + +V+ +C +
Sbjct: 121 KRVRPDFLVVG-SRGLGRFQKVFVGTVSAFCVKH 153
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 31/156 (19%), Positives = 55/156 (35%), Gaps = 29/156 (18%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITALHH-RNIISLFGFCF 396
+G G + G L + +A+K+ + E L I ++ F
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-PQLHLEYRFYKQLGSGDGIPQVYYFGP 75
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER---YKVAVGVA----EALDYLHNS 449
+V + L SLE+ F +R K + +A ++Y+H+
Sbjct: 76 CGKYNAMVLELLGP-SLED----------LFDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQ-----LSDFGLA 480
+I++DVK N L+ + DF LA
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 43/210 (20%), Positives = 83/210 (39%), Gaps = 24/210 (11%)
Query: 339 VGKGGHSHVYRGC-LPDGKELAVKILKPSEDVLKEFASEIEIITALHH-RNIISLFGFCF 396
+G+G ++ G L + +++A+K D + E L I +++ F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGCTGIPNVYYFGQ 76
Query: 397 EDNNLLLVYDFLSRGSLEE--NLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
E + +LV D L SLE+ +L G K F A + + +H +
Sbjct: 77 EGLHNVLVIDLLGP-SLEDLLDLCGRK-----FSVKTVAMAAKQMLARVQSIHEKS---L 127
Query: 455 IHKDVKSSNILLSDDFEPQ-----LSDFGLASWLSTSSSHL-----TCTDVAGTFGYLAP 504
+++D+K N L+ + DFG+ + + +++GT Y++
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 187
Query: 505 EYFMHGKVSEKIDVYAFGIVLLELLSGKKP 534
+ + S + D+ A G V + L G P
Sbjct: 188 NTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 678 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 3s3t_A | 146 | Nucleotide-binding protein, universal stress PROT | 99.69 | |
| 1mjh_A | 162 | Protein (ATP-binding domain of protein MJ0577); hy | 99.68 | |
| 3idf_A | 138 | USP-like protein; universal, stress, PSI, MCSG, st | 99.66 | |
| 3hgm_A | 147 | Universal stress protein TEAD; rossman fold, signa | 99.66 | |
| 1tq8_A | 163 | Hypothetical protein RV1636; MTCY01B2.28, structur | 99.65 | |
| 3fg9_A | 156 | Protein of universal stress protein USPA family; A | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 2dum_A | 170 | Hypothetical protein PH0823; conserved hypothetica | 99.63 | |
| 3dlo_A | 155 | Universal stress protein; unknown function, struct | 99.62 | |
| 2gm3_A | 175 | Unknown protein; AT3G01520, putative ethylene-resp | 99.62 | |
| 3fdx_A | 143 | Putative filament protein / universal stress PROT; | 99.62 | |
| 3tnj_A | 150 | Universal stress protein (USP); structural genomic | 99.6 | |
| 2z08_A | 137 | Universal stress protein family; uncharacterized c | 99.59 | |
| 1jmv_A | 141 | USPA, universal stress protein A; chaperone; 1.85A | 99.52 | |
| 1q77_A | 138 | Hypothetical protein AQ_178; structural genomics, | 99.51 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.41 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.4 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.36 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.36 | |
| 3cis_A | 309 | Uncharacterized protein; alpha/beta hydrolase, ATP | 99.34 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.33 | |
| 3mt0_A | 290 | Uncharacterized protein PA1789; structural genomic | 99.32 | |
| 3loq_A | 294 | Universal stress protein; structural genomics, PSI | 99.32 | |
| 3olq_A | 319 | Universal stress protein E; structural genomics, P | 99.26 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3ab8_A | 268 | Putative uncharacterized protein TTHA0350; tandem- | 99.19 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.02 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.86 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.66 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.45 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.34 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.31 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.31 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.13 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.08 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.97 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.65 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.52 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.49 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.48 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.47 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.39 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.17 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.13 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.97 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.88 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.77 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.62 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.31 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.28 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.7 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.63 | |
| 1wy5_A | 317 | TILS, hypothetical UPF0072 protein AQ_1887; N-type | 90.42 | |
| 3a2k_A | 464 | TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, | 90.32 | |
| 1k92_A | 455 | Argininosuccinate synthase, argininosuccinate SY; | 88.15 | |
| 1ni5_A | 433 | Putative cell cycle protein MESJ; structural genom | 86.22 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.08 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.7 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-53 Score=448.82 Aligned_cols=258 Identities=24% Similarity=0.416 Sum_probs=212.5
Q ss_pred cCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
++|...+.||+|+||+||+|.+. +|+.||||+++.. ....++|.+|+++|++|+|||||+++|+|.+++.++|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46777889999999999999853 4788999999764 4667889999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEE
Q 041755 404 VYDFLSRGSLEENLHGNK---------KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQL 474 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~---------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL 474 (678)
|||||++|+|.++|+... .....++|.+++.|+.||+.||.|||+ ++||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence 999999999999997542 234579999999999999999999999 99999999999999999999999
Q ss_pred eecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccc
Q 041755 475 SDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPI 553 (678)
Q Consensus 475 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 553 (678)
+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||...+.......
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~------- 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC------- 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------
Confidence 99999997765544444445679999999999999999999999999999999999 8999987554321111
Q ss_pred cccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 554 LKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 554 ~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
+..+.... .+......+.+++..||+.||.+||||.+|++.|+..
T Consensus 243 i~~~~~~~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 243 ITQGRVLQ---------RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCCC---------CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111110 1112234567788999999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=448.21 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=210.1
Q ss_pred CCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
+...+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+++.++||
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV 107 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI 107 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence 445678999999999999862 5688999999753 24467899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCc
Q 041755 405 YDFLSRGSLEENLHGNKK------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP 472 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 472 (678)
||||++|+|.++|..... ....++|.+++.|+.|||.||.|||+ ++||||||||+||||++++++
T Consensus 108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCCE
Confidence 999999999999975422 12468999999999999999999999 999999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcc
Q 041755 473 QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAK 551 (678)
Q Consensus 473 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 551 (678)
||+|||+|+.+.........+...||+.|||||++.++.|+.++|||||||+||||+| |+.||.+.+......
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~------ 258 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE------ 258 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH------
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH------
Confidence 9999999998765544444455789999999999999999999999999999999999 899998765432111
Q ss_pred cccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 552 PILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 552 ~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.+..+.... .+.+....+..++..||+.+|.+||+|.+|++.|+.
T Consensus 259 -~i~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 259 -MIRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp -HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -HHHcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 111121111 112233457778899999999999999999999974
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-53 Score=449.34 Aligned_cols=259 Identities=24% Similarity=0.400 Sum_probs=204.7
Q ss_pred cCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
++|...+.||+|+||+||+|.+. +++.||||+++.. ....++|.+|+++|++|+|||||+++|+|.+.+.++|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35667788999999999999853 4789999999764 4667889999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCc
Q 041755 404 VYDFLSRGSLEENLHGNKK-----------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP 472 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~-----------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 472 (678)
|||||++|+|.++|+.... ...+++|.+++.|+.||+.||.|||+ ++||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence 9999999999999976432 13469999999999999999999999 999999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcc
Q 041755 473 QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAK 551 (678)
Q Consensus 473 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 551 (678)
||+|||+|+.+.........+...||+.|||||++.+..++.++|||||||+||||+| |+.||...........+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i---- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI---- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH----
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence 9999999998765544444455789999999999999999999999999999999999 89999865433211111
Q ss_pred cccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 552 PILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 552 ~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
..+.. +.. +......+..++..||+.||.+||||.+|++.|+...
T Consensus 274 ---~~g~~-----~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 274 ---TQGRE-----LER----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp ---HHTCC-----CCC----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---HcCCC-----CCC----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 11110 111 1122345677889999999999999999999997543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=439.92 Aligned_cols=256 Identities=28% Similarity=0.467 Sum_probs=201.3
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|+||+||+|.+.+ .||||+++. +....+.|.+|+.++++++|||||+++|+|.+ +.++|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 466778899999999999998743 599999874 34667889999999999999999999999865 568999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
|++|+|.++|+.. ...++|.++..|+.|||.||.|||+ ++||||||||+||||++++++||+|||+|+......
T Consensus 113 ~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 113 CEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred CCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999753 2569999999999999999999999 999999999999999999999999999999876544
Q ss_pred CCceecccccCCCCCCcchhcc---CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMH---GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
.....+..+||+.|||||++.+ +.|+.++|||||||+||||+||+.||...+....... .+..+ ...
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~------~~~~~----~~~ 256 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF------MVGRG----YAS 256 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH------HHHTT----CCC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHH------HHhcC----CCC
Confidence 4444455789999999999964 4689999999999999999999999976543221111 11111 111
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
|.+.. ...+....+..++..||+.+|.+||||.+|++.|+.
T Consensus 257 p~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 257 PDLSK-LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp CCSTT-SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred CCccc-ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 21111 112233456778899999999999999999998863
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=435.86 Aligned_cols=249 Identities=26% Similarity=0.387 Sum_probs=202.1
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|...+.||+|+||+||+|... +|+.||||+++.. ....+.|.+|+.++++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57889999999999999999865 7999999999643 4557789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
||++|+|.++|.... +..+++.+.+.|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999997542 3568999999999999999999999 99999999999999999999999999999876432
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
. ...+..+||+.|||||++.+..|+.++|||||||+||||+||+.||...+....... +. .+.+. .
T Consensus 179 ~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~------i~-~~~~~-----~ 244 (350)
T 4b9d_A 179 V--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK------II-SGSFP-----P 244 (350)
T ss_dssp H--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HH-HTCCC-----C
T ss_pred c--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH------HH-cCCCC-----C
Confidence 1 122346899999999999999999999999999999999999999987654321111 11 11111 1
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+...+ ...+..++..||+.||.+|||+.++++
T Consensus 245 ~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 VSLHY----SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122 234667789999999999999999985
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=429.89 Aligned_cols=271 Identities=24% Similarity=0.289 Sum_probs=203.4
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----eEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDN----NLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~~~lV~E 406 (678)
.+|...+.||+|+||+||+|.+ +|+.||||+++........+..|+.++.+++|||||+++|+|.+++ .+|||||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 3566778999999999999988 6899999999765543333445666677899999999999998754 5899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC-----EQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~-----~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
||++|+|.++|+.. .++|..+.+++.|++.||.|||+.+ ..+||||||||+||||+.++++||+|||+|+
T Consensus 82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999753 5899999999999999999999731 2499999999999999999999999999998
Q ss_pred ccCCCCCCc--eecccccCCCCCCcchhccC------CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchh----h
Q 041755 482 WLSTSSSHL--TCTDVAGTFGYLAPEYFMHG------KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVM----W 549 (678)
Q Consensus 482 ~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~----~ 549 (678)
......... .....+||+.|+|||++.+. .++.++|||||||+||||+||+.||............. +
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 876543322 22346899999999999754 46789999999999999999998876543221110000 0
Q ss_pred cccccccCccccccCCCCCCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 550 AKPILKDGKVSQLLDPSLDTDY-DNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 550 ~~~~~~~~~~~~l~dp~l~~~~-~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
....+........++|.+.... ..+....+.+++..||+.||.+||||.+|++.|+..
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 0000000011122233332221 235667788999999999999999999999998643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=431.65 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=205.6
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
..|...+.||+|+||+||+|... +|+.||||+++... ...+.+.+|+++|++++|||||+++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45888889999999999999875 79999999996432 33456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++|+|.+++.. ..+++.++..++.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999999864 358999999999999999999999 9999999999999999999999999999998755433
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
. .+..+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+.......+. .+ ..+.+.
T Consensus 226 ~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-------~~-----~~~~~~ 291 (346)
T 4fih_A 226 R--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------DN-----LPPRLK 291 (346)
T ss_dssp C--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------HS-----SCCCCS
T ss_pred c--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-------cC-----CCCCCC
Confidence 2 234789999999999999999999999999999999999999998765432211111 00 111111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
. .......+..++..||+.||.+|||+.|+++
T Consensus 292 ~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 N--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp C--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c--cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 1112244667789999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=430.07 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=208.1
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||+||+|... +|+.||||++.... ...+.+.+|+++|++|+|||||++++++.+.+.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46888999999999999999865 79999999996432 33567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++.+...++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999653 469999999999999999999999 9999999999999999999999999999998766
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
..........+||+.|||||++.+..|+.++|||||||+||||+||+.||...+.......+. .+.+
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-------~~~~------ 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII-------KLEY------ 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTCC------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------cCCC------
Confidence 554444556899999999999999999999999999999999999999998755332211111 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVL 601 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl 601 (678)
.+...++ ..+..++..||+.||.+|||+.|++
T Consensus 252 ~~p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFPEKFF----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCCTTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCcccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 1112222 3456678999999999999998864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=430.03 Aligned_cols=251 Identities=23% Similarity=0.259 Sum_probs=202.8
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
+.|...+.||+|+||.||+|... +|+.||||+++... .+.+|+.+++.|+|||||++++++.+++.+|||||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence 45777788999999999999865 79999999997543 12479999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC-CcEEeecccccccCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF-EPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kL~DFGla~~~~~~~~ 488 (678)
+|+|.++|... ..+++.++..++.||+.||.|||+ ++||||||||+||||+.+| .+||+|||+|+.+.....
T Consensus 134 gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 134 GGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999753 469999999999999999999999 9999999999999999987 699999999998755322
Q ss_pred C---ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 489 H---LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 489 ~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
. .....++||+.|||||++.+..|+.++|||||||+||||+||+.||...+.......+....+ .+.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~-----~~~----- 276 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPP-----PIR----- 276 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCC-----GGG-----
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCC-----Cch-----
Confidence 1 223346899999999999999999999999999999999999999987654332211111000 000
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.+... ....+..++..||+.||.+|||+.|+++.|..
T Consensus 277 ~~~~~----~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 277 EIPPS----CAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp GSCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcCcc----CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 11112 23446667799999999999999999988754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=434.98 Aligned_cols=260 Identities=22% Similarity=0.354 Sum_probs=212.7
Q ss_pred hcCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeC-C
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS--EDVLKEFASEIEIITALHH-RNIISLFGFCFED-N 399 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~-~ 399 (678)
.++|...+.||+|+||+||+|... .++.||||+++.. ....+.|.+|+++|.++.| ||||+++|+|.+. +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 467888999999999999999753 2468999999754 3556789999999999965 8999999999764 5
Q ss_pred eEEEEEEcCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKK------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS 467 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~ 467 (678)
.+++|||||++|+|.++|+.... ....++|.++..++.|||.||.|||+ ++||||||||+||||+
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~ 219 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLS 219 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeC
Confidence 68999999999999999975432 13568999999999999999999999 9999999999999999
Q ss_pred CCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccc
Q 041755 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESL 546 (678)
Q Consensus 468 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 546 (678)
+++.+||+|||+|+.+.........+...||+.|||||++.++.|+.++|||||||+||||+| |+.||.+...... +
T Consensus 220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~--~ 297 (353)
T 4ase_A 220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F 297 (353)
T ss_dssp GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--H
T ss_pred CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH--H
Confidence 999999999999998776665555566889999999999999999999999999999999998 9999976543221 1
Q ss_pred hhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 547 VMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 547 ~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
...+..+.. +.... .....+..++..||+.||.+|||+.+|++.|+..
T Consensus 298 ----~~~i~~g~~-----~~~p~----~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 298 ----CRRLKEGTR-----MRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp ----HHHHHHTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHHcCCC-----CCCCc----cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 111112211 11111 1234466777999999999999999999998643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=419.69 Aligned_cols=243 Identities=24% Similarity=0.371 Sum_probs=194.9
Q ss_pred CCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCeEEEEE
Q 041755 334 LPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFE----DNNLLLVY 405 (678)
Q Consensus 334 ~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~lV~ 405 (678)
.....||+|+||+||+|... +|+.||||++.. .....+.|.+|++++++|+|||||+++++|.. .+.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 44567999999999999865 689999999864 34566789999999999999999999999865 34689999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCCeEecC-CCCcEEeecccccc
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP--VIHKDVKSSNILLSD-DFEPQLSDFGLASW 482 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~--iiHrDIKp~NILl~~-~~~~kL~DFGla~~ 482 (678)
|||++|+|.+++... ..+++..+..|+.||+.||.|||+ ++ ||||||||+||||+. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 999999999999753 468999999999999999999998 66 999999999999984 79999999999986
Q ss_pred cCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
.... .....+||+.|||||++. +.|+.++|||||||+||||+||+.||........ +.. .+..+.....
T Consensus 182 ~~~~----~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~----~i~~~~~~~~ 250 (290)
T 3fpq_A 182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR----RVTSGVKPAS 250 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH----HHTTTCCCGG
T ss_pred CCCC----ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHH----HHHcCCCCCC
Confidence 4332 223478999999999886 4699999999999999999999999975432211 111 1111111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+ ....+ ..+..++..||+.||.+|||+.++++
T Consensus 251 ~----~~~~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 F----DKVAI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G----GGCCC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C----CccCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 11112 24667789999999999999999885
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=433.32 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=206.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
+.|...+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56888899999999999999875 79999999996533 33456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++|+|.+++.. ..+++.++..|+.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999864 358999999999999999999999 9999999999999999999999999999998755433
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
. .+..+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+.......+. .+ ..+.+.
T Consensus 303 ~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-------~~-----~~~~~~ 368 (423)
T 4fie_A 303 R--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-------DN-----LPPRLK 368 (423)
T ss_dssp C--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-------HS-----CCCCCS
T ss_pred c--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-------cC-----CCCCCc
Confidence 2 235789999999999999999999999999999999999999998765432211111 11 111111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
. .......+..++..||+.||.+|||+.|+++
T Consensus 369 ~--~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 N--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp C--TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c--cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 0111234666779999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=409.49 Aligned_cols=244 Identities=20% Similarity=0.360 Sum_probs=190.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||+||+|... +|+.||||+++... .....+.+|++++++++|||||++++++.+.+.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999865 79999999996532 34567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+ +|+|.+++... ..+++.+...++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 78999998653 469999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCceecccccCCCCCCcchhccCCC-CccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
... ....+||+.|+|||++.+..+ +.++|||||||+||||+||+.||...+.......+ ..+.+
T Consensus 165 ~~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i-------~~~~~----- 229 (275)
T 3hyh_A 165 GNF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI-------SNGVY----- 229 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCC-----
T ss_pred CCc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HcCCC-----
Confidence 332 234689999999999998876 57999999999999999999999765432211111 11111
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+....+ ..+..++..||+.||.+|||+.|+++
T Consensus 230 -~~p~~~s----~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 230 -TLPKFLS----PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -CCCTTSC----HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCCCC----HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111222 34566779999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=417.48 Aligned_cols=241 Identities=24% Similarity=0.346 Sum_probs=192.0
Q ss_pred cCCCCceeecccCceEEEEEEeC----CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP----DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~----~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
++|...+.||+|+||+||+|+.. .++.||||+++... .....+.+|++++++++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46888999999999999999752 57899999996532 223467889999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
|||||++|+|.+++... ..+++.++..++.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999753 469999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
...... ....+||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.+.......+. .+.+
T Consensus 177 ~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-------~~~~---- 243 (304)
T 3ubd_A 177 IDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL-------KAKL---- 243 (304)
T ss_dssp ----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCC----
T ss_pred cCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH-------cCCC----
Confidence 443322 234789999999999999999999999999999999999999998765433211111 1111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQI 597 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~ 597 (678)
.+....+ ..+..++..||+.||.+|||+
T Consensus 244 --~~p~~~s----~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 --GMPQFLS----PEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --CCCTTSC----HHHHHHHHHHTCSSGGGSTTC
T ss_pred --CCCCcCC----HHHHHHHHHHcccCHHHCCCC
Confidence 1111122 345667799999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=406.94 Aligned_cols=250 Identities=23% Similarity=0.390 Sum_probs=188.1
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC--ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--------
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDN-------- 399 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-------- 399 (678)
++|...+.||+|+||+||+|... +|+.||||+++. .+...+.+.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46888899999999999999865 799999999864 3455678999999999999999999999997654
Q ss_pred ----eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEe
Q 041755 400 ----NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLS 475 (678)
Q Consensus 400 ----~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~ 475 (678)
.+|+|||||++|+|.+++..... .....+..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence 37999999999999999975432 2345677789999999999999999 999999999999999999999999
Q ss_pred ecccccccCCCCCC----------ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCccccc
Q 041755 476 DFGLASWLSTSSSH----------LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQES 545 (678)
Q Consensus 476 DFGla~~~~~~~~~----------~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~ 545 (678)
|||+|+.+...... ...+..+||+.|||||++.+..|+.++|||||||+||||++ ||...... ..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--VR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--HH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--HH
Confidence 99999987553221 12234689999999999999999999999999999999996 77532110 00
Q ss_pred chhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 546 LVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 546 l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
... .+....+... ..........++..||+.||.+|||+.++++
T Consensus 236 ~~~----~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TLT----DVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH----HHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH----HHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 0111111100 0122234556889999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=401.76 Aligned_cols=284 Identities=34% Similarity=0.658 Sum_probs=250.6
Q ss_pred ccHHHHHHhhcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 041755 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDN 399 (678)
Q Consensus 321 f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 399 (678)
+++.++..++++|...+.||+|+||.||+|...+|+.||||++.... ...+.|.+|+.+++.++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 45556667889999999999999999999998889999999987543 56678999999999999999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
..++||||+++|+|.+++.........++|..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999999997665445579999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 559 (678)
+................||+.|+|||++.++.++.++|||||||++|||++|+.||....+........|.......+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 98765433333334467999999999999999999999999999999999999999887776666666776666667778
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 560 SQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 560 ~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
...+++.+......+....+..++..||+.+|.+||++.+|++.|+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 888888888888888899999999999999999999999999999743
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=404.07 Aligned_cols=298 Identities=37% Similarity=0.720 Sum_probs=258.3
Q ss_pred CccccccHHHHHHhhcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEE
Q 041755 316 STCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFG 393 (678)
Q Consensus 316 ~~~~~f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g 393 (678)
...+.|++.++..++++|...+.||+|+||.||+|...+|+.||||+++... .....|.+|+++++.++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 4467899999999999999999999999999999998889999999997643 22336889999999999999999999
Q ss_pred EEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcE
Q 041755 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ 473 (678)
Q Consensus 394 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~k 473 (678)
+|...+..++||||+++|+|.+++.........++|..++.++.|++.||.|||+.+..+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999987766667799999999999999999999993223999999999999999999999
Q ss_pred EeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCC--Ccccccchhhcc
Q 041755 474 LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN--PKGQESLVMWAK 551 (678)
Q Consensus 474 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~--~~~~~~l~~~~~ 551 (678)
|+|||++.......... .....||+.|+|||++.++.++.++|||||||++|+|++|+.||.... .........|..
T Consensus 175 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp ECCCSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred eccCccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99999998775543332 334679999999999999999999999999999999999999996321 123334566777
Q ss_pred cccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCHhhhhHH
Q 041755 552 PILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEAANWA 614 (678)
Q Consensus 552 ~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~~~~~~~ 614 (678)
..+....+..+++..+...+..+....+..++..||+.+|.+|||+.+|++.|++..-...|.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~ 316 (326)
T 3uim_A 254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWE 316 (326)
T ss_dssp TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC
T ss_pred HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhh
Confidence 777888888999999998899999999999999999999999999999999999866554444
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=406.48 Aligned_cols=265 Identities=21% Similarity=0.295 Sum_probs=202.1
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe------CC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFE------DN 399 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~ 399 (678)
.++|...+.||+|+||+||+|... +|+.||||+++.. ....+.+.+|+++|+.|+|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 357999999999999999999865 7999999999753 3456788999999999999999999999764 36
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
.+|||||||. |+|.+++... ..+++.++..++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecce
Confidence 7999999995 7899999643 579999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCC--CCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccccc
Q 041755 480 ASWLSTSS--SHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKD 556 (678)
Q Consensus 480 a~~~~~~~--~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 556 (678)
|+.+.... .....+..+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+.......+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98765432 12233457899999999998875 5699999999999999999999999876654332222111000000
Q ss_pred --------CccccccCCCCCC-CCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 557 --------GKVSQLLDPSLDT-DYDN-----DQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 557 --------~~~~~l~dp~l~~-~~~~-----~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
......+...... .... .....+..++..||..||.+|||+.|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000000000 0000 01234567789999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=393.98 Aligned_cols=201 Identities=25% Similarity=0.406 Sum_probs=172.4
Q ss_pred HhhcCCCCceeecccCceEEEEEEeC----CCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEE
Q 041755 328 SATSNFLPEYLVGKGGHSHVYRGCLP----DGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 328 ~~t~~f~~~~~IG~G~~g~Vy~g~~~----~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 402 (678)
...++|...+.||+|+||+||+|..+ .++.||||++..... ...+.+|+++|..+ +||||+++++++.+.+++|
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 45678999999999999999999742 468899999875443 34678999999998 6999999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC-CCcEEeeccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD-FEPQLSDFGLAS 481 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~-~~~kL~DFGla~ 481 (678)
+||||+++|+|.+++. .+++.++..++.|++.||.|||+ ++||||||||+|||++.+ +.+||+|||+|+
T Consensus 97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999983 48899999999999999999999 999999999999999877 799999999998
Q ss_pred ccCCCCCC--------------------------ceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCC
Q 041755 482 WLSTSSSH--------------------------LTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKP 534 (678)
Q Consensus 482 ~~~~~~~~--------------------------~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~P 534 (678)
........ ...+..+||+.|+|||++.+. .++.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 65432211 112335799999999999875 489999999999999999999999
Q ss_pred CCCCC
Q 041755 535 INSEN 539 (678)
Q Consensus 535 f~~~~ 539 (678)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 96544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=411.16 Aligned_cols=251 Identities=25% Similarity=0.322 Sum_probs=207.4
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
.++|...+.||+|+||.||+|... +|+.||||+++.. ....+.+.+|+.+|+.|+|||||+|+++|.+.+.+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 367899999999999999999875 7999999998654 35567788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC--CCcEEeecccccccCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD--FEPQLSDFGLASWLST 485 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~--~~~kL~DFGla~~~~~ 485 (678)
|++|+|.++|... ...+++.++..++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 9999999998643 2568999999999999999999999 999999999999999854 8999999999998765
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
... ....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+.......+..... .+ .+
T Consensus 310 ~~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~-----~~----~~ 377 (573)
T 3uto_A 310 KQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW-----NM----DD 377 (573)
T ss_dssp TSE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC-----CC----CS
T ss_pred CCc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC-----CC----Cc
Confidence 432 2346899999999999999999999999999999999999999987654332211111100 00 11
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
......+ ..+..++..||+.||.+||++.|+++
T Consensus 378 ~~~~~~s----~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 378 SAFSGIS----EDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGGTTSC----HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccccCCC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111122 34556779999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=367.57 Aligned_cols=281 Identities=32% Similarity=0.579 Sum_probs=232.9
Q ss_pred ccccccHHHHHHhhcCCCCc------eeecccCceEEEEEEeCCCCEEEEEEeCCC-----hHHHHHHHHHHHHHHhcCC
Q 041755 317 TCRLFSYQELLSATSNFLPE------YLVGKGGHSHVYRGCLPDGKELAVKILKPS-----EDVLKEFASEIEIITALHH 385 (678)
Q Consensus 317 ~~~~f~~~el~~~t~~f~~~------~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~-----~~~~~~~~~Ei~il~~l~H 385 (678)
..+.|++.++..++++|... +.||+|+||.||+|.. +++.||||++... ....+.|.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45789999999999999988 8999999999999987 7899999998642 3456789999999999999
Q ss_pred CCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeE
Q 041755 386 RNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNIL 465 (678)
Q Consensus 386 pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NIL 465 (678)
|||+++++++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+ .+|+||||||+|||
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence 999999999999999999999999999999987532 23568999999999999999999999 99999999999999
Q ss_pred ecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCccccc
Q 041755 466 LSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQES 545 (678)
Q Consensus 466 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~ 545 (678)
++.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++|+.||........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-- 242 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-- 242 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence 99999999999999987665444333445679999999998864 689999999999999999999999986543321
Q ss_pred chhhccccc-ccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 546 LVMWAKPIL-KDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 546 l~~~~~~~~-~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+..+..... ....+...+++.+. .........+..++..||+.+|.+||++.+|++.|+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~ 303 (307)
T 2nru_A 243 LLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303 (307)
T ss_dssp TTHHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 111111111 11234445555543 3456677889999999999999999999999999974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=408.77 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=197.9
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-------DVLKEFASEIEIITALHHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 401 (678)
.++|...++||+|+||+||+|... +|+.||||+++... ........++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999875 79999999996421 2223334456677778999999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
|||||||+||+|.++|... ..+++..+..++.||+.||.|||+ ++||||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence 9999999999999999753 469999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 482 WLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 482 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
.+..... ...+||+.|||||++.. ..|+.++|||||||+||||++|+.||..........+... .. ..
T Consensus 341 ~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~---i~-~~--- 409 (689)
T 3v5w_A 341 DFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TL-TM--- 409 (689)
T ss_dssp ECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH---HH-HC---
T ss_pred ecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh---hc-CC---
Confidence 7755432 23689999999999975 4799999999999999999999999976543322111110 00 00
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ-----INLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs-----~~eVl~ 602 (678)
...+...++ ..+..++..||+.||.+|++ +.+|++
T Consensus 410 ---~~~~p~~~S----~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 410 ---AVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---CCCCCTTSC----HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---CCCCCccCC----HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 011112222 34566779999999999998 566653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=375.68 Aligned_cols=269 Identities=23% Similarity=0.303 Sum_probs=212.1
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----eEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDN----NLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~~~lV~E 406 (678)
++|...++||+|+||.||+|.. .++.||||+++........+..|+.++.+++||||+++++++.... .+++|||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hhchhhheecccCceEEEEEEE-CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 5788899999999999999987 4799999999876666666778999999999999999999998744 4799999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CeeeccCCCCCeEecCCCCcEEee
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ----------PVIHKDVKSSNILLSDDFEPQLSD 476 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~----------~iiHrDIKp~NILl~~~~~~kL~D 476 (678)
|+++|+|.+++... .+++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+||+|
T Consensus 103 ~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 103 FHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 99999999999653 48999999999999999999998 7 999999999999999999999999
Q ss_pred cccccccCCCCCCceecccccCCCCCCcchhccC-----CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcc
Q 041755 477 FGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-----KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK 551 (678)
Q Consensus 477 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~ 551 (678)
||+++...............||+.|+|||++.+. .++.++|||||||++|||+||+.||................
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 9999887665444444456899999999999863 56678999999999999999999998755432221111100
Q ss_pred cccccCc-----cccccCCCCCCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 552 PILKDGK-----VSQLLDPSLDTDY-DNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 552 ~~~~~~~-----~~~l~dp~l~~~~-~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
....... ......+.+...+ .......+..++..||+.||.+|||+.+|++.|+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0000000 0111112221111 2244566888999999999999999999999997544
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=377.41 Aligned_cols=259 Identities=23% Similarity=0.406 Sum_probs=212.1
Q ss_pred cCCCCceeecccCceEEEEEEe--------CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL--------PDGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDN 399 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~--------~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 399 (678)
++|...+.||+|+||.||+|.. .++..||||+++.. ......+.+|+.++..+ +||||++++++|.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 5788889999999999999975 24567999999764 35667899999999999 8999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKK------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS 467 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~ 467 (678)
.+|+||||+++|+|.+++..... ....+++.+++.++.||+.||.|||+ ++|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence 99999999999999999976532 12458999999999999999999999 9999999999999999
Q ss_pred CCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccc
Q 041755 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESL 546 (678)
Q Consensus 468 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 546 (678)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||...........
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~ 317 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 317 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999999987765443333344567889999999999999999999999999999999 9999976543221111
Q ss_pred hhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 547 VMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 547 ~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
+..+.. +. ........+..++..||+.+|.+||++.++++.|+...
T Consensus 318 -------~~~~~~-----~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 318 -------LKEGHR-----MD----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp -------HHTTCC-----CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HhcCCC-----CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111110 11 11122345777889999999999999999999997543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=365.98 Aligned_cols=258 Identities=23% Similarity=0.413 Sum_probs=210.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP-SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
++|...+.||+|+||.||+|... +|+.||+|++.. .....+.|.+|++++.+++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57888899999999999999875 689999998865 4567788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++|+|.+++... ...+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 90 KGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp TTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999753 2568999999999999999999999 9999999999999999999999999999987654322
Q ss_pred Cc------------eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccccc
Q 041755 489 HL------------TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKD 556 (678)
Q Consensus 489 ~~------------~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 556 (678)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..||............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--------- 234 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--------- 234 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB---------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh---------
Confidence 21 111357999999999999999999999999999999999999998765433221110
Q ss_pred CccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 557 GKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 557 ~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.....++....... ...+..++..||+.+|.+||++.++++.|+...
T Consensus 235 -~~~~~~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 235 -NVRGFLDRYCPPNC----PPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp -CHHHHHHHTCCTTC----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -hhhccccccCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 01111111111111 234667789999999999999999999987543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=360.18 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=206.1
Q ss_pred hcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999986 479999999986433 3356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++|+|.+++... .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999643 58999999999999999999999 999999999999999999999999999998765543
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... ..+. +.+
T Consensus 171 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------~~~~------~~~ 236 (297)
T 3fxz_A 171 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------TNGT------PEL 236 (297)
T ss_dssp CC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HHCS------CCC
T ss_pred cc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCC------CCC
Confidence 32 234679999999999999999999999999999999999999997654322111110 0000 000
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.........+..++..||+.||.+||++.++++
T Consensus 237 --~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 011122345667889999999999999999986
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=362.22 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=212.6
Q ss_pred ccccHHHHHHhhcC----------CCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCC
Q 041755 319 RLFSYQELLSATSN----------FLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHR 386 (678)
Q Consensus 319 ~~f~~~el~~~t~~----------f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~Hp 386 (678)
..|+++++..+++. |.....||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45888888888765 666778999999999999876 79999999997543 4456788999999999999
Q ss_pred CeeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe
Q 041755 387 NIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL 466 (678)
Q Consensus 387 nIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl 466 (678)
||+++++++...+..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+ .+|+||||||+|||+
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll 174 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILL 174 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEE
Confidence 999999999999999999999999999999853 358999999999999999999999 999999999999999
Q ss_pred cCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccc
Q 041755 467 SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESL 546 (678)
Q Consensus 467 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l 546 (678)
+.++.+||+|||++......... .....||+.|+|||++.++.++.++|||||||++|||++|+.||...........
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~ 252 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred CCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999876553322 2346799999999999999999999999999999999999999976543221110
Q ss_pred hhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 547 VMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 547 ~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+ .. ...+.+.. .......+..++..||+.+|.+||++.++++
T Consensus 253 ~-------~~-----~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 253 L-------RD-----SPPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp H-------HH-----SSCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred H-------hc-----CCCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 01111111 1112244667789999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=365.01 Aligned_cols=256 Identities=28% Similarity=0.447 Sum_probs=200.7
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.++|...+.||+|+||.||+|.. +|+.||||++... ....+.|.+|++++++++||||+++++++.+.+..++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 45788889999999999999987 7889999998753 3556789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP--VIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~--iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|+++|+|.+++.... ....+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...
T Consensus 115 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 115 YLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp CCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred cCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 999999999997532 11248999999999999999999998 88 9999999999999999999999999998654
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...........+.... ..
T Consensus 191 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~-----------~~ 257 (309)
T 3p86_A 191 STFL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC-----------KR 257 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSC-----------CC
T ss_pred cccc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcC-----------CC
Confidence 4322 2234679999999999999999999999999999999999999998655432211111000 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
..+... ....+..++..||+.+|.+||++.++++.|+..
T Consensus 258 ~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~ 296 (309)
T 3p86_A 258 LEIPRN----LNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296 (309)
T ss_dssp CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011111 223467788999999999999999999998743
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=373.23 Aligned_cols=270 Identities=22% Similarity=0.353 Sum_probs=215.2
Q ss_pred ccHHHHHHhhcCCCCceeecccCceEEEEEEe------CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeE
Q 041755 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCL------PDGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISL 391 (678)
Q Consensus 321 f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~------~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l 391 (678)
+...+.....++|...+.||+|+||.||+|.+ .+++.||||+++.. ....+.|.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 33444445567899999999999999999973 25689999999763 35567899999999999 79999999
Q ss_pred EEEEEeCC-eEEEEEEcCCCCCHHHHhccCCCC-----------------------------------------------
Q 041755 392 FGFCFEDN-NLLLVYDFLSRGSLEENLHGNKKD----------------------------------------------- 423 (678)
Q Consensus 392 ~g~~~~~~-~~~lV~E~~~~gsL~~~L~~~~~~----------------------------------------------- 423 (678)
+++|.+.+ ..++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998755 489999999999999999765321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 424 ---------------GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 424 ---------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 1238999999999999999999999 9999999999999999999999999999997766555
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
........||+.|+|||++.+..++.++|||||||++|||++ |+.||.......... . .+..+.. +..
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~--~----~~~~~~~-----~~~ 317 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC--R----RLKEGTR-----MRA 317 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH--H----HHHHTCC-----CCC
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH--H----HHHcCCC-----CCC
Confidence 445556788999999999999999999999999999999998 999997654322110 0 1111100 111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
... ....+..++..||+.+|.+||++.+|++.|+...
T Consensus 318 ~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 318 PDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111 1234667789999999999999999999997543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=366.52 Aligned_cols=256 Identities=25% Similarity=0.370 Sum_probs=207.1
Q ss_pred cCCCCceeecccCceEEEEEEeC----CCCEEEEEEeCC--ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP----DGKELAVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~----~g~~vAvK~l~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...+.||+|+||.||+|... .+..||||+++. .....+.|.+|+.++..++||||+++++++.+++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56888899999999999999874 345699999986 345678899999999999999999999999998999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... ...+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 129 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 129 TEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999643 2468999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCC-ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 485 TSSSH-LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 485 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........+. .+
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~----- 270 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-------EG----- 270 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-------TT-----
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-------cC-----
Confidence 54322 22233456888999999999999999999999999999999 999997654332111111 00
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
............+..++..||+.+|.+||++.+|++.|+...
T Consensus 271 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~ 312 (325)
T 3kul_A 271 ----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312 (325)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000111122345777889999999999999999999997543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=357.35 Aligned_cols=255 Identities=23% Similarity=0.398 Sum_probs=210.3
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|...+.||+|+||.||+|...+++.||+|++.......+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 56788899999999999999988899999999987655557799999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........ .
T Consensus 90 ~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 162 (269)
T 4hcu_A 90 GCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 162 (269)
T ss_dssp CBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred CcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-c
Confidence 9999999643 2568999999999999999999999 9999999999999999999999999999987644221 1
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
......||+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+. .+ ..+....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-------~~-----~~~~~~~ 230 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-------TG-----FRLYKPR 230 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-------TT-----CCCCCCT
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-------cC-----ccCCCCC
Confidence 1223467788999999999999999999999999999999 999997654332111110 00 0011111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
. ....+..++..||+.+|.+||++.++++.|+...
T Consensus 231 ~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 231 L----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp T----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred c----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 1 1244677789999999999999999999997543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=365.24 Aligned_cols=247 Identities=25% Similarity=0.417 Sum_probs=206.0
Q ss_pred hhcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
..++|...+.||+|+||.||+|.. .+|+.||||++.. .....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346899999999999999999987 4899999999864 345667889999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 9999999999999653 458999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCC-ccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVS-EKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
.... ....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+. .+..
T Consensus 166 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~-------~~~~---- 231 (328)
T 3fe3_A 166 VGGK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL-------RGKY---- 231 (328)
T ss_dssp SSCG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCC----
T ss_pred CCCc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCC----
Confidence 4332 2346899999999999988875 79999999999999999999998765432211111 1111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+... ....+..++..||..||.+|||+.++++
T Consensus 232 --~~p~~----~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 232 --RIPFY----MSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --CCCTT----SCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred --CCCCC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111 1234667779999999999999999886
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=353.31 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=211.1
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
.++|...+.||+|+||.||+|...++..||||+++........+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 35788889999999999999998888899999998765455779999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+++|.+++... +..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 87 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 87 NGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999753 2458999999999999999999999 99999999999999999999999999999876554322
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
......||+.|+|||.+.+..++.++||||||+++|+|++ |+.||.............. +. ....+
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------~~--~~~~~--- 227 (268)
T 3sxs_A 161 -SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-------GH--RLYRP--- 227 (268)
T ss_dssp -ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-------TC--CCCCC---
T ss_pred -cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc-------CC--CCCCC---
Confidence 2233556778999999999999999999999999999999 9999976543321111110 00 00111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.. ....+..++..||+.+|.+||++.++++.|+...
T Consensus 228 ~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 HL----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TT----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred Cc----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11 1234677889999999999999999999997543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=361.85 Aligned_cols=251 Identities=22% Similarity=0.267 Sum_probs=207.8
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
.++|...+.||+|+||.||+|... +|+.||+|+++........+.+|+.++..++||||+++++++.+.+..++||||+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 468889999999999999999875 6889999999877666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC--CCCcEEeecccccccCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD--DFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~--~~~~kL~DFGla~~~~~~ 486 (678)
++|+|.+++... ...+++.+++.++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||++..+...
T Consensus 84 ~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 84 SGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999643 2468999999999999999999999 99999999999999997 789999999999877543
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+... ... +++.
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------~~~--~~~~ 225 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA-------EYT--FDEE 225 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-------CCC--CCHH
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcC-------CCC--CChh
Confidence 3 223467999999999999988999999999999999999999999765432211111100 000 0000
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
... .....+..++..||..||.+|||+.++++
T Consensus 226 ~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 226 AFK----EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000 11245677889999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=364.97 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=203.6
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.++|...+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468899999999999999999876 79999999986543 345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++|+|.+++... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..+...
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 99999999998643 468999999999999999999999 99999999999999999999999999999876544
Q ss_pred CCCceecccccCCCCCCcchhccCCC-CccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ...|..... ...+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~-------~~~~ 230 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKT-------YLNP 230 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTTCT-------TSTT
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhcccc-------cCCc
Confidence 33333345689999999999988775 77999999999999999999999765432211 111111000 0000
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.......+..++..||+.||.+||++.++++
T Consensus 231 ------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 231 ------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 1112344567889999999999999999886
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=365.58 Aligned_cols=255 Identities=20% Similarity=0.378 Sum_probs=201.9
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCC----EEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGK----ELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~----~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
++|...+.||+|+||.||+|... +|+ .||+|.++... ...+.|.+|+.++++++||||++++++|.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888899999999999999854 444 35888886432 44678999999999999999999999998754 789
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
|+||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 999999999999997542 568999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
.............||+.|+|||++.++.++.++|||||||++|||++ |+.||...........+. .+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~-------~~~---- 236 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE---- 236 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC----
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH-------cCC----
Confidence 66554444445667889999999999999999999999999999999 999998655433211111 110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
...........+..++..||+.+|.+||++.++++.|+...
T Consensus 237 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 237 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 00111222345777889999999999999999999987544
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=372.88 Aligned_cols=256 Identities=24% Similarity=0.379 Sum_probs=197.8
Q ss_pred cCCCCceeecccCceEEEEEEeC----CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP----DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~----~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...+.||+|+||.||+|... ++..||||+++.. ....+.|.+|+.++.+++||||++++++|.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 57889999999999999999864 5778999999753 45677899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... +..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 125 ~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 125 TEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 9999999999999743 3568999999999999999999999 999999999999999999999999999998775
Q ss_pred CCCCC-ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 485 TSSSH-LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 485 ~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
..... .......+|+.|+|||++.++.++.++|||||||++|||++ |+.||...........+ ..+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i-------~~~----- 266 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-------DEG----- 266 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH-------HTT-----
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcC-----
Confidence 54322 12222346788999999999999999999999999999998 99999765432211111 111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
............+..++..||+.+|.+||++.+|++.|+...
T Consensus 267 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 267 ----YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp ----EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 000111123355777889999999999999999999997543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=360.51 Aligned_cols=259 Identities=24% Similarity=0.394 Sum_probs=212.5
Q ss_pred hcCCCCceeecccCceEEEEEEe------CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL------PDGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~------~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 401 (678)
.++|...+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+++++.++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45788889999999999999975 24688999999753 45668899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 041755 402 LLVYDFLSRGSLEENLHGNKK--------------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKS 461 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp 461 (678)
++||||+++|+|.+++..... ....+++.+++.++.|++.||.|||+ ++|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence 999999999999999986532 12348999999999999999999999 9999999999
Q ss_pred CCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCC
Q 041755 462 SNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENP 540 (678)
Q Consensus 462 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~ 540 (678)
+|||++.++.+||+|||++................||+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987765444333344567889999999999999999999999999999999 9999976654
Q ss_pred cccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 541 KGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 541 ~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
......+. .+.. +.. .......+..++..||+.+|.+||++.++++.|+..
T Consensus 259 ~~~~~~~~-------~~~~-----~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 ERLFNLLK-------TGHR-----MER----PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGHHHHHH-------TTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhh-------cCCc-----CCC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 32211111 1110 111 112234577788999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=364.08 Aligned_cols=260 Identities=22% Similarity=0.382 Sum_probs=210.0
Q ss_pred hcCCCCceeecccCceEEEEEEe------CCCCEEEEEEeCCCh--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCe
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL------PDGKELAVKILKPSE--DVLKEFASEIEIITAL-HHRNIISLFGFCFEDNN 400 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~------~~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 400 (678)
.++|...+.||+|+||.||+|.. .++..||||+++... ...+.+.+|+.++.++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 36788899999999999999985 246689999997532 4557899999999999 89999999999999999
Q ss_pred EEEEEEcCCCCCHHHHhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCC
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKD-------------------GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKS 461 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~-------------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp 461 (678)
.++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+ ++|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCh
Confidence 99999999999999999764321 1348999999999999999999999 9999999999
Q ss_pred CCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCC
Q 041755 462 SNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENP 540 (678)
Q Consensus 462 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~ 540 (678)
+|||++.++.+||+|||++................||+.|+|||.+.++.++.++|||||||++|||+| |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999988766555444455678999999999999999999999999999999998 9999976543
Q ss_pred cccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 541 KGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 541 ~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
... ... .+..+ ..+.. .......+..++..||+.+|.+||++.++++.|+..
T Consensus 281 ~~~--~~~----~~~~~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 281 DAN--FYK----LIQNG-----FKMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp SHH--HHH----HHHTT-----CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH--HHH----HHhcC-----CCCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 221 111 11111 00111 111234567788999999999999999999999753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=369.88 Aligned_cols=259 Identities=24% Similarity=0.410 Sum_probs=212.5
Q ss_pred cCCCCceeecccCceEEEEEEe--------CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL--------PDGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDN 399 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~--------~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 399 (678)
++|...+.||+|+||.||+|.. ..+..||||+++.. ......+.+|++++.++ +||||++++++|...+
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 5788889999999999999975 23467999999754 45668899999999999 8999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKK------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS 467 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~ 467 (678)
..++||||+++|+|.+++..... ....+++.+++.++.|++.||.|||+ .+|+||||||+|||++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEc
Confidence 99999999999999999976532 12468999999999999999999999 9999999999999999
Q ss_pred CCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccc
Q 041755 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESL 546 (678)
Q Consensus 468 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 546 (678)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||...........
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~ 305 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999997765544344445678899999999999999999999999999999999 9999976543221111
Q ss_pred hhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 547 VMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 547 ~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
+..+.. +.. .......+..++..||+.+|.+||++.+|++.|+...
T Consensus 306 -------~~~~~~-----~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 306 -------LKEGHR-----MDK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp -------HHTTCC-----CCC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHcCCC-----CCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111110 011 1112345677889999999999999999999997544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=364.49 Aligned_cols=261 Identities=23% Similarity=0.396 Sum_probs=212.1
Q ss_pred hhcCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNN 400 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 400 (678)
..++|...+.||+|+||.||+|... +++.||||+++.. ......|.+|+.++.+++||||++++++|.+++.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4578999999999999999999864 3488999999753 3567789999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCC
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKD--------------------GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVK 460 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~--------------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIK 460 (678)
.++||||+++|+|.+++...... ...+++.+++.++.||+.||.|||+ ++|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence 99999999999999999764321 2578999999999999999999999 999999999
Q ss_pred CCCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCC
Q 041755 461 SSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSEN 539 (678)
Q Consensus 461 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~ 539 (678)
|+|||++.++.+||+|||++................||+.|+|||.+.++.++.++||||||+++|||++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987654333233334678999999999999999999999999999999999 999997654
Q ss_pred CcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 540 PKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 540 ~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
...... .+..+.... . .......+..++..||+.+|.+||++.+|++.|+...
T Consensus 282 ~~~~~~-------~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~ 334 (343)
T 1luf_A 282 HEEVIY-------YVRDGNILA-----C----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 334 (343)
T ss_dssp HHHHHH-------HHHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hHHHHH-------HHhCCCcCC-----C----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence 322111 111111111 1 1112345777889999999999999999999997644
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=376.06 Aligned_cols=256 Identities=22% Similarity=0.359 Sum_probs=208.1
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.++|...+.||+|+||.||+|... +|+.||||+++.. ......|.+|++++++++||||++++++|...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356778899999999999999986 7899999999754 3556778999999999999999999999999889999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++|+|.+++... +..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999743 2458999999999999999999999 99999999999999999999999999999865443
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
..........++..|+|||.+.++.++.++|||||||++|||++ |..||........... +..+..
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~-------~~~~~~------ 333 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-------VEKGGR------ 333 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH-------HHTTCC------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCCC------
Confidence 22111122345778999999999999999999999999999998 9999976543221111 111110
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
...+......+..++..||+.+|.+||++.+|++.|+..
T Consensus 334 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 334 ---LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 001111234566778999999999999999999999753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.11 Aligned_cols=259 Identities=24% Similarity=0.379 Sum_probs=212.2
Q ss_pred cCCCCceeecccCceEEEEEEe------CCCCEEEEEEeCCCh--HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL------PDGKELAVKILKPSE--DVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~------~~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 401 (678)
++|...+.||+|+||.||+|.. .+++.||||+++... ...+.+.+|+.++.++ +||||+++++++...+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 5788889999999999999974 357899999997643 4567899999999999 899999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec
Q 041755 402 LLVYDFLSRGSLEENLHGNKK--------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS 467 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~--------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~ 467 (678)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+ ++|+||||||+|||++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEc
Confidence 999999999999999976532 12358999999999999999999999 9999999999999999
Q ss_pred CCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccc
Q 041755 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESL 546 (678)
Q Consensus 468 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 546 (678)
.++.+||+|||++................||+.|+|||.+.+..++.++||||||+++|||++ |+.||.........
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-- 257 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-- 257 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH--
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH--
Confidence 999999999999998776554444445678899999999999999999999999999999999 99999765432211
Q ss_pred hhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 547 VMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 547 ~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.. .+..+ ..+.. .......+..++..||+.+|.+||++.++++.|+..
T Consensus 258 ~~----~~~~~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 258 YK----MIKEG-----FRMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp HH----HHHHT-----CCCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----HhccC-----CCCCC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 00 01110 01111 111234567788999999999999999999999753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=372.65 Aligned_cols=259 Identities=24% Similarity=0.355 Sum_probs=208.7
Q ss_pred cCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCC--ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 402 (678)
++|...+.||+|+||.||+|... +++.||||+++. .......+.+|+.++++++||||+++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 46778899999999999999842 467899999975 3456678999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC---CcEEee
Q 041755 403 LVYDFLSRGSLEENLHGNK---KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF---EPQLSD 476 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~---~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~---~~kL~D 476 (678)
+||||+++|+|.+++.... .....+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999997543 223468999999999999999999999 9999999999999999554 599999
Q ss_pred cccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccc
Q 041755 477 FGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILK 555 (678)
Q Consensus 477 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 555 (678)
||+++...............||+.|+|||++.++.++.++|||||||++|||++ |..||...........+ .
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i-------~ 300 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------T 300 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-------H
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------H
Confidence 999986543332223334678999999999999999999999999999999998 99999765432211111 1
Q ss_pred cCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 556 DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 556 ~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.+.. + .........+..++..||+.+|.+||++.+|++.|+...
T Consensus 301 ~~~~-----~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 SGGR-----M----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TTCC-----C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCC-----C----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1110 0 011122345677889999999999999999999997543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=355.64 Aligned_cols=258 Identities=24% Similarity=0.366 Sum_probs=204.2
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC----ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP----SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
.++|...+.||+|+||.||+|... +++.||+|++.. .....+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357888999999999999999865 789999998843 346678899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999653 468999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
..... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... ...+... .... .
T Consensus 163 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~~-~~~~-~ 233 (294)
T 4eqm_A 163 ETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQDS-VPNV-T 233 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSSC-CCCH-H
T ss_pred ccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhcc-CCCc-c
Confidence 43322 223467999999999999999999999999999999999999999765432210 0001110 0000 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhhcC
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRP-QINLVLKLLQGD 607 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-s~~eVl~~L~~~ 607 (678)
..+.. +....+..++..||+.+|.+|| ++.++.+.|+..
T Consensus 234 ~~~~~----~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 234 TDVRK----DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp HHSCT----TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred hhccc----CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 00111 1234567778999999999998 899998888653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=353.70 Aligned_cols=254 Identities=22% Similarity=0.374 Sum_probs=206.6
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|...+.||+|+||.||+|...++..||||+++......+.+.+|++++.+++||||+++++++.+.+..++||||+++
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 103 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence 57788899999999999999998888999999987654557799999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++... ...+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++........ .
T Consensus 104 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 176 (283)
T 3gen_A 104 GCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T 176 (283)
T ss_dssp CBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-H
T ss_pred CcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc-c
Confidence 9999999753 2468999999999999999999999 9999999999999999999999999999987644221 1
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
......||+.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+. .+ .......
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-------~~-----~~~~~~~ 244 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------QG-----LRLYRPH 244 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-------TT-----CCCCCCT
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-------cc-----cCCCCCC
Confidence 1223456788999999999999999999999999999998 999997654332111111 00 0011111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
. ....+..++..||+.+|.+||++.++++.|+..
T Consensus 245 ~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 245 L----ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp T----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred c----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1 124567788999999999999999999998753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=355.89 Aligned_cols=264 Identities=20% Similarity=0.288 Sum_probs=202.7
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.++|...+.||+|+||.||+|...+|+.||+|+++... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 36788889999999999999998889999999997532 345778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|++ |+|.+.+... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 100 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FME-KDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCS-EEHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCC-CCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 997 5888888643 2468999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc-----
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS----- 560 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~----- 560 (678)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...........+.
T Consensus 173 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 173 VRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTS
T ss_pred ccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhcc
Confidence 322 234578999999999876 568999999999999999999999998765443221111000000000000
Q ss_pred -cccCCC---CCCC----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 -QLLDPS---LDTD----YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 -~l~dp~---l~~~----~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.+.. .... ........+.+++..||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 0000 00111245677889999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=365.96 Aligned_cols=211 Identities=26% Similarity=0.365 Sum_probs=187.7
Q ss_pred ccccHHHHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-----CCCeeeEE
Q 041755 319 RLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALH-----HRNIISLF 392 (678)
Q Consensus 319 ~~f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~ 392 (678)
..|++.+.....++|...+.||+|+||.||+|... +|+.||||+++........+..|+.++..+. ||||++++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 44666666667789999999999999999999874 7899999999877777788899999999997 99999999
Q ss_pred EEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC----
Q 041755 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD---- 468 (678)
Q Consensus 393 g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~---- 468 (678)
+++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccc
Confidence 9999999999999999 9999999976432 458999999999999999999999 99999999999999975
Q ss_pred ---------------------CCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHH
Q 041755 469 ---------------------DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLE 527 (678)
Q Consensus 469 ---------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~e 527 (678)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 7899999999998654422 23578999999999999999999999999999999
Q ss_pred HhcCCCCCCCCCC
Q 041755 528 LLSGKKPINSENP 540 (678)
Q Consensus 528 LltG~~Pf~~~~~ 540 (678)
|++|+.||.....
T Consensus 252 ll~g~~pf~~~~~ 264 (360)
T 3llt_A 252 LYTGSLLFRTHEH 264 (360)
T ss_dssp HHHSSCSCCCSSH
T ss_pred HHHCCCCCCCCcH
Confidence 9999999986543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=360.61 Aligned_cols=271 Identities=24% Similarity=0.330 Sum_probs=202.6
Q ss_pred cCCCCceeecccCceEEEEEEe-----CCCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-----PDGKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISLFGFCFED--NNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-----~~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 402 (678)
++|...+.||+|+||.||+|.. .+|+.||||++... ....+.|.+|++++.+++||||+++++++... ..++
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5778889999999999999983 36889999999764 45667899999999999999999999998653 5689
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 90 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999997542 358999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCC-ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 483 LSTSSSH-LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 483 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
....... .......||..|+|||.+.+..++.++||||||+++|||++|..||.......................+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 7554322 122234577889999999999999999999999999999999999864321100000000000000000000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.+...............+..++..||+.+|.+||++.++++.|+..
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0111111111222335577788999999999999999999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=362.83 Aligned_cols=250 Identities=23% Similarity=0.370 Sum_probs=197.5
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCC--CCeeeEEEEEEeCCeEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKP---SEDVLKEFASEIEIITALHH--RNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV 404 (678)
.++|...+.||+|+||.||++...+++.||||++.. .......|.+|+.++..++| |||+++++++..++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 456888999999999999999988899999999864 34566889999999999986 9999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|| +.+|+|.+++... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 5688999999753 468999999999999999999999 9999999999999997 5789999999999876
Q ss_pred CCCCCceecccccCCCCCCcchhcc-----------CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMH-----------GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI 553 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 553 (678)
............||+.|+|||++.+ +.++.++|||||||++|||++|+.||........
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---------- 228 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---------- 228 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----------
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH----------
Confidence 5544433445689999999999865 6789999999999999999999999975332110
Q ss_pred cccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 554 LKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 554 ~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+...+++.....+.......+..++..||+.+|.+||++.++++
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 229 ----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp ----HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 011112222222222222345677889999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=352.06 Aligned_cols=260 Identities=26% Similarity=0.388 Sum_probs=203.1
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHh--cCCCCeeeEEEEEEeC----CeEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITA--LHHRNIISLFGFCFED----NNLLL 403 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~----~~~~l 403 (678)
.++|...+.||+|+||.||+|.. +|+.||||++.... ...+..|.+++.. ++||||+++++++... ...++
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l 83 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 83 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence 46888999999999999999988 78999999997543 3456677777777 7999999999997653 45899
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeccCCCCCeEecCCCCcEEe
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH--------NSCEQPVIHKDVKSSNILLSDDFEPQLS 475 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH--------~~~~~~iiHrDIKp~NILl~~~~~~kL~ 475 (678)
||||+++|+|.+++.. ..+++..++.++.|++.||.||| + ++|+||||||+|||++.++.+||+
T Consensus 84 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 84 ITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEEC
T ss_pred ehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999953 36899999999999999999999 6 899999999999999999999999
Q ss_pred ecccccccCCCCCCce--ecccccCCCCCCcchhccC------CCCccceEeehhHHHHHHhcC----------CCCCCC
Q 041755 476 DFGLASWLSTSSSHLT--CTDVAGTFGYLAPEYFMHG------KVSEKIDVYAFGIVLLELLSG----------KKPINS 537 (678)
Q Consensus 476 DFGla~~~~~~~~~~~--~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSlGvvL~eLltG----------~~Pf~~ 537 (678)
|||+++.......... .....||+.|+|||++.+. .++.++|||||||++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9999987655433221 2235799999999999876 455799999999999999999 778765
Q ss_pred CCCcccccchhhcccccccCccccccCCCCC-CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 538 ENPKGQESLVMWAKPILKDGKVSQLLDPSLD-TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 538 ~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~-~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
..+........ .......+ ..+.+. ..+.......+..++..||+.+|.+|||+.+|++.|+.
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 236 VVPNDPSFEDM-RKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp TSCSSCCHHHH-HHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred cCCCCcchhhh-hHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 43322111100 00000000 011111 11223456778899999999999999999999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=359.73 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=203.4
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||+||++... +|+.||||+++... .....+.+|+.++..++||||+++++++...+.+++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999875 79999999997532 23567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999998643 468999999999999999999999 9999999999999999999999999999986433
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. . +. .
T Consensus 158 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------~-~~------~ 222 (337)
T 1o6l_A 158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------M-EE------I 222 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-CC------C
T ss_pred CCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH------c-CC------C
Confidence 222 2234689999999999999999999999999999999999999997654322111111 0 00 0
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~ 602 (678)
.+.... ...+..++..||+.+|.+|| ++.+|++
T Consensus 223 ~~p~~~----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 223 RFPRTL----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCC----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 111112 23466677999999999999 8888875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=353.48 Aligned_cols=269 Identities=20% Similarity=0.320 Sum_probs=210.8
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--eEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDN--NLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~lV~ 405 (678)
++|...++||+|+||.||+|... +|+.||||+++... ...+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56888999999999999999876 58999999997533 33567889999999999999999999998765 789999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe----cCCCCcEEeeccccc
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL----SDDFEPQLSDFGLAS 481 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl----~~~~~~kL~DFGla~ 481 (678)
||+++|+|.+++..... ...+++.+++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999975432 2348999999999999999999999 999999999999999 888889999999998
Q ss_pred ccCCCCCCceecccccCCCCCCcchhc--------cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhc---
Q 041755 482 WLSTSSSHLTCTDVAGTFGYLAPEYFM--------HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA--- 550 (678)
Q Consensus 482 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~--------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~--- 550 (678)
........ ....||+.|+|||++. +..++.++|||||||++|||++|+.||...............
T Consensus 165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp ECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 77554322 2357999999999986 578899999999999999999999999754432211111100
Q ss_pred -cc--------ccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 551 -KP--------ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 551 -~~--------~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.+ ....+.+.-.-+-.............+..++..||+.||.+||++.++++-...
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d 306 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence 00 000000000000111123456667778889999999999999999999987653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=362.83 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=204.6
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-------DVLKEFASEIEIITALHHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 401 (678)
.++|...+.||+|+||.||++... +|+.||||+++... ...+.+.+|+.++.+++||||+++++++.+.+.+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467889999999999999999875 69999999986432 1356789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC----CcEEeec
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF----EPQLSDF 477 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~----~~kL~DF 477 (678)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999643 568999999999999999999999 9999999999999998877 7999999
Q ss_pred ccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC
Q 041755 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557 (678)
Q Consensus 478 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 557 (678)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+. .+
T Consensus 164 G~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~-------~~ 233 (361)
T 2yab_A 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT-------AV 233 (361)
T ss_dssp SSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-------TT
T ss_pred CCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hc
Confidence 99987755332 234679999999999999999999999999999999999999997654322111111 01
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+. +++..... ....+..++..||..||.+||++.++++
T Consensus 234 ~~~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 234 SYD--FDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCC--CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCC--CCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 00000011 1234667789999999999999999985
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=356.12 Aligned_cols=261 Identities=20% Similarity=0.331 Sum_probs=194.8
Q ss_pred hhcCCCCceeecccCceEEEEEEeCC-C---CEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLPD-G---KELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~~-g---~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 401 (678)
..++|...+.||+|+||.||+|.... + ..||||+++.. ....+.|.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 34689999999999999999998653 3 27999999753 35578899999999999999999999999877654
Q ss_pred ------EEEEEcCCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcE
Q 041755 402 ------LLVYDFLSRGSLEENLHGNK--KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ 473 (678)
Q Consensus 402 ------~lV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~k 473 (678)
++||||+.+|+|.+++.... .....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEE
Confidence 99999999999999986432 222368999999999999999999999 9999999999999999999999
Q ss_pred EeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhccc
Q 041755 474 LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKP 552 (678)
Q Consensus 474 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~ 552 (678)
|+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...........+.
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~---- 253 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI---- 253 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh----
Confidence 999999987755443333334567889999999999999999999999999999999 999998655432211111
Q ss_pred ccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 553 ~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
. +.. .. ........+..++..||+.+|.+||++.++++.|+...
T Consensus 254 --~-~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 254 --G-GNR-----LK----QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp --T-TCC-----CC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --c-CCC-----CC----CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 000 00 11122345777889999999999999999999997544
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=351.47 Aligned_cols=258 Identities=21% Similarity=0.358 Sum_probs=215.2
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
..++|...+.||+|+||.||+|... ++..||||+++......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 3467888899999999999999876 588999999988777778899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++++|.+++.... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 91 ~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 91 MTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred CCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999997642 3568999999999999999999999 899999999999999999999999999998766543
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
. .......||+.|+|||.+.+..++.++||||||+++|+|++ |..||............. . .
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-------~---------~ 228 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------K---------D 228 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-------T---------T
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------c---------c
Confidence 2 23344677889999999999999999999999999999999 999997655332211111 0 0
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
............+..++..||+.+|.+||++.++++.|+...
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 001111122345777889999999999999999999997644
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=383.26 Aligned_cols=257 Identities=21% Similarity=0.362 Sum_probs=212.1
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
..+|...+.||+|+||.||+|... ++..||||+++......+.|.+|+.++++++||||++++++|.+.+.+++||||+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~ 298 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence 356788899999999999999876 4889999999876555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 299 ~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 299 TYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp TTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred CCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999997542 2568999999999999999999999 9999999999999999999999999999987654321
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
.......+|..|+|||++.++.++.++|||||||+||||++ |+.||........... +..+ .
T Consensus 374 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-------~~~~---------~ 436 (495)
T 1opk_A 374 -TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-------LEKD---------Y 436 (495)
T ss_dssp -ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-------HHTT---------C
T ss_pred -eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcC---------C
Confidence 12223456788999999999999999999999999999999 9999976543221111 1111 1
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
...........+..++..||+.+|.+||++.+|++.|+...
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11111222345677889999999999999999999998653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=360.65 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=204.0
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
.++|...+.||+|+||.||+|... +|+.||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 467889999999999999999875 6899999999653 355678899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC---CcEEeecccccc
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF---EPQLSDFGLASW 482 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~---~~kL~DFGla~~ 482 (678)
||+.+|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||++..
T Consensus 108 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999998643 468999999999999999999999 9999999999999998654 599999999987
Q ss_pred cCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+ ..+.+. .
T Consensus 181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i-------~~~~~~-~ 249 (362)
T 2bdw_A 181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI-------KAGAYD-Y 249 (362)
T ss_dssp CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------HHTCCC-C
T ss_pred ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HhCCCC-C
Confidence 654332 23467999999999999999999999999999999999999999765432211111 111110 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+.. ......+..++..||+.||.+||++.++++
T Consensus 250 ~~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 PSPEW-----DTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CTTGG-----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Ccccc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000 111244667789999999999999999985
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=355.80 Aligned_cols=249 Identities=20% Similarity=0.290 Sum_probs=203.3
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-------DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 402 (678)
++|...+.||+|+||.||+|... +|+.||||+++... .....+.+|+.++..++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46888899999999999999875 68999999986432 13577899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC----CcEEeecc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF----EPQLSDFG 478 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~----~~kL~DFG 478 (678)
+||||+++|+|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999643 568999999999999999999999 9999999999999999887 79999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
++........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... .
T Consensus 164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~-----~ 235 (326)
T 2y0a_A 164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-----E 235 (326)
T ss_dssp TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCC-----C
T ss_pred CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCC-----C
Confidence 9987754332 2346799999999999999999999999999999999999999976543221111110000 0
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+. +.... .....+..++..||+.+|.+|||+.++++
T Consensus 236 ~~----~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 FE----DEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CC----HHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cC----ccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 00000 11234667789999999999999999997
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=358.88 Aligned_cols=243 Identities=22% Similarity=0.268 Sum_probs=193.3
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||+||+|... +|+.||||++... ......+..|+..+..+ +||||++++++|.+++.+++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57888999999999999999876 7999999998642 34455566677666665 8999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+ +++|.+++... +..++|..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 77999988754 2469999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
... .....||+.|+|||++.+ .++.++|||||||++|||++|..|+...... . .+..+... +
T Consensus 210 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~-----~~~~~~~~----~ 271 (311)
T 3p1a_A 210 AGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-----Q-----QLRQGYLP----P 271 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-----H-----HHTTTCCC----H
T ss_pred CCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----H-----HHhccCCC----c
Confidence 332 233579999999998875 7999999999999999999997776532110 0 01111111 0
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.. .....+..++..||+.+|.+||++.++++
T Consensus 272 ~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 EFTA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111 12345777889999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=380.98 Aligned_cols=256 Identities=21% Similarity=0.380 Sum_probs=208.9
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
.++|...+.||+|+||.||+|..+++..||||+++......+.|.+|+.++++++||||+++++++. .+..++||||++
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 4577888999999999999999988899999999876656788999999999999999999999986 567899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 266 ~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 266 KGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp TCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred CCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 999999997432 2357899999999999999999999 99999999999999999999999999999876432111
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
......+|..|+|||++..+.++.++|||||||+||||+| |+.||...........+ ..+. ..
T Consensus 341 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-------~~~~-----~~--- 404 (454)
T 1qcf_A 341 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-------ERGY-----RM--- 404 (454)
T ss_dssp -TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-------HHTC-----CC---
T ss_pred -ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCC-----CC---
Confidence 1122456788999999999999999999999999999999 99999765432211111 1110 00
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.........+..++..||+.+|.+||++.+|++.|+...
T Consensus 405 -~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 405 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 001122345777889999999999999999999997543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=359.62 Aligned_cols=255 Identities=20% Similarity=0.382 Sum_probs=203.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCE----EEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKE----LAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~----vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
++|...+.||+|+||.||+|... +|+. ||+|.+.... .....+.+|+.++..++||||++++++|. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 47888899999999999999864 4543 7888875432 33456788999999999999999999986 467899
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+.+|+|.+++... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999753 2468899999999999999999999 99999999999999999999999999999988
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
.............||..|+|||++.++.++.++|||||||++|||++ |+.||...........+.......
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------- 237 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA-------- 237 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC--------
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC--------
Confidence 66555444455778899999999999999999999999999999999 999998765433222221111000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.+. .....+..++..||+.+|.+||++.++++.|+...
T Consensus 238 -~~~-------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 238 -QPQ-------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -CCT-------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -CCC-------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 000 01123556779999999999999999999997543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=361.50 Aligned_cols=253 Identities=25% Similarity=0.354 Sum_probs=203.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE------DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
++|...+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.++..++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46888899999999999999865 79999999986322 135678999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC---cEEeecccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE---PQLSDFGLA 480 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~---~kL~DFGla 480 (678)
||||+++|+|.+.+......+..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998886544444568999999999999999999999 99999999999999987655 999999999
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... +.. .+. .+.+.
T Consensus 181 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~---~i~-~~~~~ 250 (351)
T 3c0i_A 181 IQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LFE---GII-KGKYK 250 (351)
T ss_dssp EECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HHH---HHH-HTCCC
T ss_pred eEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HHH---HHH-cCCCC
Confidence 87755332 223467999999999999999999999999999999999999999764211 100 000 01100
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.+..... ....+..++..||+.||.+||++.++++
T Consensus 251 --~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 --MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000011 1245667789999999999999999985
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=365.58 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=197.1
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKP---SEDVLKEFASEIEIITALH--HRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~~~~~lV~ 405 (678)
.+|...+.||+|+||.||++...+|+.||||++.. .......|.+|+.++..++ ||||+++++++...+.+++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45888899999999999999988899999999864 3456788999999999996 599999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
| +.+++|.+++... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++ ++.+||+|||+++.+..
T Consensus 136 E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 5688999999754 368899999999999999999999 9999999999999996 57999999999998765
Q ss_pred CCCCceecccccCCCCCCcchhcc-----------CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccc
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMH-----------GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL 554 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 554 (678)
...........||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ .
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-~--------- 276 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-K--------- 276 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-H---------
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-H---------
Confidence 443333345689999999999865 4689999999999999999999999975432110 0
Q ss_pred ccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 555 KDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 555 ~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+..++++.....++......+..++..||+.+|.+||++.++++
T Consensus 277 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 277 ----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp ----HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 11112222111111111345667789999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=357.31 Aligned_cols=260 Identities=23% Similarity=0.406 Sum_probs=210.0
Q ss_pred cCCCCceeecccCceEEEEEEe--------CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL--------PDGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDN 399 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~--------~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 399 (678)
++|...+.||+|+||.||+|.. .++..||||+++.. ......+.+|+.++.++ +||||+++++++.+.+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 114 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 114 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCC
Confidence 5788889999999999999985 25778999999753 35677899999999999 8999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKD------------GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS 467 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~ 467 (678)
..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++
T Consensus 115 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~ 191 (334)
T 2pvf_A 115 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 191 (334)
T ss_dssp CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC
T ss_pred ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEc
Confidence 999999999999999999765321 2358999999999999999999999 9999999999999999
Q ss_pred CCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccc
Q 041755 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESL 546 (678)
Q Consensus 468 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 546 (678)
.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|||++ |+.||...........
T Consensus 192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 271 (334)
T 2pvf_A 192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271 (334)
T ss_dssp TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH
T ss_pred CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH
Confidence 999999999999987765443333334567889999999999999999999999999999999 9999976543221111
Q ss_pred hhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCHh
Q 041755 547 VMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEE 609 (678)
Q Consensus 547 ~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~~ 609 (678)
+ ..+.. +.... .....+..++..||+.+|.+||++.++++.|+....
T Consensus 272 ~-------~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 272 L-------KEGHR-----MDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp H-------HHTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H-------hcCCC-----CCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 11100 11111 123456778899999999999999999999976543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=368.08 Aligned_cols=251 Identities=25% Similarity=0.346 Sum_probs=203.5
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
.++|...+.||+|+||.||+|... +|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 467888999999999999999864 78999999986532 45677899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec---CCCCcEEeecccccc
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS---DDFEPQLSDFGLASW 482 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~---~~~~~kL~DFGla~~ 482 (678)
||+.+|+|.+.+... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++..
T Consensus 90 E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999998754 468999999999999999999999 9999999999999998 467899999999987
Q ss_pred cCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+. .+.+. .
T Consensus 163 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~-------~~~~~-~ 232 (444)
T 3soa_A 163 VEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK-------AGAYD-F 232 (444)
T ss_dssp CCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-------HTCCC-C
T ss_pred ecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-------hCCCC-C
Confidence 6553322 234689999999999999999999999999999999999999997654322111111 11110 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+.. . .....+..++..||+.||.+||++.++++
T Consensus 233 ~~~~~-~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 PSPEW-D----TVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CTTTT-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred Ccccc-c----cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00110 1 11234667789999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=359.86 Aligned_cols=261 Identities=23% Similarity=0.370 Sum_probs=211.0
Q ss_pred hcCCCCceeecccCceEEEEEEeC-C-----CCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCe
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-D-----GKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNN 400 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~-----g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 400 (678)
.++|...+.||+|+||.||+|... . ++.||+|+++.. ....+.+.+|+.++..+ +||||+++++++...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 367888999999999999999864 2 348999999764 35567899999999999 89999999999999999
Q ss_pred EEEEEEcCCCCCHHHHhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC
Q 041755 401 LLLVYDFLSRGSLEENLHGNKK----------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF 470 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~----------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~ 470 (678)
.++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCC
Confidence 9999999999999999864321 13468999999999999999999999 9999999999999999999
Q ss_pred CcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhh
Q 041755 471 EPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMW 549 (678)
Q Consensus 471 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~ 549 (678)
.+||+|||++................||+.|+|||.+.+..++.++|||||||++|||+| |..||......... ..
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--~~- 278 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--YK- 278 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--HH-
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--HH-
Confidence 999999999987765544444445678899999999999999999999999999999999 99999765432211 00
Q ss_pred cccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 550 AKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 550 ~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
....+ ..+.. .......+..++..||+.+|.+||++.+|++.|+...
T Consensus 279 ---~~~~~-----~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 279 ---LVKDG-----YQMAQ----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp ---HHHHT-----CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHhcC-----CCCCC----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 11110 00001 1111245677889999999999999999999997544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=345.49 Aligned_cols=249 Identities=30% Similarity=0.472 Sum_probs=194.0
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE-----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
.++|...+.||+|+||.||+|.. .|+.||||+++... ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 35788899999999999999987 58999999987532 2357789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC---eeeccCCCCCeEecC--------CCCcE
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP---VIHKDVKSSNILLSD--------DFEPQ 473 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~---iiHrDIKp~NILl~~--------~~~~k 473 (678)
|||+++++|.+++.. ..+++..++.++.|++.||.|||+ ++ |+||||||+|||++. ++.+|
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceE
Confidence 999999999999853 468999999999999999999999 67 999999999999986 77899
Q ss_pred EeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc
Q 041755 474 LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI 553 (678)
Q Consensus 474 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 553 (678)
|+|||++........ ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.............
T Consensus 157 l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----- 227 (271)
T 3dtc_A 157 ITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA----- 227 (271)
T ss_dssp ECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-----
T ss_pred EccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh-----
Confidence 999999986654322 23578999999999999999999999999999999999999997654322111000
Q ss_pred cccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 554 LKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 554 ~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
. +. ............+..++..||+.+|.+||++.++++.|+.
T Consensus 228 -~-~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 -M-NK--------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp -T-SC--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred -c-CC--------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0 00 0011111223457778899999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=363.04 Aligned_cols=247 Identities=26% Similarity=0.362 Sum_probs=199.1
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 403 (678)
.++|...+.||+|+||.||+|... +|+.||||+++... .....+.+|..++..+ +||||+++++++.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999875 68999999997532 3356678999999998 69999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+++|+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999753 458999999999999999999999 99999999999999999999999999999864
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. . +.+
T Consensus 175 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~-~~~---- 241 (353)
T 3txo_A 175 ICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL------N-DEV---- 241 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-CCC----
T ss_pred ccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH------c-CCC----
Confidence 33222 2234689999999999999999999999999999999999999998765432211111 0 100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCH------HHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQI------NLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~------~eVl~ 602 (678)
.+... ....+..++..||+.+|.+||++ .++++
T Consensus 242 --~~p~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 --VYPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --CCCTT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCCCC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 01111 22346667899999999999998 66664
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=353.97 Aligned_cols=268 Identities=22% Similarity=0.355 Sum_probs=214.9
Q ss_pred HHHHHHhhcCCCCceeecccCceEEEEEEe------CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEE
Q 041755 323 YQELLSATSNFLPEYLVGKGGHSHVYRGCL------PDGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFG 393 (678)
Q Consensus 323 ~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~------~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g 393 (678)
..+.....++|...+.||+|+||.||+|.. .+++.||||+++.. ......+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 334444567899999999999999999973 35789999999764 35567899999999999 7999999999
Q ss_pred EEEeCC-eEEEEEEcCCCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCC
Q 041755 394 FCFEDN-NLLLVYDFLSRGSLEENLHGNKKD------------GNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVK 460 (678)
Q Consensus 394 ~~~~~~-~~~lV~E~~~~gsL~~~L~~~~~~------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIK 460 (678)
++...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+ .+|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCc
Confidence 997754 589999999999999999765321 2238999999999999999999999 999999999
Q ss_pred CCCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCC
Q 041755 461 SSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSEN 539 (678)
Q Consensus 461 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~ 539 (678)
|+|||++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999988766555445555778999999999999999999999999999999998 999997654
Q ss_pred CcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 540 PKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 540 ~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.... +.. .+..+.. ...... ....+..++..||+.+|.+||++.++++.|+...
T Consensus 256 ~~~~--~~~----~~~~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 256 IDEE--FCR----RLKEGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp CSHH--HHH----HHHHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHH--HHH----HhccCcc-----CCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 3211 100 0111100 011111 1234677789999999999999999999997544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.33 Aligned_cols=263 Identities=20% Similarity=0.275 Sum_probs=199.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|...+.||+|+||+||+|... +|+.||||+++.. ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57888999999999999999875 6899999998643 3456788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+.+ +|.+.+... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 666665432 2568999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCceecccccCCCCCCcchhccCC-CCccceEeehhHHHHHHhcCCCCCCCCCCcc-cccchhhcccccccCc---ccc
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGK-VSEKIDVYAFGIVLLELLSGKKPINSENPKG-QESLVMWAKPILKDGK---VSQ 561 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~-~~~l~~~~~~~~~~~~---~~~ 561 (678)
... .....||+.|+|||++.+.. ++.++|||||||++|||++|..||....... ....+........... ...
T Consensus 155 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 VRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 222 23457899999999998766 7999999999999999999888864432211 1100000000000000 000
Q ss_pred ccC---------CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 562 LLD---------PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 562 l~d---------p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.+ ..............+..++..||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 00000111122345667889999999999999999985
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=346.11 Aligned_cols=255 Identities=23% Similarity=0.391 Sum_probs=209.4
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|...+.||+|+||.||+|...+++.||+|+++......+.+.+|++++..++||||+++++++.+.+..++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 56788899999999999999988889999999987654557899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
++|.+++... ...+++..++.++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++........ .
T Consensus 88 ~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~ 160 (267)
T 3t9t_A 88 GCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T 160 (267)
T ss_dssp CBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred CcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence 9999999754 2468999999999999999999999 9999999999999999999999999999987643211 1
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
......||..|+|||.+.+..++.++||||||+++|+|++ |+.||...........+ ..+ ..+....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i-------~~~-----~~~~~~~ 228 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------STG-----FRLYKPR 228 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------HTT-----CCCCCCT
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH-------hcC-----CcCCCCc
Confidence 1123467888999999999999999999999999999999 89999765432211100 011 0001111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.....+..++..||+.+|.+||++.++++.|+...
T Consensus 229 ----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 229 ----LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11245667789999999999999999999997543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=356.69 Aligned_cols=260 Identities=18% Similarity=0.209 Sum_probs=207.8
Q ss_pred hcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
.++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+|+.++..+ +||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 46789999999999999999986 4789999999864321 24578999999999 899999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC-----cEEeecccccc
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE-----PQLSDFGLASW 482 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~-----~kL~DFGla~~ 482 (678)
+ +++|.+++... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 87 L-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred C-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9 99999999754 3579999999999999999999999 99999999999999998887 99999999997
Q ss_pred cCCCCCCc-----eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC
Q 041755 483 LSTSSSHL-----TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557 (678)
Q Consensus 483 ~~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 557 (678)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||................ ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~~ 235 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG----DT 235 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH----HH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH----hh
Confidence 65433221 1234689999999999999999999999999999999999999998765433221111100 00
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 558 ~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
...... ..+... ...+..++..||+.+|.+||++.+|++.|+..
T Consensus 236 ~~~~~~-~~~~~~-----~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 236 KRATPI-EVLCEN-----FPEMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHHSCH-HHHTTT-----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hccCCH-HHHhcc-----ChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 000000 000011 11677788999999999999999999999743
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=348.18 Aligned_cols=263 Identities=21% Similarity=0.335 Sum_probs=199.1
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|+||.||+|...+|+.||||+++... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788889999999999999998889999999986532 2346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+.+ +|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 975 999988643 2468999999999999999999999 999999999999999999999999999998765432
Q ss_pred CCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc---cc--c
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK---VS--Q 561 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~---~~--~ 561 (678)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+........... .. .
T Consensus 155 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T 1ob3_A 155 RK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccc
Confidence 22 2335789999999999764 589999999999999999999999976543221111000000000000 00 0
Q ss_pred ccCCCCCC-------CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 562 LLDPSLDT-------DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 562 l~dp~l~~-------~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+++.+.. .+.......+..++..||+.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01111110 001112345667889999999999999999885
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=351.25 Aligned_cols=265 Identities=21% Similarity=0.291 Sum_probs=199.1
Q ss_pred hhcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCC------hHHHHHHHHHHHHHHhc---CCCCeeeEEEEEEeC
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPS------EDVLKEFASEIEIITAL---HHRNIISLFGFCFED 398 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~------~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~~ 398 (678)
.+++|...+.||+|+||.||+|.. .+|+.||||+++.. ......+.+|+.++..+ +||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 457899999999999999999986 47899999998631 11234566777776666 499999999999876
Q ss_pred C-----eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcE
Q 041755 399 N-----NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ 473 (678)
Q Consensus 399 ~-----~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~k 473 (678)
. ..++||||+. |+|.+++.... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEE
Confidence 5 5899999996 69999997543 2448999999999999999999999 9999999999999999999999
Q ss_pred EeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc
Q 041755 474 LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI 553 (678)
Q Consensus 474 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 553 (678)
|+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......
T Consensus 161 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999987654332 23468999999999999999999999999999999999999999876543322111111000
Q ss_pred cccCcccc-------ccCCCCCC---CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 554 LKDGKVSQ-------LLDPSLDT---DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 554 ~~~~~~~~-------l~dp~l~~---~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.....+.. .+.+.... ....+....+..++..||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000000 00000000 000112345677889999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.85 Aligned_cols=270 Identities=24% Similarity=0.349 Sum_probs=203.1
Q ss_pred HHHHHHhhcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHh--cCCCCeeeEEEEEEeC--
Q 041755 323 YQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITA--LHHRNIISLFGFCFED-- 398 (678)
Q Consensus 323 ~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~-- 398 (678)
...-....++|...+.||+|+||.||+|.. .|+.||||++..... ..+..|.+++.. ++||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc--chhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 333344557899999999999999999987 489999999975443 344555565555 4899999999999887
Q ss_pred --CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC--------CeeeccCCCCCeEecC
Q 041755 399 --NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ--------PVIHKDVKSSNILLSD 468 (678)
Q Consensus 399 --~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~--------~iiHrDIKp~NILl~~ 468 (678)
...++||||+++|+|.+++... .+++..++.++.|++.||.|||+ . +|+||||||+|||++.
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECT
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECC
Confidence 7899999999999999999643 58999999999999999999998 6 9999999999999999
Q ss_pred CCCcEEeecccccccCCCCCCc--eecccccCCCCCCcchhccCCCCcc------ceEeehhHHHHHHhcC---------
Q 041755 469 DFEPQLSDFGLASWLSTSSSHL--TCTDVAGTFGYLAPEYFMHGKVSEK------IDVYAFGIVLLELLSG--------- 531 (678)
Q Consensus 469 ~~~~kL~DFGla~~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~~~s~k------sDVwSlGvvL~eLltG--------- 531 (678)
++.+||+|||++..+....... ......||+.|+|||++.+...+.+ +|||||||++|||++|
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999998765433221 1224579999999999988776665 9999999999999999
Q ss_pred -CCCCCCCCCcccccchhhcccccccCccccccCCCCCCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCHh
Q 041755 532 -KKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDY-DNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEE 609 (678)
Q Consensus 532 -~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~-~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~~ 609 (678)
+.||............. ..... .....+.+...+ .......+..++..||+.+|.+||++.+|++.|+...+
T Consensus 258 ~~~p~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 258 YQLPYHDLVPSDPSYEDM--REIVC----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp CCCTTTTTSCSSCCHHHH--HHHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccHhhhcCCCCchhhh--HHHHh----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 55554332221110000 00000 011111111111 12566778899999999999999999999999975443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=371.03 Aligned_cols=263 Identities=23% Similarity=0.268 Sum_probs=209.4
Q ss_pred ccHHHHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 041755 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFC 395 (678)
Q Consensus 321 f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 395 (678)
+.+.++...+++|...++||+|+||+||+|... +|+.||||+++... .....+.+|+.++..++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 445666777889999999999999999999876 57899999997432 1123488999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEe
Q 041755 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLS 475 (678)
Q Consensus 396 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~ 475 (678)
.+.+.+||||||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++||||||||+||||+.++.+||+
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence 9999999999999999999999753 2568999999999999999999999 999999999999999999999999
Q ss_pred ecccccccCCCCCCceecccccCCCCCCcchhc-----cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhc
Q 041755 476 DFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA 550 (678)
Q Consensus 476 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~ 550 (678)
|||+++........ .....+||+.|+|||++. .+.++.++|||||||++|||++|+.||...+.......+...
T Consensus 218 DFGla~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~ 296 (437)
T 4aw2_A 218 DFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 296 (437)
T ss_dssp CCTTCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred chhhhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhc
Confidence 99999876543322 223468999999999997 567999999999999999999999999876543221111100
Q ss_pred ccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHH
Q 041755 551 KPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTV--RPQINLVLK 602 (678)
Q Consensus 551 ~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~--RPs~~eVl~ 602 (678)
.. .+--|......+ ..+..++..||..+|.+ ||++.++++
T Consensus 297 ~~--------~~~~p~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 297 KE--------RFQFPTQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HH--------HCCCCSSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cc--------cccCCcccccCC----HHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 00 000011111122 33556668888888877 999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=370.05 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=204.0
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-eEEEEEEcC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDN-NLLLVYDFL 408 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-~~~lV~E~~ 408 (678)
.++|...+.||+|+||.||+|.. .|+.||||+++... ..+.|.+|+.++++++||||+++++++.+.+ ..++||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 45778889999999999999988 57899999998654 4567999999999999999999999998765 799999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++|+|.+++.... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp TTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence 9999999997542 2457999999999999999999999 999999999999999999999999999998543321
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
....++..|+|||.+.++.++.++|||||||+||||++ |+.||........... +..+.
T Consensus 344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-------i~~~~--------- 403 (450)
T 1k9a_A 344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------VEKGY--------- 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-------HHTTC---------
T ss_pred ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC---------
Confidence 12357889999999999999999999999999999998 9999976543321111 11111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
....+......+..++..||+.+|.+||++.++++.|+.
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 001111223456777899999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=346.74 Aligned_cols=255 Identities=20% Similarity=0.325 Sum_probs=195.6
Q ss_pred hcCCCCceeecccCceEEEEEEeC----CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP----DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~----~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
.++|...+.||+|+||.||+|... .+..||+|+++.. ....+.|.+|+.++++++||||+++++++. ++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 357888899999999999999864 2457999998753 356678999999999999999999999984 567899
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999999754 2468999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||...........+. .+..
T Consensus 167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-------~~~~--- 235 (281)
T 1mp8_A 167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NGER--- 235 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTCC---
T ss_pred Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-------cCCC---
Confidence 543322 1223457889999999999999999999999999999997 999998654432111111 1110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
+.+.. .....+..++..||+.+|.+||++.++++.|+...
T Consensus 236 --~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 236 --LPMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp --CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00111 22345667889999999999999999999997644
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=350.02 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=195.4
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---------------------------HHHHHHHHHHHHHH
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---------------------------DVLKEFASEIEIIT 381 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---------------------------~~~~~~~~Ei~il~ 381 (678)
.++|...+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367889999999999999999865 68999999986532 12356889999999
Q ss_pred hcCCCCeeeEEEEEEe--CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccC
Q 041755 382 ALHHRNIISLFGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDV 459 (678)
Q Consensus 382 ~l~HpnIv~l~g~~~~--~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDI 459 (678)
+++||||+++++++.+ .+..++||||+++++|.+++. ...+++.+++.++.|++.||.|||+ ++|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence 9999999999999986 568999999999999987653 2468999999999999999999999 99999999
Q ss_pred CCCCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCC---CCccceEeehhHHHHHHhcCCCCCC
Q 041755 460 KSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK---VSEKIDVYAFGIVLLELLSGKKPIN 536 (678)
Q Consensus 460 Kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~ 536 (678)
||+|||++.++.+||+|||++........ ......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999987654332 223467999999999997765 4788999999999999999999997
Q ss_pred CCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 537 SENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 537 ~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..........+ ..+.... + ..... ...+..++..||+.||.+||++.++++
T Consensus 242 ~~~~~~~~~~~-------~~~~~~~---~-~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERIMCLHSKI-------KSQALEF---P-DQPDI----AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSHHHHHHHH-------HHCCCCC---C-SSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccHHHHHHHH-------hcccCCC---C-Ccccc----CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 64322111100 0000000 0 01111 244677789999999999999999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.62 Aligned_cols=263 Identities=22% Similarity=0.350 Sum_probs=191.0
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.++|...+.||+|+||.||+|... +|+.||||+++... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467888999999999999999865 68999999986532 334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 407 FLSRGSLEENLHGNK--KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|++ |+|.+++.... .....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999886432 222458999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccc--------
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILK-------- 555 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~-------- 555 (678)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.......+........
T Consensus 160 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 43222 224578999999999976 4689999999999999999999999987654322111110000000
Q ss_pred -------------cCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 556 -------------DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 556 -------------~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
...+.+.+.+...... ...+..++..||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPL----DGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCC----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccC----CHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0001111111111122 235777889999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=362.59 Aligned_cols=248 Identities=26% Similarity=0.385 Sum_probs=202.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||++... +|+.||||++.... .....+.+|+.++..++||||++++++|.+.+.+|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57888899999999999999865 68999999986432 23567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+.+|+|..++... ..+++..++.++.||+.||.|||+ .+|+||||||+||||+.++.+||+|||++..+..
T Consensus 95 e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999643 468999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCceecccccCCCCCCcchhcc---CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMH---GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
... .....||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+...... ..
T Consensus 168 ~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----~~---- 236 (384)
T 4fr4_A 168 ETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----TV---- 236 (384)
T ss_dssp TCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----CC----
T ss_pred CCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----cc----
Confidence 332 234689999999999974 4589999999999999999999999976544332222111100 00
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ-INLVLK 602 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs-~~eVl~ 602 (678)
.. ++......+..++..||+.+|.+||+ +.+|++
T Consensus 237 --~~----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 --VT----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp --CC----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred --cC----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00 11122345677889999999999998 666654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=375.34 Aligned_cols=255 Identities=23% Similarity=0.408 Sum_probs=203.1
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
.++|...+.||+|+||.||+|...++..||||+++......+.|.+|+.++++++||||+++++++.+ +..++||||++
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 35677888999999999999999888889999998765445789999999999999999999999876 67899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+|+|.+++.... +..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 262 ~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 262 KGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 999999996421 2458999999999999999999999 99999999999999999999999999999876543222
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
......+|..|+|||.+.++.++.++|||||||+||||++ |+.||........... +..+. .
T Consensus 337 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-------i~~~~---------~ 399 (452)
T 1fmk_A 337 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------VERGY---------R 399 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTTC---------C
T ss_pred -cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC---------C
Confidence 1223457889999999999999999999999999999999 9999976543221111 11110 0
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
...+......+..++..||+.+|.+||++.++++.|+..
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~ 438 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTT
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011112234567788999999999999999999999754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=353.39 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=198.6
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-------
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDN------- 399 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------- 399 (678)
.++|...+.||+|+||.||+|... +|+.||||+++.. ....+.+.+|+.++++++||||++++++|.+.+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 357888999999999999999876 7999999998643 346678999999999999999999999987654
Q ss_pred --------------------------------------------------eEEEEEEcCCCCCHHHHhccCCCCCCCCCH
Q 041755 400 --------------------------------------------------NLLLVYDFLSRGSLEENLHGNKKDGNAFGW 429 (678)
Q Consensus 400 --------------------------------------------------~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~ 429 (678)
..++||||+++|+|.+++.... ......+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 2899999999999999997653 2345677
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC----------ceecccccCC
Q 041755 430 TERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH----------LTCTDVAGTF 499 (678)
Q Consensus 430 ~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~Gt~ 499 (678)
..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 8899999999999999999 99999999999999999999999999999887654221 1223457999
Q ss_pred CCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHH
Q 041755 500 GYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERM 579 (678)
Q Consensus 500 ~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l 579 (678)
.|+|||++.+..++.++|||||||++|||++|..|+.... ..... ...+.... ........+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~~~~~----~~~~~~~~---------~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RIITD----VRNLKFPL---------LFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----HHHHH----HHTTCCCH---------HHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----HHHHH----hhccCCCc---------ccccCChhH
Confidence 9999999999999999999999999999999877642110 00000 00000000 011223456
Q ss_pred HHHHHhcccCCCCCCCCHHHHHH
Q 041755 580 VLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 580 ~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..++..||+.+|.+||++.++++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHHccCCCCcCCCHHHHhh
Confidence 77889999999999999999986
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=359.95 Aligned_cols=251 Identities=22% Similarity=0.266 Sum_probs=205.3
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
.++|...+.||+|+||.||+|... +|+.||+|++... ......+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467889999999999999999875 7899999999764 34556789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC--CCCcEEeecccccccCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD--DFEPQLSDFGLASWLST 485 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~--~~~~kL~DFGla~~~~~ 485 (678)
+.+|+|.+++... ...+++..++.++.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 9999999998643 2468999999999999999999999 99999999999999974 47799999999987755
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.. +.+ .+++
T Consensus 204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~-------~~~--~~~~ 271 (387)
T 1kob_A 204 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR-------CDW--EFDE 271 (387)
T ss_dssp TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH-------CCC--CCCS
T ss_pred Ccc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCC--CCCc
Confidence 332 2235799999999999999999999999999999999999999986543221111110 000 0111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
...... ...+..++..||+.||.+||++.++++
T Consensus 272 ~~~~~~----s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 272 DAFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp STTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccccC----CHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 111112 244667889999999999999999996
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=345.76 Aligned_cols=262 Identities=17% Similarity=0.220 Sum_probs=209.1
Q ss_pred hcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
.++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.++..+ +|+|++++++++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 46789999999999999999985 479999999986433 234578899999999 799999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC-----cEEeecccccc
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE-----PQLSDFGLASW 482 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~-----~kL~DFGla~~ 482 (678)
+ +++|.+++... +..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||++..
T Consensus 88 ~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 88 L-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9 99999999754 2468999999999999999999999 99999999999999987776 99999999987
Q ss_pred cCCCCCC-----ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC
Q 041755 483 LSTSSSH-----LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557 (678)
Q Consensus 483 ~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 557 (678)
....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 7654322 12234679999999999999999999999999999999999999998755433222111110000000
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 558 ~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.... +... ....+..++..||+.+|.+||++.+|++.|+...
T Consensus 241 ~~~~-----~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 241 PLRE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp CHHH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cHHH-----HHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 0000 1111 1245677889999999999999999999997543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=347.13 Aligned_cols=255 Identities=22% Similarity=0.382 Sum_probs=207.6
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
.++|...+.||+|+||.||+|...++..||||+++......+.|.+|+++++.++||||+++++++.. +..++||||++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 90 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence 35788889999999999999998888899999998765556789999999999999999999999864 56899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+++|.+++.... +..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 91 ~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 91 NGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999996421 1368999999999999999999999 99999999999999999999999999999876543221
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
......+|..|+|||.+.++.++.++||||||+++|||++ |+.||........... +..+ ..+...
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-------~~~~-----~~~~~~ 232 (279)
T 1qpc_A 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-------LERG-----YRMVRP 232 (279)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTT-----CCCCCC
T ss_pred -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH-------Hhcc-----cCCCCc
Confidence 2223567889999999999999999999999999999999 9999976543221110 0111 001111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
. .....+..++..||+.+|.+||++.++++.|+..
T Consensus 233 ~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 233 D----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred c----cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 1 1234567788999999999999999999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.04 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=193.6
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|+||.||+|... ..||||+++. .....+.|.+|+.++++++||||+++++++ ..+..++||||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 100 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 100 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred cceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence 57888999999999999999864 3599999874 345678899999999999999999999966 45678999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+.+++|.+++... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 101 CEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred cCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999999643 3568999999999999999999999 999999999999999999999999999998765433
Q ss_pred CCceecccccCCCCCCcchhc---cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
.........||+.|+|||.+. +..++.++||||||+++|+|++|+.||........ +.. .+..+.....+.
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~----~~~~~~~~~~~~ 248 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIE----MVGRGSLSPDLS 248 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHH----HHHHTSCCCCTT
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHH----HhcccccCcchh
Confidence 333334567999999999986 56788999999999999999999999976543221 111 111111111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.+ .......+..++..||+.+|.+||++.++++.|+..
T Consensus 249 -~~----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l 286 (289)
T 3og7_A 249 -KV----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286 (289)
T ss_dssp -SS----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred -hc----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 01 112235577788999999999999999999999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=358.31 Aligned_cols=206 Identities=23% Similarity=0.318 Sum_probs=179.4
Q ss_pred hcCCCCceeeccc--CceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 330 TSNFLPEYLVGKG--GHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 330 t~~f~~~~~IG~G--~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
.++|...+.||+| +||.||+|... +|+.||||+++.. ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678889999999 99999999876 7999999999643 4566788899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+++|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999997642 2458999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCCC-----CceecccccCCCCCCcchhcc--CCCCccceEeehhHHHHHHhcCCCCCCCCCC
Q 041755 484 STSSS-----HLTCTDVAGTFGYLAPEYFMH--GKVSEKIDVYAFGIVLLELLSGKKPINSENP 540 (678)
Q Consensus 484 ~~~~~-----~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 540 (678)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 32211 111223478999999999987 5799999999999999999999999976544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=359.71 Aligned_cols=252 Identities=20% Similarity=0.247 Sum_probs=193.2
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
.++|...+.||+|+||.||++... +|+.||||++.......+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 357888999999999999999876 7899999999765544567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC--cEEeecccccccCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE--PQLSDFGLASWLSTS 486 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~--~kL~DFGla~~~~~~ 486 (678)
++|+|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||+++.....
T Consensus 99 ~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 99 SGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 999999998643 458999999999999999999999 99999999999999987776 999999999754332
Q ss_pred CCCceecccccCCCCCCcchhccCCCCcc-ceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEK-IDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~k-sDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
.. .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............ ...+. ..
T Consensus 172 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~---------~~ 237 (361)
T 3uc3_A 172 SQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRIL---------SV 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHH---------TT
T ss_pred CC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHh---------cC
Confidence 21 233579999999999988888766 89999999999999999999765432211110 00000 00
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.............+..++..||+.+|.+|||+.++++
T Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 0000000011244667889999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=355.90 Aligned_cols=251 Identities=16% Similarity=0.203 Sum_probs=203.5
Q ss_pred hcCCCCceeecccCceEEEEEE------eCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCe
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGC------LPDGKELAVKILKPSEDVLKEFASEIEIITALH---HRNIISLFGFCFEDNN 400 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~------~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~ 400 (678)
.++|...+.||+|+||.||+|. ..+++.||||+++... ..++..|++++..++ |+||+.+++++...+.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 4678889999999999999994 4478999999998653 346778888888887 9999999999999999
Q ss_pred EEEEEEcCCCCCHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC-----------
Q 041755 401 LLLVYDFLSRGSLEENLHGNKK-DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD----------- 468 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~-~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~----------- 468 (678)
.++||||+++|+|.+++..... ....+++..++.|+.||+.||.|||+ .+||||||||+||||+.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccc
Confidence 9999999999999999975322 24579999999999999999999999 99999999999999998
Q ss_pred CCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchh
Q 041755 469 DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVM 548 (678)
Q Consensus 469 ~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~ 548 (678)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------ 292 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE------ 292 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE------
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc------
Confidence 89999999999987654444444556789999999999999999999999999999999999999985432211
Q ss_pred hcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCC-CCHHHHHHHhhc
Q 041755 549 WAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVR-PQINLVLKLLQG 606 (678)
Q Consensus 549 ~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~R-Ps~~eVl~~L~~ 606 (678)
|. +...+......+ .+..++..|++.+|.+| |++.++.+.|+.
T Consensus 293 ~~------------~~~~~~~~~~~~---~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~ 336 (365)
T 3e7e_A 293 CK------------PEGLFRRLPHLD---MWNEFFHVMLNIPDCHHLPSLDLLRQKLKK 336 (365)
T ss_dssp EE------------ECSCCTTCSSHH---HHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred ee------------echhccccCcHH---HHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence 00 111111112233 34455688899999998 678888877764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=359.89 Aligned_cols=246 Identities=24% Similarity=0.308 Sum_probs=196.0
Q ss_pred CceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCC
Q 041755 335 PEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGS 412 (678)
Q Consensus 335 ~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 412 (678)
..++||+|+||.||+|... +|+.||+|+++... ...+.|.+|++++.+++||||+++++++.+.+.+++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3567999999999999864 79999999998654 566789999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe--cCCCCcEEeecccccccCCCCCCc
Q 041755 413 LEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL--SDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 413 L~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl--~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|.+++... ...+++..++.++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.+......
T Consensus 173 L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~- 245 (373)
T 2x4f_A 173 LFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL- 245 (373)
T ss_dssp EHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC-
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc-
Confidence 99988643 2468999999999999999999999 999999999999999 56789999999999877553322
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
....||+.|+|||++.++.++.++|||||||++|||++|+.||...+.......+..... . +.+.....
T Consensus 246 --~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~-----~----~~~~~~~~ 314 (373)
T 2x4f_A 246 --KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW-----D----LEDEEFQD 314 (373)
T ss_dssp --CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-----C----SCSGGGTT
T ss_pred --ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-----C----CChhhhcc
Confidence 235799999999999999999999999999999999999999986553321111110000 0 00000011
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+ ...+..++..||+.+|.+||++.++++
T Consensus 315 ~----~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 I----SEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp S----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 245677789999999999999999997
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=354.80 Aligned_cols=245 Identities=20% Similarity=0.330 Sum_probs=201.1
Q ss_pred hcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
.++|...+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36788999999999999999986 478999999986432 2235788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+ +|+|.+++... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 78999988643 468999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhccCCC-CccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
..... ...+||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||........... +..+..
T Consensus 160 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-------i~~~~~---- 225 (336)
T 3h4j_B 160 DGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-------VNSCVY---- 225 (336)
T ss_dssp TSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-------CCSSCC----
T ss_pred CCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-------HHcCCC----
Confidence 54322 23579999999999988776 7899999999999999999999976543221111 011100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.. .....+..++..||+.||.+|||+.++++
T Consensus 226 --~~p~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 226 --VMPD----FLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp --CCCT----TSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred --CCcc----cCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0111 11234667789999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=355.34 Aligned_cols=269 Identities=17% Similarity=0.334 Sum_probs=215.0
Q ss_pred ccHHHHHHhhcCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEE
Q 041755 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLF 392 (678)
Q Consensus 321 f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~ 392 (678)
|..++.....++|...+.||+|+||.||+|... +++.||||++... ......|.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 334444455678999999999999999999753 3788999999754 35567799999999999999999999
Q ss_pred EEEEeCCeEEEEEEcCCCCCHHHHhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe
Q 041755 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNK------KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL 466 (678)
Q Consensus 393 g~~~~~~~~~lV~E~~~~gsL~~~L~~~~------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl 466 (678)
+++.+.+..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+ ++|+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEE
Confidence 99999999999999999999999986432 112457899999999999999999999 999999999999999
Q ss_pred cCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCccccc
Q 041755 467 SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQES 545 (678)
Q Consensus 467 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~ 545 (678)
+.++.+||+|||++................||+.|+|||.+.++.++.++||||||+++|+|++ |+.||..........
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 251 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence 9999999999999987655433333334567899999999999999999999999999999999 899997654322111
Q ss_pred chhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 546 LVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 546 l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
. +..+.... . .......+..++..||+.+|.+||++.++++.|+...
T Consensus 252 ~-------~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 252 F-------VMEGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp H-------HHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred H-------HHcCCcCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1 11111100 1 1112344667889999999999999999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=354.99 Aligned_cols=261 Identities=25% Similarity=0.285 Sum_probs=201.5
Q ss_pred HHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 041755 326 LLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS------EDVLKEFASEIEIITALHHRNIISLFGFCFED 398 (678)
Q Consensus 326 l~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 398 (678)
+....++|...+.||+|+||.||+|... +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 4455678999999999999999999875 7889999998642 24567899999999999999999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHhccCCCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 041755 399 NNLLLVYDFLSRGSLEENLHGNKKD------------------------------------GNAFGWTERYKVAVGVAEA 442 (678)
Q Consensus 399 ~~~~lV~E~~~~gsL~~~L~~~~~~------------------------------------~~~l~~~~~~~ia~qia~a 442 (678)
+..++||||+++|+|.+++...... ...+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998531110 1224677888999999999
Q ss_pred HHHHHhcCCCCeeeccCCCCCeEecCCC--CcEEeecccccccCCCCC--CceecccccCCCCCCcchhcc--CCCCccc
Q 041755 443 LDYLHNSCEQPVIHKDVKSSNILLSDDF--EPQLSDFGLASWLSTSSS--HLTCTDVAGTFGYLAPEYFMH--GKVSEKI 516 (678)
Q Consensus 443 L~yLH~~~~~~iiHrDIKp~NILl~~~~--~~kL~DFGla~~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~--~~~s~ks 516 (678)
|.|||+ .+|+||||||+|||++.++ .+||+|||++..+..... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999 9999999999999998776 899999999987644222 112334679999999999975 6789999
Q ss_pred eEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 041755 517 DVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ 596 (678)
Q Consensus 517 DVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs 596 (678)
|||||||++|||++|+.||...........+....... ..+.. ......+..++..||+.+|.+||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCF--------ENPNY-----NVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCT--------TSGGG-----GGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhccccc--------CCccc-----ccCCHHHHHHHHHHcCCChhHCCC
Confidence 99999999999999999997655432211111000000 00000 011345667889999999999999
Q ss_pred HHHHHH
Q 041755 597 INLVLK 602 (678)
Q Consensus 597 ~~eVl~ 602 (678)
+.++++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999986
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=354.37 Aligned_cols=251 Identities=25% Similarity=0.352 Sum_probs=188.9
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
..++|...+.||+|+||.||+|... +++.||||+++... ..+.+.+|++++.+++||||++++++|.+.+..++||||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 3567889999999999999999876 68899999997643 345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC---CCCcEEeecccccccC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD---DFEPQLSDFGLASWLS 484 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~---~~~~kL~DFGla~~~~ 484 (678)
+++|+|.+++... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++...
T Consensus 130 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 130 VTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999643 468999999999999999999999 99999999999999975 8899999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ +.. .+. .+... ...
T Consensus 203 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~---~i~-~~~~~-~~~ 272 (349)
T 2w4o_A 203 HQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFR---RIL-NCEYY-FIS 272 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHH---HHH-TTCCC-CCT
T ss_pred cccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHH---HHH-hCCCc-cCC
Confidence 4321 2346799999999999999999999999999999999999999976543211 000 001 11100 001
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+. .......+..++..||+.||.+||++.++++
T Consensus 273 ~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 PW-----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ch-----hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 1112345667889999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.43 Aligned_cols=248 Identities=17% Similarity=0.345 Sum_probs=202.4
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFED--NNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~lV~ 405 (678)
++|...+.||+|+||.||+|.. +|+.||||+++.. ....+.|.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 5788889999999999999998 5899999999753 35567899999999999999999999999876 7889999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP--VIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~--iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++.++|+|||++...
T Consensus 89 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 9999999999997542 2468999999999999999999998 78 999999999999999999999999987543
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCc---cceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSE---KIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~---ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
.. ....||+.|+|||.+.+..++. ++|||||||++|||++|+.||........... ....+
T Consensus 164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------~~~~~--- 227 (271)
T 3kmu_A 164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK------VALEG--- 227 (271)
T ss_dssp SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH------HHHSC---
T ss_pred cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH------HHhcC---
Confidence 22 2357899999999998765554 79999999999999999999976543221110 01110
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
..+.+.... ...+..++..||+.+|.+||++.++++.|+.
T Consensus 228 --~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~ 267 (271)
T 3kmu_A 228 --LRPTIPPGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEK 267 (271)
T ss_dssp --CCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --CCCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 111121222 3446777899999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=350.22 Aligned_cols=243 Identities=25% Similarity=0.368 Sum_probs=202.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||++... +|+.||+|+++... ...+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57888999999999999999875 79999999997532 23466789999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999753 468999999999999999999999 9999999999999999999999999999987644
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... ++. +.+
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------i~~-~~~------ 220 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK------ILN-AEL------ 220 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHH-CCC------
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH------HHh-CCC------
Confidence 2 1236799999999999999999999999999999999999999976543221111 111 000
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~ 602 (678)
.+...+ ...+..++..||+.+|.+|| ++.++++
T Consensus 221 ~~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 RFPPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 111112 23466777999999999999 7888874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=361.67 Aligned_cols=248 Identities=17% Similarity=0.315 Sum_probs=196.3
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...++||+|+||+||+|... +++.||||+++.. ......+..|..++.++ +||||+++++++.+.+.+++|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 57888999999999999999876 6889999999743 23445678899999887 899999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++...
T Consensus 132 ~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999999753 468999999999999999999999 999999999999999999999999999998633
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccc--cchhhcccccccCccccc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQE--SLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~--~l~~~~~~~~~~~~~~~l 562 (678)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....+....+..+.
T Consensus 205 ~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 278 (396)
T 4dc2_A 205 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 278 (396)
T ss_dssp CTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----
T ss_pred cCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----
Confidence 3222 223478999999999999999999999999999999999999999754322110 00000000011111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQI 597 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~ 597 (678)
..+... ....+..++..||+.||.+||++
T Consensus 279 --~~~p~~----~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 --IRIPRS----LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp --CCCCTT----SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred --cCCCCc----CCHHHHHHHHHHhcCCHhHcCCC
Confidence 111111 22346677899999999999996
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=346.09 Aligned_cols=251 Identities=27% Similarity=0.391 Sum_probs=198.1
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|+||.||++... +|..||+|++.... ...+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46778899999999999999865 68999999986533 3457789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe---cCCCCcEEeecccccccC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl---~~~~~~kL~DFGla~~~~ 484 (678)
+++|+|.+++......+..+++..++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999986543334679999999999999999999999 999999999999999 456889999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
.... .....||+.|+|||.+. +.++.++||||||+++|||++|+.||.............+..+. ...
T Consensus 179 ~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~-----~~~--- 246 (285)
T 3is5_A 179 SDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN-----YAV--- 246 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-----CCC---
T ss_pred Cccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcc-----ccc---
Confidence 4322 23467999999999885 57899999999999999999999999865433221111111100 000
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..... ...+..++..||+.||.+||++.++++
T Consensus 247 --~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 --ECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --ccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00011 234667789999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=358.61 Aligned_cols=247 Identities=21% Similarity=0.354 Sum_probs=202.2
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 402 (678)
..++|...+.||+|+||.||+|... +|+.||||+++... .....+..|..++..+ +||||+++++++.+.+.+|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4578999999999999999999875 68999999997532 2345678899999887 8999999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 95 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 999999999999999753 458999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
....... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.. +
T Consensus 168 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-------~----- 233 (345)
T 1xjd_A 168 NMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------D----- 233 (345)
T ss_dssp CCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------C-----
T ss_pred cccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-------C-----
Confidence 5432222 2346899999999999999999999999999999999999999986543321111110 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQIN-LVL 601 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~-eVl 601 (678)
.+.+.... ...+..++..||+.+|.+||++. +|+
T Consensus 234 -~~~~p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 -NPFYPRWL----EKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -CCCCCTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -CCCCCccc----CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 01111112 23466677999999999999997 554
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=355.00 Aligned_cols=255 Identities=20% Similarity=0.379 Sum_probs=198.4
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCE----EEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKE----LAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~----vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
++|...+.||+|+||.||+|... +|+. ||+|.+... ....+.+.+|+.++..++||||++++++|.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57888999999999999999864 4543 577877543 245678999999999999999999999998754 789
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
|+||+.+|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 999999999999997542 468999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
.............||+.|+|||.+.+..++.++|||||||++|||++ |+.||...........+. .+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-------~~~---- 236 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE---- 236 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TTC----
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC----
Confidence 65544444444567889999999999999999999999999999999 999998765433221111 110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
...........+..++..||+.+|.+||++.++++.|+...
T Consensus 237 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 237 -----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 00011112335677889999999999999999999997544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=352.36 Aligned_cols=267 Identities=25% Similarity=0.349 Sum_probs=207.3
Q ss_pred CCCceeecccCceEEEEEEeC-----CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEEE
Q 041755 333 FLPEYLVGKGGHSHVYRGCLP-----DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFED--NNLLL 403 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~~-----~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~l 403 (678)
|...+.||+|+||.||+++.. +|+.||||+++.. ......|.+|++++++++||||+++++++.+. ..+++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 377889999999999988642 6889999999764 35677899999999999999999999999874 67899
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+++|+|.+++... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999643 48999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCCc-eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSHL-TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
....... ......||..|+|||.+.+..++.++||||||+++|+|++|+.||........ ....+.........+.+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHH
Confidence 6543322 22335688889999999999999999999999999999999999865321100 000000000000011111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
++..............+..++..||+.+|.+||++.++++.|+...
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 2222222222233456778889999999999999999999997544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=347.03 Aligned_cols=263 Identities=22% Similarity=0.264 Sum_probs=199.4
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|...+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67888999999999999999875 5999999988643 3456778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999999887643 458999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcc-cc-------cccC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK-PI-------LKDG 557 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~-~~-------~~~~ 557 (678)
... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+.... .. ....
T Consensus 156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 156 SDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred ccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 322 234578999999999976 668999999999999999999999998765433221111000 00 0000
Q ss_pred -ccccccCCCCCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 -KVSQLLDPSLDTDYD-----NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 -~~~~l~dp~l~~~~~-----~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.....--+....... ......+..++..||+.||.+|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000000000000 112234677889999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=339.04 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=204.4
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
.++|...+.||+|+||.||+|... +|+.||+|++.. .......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 578999999999999999999865 689999999864 3455678899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC---cEEeecccccc
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE---PQLSDFGLASW 482 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~---~kL~DFGla~~ 482 (678)
||+++++|.+.+... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999988653 468999999999999999999999 99999999999999987655 99999999987
Q ss_pred cCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+. .+... .
T Consensus 158 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-------~~~~~-~ 226 (284)
T 3kk8_A 158 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-------AGAYD-Y 226 (284)
T ss_dssp CCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTCCC-C
T ss_pred cccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH-------hcccc-C
Confidence 654332 223679999999999999999999999999999999999999997654322111111 01100 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+.. .. ....+..++..||+.+|.+||++.++++
T Consensus 227 ~~~~~-~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 PSPEW-DT----VTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CTTTT-TT----SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred Cchhh-cc----cCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 11 1234667789999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=342.55 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=206.0
Q ss_pred cCCCCce-eecccCceEEEEEEeC---CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEY-LVGKGGHSHVYRGCLP---DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~-~IG~G~~g~Vy~g~~~---~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|.... .||+|+||.||+|... ++..||||+++.. ....+.+.+|++++..++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3444444 8999999999999753 6788999999863 45678899999999999999999999999 55679999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++++|.+++... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999643 3568999999999999999999999 999999999999999999999999999998775
Q ss_pred CCCCCce-ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 485 TSSSHLT-CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 485 ~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
....... .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||........... +..+..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------i~~~~~--- 231 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-------IEQGKR--- 231 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-------HHTTCC---
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-------HhcCCc---
Confidence 4432211 223457899999999998999999999999999999998 9999976543221111 111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
+.+ .......+..++..||+.+|.+||++.++++.|+...
T Consensus 232 --~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 232 --MEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp --CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCC----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 1122345777889999999999999999999997543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=347.40 Aligned_cols=261 Identities=22% Similarity=0.353 Sum_probs=198.1
Q ss_pred hhcCCCCceeecccCceEEEEEEeC----CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP----DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDN-- 399 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~----~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~-- 399 (678)
..++|...+.||+|+||.||+|... .+..||||+++.. ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3467888899999999999999753 3458999998743 455678999999999999999999999998754
Q ss_pred ---eEEEEEEcCCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEE
Q 041755 400 ---NLLLVYDFLSRGSLEENLHGNK--KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQL 474 (678)
Q Consensus 400 ---~~~lV~E~~~~gsL~~~L~~~~--~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL 474 (678)
..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEE
Confidence 3599999999999999985432 234579999999999999999999999 99999999999999999999999
Q ss_pred eecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccc
Q 041755 475 SDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPI 553 (678)
Q Consensus 475 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~ 553 (678)
+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||............
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~------ 262 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL------ 262 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH------
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH------
Confidence 99999987655433333334567889999999999999999999999999999999 88999765433211111
Q ss_pred cccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 554 LKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 554 ~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
. .+.. +.. .......+..++..||+.+|.+||++.++++.|+...
T Consensus 263 ~-~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 263 L-HGHR-----LKQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp H-TTCC-----CCC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-cCCC-----CCC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 0100 011 1122345777889999999999999999999997543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=352.52 Aligned_cols=248 Identities=18% Similarity=0.316 Sum_probs=198.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC----ChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP----SEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~----~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...+.||+|+||.||+|... +|+.||||+++. .......+.+|..++.++ +||||+++++++.+.+.+|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57888999999999999999875 689999999964 235567788999999998 899999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999643 468999999999999999999999 999999999999999999999999999998643
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccc--cchhhcccccccCccccc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQE--SLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~--~l~~~~~~~~~~~~~~~l 562 (678)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .........+..+.
T Consensus 162 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 235 (345)
T 3a8x_A 162 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 235 (345)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred CCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence 3222 223468999999999999999999999999999999999999999753221110 00000000011111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQI 597 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~ 597 (678)
..+... ....+..++..||+.+|.+||++
T Consensus 236 --~~~p~~----~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 --IRIPRS----LSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp --CCCCTT----SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred --CCCCCC----CCHHHHHHHHHHhcCCHhHCCCC
Confidence 011111 23346677899999999999996
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=342.97 Aligned_cols=250 Identities=28% Similarity=0.509 Sum_probs=200.6
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-----HH---HHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-----DV---LKEFASEIEIITALHHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-----~~---~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 401 (678)
++|...+.||+|+||.||+|... +++.||||++.... .. .+.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 57888899999999999999874 78999999986432 11 167899999999999999999999987655
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCCeEecCCCC-----cEE
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP--VIHKDVKSSNILLSDDFE-----PQL 474 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~--iiHrDIKp~NILl~~~~~-----~kL 474 (678)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++. +||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 7999999999999988643 3579999999999999999999998 88 999999999999988776 999
Q ss_pred eecccccccCCCCCCceecccccCCCCCCcchh--ccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccc
Q 041755 475 SDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF--MHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552 (678)
Q Consensus 475 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l--~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 552 (678)
+|||+++.... ......||+.|+|||.+ ....++.++|||||||++|||++|+.||..............
T Consensus 171 ~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--- 242 (287)
T 4f0f_A 171 ADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI--- 242 (287)
T ss_dssp CCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH---
T ss_pred CCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH---
Confidence 99999975433 22346799999999998 445678999999999999999999999976543322111110
Q ss_pred ccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 553 ~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
... ...+.+.. .....+..++..||+.+|.+||++.++++.|+.
T Consensus 243 -~~~-----~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 243 -REE-----GLRPTIPE----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -HHS-----CCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -hcc-----CCCCCCCc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 000 01111111 223457778899999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=340.36 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=204.8
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.++|...+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467888999999999999999875 7899999998643 3456788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 99999999998643 468999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCceecccccCCCCCCcchhccCCC-CccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
..........||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||........ ....|.... . ...+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~----~---~~~~ 230 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKK----T---YLNP 230 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTTC----T---TSTT
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhcc----c---ccCc
Confidence 32222334679999999999987765 7799999999999999999999976543221 111111100 0 0000
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.......+..++..||+.+|.+||++.++++
T Consensus 231 ------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 231 ------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0112344667889999999999999999886
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=345.83 Aligned_cols=260 Identities=24% Similarity=0.396 Sum_probs=198.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC----ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP----SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||+|... +|+.||||+++. .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 57888999999999999999864 799999999874 3456778999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+.+|+|.+++.........+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999987543445678999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
.... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ .+.. . +..+....
T Consensus 189 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~---~-~~~~~~~~---- 257 (310)
T 2wqm_A 189 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCK---K-IEQCDYPP---- 257 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHH---H-HHTTCSCC----
T ss_pred CCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHH---H-hhcccCCC----
Confidence 3222 2235789999999999999999999999999999999999999975432111 1110 0 11111111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
..... ....+..++..||+.||.+||++.+|++.|+...
T Consensus 258 ~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 258 LPSDH----YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp CCTTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Ccccc----cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11111 2234667789999999999999999999997543
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=350.03 Aligned_cols=246 Identities=25% Similarity=0.342 Sum_probs=192.5
Q ss_pred cCCCCceeecccCceEEEEEEe----CCCCEEEEEEeCCCh-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL----PDGKELAVKILKPSE-----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~----~~g~~vAvK~l~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 401 (678)
++|...+.||+|+||.||++.. .+|+.||||+++... .....+.+|+.+++.++||||+++++++...+.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5788889999999999999986 478999999997542 3456678999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
++||||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 97 YLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999999643 458899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 482 WLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 482 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+ .. +.
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i------~~-~~--- 237 (327)
T 3a62_A 170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI------LK-CK--- 237 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HH-TC---
T ss_pred ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH------Hh-CC---
Confidence 6443222 123467999999999999999999999999999999999999999865432211111 10 00
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLK 602 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~ 602 (678)
..+... ....+..++..||+.+|.+|| ++.++++
T Consensus 238 ---~~~p~~----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 ---LNLPPY----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---CCCCTT----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---CCCCCC----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 001111 224466777999999999999 6677765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=365.36 Aligned_cols=262 Identities=22% Similarity=0.278 Sum_probs=208.1
Q ss_pred ccHHHHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEE
Q 041755 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFC 395 (678)
Q Consensus 321 f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~ 395 (678)
+.+.++....++|...++||+|+||.||++... +|+.||||+++... .....+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 455666667889999999999999999999875 79999999997532 2234578999999999999999999999
Q ss_pred EeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEe
Q 041755 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLS 475 (678)
Q Consensus 396 ~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~ 475 (678)
.+.+.+|+||||+++|+|.+++... +..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++++||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEe
Confidence 9999999999999999999999753 2468999999999999999999999 999999999999999999999999
Q ss_pred ecccccccCCCCCCceecccccCCCCCCcchhc-------cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchh
Q 041755 476 DFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM-------HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVM 548 (678)
Q Consensus 476 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~ 548 (678)
|||+++....... ......+||+.|+|||++. .+.++.++|||||||++|||++|+.||...+.......+.
T Consensus 205 DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 205 DFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp CCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred echhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999987654332 1223468999999999997 4578999999999999999999999998765432211111
Q ss_pred hcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCC---CCHHHHHH
Q 041755 549 WAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVR---PQINLVLK 602 (678)
Q Consensus 549 ~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~R---Ps~~eVl~ 602 (678)
.... .+--|.+...+ ...+..++..||. +|.+| |++.++++
T Consensus 284 ~~~~--------~~~~p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 284 HYKE--------HLSLPLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp THHH--------HCCCC----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred hccc--------CcCCCccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0000 00011111122 2346667799998 99998 58888874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=354.86 Aligned_cols=243 Identities=21% Similarity=0.314 Sum_probs=203.1
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||++... +|+.||||+++... .....+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67888999999999999999875 79999999996532 23567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999753 458999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
.. ...+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. .+.+
T Consensus 194 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~-------~~~~------ 255 (350)
T 1rdq_E 194 RT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV-------SGKV------ 255 (350)
T ss_dssp CB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCC------
T ss_pred Cc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH-------cCCC------
Confidence 32 23679999999999999999999999999999999999999998654322111111 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQ-----INLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs-----~~eVl~ 602 (678)
.+...+ ...+..++..||+.||.+||+ +.+|++
T Consensus 256 ~~p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 RFPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 111112 244667789999999999998 777765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=360.89 Aligned_cols=268 Identities=17% Similarity=0.232 Sum_probs=204.7
Q ss_pred hhcCCCCceeecccCceEEEEEEeCC------CCEEEEEEeCCChHH------------HHHHHHHHHHHHhcCCCCeee
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLPD------GKELAVKILKPSEDV------------LKEFASEIEIITALHHRNIIS 390 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~~------g~~vAvK~l~~~~~~------------~~~~~~Ei~il~~l~HpnIv~ 390 (678)
..++|...+.||+|+||.||+|.+.. ++.||||++...... ...+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34678889999999999999998754 478999998754311 122445666777788999999
Q ss_pred EEEEEEeC----CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe
Q 041755 391 LFGFCFED----NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL 466 (678)
Q Consensus 391 l~g~~~~~----~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl 466 (678)
+++++... ...+|||||+ +++|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEE
Confidence 99999764 4589999999 99999999753 3569999999999999999999999 999999999999999
Q ss_pred c--CCCCcEEeecccccccCCCCCCc-----eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCC
Q 041755 467 S--DDFEPQLSDFGLASWLSTSSSHL-----TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSEN 539 (678)
Q Consensus 467 ~--~~~~~kL~DFGla~~~~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~ 539 (678)
+ .++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||+||||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 88999999999998765432211 1123569999999999999999999999999999999999999998533
Q ss_pred CcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCHh
Q 041755 540 PKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEE 609 (678)
Q Consensus 540 ~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~~ 609 (678)
.... ...+..... ...+..++++.+..... ...+..++..||+.+|.+||++.+|+++|+....
T Consensus 266 ~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 266 KDPK--YVRDSKIRY-RENIASLMDKCFPAANA---PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp TCHH--HHHHHHHHH-HHCHHHHHHHHSCTTCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred cCHH--HHHHHHHHh-hhhHHHHHHHhcccccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 2211 111111111 11233444444322211 2346667799999999999999999999975443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=350.79 Aligned_cols=265 Identities=26% Similarity=0.379 Sum_probs=203.8
Q ss_pred CCCCceeecccCceEEEEEEe-----CCCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--CeEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCL-----PDGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFED--NNLL 402 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~-----~~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 402 (678)
+|...+.||+|+||.||+|.. .+|+.||||+++... .....+.+|+.++..++||||+++++++... +..+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 467788999999999999983 368999999997543 3457789999999999999999999999876 6789
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 102 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccc
Confidence 9999999999999996432 468999999999999999999999 9999999999999999999999999999988
Q ss_pred cCCCCCC-ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccccc---Cc
Q 041755 483 LSTSSSH-LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKD---GK 558 (678)
Q Consensus 483 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~---~~ 558 (678)
....... .......||..|+|||.+.+..++.++||||||+++|+|++|..|+....... .....+.... ..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF----LKMIGPTHGQMTVTR 251 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH----HHHHCSCCGGGHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHH----hhccCCcccccCHHH
Confidence 7654332 22234568889999999999999999999999999999999999864321000 0000000000 00
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+...+...............+..++..||+.+|.+||++.++++.|+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 001111111111122233557788899999999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=355.50 Aligned_cols=271 Identities=22% Similarity=0.299 Sum_probs=210.0
Q ss_pred cCCCCceeecccCceEEEEEEe-----CCCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCCeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-----PDGKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISLFGFCF--EDNNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-----~~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~~~ 402 (678)
++|...+.||+|+||.||+|.. .+++.||||++... ....+.+.+|++++++++||||+++++++. +.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788889999999999999983 36889999999764 456678999999999999999999999987 456789
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence 9999999999999997532 358999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCCc-eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 483 LSTSSSHL-TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 483 ~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........... .+.........+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPALSRLLE 255 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccccccHHHHHH
Confidence 75543322 22335688899999999999999999999999999999999999865322110000 00000000001111
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.+...............+..++..||+.+|.+||++.++++.|+...
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111112222233455778889999999999999999999997654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=365.26 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=206.8
Q ss_pred HHHHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChH----HHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Q 041755 323 YQELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSED----VLKEFASEIEIITALHHRNIISLFGFCFE 397 (678)
Q Consensus 323 ~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~----~~~~~~~Ei~il~~l~HpnIv~l~g~~~~ 397 (678)
+.++....++|...+.||+|+||.||+|... +|+.||+|+++.... ....+.+|+.++..++||||++++++|.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455566789999999999999999999876 689999999964321 12347899999999999999999999999
Q ss_pred CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeec
Q 041755 398 DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDF 477 (678)
Q Consensus 398 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DF 477 (678)
.+.+|+||||+++|+|.+++... .+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999998642 48999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCCceecccccCCCCCCcchhccCC----CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc
Q 041755 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK----VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI 553 (678)
Q Consensus 478 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 553 (678)
|+++....... ......+||+.|+|||++.+.. ++.++|||||||+||||++|+.||...+.......+.....
T Consensus 213 G~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~- 290 (410)
T 3v8s_A 213 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN- 290 (410)
T ss_dssp TTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-
T ss_pred ceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc-
Confidence 99987654322 2233578999999999998755 78999999999999999999999987654322111110000
Q ss_pred cccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCC--CCCHHHHHHH
Q 041755 554 LKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTV--RPQINLVLKL 603 (678)
Q Consensus 554 ~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~--RPs~~eVl~~ 603 (678)
.+ .-|. ...+ ...+..++..||..+|.+ ||++.+|++-
T Consensus 291 ----~~---~~p~-~~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 ----SL---TFPD-DNDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ----HC---CCCT-TCCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ----cc---cCCC-cccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 00 0000 0111 234566678999988988 9999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.40 Aligned_cols=253 Identities=27% Similarity=0.479 Sum_probs=197.3
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|...+.||+|+||.||+|.. .++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||+++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 4678889999999999999987 5789999999754 345789999999999999999999998864 47999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC-cEEeecccccccCCCCCC
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE-PQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~-~kL~DFGla~~~~~~~~~ 489 (678)
|+|.+++.... ....+++..++.++.|+++||.|||+.+.++|+||||||+|||++.++. +||+|||++......
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 84 GSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp CBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 99999997542 2235789999999999999999999865578999999999999998887 799999999765432
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........ ...|.. ..+.. +.+..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~---~~~~~-----~~~~~ 227 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAV---HNGTR-----PPLIK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHH---HTTCC-----CCCBT
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHH---hcCCC-----CCccc
Confidence 1234689999999999999999999999999999999999999975432211 111110 01111 11111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.. ...+..++..||+.+|.+||++.++++.|+..
T Consensus 228 ~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 261 (307)
T 2eva_A 228 NL----PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261 (307)
T ss_dssp TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 22 23466778999999999999999999999743
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=351.63 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=178.6
Q ss_pred ceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEcCCCCCH
Q 041755 336 EYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLVYDFLSRGSL 413 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 413 (678)
.+.||+|+||.||+|... +|+.||||++... ....+.+|+.++..+. ||||+++++++.+....++||||+++|+|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 478999999999999875 6899999999643 3456788999999997 99999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC---CcEEeecccccccCCCCCCc
Q 041755 414 EENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF---EPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 414 ~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~---~~kL~DFGla~~~~~~~~~~ 490 (678)
.+++... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||+++........
T Consensus 94 ~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~- 165 (325)
T 3kn6_A 94 FERIKKK----KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP- 165 (325)
T ss_dssp HHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-
Confidence 9999754 468999999999999999999999 9999999999999998765 7999999999876543322
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||..................+..+.+. +...
T Consensus 166 -~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~ 238 (325)
T 3kn6_A 166 -LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGE 238 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSH
T ss_pred -ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCcc
Confidence 234678999999999999999999999999999999999999998654321111111111111111110 0000
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
........+..++..||+.||.+||++.++++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00112345677889999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.96 Aligned_cols=255 Identities=22% Similarity=0.350 Sum_probs=200.3
Q ss_pred cCCCCceeecccCceEEEEEEeCC----CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPD----GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFE-DNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~----g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~l 403 (678)
.+|...+.||+|+||.||+|...+ +..+|+|.++.. ....+.+.+|+.++++++||||++++++|.+ ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 467788999999999999998542 236899998753 3566889999999999999999999999754 457899
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999643 3568999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCC--CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccc
Q 041755 484 STSSS--HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 484 ~~~~~--~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
..... ........||+.|+|||.+.+..++.++||||||+++|+|++ |.+||............. .+..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-------~~~~- 250 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------QGRR- 250 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-------TTCC-
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------cCCC-
Confidence 54321 112234567889999999999999999999999999999999 556665544322111111 0000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
+..... ....+..++..||+.+|.+||++.++++.|+..
T Consensus 251 ----~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 251 ----LLQPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp ----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000111 123467778999999999999999999999753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=349.09 Aligned_cols=267 Identities=21% Similarity=0.351 Sum_probs=196.7
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHH--HHhcCCCCeeeEEEEEEe-----CCeEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEI--ITALHHRNIISLFGFCFE-----DNNLL 402 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~i--l~~l~HpnIv~l~g~~~~-----~~~~~ 402 (678)
.++|...+.||+|+||.||+|.. +|+.||||+++.... ..+..|.++ +..++||||+++++++.. ...++
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR--QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch--hhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 35788899999999999999977 789999999975443 334444444 556899999999987643 23678
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CeeeccCCCCCeEecCCCCcE
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ---------PVIHKDVKSSNILLSDDFEPQ 473 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~---------~iiHrDIKp~NILl~~~~~~k 473 (678)
+||||+++|+|.+++... .+++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+|
T Consensus 89 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred EEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEE
Confidence 999999999999999653 34899999999999999999998 6 999999999999999999999
Q ss_pred EeecccccccCCCCC------CceecccccCCCCCCcchhcc-------CCCCccceEeehhHHHHHHhcCCCCCCCCCC
Q 041755 474 LSDFGLASWLSTSSS------HLTCTDVAGTFGYLAPEYFMH-------GKVSEKIDVYAFGIVLLELLSGKKPINSENP 540 (678)
Q Consensus 474 L~DFGla~~~~~~~~------~~~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 540 (678)
|+|||++..+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987654321 112224579999999999976 4567799999999999999999877654332
Q ss_pred cccccchhhcccccccCc---c-----ccccCCCCCCCC--CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 541 KGQESLVMWAKPILKDGK---V-----SQLLDPSLDTDY--DNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 541 ~~~~~l~~~~~~~~~~~~---~-----~~l~dp~l~~~~--~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
........ ......... + .....+.+.... .......+..++..||+.+|.+|||+.++++.|+...
T Consensus 241 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 241 VPEYQMAF-QTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCTT-HHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhHHHHhh-hcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 21111000 000000000 0 000111111111 2235567888999999999999999999999997544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=356.07 Aligned_cols=251 Identities=23% Similarity=0.347 Sum_probs=190.2
Q ss_pred cCCCCc-eeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHH-hcCCCCeeeEEEEEEe----CCeEEE
Q 041755 331 SNFLPE-YLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIIT-ALHHRNIISLFGFCFE----DNNLLL 403 (678)
Q Consensus 331 ~~f~~~-~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~g~~~~----~~~~~l 403 (678)
++|... ++||+|+||+||++... +|+.||||+++... .+.+|++++. .++||||+++++++.. ...+|+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~----~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcch----hHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 456554 68999999999999875 68999999997543 4667888874 4589999999999875 567899
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC---CCCcEEeecccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD---DFEPQLSDFGLA 480 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~---~~~~kL~DFGla 480 (678)
||||+++|+|.+++.... ...+++..++.|+.||+.||.|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 137 v~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999997542 2468999999999999999999999 99999999999999998 789999999999
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
+....... ....+||+.|+|||++.+..++.++|||||||+||||++|+.||............ ...+..+.+.
T Consensus 212 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~i~~~~~~ 285 (400)
T 1nxk_A 212 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM---KTRIRMGQYE 285 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH---HHHHHHTCCC
T ss_pred cccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH---HHHHHcCccc
Confidence 87643322 23468999999999999999999999999999999999999999765543211000 0001111110
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+..+.. ......+..++..||+.||.+||++.++++
T Consensus 286 -~~~~~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 286 -FPNPEW-----SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp -CCTTTT-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCCccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 112244667789999999999999999996
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=343.62 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=206.9
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFE--DNNLLL 403 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~l 403 (678)
.++|...+.||+|+||.||++... +|+.||+|++... ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467888999999999999999875 7899999999643 4566789999999999999999999998864 568999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eeeccCCCCCeEecCCCCcEEeecc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP-----VIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~-----iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
||||+++|+|.+++.........+++..++.++.|++.||.|||+ .+ |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997654445669999999999999999999999 67 9999999999999999999999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
++........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......... .+..+.
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-------~i~~~~ 232 (279)
T 2w5a_A 162 LARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-------KIREGK 232 (279)
T ss_dssp HHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-------HHHHTC
T ss_pred hheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHH-------HHhhcc
Confidence 9987654321 1223578999999999999999999999999999999999999998654321111 111111
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.. .+... ....+..++..||+.+|.+||++.+|++.+...
T Consensus 233 ~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 233 FR-----RIPYR----YSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp CC-----CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred cc-----cCCcc----cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 11 11111 234567788999999999999999999877543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=342.18 Aligned_cols=249 Identities=21% Similarity=0.372 Sum_probs=199.9
Q ss_pred cCCCCceeecccCceEEEEEEeC-CC-------CEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DG-------KELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g-------~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 401 (678)
++|...+.||+|+||.||+|... ++ ..||+|++.... ...+.|.+|+.++++++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 57888899999999999999764 33 579999997543 5567899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC--------cE
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE--------PQ 473 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~--------~k 473 (678)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++. +|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999997542 348999999999999999999999 99999999999999998887 99
Q ss_pred EeecccccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCC-CCCCCCcccccchhhcc
Q 041755 474 LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKP-INSENPKGQESLVMWAK 551 (678)
Q Consensus 474 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~P-f~~~~~~~~~~l~~~~~ 551 (678)
|+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|||++|..| |.............
T Consensus 162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~--- 232 (289)
T 4fvq_A 162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE--- 232 (289)
T ss_dssp ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---
T ss_pred eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh---
Confidence 9999998754321 23568999999999987 7799999999999999999996554 44332211111000
Q ss_pred cccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCHh
Q 041755 552 PILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEE 609 (678)
Q Consensus 552 ~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~~ 609 (678)
.... +.... ...+..++..||+.+|.+||++.++++.|+....
T Consensus 233 ---~~~~--------~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 233 ---DRHQ--------LPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp ---TTCC--------CCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred ---ccCC--------CCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 0000 00111 1235677899999999999999999999986543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.55 Aligned_cols=248 Identities=24% Similarity=0.418 Sum_probs=182.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
.++|...+.||+|+||.||+|.. .+|+.||||++.... .....+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788899999999999999986 479999999996432 2246789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++++|.+++... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999999743 2568999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
..... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........... ... . +
T Consensus 164 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~-~------~ 228 (278)
T 3cok_A 164 MPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK------VVL-A------D 228 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCS-S------C
T ss_pred CCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH------Hhh-c------c
Confidence 33221 1235789999999999999999999999999999999999999976543221110 000 0 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+...+ ...+..++..||+.+|.+||++.++++
T Consensus 229 ~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 YEMPSFL----SIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cCCcccc----CHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0111111 234667789999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.43 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=204.3
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-------DVLKEFASEIEIITALHHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 401 (678)
.++|...+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356888999999999999999875 68999999986432 1357789999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC----CcEEeec
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF----EPQLSDF 477 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~----~~kL~DF 477 (678)
++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 9999999999999999643 468999999999999999999999 9999999999999999888 7999999
Q ss_pred ccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC
Q 041755 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557 (678)
Q Consensus 478 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 557 (678)
|++........ .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...........+. .+
T Consensus 164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~-------~~ 233 (321)
T 2a2a_A 164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT-------SV 233 (321)
T ss_dssp TTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-------TT
T ss_pred ccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------hc
Confidence 99987655332 234579999999999999999999999999999999999999997654322111100 00
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.. .+++.+.... ...+..++..||+.+|.+||++.++++
T Consensus 234 ~~--~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 SY--DFDEEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CC--CCCHHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cc--ccChhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0000000111 234677889999999999999999997
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=349.10 Aligned_cols=256 Identities=24% Similarity=0.380 Sum_probs=199.9
Q ss_pred cCCCCceeecccCceEEEEEEeCC-----CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPD-----GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~-----g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
++|...+.||+|+||.||+|.... +..||||+++.. ......|.+|+.++..++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 456678899999999999997642 246999999753 3556789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+++|+|.+++... ...+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 124 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999753 2568999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCC-ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 484 STSSSH-LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 484 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
...... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........... +..+.
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~-------~~~~~--- 267 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-------INDGF--- 267 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------HHTTC---
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHH-------HHCCC---
Confidence 543221 12223456888999999999999999999999999999999 9999976543221111 11110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.. .........+..++..||+.+|.+||++.++++.|+...
T Consensus 268 --~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 --RL----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp --CC----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --cC----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 011122345677889999999999999999999997543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=350.24 Aligned_cols=258 Identities=24% Similarity=0.365 Sum_probs=203.6
Q ss_pred cCCCCceeecccCceEEEEEEe------CCCCEEEEEEeCC--ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL------PDGKELAVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~------~~g~~vAvK~l~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 402 (678)
++|...+.||+|+||.||+|.. .+++.||||++.. .......+.+|+.++.+++||||+++++++.+.+..+
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 109 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcE
Confidence 5788889999999999999983 2578999999964 3466678999999999999999999999999998999
Q ss_pred EEEEcCCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC---CCCcEEee
Q 041755 403 LVYDFLSRGSLEENLHGNKK---DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD---DFEPQLSD 476 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~---~~~~kL~D 476 (678)
+||||+++|+|.+++..... ....+++..++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|
T Consensus 110 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~D 186 (327)
T 2yfx_A 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD 186 (327)
T ss_dssp EEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECc
Confidence 99999999999999986532 12458999999999999999999999 99999999999999984 45699999
Q ss_pred cccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccc
Q 041755 477 FGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILK 555 (678)
Q Consensus 477 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~ 555 (678)
||++................||+.|+|||.+.++.++.++||||||+++|+|++ |+.||...........+ .
T Consensus 187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-------~ 259 (327)
T 2yfx_A 187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------T 259 (327)
T ss_dssp CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-------H
T ss_pred cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH-------h
Confidence 999986654433333334678999999999999999999999999999999998 99999765432211111 1
Q ss_pred cCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 556 DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 556 ~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.+.. +.... .....+..++..||+.+|.+||++.++++.|+..
T Consensus 260 ~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 SGGR-----MDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCC-----CCCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1100 01111 1224567788999999999999999999998743
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=337.90 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=201.3
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
.++|...+.||+|+||.||+|... ++..||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 457888999999999999999875 57899999986532 3456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe---cCCCCcEEeecccccccC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl---~~~~~~kL~DFGla~~~~ 484 (678)
+++++|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999988653 458999999999999999999999 999999999999999 788999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
..... ....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...........+. .+.... .
T Consensus 161 ~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~~~~~--~ 227 (277)
T 3f3z_A 161 PGKMM---RTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR-------EGTFTF--P 227 (277)
T ss_dssp TTSCB---CCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCCCC--C
T ss_pred Cccch---hccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------hCCCCC--C
Confidence 44322 23579999999999865 49999999999999999999999997654322111111 000000 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..... .....+..++..||+.+|.+||++.++++
T Consensus 228 ~~~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 EKDWL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhhh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 11245677889999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=348.88 Aligned_cols=255 Identities=24% Similarity=0.386 Sum_probs=202.8
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEE--EEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKEL--AVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~v--AvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...+.||+|+||.||+|... +|..+ |||.++.. ......+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888899999999999999865 56644 99988753 34567789999999999 899999999999999999999
Q ss_pred EEcCCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCc
Q 041755 405 YDFLSRGSLEENLHGNK------------KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP 472 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 472 (678)
|||+++|+|.+++.... .....+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence 99999999999997643 223578999999999999999999999 999999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcc
Q 041755 473 QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAK 551 (678)
Q Consensus 473 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~ 551 (678)
||+|||+++....... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........
T Consensus 182 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~----- 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----- 253 (327)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-----
T ss_pred EEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH-----
Confidence 9999999875432211 123457889999999999999999999999999999998 9999976543221110
Q ss_pred cccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 552 PILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 552 ~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
+..+ ..+.. .......+..++..||+.+|.+||++.++++.|+..
T Consensus 254 --~~~~-----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 254 --LPQG-----YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp --GGGT-----CCCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --hhcC-----CCCCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111 00111 111234577788999999999999999999998743
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=339.46 Aligned_cols=255 Identities=21% Similarity=0.331 Sum_probs=201.0
Q ss_pred CCCCceeecccCceEEEEEEeC-C---CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE-EEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-D---GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNL-LLV 404 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~---g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~-~lV 404 (678)
.|...++||+|+||.||+|... + +..||+|++... ....+.|.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556688999999999999753 2 337999999753 35678899999999999999999999999876655 999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+.+|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 9999999999999753 3568999999999999999999999 999999999999999999999999999998664
Q ss_pred CCC--CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCC-CCCCCCcccccchhhcccccccCcccc
Q 041755 485 TSS--SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKP-INSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 485 ~~~--~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~P-f~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
... .........||+.|+|||.+.+..++.++||||||+++|+|++|..| |...........+.. +.
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-------~~--- 245 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-------GR--- 245 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT-------TC---
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc-------CC---
Confidence 432 11222345788999999999999999999999999999999996555 443332221111110 00
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.... .......+..++..||+.+|.+||++.++++.|+...
T Consensus 246 --~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 246 --RLPQ----PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp --CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCC----CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0001 1111245677889999999999999999999997543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.71 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=202.7
Q ss_pred hcCCCCceeecccCceEEEEEEeCC----CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPD----GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~----g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
.++|...+.||+|+||.||+|...+ +..||||+++.. ....+.|.+|+.+++.++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678889999999999999997532 346999999764 3567889999999999999999999999865 45689
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+++++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999753 2468999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
...... ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||...........+.. +..
T Consensus 164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~-------~~~--- 232 (281)
T 3cc6_A 164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK-------GDR--- 232 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH-------TCC---
T ss_pred cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc-------CCC---
Confidence 553322 1233567889999999999999999999999999999998 9999976544322111110 000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
...... ....+..++..||+.+|.+||++.++++.|+...
T Consensus 233 --~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 233 --LPKPDL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp --CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 000111 1244677889999999999999999999997543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=353.93 Aligned_cols=242 Identities=22% Similarity=0.303 Sum_probs=198.8
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~l 403 (678)
.++|...+.||+|+||.||+|... +|+.||||+++... .....+..|..++..+ +||||+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 468899999999999999999876 58899999997532 2356688999999988 79999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999753 358999999999999999999999 99999999999999999999999999999864
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+. . +.+
T Consensus 172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~-~~~---- 238 (353)
T 2i0e_A 172 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------E-HNV---- 238 (353)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-CCC----
T ss_pred ccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH------h-CCC----
Confidence 33222 2234689999999999999999999999999999999999999998654322111111 1 110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQI 597 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~ 597 (678)
.+.. .....+..++..||+.+|.+||++
T Consensus 239 --~~p~----~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 239 --AYPK----SMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp --CCCT----TSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred --CCCC----CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1111 122456677899999999999964
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=379.16 Aligned_cols=255 Identities=23% Similarity=0.407 Sum_probs=207.6
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
.++|...+.||+|+||.||+|.+.++..||||+++......+.|.+|++++++++||||+++++++.+ +..++||||+.
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~ 344 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 344 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhc
Confidence 45677888999999999999999888889999998765445789999999999999999999999876 67899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+|+|.++|.... +..+++.+++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.......
T Consensus 345 ~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 418 (535)
T 2h8h_A 345 KGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 418 (535)
T ss_dssp TEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-
T ss_pred CCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-
Confidence 999999996421 2458999999999999999999999 9999999999999999999999999999987653211
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
.......++..|+|||.+.++.++.++|||||||+||||++ |+.||........... +..+. .
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-------i~~~~---------~ 482 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-------VERGY---------R 482 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-------HHTTC---------C
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCC---------C
Confidence 11122456788999999999999999999999999999999 9999976543221111 11110 0
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
..........+..++..||+.+|.+||++.+|++.|+..
T Consensus 483 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 001112234567788999999999999999999999754
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=340.05 Aligned_cols=246 Identities=27% Similarity=0.430 Sum_probs=200.3
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
+.++|...+.||+|+||.||+|... ++..||||++.... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 3467888999999999999999865 67899999986432 225678899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 99999999999998653 458999999999999999999998 99999999999999999999999999998655
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
.... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+...
T Consensus 160 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------------- 222 (279)
T 3fdn_A 160 PSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------- 222 (279)
T ss_dssp ------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-------------
T ss_pred Cccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC-------------
Confidence 4322 23357899999999999999999999999999999999999999765432211111100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
...+ .......+..++..||+.+|.+||++.++++
T Consensus 223 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 223 EFTF----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp CCCC----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCC----CCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0011 1112244667789999999999999999996
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=349.78 Aligned_cols=253 Identities=23% Similarity=0.384 Sum_probs=194.4
Q ss_pred hcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----e
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDN----N 400 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~ 400 (678)
.++|...+.||+|+||.||+|.. .+|+.||||+++.. ......|.+|+.++.+++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 36788899999999999999986 47899999999753 355678999999999999999999999987653 3
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
.++||||+++|+|.+++... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 49999999999999999643 468999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCC-ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc
Q 041755 481 SWLSTSSSH-LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559 (678)
Q Consensus 481 ~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 559 (678)
..+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........... .......
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~------~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ------HVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH------HhcCCCC
Confidence 876553322 222346799999999999999999999999999999999999999976543221110 0110000
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 560 SQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 560 ~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.. ...... ....+..++..||+.||.+||++.+++.
T Consensus 238 ~~---~~~~~~----~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 238 PP---SARHEG----LSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CH---HHHSTT----CCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred Cc---ccccCC----CCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 00 000011 1244667789999999999998877664
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=360.35 Aligned_cols=204 Identities=27% Similarity=0.421 Sum_probs=167.2
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC--eE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALH-HRNIISLFGFCFEDN--NL 401 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~--~~ 401 (678)
..++|...+.||+|+||.||+|... +|+.||||++.. .......+.+|+.++..+. ||||+++++++...+ .+
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4578999999999999999999864 799999999864 3456677889999999998 999999999998654 78
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
|+||||+. |+|..++.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999996 689998864 358999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCC-------------------CCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCc
Q 041755 482 WLSTSS-------------------SHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPK 541 (678)
Q Consensus 482 ~~~~~~-------------------~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~ 541 (678)
.+.... .....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 764311 1112234689999999999976 67899999999999999999999999876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=352.90 Aligned_cols=244 Identities=27% Similarity=0.416 Sum_probs=198.9
Q ss_pred cCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
+.|...+.||+|+||.||+|.. .+|+.||||++... ....+.|.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999986 47899999998642 245678999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+. |+|.+.+... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9996 6888887543 2568999999999999999999999 9999999999999999999999999999987643
Q ss_pred CCCCceecccccCCCCCCcchhc---cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
. ....||+.|+|||++. .+.++.++|||||||++|||++|+.||...+...... . +... .
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--~----~~~~-~---- 269 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--H----IAQN-E---- 269 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--H----HHHS-C----
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--H----HHhc-C----
Confidence 2 2357999999999984 5778999999999999999999999997654322110 0 1110 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.+... .....+..++..||+.+|.+||++.++++
T Consensus 270 -~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 270 -SPALQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp -CCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1111111 11234667779999999999999999985
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=341.36 Aligned_cols=254 Identities=25% Similarity=0.347 Sum_probs=203.5
Q ss_pred cCCCCce-eecccCceEEEEEEe---CCCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEY-LVGKGGHSHVYRGCL---PDGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~-~IG~G~~g~Vy~g~~---~~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
++|.... .||+|+||.||+|.. .+++.||||+++.. ....+.|.+|+.++..++||||+++++++ +.+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4566666 899999999999953 25788999999754 24467899999999999999999999999 6678899
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 95 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999753 458999999999999999999999 99999999999999999999999999999877
Q ss_pred CCCCCCce-ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 484 STSSSHLT-CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 484 ~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
........ .....||+.|+|||.+.+..++.++||||||+++|+|++ |+.||........... +..+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------~~~~~~-- 238 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------LEKGER-- 238 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTTCC--
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------HHcCCC--
Confidence 55433221 122456788999999999899999999999999999999 9999986543221111 111110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
+.. .......+..++..||+.+|.+||++.++++.|+..-
T Consensus 239 ---~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 239 ---MGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ---CCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 1122345777889999999999999999999997543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=338.31 Aligned_cols=245 Identities=21% Similarity=0.326 Sum_probs=199.3
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 404 (678)
.++|...+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.++..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467888999999999999999876 7999999998753 35567889999999999 899999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC---------------
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD--------------- 469 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~--------------- 469 (678)
|||+++|+|.+++.........+++..++.++.|++.||.|||+ ++|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997643333568999999999999999999999 999999999999999844
Q ss_pred ----CCcEEeecccccccCCCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccc
Q 041755 470 ----FEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQE 544 (678)
Q Consensus 470 ----~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~ 544 (678)
+.+||+|||++....... ...||+.|+|||.+.+. .++.++|||||||++|+|++|.+|+.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 479999999998765432 23589999999999876 567899999999999999999987643211
Q ss_pred cchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 545 SLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 545 ~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
... +..+.. +.+...+ ...+..++..||+.+|.+||++.++++
T Consensus 237 -~~~-----~~~~~~-----~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 -WHE-----IRQGRL-----PRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -HHH-----HHTTCC-----CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHH-----HHcCCC-----CCCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 000 111111 1111222 244667789999999999999999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=346.70 Aligned_cols=263 Identities=24% Similarity=0.338 Sum_probs=194.9
Q ss_pred cCCCC-ceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLP-EYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~-~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
+.|.. .++||+|+||.||+|... +|+.||||++.... .....+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45655 468999999999999864 79999999996543 3456789999999995 79999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC---cEEeeccccccc
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE---PQLSDFGLASWL 483 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~---~kL~DFGla~~~ 483 (678)
|+++|+|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999753 468999999999999999999999 99999999999999998776 999999999865
Q ss_pred CCCCC-----CceecccccCCCCCCcchhcc-----CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc
Q 041755 484 STSSS-----HLTCTDVAGTFGYLAPEYFMH-----GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI 553 (678)
Q Consensus 484 ~~~~~-----~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 553 (678)
..... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||................+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 43211 111223569999999999975 56889999999999999999999999875433210000000000
Q ss_pred cccCccccccCCCCCCCCCH----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 554 LKDGKVSQLLDPSLDTDYDN----DQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 554 ~~~~~~~~l~dp~l~~~~~~----~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.....+..+..... .+.. .....+..++..||+.||.+||++.++++
T Consensus 245 ~~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 CQNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00000000000000 0111 11245777889999999999999999987
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=361.61 Aligned_cols=260 Identities=20% Similarity=0.243 Sum_probs=196.6
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------C
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFED------N 399 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~ 399 (678)
.++|...+.||+|+||.||+|... +|+.||||++.. .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 468999999999999999999865 689999999965 345677889999999999999999999999654 4
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
..|+||||+.+ +|.+.+. ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 67999999965 5666664 238899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcc--------
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK-------- 551 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~-------- 551 (678)
++...... ..+...||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+...+...+....
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp C-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 98765432 2234689999999999999999999999999999999999999998765332211110000
Q ss_pred --------ccc------ccCccccccCCCCCCCCC---HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 552 --------PIL------KDGKVSQLLDPSLDTDYD---NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 552 --------~~~------~~~~~~~l~dp~l~~~~~---~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+ ..-.+...+...+..... ......+..++..||+.||.+|||+.++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000111111111111001 112456788899999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=344.06 Aligned_cols=264 Identities=26% Similarity=0.362 Sum_probs=208.1
Q ss_pred HhhcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHh--cCCCCeeeEEEEEEeCC----eE
Q 041755 328 SATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITA--LHHRNIISLFGFCFEDN----NL 401 (678)
Q Consensus 328 ~~t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~g~~~~~~----~~ 401 (678)
...++|...+.||+|+||.||+|.. +|+.||||++.... ...+.+|++++.. ++||||+++++++.... ..
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh--HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 3456899999999999999999988 68999999997543 3567889999988 78999999999998876 79
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeccCCCCCeEecCCCCcE
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH--------NSCEQPVIHKDVKSSNILLSDDFEPQ 473 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH--------~~~~~~iiHrDIKp~NILl~~~~~~k 473 (678)
++||||+++|+|.+++.. ..+++.+++.++.|++.||.||| + .+|+||||||+|||++.++.+|
T Consensus 116 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~k 187 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTCC 187 (342)
T ss_dssp EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCEE
T ss_pred EEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCEE
Confidence 999999999999999964 25899999999999999999999 6 8999999999999999999999
Q ss_pred EeecccccccCCCCCCc--eecccccCCCCCCcchhccC------CCCccceEeehhHHHHHHhcC----------CCCC
Q 041755 474 LSDFGLASWLSTSSSHL--TCTDVAGTFGYLAPEYFMHG------KVSEKIDVYAFGIVLLELLSG----------KKPI 535 (678)
Q Consensus 474 L~DFGla~~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSlGvvL~eLltG----------~~Pf 535 (678)
|+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| +.||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 99999998765543321 22345799999999999775 234789999999999999999 6777
Q ss_pred CCCCCcccccchhhcccccccCccccccCCCCCCC-CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 536 NSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD-YDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 536 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~-~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
......... ...+..... ...+.+.+... ...+....+..++..||+.+|.+||++.+|++.|+...
T Consensus 268 ~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 268 YDLVPSDPS-VEEMRKVVC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TTTSCSSCC-HHHHHHHHT-----TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccCcCccc-HHHHHHHHH-----HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 654332211 001110000 11111222111 13356678889999999999999999999999997543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=337.65 Aligned_cols=263 Identities=20% Similarity=0.261 Sum_probs=203.0
Q ss_pred hhcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEE-EeCCeEEEEEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFC-FEDNNLLLVYD 406 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~-~~~~~~~lV~E 406 (678)
..++|...+.||+|+||.||+|.. .+|+.||||++.... ....+.+|+.++..++|++++..++++ .+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 457899999999999999999986 478999999876432 224578899999999988877776665 66778899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe---cCCCCcEEeeccccccc
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWL 483 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl---~~~~~~kL~DFGla~~~ 483 (678)
|+ +++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 99999999743 2468999999999999999999999 999999999999999 78999999999999877
Q ss_pred CCCCCCc-----eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 484 STSSSHL-----TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 484 ~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
....... ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||................. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----~~ 234 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE----KK 234 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH----HH
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhc----cc
Confidence 6543321 22346799999999999999999999999999999999999999987554332221111000 00
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
..... +.+...+ ...+..++..||+.+|.+||++.+|++.|+...
T Consensus 235 ~~~~~-~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 235 MSTPI-EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HHSCH-HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred ccchh-hhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 00000 0000111 245777889999999999999999999997544
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=357.22 Aligned_cols=269 Identities=20% Similarity=0.319 Sum_probs=209.7
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--eEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDN--NLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~lV~ 405 (678)
++|...++||+|+||.||+|... +|+.||||+++... .....+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56888999999999999999876 59999999997533 33567889999999999999999999998765 789999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe----cCCCCcEEeeccccc
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL----SDDFEPQLSDFGLAS 481 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl----~~~~~~kL~DFGla~ 481 (678)
||+++|+|.+++..... ...+++..++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999975422 2348999999999999999999999 999999999999999 788889999999998
Q ss_pred ccCCCCCCceecccccCCCCCCcchhcc--------CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhh----
Q 041755 482 WLSTSSSHLTCTDVAGTFGYLAPEYFMH--------GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMW---- 549 (678)
Q Consensus 482 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~---- 549 (678)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 7654322 223679999999999865 5678899999999999999999999975433221111110
Q ss_pred ccc--------ccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 550 AKP--------ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 550 ~~~--------~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
..+ ....+.+.-.-+..............+..++..||+.||.+||++.++++.|+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 000 000010100001111223446667778889999999999999999999988764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=364.60 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=194.0
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC----ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP----SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~----~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
.++|...+.||+|+||.||+|... +|+.||||+++. .......+.+|+.++..++||||++++++|...+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 357888999999999999999865 799999999974 234456788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+ ..+|+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999999653 468999999999999999999995 2689999999999999999999999999998644
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
.... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...+.......+... .
T Consensus 301 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-------~------ 365 (446)
T 4ejn_A 301 KDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-------E------ 365 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------C------
T ss_pred CCCc--ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC-------C------
Confidence 3322 223478999999999999999999999999999999999999999765433221111100 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~ 602 (678)
..+.... ...+..++..||+.||.+|| ++.++++
T Consensus 366 ~~~p~~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 366 IRFPRTL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCCCTTS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCccC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0011111 24466778999999999999 9999886
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=349.33 Aligned_cols=263 Identities=24% Similarity=0.346 Sum_probs=199.8
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|...+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 57888899999999999999875 5899999998543 3456778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 105 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 105 FVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp CCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred cCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99999998886533 458999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhc-cc-------cc-cc
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA-KP-------IL-KD 556 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~-~~-------~~-~~ 556 (678)
... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+... .. .+ ..
T Consensus 178 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (331)
T 4aaa_A 178 GEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred ccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence 222 2345789999999999875 7899999999999999999999999876543211111000 00 00 00
Q ss_pred CccccccCCCCCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 557 GKVSQLLDPSLDTDYD-----NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 557 ~~~~~l~dp~l~~~~~-----~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
........+.+..... ......+..++..||+.||.+||++.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0001111111111111 112356778889999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=346.81 Aligned_cols=261 Identities=25% Similarity=0.365 Sum_probs=203.2
Q ss_pred hcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCC-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCeEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKP-SEDVLKEFASEIEIITALHHRNIISLFGFCFE----DNNLLL 403 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~l 403 (678)
.++|...+.||+|+||.||++.. .+|+.||||++.. .....+.+.+|+++++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 35788899999999999999986 4799999998854 44667889999999999999999999999973 347899
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+.+|+|.+++......+..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999997654445779999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCCc-------eecccccCCCCCCcchhccCC---CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc
Q 041755 484 STSSSHL-------TCTDVAGTFGYLAPEYFMHGK---VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI 553 (678)
Q Consensus 484 ~~~~~~~-------~~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 553 (678)
....... ......||+.|+|||++.... ++.++||||||+++|||++|+.||...............
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--- 261 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ--- 261 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH---
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh---
Confidence 3211110 012246799999999987554 789999999999999999999999542111111000000
Q ss_pred cccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 554 LKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 554 ~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
. . ............+..++..||+.+|.+||++.++++.|+..
T Consensus 262 --~-~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 262 --N-Q--------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp --C-C----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred --c-c--------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 0 0 00000111234577788999999999999999999999743
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=352.69 Aligned_cols=241 Identities=21% Similarity=0.352 Sum_probs=200.5
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---------DVLKEFASEIEIITALHHRNIISLFGFCFEDN 399 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 399 (678)
.++|...+.||+|+||.||+|... +|+.||||+++... .....+.+|+.++.+++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 457888999999999999999854 78999999987542 13446778999999999999999999999999
Q ss_pred eEEEEEEcCCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecc
Q 041755 400 NLLLVYDFLSRG-SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 400 ~~~lV~E~~~~g-sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
..++||||+.+| +|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 999998643 468999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhccCCC-CccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 557 (678)
++......... ....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... .
T Consensus 176 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------~-- 238 (335)
T 3dls_A 176 SAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------E-- 238 (335)
T ss_dssp TCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------T--
T ss_pred cceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------h--
Confidence 99877654332 23679999999999988877 789999999999999999999996422100 0
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 558 ~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
....+ ...+ ...+..++..||+.+|.+||++.++++.
T Consensus 239 ---~~~~~--~~~~----~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 239 ---AAIHP--PYLV----SKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TCCCC--SSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---hccCC--Cccc----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0011 2346677899999999999999999974
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=354.70 Aligned_cols=254 Identities=23% Similarity=0.393 Sum_probs=192.5
Q ss_pred CCCCceeecccCceEEEEEEeC--CC--CEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CCeEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP--DG--KELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFE-DNNLLLV 404 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~--~g--~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~lV 404 (678)
.|...+.||+|+||.||+|... ++ ..||||.++.. ....+.|.+|+.++++++||||++++++|.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4666789999999999999853 32 36899998643 3567889999999999999999999999865 4578999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.
T Consensus 170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999643 3568899999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCC--ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 485 TSSSH--LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 485 ~~~~~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
..... .......||+.|+|||.+.+..++.++|||||||++|||++ |.+||...........+. .+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~-------~~~~-- 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------QGRR-- 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH-------TTCC--
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH-------cCCC--
Confidence 43221 12233567889999999999999999999999999999999 677886654332211111 1110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
...| . .....+..++..||+.+|.+||++.++++.|+..
T Consensus 315 ~~~p---~----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i 353 (373)
T 3c1x_A 315 LLQP---E----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353 (373)
T ss_dssp CCCC---T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC---C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0111 1 1123567778999999999999999999999743
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=341.88 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=186.8
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHH-HHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDV-LKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
.++|...+.||+|+||.||+|... +|+.||||+++.. ... ...+..+...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467888999999999999999864 7899999999754 233 333445555678889999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ-PVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
||++ |+|.+++......+..+++..++.++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9996 58888876533345679999999999999999999999 7 99999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchh----ccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYF----MHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l----~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
..... ....||+.|+|||++ .+..++.++|||||||++|+|++|+.||......... +.. .....
T Consensus 162 ~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~----~~~~~--- 230 (290)
T 3fme_A 162 DDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-LKQ----VVEEP--- 230 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-HHH----HHHSC---
T ss_pred ccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-HHH----HhccC---
Confidence 53322 234799999999996 5567899999999999999999999999753321111 000 01100
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+... .......+..++..||+.+|.+||++.++++
T Consensus 231 ---~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 ---SPQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ---CCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00111 1112344677889999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=348.78 Aligned_cols=256 Identities=26% Similarity=0.433 Sum_probs=205.6
Q ss_pred HHHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---------HHHHHHHHHHHHHHhc-CCCCeeeEE
Q 041755 324 QELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---------DVLKEFASEIEIITAL-HHRNIISLF 392 (678)
Q Consensus 324 ~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---------~~~~~~~~Ei~il~~l-~HpnIv~l~ 392 (678)
.......++|...+.||+|+||.||+|.+. +|+.||||+++... ...+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334455678999999999999999999875 79999999986532 2356788999999999 799999999
Q ss_pred EEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCc
Q 041755 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP 472 (678)
Q Consensus 393 g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 472 (678)
+++...+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999643 468999999999999999999999 999999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccccCCCCCCcchhcc------CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccc
Q 041755 473 QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH------GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESL 546 (678)
Q Consensus 473 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l 546 (678)
||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........
T Consensus 240 kl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 316 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM 316 (365)
T ss_dssp EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred EEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 9999999987765432 234689999999999864 3588999999999999999999999976432211110
Q ss_pred hhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 547 VMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 547 ~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+ ..+.... ..+.. . .....+..++..||+.+|.+||++.++++
T Consensus 317 i-------~~~~~~~-~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 I-------MEGQYQF-SSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp H-------HHTCCCC-CHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H-------HhCCCCC-CCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0111000 00000 0 11234677889999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=339.95 Aligned_cols=245 Identities=25% Similarity=0.445 Sum_probs=201.9
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----------
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFE----------- 397 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----------- 397 (678)
.++|...+.||+|+||.||+|... +|+.||+|+++... ..+.+|++++..++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 357888999999999999999876 79999999997654 356789999999999999999998864
Q ss_pred -----CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCc
Q 041755 398 -----DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP 472 (678)
Q Consensus 398 -----~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 472 (678)
...+++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCE
Confidence 345899999999999999997542 2568999999999999999999999 999999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccc
Q 041755 473 QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552 (678)
Q Consensus 473 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 552 (678)
||+|||++......... ....||+.|+|||.+.+..++.++||||||+++|+|++|..|+..... ...
T Consensus 162 kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~---- 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----FFT---- 229 (284)
T ss_dssp EECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----HHH----
T ss_pred EECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----HHH----
Confidence 99999999877554322 235799999999999999999999999999999999999988742110 000
Q ss_pred ccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 553 ~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.+. +..+...++ ..+..++..||+.+|.+||++.++++.|+.
T Consensus 230 ~~~--------~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 230 DLR--------DGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp HHH--------TTCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred Hhh--------cccccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 011 111112222 335677899999999999999999998864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=350.12 Aligned_cols=262 Identities=19% Similarity=0.268 Sum_probs=206.0
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcC--------CCCeeeEEEEEE----
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALH--------HRNIISLFGFCF---- 396 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~--------HpnIv~l~g~~~---- 396 (678)
.++|...+.||+|+||.||+|... +|+.||||+++........+.+|+.++..++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 368999999999999999999864 6889999999988777888999999999996 788999999987
Q ss_pred eCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCCeEecCCC-----
Q 041755 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ-PVIHKDVKSSNILLSDDF----- 470 (678)
Q Consensus 397 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~iiHrDIKp~NILl~~~~----- 470 (678)
.....++||||+ +++|.+.+.... ...+++..++.++.||+.||.|||+ + +|+||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhh
Confidence 456899999999 667777665432 2568999999999999999999999 7 999999999999999775
Q ss_pred --------------------------------------------CcEEeecccccccCCCCCCceecccccCCCCCCcch
Q 041755 471 --------------------------------------------EPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY 506 (678)
Q Consensus 471 --------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~ 506 (678)
.+||+|||++...... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 7999999999876543 233578999999999
Q ss_pred hccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccch-------hh--------------ccccc-ccCccccccC
Q 041755 507 FMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV-------MW--------------AKPIL-KDGKVSQLLD 564 (678)
Q Consensus 507 l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~-------~~--------------~~~~~-~~~~~~~l~d 564 (678)
+.+..++.++|||||||+||||++|+.||............ .. ....+ ..+.+..+.+
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 99999999999999999999999999999865543211000 00 00000 0011111110
Q ss_pred CCC---------CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSL---------DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l---------~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
... ...........+..++..||+.||.+|||+.++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 01234566678889999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=335.75 Aligned_cols=262 Identities=20% Similarity=0.270 Sum_probs=205.3
Q ss_pred hhcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEE-EeCCeEEEEEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFC-FEDNNLLLVYD 406 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~-~~~~~~~lV~E 406 (678)
..++|...+.||+|+||.||+|.. .+|+.||||++..... ...+.+|+.++..++|++++..++++ .+++..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 357899999999999999999986 5799999999865432 24588999999999998877666655 56778899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe---cCCCCcEEeeccccccc
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWL 483 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl---~~~~~~kL~DFGla~~~ 483 (678)
|+ +++|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 99999999743 2468999999999999999999999 999999999999999 48899999999999877
Q ss_pred CCCCCCc-----eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 484 STSSSHL-----TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 484 ~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||................. +.
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----~~ 234 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE----KK 234 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH----HH
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc----cc
Confidence 6543321 12346799999999999999999999999999999999999999987543322211111000 00
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
..... +.+...+ ...+..++..||+.+|.+||++.+|++.|+..
T Consensus 235 ~~~~~-~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 235 MSTPI-EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp HHSCH-HHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred cCCch-HHHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 00000 0011111 24577788999999999999999999999753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=375.96 Aligned_cols=246 Identities=23% Similarity=0.370 Sum_probs=197.1
Q ss_pred eecccCceEEEEEEeC---CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCCCC
Q 041755 338 LVGKGGHSHVYRGCLP---DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGS 412 (678)
Q Consensus 338 ~IG~G~~g~Vy~g~~~---~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 412 (678)
.||+|+||.||+|... ++..||||+++.. ....+.|.+|++++++++||||++++++|.. +.+++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999763 5668999999864 2456789999999999999999999999976 56899999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCce-
Q 041755 413 LEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT- 491 (678)
Q Consensus 413 L~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~- 491 (678)
|.+++... ...+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+........
T Consensus 422 L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99999643 3568999999999999999999999 9999999999999999999999999999987754332221
Q ss_pred ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 492 CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 492 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
.....+|+.|+|||++.++.++.++|||||||+||||++ |+.||........... +..+.. ..
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-------i~~~~~---------~~ 559 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-------IEQGKR---------ME 559 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH-------HHTTCC---------CC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-------HHcCCC---------CC
Confidence 122346789999999999999999999999999999998 9999987654321111 111110 01
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
........+..++..||+.+|.+||++.+|++.|+.
T Consensus 560 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 560 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 112223557778899999999999999999999974
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=367.23 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=204.0
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
.++|...++||+|+||.||+|... +|+.||||+++... .....+.+|+.++..++||||+++++++...+.+|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367888899999999999999875 69999999996532 2346788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++.........+++..++.++.||+.||.|||+ ++|+||||||+||||+.+|.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999997655445679999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....+.. +.
T Consensus 341 ~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~--~~~~i~~-~~------ 409 (543)
T 3c4z_A 341 AGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE--LKQRVLE-QA------ 409 (543)
T ss_dssp TTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH--HHHHHHH-CC------
T ss_pred CCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH--HHHHHhh-cc------
Confidence 54322 2335899999999999999999999999999999999999999986543211110 0111111 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQI 597 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~ 597 (678)
..+ +......+..++..||+.+|.+||++
T Consensus 410 ~~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 410 VTY----PDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCC----CTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred cCC----CcccCHHHHHHHHHhccCCHhHCCCC
Confidence 011 11123446667799999999999976
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=348.26 Aligned_cols=263 Identities=18% Similarity=0.266 Sum_probs=192.9
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
.++|...+.||+|+||.||+|... +|+.||||+++... .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 457888999999999999999864 78999999997532 34567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe-----cCCCCcEEeecccc
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL-----SDDFEPQLSDFGLA 480 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl-----~~~~~~kL~DFGla 480 (678)
||+. |+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 113 e~~~-~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp ECCS-EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred ecCC-CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9997 5999999754 458999999999999999999999 999999999999999 45556999999999
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 559 (678)
......... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+............
T Consensus 185 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 185 RAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 876543222 2345789999999999875 4899999999999999999999999765432221111100000000000
Q ss_pred ------ccccC--CCCCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 560 ------SQLLD--PSLDTDYDN-----DQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 560 ------~~l~d--p~l~~~~~~-----~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+.. +........ .....+..++..||+.||.+|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 000000000 01245677889999999999999999986
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=362.25 Aligned_cols=245 Identities=23% Similarity=0.395 Sum_probs=203.4
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||+|... +|+.||||+++... .....+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999875 79999999997532 23567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 96 E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999643 468999999999999999999999 9999999999999999999999999999987655
Q ss_pred CCCCceecccccCCCCCCcchhccCCC-CccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........... +..+.+.
T Consensus 169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~-------i~~~~~~---- 234 (476)
T 2y94_A 169 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK-------ICDGIFY---- 234 (476)
T ss_dssp TCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH-------HHTTCCC----
T ss_pred ccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH-------HhcCCcC----
Confidence 332 233679999999999988766 6899999999999999999999986543221110 1111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..... ...+..++..||+.||.+|||+.++++
T Consensus 235 --~p~~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 --TPQYL----NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --CCTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCccC----CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 01111 234667789999999999999999996
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=351.40 Aligned_cols=263 Identities=21% Similarity=0.313 Sum_probs=196.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChH--HHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSED--VLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|+||.||+|... +|+.||||+++.... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888999999999999999876 789999999975432 223456899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+. |+|.+++... +..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 96 6999988754 3568999999999999999999999 999999999999999999999999999998655432
Q ss_pred CCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc---
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL--- 563 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~--- 563 (678)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...........+....
T Consensus 155 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 155 KT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred cc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 22 233578999999999876 568999999999999999999999998765433222111100000000010000
Q ss_pred ------CCCCCCCC----CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 ------DPSLDTDY----DNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 ------dp~l~~~~----~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+...... .......+..++..||+.||.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000 0011245667889999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=337.14 Aligned_cols=246 Identities=26% Similarity=0.469 Sum_probs=204.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
+.|...+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 45778899999999999999864 7899999999654 34567899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++++|.+++.. ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999853 468999999999999999999999 999999999999999999999999999998765433
Q ss_pred CCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+ ..+. .+.+
T Consensus 174 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~-----~~~~ 239 (303)
T 3a7i_A 174 IK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI-------PKNN-----PPTL 239 (303)
T ss_dssp CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHSC-----CCCC
T ss_pred cc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh-------hcCC-----CCCC
Confidence 22 23467899999999999999999999999999999999999999765432211110 0111 1112
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
...++ ..+..++..||+.+|.+||++.++++
T Consensus 240 ~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 240 EGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CSSCC----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccccC----HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 22222 34677789999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=335.93 Aligned_cols=249 Identities=23% Similarity=0.339 Sum_probs=200.3
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-------DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 402 (678)
++|...+.||+|+||.||+|... +|+.||+|+++... ...+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999876 69999999986431 13578899999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC----CcEEeecc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF----EPQLSDFG 478 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~----~~kL~DFG 478 (678)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999643 468999999999999999999999 9999999999999998877 79999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+. ...
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~ 227 (283)
T 3bhy_A 158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS-------AVN 227 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------TTC
T ss_pred cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH-------hcc
Confidence 9987654322 223578999999999999999999999999999999999999997654322111100 000
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.. +.+.... .....+..++..||+.+|.+||++.++++
T Consensus 228 ~~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 YD--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CC--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cC--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00 0000001 11245677889999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=348.07 Aligned_cols=260 Identities=26% Similarity=0.432 Sum_probs=201.1
Q ss_pred ccHHHHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe-
Q 041755 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFE- 397 (678)
Q Consensus 321 f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~- 397 (678)
+.+.++....++|...+.||+|+||.||+|... +|+.||||++.........+.+|+.++.++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 444455566788999999999999999999874 789999999976555557788999999999 79999999999987
Q ss_pred -----CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCc
Q 041755 398 -----DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP 472 (678)
Q Consensus 398 -----~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 472 (678)
.+..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+|+|+||||+|||++.++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCE
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCE
Confidence 468999999999999999997542 2568999999999999999999999 999999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccccCCCCCCcchhc-----cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccch
Q 041755 473 QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLV 547 (678)
Q Consensus 473 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~ 547 (678)
||+|||++......... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||...........+
T Consensus 169 kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246 (326)
T ss_dssp EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred EEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence 99999999876543221 22357899999999997 567899999999999999999999999765432211100
Q ss_pred hhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 548 MWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 548 ~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+...... ...+ ...+..++..||..+|.+||++.++++
T Consensus 247 -------~~~~~~~~~----~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 247 -------PRNPAPRLK----SKKW----SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -------HHSCCCCCS----CSCS----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -------hcCccccCC----cccc----CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000111110 1111 235667789999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=339.85 Aligned_cols=250 Identities=26% Similarity=0.398 Sum_probs=196.7
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-CeEEEEEEcC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED-NNLLLVYDFL 408 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-~~~~lV~E~~ 408 (678)
.++|...+.||+|+||.||+|.. .|+.||||+++... ..+.|.+|+.++.+++||||+++++++.+. +..++||||+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 35788889999999999999987 58999999998654 456789999999999999999999998654 4789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++|+|.+++.... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 98 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp TTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 9999999996432 1247899999999999999999999 999999999999999999999999999988654322
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l 567 (678)
....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||........... +..+ ..+..
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-------~~~~-----~~~~~ 235 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-------VEKG-----YKMDA 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-------HTTT-----CCCCC
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HhcC-----CCCCC
Confidence 22467889999999999999999999999999999998 9999976543221110 1111 01111
Q ss_pred CCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 568 DTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 568 ~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.. .....+..++..||+.+|.+||++.++++.|+..
T Consensus 236 ~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 236 PD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc----cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 11 2234567788999999999999999999998753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=346.21 Aligned_cols=267 Identities=22% Similarity=0.285 Sum_probs=198.0
Q ss_pred HhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 041755 328 SATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE------DVLKEFASEIEIITALHHRNIISLFGFCFEDNN 400 (678)
Q Consensus 328 ~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 400 (678)
...++|...+.||+|+||.||+|... +|+.||||+++... .....+.+|+.++..++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999875 68999999997532 123468899999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
.++||||+.+ +|..++... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999975 898888643 3468889999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc-
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK- 558 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~- 558 (678)
+........ .....||+.|+|||.+.+. .++.++|||||||++|||++|.+||...........+...........
T Consensus 160 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 160 KSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 237 (346)
T ss_dssp STTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred eeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhh
Confidence 876543322 2346789999999999764 589999999999999999999999977553221111100000000000
Q ss_pred -----cccccCCCCCCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHHH
Q 041755 559 -----VSQLLDPSLDTDYD-----NDQIERMVLAATLSISRAPTVRPQINLVLKL 603 (678)
Q Consensus 559 -----~~~l~dp~l~~~~~-----~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~ 603 (678)
+.+.+......... ......+..++..||+.||.+|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000000001 1122567778899999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=369.65 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=205.5
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
..++|...++||+|+||.||+|... +|+.||||++.... .....+.+|+.++..++||||+++++++.+.+.+|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467889999999999999999875 79999999996432 234568899999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+++|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++..
T Consensus 262 VmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999997542 2458999999999999999999999 99999999999999999999999999999877
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
..... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. .+...
T Consensus 337 ~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~---~i~~~------ 404 (576)
T 2acx_A 337 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER---LVKEV------ 404 (576)
T ss_dssp CTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH---HHHHC------
T ss_pred ccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH---Hhhcc------
Confidence 55432 2335899999999999999999999999999999999999999987543221111110 00000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~ 602 (678)
...+... ....+..++..||+.||.+|| ++.+|++
T Consensus 405 ~~~~p~~----~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 PEEYSER----FSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCCCTT----SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cccCCcc----CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 0111111 224566777999999999999 6777774
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=345.37 Aligned_cols=260 Identities=22% Similarity=0.356 Sum_probs=199.9
Q ss_pred cccHHHHHHhhcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcC--CCCeeeEEEE
Q 041755 320 LFSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKP---SEDVLKEFASEIEIITALH--HRNIISLFGF 394 (678)
Q Consensus 320 ~f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~--HpnIv~l~g~ 394 (678)
.|.++.+....++|...+.||+|+||.||++...+|+.||||++.. .......+.+|+.++.+++ ||||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 3444555556678999999999999999999988899999999854 3456788999999999997 5999999999
Q ss_pred EEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEE
Q 041755 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQL 474 (678)
Q Consensus 395 ~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL 474 (678)
+...+..++||| +.+++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||+++ +.+||
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL 167 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKL 167 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEE
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEE
Confidence 999999999999 5688999999754 468999999999999999999999 99999999999999965 89999
Q ss_pred eecccccccCCCCCCceecccccCCCCCCcchhcc-----------CCCCccceEeehhHHHHHHhcCCCCCCCCCCccc
Q 041755 475 SDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-----------GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQ 543 (678)
Q Consensus 475 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~ 543 (678)
+|||++................||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (313)
T 3cek_A 168 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247 (313)
T ss_dssp CCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH
T ss_pred eeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH
Confidence 99999987765443333344679999999999875 4788899999999999999999999975432111
Q ss_pred ccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 544 ESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 544 ~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
. +...+++.....+.......+..++..||+.+|.+||++.++++
T Consensus 248 -~-------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 248 -K-------------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp -H-------------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -H-------------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 0 11111111111111111345667789999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=350.55 Aligned_cols=272 Identities=24% Similarity=0.330 Sum_probs=206.0
Q ss_pred cCCCCceeecccCceEEEEEEe-----CCCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC--eEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-----PDGKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISLFGFCFEDN--NLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-----~~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~--~~~ 402 (678)
++|...+.||+|+||.||++.. .+|+.||||++... ....+.|.+|+++++.++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4677889999999999999983 36899999999764 356778999999999999999999999986543 689
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 121 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 9999999999999997542 468999999999999999999999 9999999999999999999999999999988
Q ss_pred cCCCCCCce-ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 483 LSTSSSHLT-CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 483 ~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
......... .....+|..|+|||.+.+..++.++||||||+++|||++|..||.......................+.+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 765433221 2234577889999999999999999999999999999999998864211000000000000000000001
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.+...............+..++..||+.+|.+||++.+|++.|+...
T Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111111222355777889999999999999999999997544
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=355.92 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=191.1
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---------DVLKEFASEIEIITALHHRNIISLFGFCFED 398 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~ 398 (678)
..++|...+.||+|+||.||+|... +++.||||++.... .....+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 4578999999999999999999865 68999999986421 22345889999999999999999999975 4
Q ss_pred CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC---CcEEe
Q 041755 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF---EPQLS 475 (678)
Q Consensus 399 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~---~~kL~ 475 (678)
+..++||||+++|+|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEe
Confidence 6689999999999999988643 568999999999999999999999 9999999999999997544 59999
Q ss_pred ecccccccCCCCCCceecccccCCCCCCcchhcc---CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccc
Q 041755 476 DFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH---GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552 (678)
Q Consensus 476 DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 552 (678)
|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +..
T Consensus 285 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~---- 355 (419)
T 3i6u_A 285 DFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD---- 355 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH----
T ss_pred ecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH----
Confidence 9999987654322 234679999999999863 6788999999999999999999999976433211 110
Q ss_pred ccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 553 ~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+..+.... .+.... .....+..++..||+.+|.+||++.++++
T Consensus 356 ~i~~~~~~~--~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 356 QITSGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHTTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhcCCCCC--Cchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 011111100 000000 11345677889999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=354.55 Aligned_cols=248 Identities=25% Similarity=0.312 Sum_probs=192.6
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHH-HHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEI-ITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~i-l~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...+.||+|+||.||+|... +++.||||+++.. ......+..|..+ ++.++||||+++++++.+.+.+|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 57888999999999999999876 6889999999643 2344566777776 5678999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 118 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 118 LDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999753 468899999999999999999999 999999999999999999999999999998643
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+ +. +.+
T Consensus 191 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~-~~~----- 256 (373)
T 2r5t_A 191 EHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI------LN-KPL----- 256 (373)
T ss_dssp CCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH------HH-SCC-----
T ss_pred cCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------Hh-ccc-----
Confidence 3222 223468999999999999999999999999999999999999999765432211111 11 000
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHh
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLL 604 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L 604 (678)
.+...+ ...+..++..||+.+|.+||++.+.++.+
T Consensus 257 -~~~~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 257 -QLKPNI----TNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp -CCCSSS----CHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred -CCCCCC----CHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 011112 23466777999999999999986544433
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=351.75 Aligned_cols=262 Identities=16% Similarity=0.243 Sum_probs=204.4
Q ss_pred cCCCCceeecccCceEEEEEEeCC---------CCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeee-----------
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPD---------GKELAVKILKPSEDVLKEFASEIEIITALHHRNIIS----------- 390 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~---------g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~----------- 390 (678)
++|...+.||+|+||.||+|.... ++.||||++... ..+.+|++++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 578889999999999999998753 789999999765 45789999999999999887
Q ss_pred ----EEEEEEe-CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeE
Q 041755 391 ----LFGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNIL 465 (678)
Q Consensus 391 ----l~g~~~~-~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NIL 465 (678)
+++++.. ++..++||||+ +++|.+++.... ...+++.+++.++.||+.||.|||+ ++|+||||||+|||
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl 191 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF 191 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence 6788876 67899999999 999999997542 2569999999999999999999999 99999999999999
Q ss_pred ecCCC--CcEEeecccccccCCCCCCc-----eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCC
Q 041755 466 LSDDF--EPQLSDFGLASWLSTSSSHL-----TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSE 538 (678)
Q Consensus 466 l~~~~--~~kL~DFGla~~~~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~ 538 (678)
++.++ .+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 89999999998765432211 123358999999999999999999999999999999999999999865
Q ss_pred CCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 539 NPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 539 ~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
...... +........ .....+.++..... .....+..++..||+.+|.+||++.+|++.|+...
T Consensus 272 ~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 272 LPNTED-IMKQKQKFV--DKPGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp TTCHHH-HHHHHHHHH--HSCCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CcCHHH-HHHHHHhcc--CChhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 422211 111100000 01111111111100 11245667779999999999999999999997544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=350.97 Aligned_cols=262 Identities=19% Similarity=0.237 Sum_probs=196.9
Q ss_pred cCCCCceeecccCceEEEEEEeC----CCCEEEEEEeCCChH------------HHHHHHHHHHHHHhcCCCCeeeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP----DGKELAVKILKPSED------------VLKEFASEIEIITALHHRNIISLFGF 394 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~----~g~~vAvK~l~~~~~------------~~~~~~~Ei~il~~l~HpnIv~l~g~ 394 (678)
++|...+.||+|+||.||+|... ++..+|||++..... ....+.+|+.++..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57888999999999999999875 578899999875421 12346788899999999999999999
Q ss_pred EEe----CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC
Q 041755 395 CFE----DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF 470 (678)
Q Consensus 395 ~~~----~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~ 470 (678)
+.. ....++||||+ +++|.+++... ..+++.+++.++.||+.||.|||+ .+|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCC
Confidence 988 67899999999 99999999753 268999999999999999999999 9999999999999999887
Q ss_pred --CcEEeecccccccCCCCCC-----ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCccc
Q 041755 471 --EPQLSDFGLASWLSTSSSH-----LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQ 543 (678)
Q Consensus 471 --~~kL~DFGla~~~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~ 543 (678)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876543211 111346799999999999999999999999999999999999999964322111
Q ss_pred ccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 544 ESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 544 ~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.. ......... .+...+...... ......+..++..||+.+|.+||++.+|++.|+.
T Consensus 269 ~~--~~~~~~~~~-~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 325 (345)
T 2v62_A 269 AV--QTAKTNLLD-ELPQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNP 325 (345)
T ss_dssp HH--HHHHHHHHH-TTTHHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCT
T ss_pred HH--HHHHHhhcc-cccHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 11 000000000 001100000000 0123457777899999999999999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=336.24 Aligned_cols=246 Identities=26% Similarity=0.399 Sum_probs=203.6
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||++... +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 56888899999999999999876 5889999998642 355678899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++++|.+++... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 95 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 95 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp ECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999988643 468999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
.... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+ ..+..
T Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~~~~~------ 232 (294)
T 2rku_A 168 DGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI-------KKNEY------ 232 (294)
T ss_dssp TTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------HTTCC------
T ss_pred Cccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------hhccC------
Confidence 3222 23367999999999999999999999999999999999999999765432211100 00100
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.... ...+..++..||+.+|.+||++.++++
T Consensus 233 ~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 233 SIPKHI----NPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCcccc----CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111111 234667789999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=349.33 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=198.4
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
.++|...+.||+|+||.||++... +|+.||||+++.... .+.+|++++.++ +||||+++++++.+++..|+||||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 457888999999999999999875 689999999975432 245688888888 799999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC----CCcEEeeccccccc
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD----FEPQLSDFGLASWL 483 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~----~~~kL~DFGla~~~ 483 (678)
+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||+.++ +.+||+|||+++..
T Consensus 98 ~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 98 MKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999643 468999999999999999999999 999999999999998543 34999999999876
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........+... +..+.+.
T Consensus 171 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----i~~~~~~--- 241 (342)
T 2qr7_A 171 RAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR----IGSGKFS--- 241 (342)
T ss_dssp BCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH----HHHCCCC---
T ss_pred cCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH----HccCCcc---
Confidence 543322 2346799999999999888899999999999999999999999976432222111110 1111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+...+.......+..++..||+.||.+||++.++++
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000011112344667789999999999999999875
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=356.60 Aligned_cols=266 Identities=20% Similarity=0.270 Sum_probs=198.2
Q ss_pred HHhhcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-------
Q 041755 327 LSATSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED------- 398 (678)
Q Consensus 327 ~~~t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------- 398 (678)
....++|...+.||+|+||.||+|.. .+|+.||||++..+.. .+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~---~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR---YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc---hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 34567899999999999999999986 4799999999875532 223799999999999999999998543
Q ss_pred -------------------------------CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 041755 399 -------------------------------NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH 447 (678)
Q Consensus 399 -------------------------------~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH 447 (678)
..+++||||++ |+|.+.+......+..+++..++.++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34889999997 6888877654344567999999999999999999999
Q ss_pred hcCCCCeeeccCCCCCeEec-CCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHH
Q 041755 448 NSCEQPVIHKDVKSSNILLS-DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVL 525 (678)
Q Consensus 448 ~~~~~~iiHrDIKp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL 525 (678)
+ .+|+||||||+|||++ .++.+||+|||+++.+...... ....||+.|+|||.+.+. .++.++|||||||++
T Consensus 159 ~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 S---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp T---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred H---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 8 9999999999999998 6889999999999876554322 235789999999998775 489999999999999
Q ss_pred HHHhcCCCCCCCCCCcccccchhhccccc-------ccCccccccCCCCCC-----CCCHHHHHHHHHHHHhcccCCCCC
Q 041755 526 LELLSGKKPINSENPKGQESLVMWAKPIL-------KDGKVSQLLDPSLDT-----DYDNDQIERMVLAATLSISRAPTV 593 (678)
Q Consensus 526 ~eLltG~~Pf~~~~~~~~~~l~~~~~~~~-------~~~~~~~l~dp~l~~-----~~~~~~~~~l~~la~~Cl~~dP~~ 593 (678)
|||++|+.||.+.........+....... ....+....-+.+.. .+.......+..++..||+.+|.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 99999999998765432211111000000 000001100011110 011112344677889999999999
Q ss_pred CCCHHHHHH
Q 041755 594 RPQINLVLK 602 (678)
Q Consensus 594 RPs~~eVl~ 602 (678)
|||+.++++
T Consensus 313 R~t~~e~l~ 321 (383)
T 3eb0_A 313 RINPYEAMA 321 (383)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999985
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=342.52 Aligned_cols=257 Identities=21% Similarity=0.272 Sum_probs=197.7
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
.++|...+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 368889999999999999999875 7889999998743 34567899999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999753 468999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+. .......
T Consensus 186 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------~~~~~~~--- 255 (309)
T 2h34_A 186 DEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN------QAIPRPS--- 255 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH------SCCCCGG---
T ss_pred ccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc------cCCCCcc---
Confidence 43222 2234579999999999999999999999999999999999999997654321100000 0000000
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhhcCH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRP-QINLVLKLLQGDE 608 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-s~~eVl~~L~~~~ 608 (678)
.....+ ...+..++..||+.+|.+|| ++.++++.|+...
T Consensus 256 -~~~~~~----~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 256 -TVRPGI----PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp -GTSTTC----CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred -ccCCCC----CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 011111 23466778999999999999 9999999987543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.36 Aligned_cols=252 Identities=20% Similarity=0.309 Sum_probs=199.3
Q ss_pred hcCCCCc-eeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEE
Q 041755 330 TSNFLPE-YLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 330 t~~f~~~-~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~l 403 (678)
.+.|... +.||+|+||.||+|... +|+.||||+++.. ......+.+|+.++..+. ||||+++++++.+.+..++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 4456655 78999999999999875 6999999998753 234577899999999995 6999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC---CCCcEEeecccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD---DFEPQLSDFGLA 480 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~---~~~~kL~DFGla 480 (678)
||||+.+|+|.+++... ....+++.+++.++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp EEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred EEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 99999999999998643 23578999999999999999999999 99999999999999998 789999999999
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+..... .
T Consensus 182 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~-----~-- 251 (327)
T 3lm5_A 182 RKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV-----D-- 251 (327)
T ss_dssp EEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----C--
T ss_pred cccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc-----c--
Confidence 87654332 2236799999999999999999999999999999999999999976543322111110000 0
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
............+..++..||+.+|.+||++.++++
T Consensus 252 ------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 252 ------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp ------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 000001112344667789999999999999999885
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.80 Aligned_cols=199 Identities=25% Similarity=0.446 Sum_probs=177.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|+||.||+|... +|+.||+|+++.. ....+.+.+|+.++..++||||+++++++..++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57888999999999999999876 7899999999754 45678899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ-PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
+++|+|.+++... ..+++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 9999999999753 358999999999999999999998 5 8999999999999999999999999998765332
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 540 (678)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 186 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 186 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp C--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred c----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1 2235789999999999999999999999999999999999999976543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=336.51 Aligned_cols=245 Identities=24% Similarity=0.370 Sum_probs=196.5
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCeEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFE----DNNLLL 403 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~l 403 (678)
.|.....||+|+||.||+|... ++..||+|++.. .....+.+.+|+.+++.++||||+++++++.. ...+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4667778999999999999865 688999999864 34567889999999999999999999999875 356899
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCCeEec-CCCCcEEeecccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP--VIHKDVKSSNILLS-DDFEPQLSDFGLA 480 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~--iiHrDIKp~NILl~-~~~~~kL~DFGla 480 (678)
||||+++|+|.+++... ..+++..++.++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999999999653 458999999999999999999998 77 99999999999998 7899999999999
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
....... .....||+.|+|||.+. +.++.++||||||+++|+|++|+.||......... .. .+..+...
T Consensus 180 ~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~----~~~~~~~~ 248 (290)
T 1t4h_A 180 TLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YR----RVTSGVKP 248 (290)
T ss_dssp GGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HH----HHTTTCCC
T ss_pred ccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HH----HHhccCCc
Confidence 7644322 22357999999999886 56999999999999999999999999764332111 10 01111111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+ ... ....+..++..||+.+|.+||++.++++
T Consensus 249 ~~~----~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 ASF----DKV----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGG----GGC----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccc----CCC----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111 111 1234777889999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=359.08 Aligned_cols=242 Identities=12% Similarity=0.176 Sum_probs=189.9
Q ss_pred hcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCC----ChHHHHHHHHHH---HHHHhcCCCCeeeEE-------EE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKP----SEDVLKEFASEI---EIITALHHRNIISLF-------GF 394 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~----~~~~~~~~~~Ei---~il~~l~HpnIv~l~-------g~ 394 (678)
.++|...+.||+|+||.||+|.. .+|+.||||+++. .....+.|.+|+ ++++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999986 4799999999862 335667899999 455566899999998 66
Q ss_pred EEeCC-----------------eEEEEEEcCCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 041755 395 CFEDN-----------------NLLLVYDFLSRGSLEENLHGNKK---DGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454 (678)
Q Consensus 395 ~~~~~-----------------~~~lV~E~~~~gsL~~~L~~~~~---~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~i 454 (678)
+...+ ..|+||||+ +|+|.+++..... ....+++..++.|+.||+.||.|||+ ++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 66543 289999999 6899999975321 11234568899999999999999999 999
Q ss_pred eeccCCCCCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccC-----------CCCccceEeehhH
Q 041755 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-----------KVSEKIDVYAFGI 523 (678)
Q Consensus 455 iHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----------~~s~ksDVwSlGv 523 (678)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986332 2334677 999999999887 8999999999999
Q ss_pred HHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 524 VLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 524 vL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+||||++|+.||...........+ +.. . ... ...+..++..||+.||.+||++.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~---------------~~~-~-~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWI---------------FRS-C-KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGG---------------GSS-C-CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchhhh---------------hhh-c-cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999765433221110 000 0 111 234667789999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=346.81 Aligned_cols=265 Identities=21% Similarity=0.303 Sum_probs=200.4
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--------C
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFE--------D 398 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--------~ 398 (678)
++|...+.||+|+||.||+|... +|+.||||++.... .....+.+|+.++..++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57888999999999999999874 79999999986432 334567899999999999999999999987 4
Q ss_pred CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecc
Q 041755 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 399 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
+..++||||+. |+|.+.+.... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccC-CCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 56899999997 47877776432 468999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCC--CceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccc
Q 041755 479 LASWLSTSSS--HLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILK 555 (678)
Q Consensus 479 la~~~~~~~~--~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~ 555 (678)
++..+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9987653221 122334678999999999876 4589999999999999999999999987654332221111100000
Q ss_pred cC--------ccccccCCCCCCCC-CHHH------HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 556 DG--------KVSQLLDPSLDTDY-DNDQ------IERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 556 ~~--------~~~~l~dp~l~~~~-~~~~------~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.. .....+........ ..+. ...+..++..||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 00 00000000000000 1111 134677889999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=335.92 Aligned_cols=251 Identities=22% Similarity=0.321 Sum_probs=197.6
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
+|....+||+|+||.||+|... +++.||||++.... ...+.+.+|+.++..++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 4555668999999999999864 78999999987543 556789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC-CCCcEEeecccccccCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD-DFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~-~~~~kL~DFGla~~~~~~~~ 488 (678)
+++|.+++.... ....+++..++.++.|++.||.|||+ .+|+|+||||+|||++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999997542 23456799999999999999999999 99999999999999987 89999999999987654322
Q ss_pred CceecccccCCCCCCcchhccCC--CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGK--VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
......||+.|+|||++.++. ++.++||||||+++|+|++|+.||......... .+.... ....+.
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~-------~~~~~~ 246 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---MFKVGM-------FKVHPE 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH---HHHHHH-------HCCCCC
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH---HHhhcc-------cccccc
Confidence 122357899999999997654 889999999999999999999999643321110 000000 001112
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+... ....+..++..||+.+|.+||++.++++
T Consensus 247 ~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 IPES----MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCTT----SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2222 2345667789999999999999999985
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=356.43 Aligned_cols=193 Identities=22% Similarity=0.349 Sum_probs=155.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----CeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFED-----NNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~ 401 (678)
++|...+.||+|+||.||+|... +|+.||||++.. .....+.+.+|+.+|..++||||+++++++... ..+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 67888999999999999999865 789999999864 235567899999999999999999999999543 579
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
|+||||+ +|+|.+++... ..+++..++.++.||+.||.|||+ .+||||||||+||||+.++.+||+|||+++
T Consensus 133 ~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccch
Confidence 9999998 67999998643 568999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCC-------------------------ceecccccCCCCCCcchh-ccCCCCccceEeehhHHHHHHhcC
Q 041755 482 WLSTSSSH-------------------------LTCTDVAGTFGYLAPEYF-MHGKVSEKIDVYAFGIVLLELLSG 531 (678)
Q Consensus 482 ~~~~~~~~-------------------------~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSlGvvL~eLltG 531 (678)
........ ...+..+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 76532211 123446889999999986 456799999999999999999993
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=375.49 Aligned_cols=246 Identities=24% Similarity=0.357 Sum_probs=196.7
Q ss_pred eeecccCceEEEEEEeC---CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP---DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~---~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
+.||+|+||.||+|.+. .++.||||+++.. ....+.|.+|++++.+++||||++++++|.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 57999999999999642 5688999999753 2446789999999999999999999999964 568999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC-
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH- 489 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~- 489 (678)
|+|.+++... ..+++..++.|+.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999999643 468999999999999999999999 99999999999999999999999999999877554322
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
.......||+.|+|||++.+..++.++|||||||+||||++ |+.||...........+ ..+..
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-------~~~~~--------- 590 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGER--------- 590 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-------HTTCC---------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCCC---------
Confidence 22233457889999999999999999999999999999998 99999876543221111 11110
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
..........+..++..||+.+|.+||++.+|++.|+.
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 01111223557778899999999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=351.26 Aligned_cols=271 Identities=20% Similarity=0.249 Sum_probs=193.4
Q ss_pred HHHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe---
Q 041755 325 ELLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNN--- 400 (678)
Q Consensus 325 el~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~--- 400 (678)
+.....++|...+.||+|+||.||+|... +|+.||||++.........+.+|++.+..++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 34456688999999999999999999875 68999999987665445567788999999999999999999976443
Q ss_pred ----EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeeeccCCCCCeEecC-CCCcE
Q 041755 401 ----LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH--NSCEQPVIHKDVKSSNILLSD-DFEPQ 473 (678)
Q Consensus 401 ----~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH--~~~~~~iiHrDIKp~NILl~~-~~~~k 473 (678)
.++||||+.+ +|...+.........+++..++.++.|++.||.||| + .+|+||||||+|||++. ++.+|
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEE
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEE
Confidence 8899999975 555544432234467899999999999999999999 7 99999999999999997 89999
Q ss_pred EeecccccccCCCCCCceecccccCCCCCCcchhccCC-CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccc
Q 041755 474 LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK-VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552 (678)
Q Consensus 474 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 552 (678)
|+|||++......... ....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.......+.....
T Consensus 173 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp ECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 9999999877654322 2357899999999987654 89999999999999999999999987654322111110000
Q ss_pred c--------cccC-ccccccCC------CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 553 I--------LKDG-KVSQLLDP------SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 553 ~--------~~~~-~~~~l~dp------~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
. +... ......+. .............+..++..||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0000 00000000 0001111223456788889999999999999999885
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=339.86 Aligned_cols=262 Identities=21% Similarity=0.307 Sum_probs=206.7
Q ss_pred hcCCCCceeecccCceEEEEEEe--CCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCC------CeeeEEEEEEeCCeE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL--PDGKELAVKILKPSEDVLKEFASEIEIITALHHR------NIISLFGFCFEDNNL 401 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~--~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~Hp------nIv~l~g~~~~~~~~ 401 (678)
.++|...+.||+|+||.||+|.. .+|+.||||+++........+.+|+.++..++|+ +++++++++...+..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 35788999999999999999986 3688999999988777778899999999998765 499999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC-------------
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD------------- 468 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~------------- 468 (678)
++||||+ +++|.+++.... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 899999997543 2468999999999999999999999 99999999999999987
Q ss_pred ------CCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcc
Q 041755 469 ------DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542 (678)
Q Consensus 469 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 542 (678)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 6789999999998754422 23578999999999999999999999999999999999999998755432
Q ss_pred cccchhhcccccc--------cCc------------------cccccCCCCC-CCCCHHHHHHHHHHHHhcccCCCCCCC
Q 041755 543 QESLVMWAKPILK--------DGK------------------VSQLLDPSLD-TDYDNDQIERMVLAATLSISRAPTVRP 595 (678)
Q Consensus 543 ~~~l~~~~~~~~~--------~~~------------------~~~l~dp~l~-~~~~~~~~~~l~~la~~Cl~~dP~~RP 595 (678)
...........+. ... +.....+... ..........+..++..||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 2111110000000 000 0000000000 011234456788899999999999999
Q ss_pred CHHHHHH
Q 041755 596 QINLVLK 602 (678)
Q Consensus 596 s~~eVl~ 602 (678)
|+.++++
T Consensus 322 t~~ell~ 328 (339)
T 1z57_A 322 TLREALK 328 (339)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999885
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=352.51 Aligned_cols=252 Identities=13% Similarity=0.078 Sum_probs=182.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhc--CCCCeeeEE-------EEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITAL--HHRNIISLF-------GFCF 396 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l--~HpnIv~l~-------g~~~ 396 (678)
.+|...+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.++..| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 35778899999999999999865 7899999999763 24566778886555555 699988755 4554
Q ss_pred eC-----------------CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 041755 397 ED-----------------NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER------YKVAVGVAEALDYLHNSCEQP 453 (678)
Q Consensus 397 ~~-----------------~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~------~~ia~qia~aL~yLH~~~~~~ 453 (678)
.. ..+++||||++ |+|.+++.... ..+.+..+ +.++.||+.||.|||+ ++
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQS---KG 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHH---CC
Confidence 33 34899999998 89999997532 23455666 7888999999999999 99
Q ss_pred eeeccCCCCCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhcc--CCCCccceEeehhHHHHHHhcC
Q 041755 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH--GKVSEKIDVYAFGIVLLELLSG 531 (678)
Q Consensus 454 iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG 531 (678)
|+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||+||||++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999999866431 113567799999999987 6799999999999999999999
Q ss_pred CCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 532 KKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 532 ~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.||....+..... |...............+. .......+..++..||+.||.+||++.++++
T Consensus 290 ~~Pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS---WKRPSLRVPGTDSLAFGS-----CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC---CCBCCTTSCCCCSCCCTT-----SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc---hhhhhhhhccccccchhh-----ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99998765432221 111000000000000111 0122345667789999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.85 Aligned_cols=254 Identities=24% Similarity=0.298 Sum_probs=185.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEe--------CC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS-EDVLKEFASEIEIITALH-HRNIISLFGFCFE--------DN 399 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--------~~ 399 (678)
.+|...+.||+|+||.||+|... +|+.||||++... ......+.+|+.++.++. ||||+++++++.. ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 47888899999999999999865 7899999988543 456678899999999996 9999999999953 34
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCCeEecCCCCcEEeec
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP--VIHKDVKSSNILLSDDFEPQLSDF 477 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~--iiHrDIKp~NILl~~~~~~kL~DF 477 (678)
.+++||||+. |+|.+++.... ....+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++.+||+||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred eEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecC
Confidence 5899999995 79999886532 23569999999999999999999998 78 999999999999999999999999
Q ss_pred ccccccCCCCCCc----------eecccccCCCCCCcchh---ccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccc
Q 041755 478 GLASWLSTSSSHL----------TCTDVAGTFGYLAPEYF---MHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQE 544 (678)
Q Consensus 478 Gla~~~~~~~~~~----------~~~~~~Gt~~Y~APE~l---~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~ 544 (678)
|++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~- 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI- 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh-
Confidence 9998775532211 11134689999999998 566789999999999999999999999975432110
Q ss_pred cchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 545 SLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 545 ~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
. . +.... ..... ....+..++..||+.+|.+||++.++++.|+...
T Consensus 262 --~-------~-~~~~~----~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 262 --V-------N-GKYSI----PPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp --------------CCC----CTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred --h-------c-CcccC----Ccccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 0 00000 00011 1123566789999999999999999999997544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=353.08 Aligned_cols=200 Identities=26% Similarity=0.373 Sum_probs=177.5
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhc------CCCCeeeEEEEEEeCCeEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITAL------HHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l------~HpnIv~l~g~~~~~~~~~ 402 (678)
..+|...+.||+|+||.||+|... +++.||||+++........+.+|+.++..+ .|+||+++++++...+..+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 356888899999999999999765 689999999998877778888999999888 5779999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC--cEEeecccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE--PQLSDFGLA 480 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~--~kL~DFGla 480 (678)
+||||+. ++|.+++..... ..+++..++.++.||+.||.|||+ ++|+||||||+||||+.++. +||+|||++
T Consensus 176 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999995 699999876432 458999999999999999999999 89999999999999999987 999999999
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCC
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 540 (678)
....... ....||+.|+|||++.+..++.++|||||||+||||++|+.||...+.
T Consensus 250 ~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 250 CYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp EETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 7654322 235789999999999999999999999999999999999999987654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=334.43 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=199.9
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEE--eCCeE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-----DVLKEFASEIEIITALHHRNIISLFGFCF--EDNNL 401 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~--~~~~~ 401 (678)
.++|...+.||+|+||.||++... +|+.||||+++... .....+.+|+.++..++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 478999999999999999999875 68999999997532 34578999999999999999999999985 44578
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
++||||+.++ |.+++.... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 777776532 3568999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCCCceecccccCCCCCCcchhccCC--CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc
Q 041755 482 WLSTSSSHLTCTDVAGTFGYLAPEYFMHGK--VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559 (678)
Q Consensus 482 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 559 (678)
...............||+.|+|||++.+.. ++.++||||||+++|||++|+.||........... +..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------i~~~~~ 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN-------IGKGSY 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-------HHHCCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH-------HhcCCC
Confidence 776544444444567999999999997644 47899999999999999999999986543211111 011110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 560 SQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 560 ~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+... ....+..++..||+.||.+||++.++++
T Consensus 231 ------~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 231 ------AIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp ------CCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------CCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111 2244667789999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=343.22 Aligned_cols=246 Identities=26% Similarity=0.390 Sum_probs=203.8
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||++... +++.||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 57888899999999999999875 5889999998642 356678899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+.+++|.+++... ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 121 e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 121 ELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999988643 468999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
.... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+. .+. .
T Consensus 194 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------~~~------~ 258 (335)
T 2owb_A 194 DGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK-------KNE------Y 258 (335)
T ss_dssp TTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------HTC------C
T ss_pred Cccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh-------cCC------C
Confidence 3322 234679999999999999999999999999999999999999997654322111000 000 0
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.... ...+..++..||+.||.+||++.++++
T Consensus 259 ~~~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 259 SIPKHI----NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111112 234666789999999999999999885
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=337.01 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=201.2
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
.++|...+.||+|+||.||++... +|+.||+|+++... .....+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457888999999999999999875 79999999997654 3446788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe---cCCCCcEEeecccccccC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl---~~~~~~kL~DFGla~~~~ 484 (678)
+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999998643 468999999999999999999999 999999999999999 788999999999987644
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+ ..+... +.
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i-------~~~~~~--~~ 227 (304)
T 2jam_A 161 NGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI-------KEGYYE--FE 227 (304)
T ss_dssp CBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHCCCC--CC
T ss_pred CCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------HcCCCC--CC
Confidence 321 22357999999999999999999999999999999999999999765432211111 111100 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..... .....+..++..||+.+|.+||++.++++
T Consensus 228 ~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 228 SPFWD----DISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTT----TSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111 12345667789999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=348.60 Aligned_cols=272 Identities=21% Similarity=0.250 Sum_probs=201.2
Q ss_pred ccHHHHHHhhcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCC------------hHHHHHHHHHHHHHHhcCCCCe
Q 041755 321 FSYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPS------------EDVLKEFASEIEIITALHHRNI 388 (678)
Q Consensus 321 f~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~------------~~~~~~~~~Ei~il~~l~HpnI 388 (678)
....++....++|...+.||+|+||.||+|...+|+.||||++... ....+.+.+|++++.+++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 4467888899999999999999999999999888999999988531 2345789999999999999999
Q ss_pred eeEEEEEEeC-----CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCC
Q 041755 389 ISLFGFCFED-----NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSN 463 (678)
Q Consensus 389 v~l~g~~~~~-----~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~N 463 (678)
+++++++... ...++||||+. |+|.+.+... ...+++..++.++.|++.||.|||+ .+|+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHH
Confidence 9999999543 36899999997 6888888643 3578999999999999999999999 999999999999
Q ss_pred eEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcc
Q 041755 464 ILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542 (678)
Q Consensus 464 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 542 (678)
||++.++.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999985544322 234678999999999877 678999999999999999999999998754322
Q ss_pred cccchh-hcc-cc------cccCccccccCCCCCCC-------CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 543 QESLVM-WAK-PI------LKDGKVSQLLDPSLDTD-------YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 543 ~~~l~~-~~~-~~------~~~~~~~~l~dp~l~~~-------~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....+. ... +. .........+...+... ........+..++..||+.+|.+|||+.++++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 111100 000 00 00000000010000000 00111245677889999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=352.63 Aligned_cols=199 Identities=24% Similarity=0.361 Sum_probs=168.3
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----Ce
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFED-----NN 400 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 400 (678)
.++|...+.||+|+||.||+|... +|+.||||+++. .....+.+.+|+.+++.++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 468899999999999999999865 688999999975 235567899999999999999999999999766 57
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
.|+||||+. |+|.+++... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 999999985 6999999643 568999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCC--------------------ceecccccCCCCCCcchh-ccCCCCccceEeehhHHHHHHhcCCCCCC
Q 041755 481 SWLSTSSSH--------------------LTCTDVAGTFGYLAPEYF-MHGKVSEKIDVYAFGIVLLELLSGKKPIN 536 (678)
Q Consensus 481 ~~~~~~~~~--------------------~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSlGvvL~eLltG~~Pf~ 536 (678)
+........ ...+..+||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 976543221 123457899999999986 55679999999999999999998665554
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.95 Aligned_cols=260 Identities=19% Similarity=0.253 Sum_probs=193.5
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC------
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFEDN------ 399 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 399 (678)
.++|...+.||+|+||.||+|... +|+.||||++.. .....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468899999999999999999865 689999999864 3355678899999999999999999999997654
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
..++||||+. |+|.+.+. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999996 57888875 248899999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhc---------
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA--------- 550 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~--------- 550 (678)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 174 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred cccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98765432 223467999999999999999999999999999999999999999875532211100000
Q ss_pred -------------ccccccCccccccCCCCCCCC---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 551 -------------KPILKDGKVSQLLDPSLDTDY---DNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 551 -------------~~~~~~~~~~~l~dp~l~~~~---~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+......+..++........ .......+..++..||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000011111111111110 1122456788899999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=341.03 Aligned_cols=263 Identities=25% Similarity=0.397 Sum_probs=186.5
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.++|...+.||+|+||.||+|... +|+.||||++... ......+.+|+.++.+++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 468889999999999999999864 7899999998754 2446778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 407 FLSRGSLEENLHGN----KKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 407 ~~~~gsL~~~L~~~----~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
|+++++|.+++... ......+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 99999999988631 1123568999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCC---ceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 483 LSTSSSH---LTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 483 ~~~~~~~---~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
....... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||............... .....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~ 247 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN---DPPSL 247 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS---SCCCT
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc---CCCcc
Confidence 6543211 11233579999999999876 56899999999999999999999999865433211100000 00000
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.....++.....++ ..+..++..||+.+|.+||++.++++
T Consensus 248 ~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 248 ETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00111122222222 34667789999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=360.17 Aligned_cols=250 Identities=26% Similarity=0.380 Sum_probs=200.4
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--------------HHHHHHHHHHHHHHhcCCCCeeeEEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--------------DVLKEFASEIEIITALHHRNIISLFG 393 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--------------~~~~~~~~Ei~il~~l~HpnIv~l~g 393 (678)
..++|...+.||+|+||.||+|... +++.||||+++... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3568889999999999999999875 68899999986532 23567899999999999999999999
Q ss_pred EEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC---
Q 041755 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF--- 470 (678)
Q Consensus 394 ~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~--- 470 (678)
+|.+...+++||||+++|+|.+.+... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCc
Confidence 999999999999999999999998653 468999999999999999999999 9999999999999999876
Q ss_pred CcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhc
Q 041755 471 EPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA 550 (678)
Q Consensus 471 ~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~ 550 (678)
.+||+|||++........ .....||+.|+|||++. +.++.++|||||||++|+|++|+.||...+.......+.
T Consensus 187 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-- 260 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE-- 260 (504)
T ss_dssp SEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--
T ss_pred cEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--
Confidence 699999999987755432 23467999999999986 569999999999999999999999998755432211111
Q ss_pred ccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 551 KPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 551 ~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.+.. +...... ....+..++..||+.+|.+|||+.++++
T Consensus 261 -----~~~~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 261 -----KGKYYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp -----HCCCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----cCCCCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111100 0000001 1245677889999999999999999984
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=334.82 Aligned_cols=244 Identities=25% Similarity=0.401 Sum_probs=202.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||+|... +++.||||++.... .....+.+|++++..++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57888999999999999999875 67899999986432 22467889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999753 358999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
.. .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...........+ . .. +.
T Consensus 167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------~-~~------~~ 229 (284)
T 2vgo_A 167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI------V-NV------DL 229 (284)
T ss_dssp SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------H-TT------CC
T ss_pred cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH------h-cc------cc
Confidence 22 22357899999999999999999999999999999999999999765432211110 0 00 01
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.... ...+..++..||+.+|.+||++.++++
T Consensus 230 ~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 230 KFPPFL----SDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp CCCTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcC----CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111112 234667789999999999999999885
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=350.72 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=201.1
Q ss_pred cCCCCceeecccCceEEEEEEe----CCCCEEEEEEeCCCh-----HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCe
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL----PDGKELAVKILKPSE-----DVLKEFASEIEIITAL-HHRNIISLFGFCFEDNN 400 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~----~~g~~vAvK~l~~~~-----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 400 (678)
++|...+.||+|+||.||++.. .+|+.||||+++... .....+.+|++++..+ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5788899999999999999986 378999999987421 2345677899999999 69999999999999999
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
+++||||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999753 468999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccC--CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHG--KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
+.+...... ......||+.|+|||++.++ .++.++|||||||+||||++|+.||...........+ .......
T Consensus 207 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~~-- 281 (355)
T 1vzo_A 207 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKS-- 281 (355)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHC--
T ss_pred eecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHhcc--
Confidence 876443222 22346799999999999863 4789999999999999999999999765432221111 1111100
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHHHh
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLKLL 604 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~~L 604 (678)
.+.+ .......+..++..||..||.+|| ++.++++..
T Consensus 282 -----~~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 -----EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -----CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -----CCCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1111 112234466788999999999999 899988743
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.19 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=203.4
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----------hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----------EDVLKEFASEIEIITALH-HRNIISLFGFCF 396 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----------~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~ 396 (678)
..++|...+.||+|+||.||+|... +|+.||||+++.. ....+.+.+|++++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3468889999999999999999875 6899999998643 134567889999999996 999999999999
Q ss_pred eCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEee
Q 041755 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSD 476 (678)
Q Consensus 397 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~D 476 (678)
..+..++||||+++++|.+++... ..+++..++.++.|++.||.|||+ .+|+|+||||+|||++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEec
Confidence 999999999999999999999653 468999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCceecccccCCCCCCcchhc------cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhc
Q 041755 477 FGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM------HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA 550 (678)
Q Consensus 477 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~------~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~ 550 (678)
||++........ .....||+.|+|||++. ...++.++||||||+++|+|++|+.||...........+
T Consensus 168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--- 241 (298)
T 1phk_A 168 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--- 241 (298)
T ss_dssp CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---
T ss_pred ccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH---
Confidence 999987654332 23357899999999985 456889999999999999999999999765432111111
Q ss_pred ccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 551 KPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 551 ~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+... ...+ ........+..++..||+.+|.+||++.++++
T Consensus 242 ----~~~~~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 ----MSGNYQ-FGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp ----HHTCCC-CCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ----hcCCcc-cCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 011110 0000 01122345777889999999999999999885
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.79 Aligned_cols=256 Identities=19% Similarity=0.297 Sum_probs=199.3
Q ss_pred cCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEe--CCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSEDVLKEFASEIEIITALH-HRNIISLFGFCFE--DNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~--~~~~~lV~E 406 (678)
++|...+.||+|+||.||+|.. .+|+.||||+++... .+.+.+|+.++.+++ ||||+++++++.+ ....++|||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc--hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 6788999999999999999986 478999999998544 356889999999997 9999999999987 667999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC-CcEEeecccccccCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF-EPQLSDFGLASWLST 485 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kL~DFGla~~~~~ 485 (678)
|+.+++|.+++. .+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||+++....
T Consensus 114 ~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 114 HVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp CCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred ccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999884 37899999999999999999999 9999999999999999776 899999999987655
Q ss_pred CCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccc--------cc--
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP--------IL-- 554 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~--------~~-- 554 (678)
.... ....||..|+|||++.+ ..++.++|||||||++|+|++|+.||........ .+...... .+
T Consensus 184 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 184 GQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHH
T ss_pred CCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHH
Confidence 4322 23578999999999977 6789999999999999999999999965432211 00000000 00
Q ss_pred ----ccCcccc--------ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 555 ----KDGKVSQ--------LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 555 ----~~~~~~~--------l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....+.. .................+..++..||+.||.+|||+.++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 00011111111122355777889999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=360.10 Aligned_cols=248 Identities=23% Similarity=0.348 Sum_probs=196.9
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|...+.||+|+||.||+|... ++..||||+++... .....+.+|+.+++.++||||++++++|.+.+..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46888899999999999999875 78999999987532 235678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC---CCcEEeeccccccc
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD---FEPQLSDFGLASWL 483 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~---~~~kL~DFGla~~~ 483 (678)
|+.+|+|.+.+... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.. +.+||+|||++...
T Consensus 117 ~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 117 CYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999988643 458999999999999999999999 999999999999999764 55999999999877
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
..... .....||+.|+|||++. +.++.++|||||||++|+|++|+.||...........+.. +.+. ..
T Consensus 190 ~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-------~~~~-~~ 257 (494)
T 3lij_A 190 ENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK-------GKYT-FD 257 (494)
T ss_dssp BTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------TCCC-CC
T ss_pred CCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------CCCC-CC
Confidence 55332 23467999999999986 5799999999999999999999999987654322111111 1100 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.. ... ...+..++..||+.+|.+|||+.++++
T Consensus 258 ~~~~-~~~----s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPEW-KNV----SEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGGG-TTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhc-ccC----CHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0000 111 234667789999999999999999884
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=330.54 Aligned_cols=246 Identities=23% Similarity=0.390 Sum_probs=194.5
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
.++|...+.||+|+||.||+|... +|+.||||++.... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367888999999999999999876 79999999986532 2356788999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++++|.+++... ..+++..++.++.|++.||.|||+ ++|+|+||||+|||++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999999653 358999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhccCCC-CccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
.... .....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||........... +..+..
T Consensus 163 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-------~~~~~~---- 228 (276)
T 2h6d_A 163 DGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK-------IRGGVF---- 228 (276)
T ss_dssp C----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHCCC----
T ss_pred CCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH-------hhcCcc----
Confidence 4322 223578999999999987765 6899999999999999999999976432211110 011100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.... ...+..++..||+.+|.+||++.++++
T Consensus 229 --~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 229 --YIPEYL----NRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp --CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --cCchhc----CHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 011111 234667789999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=359.15 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=199.3
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|...+.||+|+||.||+|... +|+.||||++... ......+.+|++++++++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 46788899999999999999875 7999999998532 1235678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec---CCCCcEEeeccccccc
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS---DDFEPQLSDFGLASWL 483 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~---~~~~~kL~DFGla~~~ 483 (678)
|+.+|+|.+.+... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++..+
T Consensus 102 ~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 102 LYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999988653 468999999999999999999999 9999999999999995 4567999999999876
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...........+. .+.+....
T Consensus 175 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-------~~~~~~~~ 243 (486)
T 3mwu_A 175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE-------TGKYAFDL 243 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HTCCCSCS
T ss_pred CCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCCCCCC
Confidence 54332 234679999999999865 69999999999999999999999997654432111111 11110000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+. .......+..++..||+.+|.+|||+.++++
T Consensus 244 -~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 244 -PQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp -GG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -cc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0111244667889999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=358.12 Aligned_cols=261 Identities=21% Similarity=0.298 Sum_probs=194.4
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------CeEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED------NNLLLV 404 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~~~lV 404 (678)
+|...+.||+|+||.||+|... +|+.||||++..... .+.+|+++++.++||||++++++|... ..+++|
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 5777889999999999999875 699999999875432 234799999999999999999998642 236799
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC-CCcEEeeccccccc
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD-FEPQLSDFGLASWL 483 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~-~~~kL~DFGla~~~ 483 (678)
|||+++ +|.+.+.........+++..++.++.||+.||.|||+ ++|+||||||+||||+.+ +.+||+|||+++.+
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999975 6766655332334679999999999999999999999 999999999999999965 56899999999876
Q ss_pred CCCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcc--cc---c--c
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK--PI---L--K 555 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~--~~---~--~ 555 (678)
...... ....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.+.......+.... +. + .
T Consensus 208 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 208 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred ccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 544322 235789999999999765 79999999999999999999999998765322211111000 00 0 0
Q ss_pred cCccccccCCCCCCC-----CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 556 DGKVSQLLDPSLDTD-----YDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 556 ~~~~~~l~dp~l~~~-----~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
...+.++.-+.+... +.......+.+++..||+.||.+||++.++++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 001111111111110 11112345777889999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=348.00 Aligned_cols=258 Identities=21% Similarity=0.309 Sum_probs=195.1
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------C
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFED------N 399 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~ 399 (678)
.++|...+.||+|+||.||+|... +|+.||||++.. .....+.+.+|+++++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 467888999999999999999874 799999999854 335567889999999999999999999999765 3
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
.+|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 8899999864 358999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc-----
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI----- 553 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~----- 553 (678)
++..... .+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+...+...+......
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9876442 234678999999999887 67999999999999999999999999876543221111100000
Q ss_pred ---cccCc-------cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 554 ---LKDGK-------VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 554 ---~~~~~-------~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.... +.......+.. ........+..++..||+.||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000 00000000000 00112345667789999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=360.65 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=202.4
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||+|... +|+.||||++... ......+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56888899999999999999876 7999999998542 234677899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe---cCCCCcEEeecccccc
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASW 482 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl---~~~~~~kL~DFGla~~ 482 (678)
||+.+|+|.+.+... ..+++..++.++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++..
T Consensus 106 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 106 EVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp CCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999998643 468999999999999999999999 999999999999999 5678999999999987
Q ss_pred cCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+.......+. .+.+.-.
T Consensus 179 ~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-------~~~~~~~ 247 (484)
T 3nyv_A 179 FEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE-------KGKYTFE 247 (484)
T ss_dssp BCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCCCCCC
T ss_pred cccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------cCCCCCC
Confidence 655432 234679999999999865 79999999999999999999999998755432211111 1111000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+. .......+..++..||+.+|.+|||+.++++
T Consensus 248 -~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 -LPQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -SGG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -Ccc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 000 0112345667889999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=337.02 Aligned_cols=254 Identities=27% Similarity=0.409 Sum_probs=195.8
Q ss_pred cCCCCceeecccCceEEEEEEeC--CCC--EEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP--DGK--ELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~--~g~--~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 402 (678)
++|...+.||+|+||.||+|... +++ .||||+++.. ....+.|.+|++++.+++||||+++++++...+ .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57888899999999999999753 333 6899998753 356788999999999999999999999998754 79
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 97 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 9999999999999997532 458999999999999999999999 9999999999999999999999999999988
Q ss_pred cCCCCCCc-eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccc
Q 041755 483 LSTSSSHL-TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 483 ~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
........ ......||+.|+|||.+.+..++.++||||||+++|+|++ |+.||........... +...+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~------~~~~~~~- 243 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------IDKEGER- 243 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH------HHTSCCC-
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHH------HHccCCC-
Confidence 76543322 2223567889999999999999999999999999999999 9999976543221110 1011000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
... .......+..++..||+.+|.+||++.++++.|+.
T Consensus 244 ----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~ 281 (291)
T 1u46_A 244 ----LPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 281 (291)
T ss_dssp ----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ----CCC----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 001 11223457778899999999999999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.47 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=199.4
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
.++|...+.||+|+||.||+|... +|+.||||++.... ....+.+|+.++..++||||+++++++...+..++||||+
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecC
Confidence 467888999999999999999875 69999999997543 2456889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++++|.+++... ...+++..++.++.|++.||.|||+ .+++|+||||+|||++.++.+||+|||++........
T Consensus 107 ~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 107 GAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp TTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 999999998632 2568999999999999999999999 9999999999999999999999999999987654322
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............ ..+. .+.+.
T Consensus 181 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~~~~-----~~~~~ 246 (314)
T 3com_A 181 K--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI-------PTNP-----PPTFR 246 (314)
T ss_dssp C--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------HHSC-----CCCCS
T ss_pred c--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------hcCC-----CcccC
Confidence 1 23457899999999999999999999999999999999999999765432111000 0000 00000
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
........+..++..||+.+|.+||++.++++
T Consensus 247 --~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 --KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01112345677889999999999999999985
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=333.86 Aligned_cols=252 Identities=25% Similarity=0.447 Sum_probs=195.1
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----------
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFE----------- 397 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----------- 397 (678)
.++|...+.||+|+||.||+|... +|+.||||+++........+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 467888999999999999999864 79999999998777777889999999999999999999999865
Q ss_pred --CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEe
Q 041755 398 --DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLS 475 (678)
Q Consensus 398 --~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~ 475 (678)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 35689999999999999999753 2467889999999999999999999 999999999999999999999999
Q ss_pred ecccccccCCCCC------------CceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcc
Q 041755 476 DFGLASWLSTSSS------------HLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKG 542 (678)
Q Consensus 476 DFGla~~~~~~~~------------~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~ 542 (678)
|||++........ ........||+.|+|||.+.+. .++.++|||||||++|||++ ||.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-- 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-- 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence 9999987653211 1122345789999999999764 78999999999999999998 5542111
Q ss_pred cccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 543 QESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 543 ~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....... +... ...+...+.......+..++..||+.||.+||++.++++
T Consensus 234 ~~~~~~~----~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 234 RVNILKK----LRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHH----HHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHh----cccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0011100 0000 111112223333455677889999999999999999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.44 Aligned_cols=205 Identities=24% Similarity=0.342 Sum_probs=178.0
Q ss_pred HHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-CC-----CeeeEEEEEEeCC
Q 041755 327 LSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALH-HR-----NIISLFGFCFEDN 399 (678)
Q Consensus 327 ~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-Hp-----nIv~l~g~~~~~~ 399 (678)
....++|...+.||+|+||+||+|... +|+.||||+++........+..|+.++..++ |+ +|+++++++...+
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 334678999999999999999999865 6889999999987777788889999999885 55 4999999999999
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec--CCCCcEEeec
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS--DDFEPQLSDF 477 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~--~~~~~kL~DF 477 (678)
..++||||+. |+|.+++..... ..+++..++.++.|++.||.|||. +..+|+||||||+|||++ .++.+||+||
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred ceEEEEecCC-CCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 9999999995 699999976432 458999999999999999999994 127899999999999995 5788999999
Q ss_pred ccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCC
Q 041755 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540 (678)
Q Consensus 478 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 540 (678)
|++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 206 G~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 206 GSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp TTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9998765422 236789999999999999999999999999999999999999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.33 Aligned_cols=265 Identities=20% Similarity=0.278 Sum_probs=202.2
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----Ce
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFED-----NN 400 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 400 (678)
..++|...+.||+|+||.||+|... +++.||||++... ......+.+|++++.+++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4568999999999999999999865 7889999999753 35567899999999999999999999999754 36
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
.++||||+. |+|.+++.. ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 899999996 699998864 358999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCc-eecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 481 SWLSTSSSHL-TCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 481 ~~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...........
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 8765432221 1234689999999998755 4589999999999999999999999987654332211110000000000
Q ss_pred ccc--------ccCCCC-CCCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 559 VSQ--------LLDPSL-DTDYD-----NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 559 ~~~--------l~dp~l-~~~~~-----~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.. ...... ..... ......+..++..||+.||.+|||+.++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000000 00000 111245677889999999999999999985
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.83 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=195.7
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh---------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE---------DVLKEFASEIEIITALHHRNIISLFGFCFEDN 399 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~---------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~ 399 (678)
.++|...+.||+|+||.||+|... +|+.||||++.... .....+.+|++++.+++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 357888999999999999999875 68899999986532 22345889999999999999999999987654
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC---cEEee
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE---PQLSD 476 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~---~kL~D 476 (678)
.++||||+++|+|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 89999999999999998643 568999999999999999999999 99999999999999987664 99999
Q ss_pred cccccccCCCCCCceecccccCCCCCCcchhc---cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc
Q 041755 477 FGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI 553 (678)
Q Consensus 477 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 553 (678)
||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||........ +.. .
T Consensus 161 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~----~ 231 (322)
T 2ycf_A 161 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD----Q 231 (322)
T ss_dssp CTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH----H
T ss_pred Cccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH----H
Confidence 99998764421 123457999999999974 56789999999999999999999999976543211 110 0
Q ss_pred cccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 554 LKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 554 ~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+..+.... .+.... .....+..++..||+.||.+||++.++++
T Consensus 232 ~~~~~~~~--~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 232 ITSGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhCcccc--Cchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11111100 000001 11345677889999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=355.27 Aligned_cols=262 Identities=20% Similarity=0.270 Sum_probs=206.4
Q ss_pred hcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCCeEEEEEEc
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSEDVLKEFASEIEIITALHH-RNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E~ 407 (678)
.++|...++||+|+||.||+|.. .+|+.||||++..... ...+..|++++..|+| +++..+..++.+.+..+|||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 46899999999999999999986 4799999998864321 2357889999999987 5666667777888899999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe---cCCCCcEEeecccccccC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL---SDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl---~~~~~~kL~DFGla~~~~ 484 (678)
+ +++|.+++... ...+++..++.|+.||+.||.|||+ ++||||||||+|||| +.++.+||+|||+++.+.
T Consensus 85 ~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 85 L-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred C-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9 99999999743 2469999999999999999999999 999999999999999 688999999999999876
Q ss_pred CCCCCc-----eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc
Q 041755 485 TSSSHL-----TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559 (678)
Q Consensus 485 ~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 559 (678)
...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||................. ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~----~~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----KKV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH----HHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh----ccc
Confidence 543321 12246899999999999999999999999999999999999999987554332221111100 001
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 560 SQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 560 ~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
...+.. +...+ ...+..++..||+.+|.+||++.+|+++|+...
T Consensus 234 ~~~~~~-l~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 234 ATSIEA-LCRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HSCHHH-HHTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cccHHH-HhcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 000000 00111 245777889999999999999999999988653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=372.79 Aligned_cols=243 Identities=21% Similarity=0.300 Sum_probs=200.2
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~ 402 (678)
..++|...++||+|+||.||+|... +|+.||||+++... .....+..|..++..+ +||||+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3468999999999999999999875 68899999997432 2346678899999987 6999999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
|||||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++||||||||+||||+.++++||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999754 458999999999999999999999 9999999999999999999999999999986
Q ss_pred cCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
...... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.......+ +. +.+
T Consensus 492 ~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~-~~~--- 559 (674)
T 3pfq_A 492 NIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------ME-HNV--- 559 (674)
T ss_dssp CCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HS-SCC---
T ss_pred cccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH------Hh-CCC---
Confidence 433222 233478999999999999999999999999999999999999999876543221111 11 110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQI 597 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~ 597 (678)
.+ +......+..++..||+.||.+||++
T Consensus 560 ---~~----p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 560 ---AY----PKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ---CC----CTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ---CC----CccCCHHHHHHHHHHccCCHHHCCCC
Confidence 11 11223446677799999999999998
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=337.31 Aligned_cols=266 Identities=21% Similarity=0.300 Sum_probs=199.4
Q ss_pred HhhcCCCCceeecccCceEEEEEEe--CCCCEEEEEEeCCC---hHHHHHHHHHHHHHHhc---CCCCeeeEEEEEE---
Q 041755 328 SATSNFLPEYLVGKGGHSHVYRGCL--PDGKELAVKILKPS---EDVLKEFASEIEIITAL---HHRNIISLFGFCF--- 396 (678)
Q Consensus 328 ~~t~~f~~~~~IG~G~~g~Vy~g~~--~~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~--- 396 (678)
.+.++|...+.||+|+||.||+|.. .+|+.||||+++.. ......+.+|+.++..+ .||||++++++|.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999987 46889999998632 12223466777777666 8999999999997
Q ss_pred --eCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEE
Q 041755 397 --EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQL 474 (678)
Q Consensus 397 --~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL 474 (678)
.....++||||+. |+|.+++.... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEE
Confidence 4567899999997 69999987643 2458999999999999999999999 99999999999999999999999
Q ss_pred eecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccc
Q 041755 475 SDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL 554 (678)
Q Consensus 475 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 554 (678)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.......
T Consensus 162 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 162 ADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238 (326)
T ss_dssp CSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999998764322 2234678999999999999999999999999999999999999998654322111110000000
Q ss_pred ccCccc-------cccCC---CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 555 KDGKVS-------QLLDP---SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 555 ~~~~~~-------~l~dp---~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....+. ..+.. .....+.......+..++..||+.+|.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 00000 0000011122345667789999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=351.34 Aligned_cols=262 Identities=19% Similarity=0.279 Sum_probs=193.5
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe------EEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNN------LLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~------~~lV 404 (678)
.+|...++||+|+||.||+|....+..||+|++..... ...+|+++++.++||||++++++|...+. +++|
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 46888899999999999999987777799998765432 12369999999999999999999965443 8899
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec-CCCCcEEeeccccccc
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS-DDFEPQLSDFGLASWL 483 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~-~~~~~kL~DFGla~~~ 483 (678)
|||++++ +...+.........+++..++.++.||+.||.|||+ .+|+||||||+|||++ .++.+||+|||+++.+
T Consensus 117 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 117 LEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999765 443333222234678999999999999999999999 9999999999999999 7999999999999876
Q ss_pred CCCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhc------------
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA------------ 550 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~------------ 550 (678)
...... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.......+...
T Consensus 193 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 269 (394)
T 4e7w_A 193 IAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTM 269 (394)
T ss_dssp CTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 544332 235789999999998765 5899999999999999999999999876543221111000
Q ss_pred ccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 551 KPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 551 ~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+......+...-...+...+.......+..++..||+.||.+||++.++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 270 NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0000000000000000000011112345777889999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.79 Aligned_cols=263 Identities=20% Similarity=0.287 Sum_probs=203.9
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChH------------------HHHHHHHHHHHHHhcCCCCeeeE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSED------------------VLKEFASEIEIITALHHRNIISL 391 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~------------------~~~~~~~Ei~il~~l~HpnIv~l 391 (678)
.++|...+.||+|+||.||+|.. +|+.||||++..... ....|.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999998 999999999864321 12789999999999999999999
Q ss_pred EEEEEeCCeEEEEEEcCCCCCHHHH------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeE
Q 041755 392 FGFCFEDNNLLLVYDFLSRGSLEEN------LHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNIL 465 (678)
Q Consensus 392 ~g~~~~~~~~~lV~E~~~~gsL~~~------L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NIL 465 (678)
++++.+.+..++||||+++|+|.++ +.. .....+++..++.++.|++.||.|||+ ..+|+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEE
Confidence 9999999999999999999999998 543 124679999999999999999999996 379999999999999
Q ss_pred ecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccC-CCCc-cceEeehhHHHHHHhcCCCCCCCCCCc-c
Q 041755 466 LSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVSE-KIDVYAFGIVLLELLSGKKPINSENPK-G 542 (678)
Q Consensus 466 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~-ksDVwSlGvvL~eLltG~~Pf~~~~~~-~ 542 (678)
++.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||...... .
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999876443 23446799999999999887 6666 999999999999999999999865441 1
Q ss_pred cccchhhcccccccCccccccCCCCC---CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 543 QESLVMWAKPILKDGKVSQLLDPSLD---TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 543 ~~~l~~~~~~~~~~~~~~~l~dp~l~---~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....+......+. ........+... ..........+..++..||+.+|.+||++.++++
T Consensus 261 ~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFNNIRTKNIEYP-LDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHTSCCCCCC-CSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHHhccCcCCc-cchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1100000000000 000000111000 0001122345677889999999999999999997
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=336.22 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=197.9
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
..++|...+.||+|+||.||+|... +|+.||+|++.... .....+.+|++++..++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3467888999999999999999876 68999999987543 446788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++++|.+++... ...+++..++.++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999988643 2468999999999999999999999 99999999999999999999999999997643221
Q ss_pred CCCceecccccCCCCCCcchhc-----cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
.. ......||+.|+|||++. ...++.++||||||+++|+|++|+.||...+..... ... .. +....
T Consensus 171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~----~~-~~~~~ 241 (302)
T 2j7t_A 171 LQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LKI----AK-SDPPT 241 (302)
T ss_dssp HH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHH----HH-SCCCC
T ss_pred cc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH--HHH----hc-cCCcc
Confidence 10 112357899999999984 677899999999999999999999999765432211 000 00 00000
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.. ........+..++..||+.+|.+||++.++++
T Consensus 242 ~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 242 LL-------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CS-------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cC-------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 01112345677889999999999999999986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=339.61 Aligned_cols=265 Identities=22% Similarity=0.307 Sum_probs=199.9
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-----Ce
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFED-----NN 400 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-----~~ 400 (678)
..++|...+.||+|+||.||+|... +|+.||||+++.. ......+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3468899999999999999999875 6899999999753 35567889999999999999999999998764 67
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
.++||||+. |+|.+++.. ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999996 699998864 358999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCc--------eecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhc-
Q 041755 481 SWLSTSSSHL--------TCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA- 550 (678)
Q Consensus 481 ~~~~~~~~~~--------~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~- 550 (678)
.......... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...+.......+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 239 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence 8765432111 1223578999999998765 67899999999999999999999999876532211111000
Q ss_pred c-c-------ccccCccccccCCCCC-CCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 551 K-P-------ILKDGKVSQLLDPSLD-TDYD-----NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 551 ~-~-------~~~~~~~~~l~dp~l~-~~~~-----~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
. + ........+.+..... .... ......+..++..||+.||.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 0 0000000000000000 0000 012245677889999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.22 Aligned_cols=264 Identities=22% Similarity=0.339 Sum_probs=193.9
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----------
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISLFGFCF----------- 396 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~----------- 396 (678)
.++|...+.||+|+||.||+|... +|+.||||++... ....+.+.+|+++++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 367888999999999999999876 5899999998754 466788999999999999999999999873
Q ss_pred ---eCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec-CCCCc
Q 041755 397 ---EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS-DDFEP 472 (678)
Q Consensus 397 ---~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~-~~~~~ 472 (678)
+.+..++||||+. |+|.+++.. ..+++..++.++.|++.||.|||+ ++|+||||||+|||++ +++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeE
Confidence 3467899999997 699999853 458999999999999999999999 9999999999999997 56799
Q ss_pred EEeecccccccCCCCCC-ceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhc
Q 041755 473 QLSDFGLASWLSTSSSH-LTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA 550 (678)
Q Consensus 473 kL~DFGla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~ 550 (678)
||+|||++......... .......||..|+|||.+.. ..++.++|||||||++|||++|+.||...........+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999999876543221 12233567999999998865 67899999999999999999999999876543221111111
Q ss_pred ccccccCccccccC-------CCCC-CCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 551 KPILKDGKVSQLLD-------PSLD-TDYD-----NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 551 ~~~~~~~~~~~l~d-------p~l~-~~~~-----~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+........++.. .... .... ......+..++..||+.||.+||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 11111000000000 0000 0000 112345777889999999999999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=335.27 Aligned_cols=261 Identities=18% Similarity=0.260 Sum_probs=202.9
Q ss_pred cCCCCceeecccCceEEEEEEeC-CC-CEEEEEEeCCChHHHHHHHHHHHHHHhcCCCC------eeeEEEEEEeCCeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DG-KELAVKILKPSEDVLKEFASEIEIITALHHRN------IISLFGFCFEDNNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g-~~vAvK~l~~~~~~~~~~~~Ei~il~~l~Hpn------Iv~l~g~~~~~~~~~ 402 (678)
++|...+.||+|+||.||+|... ++ +.||||+++........+.+|+.++..++|++ ++.+++++...+..+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 67888999999999999999864 44 68999999887777788999999999998765 999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe----------------
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL---------------- 466 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl---------------- 466 (678)
+||||+ +++|.+++.... ...+++.+++.++.||+.||.|||+ ++|+||||||+|||+
T Consensus 99 lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeccccccccccccccc
Confidence 999999 677777776532 2468999999999999999999999 999999999999999
Q ss_pred ---cCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCccc
Q 041755 467 ---SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQ 543 (678)
Q Consensus 467 ---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~ 543 (678)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 678899999999998654422 235799999999999999999999999999999999999999986543221
Q ss_pred ccchhhcc-ccc-------c------cCc------------cccccCCCC-CCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 041755 544 ESLVMWAK-PIL-------K------DGK------------VSQLLDPSL-DTDYDNDQIERMVLAATLSISRAPTVRPQ 596 (678)
Q Consensus 544 ~~l~~~~~-~~~-------~------~~~------------~~~l~dp~l-~~~~~~~~~~~l~~la~~Cl~~dP~~RPs 596 (678)
........ +.. . .+. ......+.. ...........+..++..||+.||.+|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 11110000 000 0 000 000000000 00112233456788899999999999999
Q ss_pred HHHHHH
Q 041755 597 INLVLK 602 (678)
Q Consensus 597 ~~eVl~ 602 (678)
+.++++
T Consensus 328 ~~e~l~ 333 (355)
T 2eu9_A 328 LAEALL 333 (355)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=339.00 Aligned_cols=261 Identities=16% Similarity=0.297 Sum_probs=202.1
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-----------CCCeeeEEEEEEeC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALH-----------HRNIISLFGFCFED 398 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~g~~~~~ 398 (678)
++|...+.||+|+||.||+|... +|+.||||++.........+.+|+.++.+++ ||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 57889999999999999999864 7899999999987777788899999999886 89999999999765
Q ss_pred C----eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCCeEec------
Q 041755 399 N----NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ-PVIHKDVKSSNILLS------ 467 (678)
Q Consensus 399 ~----~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~iiHrDIKp~NILl~------ 467 (678)
+ ..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+ + +|+||||||+|||++
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTT
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCc
Confidence 4 789999999 999999997643 2458999999999999999999999 8 999999999999994
Q ss_pred CCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCccccc--
Q 041755 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQES-- 545 (678)
Q Consensus 468 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-- 545 (678)
..+.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 44579999999998765432 23578999999999999999999999999999999999999998654321110
Q ss_pred --c---hhhcc--------------ccccc-CccccccCCC---------CCCCCCHHHHHHHHHHHHhcccCCCCCCCC
Q 041755 546 --L---VMWAK--------------PILKD-GKVSQLLDPS---------LDTDYDNDQIERMVLAATLSISRAPTVRPQ 596 (678)
Q Consensus 546 --l---~~~~~--------------~~~~~-~~~~~l~dp~---------l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs 596 (678)
+ ..... ..+.. +.+..+.... -...+.......+..++..||+.||.+|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 0 00000 00000 0000000000 011234566778889999999999999999
Q ss_pred HHHHHH
Q 041755 597 INLVLK 602 (678)
Q Consensus 597 ~~eVl~ 602 (678)
+.++++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=342.88 Aligned_cols=259 Identities=20% Similarity=0.280 Sum_probs=183.6
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------C
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFED------N 399 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~ 399 (678)
.++|...+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 468889999999999999999854 7899999999642 35567889999999999999999999999654 5
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
..++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 7899888753 468999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc-----
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI----- 553 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~----- 553 (678)
++..... .+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+.......+......
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9875432 234679999999999987 67899999999999999999999999876543222111100000
Q ss_pred ---cccCccccccCCCCC-CCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 554 ---LKDGKVSQLLDPSLD-TDYDN-----DQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 554 ---~~~~~~~~l~dp~l~-~~~~~-----~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.......++..... ..... .....+..++..||+.||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000000000000000 00000 11234677889999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=335.45 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=172.6
Q ss_pred hcCCCC-ceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCeEEE
Q 041755 330 TSNFLP-EYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFE----DNNLLL 403 (678)
Q Consensus 330 t~~f~~-~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~l 403 (678)
.++|.. .++||+|+||.||+|... +|+.||||++........++ ...+..+.||||+++++++.. ....++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~---~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 103 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEV---DHHWQASGGPHIVCILDVYENMHHGKRCLLI 103 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHH---HHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHH---HHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence 357777 457999999999999876 79999999998765433332 234567799999999999976 445899
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC---CCCcEEeecccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD---DFEPQLSDFGLA 480 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~---~~~~kL~DFGla 480 (678)
||||+++|+|.+++.... ...+++.+++.++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||++
T Consensus 104 v~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 104 IMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999997542 2579999999999999999999999 99999999999999986 455999999999
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||............ ...+..+...
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~ 251 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLGQYG 251 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------C
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhccccc
Confidence 8655332 22357899999999999899999999999999999999999999765432211000 0000000000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
...+. .......+..++..||+.+|.+||++.++++
T Consensus 252 -~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 252 -FPNPE-----WSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -CCTTT-----STTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -cCchh-----hccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 0112345667789999999999999999996
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=338.67 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=195.7
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE----
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNL---- 401 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~---- 401 (678)
.++|...+.||+|+||.||+|... +|+.||||++.. .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468888999999999999999865 789999999975 345578889999999999999999999999876654
Q ss_pred --EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 402 --LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 402 --~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
++||||+. ++|.+.+. ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 68888873 348999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc-----
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI----- 553 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~----- 553 (678)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+......
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 9865432 234578999999999987 67899999999999999999999999865432211111000000
Q ss_pred ---cccCccccc---cCCCCCCCC---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 554 ---LKDGKVSQL---LDPSLDTDY---DNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 554 ---~~~~~~~~l---~dp~l~~~~---~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+........ +.......+ .......+..++..||+.||.+||++.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000000000 000000000 0111345777889999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=325.88 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=200.2
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
.++|...+.||+|+||.||+|... +++.||||++... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 457888999999999999999875 7899999998643 234577899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC---CCcEEeecccccc
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD---FEPQLSDFGLASW 482 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~---~~~kL~DFGla~~ 482 (678)
||+++++|.+.+... ..+++.+++.++.|++.||.|||+ .+|+||||||+|||++.+ +.+||+|||++..
T Consensus 101 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 999999999988643 358999999999999999999999 999999999999999764 4699999999987
Q ss_pred cCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
....... ....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||........... +..+.....
T Consensus 174 ~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~ 242 (287)
T 2wei_A 174 FQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKR-------VETGKYAFD 242 (287)
T ss_dssp BCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------HHHCCCCCC
T ss_pred ecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHcCCCCCC
Confidence 6543322 23568999999998865 589999999999999999999999976543221111 111111000
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
. +. ...+ ...+..++..||+.+|.+||++.++++
T Consensus 243 ~-~~-~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 243 L-PQ-WRTI----SDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp S-GG-GTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred c-hh-hhhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 0 00 0111 234667889999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=333.66 Aligned_cols=254 Identities=23% Similarity=0.363 Sum_probs=178.1
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHH-HHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIE-IITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|...+.||+|+||.||+|... +|+.||||+++.. ......+..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57888899999999999999875 7899999999753 345566667776 6777899999999999999999999999
Q ss_pred cCCCCCHHHHhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 407 FLSRGSLEENLHGN-KKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ-PVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 407 ~~~~gsL~~~L~~~-~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|+.+ +|.+++... ......+++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9974 887776521 1123578999999999999999999999 7 99999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchh----ccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYF----MHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l----~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
.... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||........ . ...... +..
T Consensus 178 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~----~~~~~~-~~~- 247 (327)
T 3aln_A 178 DSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-Q----LTQVVK-GDP- 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCC-SCC-
T ss_pred cccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-H----HHHHhc-CCC-
Confidence 4322 2234799999999998 456789999999999999999999999976432111 0 001111 111
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.+...........+..++..||+.+|.+||++.++++
T Consensus 248 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 ----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11111111112345777889999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=336.51 Aligned_cols=257 Identities=21% Similarity=0.302 Sum_probs=195.4
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe-----
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNN----- 400 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~----- 400 (678)
.++|...+.||+|+||.||+|... +|+.||||++... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 367888999999999999999865 7899999999653 3556788999999999999999999999987653
Q ss_pred -EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 401 -LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 401 -~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
.++||||+. |+|.+++. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 599999996 68887763 248999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccc------
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP------ 552 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~------ 552 (678)
+...... .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865432 223578999999999987 6789999999999999999999999986553221111000000
Q ss_pred --ccccCc-------cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 553 --ILKDGK-------VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 553 --~~~~~~-------~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.+.. +.....+.+. .........+..++..||+.||.+||++.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 0000000010 011122345777889999999999999999885
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=338.29 Aligned_cols=256 Identities=21% Similarity=0.332 Sum_probs=197.5
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.++|...+.||+|+||.||+|...+ .+|+|+++.. ....+.|.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4678889999999999999998743 4999998743 2334567889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++++|.+++... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++ ++.+||+|||++......
T Consensus 110 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp CCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred cccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999643 3468999999999999999999999 9999999999999998 679999999998765422
Q ss_pred C---CCceecccccCCCCCCcchhcc---------CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccc
Q 041755 487 S---SHLTCTDVAGTFGYLAPEYFMH---------GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL 554 (678)
Q Consensus 487 ~---~~~~~~~~~Gt~~Y~APE~l~~---------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 554 (678)
. .........||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........... +
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-------~ 255 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ-------M 255 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH-------H
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------h
Confidence 1 1112233568999999999874 4578899999999999999999999976543221110 0
Q ss_pred ccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCHh
Q 041755 555 KDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEE 609 (678)
Q Consensus 555 ~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~~ 609 (678)
..+. .+.+... .....+..++..||..+|.+||++.++++.|+....
T Consensus 256 ~~~~-----~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 256 GTGM-----KPNLSQI---GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HTTC-----CCCCCCS---SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred ccCC-----CCCCCcC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1111 1111110 011236677899999999999999999999987553
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=343.84 Aligned_cols=203 Identities=25% Similarity=0.411 Sum_probs=155.1
Q ss_pred CCC-ceeecccCceEEEEEEeC---CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEEEEEE
Q 041755 333 FLP-EYLVGKGGHSHVYRGCLP---DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFE--DNNLLLVYD 406 (678)
Q Consensus 333 f~~-~~~IG~G~~g~Vy~g~~~---~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV~E 406 (678)
|.. .++||+|+||.||+|... +++.||||++.... ....+.+|+.+++.++||||+++++++.. ....++|||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e 100 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 100 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEe
Confidence 444 457999999999999864 57899999997543 22467899999999999999999999965 678999999
Q ss_pred cCCCCCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEe----cCCCCcEEeec
Q 041755 407 FLSRGSLEENLHGNK-----KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILL----SDDFEPQLSDF 477 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~-----~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl----~~~~~~kL~DF 477 (678)
|+. |+|.+++.... .....+++..++.++.||+.||.|||+ .+|+||||||+|||| +.++.+||+||
T Consensus 101 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 101 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp CCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred CCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 996 58887775321 122358999999999999999999999 999999999999999 77899999999
Q ss_pred ccccccCCCCCC-ceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCC
Q 041755 478 GLASWLSTSSSH-LTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENP 540 (678)
Q Consensus 478 Gla~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 540 (678)
|+++.+...... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||.....
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 999877543221 223346899999999999874 589999999999999999999999976543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=345.57 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=187.8
Q ss_pred CCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
.|...++||+|+||+||.+...+|+.||||++.... ...+.+|+.++.++ +||||+++++++.+.+..++||||+.
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~- 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN- 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-
Confidence 345568899999999987766689999999986533 34678999999986 89999999999999999999999995
Q ss_pred CCHHHHhccCCCCCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC-------------CCcEE
Q 041755 411 GSLEENLHGNKKDGNA---FGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD-------------FEPQL 474 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~---l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~-------------~~~kL 474 (678)
|+|.+++......... ..+..++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+||
T Consensus 93 gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 93 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 7999999765332221 1333457899999999999999 999999999999999754 48999
Q ss_pred eecccccccCCCCCCc--eecccccCCCCCCcchhcc-------CCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccc
Q 041755 475 SDFGLASWLSTSSSHL--TCTDVAGTFGYLAPEYFMH-------GKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQE 544 (678)
Q Consensus 475 ~DFGla~~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~ 544 (678)
+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||....... .
T Consensus 170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~ 248 (434)
T 2rio_A 170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-S 248 (434)
T ss_dssp CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-H
T ss_pred cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-H
Confidence 9999999876543221 2234679999999999976 678999999999999999999 999997543321 1
Q ss_pred cchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 545 SLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 545 ~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.... .... . +.+...........+..++..||+.+|.+||++.+|++
T Consensus 249 ~i~~---~~~~---~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NIIR---GIFS---L-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHH---TCCC---C-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhc---CCCC---c-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111 0000 0 11111123445567888999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=362.12 Aligned_cols=255 Identities=20% Similarity=0.327 Sum_probs=203.0
Q ss_pred hcCCCCceeecccCceEEEEEEeC----CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP----DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~----~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
.++|...+.||+|+||.||+|... .+..||||+++.. ....+.|.+|+.++++++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 357888899999999999999864 2567999998753 455678999999999999999999999985 466899
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+++|+|.+++... ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 468 v~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 99999999999999753 2468999999999999999999999 99999999999999999999999999999877
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
...... ......||+.|+|||++.+..++.++|||||||++|||++ |..||...........+ ..+..
T Consensus 542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i-------~~~~~--- 610 (656)
T 2j0j_A 542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENGER--- 610 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------HHTCC---
T ss_pred CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------HcCCC---
Confidence 543322 2233567889999999999999999999999999999997 99999765432211111 11100
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
+.+ .......+..++..||+.+|.+||++.++++.|+...
T Consensus 611 --~~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 611 --LPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp --CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 001 1122345677889999999999999999999997544
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=329.30 Aligned_cols=240 Identities=21% Similarity=0.355 Sum_probs=190.4
Q ss_pred hhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-------HHHHHHHHHHHHHHhc----CCCCeeeEEEEEE
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-------DVLKEFASEIEIITAL----HHRNIISLFGFCF 396 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-------~~~~~~~~Ei~il~~l----~HpnIv~l~g~~~ 396 (678)
..++|...+.||+|+||.||+|... +|+.||||++.... .....+.+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 4578999999999999999999864 78999999996542 2234466799999999 8999999999999
Q ss_pred eCCeEEEEEEc-CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec-CCCCcEE
Q 041755 397 EDNNLLLVYDF-LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS-DDFEPQL 474 (678)
Q Consensus 397 ~~~~~~lV~E~-~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~-~~~~~kL 474 (678)
..+..++|||| +.+++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++ .++.+||
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEE
Confidence 88899999999 7899999999753 458999999999999999999999 8999999999999999 8899999
Q ss_pred eecccccccCCCCCCceecccccCCCCCCcchhccCCCC-ccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc
Q 041755 475 SDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVS-EKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI 553 (678)
Q Consensus 475 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~ 553 (678)
+|||++....... .....||..|+|||++.+..+. .++||||||+++|||++|+.||..... ...
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~----- 247 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----ILE----- 247 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHH-----
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----Hhh-----
Confidence 9999998765432 2345789999999999877764 589999999999999999999964311 000
Q ss_pred cccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 554 LKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 554 ~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.. ..+... ....+..++..||+.+|.+||++.++++
T Consensus 248 ---~~------~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 ---AE------LHFPAH----VSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ---TC------CCCCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---hc------cCCccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 001111 2234667889999999999999999997
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=334.95 Aligned_cols=243 Identities=21% Similarity=0.329 Sum_probs=198.0
Q ss_pred HHHhhcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-------HHHHHHHHHHHHHHhcC--CCCeeeEEEEE
Q 041755 326 LLSATSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-------DVLKEFASEIEIITALH--HRNIISLFGFC 395 (678)
Q Consensus 326 l~~~t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-------~~~~~~~~Ei~il~~l~--HpnIv~l~g~~ 395 (678)
.....++|...+.||+|+||.||+|... +|+.||||+++... .....+.+|+.++.+++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3345578999999999999999999864 78999999986432 12345678999999996 59999999999
Q ss_pred EeCCeEEEEEEcCCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec-CCCCcE
Q 041755 396 FEDNNLLLVYDFLSR-GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS-DDFEPQ 473 (678)
Q Consensus 396 ~~~~~~~lV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~-~~~~~k 473 (678)
...+..++||||+.+ ++|.+++... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++ +++.+|
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEE
Confidence 999999999999976 8999998653 468999999999999999999999 9999999999999999 789999
Q ss_pred EeecccccccCCCCCCceecccccCCCCCCcchhccCCC-CccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccc
Q 041755 474 LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552 (678)
Q Consensus 474 L~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 552 (678)
|+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ... .
T Consensus 191 L~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~-~-- 258 (320)
T 3a99_A 191 LIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----IIR-G-- 258 (320)
T ss_dssp ECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHH-C--
T ss_pred EeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----hhc-c--
Confidence 99999998765432 223579999999999987776 6789999999999999999999964321 000 0
Q ss_pred ccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 553 ~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.. .+...+ ...+..++..||+.+|.+||++.++++
T Consensus 259 -----~~------~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 259 -----QV------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -----CC------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----cc------cccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 011112 234667789999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=321.78 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=177.4
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HH-HHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DV-LKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~-~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
.++|...+.||+|+||.||+|... +|+.||||++.... .. ...+..+..++..++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 357888899999999999999875 79999999997542 33 333445556788889999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ-PVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~-~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
||+ ++.+..++... ...+++..++.++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 55555554321 2568999999999999999999998 6 99999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhc-----cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 559 (678)
.... .....||+.|+|||++. ...++.++|||||||++|||++|+.||........ ... ..... .
T Consensus 177 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~---~~~~~-~- 246 (318)
T 2dyl_A 177 DDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLT---KVLQE-E- 246 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHH---HHHHS-C-
T ss_pred CCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHH---HHhcc-C-
Confidence 4322 22357999999999994 56788999999999999999999999975432111 000 00110 0
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 560 SQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 560 ~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.+... ......+..++..||+.+|.+||++.++++
T Consensus 247 ----~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 ----PPLLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----CCCCCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCCCCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0111100 011234667789999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=340.69 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=186.0
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
.+|...++||+|+||+||.....+|+.||||++..... ..+.+|+.++..+ +||||+++++++.+.+..|+||||+.
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 46888899999999997655556899999999975431 2356899999999 79999999999999999999999995
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC-----CCCcEEeecccccccC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD-----DFEPQLSDFGLASWLS 484 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~-----~~~~kL~DFGla~~~~ 484 (678)
|+|.+++.... ..+.+..++.++.||+.||.|||+ .+|+||||||+|||++. ...+||+|||+++...
T Consensus 102 -g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 102 -ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp -EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred -CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 69999997543 234455667899999999999999 99999999999999953 3357899999998776
Q ss_pred CCCCC-ceecccccCCCCCCcchhc---cCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCcc
Q 041755 485 TSSSH-LTCTDVAGTFGYLAPEYFM---HGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKV 559 (678)
Q Consensus 485 ~~~~~-~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 559 (678)
..... .......||+.|+|||++. ...++.++|||||||++|||++ |..||.......... .......
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-------~~~~~~~ 247 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-------LLGACSL 247 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-------HTTCCCC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-------HhccCCc
Confidence 44221 2233467999999999997 4667889999999999999999 999996443221100 0000000
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 560 SQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 560 ~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
. . + .........+..++..||+.||.+||++.+|++
T Consensus 248 ~-~----~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 D-C----L--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp T-T----S--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-c----c--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 0 0 011223344667889999999999999999995
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=352.40 Aligned_cols=258 Identities=21% Similarity=0.301 Sum_probs=199.8
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe------CCeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFE------DNNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~~~ 401 (678)
++|...+.||+|+||.||+|... +|+.||||+++.. ......|.+|++++..++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 68999999999999999999864 6899999998753 4567789999999999999999999998755 6678
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC---cEEeecc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE---PQLSDFG 478 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~---~kL~DFG 478 (678)
++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999997643 23468899999999999999999999 99999999999999997765 8999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
++......... ....||+.|+|||++.++.++.++|||||||++|+|++|+.||...... ..|.......+.
T Consensus 170 ~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~ 241 (676)
T 3qa8_A 170 YAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSN 241 (676)
T ss_dssp CCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC----
T ss_pred ccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccc
Confidence 99877554322 3467999999999999999999999999999999999999999754221 112111111111
Q ss_pred cccccC----------CC--CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 041755 559 VSQLLD----------PS--LDTDYDNDQIERMVLAATLSISRAPTVRPQINLV 600 (678)
Q Consensus 559 ~~~l~d----------p~--l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eV 600 (678)
...... .. ............+..++..||..||.+||++.++
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 100000 00 1122344556778889999999999999999663
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=352.12 Aligned_cols=236 Identities=21% Similarity=0.307 Sum_probs=192.1
Q ss_pred cCCCCceeecccCceEEEEEEeC--CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe-----E
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP--DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNN-----L 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~--~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~-----~ 401 (678)
++|...+.||+|+||.||+|... +|+.||||++... ......|.+|++++.+++||||++++++|...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 68889999999999999999875 6899999998643 3566788999999999999999999999987665 7
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
||||||+++++|.+++.. .+++.+++.++.||+.||.|||+ ++||||||||+|||++.+ .+||+|||+++
T Consensus 160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccch
Confidence 999999999999887642 68999999999999999999999 999999999999999986 89999999998
Q ss_pred ccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 482 WLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 482 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
..... ....||++|+|||++.++. +.++|||||||+||+|++|..||....... +.
T Consensus 230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~------- 285 (681)
T 2pzi_A 230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LP------- 285 (681)
T ss_dssp ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CC-------
T ss_pred hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------cc-------
Confidence 76543 3357999999999997764 899999999999999999998876421110 00
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-HHHHHHHhhc
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ-INLVLKLLQG 606 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs-~~eVl~~L~~ 606 (678)
...........+..++..||+.+|.+||+ +.++...|.+
T Consensus 286 ------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 ------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00001122345777889999999999995 5556666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.10 Aligned_cols=228 Identities=17% Similarity=0.166 Sum_probs=181.6
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||+|... +|+.||||++... ....+.|.+|+.++.+++||||+++++++.+.+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 57888899999999999999875 5899999999754 455688999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++++|.+++... ....+...++.|++.||.|||+ ++|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999998431 2455678899999999999999 999999999999999999999997443
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
|++| ++.++|||||||++|||+||+.||...+...... .+....... .... .
T Consensus 175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---~~~~~~~~~-~~~~--~ 226 (286)
T 3uqc_A 175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---PAERDTAGQ-PIEP--A 226 (286)
T ss_dssp ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---ECCBCTTSC-BCCH--H
T ss_pred ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---HHHHHhccC-CCCh--h
Confidence 4433 6889999999999999999999998765432110 000011100 0000 0
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.+... ....+..++..||+.||.+| |+.++++.|+..
T Consensus 227 ~~~~~----~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 227 DIDRD----IPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp HHCTT----SCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred hcccC----CCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 01111 12346778899999999999 999999999753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=331.09 Aligned_cols=242 Identities=13% Similarity=0.165 Sum_probs=181.3
Q ss_pred hcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCC-CCe---------e-----
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPS----EDVLKEFASEIEIITALHH-RNI---------I----- 389 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~H-pnI---------v----- 389 (678)
+.+|...++||+|+||.||+|.. .+|+.||||+++.. ....+.|.+|+.++..++| +|. +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577788999999999999985 47999999999732 2335778999999999987 211 1
Q ss_pred -------eEEEEEEe-----CCeEEEEEEcCCCCCHHHHhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 041755 390 -------SLFGFCFE-----DNNLLLVYDFLSRGSLEENLHGN---KKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454 (678)
Q Consensus 390 -------~l~g~~~~-----~~~~~lV~E~~~~gsL~~~L~~~---~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~i 454 (678)
.+..++.. ....+++|+++ +++|.+++... ......+++..++.++.|++.||.|||+ ++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 11111111 12467777766 78999888421 1233568899999999999999999999 999
Q ss_pred eeccCCCCCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchh----------ccCCCCccceEeehhHH
Q 041755 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF----------MHGKVSEKIDVYAFGIV 524 (678)
Q Consensus 455 iHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l----------~~~~~s~ksDVwSlGvv 524 (678)
+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999998865442 334577 999999999 55568899999999999
Q ss_pred HHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 525 LLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 525 L~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+|||++|+.||.......... .. +... ..++ ..+..++..||+.+|.+||++.++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~------~~---------~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSE------WI---------FRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSG------GG---------GSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchhhhHH------HH---------Hhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999997654322111 01 1100 0112 45777789999999999999998875
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=306.84 Aligned_cols=230 Identities=22% Similarity=0.346 Sum_probs=176.2
Q ss_pred cCCCCc-eeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHH-HhcCCCCeeeEEEEEEe----CCeEEE
Q 041755 331 SNFLPE-YLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEII-TALHHRNIISLFGFCFE----DNNLLL 403 (678)
Q Consensus 331 ~~f~~~-~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~g~~~~----~~~~~l 403 (678)
++|... ++||+|+||.||++... +|+.||||+++... .+.+|++++ +.++||||+++++++.. ....++
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH----HHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 456555 78999999999999864 78999999997543 466788887 56689999999999987 677999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC---CCCcEEeecccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD---DFEPQLSDFGLA 480 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~---~~~~kL~DFGla 480 (678)
||||+++|+|.+++.... ...+++..++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||++
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999997642 2468999999999999999999999 99999999999999998 789999999998
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccc
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
.... +..++.++|||||||++|||++|+.||........... ....+..+...
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~ 220 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYE 220 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC---SCCSSCTTCCS
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH---HHHHHhhcccc
Confidence 6432 24567899999999999999999999976543221100 00000000000
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
...+ .. ......+..++..||+.+|.+||++.++++
T Consensus 221 -~~~~-~~----~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 221 -FPNP-EW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -SCHH-HH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CCch-hc----ccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 00 011345677889999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=306.49 Aligned_cols=240 Identities=16% Similarity=0.150 Sum_probs=183.2
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh---------HHHHHHHHHHHHHHhcC---------CCCeeeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE---------DVLKEFASEIEIITALH---------HRNIISLF 392 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~---------~~~~~~~~Ei~il~~l~---------HpnIv~l~ 392 (678)
++|...+.||+|+||.||+|.. +|+.||||+++... ...+.+.+|+.+++.++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 5678889999999999999988 78999999986431 23477889999999886 88888888
Q ss_pred EEEE------------------------------eCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHH
Q 041755 393 GFCF------------------------------EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEA 442 (678)
Q Consensus 393 g~~~------------------------------~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~a 442 (678)
+++. ..+.+++||||+++|++.+.+.. ..+++..++.++.||+.|
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHH
Confidence 8754 26789999999999987777632 458999999999999999
Q ss_pred HHHHH-hcCCCCeeeccCCCCCeEecCCC--------------------CcEEeecccccccCCCCCCceecccccCCCC
Q 041755 443 LDYLH-NSCEQPVIHKDVKSSNILLSDDF--------------------EPQLSDFGLASWLSTSSSHLTCTDVAGTFGY 501 (678)
Q Consensus 443 L~yLH-~~~~~~iiHrDIKp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y 501 (678)
|.||| + ++|+||||||+||||+.++ .+||+|||+|+..... ...||+.|
T Consensus 174 L~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 8 8999999999999999887 8999999999876542 24799999
Q ss_pred CCcchhccCCCCccceEeehhHH-HHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHH
Q 041755 502 LAPEYFMHGKVSEKIDVYAFGIV-LLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMV 580 (678)
Q Consensus 502 ~APE~l~~~~~s~ksDVwSlGvv-L~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~ 580 (678)
+|||++.+.. +.++||||||++ .+++++|..||...... ..+.. .+..... ................+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~~---~~~~~~~----~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLTD---KMLKQMT----FKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHHH---HHHHTCC----CSSCCCSHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHHH---hhhhhhc----cCcccchhhhhhcCHHHH
Confidence 9999998666 899999998777 77788999998431000 00000 0000000 000000111224456788
Q ss_pred HHHHhcccCCCCCCCCHHHHH
Q 041755 581 LAATLSISRAPTVRPQINLVL 601 (678)
Q Consensus 581 ~la~~Cl~~dP~~RPs~~eVl 601 (678)
.++..||+.+ |+.+++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 8999999966 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-30 Score=292.76 Aligned_cols=184 Identities=17% Similarity=0.111 Sum_probs=131.8
Q ss_pred ecccCceEEEEEEe-CCCCEEEEEEeCCC-----------hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEEE
Q 041755 339 VGKGGHSHVYRGCL-PDGKELAVKILKPS-----------EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 339 IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~-----------~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
.+.|++|.+..++. --|+.||||++... +...++|.+|+++|+++ .|+||+++++++.+++.+||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 46666766665542 25889999998642 23457799999999999 6999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||++|++|.+.|... .+++.. +|+.||+.||.|||+ +|||||||||+||||+.+|.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999643 456653 488999999999999 9999999999999999999999999999987655
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPI 535 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf 535 (678)
.... .+..+||++|+|||++.+ .+..++|+|++|+++++|.++..++
T Consensus 392 ~~~~--~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DCSW--PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp --CC--SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCcc--ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 4332 234789999999999864 5678899999999999887776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.7e-27 Score=265.99 Aligned_cols=184 Identities=18% Similarity=0.244 Sum_probs=147.5
Q ss_pred CCceeecccCceEEEEEEeCCCCEEEEEEeCCC----h-----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 334 LPEYLVGKGGHSHVYRGCLPDGKELAVKILKPS----E-----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 334 ~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~----~-----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
...++||+|+||.||+|.. .++.+++|+.... . ...+.|.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4567899999999999954 6788999986432 1 1245689999999999999999777777777788999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++++|.+++.. +..++.|++.||.|||+ ++|+||||||+|||++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999863 45799999999999999 99999999999999999 99999999999875
Q ss_pred CCCCCc-----eecccccCCCCCCcchhcc--CCCCccceEeehhHHHHHHhcCCCCC
Q 041755 485 TSSSHL-----TCTDVAGTFGYLAPEYFMH--GKVSEKIDVYAFGIVLLELLSGKKPI 535 (678)
Q Consensus 485 ~~~~~~-----~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGvvL~eLltG~~Pf 535 (678)
...... ......||+.|+|||++.. ..|+...|+|+..+-.++.+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 532211 1234689999999999987 66888999999999999988887776
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-23 Score=215.87 Aligned_cols=154 Identities=16% Similarity=0.117 Sum_probs=124.9
Q ss_pred cHHHHHHhhcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh-------------------HHHHHHHHHHHHHHh
Q 041755 322 SYQELLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE-------------------DVLKEFASEIEIITA 382 (678)
Q Consensus 322 ~~~el~~~t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~-------------------~~~~~~~~Ei~il~~ 382 (678)
....+......|...+.||+|+||.||+|...+|+.||||+++... .....+.+|+.++++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 3445555566777889999999999999998779999999997432 135678999999999
Q ss_pred cCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 041755 383 LHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSS 462 (678)
Q Consensus 383 l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~ 462 (678)
++ | +++.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.|||+ .+|+||||||+
T Consensus 161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~ 222 (282)
T 1zar_A 161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQY 222 (282)
T ss_dssp TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTT
T ss_pred cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHH
Confidence 99 5 666665544 45699999999999988 421 1234699999999999999 99999999999
Q ss_pred CeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhcc
Q 041755 463 NILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH 509 (678)
Q Consensus 463 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~ 509 (678)
|||++ ++.+||+|||+++. +..|.|||++..
T Consensus 223 NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred HEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999 99999999999862 445889998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.6e-19 Score=183.79 Aligned_cols=135 Identities=20% Similarity=0.231 Sum_probs=106.7
Q ss_pred CCCceeecccCceEEEEEEe-CCCCE--EEEEEeCCChH-------------------------HHHHHHHHHHHHHhcC
Q 041755 333 FLPEYLVGKGGHSHVYRGCL-PDGKE--LAVKILKPSED-------------------------VLKEFASEIEIITALH 384 (678)
Q Consensus 333 f~~~~~IG~G~~g~Vy~g~~-~~g~~--vAvK~l~~~~~-------------------------~~~~~~~Ei~il~~l~ 384 (678)
|...+.||+|+||.||+|.. .+|+. ||||+++.... ....+.+|+.++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999987 68999 99999865421 1236789999999998
Q ss_pred CCCe--eeEEEEEEeCCeEEEEEEcCCC-C----CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeee
Q 041755 385 HRNI--ISLFGFCFEDNNLLLVYDFLSR-G----SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH-NSCEQPVIH 456 (678)
Q Consensus 385 HpnI--v~l~g~~~~~~~~~lV~E~~~~-g----sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH-~~~~~~iiH 456 (678)
|+++ ..++.+ +..+|||||+.+ | +|.+.... .++.....++.|++.||.||| . .+|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~---~givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQE---AELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHT---SCEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHH---CCEEe
Confidence 8764 334432 245899999942 4 67766532 124456789999999999999 8 89999
Q ss_pred ccCCCCCeEecCCCCcEEeeccccccc
Q 041755 457 KDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 457 rDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999754
|
| >3s3t_A Nucleotide-binding protein, universal stress PROT family; structural genomics, PSI-biology, midwest center for structu genomics, MCSG; HET: ATP; 1.90A {Lactobacillus plantarum} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.69 E-value=1.9e-16 Score=147.02 Aligned_cols=132 Identities=16% Similarity=0.146 Sum_probs=107.2
Q ss_pred CCcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCCcCch--------hhhhhHHHHHHHHHHhhhhccCC
Q 041755 3 QGKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSL--------LSLVKTFDSMLSVYEGFCNLKQV 74 (678)
Q Consensus 3 ~~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~~~~--------~~~~~~~~~~l~~~~~~C~~k~v 74 (678)
+-++|+|++|+|+.|..||+||+......|..|++|||.+++....... ....+...+.|+.+...+...++
T Consensus 4 ~~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~ 83 (146)
T 3s3t_A 4 RYTNILVPVDSSDAAQAAFTEAVNIAQRHQANLTALYVVDDSAYHTPALDPVLSELLDAEAAHAKDAMRQRQQFVATTSA 83 (146)
T ss_dssp CCCEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEEECCCCCCGGGHHHHHHHHHHHHHHHHHHHHHHHHHHTTSSC
T ss_pred ccceEEEEcCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccHHHHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4589999999999999999999998888899999999998754111110 11223335788889988988899
Q ss_pred -eEEEEEEECCchhHHHHH-HHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEe
Q 041755 75 -DLKLKVCRGTSVKKIIVK-EAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVE 137 (678)
Q Consensus 75 -~~~~~v~~~~d~~~~l~~-~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~ 137 (678)
.++..+.. |++.+.|++ +|++.++|+||||+++++...+. .||++.+++++++ |||++|+
T Consensus 84 ~~~~~~~~~-g~~~~~I~~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvV~ 146 (146)
T 3s3t_A 84 PNLKTEISY-GIPKHTIEDYAKQHPEIDLIVLGATGTNSPHRVAVGSTTSYVVDHAP--CNVIVIR 146 (146)
T ss_dssp CCCEEEEEE-ECHHHHHHHHHHHSTTCCEEEEESCCSSCTTTCSSCHHHHHHHHHCS--SEEEEEC
T ss_pred cceEEEEec-CChHHHHHHHHHhhcCCCEEEECCCCCCCcceEEEcchHHHHhccCC--CCEEEeC
Confidence 99999988 899999999 99999999999999988543332 3599999999996 8888874
|
| >1mjh_A Protein (ATP-binding domain of protein MJ0577); hypothetical protein, structural genomics, functional assignment; HET: ATP; 1.70A {Methanocaldococcus jannaschii} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.68 E-value=3.6e-16 Score=148.05 Aligned_cols=133 Identities=18% Similarity=0.100 Sum_probs=105.3
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCC-----C---CC--c----Cc-------h-hhhhhHHHHH
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTI-----T---ES--T----GS-------L-LSLVKTFDSM 61 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~-----~---~~--~----~~-------~-~~~~~~~~~~ 61 (678)
-++|+|++|+|+.|..||+||+......|..|++|||.++. . .. . .. . ....+...+.
T Consensus 5 ~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (162)
T 1mjh_A 5 YKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNK 84 (162)
T ss_dssp CCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCeEEEEEEecCccccccccccccccccccccchhhhHHHHHHHHHHHHHHH
Confidence 57999999999999999999999888889999999998754 1 10 0 00 0 0111233477
Q ss_pred HHHHHhhhhccCCeEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeCC
Q 041755 62 LSVYEGFCNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVENG 139 (678)
Q Consensus 62 l~~~~~~C~~k~v~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~~ 139 (678)
|+.+...+...+++++..+.. |++.++|+++|++.++|+||||+++++...+. .|||+.+++++++ |||++|+.+
T Consensus 85 l~~~~~~~~~~g~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~~GSv~~~vl~~~~--~pVlvv~~~ 160 (162)
T 1mjh_A 85 MENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSN--KPVLVVKRK 160 (162)
T ss_dssp HHHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCC--SCEEEECCC
T ss_pred HHHHHHHHHHcCCceEEEEcC-CCHHHHHHHHHHHcCCCEEEEcCCCCCCccceEecchHHHHHHhCC--CCEEEEeCC
Confidence 888888888889999999888 89999999999999999999999988533321 3599999999996 888888654
|
| >3idf_A USP-like protein; universal, stress, PSI, MCSG, structural genomics, midwest center for structural genomics structure initiative; 2.00A {Wolinella succinogenes} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.9e-16 Score=144.45 Aligned_cols=128 Identities=13% Similarity=0.100 Sum_probs=103.0
Q ss_pred cEEEEEEcCChhhHHHHHHHHhhc-cCCCCeEEEEEeecCCCCCc-------Cchhhhh-hHHHHHHHHHHhhhhccCCe
Q 041755 5 KVVVVGVKFDGESRELLTWALVKV-AQPGDRIIALHVLDTITEST-------GSLLSLV-KTFDSMLSVYEGFCNLKQVD 75 (678)
Q Consensus 5 r~I~VavD~s~~S~~AL~WAl~~~-~~~gd~vvlvhV~~~~~~~~-------~~~~~~~-~~~~~~l~~~~~~C~~k~v~ 75 (678)
++|+|++|+|+.|..||+||+... ...|..|++|||.++..... ....... +...+.|+.+...+...+++
T Consensus 2 ~~ILv~~D~s~~s~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 81 (138)
T 3idf_A 2 KKLLFAIDDTEACERAAQYILDMFGKDADCTLTLIHVKPEFMLYGEAVLAAYDEIEMKEEEKAKLLTQKFSTFFTEKGIN 81 (138)
T ss_dssp EEEEEECCSSHHHHHHHHHHHHHHTTCTTEEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEEEEeCCCHHHHHHHHHHHHHhccCCCCEEEEEEEecCCCcccccccCcHHHHHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 689999999999999999999999 88899999999998754110 0011112 44457888899999889999
Q ss_pred EEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCccccccCcchhhHhhhcCCCceEEEEEe
Q 041755 76 LKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAKYCARKLSKNFGVFAVE 137 (678)
Q Consensus 76 ~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~~~svs~yc~~~ap~~c~V~~v~ 137 (678)
++..+.. |++.+.|+++|+ ++|+||||+++++...+..||++.+++++++ |||++|+
T Consensus 82 ~~~~v~~-g~~~~~I~~~a~--~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv~ 138 (138)
T 3idf_A 82 PFVVIKE-GEPVEMVLEEAK--DYNLLIIGSSENSFLNKIFASHQDDFIQKAP--IPVLIVK 138 (138)
T ss_dssp CEEEEEE-SCHHHHHHHHHT--TCSEEEEECCTTSTTSSCCCCTTCHHHHHCS--SCEEEEC
T ss_pred eEEEEec-CChHHHHHHHHh--cCCEEEEeCCCcchHHHHhCcHHHHHHhcCC--CCEEEeC
Confidence 9999998 899999999999 8999999999874322211499999999997 7777763
|
| >3hgm_A Universal stress protein TEAD; rossman fold, signaling protein; HET: ATP; 1.90A {Halomonas elongata} SCOP: c.26.2.0 | Back alignment and structure |
|---|
Probab=99.66 E-value=3.2e-16 Score=145.55 Aligned_cols=130 Identities=16% Similarity=0.022 Sum_probs=104.9
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCC----CC---c-Cc----hhhhhhHHHHHHHHHHhhhhc
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTIT----ES---T-GS----LLSLVKTFDSMLSVYEGFCNL 71 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~----~~---~-~~----~~~~~~~~~~~l~~~~~~C~~ 71 (678)
-++|+|++|+|+.|..||+||+....+.|..|++|||.+++. .. . .. .....+...+.++.+...+..
T Consensus 2 ~~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 81 (147)
T 3hgm_A 2 FNRIMVPVDGSKGAVKALEKGVGLQQLTGAELYILCVFKHHSLLEASLSMARPEQLDIPDDALKDYATEIAVQAKTRATE 81 (147)
T ss_dssp CSEEEEECCSBHHHHHHHHHHHHHHHHHCCEEEEEEEECCHHHHHHTBSSCCCGGGCCCTTHHHHHHHHHHHHHHHHHHH
T ss_pred CceEEEEeCCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCcccccccccccChhhhhhHHHHHHHHHHHHHHHHHHHHHh
Confidence 379999999999999999999998888899999999997642 00 0 00 112234456888999999998
Q ss_pred cCCeE---EEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEE
Q 041755 72 KQVDL---KLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAV 136 (678)
Q Consensus 72 k~v~~---~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v 136 (678)
.++.+ +..+.. |++.+.|+++|++.++|+||||+++++...+. .||++.+++++++ |||++|
T Consensus 82 ~g~~~~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvV 147 (147)
T 3hgm_A 82 LGVPADKVRAFVKG-GRPSRTIVRFARKRECDLVVIGAQGTNGDKSLLLGSVAQRVAGSAH--CPVLVV 147 (147)
T ss_dssp TTCCGGGEEEEEEE-SCHHHHHHHHHHHTTCSEEEECSSCTTCCSCCCCCHHHHHHHHHCS--SCEEEC
T ss_pred cCCCccceEEEEec-CCHHHHHHHHHHHhCCCEEEEeCCCCccccceeeccHHHHHHhhCC--CCEEEC
Confidence 99888 888888 89999999999999999999999987543331 3599999999997 667664
|
| >1tq8_A Hypothetical protein RV1636; MTCY01B2.28, structural target, NYSGXRC, PSI, protein structure initiative; 2.40A {Mycobacterium tuberculosis} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.65 E-value=6.5e-16 Score=147.24 Aligned_cols=132 Identities=14% Similarity=0.064 Sum_probs=102.4
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEE--EeecCCCC-Cc-----Cch-hhhhhHHHHHHHHHHhhhhccCC
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIAL--HVLDTITE-ST-----GSL-LSLVKTFDSMLSVYEGFCNLKQV 74 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlv--hV~~~~~~-~~-----~~~-~~~~~~~~~~l~~~~~~C~~k~v 74 (678)
-++|+|+||+|+.|..||+||+..+. .|..|++| ||.+++.. .. ... ....+...+.|+.+...+...++
T Consensus 17 ~~~ILv~vD~s~~s~~al~~A~~lA~-~~a~l~ll~a~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~gv 95 (163)
T 1tq8_A 17 YKTVVVGTDGSDSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHNAGA 95 (163)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHHHT-TTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHTTTC
T ss_pred CCEEEEEcCCCHHHHHHHHHHHHHhC-CCCEEEEEEeeeccCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 57999999999999999999999988 99999999 88764321 00 000 11223345788888888888899
Q ss_pred e-EEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeCC
Q 041755 75 D-LKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVENG 139 (678)
Q Consensus 75 ~-~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~~ 139 (678)
. ++..+.. |++.++|+++|++.++|+||||+++++.+.+. .||++.+++++++ |||++|+..
T Consensus 96 ~~v~~~v~~-G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSva~~vl~~a~--~PVlvV~~~ 159 (163)
T 1tq8_A 96 KNVEERPIV-GAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAK--VDVLIVHTT 159 (163)
T ss_dssp CEEEEEEEC-SSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTT--CEEEEECCC
T ss_pred CeEEEEEec-CCHHHHHHHHHHhcCCCEEEECCCCCCcccceeeccHHHHHHHhCC--CCEEEEeCC
Confidence 8 9888887 89999999999999999999999988543221 3599999999996 999998754
|
| >3fg9_A Protein of universal stress protein USPA family; APC60691, nucleotide- binding, lactobacillus plantarum WCFS1, structural genomics PSI-2; 1.47A {Lactobacillus plantarum} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.2e-16 Score=146.11 Aligned_cols=132 Identities=14% Similarity=0.189 Sum_probs=105.2
Q ss_pred CcEEEEEEc--CChhhHHHHHHHHhhccCCCCeEEEEEeecCCCC-CcCc-----hhhhhhHHHHHHHHHHhhhhccCC-
Q 041755 4 GKVVVVGVK--FDGESRELLTWALVKVAQPGDRIIALHVLDTITE-STGS-----LLSLVKTFDSMLSVYEGFCNLKQV- 74 (678)
Q Consensus 4 ~r~I~VavD--~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~-~~~~-----~~~~~~~~~~~l~~~~~~C~~k~v- 74 (678)
-++|+|++| +|+.|..||+||+......|..|++|||.++... .... .....+...+.|+.+...+...++
T Consensus 15 ~~~ILv~vD~~~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 94 (156)
T 3fg9_A 15 YRRILLTVDEDDNTSSERAFRYATTLAHDYDVPLGICSVLESEDINIFDSLTPSKIQAKRKHVEDVVAEYVQLAEQRGVN 94 (156)
T ss_dssp CC-EEEECCSCCCHHHHHHHHHHHHHHHHHTCCEEEEEEECCCCTTCCCSSHHHHHHHHHHHHHHHHHHHHHHHHHHTCS
T ss_pred CceEEEEECCCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEeCCCccccccCCHHHHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 479999999 9999999999999988778999999999987541 1000 011223345788888888888899
Q ss_pred eEEEEEEECCchhHHHHHH-HHhcCCcEEEEccCCCccccccCcchhhHhhhcCCCceEEEEEe
Q 041755 75 DLKLKVCRGTSVKKIIVKE-AKSYGEAKVIVGISKTHRTIRSSVSVAKYCARKLSKNFGVFAVE 137 (678)
Q Consensus 75 ~~~~~v~~~~d~~~~l~~~-a~~~~a~~LVlG~~~~~~~~r~~~svs~yc~~~ap~~c~V~~v~ 137 (678)
.++..+..+|++.++|+++ |++.++|+||||+++++...+..||++.+++++++ |||++|+
T Consensus 95 ~~~~~v~~~g~~~~~I~~~~a~~~~~DlIV~G~~g~~~~~~~~Gs~~~~vl~~a~--~PVlvV~ 156 (156)
T 3fg9_A 95 QVEPLVYEGGDVDDVILEQVIPEFKPDLLVTGADTEFPHSKIAGAIGPRLARKAP--ISVIVVR 156 (156)
T ss_dssp SEEEEEEECSCHHHHHHHTHHHHHCCSEEEEETTCCCTTSSSCSCHHHHHHHHCS--SEEEEEC
T ss_pred ceEEEEEeCCCHHHHHHHHHHHhcCCCEEEECCCCCCccceeecchHHHHHHhCC--CCEEEeC
Confidence 5888888879999999999 99999999999999875432224599999999996 8888874
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=4e-16 Score=168.23 Aligned_cols=142 Identities=14% Similarity=0.123 Sum_probs=103.9
Q ss_pred HHHhhcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh-------------------HH----HHHHHHHHHHHHh
Q 041755 326 LLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE-------------------DV----LKEFASEIEIITA 382 (678)
Q Consensus 326 l~~~t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~-------------------~~----~~~~~~Ei~il~~ 382 (678)
+.+-..-|...+.||.|+||.||+|...+|+.||||+++... .. ......|+..|.+
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 333333488899999999999999999899999999976321 00 1112457777888
Q ss_pred cCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 041755 383 LHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSS 462 (678)
Q Consensus 383 l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~ 462 (678)
+.+.++.-..-+.... .+|||||+++++|...... .....++.|++.+|.|||. .+||||||||.
T Consensus 170 L~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~ 234 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAK---HGLIHGDFNEF 234 (397)
T ss_dssp HHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTT
T ss_pred HHhcCCCCCeeeeccC--ceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHH
Confidence 8665543222222232 2799999999888655421 1235678999999999999 89999999999
Q ss_pred CeEecCCCC----------cEEeecccccc
Q 041755 463 NILLSDDFE----------PQLSDFGLASW 482 (678)
Q Consensus 463 NILl~~~~~----------~kL~DFGla~~ 482 (678)
|||+++++. +.|+||+-+..
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HEEEeCCCCcccccccccceEEEEeCCccc
Confidence 999998773 89999987653
|
| >2dum_A Hypothetical protein PH0823; conserved hypothetical protein, putative universal protein A structural genomics, NPPSFA; 2.75A {Pyrococcus horikoshii} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.3e-15 Score=143.79 Aligned_cols=134 Identities=15% Similarity=-0.021 Sum_probs=104.6
Q ss_pred CCcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCC--Cc--C---------ch----hhhhhHHHHHHHHH
Q 041755 3 QGKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITE--ST--G---------SL----LSLVKTFDSMLSVY 65 (678)
Q Consensus 3 ~~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~--~~--~---------~~----~~~~~~~~~~l~~~ 65 (678)
.-++|+|++|+|+.|..||+||+..+.+.|..|++|||.++... .. . .. ....+...+.|+.+
T Consensus 4 m~~~ILv~vD~s~~s~~al~~A~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 83 (170)
T 2dum_A 4 MFRKVLFPTDFSEGAYRAVEVFEKRNKMEVGEVILLHVIDEGTLEELMDGYSFFYDNAEIELKDIKEKLKEEASRKLQEK 83 (170)
T ss_dssp CCSEEEEECCSSHHHHHHHHHHHHHCCSCCSEEEEEEEEETTGGGCCC------------CCTTSHHHHHHHHHHHHHHH
T ss_pred ccceEEEEecCCHHHHHHHHHHHHHHHhcCCEEEEEEEecCccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 35799999999999999999999998888999999999875421 00 0 00 11123335778888
Q ss_pred HhhhhccCCeEEE--EEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeCC
Q 041755 66 EGFCNLKQVDLKL--KVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVENG 139 (678)
Q Consensus 66 ~~~C~~k~v~~~~--~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~~ 139 (678)
...+...+++++. .+.. |++.+.|+++|++.++|+||||+++++...+. .+|++.+++++++ |||++|+.+
T Consensus 84 ~~~~~~~g~~~~~~~~~~~-g~~~~~I~~~a~~~~~DlIV~G~~g~~~~~~~~~Gsv~~~vl~~~~--~PVlvv~~~ 157 (170)
T 2dum_A 84 AEEVKRAFRAKNVRTIIRF-GIPWDEIVKVAEEENVSLIILPSRGKLSLSHEFLGSTVMRVLRKTK--KPVLIIKEV 157 (170)
T ss_dssp HHHHHHHTTCSEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCCCC--TTCCCHHHHHHHHHCS--SCEEEECCC
T ss_pred HHHHHHcCCceeeeeEEec-CChHHHHHHHHHHcCCCEEEECCCCCCccccceechHHHHHHHhCC--CCEEEEccC
Confidence 8888778888887 7777 89999999999999999999999987533221 3599999999996 888888643
|
| >3dlo_A Universal stress protein; unknown function, structural genomics, PSI-2, protein struct initiative, midwest center for structural genomics; HET: MSE; 1.97A {Archaeoglobus fulgidus} PDB: 3qtb_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-15 Score=143.50 Aligned_cols=129 Identities=19% Similarity=0.124 Sum_probs=104.0
Q ss_pred CcEEEEEEcC-ChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCCcCchhhhhhHHHHHHHHHHhhhhccCCeEEEEE-E
Q 041755 4 GKVVVVGVKF-DGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLKQVDLKLKV-C 81 (678)
Q Consensus 4 ~r~I~VavD~-s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~v~~~~~v-~ 81 (678)
-++|+|++|+ |+.|..||+||+..+...|..|++|||.+++.. ......+...+.|+.+...+...++.++..+ +
T Consensus 24 ~~~ILv~vD~~s~~s~~al~~A~~la~~~~a~l~llhV~~~~~~---~~~~~~~~~~~~l~~~~~~~~~~g~~~~~~~~v 100 (155)
T 3dlo_A 24 YMPIVVAVDKKSDRAERVLRFAAEEARLRGVPVYVVHSLPGGGR---TKDEDIIEAKETLSWAVSIIRKEGAEGEEHLLV 100 (155)
T ss_dssp CCCEEEECCSSSHHHHHHHHHHHHHHHHHTCCEEEEEEECCSTT---SCHHHHHHHHHHHHHHHHHHHHTTCCEEEEEEE
T ss_pred cCeEEEEECCCCHHHHHHHHHHHHHHHhcCCEEEEEEEEcCCCc---ccHHHHHHHHHHHHHHHHHHHhcCCCceEEEEe
Confidence 4789999999 999999999999988888999999999976421 1122234455788888888888888888754 5
Q ss_pred ECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEe
Q 041755 82 RGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVE 137 (678)
Q Consensus 82 ~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~ 137 (678)
..|++.++|+++|++.+||+||||+++++...+. .||++.+++++++ |||++|+
T Consensus 101 ~~G~~~~~I~~~a~~~~~DLIV~G~~g~~~~~~~~lGSv~~~vl~~a~--~PVLvVr 155 (155)
T 3dlo_A 101 RGKEPPDDIVDFADEVDAIAIVIGIRKRSPTGKLIFGSVARDVILKAN--KPVICIK 155 (155)
T ss_dssp SSSCHHHHHHHHHHHTTCSEEEEECCEECTTSCEECCHHHHHHHHHCS--SCEEEEC
T ss_pred cCCCHHHHHHHHHHHcCCCEEEECCCCCCCCCCEEeccHHHHHHHhCC--CCEEEeC
Confidence 5699999999999999999999999987433321 3599999999997 7777774
|
| >2gm3_A Unknown protein; AT3G01520, putative ethylene-responsive protein, USP domain, nucleotide binding domain, AMP; HET: MSE AMP; 2.46A {Arabidopsis thaliana} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.62 E-value=3e-15 Score=143.75 Aligned_cols=134 Identities=19% Similarity=0.234 Sum_probs=100.4
Q ss_pred CCcEEEEEEcCCh---------hhHHHHHHHHhhccC---CCCeEEEEEeecCCC--CC---c--Cchh-------hhhh
Q 041755 3 QGKVVVVGVKFDG---------ESRELLTWALVKVAQ---PGDRIIALHVLDTIT--ES---T--GSLL-------SLVK 56 (678)
Q Consensus 3 ~~r~I~VavD~s~---------~S~~AL~WAl~~~~~---~gd~vvlvhV~~~~~--~~---~--~~~~-------~~~~ 56 (678)
.-++|+|+||+|+ .|..||+||+..+++ .+..|++|||.++.. .. . .... ...+
T Consensus 4 ~~~~ILv~vD~s~~~~~~~~~~~s~~al~~a~~la~~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (175)
T 2gm3_A 4 EPTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKA 83 (175)
T ss_dssp -CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHH
T ss_pred CccEEEEEECCCcccccccccHHHHHHHHHHHHHhhcccCCCCEEEEEEEeecccccccccccccCCHHHHHHHHHHHHH
Confidence 3589999999999 999999999998876 478999999986432 10 0 0000 0111
Q ss_pred HHHHHHHHHHhhhhccCCeEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEE
Q 041755 57 TFDSMLSVYEGFCNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFA 135 (678)
Q Consensus 57 ~~~~~l~~~~~~C~~k~v~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~ 135 (678)
...+.|+.+...+...++.++..+.. |++.+.|+++|++.++|+||||+++++.+.+. .||++.+++++++ |||++
T Consensus 84 ~~~~~l~~~~~~~~~~g~~~~~~v~~-G~~~~~I~~~a~~~~~DLIVmG~~g~~~~~~~~~Gsva~~vl~~a~--~pVlv 160 (175)
T 2gm3_A 84 KGLHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMT 160 (175)
T ss_dssp HHHHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCS--SCEEE
T ss_pred HHHHHHHHHHHHHHHCCCceEEEEec-CCHHHHHHHHHHHhCCCEEEEeCCCCChhhhhhcCchHHHHHhCCC--CCEEE
Confidence 23467888888888889999998888 89999999999999999999999988533221 3599999999996 88888
Q ss_pred EeCC
Q 041755 136 VENG 139 (678)
Q Consensus 136 v~~~ 139 (678)
|+.+
T Consensus 161 v~~~ 164 (175)
T 2gm3_A 161 IKRN 164 (175)
T ss_dssp EECC
T ss_pred EcCC
Confidence 8754
|
| >3fdx_A Putative filament protein / universal stress PROT; structural genomics, APC60640.1, universal protein F, PSI-2; HET: MSE ATP; 1.58A {Klebsiella pneumoniae subsp} PDB: 3fh0_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=2.3e-15 Score=139.13 Aligned_cols=130 Identities=14% Similarity=0.127 Sum_probs=99.4
Q ss_pred CcEEEEEEcCChh--hHHHHHHHHhhccCCCCeEEEEEeecCCCC---Cc----CchhhhhhHHHHHHHHHHhhhhccC-
Q 041755 4 GKVVVVGVKFDGE--SRELLTWALVKVAQPGDRIIALHVLDTITE---ST----GSLLSLVKTFDSMLSVYEGFCNLKQ- 73 (678)
Q Consensus 4 ~r~I~VavD~s~~--S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~---~~----~~~~~~~~~~~~~l~~~~~~C~~k~- 73 (678)
.++|+|++|+|+. |..||+||+......|..|++|||.++... .. .......+...+.+..++.++...+
T Consensus 1 ~k~ILv~vD~s~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 80 (143)
T 3fdx_A 1 SNAILVPIDISDKEFTERIISHVESEARIDDAEVHFLTVIPSLPYYASLGMAYTAELPGMDELREGSETQLKEIAKKFSI 80 (143)
T ss_dssp CCEEEEECCTTCSSCCTTHHHHHHHHHHHHTCEEEEEEEECC----------------CHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCEEEEEecCChHhhHHHHHHHHHHHHHhcCCeEEEEEEecCCcccccccccccchhhhHHHHHHHHHHHHHHHHHHcCC
Confidence 3799999999999 999999999988788999999999987430 00 0011122334567777788887764
Q ss_pred --CeEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEe
Q 041755 74 --VDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVE 137 (678)
Q Consensus 74 --v~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~ 137 (678)
+.++..+.. |++.+.|+++|++.++|+||||+++ +...+. .||++.+++++++ |||++|+
T Consensus 81 ~~~~v~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~-~~~~~~~~Gs~~~~v~~~~~--~pVlvv~ 143 (143)
T 3fdx_A 81 PEDRMHFHVAE-GSPKDKILALAKSLPADLVIIASHR-PDITTYLLGSNAAAVVRHAE--CSVLVVR 143 (143)
T ss_dssp CGGGEEEEEEE-SCHHHHHHHHHHHTTCSEEEEESSC-TTCCSCSSCHHHHHHHHHCS--SEEEEEC
T ss_pred CCCceEEEEEe-cChHHHHHHHHHHhCCCEEEEeCCC-CCCeeeeeccHHHHHHHhCC--CCEEEeC
Confidence 567888888 7999999999999999999999996 332221 3599999999996 8888874
|
| >3tnj_A Universal stress protein (USP); structural genomics, PSI-biology, midwest center for structu genomics, MCSG, chaperone; HET: AMP; 2.00A {Nitrosomonas europaea} PDB: 2pfs_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=3.7e-15 Score=139.11 Aligned_cols=133 Identities=19% Similarity=0.139 Sum_probs=93.9
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCC-----Cc---Cchhhh-hhHHHHHHHHHHhhhhccCC
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITE-----ST---GSLLSL-VKTFDSMLSVYEGFCNLKQV 74 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~-----~~---~~~~~~-~~~~~~~l~~~~~~C~~k~v 74 (678)
-++|+|++|+|+.|..||+||+....+.+..|++|||.++... .. ...... .+...+....++.++...++
T Consensus 6 ~~~ILv~vD~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 85 (150)
T 3tnj_A 6 YHHILLAVDFSSEDSQVVQKVRNLASQIGARLSLIHVLDNIPMPDTPYGTAIPLDTETTYDAMLDVEKQKLSQIGNTLGI 85 (150)
T ss_dssp CSEEEEECCCSTTHHHHHHHHHHHHHHHTCEEEEEEEEC--------CTTCCCSSSCCCHHHHHHHHHHHHHHHHHHHTC
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEEcCccccccccccccCcCHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 5899999999999999999999988888999999999876421 00 000111 11222334444445555567
Q ss_pred e-EEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCccccccCcchhhHhhhcCCCceEEEEEeCC
Q 041755 75 D-LKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAKYCARKLSKNFGVFAVENG 139 (678)
Q Consensus 75 ~-~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~~~svs~yc~~~ap~~c~V~~v~~~ 139 (678)
. ++..+.. |++.++|+++|++.++|+||||+++++......+|++.+++++++ |||++|+..
T Consensus 86 ~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv~~~ 148 (150)
T 3tnj_A 86 DPAHRWLVW-GEPREEIIRIAEQENVDLIVVGSHGRHGLALLLGSTANSVLHYAK--CDVLAVRLR 148 (150)
T ss_dssp CGGGEEEEE-SCHHHHHHHHHHHTTCSEEEEEEC--------CCCHHHHHHHHCS--SEEEEEECC
T ss_pred CcceEEEec-CCHHHHHHHHHHHcCCCEEEEecCCCCCcCeEecchHHHHHHhCC--CCEEEEeCC
Confidence 6 4666777 899999999999999999999999874332113599999999996 899998753
|
| >2z08_A Universal stress protein family; uncharacterized conserved protein, structural genomics, unknown function, NPPSFA; HET: ATP; 1.55A {Thermus thermophilus} SCOP: c.26.2.4 PDB: 1wjg_A* 2z09_A* 2z3v_A | Back alignment and structure |
|---|
Probab=99.59 E-value=4.1e-15 Score=136.81 Aligned_cols=128 Identities=13% Similarity=0.124 Sum_probs=94.1
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCCcC-----ch-hhhhhHHHHHHHHHHhhhhccCC-eE
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTG-----SL-LSLVKTFDSMLSVYEGFCNLKQV-DL 76 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~~-----~~-~~~~~~~~~~l~~~~~~C~~k~v-~~ 76 (678)
-++|+|++|+|+.|..||+||+......|..|++|||.++...... .. ....+...+.|+.+. ...++ .+
T Consensus 2 ~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~---~~~g~~~~ 78 (137)
T 2z08_A 2 FKTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGEPFFEEALRRRLERAEGVLEEAR---ALTGVPKE 78 (137)
T ss_dssp CSEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECC--------------CHHHHHHHHHHHHHH---HHHCCCGG
T ss_pred cceEEEEeCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCCCccccccchHHHHHHHHHHHHHHHHHHH---HHcCCCcc
Confidence 3799999999999999999999988778999999999975321000 00 011122234444443 33677 77
Q ss_pred EEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEe
Q 041755 77 KLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVE 137 (678)
Q Consensus 77 ~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~ 137 (678)
+..+.. |++.+.|+++|++.++|+||||+++++...+. .||++.+++++++ |||++|+
T Consensus 79 ~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pVlvv~ 137 (137)
T 2z08_A 79 DALLLE-GVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAP--CPVLLVR 137 (137)
T ss_dssp GEEEEE-SSHHHHHHHHHHHTTCSEEEEESSCTTCCSCSSSCHHHHHHHHHCS--SCEEEEC
T ss_pred EEEEEe-cCHHHHHHHHHHHcCCCEEEECCCCCchhhhhhhccHHHHHHhcCC--CCEEEeC
Confidence 777777 89999999999999999999999987533221 3599999999996 7777763
|
| >1jmv_A USPA, universal stress protein A; chaperone; 1.85A {Haemophilus influenzae} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.52 E-value=4.5e-14 Score=130.23 Aligned_cols=128 Identities=12% Similarity=0.093 Sum_probs=94.0
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecC-CC-CCcCc------h-hhhhhHHHHHHHHHHhhhhccCC
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDT-IT-ESTGS------L-LSLVKTFDSMLSVYEGFCNLKQV 74 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~-~~-~~~~~------~-~~~~~~~~~~l~~~~~~C~~k~v 74 (678)
-++|+|++|+|+.|..||+||+......|..|++|||.+. +. ..... . ....+...+.|+ .++...++
T Consensus 2 ~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~---~~~~~~~~ 78 (141)
T 1jmv_A 2 YKHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALL---DLAESVDY 78 (141)
T ss_dssp CSEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHH---HHHHHSSS
T ss_pred CceEEEEecCchhhHHHHHHHHHHHHhcCCEEEEEEEecCchhhhccccccchHHHHHHHHHHHHHHHH---HHHHHcCC
Confidence 3789999999999999999999988778999999999854 21 11000 0 001112223333 34555577
Q ss_pred eE-EEEEEECCchhHHHHHHHHhcCCcEEEEccCCCccccccCcchhhHhhhcCCCceEEEEEeCC
Q 041755 75 DL-KLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAKYCARKLSKNFGVFAVENG 139 (678)
Q Consensus 75 ~~-~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~~~svs~yc~~~ap~~c~V~~v~~~ 139 (678)
.+ +..+.. |++.+.|+++|++.++|+||||++ ++...+ .+|++.+++++++ |||++|+.+
T Consensus 79 ~~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~-~~~~~~-lgs~~~~vl~~~~--~pVlvv~~~ 139 (141)
T 1jmv_A 79 PISEKLSGS-GDLGQVLSDAIEQYDVDLLVTGHH-QDFWSK-LMSSTRQVMNTIK--IDMLVVPLR 139 (141)
T ss_dssp CCCCEEEEE-ECHHHHHHHHHHHTTCCEEEEEEC-CCCHHH-HHHHHHHHHTTCC--SEEEEEECC
T ss_pred CceEEEEec-CCHHHHHHHHHHhcCCCEEEEeCC-Cchhhh-hcchHHHHHhcCC--CCEEEeeCC
Confidence 76 455555 999999999999999999999999 754333 2599999999996 999998754
|
| >1q77_A Hypothetical protein AQ_178; structural genomics, universal stress protein, PSI, protein structure initiative; 2.70A {Aquifex aeolicus} SCOP: c.26.2.4 | Back alignment and structure |
|---|
Probab=99.51 E-value=6.4e-14 Score=128.82 Aligned_cols=122 Identities=14% Similarity=0.041 Sum_probs=93.9
Q ss_pred CCcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEee-cC-C--C---C--Cc--Cch-hhhhhHHHHHHHHHHhhh-
Q 041755 3 QGKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVL-DT-I--T---E--ST--GSL-LSLVKTFDSMLSVYEGFC- 69 (678)
Q Consensus 3 ~~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~-~~-~--~---~--~~--~~~-~~~~~~~~~~l~~~~~~C- 69 (678)
.-++|+|++|+|+.|..||+||+......|..|++|||. +. + . . .. ... ....+...+.|+.+ ..|
T Consensus 3 ~~~~ILv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~ 81 (138)
T 1q77_A 3 AMKVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREV-WEKL 81 (138)
T ss_dssp CCEEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHH-HHHH
T ss_pred cccEEEEEccCCHhHHHHHHHHHHHHHHcCCeEEEEEEecccccccccccccCCCCChHHHHHHHHHHHHHHHHH-HHHh
Confidence 457999999999999999999999888889999999998 63 1 0 0 00 111 11122334667777 553
Q ss_pred -hccCCeEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCccccccCcchhhHhhhcCCCceEEEEEe
Q 041755 70 -NLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAKYCARKLSKNFGVFAVE 137 (678)
Q Consensus 70 -~~k~v~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~~~svs~yc~~~ap~~c~V~~v~ 137 (678)
...+ .++..+.. |++.+.|+++|++.++|+||||++++ |++.+++++++ |||++|+
T Consensus 82 ~~~~~-~~~~~~~~-g~~~~~I~~~a~~~~~dliV~G~~g~--------sv~~~vl~~a~--~PVlvv~ 138 (138)
T 1q77_A 82 TGSTE-IPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPS--------AYLCKVIDGLN--LASLIVK 138 (138)
T ss_dssp HSCCC-CCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCG--------GGTHHHHHHSS--SEEEECC
T ss_pred hccCC-cceEEEEc-CCHHHHHHHHHHhcCCCEEEEeCCCC--------chHHHHHHhCC--CceEeeC
Confidence 4455 67777666 89999999999999999999999974 89999999997 8888773
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.41 E-value=9.1e-13 Score=136.96 Aligned_cols=132 Identities=9% Similarity=0.059 Sum_probs=95.4
Q ss_pred CcEEEEEEcCChh-------hHHHHHHHHhhccCCCCeEEEEEeecCCCCC--cCchhhhhhHHHHHHHHHHhhhhccCC
Q 041755 4 GKVVVVGVKFDGE-------SRELLTWALVKVAQPGDRIIALHVLDTITES--TGSLLSLVKTFDSMLSVYEGFCNLKQV 74 (678)
Q Consensus 4 ~r~I~VavD~s~~-------S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~--~~~~~~~~~~~~~~l~~~~~~C~~k~v 74 (678)
.++|+||+|+|+. |..||+||+..+...+..|++|||.++.... ........+...+..+.+..++...++
T Consensus 134 ~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~g~ 213 (290)
T 3mt0_A 134 GGKILAAVDVGNNDGEHRSLHAGIISHAYDIAGLAKATLHVISAHPSPMLSSADPTFQLSETIEARYREACRTFQAEYGF 213 (290)
T ss_dssp TCEEEEEECTTCCSHHHHHHHHHHHHHHHHHHHHTTCEEEEEEEEC---------CHHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred CCeEEEEECCCCcchhhhHHHHHHHHHHHHHHHHcCCeEEEEEEecCccccccCchhHHHHHHHHHHHHHHHHHHHHcCC
Confidence 4799999999998 9999999999988889999999999865311 000000011112233333445555566
Q ss_pred e-EEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeC
Q 041755 75 D-LKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVEN 138 (678)
Q Consensus 75 ~-~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~ 138 (678)
. ++..+.. |++.++|+++|++.++|+||||+++++++.+. .||++.+++++++ |||++|+.
T Consensus 214 ~~~~~~v~~-g~~~~~I~~~a~~~~~dLiVmG~~g~~~~~~~~~Gsv~~~vl~~~~--~pVLvv~~ 276 (290)
T 3mt0_A 214 SDEQLHIEE-GPADVLIPRTAQKLDAVVTVIGTVARTGLSGALIGNTAEVVLDTLE--SDVLVLKP 276 (290)
T ss_dssp CTTTEEEEE-SCHHHHHHHHHHHHTCSEEEEECCSSCCGGGCCSCHHHHHHHTTCS--SEEEEECC
T ss_pred CcceEEEec-cCHHHHHHHHHHhcCCCEEEECCCCCcCCcceecchHHHHHHhcCC--CCEEEECC
Confidence 4 5566677 89999999999999999999999998544332 3599999999996 88998864
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.40 E-value=5.6e-13 Score=136.65 Aligned_cols=130 Identities=13% Similarity=0.036 Sum_probs=102.2
Q ss_pred cEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCC-C-----CcC----c--------hhhhhhHHHHHHHHHH
Q 041755 5 KVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTIT-E-----STG----S--------LLSLVKTFDSMLSVYE 66 (678)
Q Consensus 5 r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~-~-----~~~----~--------~~~~~~~~~~~l~~~~ 66 (678)
++|+|++|+|+.|..||+||+....+.|..|++|||.++.. . +.. . .....+...+.|+.+.
T Consensus 1 k~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 80 (268)
T 3ab8_A 1 MRILLATDGSPQARGAEALAEWLAYKLSAPLTVLFVVDTRLARIPELLDFGALTVPVPVLRTELERALALRGEAVLERVR 80 (268)
T ss_dssp CCEEEECCSCGGGHHHHHHHHHHHHHHTCCEEEEEEEEHHHHTHHHHC-------CHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcEEEEcCCCHHHHHHHHHHHHHHHHhCCcEEEEEEeccCCcccccccCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 57999999999999999999998877899999999986532 0 000 0 0111223357888888
Q ss_pred hhhhccCCeEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCc-ccccc-CcchhhHhhhcCCCceEEEEEeCC
Q 041755 67 GFCNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTH-RTIRS-SVSVAKYCARKLSKNFGVFAVENG 139 (678)
Q Consensus 67 ~~C~~k~v~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~-~~~r~-~~svs~yc~~~ap~~c~V~~v~~~ 139 (678)
..+...++.++..+.. |++.+.|+++ ..++|++|||+++++ ...+. .||++.+++++++ |||++|+.+
T Consensus 81 ~~~~~~g~~~~~~~~~-g~~~~~I~~~--~~~~dliV~G~~g~~~~~~~~~~Gs~~~~v~~~a~--~PVlvv~~~ 150 (268)
T 3ab8_A 81 QSALAAGVAVEAVLEE-GVPHEAILRR--ARAADLLVLGRSGEAHGDGFGGLGSTADRVLRASP--VPVLLAPGE 150 (268)
T ss_dssp HHHHHTTCCEEEEEEE-ECHHHHHHHH--HTTCSEEEEESSCTTSCTTCCSCCHHHHHHHHHCS--SCEEEECSS
T ss_pred HHHHhCCCCeEEEEec-CCHHHHHHhh--ccCCCEEEEeccCCCccccccccchhHHHHHHhCC--CCEEEECCC
Confidence 8888889999999887 8999999999 778999999999875 43321 3599999999996 888888643
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-12 Score=136.95 Aligned_cols=131 Identities=11% Similarity=0.069 Sum_probs=101.4
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCC--cC----ch-hhhhhHHHHHHHHHHhhhhcc----
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITES--TG----SL-LSLVKTFDSMLSVYEGFCNLK---- 72 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~--~~----~~-~~~~~~~~~~l~~~~~~C~~k---- 72 (678)
-++|+|++|+|+.|..||+||+..+.+.|..|++|||.++.... .. .. ....+...+.|+.+...|...
T Consensus 19 ~~~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 98 (309)
T 3cis_A 19 SLGIIVGIDDSPAAQVAVRWAARDAELRKIPLTLVHAVSPEVATWLEVPLPPGVLRWQQDHGRHLIDDALKVVEQASLRA 98 (309)
T ss_dssp TTEEEEECCSSHHHHHHHHHHHHHHHHHTCCEEEEEECCCCCCCTTCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHCSSS
T ss_pred CCeEEEEECCCHHHHHHHHHHHHHHHhcCCcEEEEEEecCcccccccCCCCchhhHHHHHHHHHHHHHHHHHHHHhcccC
Confidence 57999999999999999999999988889999999998743210 00 01 111233347778877777665
Q ss_pred -CCeEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeCC
Q 041755 73 -QVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVENG 139 (678)
Q Consensus 73 -~v~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~~ 139 (678)
++.++..+.. |++.+.|+++|+ ++|+||||+++++...+. .+|++.+++++++ |||++|+.+
T Consensus 99 ~~~~~~~~~~~-g~~~~~I~~~a~--~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~~ 162 (309)
T 3cis_A 99 GPPTVHSEIVP-AAAVPTLVDMSK--DAVLMVVGCLGSGRWPGRLLGSVSSGLLRHAH--CPVVIIHDE 162 (309)
T ss_dssp CCSCEEEEEES-SCHHHHHHHHGG--GEEEEEEESSCTTCCTTCCSCHHHHHHHHHCS--SCEEEECTT
T ss_pred CCceEEEEEec-CCHHHHHHHHhc--CCCEEEECCCCCccccccccCcHHHHHHHhCC--CCEEEEcCC
Confidence 8999998887 899999999997 699999999987533221 3599999999995 888888654
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.5e-12 Score=135.18 Aligned_cols=134 Identities=13% Similarity=0.096 Sum_probs=104.6
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCC-cC----c-hh----hhhhHHHHHHHHHHhhhhccC
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITES-TG----S-LL----SLVKTFDSMLSVYEGFCNLKQ 73 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~-~~----~-~~----~~~~~~~~~l~~~~~~C~~k~ 73 (678)
-++|+|++|+|+.|..||+||+.-..+.|.+|++|||.++.... .. . .. ...+...+.|+.+...+...+
T Consensus 7 ~k~ILv~~D~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 86 (319)
T 3olq_A 7 YQNLLVVIDPNQDDQPALRRAVYIVQRNGGRIKAFLPVYDLSYDMTTLLSPDERNAMRKGVINQKTAWIKQQARYYLEAG 86 (319)
T ss_dssp SCEEEEECCTTCSCCHHHHHHHHHHHHHCCEEEEEEEECCGGGGCTTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cceEEEEECCCcccHHHHHHHHHHHHHcCCeEEEEEEecccchhhccccChhhHHHHHHHHHHHHHHHHHHHHHHHhhcC
Confidence 47999999999999999999999888889999999997643210 00 0 00 111223467777777787889
Q ss_pred CeEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeCC
Q 041755 74 VDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVENG 139 (678)
Q Consensus 74 v~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~~ 139 (678)
+.++..+.+.|++.+.|+++|+..++|++|||+++++...+. .+|++..++++++ |||++|..+
T Consensus 87 v~~~~~~~~~g~~~~~i~~~a~~~~~DLiV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~~ 151 (319)
T 3olq_A 87 IQIDIKVIWHNRPYEAIIEEVITDKHDLLIKMAHQHDKLGSLIFTPLDWQLLRKCP--APVWMVKDK 151 (319)
T ss_dssp CCEEEEEEECSCHHHHHHHHHHHHTCSEEEEEEBCC--CCSCBCCHHHHHHHHHCS--SCEEEEESS
T ss_pred CeEEEEEEecCChHHHHHHHHHhcCCCEEEEecCcCchhhcccccccHHHHHhcCC--CCEEEecCc
Confidence 999999996699999999999999999999999997433222 3599999999996 888888754
|
| >3cis_A Uncharacterized protein; alpha/beta hydrolase, ATP, universal stress protein, unknown function; HET: ATP; 2.90A {Mycobacterium tuberculosis} PDB: 2jax_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=4.1e-12 Score=133.27 Aligned_cols=130 Identities=17% Similarity=0.103 Sum_probs=96.0
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCC---cCchhhhhhHHHHHHHHHHhhhhc--cCCeEEE
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITES---TGSLLSLVKTFDSMLSVYEGFCNL--KQVDLKL 78 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~---~~~~~~~~~~~~~~l~~~~~~C~~--k~v~~~~ 78 (678)
.++|+||+|+++.|..||+||+..+...+..|++|||.++.... ........+...+.++.+...+.. .++.++.
T Consensus 171 ~~~Ilv~~D~s~~s~~al~~a~~la~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 250 (309)
T 3cis_A 171 QAPVLVGVDGSSASELATAIAFDEASRRNVDLVALHAWSDVDVSEWPGIDWPATQSMAEQVLAERLAGWQERYPNVAITR 250 (309)
T ss_dssp CCCEEEECCSSHHHHHHHHHHHHHHHHTTCCEEEEEESCSSCCTTCSSCCHHHHHHHHHHHHHHHHTTHHHHCTTSCEEE
T ss_pred CCeEEEEeCCChHHHHHHHHHHHHHHhcCCEEEEEEEeecccccCCCcccHHHHHHHHHHHHHHHHHHHHhhCCCCcEEE
Confidence 46899999999999999999999887789999999998754211 111111122223344444333322 4788888
Q ss_pred EEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeC
Q 041755 79 KVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVEN 138 (678)
Q Consensus 79 ~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~ 138 (678)
.+.. |++.++|+++|+ +||+||||+++++.+.+. .||++.+++++++ |||++|+.
T Consensus 251 ~~~~-g~~~~~I~~~a~--~adliV~G~~~~~~~~~~l~Gsv~~~vl~~~~--~pVlvv~~ 306 (309)
T 3cis_A 251 VVVR-DQPARQLVQRSE--EAQLVVVGSRGRGGYAGMLVGSVGETVAQLAR--TPVIVARE 306 (309)
T ss_dssp EEES-SCHHHHHHHHHT--TCSEEEEESSCSSCCTTCSSCHHHHHHHHHCS--SCEEEECC
T ss_pred EEEc-CCHHHHHHHhhC--CCCEEEECCCCCCCccccccCcHHHHHHhcCC--CCEEEeCC
Confidence 8776 899999999998 799999999988543322 3599999999996 88888863
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.33 E-value=3.1e-12 Score=133.12 Aligned_cols=122 Identities=16% Similarity=0.220 Sum_probs=100.3
Q ss_pred CCcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCCcCchhhhhhHHHHHHHHHHhhhhccCCeEEEEEEE
Q 041755 3 QGKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLKQVDLKLKVCR 82 (678)
Q Consensus 3 ~~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~v~~~~~v~~ 82 (678)
..++|+||+|+++.|..||+||+.-+...+..|.+|||.++.. ..+.++.+...+...+++++..+..
T Consensus 169 ~~~~Ilv~~d~s~~s~~al~~a~~la~~~~~~l~ll~v~~~~~------------~~~~l~~~~~~l~~~~~~~~~~~~~ 236 (294)
T 3loq_A 169 LFDRVLVAYDFSKWADRALEYAKFVVKKTGGELHIIHVSEDGD------------KTADLRVMEEVIGAEGIEVHVHIES 236 (294)
T ss_dssp TTSEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEECSSSC------------CHHHHHHHHHHHHHTTCCEEEEEEC
T ss_pred cCCEEEEEECCCHHHHHHHHHHHHHhhhcCCEEEEEEEccCch------------HHHHHHHHHHHHHHcCCcEEEEEec
Confidence 3579999999999999999999998777899999999997531 1234555666666678898888777
Q ss_pred CCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeCC
Q 041755 83 GTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVENG 139 (678)
Q Consensus 83 ~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~~ 139 (678)
|++.++|+++|++.++|+||||+++++++.+. .+|++.+++++++ |||++|+.+
T Consensus 237 -g~~~~~I~~~a~~~~~dLlV~G~~~~~~~~~~~~Gs~~~~vl~~~~--~pvLvv~~~ 291 (294)
T 3loq_A 237 -GTPHKAILAKREEINATTIFMGSRGAGSVMTMILGSTSESVIRRSP--VPVFVCKRG 291 (294)
T ss_dssp -SCHHHHHHHHHHHTTCSEEEEECCCCSCHHHHHHHCHHHHHHHHCS--SCEEEECSC
T ss_pred -CCHHHHHHHHHHhcCcCEEEEeCCCCCCccceeeCcHHHHHHhcCC--CCEEEECCC
Confidence 89999999999999999999999998543321 3499999999996 888888754
|
| >3mt0_A Uncharacterized protein PA1789; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: MSE; 1.58A {Pseudomonas aeruginosa} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.8e-12 Score=133.31 Aligned_cols=121 Identities=11% Similarity=0.009 Sum_probs=100.0
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCCcCchhhhhhHHHHHHHHHHhhhhccCCeEEEEEEEC
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLKQVDLKLKVCRG 83 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~v~~~~~v~~~ 83 (678)
-++|+|++|+|+.|..||+||+.-..+.|..|++|||.++ +...+.|+.+...+...++.++..+.++
T Consensus 7 ~~~ILv~~D~s~~s~~al~~A~~la~~~~a~l~ll~v~~~------------~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 74 (290)
T 3mt0_A 7 IRSILVVIEPDQLEGLALKRAQLIAGVTQSHLHLLVCEKR------------RDHSAALNDLAQELREEGYSVSTNQAWK 74 (290)
T ss_dssp CCEEEEECCSSCSCCHHHHHHHHHHHHHCCEEEEEEECSS------------SCCHHHHHHHHHHHHHTTCCEEEEEECS
T ss_pred hceEEEEeCCCccchHHHHHHHHHHHhcCCeEEEEEeeCc------------HHHHHHHHHHHHHHhhCCCeEEEEEEeC
Confidence 5899999999999999999999988888999999999863 1122344555555567889999999988
Q ss_pred CchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeC
Q 041755 84 TSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVEN 138 (678)
Q Consensus 84 ~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~ 138 (678)
|++.+.|+++|+..++|++|||+++++...+. .+|++.+++++++ |||++|..
T Consensus 75 g~~~~~i~~~a~~~~~dliV~G~~~~~~~~~~~~gs~~~~vl~~~~--~PVlvv~~ 128 (290)
T 3mt0_A 75 DSLHQTIIAEQQAEGCGLIIKQHFPDNPLKKAILTPDDWKLLRFAP--CPVLMTKT 128 (290)
T ss_dssp SSHHHHHHHHHHHHTCSEEEEECCCSCTTSTTSCCHHHHHHHHHCS--SCEEEECC
T ss_pred CCHHHHHHHHHHhcCCCEEEEecccCCchhhcccCHHHHHHHhcCC--CCEEEecC
Confidence 99999999999999999999999987533221 3599999999996 88888863
|
| >3loq_A Universal stress protein; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: AMP; 2.32A {Archaeoglobus fulgidus} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.4e-12 Score=135.76 Aligned_cols=132 Identities=11% Similarity=0.028 Sum_probs=104.4
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCC-------cCch-hhhhhHHHHHHHHHHhhhhccCCe
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITES-------TGSL-LSLVKTFDSMLSVYEGFCNLKQVD 75 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~-------~~~~-~~~~~~~~~~l~~~~~~C~~k~v~ 75 (678)
-++|+|++|+|+.|..||+||+.-..+.|..|++|||.+.+... .... ....+...+.|+.+...+...++.
T Consensus 22 ~~~ILv~vD~s~~s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~g~~ 101 (294)
T 3loq_A 22 SNAMLLPTDLSENSFKVLEYLGDFKKVGVEEIGVLFVINLTKLSTVSGGIDIDHYIDEMSEKAEEVLPEVAQKIEAAGIK 101 (294)
T ss_dssp TCEEEEECCSCTGGGGGGGGHHHHHHTTCCEEEEECCEECTTC-----CCCTTHHHHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred hccEEEecCCCHHHHHHHHHHHHHHhhcCCEEEEEEEecCcccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 57999999999999999999999888889999999998765310 0111 122234458889999999889999
Q ss_pred EEE-EEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeCC
Q 041755 76 LKL-KVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVENG 139 (678)
Q Consensus 76 ~~~-~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~~ 139 (678)
++. .+.+.|++.++| +++..++|+||||+++++...+. .+|++.+++++++ |||++|..+
T Consensus 102 ~~~~~v~~~g~~~~~I--~a~~~~~DliV~G~~g~~~~~~~~~Gs~~~~vl~~~~--~PVlvv~~~ 163 (294)
T 3loq_A 102 AEVIKPFPAGDPVVEI--IKASENYSFIAMGSRGASKFKKILLGSVSEGVLHDSK--VPVYIFKHD 163 (294)
T ss_dssp EEECSSCCEECHHHHH--HHHHTTSSEEEEECCCCCHHHHHHHCCHHHHHHHHCS--SCEEEECCC
T ss_pred cceeEeeccCChhHhe--eeccCCCCEEEEcCCCCccccceeeccHHHHHHhcCC--CCEEEecCc
Confidence 998 777249999999 99999999999999987533221 2499999999997 888888643
|
| >3olq_A Universal stress protein E; structural genomics, PSI-2, protein structure initiative, MI center for structural genomics, MCSG; HET: UNL; 1.82A {Proteus mirabilis} | Back alignment and structure |
|---|
Probab=99.26 E-value=9.9e-12 Score=130.58 Aligned_cols=133 Identities=10% Similarity=0.020 Sum_probs=96.1
Q ss_pred CcEEEEEEcCCh-------hhHHHHHHHHhhccCC--CCeEEEEEeecCCCCCc------Cchhhhh-hHHHHHHHHHHh
Q 041755 4 GKVVVVGVKFDG-------ESRELLTWALVKVAQP--GDRIIALHVLDTITEST------GSLLSLV-KTFDSMLSVYEG 67 (678)
Q Consensus 4 ~r~I~VavD~s~-------~S~~AL~WAl~~~~~~--gd~vvlvhV~~~~~~~~------~~~~~~~-~~~~~~l~~~~~ 67 (678)
.++|+||+|+|+ .|..||+||+..+... |..|++|||.++..... ....... +...+..+.++.
T Consensus 156 ~~~Ilva~D~s~~~~~~~~~s~~al~~a~~la~~~~~~a~l~ll~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (319)
T 3olq_A 156 YGTIVVAANLSNEESYHDALNLKLIELTNDLSHRIQKDPDVHLLSAYPVAPINIAIELPDFDPNLYNNALRGQHLIAMKE 235 (319)
T ss_dssp TCEEEEECCCSCCSTHHHHHHHHHHHHHHHHHHHHCSSCCEEEEEEECCCSCSCCTTCTTCCHHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEECCCCcchhHHHHHHHHHHHHHHHHHhccCCCeEEEEEeecCcchhhhccCCcccHHHHHHHHHHHHHHHHHH
Confidence 579999999999 5799999999877655 89999999998754110 0111111 111233344444
Q ss_pred hhhccCC-eEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeCC
Q 041755 68 FCNLKQV-DLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVENG 139 (678)
Q Consensus 68 ~C~~k~v-~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~~ 139 (678)
++...++ .++..+.. |++.++|+++|++.++|+||||+++++++.+. .|||+.+++++++ |||++|+..
T Consensus 236 ~~~~~~~~~~~~~v~~-g~~~~~I~~~a~~~~~dLiV~G~~g~~~~~~~~~Gsv~~~vl~~~~--~pVLvv~~~ 306 (319)
T 3olq_A 236 LRQKFSIPEEKTHVKE-GLPEQVIPQVCEELNAGIVVLGILGRTGLSAAFLGNTAEQLIDHIK--CDLLAIKPD 306 (319)
T ss_dssp HHHHTTCCGGGEEEEE-SCHHHHHHHHHHHTTEEEEEEECCSCCSTHHHHHHHHHHHHHTTCC--SEEEEECCT
T ss_pred HHHHhCCCcccEEEec-CCcHHHHHHHHHHhCCCEEEEeccCccCCccccccHHHHHHHhhCC--CCEEEECCC
Confidence 5555555 34566666 89999999999999999999999988544331 3599999999996 889999753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.5e-11 Score=125.44 Aligned_cols=143 Identities=16% Similarity=0.109 Sum_probs=111.6
Q ss_pred hcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEc
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE-DVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
...|.....++.|+++.||+... +|..+++|+..... .....+.+|+.++..+. +..+.++++++...+..++||||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 34677777788888999999876 47899999986421 12235888999999985 67788999999988899999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC------------------------------------- 450 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~------------------------------------- 450 (678)
++|.+|.+.+.. ......++.+++++|..||...
T Consensus 92 i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 92 ADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp CSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred cCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 999999876421 1123467889999999999811
Q ss_pred -------------------CCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 451 -------------------EQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 451 -------------------~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 14589999999999998766667999987653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=1.6e-11 Score=124.26 Aligned_cols=129 Identities=18% Similarity=0.115 Sum_probs=97.8
Q ss_pred cccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCC--eeeEEEEEEeCCeEEEEEEcCCCCCHHHHh
Q 041755 340 GKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRN--IISLFGFCFEDNNLLLVYDFLSRGSLEENL 417 (678)
Q Consensus 340 G~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~L 417 (678)
+.|..+.||+....+|..+++|+.... ....+.+|+.++..+.+.+ +.++++++..++..++||||++|.+|. .
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 355569999998777889999998754 2245778999999986544 456888888878899999999998884 2
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------------
Q 041755 418 HGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC----------------------------------------------- 450 (678)
Q Consensus 418 ~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~----------------------------------------------- 450 (678)
.. .. ...++.++++.|..||...
T Consensus 105 ~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 105 SH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp SC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred Cc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 11 11 2356778888888888632
Q ss_pred --------CCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 451 --------EQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 451 --------~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
...++|+|++|.|||+++++.+.|+|||.+..
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11299999999999998876677999998754
|
| >3ab8_A Putative uncharacterized protein TTHA0350; tandem-type universal stress protein, unknown function; HET: ATP; 1.70A {Thermus thermophilus} PDB: 3ab7_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=3.4e-11 Score=123.25 Aligned_cols=115 Identities=11% Similarity=0.027 Sum_probs=94.2
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCCcCchhhhhhHHHHHHHHHHhhhhccCCeEEEEEEEC
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLKQVDLKLKVCRG 83 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~v~~~~~v~~~ 83 (678)
.++|+||+|+++.|..||+||.......|..|++|||.++. +...+.++.+.......+++++..+..
T Consensus 154 ~~~ilv~~d~s~~~~~al~~a~~la~~~~a~l~ll~v~~~~-----------~~~~~~l~~~~~~l~~~~~~~~~~~~~- 221 (268)
T 3ab8_A 154 LEGALLGYDASESAVRALHALAPLARALGLGVRVVSVHEDP-----------ARAEAWALEAEAYLRDHGVEASALVLG- 221 (268)
T ss_dssp CCEEEEECCSCHHHHHHHHHHHHHHHHHTCCEEEEEECSSH-----------HHHHHHHHHHHHHHHHTTCCEEEEEEC-
T ss_pred CCEEEEEECCCHHHHHHHHHHHHhhhcCCCEEEEEEEcCcH-----------HHHHHHHHHHHHHHHHcCCceEEEEeC-
Confidence 47999999999999999999988776678889999998642 122345566666666678999888776
Q ss_pred CchhHHHHHHHHhcCCcEEEEccCCCccccccCcchhhHhhhcCCCceEEEEEe
Q 041755 84 TSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAKYCARKLSKNFGVFAVE 137 (678)
Q Consensus 84 ~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~~~svs~yc~~~ap~~c~V~~v~ 137 (678)
|++.++|++++++. |+||||+ +..+.+.| |++.+++++++ |||++|+
T Consensus 222 g~~~~~i~~~a~~~--dliV~G~-~~~~~~~G--s~~~~vl~~~~--~pvlvv~ 268 (268)
T 3ab8_A 222 GDAADHLLRLQGPG--DLLALGA-PVRRLVFG--STAERVIRNAQ--GPVLTAR 268 (268)
T ss_dssp SCHHHHHHHHCCTT--EEEEEEC-CCSCCSSC--CHHHHHHHHCS--SCEEEEC
T ss_pred CChHHHHHHHHHhC--CEEEECC-cccccEec--cHHHHHHhcCC--CCEEEeC
Confidence 89999999999998 9999999 65666666 99999999996 7777763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.02 E-value=7.9e-10 Score=118.21 Aligned_cols=140 Identities=14% Similarity=0.255 Sum_probs=106.4
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeC--CCh--HHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeC---CeEEEEEE
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILK--PSE--DVLKEFASEIEIITALH--HRNIISLFGFCFED---NNLLLVYD 406 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~--~~~--~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~---~~~~lV~E 406 (678)
...|+.|.++.||+.... +..+++|+.. ... .....+.+|+.+++.|. +..+.+++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 456899999999998774 4688999876 433 22456788999999997 45678889888766 34799999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC------------------------------------ 450 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~------------------------------------ 450 (678)
|+++..+.+... ..++..++..++.++++.|..||...
T Consensus 122 ~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999877744221 24678888999999999999999731
Q ss_pred -------------------CCCeeeccCCCCCeEecCCCC--cEEeecccccc
Q 041755 451 -------------------EQPVIHKDVKSSNILLSDDFE--PQLSDFGLASW 482 (678)
Q Consensus 451 -------------------~~~iiHrDIKp~NILl~~~~~--~kL~DFGla~~ 482 (678)
...++|+|+++.|||++.++. +.|+||+.+.+
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 256999999999999997753 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.86 E-value=1.4e-09 Score=113.50 Aligned_cols=184 Identities=18% Similarity=0.166 Sum_probs=123.9
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-CCC--eeeEEEEEEeCC---eEEEEEEcCC
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALH-HRN--IISLFGFCFEDN---NLLLVYDFLS 409 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-Hpn--Iv~l~g~~~~~~---~~~lV~E~~~ 409 (678)
...++.|.+..||+.. ..+++|+.... .....+.+|++++..+. +.. +..++.+....+ ..|+||+|++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3458999999999852 56899986543 45567889999999884 332 344444433322 3488999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC--------------------------------------- 450 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--------------------------------------- 450 (678)
|.+|..... ..++..++..++.+++..|..||...
T Consensus 100 G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 100 GVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 988865432 23567778888899999999988611
Q ss_pred ----------------CCCeeeccCCCCCeEecC--CCCcEEeecccccccCCCCCCceecccccCCCC---CCcchhc-
Q 041755 451 ----------------EQPVIHKDVKSSNILLSD--DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY---LAPEYFM- 508 (678)
Q Consensus 451 ----------------~~~iiHrDIKp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y---~APE~l~- 508 (678)
...++|+|++|.|||+++ +..+.|+||+.+....... +......+ ..|+...
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~------Dl~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN------DFISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH------HHHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH------HHHHHHhhccccCHHHHHH
Confidence 135899999999999998 5567899999987543210 01111111 2333221
Q ss_pred ----cCCC---------CccceEeehhHHHHHHhcCCCCCC
Q 041755 509 ----HGKV---------SEKIDVYAFGIVLLELLSGKKPIN 536 (678)
Q Consensus 509 ----~~~~---------s~ksDVwSlGvvL~eLltG~~Pf~ 536 (678)
++.. ....+.|++|.++|.+.+|..+|.
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0111 122588999999999999998763
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.4e-06 Score=90.98 Aligned_cols=136 Identities=20% Similarity=0.188 Sum_probs=97.0
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCC---CeeeEEEEEE-eCCeEEEEEEcCCCC
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHR---NIISLFGFCF-EDNNLLLVYDFLSRG 411 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~~-~~~~~~lV~E~~~~g 411 (678)
...++.|....||+. |..+++|+-. .......+.+|+++|..|.+. .+.+++.++. ..+..++||||++|.
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 356888888999987 5678899853 334567789999999999753 3556666664 345578999999998
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 041755 412 SLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS------------------------------------------ 449 (678)
Q Consensus 412 sL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~------------------------------------------ 449 (678)
+|..... ..++..++..++.+++..|..||..
T Consensus 99 ~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8876322 1234455556666666666666642
Q ss_pred ---------------CCCCeeeccCCCCCeEecC---CCC-cEEeecccccc
Q 041755 450 ---------------CEQPVIHKDVKSSNILLSD---DFE-PQLSDFGLASW 482 (678)
Q Consensus 450 ---------------~~~~iiHrDIKp~NILl~~---~~~-~kL~DFGla~~ 482 (678)
....++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235699999999999997 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=3e-06 Score=86.21 Aligned_cols=134 Identities=18% Similarity=0.136 Sum_probs=98.4
Q ss_pred ecccCce-EEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEcCCCCCHHH
Q 041755 339 VGKGGHS-HVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415 (678)
Q Consensus 339 IG~G~~g-~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 415 (678)
+..|..| .||+.... ++..+++|+-... ....+.+|..+|+.|. +--+.+++.++.+.+..++|||++++.++.+
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 4455554 69987654 5678999987643 3456788999999885 3346778899988899999999999988877
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 041755 416 NLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC--------------------------------------------- 450 (678)
Q Consensus 416 ~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--------------------------------------------- 450 (678)
..... ......++.+++..|..||...
T Consensus 110 ~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 110 VLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp HHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 65321 1223456677777777777521
Q ss_pred ----------CCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 451 ----------EQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 451 ----------~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
...++|+|+.+.|||+++++.+-|+||+.+.+
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 02379999999999999887778999998754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.13 E-value=1.5e-05 Score=83.53 Aligned_cols=141 Identities=18% Similarity=0.222 Sum_probs=81.0
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-----CCCeeeEE-E--EEEeCCeEEEEEEcC
Q 041755 337 YLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALH-----HRNIISLF-G--FCFEDNNLLLVYDFL 408 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~-g--~~~~~~~~~lV~E~~ 408 (678)
..|+.|..+.||+....+| .+++|+....... +..|+.++..|. .|.++... | +....+..++||+|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~~~---~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPEKK---ALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCHHH---HHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCHHH---HHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 3466667899999887555 5999999865432 334455554442 34444311 1 123456789999999
Q ss_pred CCCCHH--------------HHhccCCC----C------CCCCCHHHHH-------------------------------
Q 041755 409 SRGSLE--------------ENLHGNKK----D------GNAFGWTERY------------------------------- 433 (678)
Q Consensus 409 ~~gsL~--------------~~L~~~~~----~------~~~l~~~~~~------------------------------- 433 (678)
+|.++. ..+|.... . .....|...+
T Consensus 114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 193 (346)
T 2q83_A 114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID 193 (346)
T ss_dssp CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence 886542 12221100 0 0112343211
Q ss_pred HHHHHHHHHHHHHHh----------cCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 434 KVAVGVAEALDYLHN----------SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 434 ~ia~qia~aL~yLH~----------~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
.+...+..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123345666653 134789999999999999888899999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=3.1e-06 Score=89.94 Aligned_cols=78 Identities=12% Similarity=0.062 Sum_probs=55.1
Q ss_pred eee-cccCceEEEEEEeC-------CCCEEEEEEeCCChH----HHHHHHHHHHHHHhcCC---CCeeeEEEEEEeC---
Q 041755 337 YLV-GKGGHSHVYRGCLP-------DGKELAVKILKPSED----VLKEFASEIEIITALHH---RNIISLFGFCFED--- 398 (678)
Q Consensus 337 ~~I-G~G~~g~Vy~g~~~-------~g~~vAvK~l~~~~~----~~~~~~~Ei~il~~l~H---pnIv~l~g~~~~~--- 398 (678)
..| +.|....+|+.... +|..+++|+...... ....+.+|+.++..|.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88888999998764 267899998765331 12456788888888752 3567788877654
Q ss_pred CeEEEEEEcCCCCCHH
Q 041755 399 NNLLLVYDFLSRGSLE 414 (678)
Q Consensus 399 ~~~~lV~E~~~~gsL~ 414 (678)
+..++||||++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999886654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.97 E-value=1.8e-05 Score=85.41 Aligned_cols=74 Identities=15% Similarity=0.123 Sum_probs=49.5
Q ss_pred ceeecccCceEEEEEEeC-CCCEEEEEEeCCChH--------HHHHHHHHHHHHHhcCC--CC-eeeEEEEEEeCCeEEE
Q 041755 336 EYLVGKGGHSHVYRGCLP-DGKELAVKILKPSED--------VLKEFASEIEIITALHH--RN-IISLFGFCFEDNNLLL 403 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~--------~~~~~~~Ei~il~~l~H--pn-Iv~l~g~~~~~~~~~l 403 (678)
...||.|.++.||++... +++.++||...+... ....+..|.+++..+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 578999998754321 12456779999888742 33 3455543 3445689
Q ss_pred EEEcCCCC
Q 041755 404 VYDFLSRG 411 (678)
Q Consensus 404 V~E~~~~g 411 (678)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00022 Score=74.57 Aligned_cols=139 Identities=17% Similarity=0.237 Sum_probs=92.7
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcC---CCCeeeEEEEEEeCCeEEEEEEcCCCCC
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALH---HRNIISLFGFCFEDNNLLLVYDFLSRGS 412 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~~~~~~~~~lV~E~~~~gs 412 (678)
...|+.|.+..+|+... ++..+++|+.... ....|..|...|+.|. ...+.+++.++...+..++||||+++..
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 45689999999999876 5778999987643 2456788999988884 3568888888887788999999999875
Q ss_pred HH-----------HHhccCCC-C--C---------------CCCCHHHHH---HHHHH----------------HHHH-H
Q 041755 413 LE-----------ENLHGNKK-D--G---------------NAFGWTERY---KVAVG----------------VAEA-L 443 (678)
Q Consensus 413 L~-----------~~L~~~~~-~--~---------------~~l~~~~~~---~ia~q----------------ia~a-L 443 (678)
+. -.||.... . + ..-+|...+ ++..+ ++.. .
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 41 13343211 0 0 012465432 11111 1111 1
Q ss_pred HHHHh-cCCCCeeeccCCCCCeEecCCCCcEEeecc
Q 041755 444 DYLHN-SCEQPVIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 444 ~yLH~-~~~~~iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
..|.. .....+||+|+.+.|++++.++ +.|+||+
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 1236799999999999999887 8899973
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00027 Score=73.53 Aligned_cols=159 Identities=17% Similarity=0.167 Sum_probs=86.7
Q ss_pred ccHHHHHHhhcCCCC-----ceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-----CCCeee
Q 041755 321 FSYQELLSATSNFLP-----EYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALH-----HRNIIS 390 (678)
Q Consensus 321 f~~~el~~~t~~f~~-----~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-----HpnIv~ 390 (678)
++.+++......|.. ...|+.|....+|+....+| .+++|+..... ....+..|+.++..|. -|.++.
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC-CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 344444444444543 23467788899999887666 68899987621 1223456777776664 233332
Q ss_pred EE-E--EEEeCCeEEEEEEcCCCCCHH--------------HHhccCC----CCC-CC---CCHHHHHHH----------
Q 041755 391 LF-G--FCFEDNNLLLVYDFLSRGSLE--------------ENLHGNK----KDG-NA---FGWTERYKV---------- 435 (678)
Q Consensus 391 l~-g--~~~~~~~~~lV~E~~~~gsL~--------------~~L~~~~----~~~-~~---l~~~~~~~i---------- 435 (678)
.. | +....+..+++|+|++|..+. ..+|... ... .. ..|...+.-
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 10 1 112245678999999875431 1122110 000 00 123331110
Q ss_pred --HHHHHHHHHHHHhc----CCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 436 --AVGVAEALDYLHNS----CEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 436 --a~qia~aL~yLH~~----~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
...+...+.+|+.. ...+++|+|+.+.|||++++..+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 11244455666532 23579999999999999987666899998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00042 Score=71.12 Aligned_cols=77 Identities=22% Similarity=0.268 Sum_probs=55.1
Q ss_pred CCCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCC---CeeeEEEEEEeCCeEEEEEEc
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE-DVLKEFASEIEIITALHHR---NIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~Hp---nIv~l~g~~~~~~~~~lV~E~ 407 (678)
.......+|.|..+.||+..+.||+.|++|+..... .....|..|+..|+.|.-- -+.+++++ ... ++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~--~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDR--TLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETT--EEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cCc--eEEEEe
Confidence 344556789999999999999999999999875432 2234577899999988521 23444443 223 789999
Q ss_pred CCCCC
Q 041755 408 LSRGS 412 (678)
Q Consensus 408 ~~~gs 412 (678)
+..+.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00053 Score=71.51 Aligned_cols=143 Identities=17% Similarity=0.219 Sum_probs=82.5
Q ss_pred eeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCC--CeeeEEEE-----EEeCCeEEEEEEcCC
Q 041755 337 YLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHR--NIISLFGF-----CFEDNNLLLVYDFLS 409 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~g~-----~~~~~~~~lV~E~~~ 409 (678)
..++ |....||+....+|+.+++|+.++.......+..|..++..|... .+.+++.. ...++..++||+|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 3566 888999998777788899999975432234566688877776422 23334332 223456788999998
Q ss_pred CCCHH-----------H---HhccCCC-----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhc--
Q 041755 410 RGSLE-----------E---NLHGNKK-----DGNAFGWTER----YKV---------------AVGVAEALDYLHNS-- 449 (678)
Q Consensus 410 ~gsL~-----------~---~L~~~~~-----~~~~l~~~~~----~~i---------------a~qia~aL~yLH~~-- 449 (678)
|.++. . .+|.... ....+.+... ..+ ...+...+..+...
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 75431 0 1221100 0112222211 001 01111223333321
Q ss_pred --CCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 450 --CEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 450 --~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 235689999999999999 4 899999987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.00041 Score=75.40 Aligned_cols=32 Identities=22% Similarity=0.402 Sum_probs=28.3
Q ss_pred CCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 451 ~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
...++|+|++|.|||++.++ ++|+||+.+.+-
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 47899999999999999876 999999988753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00035 Score=72.28 Aligned_cols=71 Identities=11% Similarity=0.114 Sum_probs=44.7
Q ss_pred ceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCeEEEEEEcC-CCCCH
Q 041755 336 EYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNI-ISLFGFCFEDNNLLLVYDFL-SRGSL 413 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~-~~gsL 413 (678)
...|+.|....+|+. ..+++|+............+|+.++..+...++ .++++++ .+.-++|+||+ ++.+|
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEEC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccC
Confidence 567899999999997 568999887543222223468877777753223 4555543 33347899999 55443
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00058 Score=74.64 Aligned_cols=72 Identities=14% Similarity=0.216 Sum_probs=49.1
Q ss_pred ceeecccCceEEEEEEeCC--------CCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCeEEEEEE
Q 041755 336 EYLVGKGGHSHVYRGCLPD--------GKELAVKILKPSEDVLKEFASEIEIITALHHRNI-ISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~--------g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E 406 (678)
...|+.|....||+....+ +..+++|+..... ....+..|..++..|...++ .++++.+. + .+|||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 3467888889999998653 5789999985421 11345579998888853333 56666553 2 38999
Q ss_pred cCCCCC
Q 041755 407 FLSRGS 412 (678)
Q Consensus 407 ~~~~gs 412 (678)
|+++.+
T Consensus 153 ~l~G~~ 158 (429)
T 1nw1_A 153 YIPSRP 158 (429)
T ss_dssp CCCEEE
T ss_pred EeCCcc
Confidence 997633
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0012 Score=68.97 Aligned_cols=141 Identities=13% Similarity=0.114 Sum_probs=73.5
Q ss_pred eecccCceE-EEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCC--CCeeeEEEEEEeCCeEEEEEEcCCCCCHH
Q 041755 338 LVGKGGHSH-VYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHH--RNIISLFGFCFEDNNLLLVYDFLSRGSLE 414 (678)
Q Consensus 338 ~IG~G~~g~-Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 414 (678)
.|+.|+... +|+....+|..+++|...+... ..+..|+.++..|.. -.+.+++.+..+.+ +++||++.+.++.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~--~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~ 100 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG--GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFT 100 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT--CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHH
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC--ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchH
Confidence 355555554 6676654477888887655421 233456666666642 23455666543333 7899999776665
Q ss_pred HHhccCC---------------------CC-CCCCCHHHHH---------HH-----------HHHHHHHHHHHH---hc
Q 041755 415 ENLHGNK---------------------KD-GNAFGWTERY---------KV-----------AVGVAEALDYLH---NS 449 (678)
Q Consensus 415 ~~L~~~~---------------------~~-~~~l~~~~~~---------~i-----------a~qia~aL~yLH---~~ 449 (678)
+.+.... .. -..+...... .. ...+...+..|. ..
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~ 180 (333)
T 3csv_A 101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE 180 (333)
T ss_dssp HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence 4432210 00 0112111100 00 001112222221 12
Q ss_pred CCCCeeeccCCCCCeEecCC----CCcEEeecccccc
Q 041755 450 CEQPVIHKDVKSSNILLSDD----FEPQLSDFGLASW 482 (678)
Q Consensus 450 ~~~~iiHrDIKp~NILl~~~----~~~kL~DFGla~~ 482 (678)
....++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 24679999999999999875 6789999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0014 Score=70.34 Aligned_cols=141 Identities=18% Similarity=0.244 Sum_probs=82.5
Q ss_pred eeecccCceEEEEEEeC--------CCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEEEEEc
Q 041755 337 YLVGKGGHSHVYRGCLP--------DGKELAVKILKPSEDVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~--------~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
..|..|-...+|+.... +++.+++|+..........+.+|..+++.|. +.-..++++++. + .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEEE
Confidence 45667878899998764 3578999986432223455668999988885 222355666553 2 399999
Q ss_pred CCCCCHHH-----------------HhccCCC-CCCCC--CHHHHHHHHHHHHH-------------------HHHHHHh
Q 041755 408 LSRGSLEE-----------------NLHGNKK-DGNAF--GWTERYKVAVGVAE-------------------ALDYLHN 448 (678)
Q Consensus 408 ~~~gsL~~-----------------~L~~~~~-~~~~l--~~~~~~~ia~qia~-------------------aL~yLH~ 448 (678)
++|.+|.. .||.... .+... -|.+..++..++.. .+..|..
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 98755421 1222111 11222 24555555544322 2333332
Q ss_pred -----cCCCCeeeccCCCCCeEecCC----CCcEEeeccccc
Q 041755 449 -----SCEQPVIHKDVKSSNILLSDD----FEPQLSDFGLAS 481 (678)
Q Consensus 449 -----~~~~~iiHrDIKp~NILl~~~----~~~kL~DFGla~ 481 (678)
.....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 123468999999999999876 789999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0013 Score=69.89 Aligned_cols=72 Identities=14% Similarity=0.155 Sum_probs=44.8
Q ss_pred eeecccCceEEEEEEeCC---------CCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCCeEEEEEE
Q 041755 337 YLVGKGGHSHVYRGCLPD---------GKELAVKILKPSEDVLKEFASEIEIITALHHRN-IISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~---------g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~E 406 (678)
..|+.|....+|+....+ +..+++|+.............|..++..|...+ ..++++.. .+ ++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEEE
Confidence 457788888999987654 278999988654332223357888888775333 34566543 23 78999
Q ss_pred cCCCCC
Q 041755 407 FLSRGS 412 (678)
Q Consensus 407 ~~~~gs 412 (678)
|+++.+
T Consensus 115 ~i~G~~ 120 (369)
T 3c5i_A 115 WLYGDP 120 (369)
T ss_dssp CCCSEE
T ss_pred EecCCc
Confidence 998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0027 Score=69.88 Aligned_cols=74 Identities=16% Similarity=0.196 Sum_probs=47.8
Q ss_pred ceeecccCceEEEEEEeCC-CCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCeEEEEEEcCCCCCH
Q 041755 336 EYLVGKGGHSHVYRGCLPD-GKELAVKILKPSEDVLKEFASEIEIITALHHRNI-ISLFGFCFEDNNLLLVYDFLSRGSL 413 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~-g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~~~~gsL 413 (678)
...|+.|-...+|+....+ +..+++|+........-.-.+|..++..|...++ .++++++ .+ .+||||+++.+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 3467888889999988754 5789999875432111112479999999875555 4667666 23 359999987443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0036 Score=65.93 Aligned_cols=68 Identities=18% Similarity=0.203 Sum_probs=43.5
Q ss_pred cccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcC---CCCeeeEEEE------EEeCCeEEEEEEcCCC
Q 041755 340 GKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALH---HRNIISLFGF------CFEDNNLLLVYDFLSR 410 (678)
Q Consensus 340 G~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~g~------~~~~~~~~lV~E~~~~ 410 (678)
|.|....||+....+| .+++|+...... ..|+.++..|. -|++.+++.. ....+..++||+|++|
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~-----~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD-----EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC-----CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc-----hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 3333689999987777 899998876431 34555555553 2224444422 2335678999999988
Q ss_pred CCH
Q 041755 411 GSL 413 (678)
Q Consensus 411 gsL 413 (678)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 655
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.31 E-value=0.027 Score=61.28 Aligned_cols=140 Identities=14% Similarity=0.192 Sum_probs=83.2
Q ss_pred eeecccCceEEEEEEeCC--------CCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCCeEEEEEEc
Q 041755 337 YLVGKGGHSHVYRGCLPD--------GKELAVKILKPSEDVLKEFASEIEIITALHHRN-IISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~--------g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~lV~E~ 407 (678)
..|..|-...+|+....+ +..|++|+........-.-.+|..+++.|.-.+ ..++++.+ .+ ++||||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEEE
Confidence 456677788999988753 688999997553322222346888888775322 34555433 23 789999
Q ss_pred CCCCCHHH-----------------HhccCCC---------CCCCCCHHHHHHHHHHH-------------------HHH
Q 041755 408 LSRGSLEE-----------------NLHGNKK---------DGNAFGWTERYKVAVGV-------------------AEA 442 (678)
Q Consensus 408 ~~~gsL~~-----------------~L~~~~~---------~~~~l~~~~~~~ia~qi-------------------a~a 442 (678)
++|.+|.. .||.... ...+..|.+..++..++ ...
T Consensus 152 I~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~e 231 (424)
T 3mes_A 152 IDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILEE 231 (424)
T ss_dssp CCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHHH
T ss_pred eCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHHH
Confidence 98865321 1111100 11222355444443322 222
Q ss_pred HHHHHh---------------------cCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 443 LDYLHN---------------------SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 443 L~yLH~---------------------~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
+.+|.. .....++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 232 ~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 232 IDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 333321 11345899999999999 778899999998764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.70 E-value=0.083 Score=51.82 Aligned_cols=100 Identities=18% Similarity=0.115 Sum_probs=65.5
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
-+|.+.|... +.+++++++|.++.|.+.+|.-+-.. ..-..+=+-|..|+|..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc---------
Confidence 3799999754 47899999999999999998776211 1111333457899999999888764 1110
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSG 531 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG 531 (678)
.....+.+||.+. ...+.+.=|||||+++|.-+-=
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1123466888763 3456788999999999988763
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.63 E-value=0.58 Score=50.08 Aligned_cols=28 Identities=39% Similarity=0.542 Sum_probs=23.8
Q ss_pred eeeccCCCCCeEe------cCCCCcEEeeccccc
Q 041755 454 VIHKDVKSSNILL------SDDFEPQLSDFGLAS 481 (678)
Q Consensus 454 iiHrDIKp~NILl------~~~~~~kL~DFGla~ 481 (678)
++|+|+.+.|||+ +++..+.++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 5799999999999 456779999998764
|
| >1wy5_A TILS, hypothetical UPF0072 protein AQ_1887; N-type ATP-ppase, structural genomics, translation, NPPSFA; 2.42A {Aquifex aeolicus} SCOP: c.26.2.5 d.229.1.1 PDB: 2e21_A* 2e89_A* | Back alignment and structure |
|---|
Probab=90.42 E-value=1.2 Score=46.18 Aligned_cols=97 Identities=10% Similarity=0.026 Sum_probs=64.4
Q ss_pred CCcEEEEEEcCChhhHHHHHHHHhhccCCCCe-EEEEEeecCCCCCcCchhhhhhHHHHHHHHHHhhhhccCCeEEEEEE
Q 041755 3 QGKVVVVGVKFDGESRELLTWALVKVAQPGDR-IIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLKQVDLKLKVC 81 (678)
Q Consensus 3 ~~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~-vvlvhV~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~v~~~~~v~ 81 (678)
.+.+|+||+.+...|.-+|.++.......|-. |+++||-.... .....-.+..+.+|...+|.+...-+
T Consensus 23 ~~~~vlva~SGG~DS~~Ll~ll~~~~~~~g~~~v~av~vd~g~r----------~~s~~~~~~v~~~a~~lgi~~~v~~~ 92 (317)
T 1wy5_A 23 GERRVLIAFSGGVDSVVLTDVLLKLKNYFSLKEVALAHFNHMLR----------ESAERDEEFCKEFAKERNMKIFVGKE 92 (317)
T ss_dssp SCCEEEEECCSSHHHHHHHHHHHHSTTTTTCSEEEEEEEECCSS----------THHHHHHHHHHHHHHHHTCCEEEEEC
T ss_pred CCCEEEEEecchHHHHHHHHHHHHHHHHcCCCEEEEEEEECCCC----------cccHHHHHHHHHHHHHcCCcEEEEEE
Confidence 35689999999999997776655433344667 99999975320 11122345567788888887765543
Q ss_pred E--------CCch-------h-HHHHHHHHhcCCcEEEEccCCC
Q 041755 82 R--------GTSV-------K-KIIVKEAKSYGEAKVIVGISKT 109 (678)
Q Consensus 82 ~--------~~d~-------~-~~l~~~a~~~~a~~LVlG~~~~ 109 (678)
. +.++ + ..+.+.|++++++.|++|.+..
T Consensus 93 ~~~~~~~~~~~~~e~~ar~~Ry~~l~~~a~~~g~~~i~~Gh~~d 136 (317)
T 1wy5_A 93 DVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (317)
T ss_dssp CHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred echhhhccCCCCHHHHHHHHHHHHHHHHHHHcCCCEEEEeCchh
Confidence 2 1111 1 2466778889999999998853
|
| >3a2k_A TRNA(Ile)-lysidine synthase; ligase, pseudo-knot, ligase/RNA complex; 3.65A {Geobacillus kaustophilus} | Back alignment and structure |
|---|
Probab=90.32 E-value=0.91 Score=49.69 Aligned_cols=96 Identities=20% Similarity=0.180 Sum_probs=65.5
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCCcCchhhhhhHHHHHHHHHHhhhhccCCeEEEEEEEC
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLKQVDLKLKVCRG 83 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~v~~~~~v~~~ 83 (678)
+.+|+||+.+...|.-+|.++.....+.|-.|+++||-+... + ...+.-.+..+.+|...+|.+...-+..
T Consensus 18 ~~~vlVa~SGG~DS~~Ll~ll~~~~~~~~~~v~avhvdhglr-g--------~~s~~~~~~v~~~~~~lgi~~~v~~~~~ 88 (464)
T 3a2k_A 18 GAAVIVGVSGGPDSLALLHVFLSLRDEWKLQVIAAHVDHMFR-G--------RESEEEMEFVKRFCVERRILCETAQIDV 88 (464)
T ss_dssp SSBEEEECCSSHHHHHHHHHHHHHHHTTTCBCEEEEEECTTC-T--------HHHHHHHHHHHHHHHHTTCEEEEEECCC
T ss_pred CCEEEEEEcCcHHHHHHHHHHHHHHHHcCCeEEEEEEECCCC-c--------cccHHHHHHHHHHHHHcCCcEEEEEech
Confidence 568999999999999877666554334578999999976320 0 1112233566788998899877665431
Q ss_pred C----ch------------hHHHHHHHHhcCCcEEEEccCC
Q 041755 84 T----SV------------KKIIVKEAKSYGEAKVIVGISK 108 (678)
Q Consensus 84 ~----d~------------~~~l~~~a~~~~a~~LVlG~~~ 108 (678)
. +. ...+.+.|++++++.|++|.|.
T Consensus 89 ~~~~~~~~~~~e~~aR~~Ry~~l~~~a~~~g~~~IatgH~~ 129 (464)
T 3a2k_A 89 PAFQRSAGLGAQEAARICRYRFFAELMEKHQAGYVAVGHHG 129 (464)
T ss_dssp HHHHTTTTCCSHHHHHHHHHHHHHHHHHTTTCCEEECCCCH
T ss_pred hhhhhccCCCHHHHHHHHHHHHHHHHHHHcCcCEEEEeCCh
Confidence 0 00 1346677788899999999885
|
| >1k92_A Argininosuccinate synthase, argininosuccinate SY; N-type ATP pyrophosphatase, ligase; 1.60A {Escherichia coli} SCOP: c.26.2.1 d.210.1.1 PDB: 1k97_A* 1kp2_A* 1kp3_A* | Back alignment and structure |
|---|
Probab=88.15 E-value=2.6 Score=45.82 Aligned_cols=90 Identities=14% Similarity=0.096 Sum_probs=58.9
Q ss_pred CCcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCCCcCchhhhhhHHHHHHHHHHhhhhccCC-eEEEEEE
Q 041755 3 QGKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLKQV-DLKLKVC 81 (678)
Q Consensus 3 ~~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~v-~~~~~v~ 81 (678)
.+.+|+||+-+...|.-+|.|+.+. |..|+++|+...... ... ++..+.+|..-+| ++...=+
T Consensus 9 ~~~KVvVA~SGGlDSSvll~~L~e~----G~eViavtvd~Gq~~-~~e-----------le~a~~~A~~lGi~~~~vvD~ 72 (455)
T 1k92_A 9 VGQRIGIAFSGGLDTSAALLWMRQK----GAVPYAYTANLGQPD-EED-----------YDAIPRRAMEYGAENARLIDC 72 (455)
T ss_dssp TTSEEEEECCSSHHHHHHHHHHHHT----TCEEEEEEEECCCTT-CSC-----------TTHHHHHHHHHTCSEEEEEEC
T ss_pred CCCeEEEEEcChHHHHHHHHHHHHc----CCEEEEEEEEcCCCC-HHH-----------HHHHHHHHHHhCCCeEEEEeC
Confidence 3568999999999999999999774 889999999754210 000 1223333433343 2221111
Q ss_pred --------------------ECC------c------hhHHHHHHHHhcCCcEEEEccCC
Q 041755 82 --------------------RGT------S------VKKIIVKEAKSYGEAKVIVGISK 108 (678)
Q Consensus 82 --------------------~~~------d------~~~~l~~~a~~~~a~~LVlG~~~ 108 (678)
++. . +.+.+++.|++.+|+.|+.|.++
T Consensus 73 ~eef~~~v~p~i~~na~y~~eg~rcY~l~t~~aRp~i~~~l~e~A~e~Gad~IAtGht~ 131 (455)
T 1k92_A 73 RKQLVAEGIAAIQCGAFHNTTGGLTYFNTTPLGRAVTGTMLVAAMKEDGVNIWGDGSTY 131 (455)
T ss_dssp HHHHHHHHHHHHHHTCCCCEETTEECCCHHHHHHHHHHHHHHHHHHHTTCCEEECCCCT
T ss_pred hHHHHHHhHHHHHcCCcccccCceecccCCcchHHHHHHHHHHHHHHcCCCEEEECCcC
Confidence 211 1 13678999999999999999975
|
| >1ni5_A Putative cell cycle protein MESJ; structural genomics, ATPase, PP-type, putative cell cycle PR PSI, protein structure initiative; 2.65A {Escherichia coli} SCOP: b.153.1.2 c.26.2.5 d.229.1.1 | Back alignment and structure |
|---|
Probab=86.22 E-value=1.2 Score=48.40 Aligned_cols=69 Identities=22% Similarity=0.277 Sum_probs=47.1
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccC-CCCeEEEEEeecCCCCCcCchhhhhhHHHHHHHHHHhhhhccCCeEEEEEEE
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQ-PGDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLKQVDLKLKVCR 82 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~-~gd~vvlvhV~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~v~~~~~v~~ 82 (678)
+.+|+||+.+...|.-+|.++.....+ .|-.|+++||-+... ...+.-.+..+.+|...+|.+...-+.
T Consensus 13 ~~~vlVa~SGG~DS~~Ll~ll~~~~~~~~g~~v~avhvdhglr----------~~s~~~~~~v~~~~~~lgi~~~v~~~~ 82 (433)
T 1ni5_A 13 SRQILVAFSGGLDSTVLLHQLVQWRTENPGVALRAIHVHHGLS----------ANADAWVTHCENVCQQWQVPLVVERVQ 82 (433)
T ss_dssp CSEEEEECCSBHHHHHHHHHHHHHHTTSTTCEEEEEEECCSCC----------SSHHHHHHHHHHHHHHTTCCEEEECCC
T ss_pred CCEEEEEEcchHHHHHHHHHHHHHHHhcCCCeEEEEEEECCCC----------cccHHHHHHHHHHHHHcCCcEEEEEec
Confidence 578999999999999777665543333 678999999975421 011122355677898888887665443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.08 E-value=1.9 Score=42.11 Aligned_cols=116 Identities=13% Similarity=0.111 Sum_probs=79.7
Q ss_pred cCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeeeccCCC
Q 041755 383 LHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALD-YLHNSCEQPVIHKDVKS 461 (678)
Q Consensus 383 l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~-yLH~~~~~~iiHrDIKp 461 (678)
..||++ -..+-.+++.+.+.|+.-+++.=+..+. .++...+++++..|+.... +++. -+|-=|.|
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 368888 4444577788888888765554444442 3678899999999988766 5543 57888999
Q ss_pred CCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCC
Q 041755 462 SNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPIN 536 (678)
Q Consensus 462 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~ 536 (678)
+||+++.++.++|.-.|+-..+++-. +.+|-+ +-.+=+++..++.++..|.
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~lpP~e--------------~~ee~f----------l~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKESLPPDE--------------WDDERL----------LREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GGEEECTTCCEEESCCEETTTBSSCS--------------CCHHHH----------HHHHHHHHHHHTTCSSCHH
T ss_pred ceEEEeCCCcEEEEEcCCcccCCCCC--------------CCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 99999999999998877644332211 122222 2245678888888888774
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.70 E-value=1.4 Score=42.82 Aligned_cols=117 Identities=11% Similarity=0.181 Sum_probs=81.2
Q ss_pred cCCCCeeeEEEEEEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 041755 383 LHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSS 462 (678)
Q Consensus 383 l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~ 462 (678)
..||++++. .+-.+++.+.+.|+.-+.+.=+..+ ..++...+++++..|+....+++. -+|-=|.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 368988877 5666777777777765433222233 236788999999999988766654 478889999
Q ss_pred CeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCC
Q 041755 463 NILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPIN 536 (678)
Q Consensus 463 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~ 536 (678)
||+++.++.+++.-.|+-..+++.. +.+|-+ +-.+=+++..+++++..|.
T Consensus 109 NL~f~~~~~p~i~~RGik~~l~P~~--------------~~ee~f----------L~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVVDPLP--------------VSEAEF----------LTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTBSCCC--------------CCHHHH----------HHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCCCCCC--------------CCHHHH----------HHHHHHHHHHHHcCCCCHH
Confidence 9999999999998877644332210 122222 2245678889999998875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 678 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-56 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-55 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-49 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 6e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-43 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-43 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-35 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 9e-60
Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 26/274 (9%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKILK---PSEDVLKEFASEIEIITALHHRNIISLFGF 394
+G G VY+G ++AVK+L P+ L+ F +E+ ++ H NI+ G+
Sbjct: 15 RIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
L +V + SL +LH + F + +A A+ +DYLH + +
Sbjct: 73 S-TAPQLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHA---KSI 125
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH---GK 511
IH+D+KS+NI L +D ++ DFGLA+ S S ++G+ ++APE
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 512 VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDY 571
S + DVYAFGIVL EL++G+ P ++ N + Q ++ L P L
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG----------RGYLSPDLS-KV 234
Query: 572 DNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605
++ + M + + RP +L ++
Sbjct: 235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-56
Identities = 59/294 (20%), Positives = 116/294 (39%), Gaps = 23/294 (7%)
Query: 329 ATSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILKPS--EDVLKEFASEIEIITALHH 385
+F +G G V++ P G +A K++ + + E++++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 386 RNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDY 445
I+ +G + D + + + + GSL++ L + KV++ V + L Y
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTY 119
Query: 446 LHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
L + ++H+DVK SNIL++ E +L DFG++ L S + GT Y++PE
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPE 173
Query: 506 YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESL---VMWAKPILKDGKVSQL 562
S + D+++ G+ L+E+ G+ PI + K E + + +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ-------INLVLKLLQGDEE 609
P D+ + ++ P P + V K L +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 6e-56
Identities = 53/269 (19%), Positives = 109/269 (40%), Gaps = 24/269 (8%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFE 397
+G G V+ G ++AVK LK F +E ++ L H+ ++ L+
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-T 78
Query: 398 DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHK 457
+ ++ +++ GSL + L G + +A +AE + ++ E+ IH+
Sbjct: 79 QEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133
Query: 458 DVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKID 517
D++++NIL+SD +++DFGLA + + + APE +G + K D
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 518 VYAFGIVLLELLSGKKPI-NSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQI 576
V++FGI+L E+++ + + +++ + L +
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY---------QLM 243
Query: 577 ERMVLAATLSISRAPTVRPQINLVLKLLQ 605
P RP + + +L+
Sbjct: 244 RLCW-------KERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 2e-55
Identities = 62/280 (22%), Positives = 115/280 (41%), Gaps = 22/280 (7%)
Query: 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIIS 390
S +G G V+ G + ++A+K ++ ++F E E++ L H ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
L+G C E + LV++F+ G L + L F + + V E + YL
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYL---E 118
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510
E VIH+D+ + N L+ ++ ++SDFG+ ++ + + +PE F
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFS 177
Query: 511 KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570
+ S K DV++FG+++ E+ S K P S + I + L P L +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKI-----PYENRSNSEVVEDISTGFR---LYKPRLAST 229
Query: 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEA 610
+ + P RP + +L+ L E+
Sbjct: 230 HVYQIMNHCW-------KERPEDRPAFSRLLRQLAEIAES 262
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-55
Identities = 68/289 (23%), Positives = 112/289 (38%), Gaps = 28/289 (9%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED 398
+GKG V+RG G+E+AVKI E+ +EI L H NI+ +D
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKD 69
Query: 399 NN----LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC---- 450
N L LV D+ GSL + L+ K+A+ A L +LH
Sbjct: 70 NGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 451 -EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL--STSSSHLTCTDVAGTFGYLAPEYF 507
+ + H+D+KS NIL+ + ++D GLA +T + + GT Y+APE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 508 ------MHGKVSEKIDVYAFGIVLLELLSGKKPINS----ENPKGQESLVMWAKPILKDG 557
H + ++ D+YA G+V E+ + P + ++
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 558 KVSQLLDPSLDTDYDNDQIERMVLA-ATLSISRAPTVRPQINLVLKLLQ 605
Q L P++ + + + R++ R + K L
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 2e-54
Identities = 64/283 (22%), Positives = 112/283 (39%), Gaps = 26/283 (9%)
Query: 328 SATSNFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILKP---SEDVLKEFASEIEIITAL 383
S ++ Y +G G + + DGK L K L +E + SE+ ++ L
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 384 HHRNIISLFGFCFE--DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE 441
H NI+ + + + L +V ++ G L + K+ +V +
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 442 ALDYLH--NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF 499
AL H + V+H+D+K +N+ L +L DFGLA L+ +S GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--AFVGTP 178
Query: 500 GYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559
Y++PE +EK D+++ G +L EL + P + + K + K +
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238
Query: 560 SQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602
S L N+ I RM ++ RP + +L+
Sbjct: 239 SDEL---------NEIITRM-------LNLKDYHRPSVEEILE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 8e-53
Identities = 53/276 (19%), Positives = 111/276 (40%), Gaps = 24/276 (8%)
Query: 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIIS 390
+ +G G V G ++A+K++K EF E +++ L H ++
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
L+G C + + ++ ++++ G L L + F + ++ V EA++YL +
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLES-- 118
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510
+ +H+D+ + N L++D ++SDFGL+ ++ + + PE M+
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYS 176
Query: 511 KVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569
K S K D++AFG+++ E+ S GK P + + + S+ +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY----- 231
Query: 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605
+ RP ++L +
Sbjct: 232 ----TIMYSCW-------HEKADERPTFKILLSNIL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (458), Expect = 2e-52
Identities = 66/304 (21%), Positives = 123/304 (40%), Gaps = 41/304 (13%)
Query: 321 FSYQELLSATSNFLPEY---------LVGKGGHSHVYRGCLPDGKEL----AVKILKP-- 365
F++++ A F E ++G G V G L + A+K LK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 366 SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGN 425
+E ++F SE I+ H N+I L G + ++++ +F+ GSL+ L N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 426 AFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485
+ + G+A + YL + +H+D+ + NIL++ + ++SDFGL+ +L
Sbjct: 127 ---VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 486 SSSHLTCTDVAG---TFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPK 541
+S T T G + APE + K + DV+++GIV+ E++S G++P +
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 542 GQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVL 601
V ++ D + + RP+ ++
Sbjct: 241 ----------------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 602 KLLQ 605
L
Sbjct: 285 NTLD 288
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 3e-52
Identities = 53/275 (19%), Positives = 112/275 (40%), Gaps = 22/275 (8%)
Query: 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIIS 390
+ E +G+G V+ G +A+K LKP + F E +++ L H ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
L+ + + +V +++S+GSL + G + +A +A + Y+
Sbjct: 77 LYAVV-SEEPIYIVTEYMSKGSLL--DFLKGETGKYLRLPQLVDMAAQIASGMAYVER-- 131
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510
+H+D++++NIL+ ++ +++DFGLA + + + APE ++G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYG 189
Query: 511 KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570
+ + K DV++FGI+L EL + + + +V ++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMV---------------NREVLDQVERGYRMP 234
Query: 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605
+ E + + P RP + L+
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 9e-52
Identities = 60/232 (25%), Positives = 98/232 (42%), Gaps = 16/232 (6%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLF 392
+GKG +VY LA+K+L + V + E+EI + L H NI+ L+
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 393 GFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
G+ + + L+ ++ G++ L K F +A AL Y H +
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCH---SK 125
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
VIH+D+K N+LL E +++DFG + +S C GT YL PE
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC----GTLDYLPPEMIEGRMH 181
Query: 513 SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564
EK+D+++ G++ E L GK P + + + + D D
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 233
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 1e-51
Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 22/234 (9%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKP----SEDVLKEFASEIEIITALHHRNIISLFG 393
+G G VY + + + +A+K + S + ++ E+ + L H N I G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
++ LV ++ + + K E V G + L YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM---HG 510
+IH+DVK+ NILLS+ +L DFG AS ++ ++S GT ++APE + G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILAMDEG 189
Query: 511 KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQ-ESLVMWAKPILKDGKVSQLL 563
+ K+DV++ GI +EL K P+ + N + P L+ G S+
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 8e-51
Identities = 60/290 (20%), Positives = 115/290 (39%), Gaps = 31/290 (10%)
Query: 324 QELLSATSNF-LPEYLVGKGGHSHVYRGCL---PDGKELAVKILKP--SEDVLKEFASEI 377
++L N + + +G G V +G ++A+K+LK + +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 378 EIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAV 437
+I+ L + I+ L G C + L+LV + G L + L G +++ + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLH 116
Query: 438 GVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD-VA 496
V+ + YL + +H+D+ + N+LL + ++SDFGL+ L S+ T
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 497 GTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILK 555
+ APE K S + DV+++G+ + E LS G+KP + + K +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 233
Query: 556 DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605
+ L + RP V + ++
Sbjct: 234 PPECPPELY---------ALMSDC-------WIYKWEDRPDFLTVEQRMR 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 9e-51
Identities = 56/229 (24%), Positives = 102/229 (44%), Gaps = 15/229 (6%)
Query: 333 FLPEY----LVGKGGHSHVYRG-CLPDGKELAVKILKP--SEDVLKEFASEIEIITALHH 385
F+ ++ +G+G + V + +AVKI+ + D + EI I L+H
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62
Query: 386 RNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDY 445
N++ +G E N L ++ S G L + + + + + + + Y
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVY 118
Query: 446 LHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
LH + H+D+K N+LL + ++SDFGLA+ ++ + GT Y+APE
Sbjct: 119 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 506 YFMHGKV-SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI 553
+ +E +DV++ GIVL +L+G+ P + + QE K
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-50
Identities = 67/269 (24%), Positives = 115/269 (42%), Gaps = 28/269 (10%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFE 397
+GKG V G G ++AVK +K ++ + F +E ++T L H N++ L G E
Sbjct: 14 TIGKGEFGDVMLGDY-RGNKVAVKCIK-NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 398 DNN-LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIH 456
+ L +V +++++GSL + L + + G K ++ V EA++YL +H
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVH 126
Query: 457 KDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKI 516
+D+ + N+L+S+D ++SDFGL S+ T + APE K S K
Sbjct: 127 RDLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKS 181
Query: 517 DVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQI 576
DV++FGI+L E+ S + P + L + K
Sbjct: 182 DVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKG------YKMDAPDGCPPAVY 230
Query: 577 ERMVLAATLSISRAPTVRPQINLVLKLLQ 605
E M +RP + + L+
Sbjct: 231 EVMKNC----WHLDAAMRPSFLQLREQLE 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-49
Identities = 60/293 (20%), Positives = 111/293 (37%), Gaps = 40/293 (13%)
Query: 338 LVGKGGHSHVYRGCL------PDGKELAVKILKPSEDV--LKEFASEIEIITAL-HHRNI 388
+G G V +AVK+LKPS + + SE+++++ L +H NI
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 389 ISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKK--------------DGNAFGWTERYK 434
++L G C L++ ++ G L L + D A +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 435 VAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD 494
+ VA+ + +L + IH+D+ + NILL+ ++ DFGLA + S+++ +
Sbjct: 150 FSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 495 VAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL 554
++APE + + + DV+++GI L EL S P
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP-------------- 252
Query: 555 KDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607
D K +++ M P RP +++L++
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-49
Identities = 63/267 (23%), Positives = 117/267 (43%), Gaps = 26/267 (9%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKE-FASEIEIITALHHRNIISLFGFC 395
+G+G VY + G+E+A++ + + KE +EI ++ + NI++
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
+ L +V ++L+ GSL + + D + V +AL++LH VI
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRECLQALEFLH---SNQVI 138
Query: 456 HKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEK 515
H+D+KS NILL D +L+DFG + ++ S + + GT ++APE K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 196
Query: 516 IDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQ 575
+D+++ GI+ +E++ G+ P +ENP + I +G L + D
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTPELQNPEKLSAIF-RDF 249
Query: 576 IERMVLAATLSISRAPTVRPQINLVLK 602
+ R + R +L+
Sbjct: 250 LNRC-------LDMDVEKRGSAKELLQ 269
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 171 bits (435), Expect = 3e-49
Identities = 60/305 (19%), Positives = 127/305 (41%), Gaps = 29/305 (9%)
Query: 322 SYQELLSATSNFLPEYLVGKGGHSHVYRGCLPD-GKELAVKILKPSEDVLKEFASEIEII 380
+Y + ++ ++ +G G + VY G +AVK LK ++EF E ++
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM 67
Query: 381 TALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVA 440
+ H N++ L G C + ++ +F++ G+L + L + + +A ++
Sbjct: 68 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQIS 125
Query: 441 EALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFG 500
A++YL ++ IH+D+ + N L+ ++ +++DFGL+ ++ +
Sbjct: 126 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIK 181
Query: 501 YLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVS 560
+ APE + K S K DV+AFG++L E+ + Q V
Sbjct: 182 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VY 226
Query: 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEAANWAKEQVSA 620
+LL+ + E++ P+ RP + + + ++ S
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET-------MFQESSI 279
Query: 621 SEELD 625
S+E++
Sbjct: 280 SDEVE 284
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 4e-49
Identities = 56/221 (25%), Positives = 109/221 (49%), Gaps = 15/221 (6%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKP-SEDVLKEFASEIEIITALHHRNIISLFGFCF 396
+G G VY+ A K++ SE+ L+++ EI+I+ + H NI+ L +
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIH 456
+NNL ++ +F + G+++ + ++ ++ V +AL+YLH + +IH
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKIIH 133
Query: 457 KDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM-----HGK 511
+D+K+ NIL + D + +L+DFG+++ + + GT ++APE M
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRP 191
Query: 512 VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552
K DV++ GI L+E+ + P + NP + ++P
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP 232
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 7e-49
Identities = 59/277 (21%), Positives = 112/277 (40%), Gaps = 30/277 (10%)
Query: 338 LVGKGGHSHVYRGCLPDGK----ELAVKILKPSEDV--LKEFASEIEIITALHHRNIISL 391
++G+G VY G L D AVK L D+ + +F +E I+ H N++SL
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 392 FGFCFE-DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
G C + + L+V ++ G L + + + + VA+ +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGLQVAKGM---KFLA 147
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS--SHLTCTDVAGTFGYLAPEYFM 508
+ +H+D+ + N +L + F +++DFGLA + S T ++A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 509 HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568
K + K DV++FG++L EL++ P P + +L+ + LL P
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRR---LLQPEYC 259
Query: 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605
D + + + +RP + ++ +
Sbjct: 260 PDPLYEVMLKCW-------HPKAEMRPSFSELVSRIS 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 1e-48
Identities = 60/288 (20%), Positives = 108/288 (37%), Gaps = 39/288 (13%)
Query: 333 FLPEYLV-------GKGGHSHVYRGCLPD---GKELAVKILKP---SEDVLKEFASEIEI 379
+L L+ G G V +G K +AVKILK + E +E +
Sbjct: 2 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 61
Query: 380 ITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGV 439
+ L + I+ + G C E + +LV + G L + L N+ ++ V
Sbjct: 62 MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQV 116
Query: 440 AEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD-VAGT 498
+ + YL +H+D+ + N+LL ++SDFGL+ L ++
Sbjct: 117 SMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 499 FGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDG 557
+ APE + K S K DV++FG+++ E S G+KP +++ + +
Sbjct: 174 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPA 233
Query: 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605
+ + D + + RP V L+
Sbjct: 234 GCPREM---------YDLMNLCW-------TYDVENRPGFAAVELRLR 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-48
Identities = 57/238 (23%), Positives = 102/238 (42%), Gaps = 12/238 (5%)
Query: 332 NFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILKP----SEDVLKEFASEIEIITALHHR 386
+F ++G+G S V L +E A+KIL+ E+ + E ++++ L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 387 NIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYL 446
+ L+ +D L + G L + + F T + AL+YL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYL 124
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY 506
H + +IH+D+K NILL++D Q++DFG A LS S GT Y++PE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 507 FMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564
+ D++A G ++ +L++G P + N ++ + + + D
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 239
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-48
Identities = 62/273 (22%), Positives = 111/273 (40%), Gaps = 33/273 (12%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGF 394
+G+G VY+G E+A L+ ++ + F E E++ L H NI+ +
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 395 CFE----DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
++LV + ++ G+L+ L K + + L +LH
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTRT 132
Query: 451 EQPVIHKDVKSSNILLSD-DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMH 509
P+IH+D+K NI ++ ++ D GLA+ S + V GT ++APE +
Sbjct: 133 -PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA----KAVIGTPEFMAPEMY-E 186
Query: 510 GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569
K E +DVYAFG+ +LE+ + + P + Q + +K ++ P +
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVKPASFDKVAIPEVK- 243
Query: 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602
+ IE I + R I +L
Sbjct: 244 ----EIIEGC-------IRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 4e-48
Identities = 58/296 (19%), Positives = 113/296 (38%), Gaps = 45/296 (15%)
Query: 338 LVGKGGHSHVYRGCLPD------GKELAVKILKPSED--VLKEFASEIEIITAL-HHRNI 388
++G G V ++AVK+LK D + SE++++T L H NI
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 389 ISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKK-------------------DGNAFGW 429
++L G C + L++++ G L L ++ D N +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 430 TERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489
+ A VA+ +++L + +H+D+ + N+L++ ++ DFGLA + + S++
Sbjct: 164 EDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMW 549
+ + ++APE G + K DV+++GI+L E+ S P
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN----- 275
Query: 550 AKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605
+L+ D E + + + RP + L
Sbjct: 276 ---------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-47
Identities = 57/284 (20%), Positives = 112/284 (39%), Gaps = 29/284 (10%)
Query: 331 SNFLPEYLVGKGGHSHVYRGCLPDGKE-----LAVKILKP--SEDVLKEFASEIEIITAL 383
S + ++G G VY+G L +A+K LK +E +F E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 384 HHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEAL 443
H NII L G + ++++ +++ G+ ++ F + + G+A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGA---LDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 444 DYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL-TCTDVAGTFGYL 502
YL N +H+D+ + NIL++ + ++SDFGL+ L T + +
Sbjct: 124 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 503 APEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562
APE + K + DV++FGIV+ E+++ + E + V +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---------------VMKA 225
Query: 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606
++ D + + RP+ ++ +L
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (424), Expect = 2e-47
Identities = 61/312 (19%), Positives = 124/312 (39%), Gaps = 46/312 (14%)
Query: 322 SYQELLSATSNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKP--SEDVLKEF 373
L +N +G+G V++ P +AVK+LK S D+ +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 374 ASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGN-------- 425
E ++ + NI+ L G C + L++++++ G L E L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 426 ------------AFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQ 473
E+ +A VA + YL E+ +H+D+ + N L+ ++ +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVK 180
Query: 474 LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKK 533
++DFGL+ + ++ + + A ++ PE + + + + DV+A+G+VL E+ S
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 534 PINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTV 593
E ++ + ++DG + + + + L S+ P
Sbjct: 241 QPYYGMA--HEEVIYY----VRDGNILACPE---------NCPLELYNLMRLCWSKLPAD 285
Query: 594 RPQINLVLKLLQ 605
RP + ++LQ
Sbjct: 286 RPSFCSIHRILQ 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 164 bits (417), Expect = 6e-46
Identities = 65/269 (24%), Positives = 108/269 (40%), Gaps = 26/269 (9%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKIL-KPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+G G V+R G A K + P E + EI+ ++ L H +++L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
+DN ++++Y+F+S G L E + + N E + V + L ++H E +
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYV 146
Query: 456 HKDVKSSNILLSDDFEPQ--LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVS 513
H D+K NI+ + + L DFGL + L S T GT + APE V
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVG 203
Query: 514 EKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDN 573
D+++ G++ LLSG P EN V + D S + + D
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF---- 259
Query: 574 DQIERMVLAATLSISRAPTVRPQINLVLK 602
I ++ + P R I+ L+
Sbjct: 260 --IRKL-------LLADPNTRMTIHQALE 279
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 4e-45
Identities = 58/293 (19%), Positives = 119/293 (40%), Gaps = 39/293 (13%)
Query: 331 SNFLPEYLVGKGGHSHVYRGCLPDGKEL---AVKILKP--SEDVLKEFASEIEIITAL-H 384
++ + ++G+G V + + A+K +K S+D ++FA E+E++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 385 HRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGN------------KKDGNAFGWTER 432
H NII+L G C L L ++ G+L + L + + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 433 YKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492
A VA +DYL ++ IH+D+ + NIL+ +++ +++DFGL+
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 493 TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552
++A E + + DV+++G++L E++S P + +
Sbjct: 187 R---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEK 238
Query: 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605
+ + ++ + L+ + D + + P RP +L L
Sbjct: 239 LPQGYRLEKPLNCDDEV---YDLMRQCW-------REKPYERPSFAQILVSLN 281
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 60/337 (17%), Positives = 134/337 (39%), Gaps = 43/337 (12%)
Query: 338 LVGKGGHSHVYRG-CLPDGKEL----AVKILKP--SEDVLKEFASEIEIITALHHRNIIS 390
++G G VY+G +P+G+++ A+K L+ S KE E ++ ++ + ++
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
L G C + + L+ + G L L ++ + G V +A+ ++YL +
Sbjct: 76 LLGIC-LTSTVQLITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-- 129
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510
+ ++H+D+ + N+L+ +++DFGLA L ++A E +H
Sbjct: 130 -RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 511 KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570
+ + DV+++G+ + EL++ P + +S +L+
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------------ISSILEKGERLP 233
Query: 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEEAANWAKEQVSASEELDSIDGE 630
+ + RP+ ++ + A + + V +E +
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF--SKMARDPQRYLVIQGDERMHL--- 288
Query: 631 ASPTNIQSHLNLALLDLDDDSVSAGSTQQIISVEDYL 667
P+ S+ AL+D +D ++ ++YL
Sbjct: 289 --PSPTDSNFYRALMDEEDMD-------DVVDADEYL 316
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 158 bits (400), Expect = 2e-44
Identities = 63/269 (23%), Positives = 117/269 (43%), Gaps = 30/269 (11%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLF 392
++G GG S V+ L +++AVK+L+ F E + AL+H I++++
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 393 GFCFEDNN----LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHN 448
+ +V +++ +L + +H +V +AL++
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFS-- 127
Query: 449 SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLT-CTDVAGTFGYLAPEYF 507
+ +IH+DVK +NI++S ++ DFG+A ++ S + +T V GT YL+PE
Sbjct: 128 -HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 508 MHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567
V + DVY+ G VL E+L+G+ P ++P + PI + L L
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG-LSADL 245
Query: 568 DTDYDNDQIERMVLAATLSISRAPTVRPQ 596
D + + +++ P R Q
Sbjct: 246 D-----AVVLKA-------LAKNPENRYQ 262
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 6e-44
Identities = 68/276 (24%), Positives = 105/276 (38%), Gaps = 30/276 (10%)
Query: 339 VGKGGHSHVYRGCLP----DGKELAVKILKP----SEDVLKEFASEIEIITALHHRNIIS 390
+G G V RG +AVK LKP + + +F E+ + +L HRN+I
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
L+G + +V + GSL L +K F + AV VAE + YL
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSL---LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE--- 128
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD-VAGTFGYLAPEYFMH 509
+ IH+D+ + N+LL+ ++ DFGL L + H + F + APE
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 510 GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569
S D + FG+ L E+ + + P + I K+G+
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGE-----RLPRPE 238
Query: 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605
D D MV + P RP + L
Sbjct: 239 DCPQDIYNVMVQC----WAHKPEDRPTFVALRDFLL 270
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 52/234 (22%), Positives = 88/234 (37%), Gaps = 12/234 (5%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCF 396
+G+G V+R K K +K EI I+ HRNI+ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIH 456
L+++++F+S + E + E V EAL +LH + H
Sbjct: 72 SMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLH---SHNIGH 125
Query: 457 KDVKSSNILLSDDFEPQ--LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSE 514
D++ NI+ + +FG A L + Y APE H VS
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQHDVVST 182
Query: 515 KIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568
D+++ G ++ LLSG P +E + +M A+ + ++ ++D
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD 236
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-43
Identities = 60/290 (20%), Positives = 117/290 (40%), Gaps = 39/290 (13%)
Query: 338 LVGKGGHSHVYRGC------LPDGKELAVKILKPS--EDVLKEFASEIEIITA-LHHRNI 388
+G+G V + +AVK+LK + SE++I+ HH N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 389 ISLFGFCFEDNN-LLLVYDFLSRGSLEENLHGNKKD------------GNAFGWTERYKV 435
++L G C + L+++ +F G+L L + + +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 436 AVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDV 495
+ VA+ +++L + IH+D+ + NILLS+ ++ DFGLA + ++ D
Sbjct: 140 SFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 496 AGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILK 555
++APE + + DV++FG++L E+ S P + LK
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRLK 251
Query: 556 DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605
+G + DY ++ + +L P+ RP + +++ L
Sbjct: 252 EGTRMRAP------DYTTPEMYQTMLDC---WHGEPSQRPTFSELVEHLG 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 52/239 (21%), Positives = 102/239 (42%), Gaps = 15/239 (6%)
Query: 332 NFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILKPS----EDVLKEFASEIEIIT-ALHH 385
+F+ ++GKG V+ + A+K LK +D ++ E +++ A H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 386 RNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDY 445
+ +F NL V ++L+ G L ++ K F + A + L +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQF 118
Query: 446 LHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
L + ++++D+K NILL D +++DFG+ + GT Y+APE
Sbjct: 119 L---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDYIAPE 173
Query: 506 YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564
+ K + +D ++FG++L E+L G+ P + ++ + + P + D
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 232
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 157 bits (397), Expect = 4e-43
Identities = 62/278 (22%), Positives = 104/278 (37%), Gaps = 28/278 (10%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKIL-KPSEDVLKEFASEIEIITALHHRNIISLFGFC 395
+G G V+R G+ K + P +EI I+ LHH +I+L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
+ ++L+ +FLS G L + + + E E L ++H E ++
Sbjct: 96 EDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149
Query: 456 HKDVKSSNILLSDDFEPQ--LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVS 513
H D+K NI+ + DFGLA+ L+ T T + APE V
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVG 206
Query: 514 EKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDN 573
D++A G++ LLSG P E+ V + S + + D
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF---- 262
Query: 574 DQIERMVLAATLSISRAPTVRPQINLVLK--LLQGDEE 609
I+ + + + P R ++ L+ L+GD
Sbjct: 263 --IKNL-------LQKEPRKRLTVHDALEHPWLKGDHS 291
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (389), Expect = 1e-42
Identities = 56/268 (20%), Positives = 100/268 (37%), Gaps = 23/268 (8%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGF 394
++G G S V K +A+K + E +EI ++ + H NI++L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
+L L+ +S G L + + + + ++ V +A+ YLH+
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSE 514
K L +D + +SDFGL+ S + GT GY+APE S+
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSK 188
Query: 515 KIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDND 574
+D ++ G++ LL G P EN ++ A+ + D + D
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF----- 243
Query: 575 QIERMVLAATLSISRAPTVRPQINLVLK 602
I + + + P R L+
Sbjct: 244 -IRHL-------MEKDPEKRFTCEQALQ 263
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 1e-42
Identities = 51/275 (18%), Positives = 106/275 (38%), Gaps = 31/275 (11%)
Query: 338 LVGKGGHSHVYRGCLPDGKE----LAVKILKP--SEDVLKEFASEIEIITALHHRNIISL 391
+G+G V++G + +A+K K S+ V ++F E + H +I+ L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 392 FGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCE 451
G +N + ++ + + G L + + A ++ AL YL
Sbjct: 74 IGVI-TENPVWIIMELCTLGEL---RSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 126
Query: 452 QPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGK 511
+ +H+D+ + N+L+S + +L DFGL+ ++ S+ + + ++APE +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRR 185
Query: 512 VSEKIDVYAFGIVLLELL-SGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570
+ DV+ FG+ + E+L G KP + + + L
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY------ 239
Query: 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605
+ + + P+ RP+ + L
Sbjct: 240 ---SLMTKC-------WAYDPSRRPRFTELKAQLS 264
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (386), Expect = 2e-42
Identities = 64/255 (25%), Positives = 109/255 (42%), Gaps = 28/255 (10%)
Query: 332 NFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILKPS----------EDVLKEFASEIEII 380
N+ P+ ++G+G S V R P KE AVKI+ + +++ + E++I+
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 381 TALH-HRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGV 439
+ H NII L + LV+D + +G L + L E K+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRAL 119
Query: 440 AEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTF 499
E + LH + ++H+D+K NILL DD +L+DFG + L +V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 500 GYLAPEYFM------HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI 553
YLAPE H +++D+++ G+++ LL+G P ++M
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 554 LKDGKVSQLLDPSLD 568
+ D D
Sbjct: 234 FGSPEWDDYSDTVKD 248
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 3e-42
Identities = 53/311 (17%), Positives = 118/311 (37%), Gaps = 34/311 (10%)
Query: 314 YSSTCRLFSYQELLSATSNFLPEYLVGKGGHSHVYRGCL------PDGKELAVKILKP-- 365
Y S ++ E A +G+G VY G +A+K +
Sbjct: 3 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 62
Query: 366 SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDG- 424
S EF +E ++ + +++ L G + L++ + ++RG L+ L +
Sbjct: 63 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122
Query: 425 -----NAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479
++ ++A +A+ + YL +H+D+ + N ++++DF ++ DFG+
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGM 179
Query: 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKK-PINSE 538
+ + + +++PE G + DV++FG+VL E+ + + P
Sbjct: 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239
Query: 539 NPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQIN 598
+ + VM + K +L + + P +RP
Sbjct: 240 SNEQVLRFVMEGGLLDKPDNCPDMLF---------ELMRMCW-------QYNPKMRPSFL 283
Query: 599 LVLKLLQGDEE 609
++ ++ + E
Sbjct: 284 EIISSIKEEME 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 153 bits (388), Expect = 7e-42
Identities = 52/230 (22%), Positives = 92/230 (40%), Gaps = 20/230 (8%)
Query: 332 NFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILKPS-------EDVLKEFASEIEIITAL 383
+F ++G+GG VY GK A+K L E + + +++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 384 HHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEAL 443
I+ + + L + D ++ G L +L + F + A + L
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGL 120
Query: 444 DYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLA 503
+++H + V+++D+K +NILL + ++SD GLA S H + GT GY+A
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMA 173
Query: 504 PEYFMHGK-VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552
PE G D ++ G +L +LL G P K + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-41
Identities = 64/291 (21%), Positives = 122/291 (41%), Gaps = 41/291 (14%)
Query: 338 LVGKGGHSHVYRGCLP--------DGKELAVKILKP--SEDVLKEFASEIEIITAL-HHR 386
+G+G V ++AVK+LK +E L + SE+E++ + H+
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 387 NIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDG------------NAFGWTERYK 434
NII+L G C +D L ++ ++ S+G+L E L + G +
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 435 VAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTD 494
A VA ++YL + IH+D+ + N+L+++D +++DFGLA + + T+
Sbjct: 140 CAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 495 VAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL 554
++APE + + DV++FG++L E+ + P V +L
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEELFKLL 250
Query: 555 KDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605
K+G D ++ + + P+ RP +++ L
Sbjct: 251 KEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 148 bits (374), Expect = 2e-40
Identities = 49/227 (21%), Positives = 96/227 (42%), Gaps = 17/227 (7%)
Query: 331 SNFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILKPS----EDVLKEFASEIEIITALHH 385
+F +G G V+ +G+ A+K+LK ++ E +++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 386 RNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDY 445
II ++G + + ++ D++ G L L ++ AE
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-------RFPNPVAKFYAAEVCLA 116
Query: 446 LHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
L + +I++D+K NILL + +++DFG A ++ + GT Y+APE
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPE 171
Query: 506 YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552
++ ID ++FGI++ E+L+G P N ++ A+
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 218
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 7e-40
Identities = 55/279 (19%), Positives = 109/279 (39%), Gaps = 25/279 (8%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPS------EDVLKEFASEIEIITALHHRNIIS 390
+G+G + VY+ + +A+K +K + + + EI+++ L H NII
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 391 LFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC 450
L +N+ LV+DF+ + + + + L+YLH
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLV----LTPSHIKAYMLMTLQGLEYLH--- 117
Query: 451 EQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG 510
+ ++H+D+K +N+LL ++ +L+DFGLA S + T T Y APE
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 511 KV-SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569
++ +D++A G +L ELL + ++ Q + + + + + D
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIF-------ETLGTPTEEQWPDM 228
Query: 570 DYDNDQIERMVLAATLSISRAPTVRPQ-INLVLKLLQGD 607
D + ++L+ L +
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 142 bits (359), Expect = 1e-38
Identities = 52/272 (19%), Positives = 104/272 (38%), Gaps = 16/272 (5%)
Query: 339 VGKGGHSHVYRGCLPDGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFC 395
+G+G + VY+ G+ A+K ++ E + EI I+ L H NI+ L+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
L+LV++ L + + + + + Y H ++ V+
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLNGIAYCH---DRRVL 122
Query: 456 HKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEK 515
H+D+K N+L++ + E +++DFGLA ++ + K S
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 516 IDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQ 575
ID+++ G + E+++G + Q + IL + + YD +
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR---ILGTPNSKNWPNVTELPKYDPNF 238
Query: 576 IERMVLAATLSISRAPTVRPQINLVLKLLQGD 607
L + I+L+ K+L+ D
Sbjct: 239 TVYEPLPWESFLKGLD--ESGIDLLSKMLKLD 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-38
Identities = 56/281 (19%), Positives = 109/281 (38%), Gaps = 18/281 (6%)
Query: 332 NFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILKP---SEDVLKEFASEIEIITALHHRN 387
NF +G+G + VY+ G+ +A+K ++ +E V EI ++ L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 388 IISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH 447
I+ L +N L LV++FL + + + + + L +
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQLLQGLAFC- 118
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE-Y 506
V+H+D+K N+L++ + +L+DFGLA T T Y APE
Sbjct: 119 --HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEIL 174
Query: 507 FMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566
S +D+++ G + E+++ + ++ Q + G +++ P
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ-----LFRIFRTLGTPDEVVWPG 229
Query: 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607
+ + D S P +L+ ++L D
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYD 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 5e-38
Identities = 61/335 (18%), Positives = 131/335 (39%), Gaps = 22/335 (6%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPSED--VLKEFASEIEIITALHHRNIISLFGF 394
+G+G + V + +A+K + P E + EI+I+ H NII +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
+ +L + +L+ K + + L Y+H V
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIH---SANV 130
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL-TCTDVAGTFGYLAPEYFMHGKV- 512
+H+D+K SN+LL+ + ++ DFGLA H T+ T Y APE ++ K
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 513 SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYD 572
++ ID+++ G +L E+LS + ++ Q + ++ ++ +++
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250
Query: 573 NDQIERMVLAATLSISRAPTVRPQ-INLVLKLLQGDEEAANWAKEQVSASEELDS--IDG 629
+ + V L P + ++L+ K+L + +++ + L ++
Sbjct: 251 SLPHKNKVPWNRLF----PNADSKALDLLDKMLTFN------PHKRIEVEQALAHPYLEQ 300
Query: 630 EASPTNIQSHLNLALLDLDDDSVSAGSTQQIISVE 664
P++ D++ D + +++I E
Sbjct: 301 YYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEE 335
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (355), Expect = 5e-38
Identities = 47/277 (16%), Positives = 94/277 (33%), Gaps = 25/277 (9%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCF 396
+G G +Y G + G+E+A+K+ + E +I + I +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-PQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 397 EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIH 456
+ + ++ L SL F +A + ++Y+H + IH
Sbjct: 73 AEGDYNVMVMELLGPSL---EDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 457 KDVKSSNILLSD---DFEPQLSDFGLASWLSTSSSHLTC-----TDVAGTFGYLAPEYFM 508
+DVK N L+ + DFGLA + +H ++ GT Y + +
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 509 HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568
+ S + D+ + G VL+ G P + K ++L
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-KMSTPIEVLCKGYP 245
Query: 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605
+++ + S +P + + +L +
Sbjct: 246 SEF-ATYLNFC-------RSLRFDDKPDYSYLRQLFR 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 53/277 (19%), Positives = 106/277 (38%), Gaps = 35/277 (12%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPS-------EDVLKEFASEIEIITALHHRNII 389
+G G + V + G + A K +K ++ E+ I+ + H N+I
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 390 SLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS 449
+L +++L+ + ++ G L + L + E + + + +
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGV---YYL 129
Query: 450 CEQPVIHKDVKSSNILLSDDFEPQ----LSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
+ H D+K NI+L D P+ + DFGLA + + ++ GT ++APE
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186
Query: 506 YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565
+ + + D+++ G++ LLSG P + + + V +D S
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602
+ D I R+ + + P R I L+
Sbjct: 247 AKDF------IRRL-------LVKDPKKRMTIQDSLQ 270
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-37
Identities = 56/284 (19%), Positives = 108/284 (38%), Gaps = 22/284 (7%)
Query: 332 NFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIIS 390
++ ++G G VY+ G+ +A+K + + + E++I+ L H NI+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVR 77
Query: 391 LFGFCFE------DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALD 444
L F + + L LV D++ H ++ + +L
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-TLPVIYVKLYMYQLFRSLA 136
Query: 445 YLHNSCEQPVIHKDVKSSNILL-SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLA 503
Y+H + H+D+K N+LL D +L DFG A L + + + +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRYYRAP 191
Query: 504 PEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563
F + IDV++ G VL ELL G+ ++ Q ++ G ++
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL-----GTPTREQ 246
Query: 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607
++ +Y + ++ + R T I L +LL+
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT 290
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-37
Identities = 55/284 (19%), Positives = 114/284 (40%), Gaps = 24/284 (8%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGF 394
+G+G V++ G+++A+K + E EI+I+ L H N+++L
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 395 CFE--------DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYL 446
C ++ LV+DF + K + +R + L+ L
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS--EIKRV-----MQMLLNGL 130
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS--SSHLTCTDVAGTFGYLAP 504
+ ++H+D+K++N+L++ D +L+DFGLA S + S T+ T Y P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 505 EYFMHGK-VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563
E + + ID++ G ++ E+ + + + Q +L+ + +
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 250
Query: 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607
+ L + + ++ + L ++L+ KLL D
Sbjct: 251 NYELYEKLELVKGQKRKVKDRLKAYVRDPY--ALDLIDKLLVLD 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 138 bits (347), Expect = 5e-37
Identities = 44/280 (15%), Positives = 94/280 (33%), Gaps = 29/280 (10%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFC 395
+G+G ++ G L + +++A+K D + E L I +++ F
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-PQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 396 FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVI 455
E + +LV D L G F A + + +H E+ ++
Sbjct: 71 QEGLHNVLVIDLLGPS----LEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123
Query: 456 HKDVKSSNILLSDDFEPQ-----LSDFGLASWLSTSSSH-----LTCTDVAGTFGYLAPE 505
++D+K N L+ + DFG+ + + +++GT Y++
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 506 YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565
+ + S + D+ A G V + L G P + + + +L
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605
++ + + A + A P + + L
Sbjct: 244 F------PEEFYKYMHYA---RNLAFDATPDYDYLQGLFS 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 6e-37
Identities = 51/270 (18%), Positives = 98/270 (36%), Gaps = 22/270 (8%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFC- 395
++G G + V + ++ A+K+L+ +E +I+ +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA---SQCPHIVRIVDVYE 75
Query: 396 ---FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQ 452
LL+V + L G L + + AF E ++ + EA+ YLH
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLH---SI 130
Query: 453 PVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV 512
+ H+DVK N+L + + + ++SH + T T Y+APE K
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190
Query: 513 SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYD 572
+ D+++ G+++ LL G P S + S M + + + + +
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGMKTRIRMGQYEFPNPEWSEVSEEV- 248
Query: 573 NDQIERMVLAATLSISRAPTVRPQINLVLK 602
I + + PT R I +
Sbjct: 249 KMLIRNL-------LKTEPTQRMTITEFMN 271
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 7e-37
Identities = 52/282 (18%), Positives = 107/282 (37%), Gaps = 29/282 (10%)
Query: 339 VGKGGHSHVYRG--CLPDGKELAVKILKPS---EDVLKEFASEIEIITAL---HHRNIIS 390
+G+G + V++ G+ +A+K ++ E + E+ ++ L H N++
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 391 LFGFCF-----EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDY 445
LF C + L LV++ + + + +K + + LD+
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 446 LHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPE 505
LH V+H+D+K NIL++ + +L+DFGLA S + T V T Y APE
Sbjct: 132 LH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 185
Query: 506 YFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565
+ + +D+++ G + E+ K + Q ++ + + + +
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607
+ + +L+LK L +
Sbjct: 246 PRQAFHSKSAQPIEKFVTDID-------ELGKDLLLKCLTFN 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-36
Identities = 49/238 (20%), Positives = 98/238 (41%), Gaps = 14/238 (5%)
Query: 332 NFLPEYLVGKGGHSHVYRG-CLPDGKELAVKILKP----SEDVLKEFASEIEIITALHHR 386
+F L+GKG V G+ A+KIL+ ++D + +E ++ H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 387 NIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYL 446
+ +L + L V ++ + G L +L +TE + AE + L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE------RVFTEE-RARFYGAEIVSAL 118
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY 506
+ V+++D+K N++L D +++DFGL + + + GT YLAPE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176
Query: 507 FMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564
+D + G+V+ E++ G+ P +++ + L++ + +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKS 234
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-35
Identities = 44/215 (20%), Positives = 83/215 (38%), Gaps = 22/215 (10%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPSE-------DVLKEFASEIEIITALH--HRN 387
L+G GG VY G + D +A+K ++ E+ ++ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 388 IISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH 447
+I L + ++ +L+ + + + A V EA+ +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHC- 126
Query: 448 NSCEQPVIHKDVKSSNILLS-DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEY 506
V+H+D+K NIL+ + E +L DFG + L + TD GT Y PE+
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEW 180
Query: 507 FMHGKV-SEKIDVYAFGIVLLELLSGKKPINSENP 540
+ + V++ GI+L +++ G P +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 2e-35
Identities = 61/297 (20%), Positives = 111/297 (37%), Gaps = 22/297 (7%)
Query: 321 FSYQELLSATSNFLPEY----LVGKGGHSHVYRG-CLPDGKELAVKILKP---SEDVLKE 372
F QE+ Y VG G + V G ++A+K L SE K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 373 FASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER 432
E+ ++ + H N+I L D L DF G G
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 433 YKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492
+ + + L Y+H +IH+D+K N+ +++D E ++ DFGLA + +
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---- 176
Query: 493 TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552
V + + ++ +D+++ G ++ E+++GK + Q +M
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 553 ILKDGKVSQL-LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ-INLVLKLLQGD 607
V +L D + + ++E+ A+ L P +NL+ K+L D
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL-----TNASPLAVNLLEKMLVLD 288
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-34
Identities = 52/273 (19%), Positives = 104/273 (38%), Gaps = 16/273 (5%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGF 394
+G+G + V++ + +A+K ++ E V EI ++ L H+NI+ L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPV 454
D L LV++F + + N + + L + H+ + V
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGD----LDPEIVKSFLFQLLKGLGFCHS---RNV 122
Query: 455 IHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSE 514
+H+D+K N+L++ + E +L++FGLA + V + F S
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLYST 181
Query: 515 KIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDND 574
ID+++ G + EL + +P+ G + + G ++ PS+ D
Sbjct: 182 SIDMWSAGCIFAELANAGRPL----FPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 575 QIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607
+L +L+ LL+ +
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCN 270
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (332), Expect = 2e-34
Identities = 46/223 (20%), Positives = 92/223 (41%), Gaps = 17/223 (7%)
Query: 339 VGKGGHSHVYRG-CLPDGKELAVKILKP----SEDVLKEFASEIEIITALHHRNIISLFG 393
+G G V G A+KIL ++ +E I+ A++ ++ L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 394 FCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
+++NL +V ++++ G + +L + F A + +YLH
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLH---SLD 161
Query: 454 VIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVS 513
+I++D+K N+L+ Q++DFG A + GT LAPE + +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 514 EKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKD 556
+ +D +A G+++ E+ +G P ++ P ++ K
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS 259
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 2e-31
Identities = 51/229 (22%), Positives = 101/229 (44%), Gaps = 20/229 (8%)
Query: 332 NFLPEYLVGKGGHSHVYRG----CLPDGKELAVKILKPS-----EDVLKEFASEIEIITA 382
NF ++G G + V+ GK A+K+LK + + +E +++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 383 L-HHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAE 441
+ +++L + L L+ D+++ G L +L ++ F E +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVL 140
Query: 442 ALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGY 501
AL++LH + +I++D+K NILL + L+DFGL+ + GT Y
Sbjct: 141 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEY 196
Query: 502 LAPEYFMHGK--VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVM 548
+AP+ G + +D ++ G+++ ELL+G P + K ++ +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 245
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (304), Expect = 7e-31
Identities = 53/280 (18%), Positives = 114/280 (40%), Gaps = 25/280 (8%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFC 395
+G+G +S V+ + + +++ VKILKP + K+ EI+I+ L NII+L
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIV 99
Query: 396 FE--DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP 453
+ LV++ ++ ++ + + +ALDY H
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCH---SMG 149
Query: 454 VIHKDVKSSNILL-SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFM-HGK 511
++H+DVK N+++ + + +L D+GLA + + + PE + +
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQM 206
Query: 512 VSEKIDVYAFGIVLLELLSGKKPI-NSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570
+D+++ G +L ++ K+P + + Q + + LD
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 571 YDN--DQIERMVLAATLSISRAPTVRPQ-INLVLKLLQGD 607
+++ + R + V P+ ++ + KLL+ D
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 5e-30
Identities = 57/297 (19%), Positives = 105/297 (35%), Gaps = 22/297 (7%)
Query: 321 FSYQELLSATSNFLPEY----LVGKGGHSHVYRG-CLPDGKELAVKILKP---SEDVLKE 372
F QEL Y VG G + V G +AVK L S K
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 373 FASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTER 432
E+ ++ + H N+I L +L D L N
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 123
Query: 433 YKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTC 492
+ + L Y+H +IH+D+K SN+ +++D E ++ DFGLA +
Sbjct: 124 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA 180
Query: 493 TDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552
T + ++ +D+++ G ++ ELL+G+ + Q L++
Sbjct: 181 T----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL-- 234
Query: 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ--INLVLKLLQGD 607
G L + ++ + I+ + ++ + ++L+ K+L D
Sbjct: 235 ---VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 288
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 54/288 (18%), Positives = 105/288 (36%), Gaps = 31/288 (10%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFG 393
+G G V + +A+K L ++ K E+ ++ ++H+NIISL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 394 FCF------EDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLH 447
E ++ LV + + + + + + +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHLH 136
Query: 448 NSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYF 507
++ +IH+D+K SNI++ D ++ DFGLA TS T T Y APE
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVI 190
Query: 508 MHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSL 567
+ E +D+++ G ++ E++ K + Q + V+ + +L
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250
Query: 568 DTDYDNDQIERMVLAATLSISRAPTVRPQ--------INLVLKLLQGD 607
+ + + + S P +L+ K+L D
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 3e-28
Identities = 51/298 (17%), Positives = 106/298 (35%), Gaps = 30/298 (10%)
Query: 338 LVGKGGHSHVYRG-CLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFC- 395
+G G S V+ + + +A+KI++ + + EI+++ ++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 396 ---------FEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERY--KVAVGVAEALD 444
F V+ + L ENL K G Y +++ + LD
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 445 YLHNSCEQPVIHKDVKSSNILL-SDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLA 503
Y+H +IH D+K N+L+ D L +A + T+ T Y +
Sbjct: 140 YMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 504 PEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKG-----------QESLVMWAKP 552
PE + D+++ ++ EL++G + E L
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257
Query: 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLS--ISRAPTVRPQ-INLVLKLLQGD 607
+L++GK ++ S + +++ L L+ + + + + +LQ D
Sbjct: 258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.2 bits (197), Expect = 6e-18
Identities = 24/154 (15%), Positives = 45/154 (29%), Gaps = 22/154 (14%)
Query: 338 LVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLK-----------EFASEIEIITALHHR 386
L+G+G S V+ E VK K K F+ R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 387 NIISLFGFCFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYL 446
+ L G Y + L E + + + + E +
Sbjct: 67 ALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEV--LDMILEEVAKF 119
Query: 447 HNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480
++ ++H D+ N+L+ + + DF +
Sbjct: 120 YHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQS 149
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 678 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.84 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.76 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.74 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 99.69 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 99.67 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 99.47 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.45 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.0 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.35 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.28 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.54 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.34 | |
| d1wy5a1 | 216 | TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId | 93.18 | |
| d1ni5a1 | 227 | tRNA-Ile-lysidine synthetase, TilS, N-terminal dom | 90.23 | |
| d2c5sa1 | 218 | Thiamine biosynthesis protein ThiI, C-terminal dom | 85.64 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-51 Score=418.20 Aligned_cols=256 Identities=23% Similarity=0.410 Sum_probs=200.7
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|...+.||+|+||+||+|.+.+++.||||+++......++|.+|++++++++||||++++|+|.+.+..++||||+++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 46788899999999999999998889999999987665567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++... ...++|..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 85 g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 85 GCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999998753 3568999999999999999999999 999999999999999999999999999998775543322
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcC-CCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSG-KKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
.....||+.|+|||++.++.++.++|||||||+||||+|+ ++||...........+. .+ .....|
T Consensus 159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~-------~~--~~~~~p---- 224 (263)
T d1sm2a_ 159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-------TG--FRLYKP---- 224 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH-------HT--CCCCCC----
T ss_pred -ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------hc--CCCCCc----
Confidence 2346799999999999999999999999999999999995 55554433211111111 11 001111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCHh
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEE 609 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~~ 609 (678)
......+..++..||+.+|.+||||.+|++.|+...+
T Consensus 225 ---~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 ---RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1122456778899999999999999999999986543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=418.03 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=203.8
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.++|...+.||+|+||+||+|... +|+.||||+++... +..+.|.+|++++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357888999999999999999875 79999999986543 445678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+|+.+...
T Consensus 84 y~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99999999998643 569999999999999999999999 99999999999999999999999999999987654
Q ss_pred CCCceecccccCCCCCCcchhccCCC-CccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
......+..+||+.|+|||++.+..+ +.++|||||||+||||+||+.||........... .+. ......
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-~~~----~~~~~~----- 226 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DWK----EKKTYL----- 226 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-HHH----TTCTTS-----
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-HHh----cCCCCC-----
Confidence 44334455789999999999988876 5789999999999999999999976543222111 110 000000
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.........+..++..||+.||.+|||+.++++
T Consensus 227 ----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000111234556779999999999999999865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-50 Score=423.54 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=195.4
Q ss_pred CCCCceeecccCceEEEEEEeC-CCC---EEEEEEeCC--ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGK---ELAVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~---~vAvK~l~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
+|...++||+|+||+||+|... +|+ .||||.+.. .....+.|.+|+++|++++|||||+++|+|.+.+.+++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 4555689999999999999864 332 689998865 3466788999999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ...++|.+++.++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+++.+..
T Consensus 107 Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp ECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999988743 3569999999999999999999999 9999999999999999999999999999998765
Q ss_pred CCCCce---ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 486 SSSHLT---CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 486 ~~~~~~---~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
...... .....||+.|+|||++.++.++.++|||||||+||||+| |+.||...........+ ..+.
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i-------~~~~--- 250 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-------EQDY--- 250 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------HTTC---
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH-------HcCC---
Confidence 433222 223467999999999999999999999999999999998 89999865543211111 1110
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
....+.+....+..++..||+.+|.+||+|.+|++.|+..
T Consensus 251 ------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 251 ------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred ------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 0111222334577788999999999999999999998643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=416.58 Aligned_cols=257 Identities=28% Similarity=0.453 Sum_probs=201.4
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|+||+||+|.++ ..||||+++. +....+.|.+|+.++++++|||||++++++.+ +.+++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 57888999999999999999864 3599999864 34567889999999999999999999999855 568999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+++|+|.+++... +..+++..+..++.||+.||+|||+ ++||||||||+||||+.++.+||+|||+|+......
T Consensus 85 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 85 CEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred CCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999743 2469999999999999999999999 999999999999999999999999999998876654
Q ss_pred CCceecccccCCCCCCcchhcc---CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMH---GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
.........||+.|+|||++.+ +.++.++|||||||+||||+||+.||............ +..+. ..
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~------~~~~~----~~ 228 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM------VGRGY----LS 228 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------HHHTS----CC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH------HhcCC----CC
Confidence 4444556789999999999964 45899999999999999999999999865443221111 11111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
|.+. .......+.+..++..||+.+|.+||||.+|++.|+..
T Consensus 229 p~~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 229 PDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp CCGG-GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccch-hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1110 01112234567778999999999999999999998743
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=417.83 Aligned_cols=253 Identities=22% Similarity=0.375 Sum_probs=205.9
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|...+.||+|+||.||+|.+++++.||||+++......+.|.+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCC
Confidence 4677788999999999999999888999999998766556789999999999999999999998855 567999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++.... ...++|..++.|+.||+.||.|||+ ++|+||||||+||||++++.+||+|||+|+.+......
T Consensus 92 g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~- 165 (272)
T d1qpca_ 92 GSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 165 (272)
T ss_dssp CBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred CcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc-
Confidence 99999876432 2468999999999999999999999 99999999999999999999999999999987654322
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCC-CCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPIN-SENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~-~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
......||+.|+|||++.++.++.++|||||||+||||+||..|+. ...... +... +..+ ..+....
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~---~~~~----i~~~-----~~~~~p~ 233 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQN----LERG-----YRMVRPD 233 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHH----HHTT-----CCCCCCT
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHhc-----CCCCCcc
Confidence 2334679999999999999999999999999999999999665544 332211 1111 1111 1111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
. ....+..++..||+.+|.+||||.+|++.|+.
T Consensus 234 ~----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 234 N----CPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred c----ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 2 22456778899999999999999999999863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-50 Score=420.61 Aligned_cols=256 Identities=21% Similarity=0.347 Sum_probs=211.1
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLS 409 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 409 (678)
++|...+.||+|+||+||+|.+. +|+.||||+++.+....++|.+|+.++++++|||||+++++|.+++.+++||||++
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 96 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeeccc
Confidence 46777889999999999999875 68899999998766566789999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+|+|.+++.... ...++|..++.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+|+.......
T Consensus 97 ~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~- 170 (287)
T d1opja_ 97 YGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 170 (287)
T ss_dssp TCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-
T ss_pred CcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCc-
Confidence 999999997542 3678999999999999999999999 9999999999999999999999999999997765433
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
...+...||+.|+|||++.++.++.++|||||||++|||++|..||........ +.. .+..+ ...
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~----~i~~~---------~~~ 235 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYE----LLEKD---------YRM 235 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH----HHHTT---------CCC
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHH----HHhcC---------CCC
Confidence 233456789999999999999999999999999999999997776644322111 111 11111 111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.........+..++..||+.||.+||||.+|++.|+..
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11122234577788999999999999999999988643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-50 Score=412.17 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=195.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFE--DNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~lV 404 (678)
++|...+.||+|+||+||+|... +|+.||||+++.. +...+.|.+|++++++++||||+++++++.+ ++.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57888999999999999999864 7999999998653 3556779999999999999999999999965 4568999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC--EQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
|||+++|+|.+++......+..+++..++.++.|++.||.|||+.. ..+||||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998765444568999999999999999999999822 13499999999999999999999999999998
Q ss_pred cCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
+...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+....... +..+.+..
T Consensus 164 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~-------i~~~~~~~- 233 (269)
T d2java1 164 LNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-------IREGKFRR- 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-------HHHTCCCC-
T ss_pred cccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHH-------HHcCCCCC-
Confidence 7653322 2347899999999999999999999999999999999999999976543321111 11111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+...++ ..+..++..||+.||.+|||+.|+++
T Consensus 234 ----~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ----IPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ----CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112222 34667789999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=407.75 Aligned_cols=244 Identities=26% Similarity=0.419 Sum_probs=204.7
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||+||+|... +|+.||||++.... .....+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999875 78999999986432 33567889999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999999753 468999999999999999999999 9999999999999999999999999999987654
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
.. .....||+.|+|||++.+..++.++|||||||+||||++|+.||...+.......+. .+. +
T Consensus 159 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~-------~~~------~ 221 (263)
T d2j4za1 159 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS-------RVE------F 221 (263)
T ss_dssp CC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-------TTC------C
T ss_pred Cc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCC------C
Confidence 32 234689999999999999999999999999999999999999997655432211111 111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.... .+.+..++..||+.||.+|||+.|+++
T Consensus 222 ~~p~~~----s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 TFPDFV----TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCccC----CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111112 234566779999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=402.78 Aligned_cols=252 Identities=22% Similarity=0.401 Sum_probs=212.9
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|...+.||+|+||+||+|..++++.||||+++.+....++|.+|+.++++++||||++++|+|.+.+.+++||||+++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 68889999999999999999998888999999987665567899999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|..++... ...+++..+++++.|+++||.|||+ ++|+||||||+|||+++++.+||+|||+++........
T Consensus 84 g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 84 GCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp EEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence 9999997643 2568999999999999999999999 99999999999999999999999999999876654333
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDT 569 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~ 569 (678)
......||+.|+|||.+.++.++.++|||||||++|||+| |+.||...+.......+ ..+. .+..|.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-------~~~~--~~~~p~--- 224 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-------AQGL--RLYRPH--- 224 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-------HTTC--CCCCCT---
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH-------HhCC--CCCCcc---
Confidence 2334679999999999999999999999999999999998 89999876543221111 1111 111111
Q ss_pred CCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 570 DYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 570 ~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
.....+..++..||+.+|.+|||+.+|++.|.
T Consensus 225 ----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 225 ----LASEKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp ----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ----cccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 12245677889999999999999999999885
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=418.62 Aligned_cols=257 Identities=23% Similarity=0.403 Sum_probs=208.4
Q ss_pred cCCCCceeecccCceEEEEEEeCC------CCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPD------GKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~------g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 401 (678)
++|...+.||+|+||+||+|.... ...||||++... ......|.+|+.++.++ +|||||+++++|.+.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 467888999999999999998542 236999998653 34557789999999998 899999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCC
Q 041755 402 LLVYDFLSRGSLEENLHGNKK-------------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSS 462 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~-------------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~ 462 (678)
++||||+++|+|.++|..... ....++|..++.++.||+.||.|||+ ++||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 999999999999999976432 12468999999999999999999999 99999999999
Q ss_pred CeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCc
Q 041755 463 NILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPK 541 (678)
Q Consensus 463 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~ 541 (678)
|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||+||||+| |+.||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999998777666555556789999999999999999999999999999999998 89999765432
Q ss_pred ccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 542 GQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 542 ~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
.. +.. ++..+ .....+......+..++..||+.+|.+|||+.+|++.|.
T Consensus 274 ~~--~~~----~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 AN--FYK----LIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HH--HHH----HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH--HHH----HHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 111 11111 011111122345777889999999999999999999984
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-49 Score=408.91 Aligned_cols=248 Identities=24% Similarity=0.388 Sum_probs=205.3
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
++|...+.||+|+||+||+|... +|+.||||+++... ...+.+.+|++++++++||||+++++++.+.+.+|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999864 79999999986433 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++|+|.+++.. ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 99999998764 358999999999999999999999 9999999999999999999999999999998755433
Q ss_pred CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
. ....+||+.|+|||++.++.++.++|||||||++|||+||+.||...+.......+ ...+. +.+
T Consensus 172 ~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~------~~~~~------~~~- 236 (293)
T d1yhwa1 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGT------PEL- 236 (293)
T ss_dssp C--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHCS------CCC-
T ss_pred c--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH------HhCCC------CCC-
Confidence 2 23468999999999999999999999999999999999999999765432211111 11110 000
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.........+..++..||+.||.+|||+.|+++
T Consensus 237 -~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 -QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011112344667789999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=407.92 Aligned_cols=257 Identities=23% Similarity=0.367 Sum_probs=199.7
Q ss_pred cCCCCceeecccCceEEEEEEeCCC-----CEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDG-----KELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g-----~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
+.|...++||+|+||.||+|.+.++ ..||||+++.. .....+|.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4677889999999999999986532 37999999653 4556789999999999999999999999999999999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
||||+.+|+|.+.+... ...++|.++..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+
T Consensus 87 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999988643 2579999999999999999999999 99999999999999999999999999999987
Q ss_pred CCCCCC-ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSH-LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
...... .......||+.|+|||++.++.++.++|||||||+||||++|..|+....... .+.. .+..+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~~~----~i~~~----- 229 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMK----AINDG----- 229 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH----HHHTT-----
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HHHH----HHhcc-----
Confidence 554322 22334578999999999999999999999999999999999766654332211 1111 11111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
.....+.+....+..++.+||+.+|.+||+|.+|++.|+...
T Consensus 230 ----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 230 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 111122223456778889999999999999999999987543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-49 Score=407.58 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=205.2
Q ss_pred cCCCCcee-ecccCceEEEEEEeC---CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYL-VGKGGHSHVYRGCLP---DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~-IG~G~~g~Vy~g~~~---~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|....+ ||+|+||.||+|... ++..||||+++.. ....+.|.+|++++++++|||||+++|+|.. +.+|||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 35555664 999999999999753 4557999999753 4567889999999999999999999999865 568999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... +..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 mE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998643 3579999999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCCc-eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 485 TSSSHL-TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 485 ~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||........... +..+...
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~-------i~~~~~~-- 231 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-------IEQGKRM-- 231 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-------HHTTCCC--
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-------HHcCCCC--
Confidence 543322 2234578999999999999999999999999999999998 9999986543321111 1112111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.... .....+..++..||+.+|.+||+|.+|++.|+.
T Consensus 232 ---~~p~----~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 232 ---ECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp ---CCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCC----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1111 223456678899999999999999999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=404.53 Aligned_cols=246 Identities=25% Similarity=0.359 Sum_probs=198.8
Q ss_pred eeecccCceEEEEEEeC---CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 337 YLVGKGGHSHVYRGCLP---DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~---~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
+.||+|+||+||+|.+. .++.||||+++.. ....+.|.+|++++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999753 3568999999643 2456789999999999999999999999864 567999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|.+++... ..++|..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 9999999754 469999999999999999999999 999999999999999999999999999999775543332
Q ss_pred -eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 491 -TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 491 -~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
......||+.|+|||.+.++.++.++|||||||++|||+| |+.||.+......... +..+.. +..
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~-------i~~~~~-----~~~- 231 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-------LEKGER-----MGC- 231 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-------HHTTCC-----CCC-
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH-------HHcCCC-----CCC-
Confidence 2234678999999999999999999999999999999998 8999986543321111 111111 111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+......+..++..||+.+|.+||++.+|++.|+.
T Consensus 232 ---p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 ---PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ---CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 11223456678899999999999999999998863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=411.09 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=202.9
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||+||+|... +|+.||||+++... ...+.+.+|++++++++||||+++++++.+.+.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46888999999999999999874 79999999986432 33567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+++|+|.+++... ..+++..++.++.|++.||.|||+ ++||||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 999999999988643 468999999999999999999999 9999999999999999999999999999998766
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
..........+||+.|+|||++.+..++.++|||||||+||||++|+.||...+.......+. .+.+
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-------~~~~------ 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII-------KLEY------ 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------TTCC------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH-------cCCC------
Confidence 544444455789999999999999999999999999999999999999998754332211111 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+...+ ...+..++..||+.||.+|||+.|++.
T Consensus 228 ~~p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 DFPEKF----FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCCTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCccC----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 111122 234667789999999999999998753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-49 Score=407.55 Aligned_cols=254 Identities=22% Similarity=0.389 Sum_probs=201.1
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcCCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFLSR 410 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 410 (678)
++|...+.||+|+||+||+|.+++++.||||+++......+.|.+|+.++++++|||||+++|+|.+ +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 4688889999999999999999888899999998766556789999999999999999999999854 567999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCCc
Q 041755 411 GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSHL 490 (678)
Q Consensus 411 gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 490 (678)
|+|..++.... ...++|.+++.++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+++........
T Consensus 96 g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 96 GSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp CBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred Cchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 99999987532 2469999999999999999999999 99999999999999999999999999999877544322
Q ss_pred eecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCCCCCC
Q 041755 491 TCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLDTD 570 (678)
Q Consensus 491 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~ 570 (678)
......||+.|+|||++..+.++.++|||||||+||||+||..|+....... .+..+ +..+. .+..
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~~~----i~~~~-----~~~~--- 235 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQ----VERGY-----RMPC--- 235 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH----HHTTC-----CCCC---
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HHHHH----HHhcC-----CCCC---
Confidence 2334679999999999999999999999999999999999766654432211 11111 11110 1111
Q ss_pred CCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 571 YDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 571 ~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
.....+.+..++.+||+.+|++||+|.+|+++|+.
T Consensus 236 -~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 236 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 11223457778899999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=405.12 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=203.4
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS-EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
+.|...+.||+|+||+||+|... +|+.||||+++.. ....+.|.+|++++++++|||||++++++.+.+.+++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 35778889999999999999865 7899999999653 355678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++|+|.+++... ...+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 999999987643 2469999999999999999999999 999999999999999999999999999997654321
Q ss_pred CceecccccCCCCCCcchhc-----cCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 489 HLTCTDVAGTFGYLAPEYFM-----HGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
.......||+.|+|||++. ...|+.++|||||||+||||+||+.||...++......+. . +...
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~------~-~~~~--- 233 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA------K-SEPP--- 233 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH------H-SCCC---
T ss_pred -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH------c-CCCC---
Confidence 1223468999999999984 4568999999999999999999999998765432211111 1 1110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+. ........+..++..||+.||.+|||+.|+++
T Consensus 234 --~~~--~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 --TLA--QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --CCS--SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCC--ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 010 01122345667789999999999999999876
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=414.35 Aligned_cols=201 Identities=24% Similarity=0.441 Sum_probs=179.0
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.++|...+.||+|+||+||+|... +|+.||||+++.. ......+.+|+.+|++++|||||+++++|.+.+++|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 468999999999999999999864 7899999998643 3556789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+++|+|.+++... ..+++..++.++.|++.||.|||+. ++|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 99999999999753 4689999999999999999999971 48999999999999999999999999999976543
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENP 540 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~ 540 (678)
. .+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.
T Consensus 159 ~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 159 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp T----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred c----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 2 2246899999999999999999999999999999999999999987554
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-48 Score=409.36 Aligned_cols=253 Identities=19% Similarity=0.379 Sum_probs=202.3
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCC----EEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGK----ELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~----~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~l 403 (678)
.+|...++||+|+||+||+|... +|+ .||||.++.. ....+.|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999864 454 6899988753 24567899999999999999999999999875 5688
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccccccc
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWL 483 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~ 483 (678)
++||+.+|+|.+++... ...+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+..
T Consensus 88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 89999999999988754 3578999999999999999999999 99999999999999999999999999999988
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
.............||+.|+|||++.++.++.++|||||||+||||+| |..||...........+. .+.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~-------~~~---- 230 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-------KGE---- 230 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH-------HTC----
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC----
Confidence 76655555555679999999999999999999999999999999998 788887655433222111 111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
....+......+..++..||+.+|.+|||+.+|++.|..
T Consensus 231 -----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 231 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 001112223457778899999999999999999998864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=398.34 Aligned_cols=243 Identities=25% Similarity=0.387 Sum_probs=194.3
Q ss_pred CCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe----CCeEEEEE
Q 041755 334 LPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFE----DNNLLLVY 405 (678)
Q Consensus 334 ~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~lV~ 405 (678)
.....||+|+||+||+|... +++.||+|++.. .....+.|.+|++++++++|||||++++++.. ...+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44567999999999999875 688999999864 34556789999999999999999999999865 34689999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eeeccCCCCCeEec-CCCCcEEeecccccc
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQP--VIHKDVKSSNILLS-DDFEPQLSDFGLASW 482 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~--iiHrDIKp~NILl~-~~~~~kL~DFGla~~ 482 (678)
||+++|+|.+++... ..+++..++.++.||+.||.|||+ ++ |+||||||+||||+ +++.+||+|||+|+.
T Consensus 92 E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 999999999999653 468999999999999999999998 77 99999999999996 578999999999986
Q ss_pred cCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccc
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQL 562 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l 562 (678)
..... ....+||+.|+|||++.+ .++.++|||||||+||||++|+.||........ +.. .+..+....
T Consensus 165 ~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~----~i~~~~~~~- 232 (270)
T d1t4ha_ 165 KRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYR----RVTSGVKPA- 232 (270)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHH----HHTTTCCCG-
T ss_pred ccCCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHH----HHHcCCCCc-
Confidence 44322 234689999999998865 699999999999999999999999975432211 111 111111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 563 LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 563 ~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+.... ...+.+++..||+.||++|||+.|+++
T Consensus 233 ---~~~~~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ---SFDKVA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---GGGGCC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccCccC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111111 233667789999999999999999975
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-48 Score=405.70 Aligned_cols=250 Identities=23% Similarity=0.346 Sum_probs=189.7
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh--HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE--DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.+.|...+.||+|+||+||+|... +|+.||||++.... .....+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456888999999999999999875 78999999987542 345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec---CCCCcEEeeccccccc
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS---DDFEPQLSDFGLASWL 483 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~---~~~~~kL~DFGla~~~ 483 (678)
|+++|+|.+++... ..+++.++..++.||+.||.|||+ ++|+||||||+|||+. +++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999643 569999999999999999999999 9999999999999994 5789999999999876
Q ss_pred CCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
..... ....+||+.|+|||++.++.++.++|||||||+||||++|+.||...........+. . +... +
T Consensus 161 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------~-~~~~--~ 228 (307)
T d1a06a_ 161 DPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL------K-AEYE--F 228 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------T-TCCC--C
T ss_pred cCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh------c-cCCC--C
Confidence 54432 234679999999999999999999999999999999999999998654332211111 0 1100 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
....... ....+..++..||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 229 DSPYWDD----ISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CTTTTTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCccccC----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111111 2244667789999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.3e-47 Score=406.95 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=206.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
++|...+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+|++++|||||++++++.+.+.+|||||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57888999999999999999864 79999999997543 55678899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC--CCCcEEeecccccccCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD--DFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~--~~~~kL~DFGla~~~~~~ 486 (678)
++|+|.+++... ...+++.+++.|+.||+.||.|||+ ++||||||||+|||++. ++.+||+|||+++.+...
T Consensus 106 ~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999998643 2469999999999999999999999 99999999999999964 678999999999987654
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.......+..... .+ .+.
T Consensus 180 ~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-----~~----~~~ 247 (350)
T d1koaa2 180 QSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW-----NM----DDS 247 (350)
T ss_dssp SCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC-----CS----CCG
T ss_pred ccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CC----Ccc
Confidence 332 346899999999999999999999999999999999999999986544322111111000 00 000
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.. ....+.+..++..||+.||.+|||+.|+++
T Consensus 248 ~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 248 AF----SGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GG----GGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cc----cCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 10 111234667789999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.7e-48 Score=404.63 Aligned_cols=243 Identities=26% Similarity=0.384 Sum_probs=199.8
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
.|...+.||+|+||.||+|... +|+.||||+++.. ....+.|.+|++++++++|||||++++++.+.+.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4788889999999999999864 7899999998643 2456789999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
||.+|+|..++... ..+++.+++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|......
T Consensus 96 ~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 99999998766533 568999999999999999999999 99999999999999999999999999999875432
Q ss_pred CCCceecccccCCCCCCcchhcc---CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMH---GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||........... ... +..
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~------i~~-~~~---- 231 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQ-NES---- 231 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHH-SCC----
T ss_pred ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH------HHh-CCC----
Confidence 23579999999999864 5689999999999999999999999976543221110 011 111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
+.+... .....+..++..||+.||.+|||+.++++
T Consensus 232 -~~~~~~---~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 -PALQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -CCCSCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCC---CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111111 11234667779999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-48 Score=403.83 Aligned_cols=260 Identities=22% Similarity=0.389 Sum_probs=211.8
Q ss_pred hhcCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCe
Q 041755 329 ATSNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNN 400 (678)
Q Consensus 329 ~t~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~ 400 (678)
..++|...+.||+|+||+||+|+.. +++.||||+++.. ....++|.+|++++++++||||++++++|.+.+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 4568999999999999999999853 4678999999753 3567889999999999999999999999999999
Q ss_pred EEEEEEcCCCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCC
Q 041755 401 LLLVYDFLSRGSLEENLHGNKK--------------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVK 460 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~--------------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIK 460 (678)
.++||||+++|+|.+++..... ....+++..++.|+.|++.||+|||+ ++|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEc
Confidence 9999999999999999964321 12358999999999999999999999 999999999
Q ss_pred CCCeEecCCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCC-CCCCCCC
Q 041755 461 SSNILLSDDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGK-KPINSEN 539 (678)
Q Consensus 461 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~-~Pf~~~~ 539 (678)
|+||||+.++.+||+|||+++.+.........+...||+.|+|||++.+..++.++|||||||+||||++|. +||...+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999998775554444445578899999999999999999999999999999999985 5776654
Q ss_pred CcccccchhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 540 PKGQESLVMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 540 ~~~~~~l~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
....... +..+.... . +......+..++..||+.+|.+||||.+|+++|+..
T Consensus 248 ~~e~~~~-------v~~~~~~~-----~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 248 HEEVIYY-------VRDGNILA-----C----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHHHHH-------HHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHHHHHH-------HHcCCCCC-----C----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 4322111 11222111 1 112234577888999999999999999999999753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=8.1e-47 Score=404.23 Aligned_cols=250 Identities=22% Similarity=0.270 Sum_probs=206.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
++|...+.||+|+||.||+|... +|+.||||+++... .....+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46888999999999999999864 79999999987543 45667889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec--CCCCcEEeecccccccCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS--DDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~--~~~~~kL~DFGla~~~~~~ 486 (678)
++|+|.+.+... +..+++.+++.|+.||+.||.|||+ ++||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 109 ~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999887532 3569999999999999999999999 9999999999999998 6789999999999987654
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
... ....||+.|+|||++.+..++.++|||||||+||||+||+.||.+.+.......+. .+... +.+.
T Consensus 183 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~-------~~~~~--~~~~ 250 (352)
T d1koba_ 183 EIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK-------RCDWE--FDED 250 (352)
T ss_dssp SCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-------HCCCC--CCSS
T ss_pred Cce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------hCCCC--CCcc
Confidence 332 33679999999999999999999999999999999999999998655432211111 01100 0111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..... ...+..++..||+.||.+|||+.|+++
T Consensus 251 ~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 251 AFSSV----SPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112 234567789999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=397.89 Aligned_cols=260 Identities=22% Similarity=0.349 Sum_probs=200.1
Q ss_pred cCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeC-Ce
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFED-NN 400 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~-~~ 400 (678)
++|...+.||+|+||.||+|... +++.||||+++.. ....+.+.+|+.++.++ +|+||+.+++++.+. +.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 56888899999999999999742 3568999999753 35567888999888887 689999999998765 46
Q ss_pred EEEEEEcCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC
Q 041755 401 LLLVYDFLSRGSLEENLHGNKK------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD 468 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~ 468 (678)
+++||||+++|+|.++|..... ....+++.+++.++.||+.||.|||+ ++||||||||+||||+.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECC
Confidence 8999999999999999975432 13458999999999999999999999 99999999999999999
Q ss_pred CCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCC-CCCCCCCCcccccch
Q 041755 469 DFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGK-KPINSENPKGQESLV 547 (678)
Q Consensus 469 ~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~-~Pf~~~~~~~~~~l~ 547 (678)
++++||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||. .||........ +.
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--~~ 247 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC 247 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--HH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--HH
Confidence 9999999999999876655555555678999999999999999999999999999999999975 57765433211 11
Q ss_pred hhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCH
Q 041755 548 MWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDE 608 (678)
Q Consensus 548 ~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~ 608 (678)
..+..+.. +.... .....+..++..||+.||.+|||+.+|++.|+...
T Consensus 248 ----~~~~~~~~-----~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 248 ----RRLKEGTR-----MRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp ----HHHHHTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHhcCCC-----CCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111111 11111 12345677889999999999999999999997543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=391.16 Aligned_cols=253 Identities=21% Similarity=0.338 Sum_probs=195.6
Q ss_pred cCCCCceeecccCceEEEEEEeCC----CCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPD----GKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~----g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...+.||+|+||.||+|.... +..||||.++.. ....+.|.+|++++++++||||++++|+|. .+.+++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 467888999999999999998642 457899998753 456788999999999999999999999995 4678999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... ...+++..++.++.||+.||.|||+ ++||||||||+|||++.++.+||+|||+|+.+.
T Consensus 86 ~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999987643 2568999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCcccccc
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLL 563 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~ 563 (678)
..... ..+...||+.|+|||.+.++.++.++|||||||++|||+| |.+||...........+ ..+...
T Consensus 160 ~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i-------~~~~~~--- 228 (273)
T d1mp8a_ 160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENGERL--- 228 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-------HTTCCC---
T ss_pred CCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH-------HcCCCC---
Confidence 54332 2234678999999999999999999999999999999998 89999876543321111 111111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 564 DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 564 dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.+.. .....+..++..||..||.+|||+.+|++.|+..
T Consensus 229 --~~~~----~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 229 --PMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp --CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCC----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 2234577788999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=392.78 Aligned_cols=250 Identities=20% Similarity=0.285 Sum_probs=204.7
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC-------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS-------EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 401 (678)
.++|...+.||+|+||+||+|... +|+.||||+++.. ....+.|.+|+.+|++++|||||++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 357899999999999999999874 7999999998532 12367899999999999999999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC----CcEEeec
Q 041755 402 LLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF----EPQLSDF 477 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~----~~kL~DF 477 (678)
|+|||||++|+|.+++... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++ .+||+||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecch
Confidence 9999999999999999653 469999999999999999999999 9999999999999998876 4999999
Q ss_pred ccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC
Q 041755 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557 (678)
Q Consensus 478 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 557 (678)
|+|......... ....||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+.......+.... .
T Consensus 162 G~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~-----~ 233 (293)
T d1jksa_ 162 GLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN-----Y 233 (293)
T ss_dssp TTCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC-----C
T ss_pred hhhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcC-----C
Confidence 999887554322 34679999999999999999999999999999999999999998755432211111000 0
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
...... .. .....+.+++..||+.||.+|||+.++++
T Consensus 234 ~~~~~~----~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 EFEDEY----FS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCHHH----HT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCchh----cC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 01 11234667789999999999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=396.56 Aligned_cols=259 Identities=23% Similarity=0.362 Sum_probs=212.0
Q ss_pred cCCCCceeecccCceEEEEEEe------CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL------PDGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNL 401 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~------~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 401 (678)
++|...+.||+|+||.||+|.+ .+++.||||+++.. ......|.+|+.+++.+ +|||||+++++|.+.+.+
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 4677788999999999999974 35678999999754 35567899999999999 699999999999999999
Q ss_pred EEEEEcCCCCCHHHHhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec
Q 041755 402 LLVYDFLSRGSLEENLHGNKK--------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS 467 (678)
Q Consensus 402 ~lV~E~~~~gsL~~~L~~~~~--------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~ 467 (678)
++||||+++|+|.+++..... ....+++..+..++.||+.||.|||+ ++++||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 999999999999999976532 23468999999999999999999999 9999999999999999
Q ss_pred CCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcC-CCCCCCCCCcccccc
Q 041755 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSG-KKPINSENPKGQESL 546 (678)
Q Consensus 468 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG-~~Pf~~~~~~~~~~l 546 (678)
.++.+||+|||+++...........+...||+.|+|||++.++.++.++|||||||++|||+|+ .+||.........
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~-- 257 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-- 257 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH--
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH--
Confidence 9999999999999988776666666678999999999999999999999999999999999995 5555444332211
Q ss_pred hhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 547 VMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 547 ~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
. .++..+ .....+......+..++..||+.||.+||||.+|+++|+..
T Consensus 258 ~----~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 258 Y----KMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp H----HHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 0 011111 11111112234577788999999999999999999999753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=390.62 Aligned_cols=248 Identities=27% Similarity=0.412 Sum_probs=196.2
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-CeEEEEEEcCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED-NNLLLVYDFLS 409 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-~~~~lV~E~~~ 409 (678)
++|...+.||+|+||.||+|.+ .|+.||||+++.+. ..+.|.+|++++++++||||++++|+|.+. +.+++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 4567788999999999999998 57899999997653 446799999999999999999999999654 56899999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCCC
Q 041755 410 RGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSSH 489 (678)
Q Consensus 410 ~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~~ 489 (678)
+|+|.++|.... ...++|..+++++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-- 157 (262)
T d1byga_ 85 KGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 157 (262)
T ss_dssp TEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC--
Confidence 999999997532 2358999999999999999999999 999999999999999999999999999998654422
Q ss_pred ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccccccCCCCC
Q 041755 490 LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPSLD 568 (678)
Q Consensus 490 ~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~l~ 568 (678)
....+|..|+|||++.++.++.++|||||||++|||+| |+.||........ ..+ +..+. .+.+
T Consensus 158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~----i~~~~-----~~~~- 221 (262)
T d1byga_ 158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPR----VEKGY-----KMDA- 221 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHH----HTTTC-----CCCC-
T ss_pred ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHH----HHcCC-----CCCC-
Confidence 23467999999999999999999999999999999998 6788765543321 111 11111 1111
Q ss_pred CCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 569 TDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 569 ~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+......+.+++..||+.||.+||||.+|++.|+.
T Consensus 222 ---~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 222 ---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 12223456778899999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=395.32 Aligned_cols=270 Identities=24% Similarity=0.294 Sum_probs=202.1
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----eEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDN----NLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~~~lV~E 406 (678)
.+|...+.||+|+||.||+|+. +|+.||||+++........+..|+..+.+++||||++++++|.+.+ .+++|||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 3566778899999999999987 7899999999765443333334555566789999999999998654 6899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNS-----CEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-----~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
|+++|+|.++|+.. .++|..++.++.|++.||.|||.. ..++||||||||+||||+.++.+||+|||+++
T Consensus 82 y~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999753 589999999999999999999963 13699999999999999999999999999999
Q ss_pred ccCCCCCCc--eecccccCCCCCCcchhccC------CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchh----h
Q 041755 482 WLSTSSSHL--TCTDVAGTFGYLAPEYFMHG------KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVM----W 549 (678)
Q Consensus 482 ~~~~~~~~~--~~~~~~Gt~~Y~APE~l~~~------~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~----~ 549 (678)
......... ......||+.|+|||++... .++.++|||||||+||||+||..||............. .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 876543322 23347899999999998764 26779999999999999999998886543222111000 0
Q ss_pred cccccccCccccccCCCCCCCC-CHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 550 AKPILKDGKVSQLLDPSLDTDY-DNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 550 ~~~~~~~~~~~~l~dp~l~~~~-~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
....+........++|.+.... ..+....+..++..||+.||.+|||+.||++.|+.
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~ 294 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 0000000011112223332222 23456678889999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-46 Score=397.13 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=205.4
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
.++|...+.||+|+||.||+|... +|+.||||+++... ...+.+.+|+.+|++++||||+++++++.+.+.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 367899999999999999999864 79999999997432 3357789999999999999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... ..+++...+.++.||+.||.|||+ ++||||||||+|||++.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 9999999999998754 468999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
.... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+.......+. .+.
T Consensus 157 ~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~-------~~~------ 221 (337)
T d1o6la_ 157 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-------MEE------ 221 (337)
T ss_dssp CTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCC------
T ss_pred cCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh-------cCC------
Confidence 4332 2334789999999999999999999999999999999999999998765432211111 111
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQ-----INLVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs-----~~eVl~ 602 (678)
+.+...++ ..+..++..||+.||.+||+ +.++++
T Consensus 222 ~~~p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 222 IRFPRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCCTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11111222 33566779999999999995 677764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=393.88 Aligned_cols=258 Identities=24% Similarity=0.416 Sum_probs=207.6
Q ss_pred cCCCCceeecccCceEEEEEEeC--------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP--------DGKELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDN 399 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~--------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~ 399 (678)
++|...+.||+|+||.||+|+.. ++..||||+++.+ .....++.+|+.++.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 46777889999999999999752 2347999999754 35668899999999988 7999999999999999
Q ss_pred eEEEEEEcCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKK------------DGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS 467 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~ 467 (678)
..++||||+++|+|.++|..... ....+++.+++.++.||+.||+|||+ ++||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 99999999999999999975532 23568999999999999999999999 9999999999999999
Q ss_pred CCCCcEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccc
Q 041755 468 DDFEPQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESL 546 (678)
Q Consensus 468 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l 546 (678)
.++.+||+|||+++...............||+.|+|||.+.++.|+.++|||||||++|||++ |+.||........
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~--- 246 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL--- 246 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH---
Confidence 999999999999998877665555566789999999999999999999999999999999998 6888876543221
Q ss_pred hhhcccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 547 VMWAKPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 547 ~~~~~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
.. .+..+. .+.... .....+..++.+||+.+|.+|||+.+|++.|+..
T Consensus 247 ~~----~i~~~~-----~~~~p~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 247 FK----LLKEGH-----RMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp HH----HHHTTC-----CCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH----HHHcCC-----CCCCCc----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11 111111 111111 2234577788999999999999999999999653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-46 Score=392.80 Aligned_cols=243 Identities=24% Similarity=0.369 Sum_probs=203.3
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||+||+|... +|+.||||+++... ...+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56888999999999999999874 79999999996432 33577899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+.+|+|..++... ..+++...+.++.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999999988654 457889999999999999999999 9999999999999999999999999999998654
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
.. ...+||+.|+|||++.+..++.++|||||||+||||+||+.||...+.......+.. +..
T Consensus 157 ~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-------~~~------ 218 (316)
T d1fota_ 157 VT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-------AEL------ 218 (316)
T ss_dssp CB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-------CCC------
T ss_pred cc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc-------CCC------
Confidence 32 346899999999999999999999999999999999999999987554322111111 110
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~ 602 (678)
.+....+ ..+..++..||..+|.+|| ++.++++
T Consensus 219 ~~p~~~s----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 RFPPFFN----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCCTTSC----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCC----HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1111122 3466677999999999996 8888875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=392.02 Aligned_cols=251 Identities=21% Similarity=0.254 Sum_probs=206.4
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
.++|...+.||+|+||+||+|... +|+.||||+++........+.+|+++|+.++||||+++++++.+.+.+|+|||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 467889999999999999999875 7889999999877666667889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCC--CCcEEeecccccccCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDD--FEPQLSDFGLASWLSTS 486 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~--~~~kL~DFGla~~~~~~ 486 (678)
++|+|.+++... +..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 84 SGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999643 2468999999999999999999999 999999999999999854 57999999999876543
Q ss_pred CCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
.. .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+..... .+...
T Consensus 158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~-----~~~~~---- 225 (321)
T d1tkia_ 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY-----TFDEE---- 225 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC-----CCCHH----
T ss_pred Cc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----CCChh----
Confidence 32 2336789999999999999999999999999999999999999987654322111110000 00000
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..... ...+.+++..||..||.+|||+.|+++
T Consensus 226 ~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFKEI----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00011 234667889999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=388.23 Aligned_cols=251 Identities=23% Similarity=0.402 Sum_probs=200.6
Q ss_pred ceeecccCceEEEEEEeCC--C--CEEEEEEeCC--ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-CeEEEEEEcC
Q 041755 336 EYLVGKGGHSHVYRGCLPD--G--KELAVKILKP--SEDVLKEFASEIEIITALHHRNIISLFGFCFED-NNLLLVYDFL 408 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~~--g--~~vAvK~l~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~-~~~~lV~E~~ 408 (678)
.++||+|+||+||+|.+.+ + ..||||+++. +....++|.+|++++++++||||++++|+|.+. +..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999998643 2 2589999974 446678899999999999999999999998764 5899999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
++|+|.+++... ...+++..+..++.|++.||.|||+ .+|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 999999998754 3567899999999999999999999 9999999999999999999999999999998755432
Q ss_pred C--ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCCC
Q 041755 489 H--LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDPS 566 (678)
Q Consensus 489 ~--~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp~ 566 (678)
. .......||+.|+|||.+..+.++.++||||||++||||+||+.||....... .+..+ +..|.. ...|
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~----i~~g~~--~~~p- 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY----LLQGRR--LLQP- 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTCC--CCCC-
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH----HHcCCC--CCCc-
Confidence 2 22234678999999999999999999999999999999999888876543211 11111 111111 1111
Q ss_pred CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 567 LDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 567 l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
......+.+++..||+.||++||+|.||++.|+..
T Consensus 257 ------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i 291 (311)
T d1r0pa_ 257 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291 (311)
T ss_dssp ------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11124566788999999999999999999998644
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.4e-46 Score=384.79 Aligned_cols=255 Identities=22% Similarity=0.352 Sum_probs=198.9
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----e
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDN----N 400 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~ 400 (678)
.++|...+.||+|+||.||+|... +|+.||||+++.. ......|.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367889999999999999999864 7999999999642 355678999999999999999999999997654 3
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
+|+||||+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++..+|+|||++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhh
Confidence 89999999999999988643 468999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCCC-CceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc
Q 041755 481 SWLSTSSS-HLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559 (678)
Q Consensus 481 ~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 559 (678)
........ ........||+.|+|||++.+..++.++|||||||++|||+||+.||...++..... ..+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH------HHHhcCCC
Confidence 76544322 223345689999999999999999999999999999999999999998654432111 11111110
Q ss_pred -ccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCC-CHHHHHHHhh
Q 041755 560 -SQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRP-QINLVLKLLQ 605 (678)
Q Consensus 560 -~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-s~~eVl~~L~ 605 (678)
.... .... ...+..++..||+.||.+|| ++.++++.|.
T Consensus 233 ~~~~~----~~~~----s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 233 PPSAR----HEGL----SADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp CGGGT----SSSC----CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred CCchh----ccCC----CHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 0111 1111 24466777999999999999 8999887764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=388.90 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=196.0
Q ss_pred cCCCCceeecccCceEEEEEEeC--CC--CEEEEEEeCCC----hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP--DG--KELAVKILKPS----EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~--~g--~~vAvK~l~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 402 (678)
++|...+.||+|+||.||+|... ++ ..||||+++.. ....+.|.+|+.++++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 46778889999999999999753 33 37899998753 3556889999999999999999999999965 5678
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||||+.++++||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhh
Confidence 9999999999999887532 468999999999999999999999 9999999999999999999999999999998
Q ss_pred cCCCCCCce-ecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhc-CCCCCCCCCCcccccchhhcccccccCccc
Q 041755 483 LSTSSSHLT-CTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLS-GKKPINSENPKGQESLVMWAKPILKDGKVS 560 (678)
Q Consensus 483 ~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLlt-G~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~ 560 (678)
+........ .....||..|+|||.+.+..++.++|||||||++|||+| |+.||...+...... + +...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~---~---i~~~~~~- 233 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH---K---IDKEGER- 233 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---H---HHTSCCC-
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHH---H---HHhCCCC-
Confidence 765543332 234568889999999999999999999999999999998 899997654432211 1 1111110
Q ss_pred cccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhh
Q 041755 561 QLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQ 605 (678)
Q Consensus 561 ~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~ 605 (678)
+.. .......+.+++..||+.||++||||.+|+++|+
T Consensus 234 ----~~~----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~ 270 (273)
T d1u46a_ 234 ----LPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270 (273)
T ss_dssp ----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----CCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 111 1112245667889999999999999999999886
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-45 Score=381.15 Aligned_cols=249 Identities=26% Similarity=0.408 Sum_probs=204.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC----------hHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeC
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS----------EDVLKEFASEIEIITALH-HRNIISLFGFCFED 398 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~----------~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~ 398 (678)
++|...+.||+|+||+||+|+.. +|+.||||+++.. +...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57888999999999999999864 7999999998642 123457889999999997 99999999999999
Q ss_pred CeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecc
Q 041755 399 NNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFG 478 (678)
Q Consensus 399 ~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFG 478 (678)
+..||||||+++|+|.++|... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999643 469999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCCCCceecccccCCCCCCcchhcc------CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccc
Q 041755 479 LASWLSTSSSHLTCTDVAGTFGYLAPEYFMH------GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKP 552 (678)
Q Consensus 479 la~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~ 552 (678)
+++........ +...||+.|+|||++.+ ..++.++||||+||+||||++|+.||...+.......+.
T Consensus 156 ~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~---- 228 (277)
T d1phka_ 156 FSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM---- 228 (277)
T ss_dssp TCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----
T ss_pred heeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH----
Confidence 99987654322 34689999999999863 357889999999999999999999998765432211111
Q ss_pred ccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 553 ILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 553 ~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+... ............+.+++..||+.+|.+||++.+|++
T Consensus 229 ---~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 ---SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ---HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---hCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111 000011122345677889999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=391.84 Aligned_cols=255 Identities=24% Similarity=0.376 Sum_probs=202.2
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCC--EEEEEEeCCC--hHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGK--ELAVKILKPS--EDVLKEFASEIEIITAL-HHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~--~vAvK~l~~~--~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...+.||+|+||.||+|.+. +|. .||||.++.. ....+.|.+|+++|+++ +||||++++|+|.+.+.+++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57778899999999999999875 444 4788887543 34567899999999999 799999999999999999999
Q ss_pred EEcCCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCc
Q 041755 405 YDFLSRGSLEENLHGNK------------KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEP 472 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 472 (678)
|||+++|+|.++|+... .....++|.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence 99999999999997542 234679999999999999999999999 999999999999999999999
Q ss_pred EEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCC-CCCCCCCCcccccchhhcc
Q 041755 473 QLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGK-KPINSENPKGQESLVMWAK 551 (678)
Q Consensus 473 kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~-~Pf~~~~~~~~~~l~~~~~ 551 (678)
||+|||+++........ ....||..|+|||.+.++.++.++|||||||++|||++|. +||...+... +...
T Consensus 167 kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~-- 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEK-- 238 (309)
T ss_dssp EECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHH--
T ss_pred EEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHH--
Confidence 99999999865443222 2356899999999999999999999999999999999976 5665543322 1111
Q ss_pred cccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcC
Q 041755 552 PILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGD 607 (678)
Q Consensus 552 ~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~ 607 (678)
+..+. .+.. .......+..++..||+.+|++||+|.+|++.|+..
T Consensus 239 --i~~~~-----~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 239 --LPQGY-----RLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp --GGGTC-----CCCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHhcC-----CCCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11111 1111 112234577778999999999999999999998643
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-46 Score=390.90 Aligned_cols=260 Identities=17% Similarity=0.335 Sum_probs=211.7
Q ss_pred cCCCCceeecccCceEEEEEEeC------CCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP------DGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~------~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 402 (678)
++|...+.||+|+||.||+|.+. +++.||||+++.. ......|.+|++++++++||||++++|+|...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 46677889999999999999753 3678999999753 355677999999999999999999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEee
Q 041755 403 LVYDFLSRGSLEENLHGNK------KDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSD 476 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~D 476 (678)
+||||+++|+|.+++.... .....+++..+..++.|+++||.|||+ ++|+||||||+||||+.++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 9999999999999886432 122457999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCC-CCCCCCCCcccccchhhcccccc
Q 041755 477 FGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGK-KPINSENPKGQESLVMWAKPILK 555 (678)
Q Consensus 477 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~-~Pf~~~~~~~~~~l~~~~~~~~~ 555 (678)
||+++.+.............||+.|+|||.+.++.++.++|||||||++|||+||. .||...+....... +.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~-------i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF-------VM 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH-------HH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHH-------HH
Confidence 99999876655555555568999999999999999999999999999999999985 67765433221111 11
Q ss_pred cCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhcCHh
Q 041755 556 DGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQGDEE 609 (678)
Q Consensus 556 ~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~~~~ 609 (678)
++.... ... .....+..++..||+.+|.+||||.+|++.|+...+
T Consensus 250 ~~~~~~-----~p~----~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLD-----KPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCC-----Ccc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111111 111 122457778899999999999999999999986543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-45 Score=393.65 Aligned_cols=247 Identities=23% Similarity=0.336 Sum_probs=197.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHH---HHHHHHHhcCCCCeeeEEEEEEeCCeEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFA---SEIEIITALHHRNIISLFGFCFEDNNLL 402 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~---~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 402 (678)
++|...++||+|+||.||+|... +|+.||||++.... .....+. .|+.+++.++|||||++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999865 79999999986422 1122333 4466777778999999999999999999
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
+||||+++|+|.++|... ..+++..++.++.||+.||.|||+ ++||||||||+||||+.+|.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999653 468899999999999999999999 9999999999999999999999999999997
Q ss_pred cCCCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcccc
Q 041755 483 LSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQ 561 (678)
Q Consensus 483 ~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~ 561 (678)
+..... ....||+.|+|||++..+ .++.++|||||||+||||+||+.||..........+.... . ..
T Consensus 157 ~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~-~~---- 224 (364)
T d1omwa3 157 FSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---L-TM---- 224 (364)
T ss_dssp CSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS---S-SC----
T ss_pred cCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---c-cC----
Confidence 765432 335799999999999754 6899999999999999999999999876543322211110 0 00
Q ss_pred ccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041755 562 LLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ-----INLVLK 602 (678)
Q Consensus 562 l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs-----~~eVl~ 602 (678)
.+.+...++ ..+..++..||+.||.+||+ +.++++
T Consensus 225 --~~~~~~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 --AVELPDSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --CCCCCSSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --CCCCCCCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 011111222 34667779999999999999 577764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=388.98 Aligned_cols=252 Identities=22% Similarity=0.315 Sum_probs=197.6
Q ss_pred hcCCCCc-eeecccCceEEEEEEe-CCCCEEEEEEeCCChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe----CCeEE
Q 041755 330 TSNFLPE-YLVGKGGHSHVYRGCL-PDGKELAVKILKPSEDVLKEFASEIEIITAL-HHRNIISLFGFCFE----DNNLL 402 (678)
Q Consensus 330 t~~f~~~-~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~g~~~~----~~~~~ 402 (678)
.++|... ++||+|+||+||+|.. .+|+.||||+++... .+.+|++++.++ +||||++++++|.+ +..+|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP----KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH----HHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 3577765 5699999999999986 479999999997653 466799987655 89999999999865 35789
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC---CCCcEEeeccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD---DFEPQLSDFGL 479 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~---~~~~kL~DFGl 479 (678)
+|||||++|+|.++|... ....+++.+++.|+.||+.||.|||+ ++|+||||||+|||++. ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccce
Confidence 999999999999999753 23579999999999999999999999 99999999999999985 56799999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 559 (678)
|+........ ....||+.|+|||++.+..|+.++|||||||+||+|+||+.||.+.+......... ..+..+.+
T Consensus 161 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---~~i~~~~~ 234 (335)
T d2ozaa1 161 AKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRMGQY 234 (335)
T ss_dssp CEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS
T ss_pred eeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH---HHHhcCCC
Confidence 9877654432 34689999999999999999999999999999999999999997654332211100 00111110
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 560 SQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 560 ~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
. +...........+..++..||+.||.+|||+.++++
T Consensus 235 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 235 E------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp S------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 000001122345777889999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-45 Score=393.21 Aligned_cols=243 Identities=21% Similarity=0.302 Sum_probs=203.5
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVY 405 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~ 405 (678)
++|...+.||+|+||.||+|... +|+.||||++.... ...+.+.+|+.+|+.++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57889999999999999999875 79999999986432 33567899999999999999999999999999999999
Q ss_pred EcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCC
Q 041755 406 DFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLST 485 (678)
Q Consensus 406 E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~ 485 (678)
||+.+|+|..++... ..+++..++.++.||+.||.|||+ ++||||||||+||||+.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999998654 468999999999999999999999 9999999999999999999999999999997654
Q ss_pred CCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccCC
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLDP 565 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~dp 565 (678)
.. ....||+.|+|||++.+..++.++|||||||+||||+||+.||.+.+.......+.. +. +
T Consensus 194 ~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-------~~------~ 255 (350)
T d1rdqe_ 194 RT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS-------GK------V 255 (350)
T ss_dssp CB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------CC------C
T ss_pred cc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhc-------CC------C
Confidence 32 246899999999999999999999999999999999999999986543221111110 11 0
Q ss_pred CCCCCCCHHHHHHHHHHHHhcccCCCCCCC-----CHHHHHH
Q 041755 566 SLDTDYDNDQIERMVLAATLSISRAPTVRP-----QINLVLK 602 (678)
Q Consensus 566 ~l~~~~~~~~~~~l~~la~~Cl~~dP~~RP-----s~~eVl~ 602 (678)
...... ...+..++..||+.||.+|+ ++.++++
T Consensus 256 ~~p~~~----s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 RFPSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCccC----CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111122 23466777999999999994 8999886
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-45 Score=383.02 Aligned_cols=258 Identities=22% Similarity=0.263 Sum_probs=194.2
Q ss_pred ceeecccCceEEEEEEeC-CCCEEEEEEeCCCh------HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEcC
Q 041755 336 EYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE------DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDFL 408 (678)
Q Consensus 336 ~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~------~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 408 (678)
.++||+|+||+||+|... +|+.||||+++... ...+.+.+|+.++++++|||||++++++..+++.|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 368999999999999875 69999999986532 12356889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCCC
Q 041755 409 SRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSSS 488 (678)
Q Consensus 409 ~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~~ 488 (678)
.++++...+.. +..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 88877766532 3568889999999999999999999 9999999999999999999999999999987655433
Q ss_pred CceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc---ccccC
Q 041755 489 HLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV---SQLLD 564 (678)
Q Consensus 489 ~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~---~~l~d 564 (678)
. ....+||+.|+|||.+..+ .++.++|||||||++|||+||+.||...+.......+...........+ ....+
T Consensus 156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 156 A--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp C--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred c--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 2 2236799999999998755 5799999999999999999999999765543221111100000000000 00000
Q ss_pred C-CCC--CCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 565 P-SLD--TDYDN-----DQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 565 p-~l~--~~~~~-----~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
. ... ..... ...+.+.+++..||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 000 00010 11245777889999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=389.51 Aligned_cols=246 Identities=22% Similarity=0.372 Sum_probs=202.4
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh----HHHHHHHHHHHHHH-hcCCCCeeeEEEEEEeCCeEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE----DVLKEFASEIEIIT-ALHHRNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~----~~~~~~~~Ei~il~-~l~HpnIv~l~g~~~~~~~~~lV 404 (678)
++|...+.||+|+||+||+|... +|+.||||+++.+. .....+..|..++. .++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57888999999999999999875 79999999997432 23456777877765 68999999999999999999999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccC
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLS 484 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~ 484 (678)
|||+++|+|.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 9999999999999753 458999999999999999999999 999999999999999999999999999998765
Q ss_pred CCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCccccccC
Q 041755 485 TSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKVSQLLD 564 (678)
Q Consensus 485 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~~~l~d 564 (678)
..... .+...||+.|+|||++.++.++.++|||||||++|||++|+.||.+.+.......+.. + .
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-------~------~ 219 (320)
T d1xjda_ 155 LGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------D------N 219 (320)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------C------C
T ss_pred ccccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc-------C------C
Confidence 44332 3346899999999999999999999999999999999999999987654332111111 1 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHH-HHHH
Q 041755 565 PSLDTDYDNDQIERMVLAATLSISRAPTVRPQIN-LVLK 602 (678)
Q Consensus 565 p~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~-eVl~ 602 (678)
+.+....+ ..+..++..||..||.+||++. ++++
T Consensus 220 ~~~p~~~s----~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 PFYPRWLE----KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCCCTTSC----HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCCCccCC----HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11111222 3466778999999999999985 6653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=378.17 Aligned_cols=264 Identities=21% Similarity=0.305 Sum_probs=198.6
Q ss_pred cCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|...+.||+|+||+||+|.. .+|+.||||+++... .....+.+|++++++++||||+++++++.+++++|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5788999999999999999986 479999999996533 235778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
|+.++ +..++... ....+++..++.++.|++.||.|||+ ++||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~-~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCc-hhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99654 44444332 23569999999999999999999999 99999999999999999999999999999876543
Q ss_pred CCCceecccccCCCCCCcchhccCC-CCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccccc---------
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGK-VSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKD--------- 556 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~--------- 556 (678)
.. ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+.......+........+
T Consensus 156 ~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 VR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp SB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred cc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 32 233468999999999887765 578999999999999999999999865532211110000000000
Q ss_pred CccccccCCCCCCCC---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 557 GKVSQLLDPSLDTDY---DNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 557 ~~~~~l~dp~l~~~~---~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
......+.......+ .......+.+++..||..||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 000000000000000 0011245667789999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-44 Score=374.20 Aligned_cols=263 Identities=20% Similarity=0.286 Sum_probs=199.5
Q ss_pred cCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh---HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEEc
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE---DVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E~ 407 (678)
++|...+.||+|+||+||+|..++|+.||||+++... ...+.|.+|+.++++++||||+++++++...+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788889999999999999999899999999996532 3357899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCCC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTSS 487 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~~ 487 (678)
+.++.+..+... ...+++..++.++.||+.||+|||+ .+||||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 987777666543 3579999999999999999999999 999999999999999999999999999998765433
Q ss_pred CCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcc-----c----ccccC
Q 041755 488 SHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAK-----P----ILKDG 557 (678)
Q Consensus 488 ~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~-----~----~~~~~ 557 (678)
.. .....|++.|+|||.+.. ..++.++|||||||++|||++|+.||.+.+.......+.... . .....
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 RK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred cc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 22 233578999999999875 457899999999999999999999997654322111110000 0 00000
Q ss_pred ccccc---cCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 558 KVSQL---LDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 558 ~~~~l---~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..... ..+.............+..++..||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0000000111112245667889999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-44 Score=374.42 Aligned_cols=264 Identities=20% Similarity=0.278 Sum_probs=195.0
Q ss_pred hcCCCCceeecccCceEEEEEEeC-C-CCEEEEEEeCCC---hHHHHHHHHHHHHHHhc---CCCCeeeEEEEEEe----
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-D-GKELAVKILKPS---EDVLKEFASEIEIITAL---HHRNIISLFGFCFE---- 397 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~-g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l---~HpnIv~l~g~~~~---- 397 (678)
.++|...+.||+|+||+||+|... + ++.||||+++.. +.....+.+|+.+++.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999863 4 667999998532 22233456777776665 79999999999863
Q ss_pred -CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEee
Q 041755 398 -DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSD 476 (678)
Q Consensus 398 -~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~D 476 (678)
...++++|||+.++.+...... ....+++..++.++.|++.||+|||+ ++||||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecc
Confidence 2468999999988877655442 23568999999999999999999999 9999999999999999999999999
Q ss_pred cccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccc--
Q 041755 477 FGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL-- 554 (678)
Q Consensus 477 FGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~-- 554 (678)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.......
T Consensus 160 fg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 99988654332 2234789999999999999999999999999999999999999998765432211111100000
Q ss_pred ----ccCcccccc----CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 555 ----KDGKVSQLL----DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 555 ----~~~~~~~l~----dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
......... .+.....+.....+.+.+++..||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000 000000011112234566789999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-45 Score=375.17 Aligned_cols=239 Identities=21% Similarity=0.330 Sum_probs=194.8
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCCh-------HHHHHHHHHHHHHHhcC--CCCeeeEEEEEEeCC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSE-------DVLKEFASEIEIITALH--HRNIISLFGFCFEDN 399 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~-------~~~~~~~~Ei~il~~l~--HpnIv~l~g~~~~~~ 399 (678)
.++|...++||+|+||.||+|... +|+.||||+++... .....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 367899999999999999999864 79999999986421 12244678999999997 899999999999999
Q ss_pred eEEEEEEcCCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC-CCCcEEeec
Q 041755 400 NLLLVYDFLSR-GSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD-DFEPQLSDF 477 (678)
Q Consensus 400 ~~~lV~E~~~~-gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~-~~~~kL~DF 477 (678)
..++||||+.+ +++.+++... ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 5787777543 468999999999999999999999 99999999999999985 479999999
Q ss_pred ccccccCCCCCCceecccccCCCCCCcchhccCCC-CccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccccc
Q 041755 478 GLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKV-SEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKD 556 (678)
Q Consensus 478 Gla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~ 556 (678)
|+|+...... .+...||+.|+|||++.+..+ +.++|||||||+||||+||+.||...+. +.....
T Consensus 156 G~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~~~~~---- 221 (273)
T d1xwsa_ 156 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQV---- 221 (273)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHHCCC----
T ss_pred ccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------Hhhccc----
Confidence 9998754432 234689999999999987765 5679999999999999999999975321 111100
Q ss_pred CccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 557 GKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 557 ~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+...++ ..+.+++..||+.||.+|||+.|+++
T Consensus 222 ---------~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 ---------FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---------CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111222 34666779999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-43 Score=367.55 Aligned_cols=266 Identities=21% Similarity=0.287 Sum_probs=196.2
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--------
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFE-------- 397 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-------- 397 (678)
.++|...+.||+|+||+||+|... +|+.||||++... +.....+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 368888999999999999999864 7999999998643 2345678899999999999999999999865
Q ss_pred CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeec
Q 041755 398 DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDF 477 (678)
Q Consensus 398 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DF 477 (678)
.+..++||||+.++.+..... ....+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence 346899999998877765543 23568999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCC--ceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccc
Q 041755 478 GLASWLSTSSSH--LTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL 554 (678)
Q Consensus 478 Gla~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~ 554 (678)
|+++........ .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+.......+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999876543221 122235799999999998765 68999999999999999999999998655433222211111000
Q ss_pred ccC--------ccccccCCCCCCCCCH-HH------HHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 555 KDG--------KVSQLLDPSLDTDYDN-DQ------IERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 555 ~~~--------~~~~l~dp~l~~~~~~-~~------~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
... .....+.......... +. ...+..++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000 0000010000111111 11 123456789999999999999999985
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-43 Score=373.73 Aligned_cols=261 Identities=22% Similarity=0.285 Sum_probs=192.3
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC------CeEEEE
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIISLFGFCFED------NNLLLV 404 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~------~~~~lV 404 (678)
+|...++||+|+||+||+|... +|+.||||+++.... .+.+|+++|++++||||++++++|... .+++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 97 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEE
Confidence 4667789999999999999875 799999999976542 234799999999999999999998643 357999
Q ss_pred EEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC-CcEEeeccccccc
Q 041755 405 YDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF-EPQLSDFGLASWL 483 (678)
Q Consensus 405 ~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kL~DFGla~~~ 483 (678)
|||++++.+..... .......+++.+++.++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+++.+
T Consensus 98 ~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 98 LDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99997664443332 22334679999999999999999999999 9999999999999999775 8999999999877
Q ss_pred CCCCCCceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhc------------
Q 041755 484 STSSSHLTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWA------------ 550 (678)
Q Consensus 484 ~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~------------ 550 (678)
...... ....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+...
T Consensus 174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 554332 23579999999998865 56899999999999999999999999765533221111000
Q ss_pred ccccccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 551 KPILKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 551 ~~~~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.+......+...................+.+++.+||+.||.+|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000111100000000001112234667789999999999999999885
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-42 Score=354.57 Aligned_cols=263 Identities=19% Similarity=0.228 Sum_probs=202.0
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFEDNNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~~~~lV~E 406 (678)
++|...+.||+|+||+||+|... +|+.||||+++.. ......+.+|+.+++.++||||++++++|.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57888999999999999999864 7899999998643 3567889999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccccCCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASWLSTS 486 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~~~~~ 486 (678)
++.+++|..++... ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99999988887543 568899999999999999999999 99999999999999999999999999999987654
Q ss_pred CCCceecccccCCCCCCcchhccCC-CCccceEeehhHHHHHHhcCCCCCCCCCCcccc-cchhh-cccc----------
Q 041755 487 SSHLTCTDVAGTFGYLAPEYFMHGK-VSEKIDVYAFGIVLLELLSGKKPINSENPKGQE-SLVMW-AKPI---------- 553 (678)
Q Consensus 487 ~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~-~l~~~-~~~~---------- 553 (678)
.... ....+++.|+|||.+.... ++.++|||||||++|||++|+.||......... ..+.. ....
T Consensus 155 ~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 VRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred Cccc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 3322 2346788999999987665 689999999999999999999997543322111 10000 0000
Q ss_pred -cccCccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 554 -LKDGKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 554 -~~~~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.............-...........+.+++..||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000000000111122244667789999999999999999875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=370.43 Aligned_cols=264 Identities=19% Similarity=0.256 Sum_probs=196.6
Q ss_pred hcCCCCceeecccCceEEEEEEe-CCCCEEEEEEeCCC--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC----eEE
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCL-PDGKELAVKILKPS--EDVLKEFASEIEIITALHHRNIISLFGFCFEDN----NLL 402 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~-~~g~~vAvK~l~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~----~~~ 402 (678)
+++|...+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|+++|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46788999999999999999986 48999999999753 356778999999999999999999999997643 234
Q ss_pred EEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 403 LVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 403 lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
++++|+.+|+|.+++.. ..+++..++.++.|++.||.|||+ ++||||||||+||||+.++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence 44556679999999964 358999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCCC-ceecccccCCCCCCcchhcc-CCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc--
Q 041755 483 LSTSSSH-LTCTDVAGTFGYLAPEYFMH-GKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK-- 558 (678)
Q Consensus 483 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~-- 558 (678)
....... ......+||+.|+|||.+.. ..++.++||||+||++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 6543222 12234679999999999854 5678999999999999999999999987654322211111100000000
Q ss_pred ------cccc--cCCCCCCCCCH-----HHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 559 ------VSQL--LDPSLDTDYDN-----DQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 559 ------~~~l--~dp~l~~~~~~-----~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.... ..+... .... .....+..++..||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKN-KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TCCCHHHHHHHHTSCCCC-CCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhcccccCCccC-CCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000000 0000 01134667889999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-42 Score=357.76 Aligned_cols=260 Identities=19% Similarity=0.230 Sum_probs=196.5
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCeee-EEEEEEeCCeEEEEEEc
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHHRNIIS-LFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnIv~-l~g~~~~~~~~~lV~E~ 407 (678)
.++|...+.||+|+||.||+|... +|+.||||++.... ...++..|+++++.++|+|++. +.+++.+++..++||||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 357899999999999999999864 78999999987543 2245788999999998776555 45556777889999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEec---CCCCcEEeecccccccC
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLS---DDFEPQLSDFGLASWLS 484 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~---~~~~~kL~DFGla~~~~ 484 (678)
+ +++|...+... ...+++..+..++.|++.||+|||+ ++||||||||+|||++ .+..+||+|||+|+.+.
T Consensus 85 ~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 L-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred c-CCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9 56776666532 3568999999999999999999999 9999999999999975 45679999999999876
Q ss_pred CCCCC-----ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCcc
Q 041755 485 TSSSH-----LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGKV 559 (678)
Q Consensus 485 ~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~~ 559 (678)
..... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 54322 1233468999999999999999999999999999999999999999775543322211110000000000
Q ss_pred ccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 560 SQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 560 ~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
+.+...+ ...+..++..||+.+|.+||++.++.++|+.
T Consensus 238 -----~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 238 -----EVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp -----HHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred -----hHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 0111111 2346677799999999999999999988864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-41 Score=355.25 Aligned_cols=260 Identities=18% Similarity=0.250 Sum_probs=204.5
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCCeEEEEEEc
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALHH-RNIISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~lV~E~ 407 (678)
.++|...+.||+|+||+||+|... +|+.||||+++.... ...+.+|++++..|.| +|++.+++++.++...++||||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 468999999999999999999865 789999999864321 2356789999999975 8999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecC-----CCCcEEeecccccc
Q 041755 408 LSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSD-----DFEPQLSDFGLASW 482 (678)
Q Consensus 408 ~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~-----~~~~kL~DFGla~~ 482 (678)
+ +++|.+++... +..+++..+..++.|++.||+|||+ ++||||||||+|||++. ++.+||+|||+|+.
T Consensus 83 ~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 83 L-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp C-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9 78999988653 2468999999999999999999999 99999999999999974 57899999999998
Q ss_pred cCCCCCC-----ceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccC
Q 041755 483 LSTSSSH-----LTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDG 557 (678)
Q Consensus 483 ~~~~~~~-----~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~ 557 (678)
+...... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 7543221 12234689999999999999999999999999999999999999998665443222111100000000
Q ss_pred ccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHHHhhc
Q 041755 558 KVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLKLLQG 606 (678)
Q Consensus 558 ~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~~L~~ 606 (678)
...+ +....+ +.+..++..|++.+|.+||++..+.+.|+.
T Consensus 236 ~~~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 236 PLRE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp CHHH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred ChHH-----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 1111 111122 346667789999999999999999888764
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-42 Score=366.10 Aligned_cols=258 Identities=21% Similarity=0.303 Sum_probs=192.3
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCC---ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC------
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKP---SEDVLKEFASEIEIITALHHRNIISLFGFCFEDN------ 399 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~~~------ 399 (678)
.++|...+.||+|+||+||+|... +|+.||||+++. .+...+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 367888999999999999999864 799999999974 3355678999999999999999999999997654
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
++|+||||+ +++|...+.. ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccc
Confidence 579999999 6677777643 458999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccc-----
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPI----- 553 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~----- 553 (678)
|+...... +...||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+..............
T Consensus 168 a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 98765432 346799999999998764 5689999999999999999999999775432211110000000
Q ss_pred ---ccc-------CccccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 554 ---LKD-------GKVSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 554 ---~~~-------~~~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
... ..+.+.....+.. ........+.+++..||..||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhhhcchhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0000000000000 00111234566789999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-41 Score=358.54 Aligned_cols=257 Identities=18% Similarity=0.288 Sum_probs=195.8
Q ss_pred cCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeC--CeEEEEEE
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALH-HRNIISLFGFCFED--NNLLLVYD 406 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~--~~~~lV~E 406 (678)
++|...+.||+|+||+||+|... +|+.||||+++... .+.+.+|+.+|..++ ||||+++++++... ..+++|||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 57999999999999999999874 79999999997654 356889999999996 99999999999743 56999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCC-CcEEeecccccccCC
Q 041755 407 FLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDF-EPQLSDFGLASWLST 485 (678)
Q Consensus 407 ~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kL~DFGla~~~~~ 485 (678)
|+.+++|.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+|+....
T Consensus 113 ~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 113 HVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp CCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred ecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccC
Confidence 99999987654 358999999999999999999999 9999999999999998655 699999999987755
Q ss_pred CCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCccccc-ch----------hhcc--
Q 041755 486 SSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQES-LV----------MWAK-- 551 (678)
Q Consensus 486 ~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~-l~----------~~~~-- 551 (678)
.... ....||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......... .+ .|..
T Consensus 183 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 4322 346789999999998765 47999999999999999999999997654321110 00 0000
Q ss_pred cccccCcccccc--------CCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 552 PILKDGKVSQLL--------DPSLDTDYDNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 552 ~~~~~~~~~~l~--------dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.......+.... ...............+.+++..||+.||.+|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000 000111111112234667789999999999999999985
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-41 Score=357.63 Aligned_cols=260 Identities=21% Similarity=0.254 Sum_probs=191.3
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe------CC
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFE------DN 399 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~------~~ 399 (678)
.++|...++||+|+||+||+|... +|+.||||+++.. ......+.+|+.++++++||||++++++|.. .+
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999865 6999999999643 4556788999999999999999999999963 36
Q ss_pred eEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeeccc
Q 041755 400 NLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGL 479 (678)
Q Consensus 400 ~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGl 479 (678)
++|+||||+.++ +...+. ..+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhh
Confidence 899999999655 445543 358999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchh----------h
Q 041755 480 ASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVM----------W 549 (678)
Q Consensus 480 a~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~----------~ 549 (678)
++...... ..+...||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.......+. |
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 88765433 2334679999999999999999999999999999999999999997654322111100 0
Q ss_pred ------------cccccccCccccccCCCCCCCC---CHHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 550 ------------AKPILKDGKVSQLLDPSLDTDY---DNDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 550 ------------~~~~~~~~~~~~l~dp~l~~~~---~~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
..+..........+........ .......+.+++.+||..||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000000011111111111111 1223456788899999999999999999985
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=357.93 Aligned_cols=251 Identities=23% Similarity=0.349 Sum_probs=199.6
Q ss_pred cCCCCceeecccCceEEEEEEe----CCCCEEEEEEeCCC-----hHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCCe
Q 041755 331 SNFLPEYLVGKGGHSHVYRGCL----PDGKELAVKILKPS-----EDVLKEFASEIEIITALHH-RNIISLFGFCFEDNN 400 (678)
Q Consensus 331 ~~f~~~~~IG~G~~g~Vy~g~~----~~g~~vAvK~l~~~-----~~~~~~~~~Ei~il~~l~H-pnIv~l~g~~~~~~~ 400 (678)
++|...+.||+|+||+||+|.. .+|+.||||+++.. ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5688899999999999999974 25899999998642 2335668899999999976 899999999999999
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
.++||||+.+|+|.+++... ..+++...+.++.||+.||.|||+ ++|+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999754 357888999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccC--CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhcccccccCc
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHG--KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPILKDGK 558 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~~~~~ 558 (678)
+.+....... .....||+.|+|||.+.+. .++.++|||||||+||||++|+.||...........+... ..
T Consensus 177 ~~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--~~---- 249 (322)
T d1vzoa_ 177 KEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--IL---- 249 (322)
T ss_dssp EECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--HH----
T ss_pred hhhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--cc----
Confidence 8765543332 2346899999999999764 4688999999999999999999999876544322111100 00
Q ss_pred cccccCCCCCCCCCHHHHHHHHHHHHhcccCCCCCCCC-----HHHHHH
Q 041755 559 VSQLLDPSLDTDYDNDQIERMVLAATLSISRAPTVRPQ-----INLVLK 602 (678)
Q Consensus 559 ~~~l~dp~l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs-----~~eVl~ 602 (678)
. ..+.+ .......+..++..||..||.+||+ +.|+++
T Consensus 250 -~--~~~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 -K--SEPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -H--CCCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -c--CCCCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0 00111 1122345667779999999999995 677764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-41 Score=358.14 Aligned_cols=260 Identities=20% Similarity=0.254 Sum_probs=193.6
Q ss_pred hcCCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCC---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-----CCe
Q 041755 330 TSNFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPS---EDVLKEFASEIEIITALHHRNIISLFGFCFE-----DNN 400 (678)
Q Consensus 330 t~~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~g~~~~-----~~~ 400 (678)
.++|...+.||+|+||+||+|... +|+.||||+++.. ....+.+.+|+++|++++||||+++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999864 7999999999753 3456778999999999999999999999863 234
Q ss_pred EEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEEeecccc
Q 041755 401 LLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQLSDFGLA 480 (678)
Q Consensus 401 ~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla 480 (678)
.+++++|+.+|+|.+++.. ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchh
Confidence 5667788889999999853 358999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCCCceecccccCCCCCCcchhccC-CCCccceEeehhHHHHHHhcCCCCCCCCCCcccccchhhccccc-----
Q 041755 481 SWLSTSSSHLTCTDVAGTFGYLAPEYFMHG-KVSEKIDVYAFGIVLLELLSGKKPINSENPKGQESLVMWAKPIL----- 554 (678)
Q Consensus 481 ~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~l~~~~~~~~----- 554 (678)
...... .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+.......
T Consensus 169 ~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 765432 2346789999999987765 46889999999999999999999998765332211111000000
Q ss_pred ---ccCccccccCCCCC-CCCC-----HHHHHHHHHHHHhcccCCCCCCCCHHHHHH
Q 041755 555 ---KDGKVSQLLDPSLD-TDYD-----NDQIERMVLAATLSISRAPTVRPQINLVLK 602 (678)
Q Consensus 555 ---~~~~~~~l~dp~l~-~~~~-----~~~~~~l~~la~~Cl~~dP~~RPs~~eVl~ 602 (678)
.............. .... ......+.+++..||+.||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00000000000000 0000 011234567789999999999999999985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.2e-36 Score=322.01 Aligned_cols=263 Identities=16% Similarity=0.241 Sum_probs=193.0
Q ss_pred CCCCceeecccCceEEEEEEeC-CCCEEEEEEeCCChHHHHHHHHHHHHHHhcC-----------CCCeeeEEEEEEe--
Q 041755 332 NFLPEYLVGKGGHSHVYRGCLP-DGKELAVKILKPSEDVLKEFASEIEIITALH-----------HRNIISLFGFCFE-- 397 (678)
Q Consensus 332 ~f~~~~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~-----------HpnIv~l~g~~~~-- 397 (678)
+|...+.||+|+||+||+|+.. +|+.||||+++......+.+.+|+.+++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 5888999999999999999864 7999999999988766778889999998875 5789999998854
Q ss_pred CCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCC------
Q 041755 398 DNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFE------ 471 (678)
Q Consensus 398 ~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~------ 471 (678)
....+++|+++..+......... .....+++..+..++.||+.||.|||+ ..+|+||||||+||||+.++.
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred ccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 35667777776555433332221 234678899999999999999999996 378999999999999986654
Q ss_pred cEEeecccccccCCCCCCceecccccCCCCCCcchhccCCCCccceEeehhHHHHHHhcCCCCCCCCCCccccc----ch
Q 041755 472 PQLSDFGLASWLSTSSSHLTCTDVAGTFGYLAPEYFMHGKVSEKIDVYAFGIVLLELLSGKKPINSENPKGQES----LV 547 (678)
Q Consensus 472 ~kL~DFGla~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvvL~eLltG~~Pf~~~~~~~~~~----l~ 547 (678)
++|+|||.+....... ....||+.|+|||++.+..++.++||||+||++++|++|+.||.......... +.
T Consensus 171 ~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 8999999998654422 23679999999999999999999999999999999999999997654321110 00
Q ss_pred hhcc-----------------cccccCccccccCCC----------CCCCCCHHHHHHHHHHHHhcccCCCCCCCCHHHH
Q 041755 548 MWAK-----------------PILKDGKVSQLLDPS----------LDTDYDNDQIERMVLAATLSISRAPTVRPQINLV 600 (678)
Q Consensus 548 ~~~~-----------------~~~~~~~~~~l~dp~----------l~~~~~~~~~~~l~~la~~Cl~~dP~~RPs~~eV 600 (678)
.... ...........+... ....+.......+.+++..||..||.+|||+.|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 0000 000000000000000 0123345667788899999999999999999998
Q ss_pred HH
Q 041755 601 LK 602 (678)
Q Consensus 601 l~ 602 (678)
++
T Consensus 326 L~ 327 (362)
T d1q8ya_ 326 VN 327 (362)
T ss_dssp HT
T ss_pred hc
Confidence 74
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.8e-23 Score=202.73 Aligned_cols=162 Identities=15% Similarity=0.180 Sum_probs=121.2
Q ss_pred CCceeecccCceEEEEEEeCCCCEEEEEEeCCCh-------------------HHHHHHHHHHHHHHhcCCCCeeeEEEE
Q 041755 334 LPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE-------------------DVLKEFASEIEIITALHHRNIISLFGF 394 (678)
Q Consensus 334 ~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~-------------------~~~~~~~~Ei~il~~l~HpnIv~l~g~ 394 (678)
...+.||+|+||.||+|...+|+.||||+++.+. .....+..|+..+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4578899999999999998899999999876421 112345678899999999999988865
Q ss_pred EEeCCeEEEEEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCCCCCeEecCCCCcEE
Q 041755 395 CFEDNNLLLVYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSCEQPVIHKDVKSSNILLSDDFEPQL 474 (678)
Q Consensus 395 ~~~~~~~~lV~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kL 474 (678)
. . .+++|||++++.+.. +++.....++.|++.+|.|||+ .+|+||||||+|||++++ .++|
T Consensus 83 ~--~--~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E--G--NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E--T--TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEE
T ss_pred c--C--CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEE
Confidence 3 2 289999998765433 2233456789999999999999 999999999999999976 4899
Q ss_pred eecccccccCCCCCCceecccccCCCCCC------cchhccCCCCccceEeehhHHH
Q 041755 475 SDFGLASWLSTSSSHLTCTDVAGTFGYLA------PEYFMHGKVSEKIDVYAFGIVL 525 (678)
Q Consensus 475 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~A------PE~l~~~~~s~ksDVwSlGvvL 525 (678)
+|||+|......... .|+. .+++ ...|+.++|+||..--+
T Consensus 144 iDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999998765432211 0111 1222 36678899999976544
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.84 E-value=3.3e-21 Score=183.20 Aligned_cols=133 Identities=19% Similarity=0.242 Sum_probs=103.9
Q ss_pred CcEEEEEEcCCh---------hhHHHHHHHHhhccCCCCe---EEEEEeecCCCC-------CcCc-------hhhhhhH
Q 041755 4 GKVVVVGVKFDG---------ESRELLTWALVKVAQPGDR---IIALHVLDTITE-------STGS-------LLSLVKT 57 (678)
Q Consensus 4 ~r~I~VavD~s~---------~S~~AL~WAl~~~~~~gd~---vvlvhV~~~~~~-------~~~~-------~~~~~~~ 57 (678)
.++|+||||+|. .|++||+||++++.+.||+ |+++||.+.... .... .....+.
T Consensus 1 p~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (171)
T d2gm3a1 1 PTKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFDDVDSIYASPEDFRDMRQSNKAK 80 (171)
T ss_dssp CEEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC----------CCCCSHHHHHHHTTSHHHH
T ss_pred CCEEEEEEcCCcccCCCCCCHHHHHHHHHHHHHHHHCCCCCcEEEEEEeccccccccccccccccCHHHHHHHHHHHHHH
Confidence 479999999986 7999999999999999995 999999876440 0000 1112234
Q ss_pred HHHHHHHHHhhhhccCCeEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEE
Q 041755 58 FDSMLSVYEGFCNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAV 136 (678)
Q Consensus 58 ~~~~l~~~~~~C~~k~v~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v 136 (678)
..++|+.+...|..+++.++..+.. |++.++|+++|++.++|+||||+++++.+.+. .|||++||++|++ |+|++|
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~lGSv~~~vi~~~~--cpVlvV 157 (171)
T d2gm3a1 81 GLHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVMTI 157 (171)
T ss_dssp HHHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCS--SCEEEE
T ss_pred HHHHHHHHHHHHHhcCCceEEEEEe-CChHHHHHHHHhhcCCcEEEeccCCccccccCccCcHHHHHHhCCC--CCEEEE
Confidence 4589999999999999999999988 89999999999999999999999998544332 3599999999996 888888
Q ss_pred eCC
Q 041755 137 ENG 139 (678)
Q Consensus 137 ~~~ 139 (678)
+.+
T Consensus 158 ~~~ 160 (171)
T d2gm3a1 158 KRN 160 (171)
T ss_dssp ECC
T ss_pred eCC
Confidence 754
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.76 E-value=1.7e-18 Score=161.97 Aligned_cols=133 Identities=17% Similarity=0.101 Sum_probs=107.2
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCC----------Cc----Cch--------hhhhhHHHHH
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITE----------ST----GSL--------LSLVKTFDSM 61 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~----------~~----~~~--------~~~~~~~~~~ 61 (678)
=|+|+||||+|+.|.+||+||++.+...+..|++|||.++... +. ... ....+...+.
T Consensus 3 ~~~ILvavD~s~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (160)
T d1mjha_ 3 YKKILYPTDFSETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNK 82 (160)
T ss_dssp CCEEEEECCSCHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHH
T ss_pred cCeEEEEECCCHHHHHHHHHHHHHHHhcCCEEEEEEecccccccccccccccccccccchhHHHHHHHHHHHHHHHHHHH
Confidence 4899999999999999999999988889999999999876430 00 000 0112233478
Q ss_pred HHHHHhhhhccCCeEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeCC
Q 041755 62 LSVYEGFCNLKQVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVENG 139 (678)
Q Consensus 62 l~~~~~~C~~k~v~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~~ 139 (678)
|+.+...|...+|.++.++.. |++.+.|+++|++.++|++|||+|+++.+.+. .||+++|+++|++ |||++|+++
T Consensus 83 l~~~~~~~~~~gv~~~~~~~~-G~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~GS~a~~vl~~s~--~pVlvV~~~ 158 (160)
T d1mjha_ 83 MENIKKELEDVGFKVKDIIVV-GIPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSN--KPVLVVKRK 158 (160)
T ss_dssp HHHHHHHHHHTTCEEEEEEEE-ECHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCC--SCEEEECCC
T ss_pred HHHHHHHHHhcCCeEEEEEEe-ccHHHHHhhhhhccccceEEeccCCCCcccccccCcHHHHHHhcCC--CCEEEEcCC
Confidence 888888899999999999998 89999999999999999999999988433332 3499999999996 888888764
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.74 E-value=2.1e-18 Score=156.60 Aligned_cols=130 Identities=14% Similarity=0.112 Sum_probs=98.4
Q ss_pred cEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCC-CCcCch--hhhhhHHHHHHHHHHhhhhccCCeEEEEEE
Q 041755 5 KVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTIT-ESTGSL--LSLVKTFDSMLSVYEGFCNLKQVDLKLKVC 81 (678)
Q Consensus 5 r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~-~~~~~~--~~~~~~~~~~l~~~~~~C~~k~v~~~~~v~ 81 (678)
|+|+|+||+|+.|++||+||++.+.+.++.|+++||.++.. ...... ....+..+++.+.++.++...++.....++
T Consensus 2 k~Ilv~~D~s~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 81 (135)
T d2z3va1 2 KTILLAYDGSEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLGEPFFEEALRRRLERAEGVLEEARALTGVPKEDALL 81 (135)
T ss_dssp CEEEEECCSSHHHHHHHHHHHHHHHHHTCEEEEEEEECCCCTTCCTTHHHHHHHHHHHHHHHHHHHHHHHHCCCGGGEEE
T ss_pred CEEEEEECCCHHHHHHHHHHHHHHHHcCCEEEEEEEecCCccccccchhHHHHHHHHHHHHHHHHHHHHhcCCCeEEEEE
Confidence 78999999999999999999999889999999999998654 111111 111222234445555555556666555666
Q ss_pred ECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEE
Q 041755 82 RGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAV 136 (678)
Q Consensus 82 ~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v 136 (678)
.+|++.++|+++|++.++|+||||+++++...+. .||+++||++|++ |||++|
T Consensus 82 ~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~ll~~~~--~pVlvV 135 (135)
T d2z3va1 82 LEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAP--CPVLLV 135 (135)
T ss_dssp EESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSCBHHHHHHHHHCS--SCEEEE
T ss_pred EcCChHHHHHHHhhhhheeeEEeccCCCCcccccccCcHHHHHHHhCC--CCEEeC
Confidence 6699999999999999999999999998543332 3599999999997 777765
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=99.69 E-value=2.5e-17 Score=150.09 Aligned_cols=131 Identities=13% Similarity=0.145 Sum_probs=101.3
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCCC-CcCchhhhhhH-----HHHHHHHHHhhhhccCCeEE
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTITE-STGSLLSLVKT-----FDSMLSVYEGFCNLKQVDLK 77 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~~-~~~~~~~~~~~-----~~~~l~~~~~~C~~k~v~~~ 77 (678)
-++|+||||+++.|+.||+||+..+.+.|+.|+++||.+++.. ........... ..+....+..++...+....
T Consensus 2 yk~ILv~vD~s~~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (140)
T d1jmva_ 2 YKHILVAVDLSEESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYTGLIDVNMSSMQDRISTETQKALLDLAESVDYPIS 81 (140)
T ss_dssp CSEEEEEECCSTTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCCCCEEHHHHHHTTCCCCHHHHHHHHHHHHSSSCCC
T ss_pred CCeEEEEECCCHHHHHHHHHHHHHHHHcCCeEEEEEEeeecccccccccccchHHHHHHHHHHHHHHHHHHHHhcCCceE
Confidence 4799999999999999999999998888999999999887651 11110000000 11445555666666666666
Q ss_pred EEEEECCchhHHHHHHHHhcCCcEEEEccCCCccccccCcchhhHhhhcCCCceEEEEEeC
Q 041755 78 LKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAKYCARKLSKNFGVFAVEN 138 (678)
Q Consensus 78 ~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~~~svs~yc~~~ap~~c~V~~v~~ 138 (678)
..++++|++.++|+++|+++++|+||||+|+++....| |+++|+++|++ |||++|+-
T Consensus 82 ~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~~lg--s~~~~li~~~~--~pVliVp~ 138 (140)
T d1jmva_ 82 EKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWSKLM--SSTRQVMNTIK--IDMLVVPL 138 (140)
T ss_dssp CEEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHHHHH--HHHHHHHTTCC--SEEEEEEC
T ss_pred EEEEEecCHHHHHHHhhhhchhhEEEeccCCCCCCCcc--cHHHHHHhccC--CCEEEEec
Confidence 66777799999999999999999999999987655555 99999999996 88888863
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.67 E-value=1.4e-16 Score=146.31 Aligned_cols=132 Identities=14% Similarity=0.034 Sum_probs=95.5
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEe-ecCCCC--------CcCchhhhhhHHHHHHHHHHhhhhccCC
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHV-LDTITE--------STGSLLSLVKTFDSMLSVYEGFCNLKQV 74 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV-~~~~~~--------~~~~~~~~~~~~~~~l~~~~~~C~~k~v 74 (678)
-|+|+|+||+|+.|++||+||+..+. .++.++++|+ .++... .........+...+.++.++..|...++
T Consensus 5 yk~ILv~vD~s~~s~~al~~A~~la~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 83 (147)
T d1tq8a_ 5 YKTVVVGTDGSDSSMRAVDRAAQIAG-ADAKLIIASAYLPQHEDARAADILKDESYKVTGTAPIYEILHDAKERAHNAGA 83 (147)
T ss_dssp CCEEEEECCSSHHHHHHHHHHHHHHT-TTSEEEEEEECCC--------------------CCTHHHHHHHHHHHHHTTTC
T ss_pred CCEEEEEECCCHHHHHHHHHHHHHHh-cCCCEEEEEEEecccccccccccchhhhHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 48999999999999999999998664 4555445554 433220 0111122233445888999999998888
Q ss_pred eEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCcccccc-CcchhhHhhhcCCCceEEEEEeC
Q 041755 75 DLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRS-SVSVAKYCARKLSKNFGVFAVEN 138 (678)
Q Consensus 75 ~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~-~~svs~yc~~~ap~~c~V~~v~~ 138 (678)
......+..|++.+.|+++|+++++|+||||+++++...+. .||++.||+++++ |||++|+.
T Consensus 84 ~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~Gs~~~~ll~~~~--~pVlvV~~ 146 (147)
T d1tq8a_ 84 KNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAK--VDVLIVHT 146 (147)
T ss_dssp CEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTT--CEEEEECC
T ss_pred CcEEEEEEecChHHHHHHhhhccceeEEEecCCCCCcccccccccHHHHHHHhCC--CCEEEEec
Confidence 74444445599999999999999999999999987543331 3599999999996 89999873
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=99.47 E-value=5.5e-14 Score=126.91 Aligned_cols=122 Identities=14% Similarity=0.018 Sum_probs=90.0
Q ss_pred cEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecCCC--------CCcCchhh----hhhHHHHHHHHHHhhhhcc
Q 041755 5 KVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDTIT--------ESTGSLLS----LVKTFDSMLSVYEGFCNLK 72 (678)
Q Consensus 5 r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~~~--------~~~~~~~~----~~~~~~~~l~~~~~~C~~k 72 (678)
|+|+||+|+|+.|+.||+||++...+.|+.|+++||..+.. .+...... ..+...+.++.+..-+...
T Consensus 5 k~ILv~~D~S~~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~l~~~~~~~~~~ 84 (138)
T d1q77a_ 5 KVLLVLTDAYSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPFPPEIKEESKKRIERRLREVWEKLTGS 84 (138)
T ss_dssp EEEEEEESTTCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCCCTHHHHHHHHHHHHHHHHHHHHHHSC
T ss_pred CEEEEEEeCCHHHHHHHHHHHHhhhhccceEEEEEEccCcccccccccccccchhhhhhhhhhhhccccchhhccccccc
Confidence 79999999999999999999999999999999999986532 01111111 1122234444444444456
Q ss_pred CCeEEEEEEECCchhHHHHHHHHhcCCcEEEEccCCCccccccCcchhhHhhhcCCCceEEEEEe
Q 041755 73 QVDLKLKVCRGTSVKKIIVKEAKSYGEAKVIVGISKTHRTIRSSVSVAKYCARKLSKNFGVFAVE 137 (678)
Q Consensus 73 ~v~~~~~v~~~~d~~~~l~~~a~~~~a~~LVlG~~~~~~~~r~~~svs~yc~~~ap~~c~V~~v~ 137 (678)
++.++.++.. |++.+.|+++|++.++|++|||+|+++ ....++... .|++++||
T Consensus 85 ~~~~~~~v~~-G~~~~~I~~~a~~~~~DLIV~Gs~g~~--------~l~r~l~g~--~~~~livk 138 (138)
T d1q77a_ 85 TEIPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPSA--------YLCKVIDGL--NLASLIVK 138 (138)
T ss_dssp CCCCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCGG--------GTHHHHHHS--SSEEEECC
T ss_pred ceeEEEeeec-chhHHHHHHhhhhccCCEEEEecCCCc--------HHHHHhcCC--CCCEEEeC
Confidence 7888888888 999999999999999999999999863 223344444 48888875
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.45 E-value=2.4e-07 Score=91.39 Aligned_cols=147 Identities=16% Similarity=0.114 Sum_probs=98.4
Q ss_pred HHHhhcCCCCceeecccCceEEEEEEeCCCCEEEEEEeCCCh-HHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCCeEEE
Q 041755 326 LLSATSNFLPEYLVGKGGHSHVYRGCLPDGKELAVKILKPSE-DVLKEFASEIEIITALH-HRNIISLFGFCFEDNNLLL 403 (678)
Q Consensus 326 l~~~t~~f~~~~~IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~-~~~~~~~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~l 403 (678)
+......|...+..+-+..+.||+... +++.+++|+..... .....+.+|..++..|. +--+.+++.++..++..++
T Consensus 9 l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence 333344454444333333468999765 66778888876432 22334677888888775 3335677888888889999
Q ss_pred EEEcCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 041755 404 VYDFLSRGSLEENLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC--------------------------------- 450 (678)
Q Consensus 404 V~E~~~~gsL~~~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--------------------------------- 450 (678)
||+++++.++.+..... . ....++.++++.|..||+..
T Consensus 88 v~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEeccccccccccccc------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 99999998886654211 1 12335566667777777521
Q ss_pred -----------------------CCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 451 -----------------------EQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 451 -----------------------~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 02378999999999999877777999987653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.00 E-value=6e-06 Score=80.63 Aligned_cols=130 Identities=18% Similarity=0.099 Sum_probs=86.5
Q ss_pred ecccCc-eEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCC--CCeeeEEEEEEeCCeEEEEEEcCCCCCHHH
Q 041755 339 VGKGGH-SHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHH--RNIISLFGFCFEDNNLLLVYDFLSRGSLEE 415 (678)
Q Consensus 339 IG~G~~-g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 415 (678)
+..|.. +.||+....+|..+++|....... ..+..|...++.|.. -.+.+++.++.+++..++||+|+++.++.+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence 455554 689999887888899998876542 245677877777643 335677888888888999999998765432
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------------
Q 041755 416 NLHGNKKDGNAFGWTERYKVAVGVAEALDYLHNSC--------------------------------------------- 450 (678)
Q Consensus 416 ~L~~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--------------------------------------------- 450 (678)
.. ..- ..++.+++..|.-||...
T Consensus 96 ~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 96 SH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp SC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 10 010 112223333344444210
Q ss_pred ----------CCCeeeccCCCCCeEecCCCCcEEeecccccc
Q 041755 451 ----------EQPVIHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 451 ----------~~~iiHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
...++|+|+.|.|||++++..+-|+||+.+.+
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 12379999999999999887778999987653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.35 E-value=0.00014 Score=75.93 Aligned_cols=75 Identities=17% Similarity=0.156 Sum_probs=47.9
Q ss_pred eeecccCceEEEEEEeC-CCCEEEEEEeCCC-----h---HHHHHHHHHHHHHHhcC-C--CCeeeEEEEEEeCCeEEEE
Q 041755 337 YLVGKGGHSHVYRGCLP-DGKELAVKILKPS-----E---DVLKEFASEIEIITALH-H--RNIISLFGFCFEDNNLLLV 404 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~-~g~~vAvK~l~~~-----~---~~~~~~~~Ei~il~~l~-H--pnIv~l~g~~~~~~~~~lV 404 (678)
+.||.|....||+.... +|+.|+||.-.+. + ....+...|.+.|..+. + ..+.+++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 46899999999999865 4778999975431 1 11233456887777663 2 345556654 34455899
Q ss_pred EEcCCCCCH
Q 041755 405 YDFLSRGSL 413 (678)
Q Consensus 405 ~E~~~~gsL 413 (678)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999977543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.28 E-value=0.00046 Score=69.92 Aligned_cols=137 Identities=17% Similarity=0.227 Sum_probs=80.1
Q ss_pred ceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCe-----eeEE--EEEEeCCeEEEEEEcCCCCCHH--
Q 041755 344 HSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHHRNI-----ISLF--GFCFEDNNLLLVYDFLSRGSLE-- 414 (678)
Q Consensus 344 ~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l~--g~~~~~~~~~lV~E~~~~gsL~-- 414 (678)
--.||+....+|..|++|+.++.....+++..|+..+..|...++ +..- ..+..++..+.+++|++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 368999999999999999999876555677788888887742211 1111 1223456788899998763221
Q ss_pred ------------HHhc----cCC-CCCCCCCHHH-------------------HHHHHHHHHHHHHHHHh----cCCCCe
Q 041755 415 ------------ENLH----GNK-KDGNAFGWTE-------------------RYKVAVGVAEALDYLHN----SCEQPV 454 (678)
Q Consensus 415 ------------~~L~----~~~-~~~~~l~~~~-------------------~~~ia~qia~aL~yLH~----~~~~~i 454 (678)
-.+| ... .....+++.. +..+...+...+..+.. ....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 1111 110 0111222211 11112222223333322 224678
Q ss_pred eeccCCCCCeEecCCCCcEEeecccccc
Q 041755 455 IHKDVKSSNILLSDDFEPQLSDFGLASW 482 (678)
Q Consensus 455 iHrDIKp~NILl~~~~~~kL~DFGla~~ 482 (678)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 46899987753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.54 E-value=0.0098 Score=59.02 Aligned_cols=159 Identities=14% Similarity=0.061 Sum_probs=81.3
Q ss_pred ccHHHHHHhhcCCCCcee-----ecccCceEEEEEEeCCCCEEEEEEeCCChHHHHHHHHHHHHHHhcCC-----CCeee
Q 041755 321 FSYQELLSATSNFLPEYL-----VGKGGHSHVYRGCLPDGKELAVKILKPSEDVLKEFASEIEIITALHH-----RNIIS 390 (678)
Q Consensus 321 f~~~el~~~t~~f~~~~~-----IG~G~~g~Vy~g~~~~g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~H-----pnIv~ 390 (678)
.+.+|+.....+|..+.+ |..|---+.|+...++|+ +++|+..... ...++..|++++..|.. |..+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~-~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV-EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC-CHHHHHHHHHHHHhhhhccccccccce
Confidence 355677777777766544 335556788998886665 8999986532 22334456666666632 22221
Q ss_pred EE-E--EEEeCCeEEEEEEcCCCCCHH--------------HHhccC----C--CCCCCCCH-H----------------
Q 041755 391 LF-G--FCFEDNNLLLVYDFLSRGSLE--------------ENLHGN----K--KDGNAFGW-T---------------- 430 (678)
Q Consensus 391 l~-g--~~~~~~~~~lV~E~~~~gsL~--------------~~L~~~----~--~~~~~l~~-~---------------- 430 (678)
.. | +..-......++.++.+.... ..++.. . .......+ .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11 0 112234566677776553221 011100 0 00000000 0
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCCeeeccCCCCCeEecCCCCcEEeeccccc
Q 041755 431 ERYKVAVGVAEALDYLHN-SCEQPVIHKDVKSSNILLSDDFEPQLSDFGLAS 481 (678)
Q Consensus 431 ~~~~ia~qia~aL~yLH~-~~~~~iiHrDIKp~NILl~~~~~~kL~DFGla~ 481 (678)
.....+..+...+.-.+. ....++||+|+.++||+++.+...-|+||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011111112222222211 224789999999999999998777899999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.34 E-value=0.0049 Score=63.73 Aligned_cols=72 Identities=15% Similarity=0.251 Sum_probs=48.6
Q ss_pred eeecccCceEEEEEEeCC--------CCEEEEEEeCCChHHHHHHHHHHHHHHhcCCCCe-eeEEEEEEeCCeEEEEEEc
Q 041755 337 YLVGKGGHSHVYRGCLPD--------GKELAVKILKPSEDVLKEFASEIEIITALHHRNI-ISLFGFCFEDNNLLLVYDF 407 (678)
Q Consensus 337 ~~IG~G~~g~Vy~g~~~~--------g~~vAvK~l~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~lV~E~ 407 (678)
..|+-|-.-.+|+....+ .+.|.+++.-..... ....+|..+++.+.-.++ .++++++. + .+||||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-SHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-HHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-hHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEEEE
Confidence 457888889999998654 356788877533222 345578888888863344 46777663 2 689999
Q ss_pred CCCCCH
Q 041755 408 LSRGSL 413 (678)
Q Consensus 408 ~~~gsL 413 (678)
+++.+|
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 976443
|
| >d1wy5a1 c.26.2.5 (A:1-216) TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: TilS-like protein Aq 1887 species: Aquifex aeolicus [TaxId: 63363]
Probab=93.18 E-value=0.2 Score=46.70 Aligned_cols=96 Identities=10% Similarity=0.045 Sum_probs=63.4
Q ss_pred CCcEEEEEEcCChhhHHHHHHHHhhccC--CCCeEEEEEeecCCCCCcCchhhhhhHHHHHHHHHHhhhhccCCeEEEEE
Q 041755 3 QGKVVVVGVKFDGESRELLTWALVKVAQ--PGDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLKQVDLKLKV 80 (678)
Q Consensus 3 ~~r~I~VavD~s~~S~~AL~WAl~~~~~--~gd~vvlvhV~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~v~~~~~v 80 (678)
++++|+|||-+...|..+|.+ |..+.. ....|.++||-+.-. +....-....+.+|...+|.+...-
T Consensus 23 ~~~kv~Va~SGG~DS~~Ll~l-L~~~~~~~~~~~i~~~~vdh~~r----------~~s~~~~~~~~~~~~~l~i~~~i~~ 91 (216)
T d1wy5a1 23 GERRVLIAFSGGVDSVVLTDV-LLKLKNYFSLKEVALAHFNHMLR----------ESAERDEEFCKEFAKERNMKIFVGK 91 (216)
T ss_dssp SCCEEEEECCSSHHHHHHHHH-HHHSTTTTTCSEEEEEEEECCSS----------THHHHHHHHHHHHHHHHTCCEEEEE
T ss_pred CCCeEEEEeCCcHHHHHHHHH-HHHHHHhcCCCcEEEEEeecccc----------cchhhhhhHHHHHHHhhhhhhhhhc
Confidence 467999999999999966644 444443 234799999975321 1111122446778888888775443
Q ss_pred EEC--------C-------ch-hHHHHHHHHhcCCcEEEEccCCC
Q 041755 81 CRG--------T-------SV-KKIIVKEAKSYGEAKVIVGISKT 109 (678)
Q Consensus 81 ~~~--------~-------d~-~~~l~~~a~~~~a~~LVlG~~~~ 109 (678)
+.. . .. ...+.+.|++.+++.|++|.|..
T Consensus 92 ~~~~~~~~~~~~~~~~~~R~~Ry~~l~~~a~~~~~~~ia~GH~~d 136 (216)
T d1wy5a1 92 EDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (216)
T ss_dssp CCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred cchhhhccCCccchHHHHHHHHHHHhhhhccccccceeEeeeecc
Confidence 320 0 11 24678899999999999999964
|
| >d1ni5a1 c.26.2.5 (A:0-226) tRNA-Ile-lysidine synthetase, TilS, N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: tRNA-Ile-lysidine synthetase, TilS, N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=90.23 E-value=0.21 Score=46.79 Aligned_cols=96 Identities=16% Similarity=0.144 Sum_probs=61.1
Q ss_pred CCcEEEEEEcCChhhHHHHHHHHhhcc-CCCCeEEEEEeecCCCCCcCchhhhhhHHHHHHHHHHhhhhccCCeEEEEEE
Q 041755 3 QGKVVVVGVKFDGESRELLTWALVKVA-QPGDRIIALHVLDTITESTGSLLSLVKTFDSMLSVYEGFCNLKQVDLKLKVC 81 (678)
Q Consensus 3 ~~r~I~VavD~s~~S~~AL~WAl~~~~-~~gd~vvlvhV~~~~~~~~~~~~~~~~~~~~~l~~~~~~C~~k~v~~~~~v~ 81 (678)
.+++|+|||-+...|..+|..+.+-.. .++-.|+++||-+... .....-....+.+|...+|.+...-.
T Consensus 12 ~~kkvlva~SGG~DS~~Ll~ll~~~~~~~~~~~l~~~~vdh~~r----------~~s~~~~~~~~~~~~~~~i~~~i~~~ 81 (227)
T d1ni5a1 12 TSRQILVAFSGGLDSTVLLHQLVQWRTENPGVALRAIHVHHGLS----------ANADAWVTHCENVCQQWQVPLVVERV 81 (227)
T ss_dssp TCSEEEEECCSBHHHHHHHHHHHHHHTTSTTCEEEEEEECCSCC----------SSHHHHHHHHHHHHHHTTCCEEEECC
T ss_pred CCCcEEEEecCcHHHHHHHHHHHHHHHhCCCceEEEEEeCCCCC----------cchhhhHHHHHHHHhhccCcceeeec
Confidence 367999999999999977765544432 3578999999975321 01122335567789988888776544
Q ss_pred ECCchh----------HHHHHHHHhcCCcEEEEccCC
Q 041755 82 RGTSVK----------KIIVKEAKSYGEAKVIVGISK 108 (678)
Q Consensus 82 ~~~d~~----------~~l~~~a~~~~a~~LVlG~~~ 108 (678)
...... ......+...+++.+++|-|.
T Consensus 82 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~i~~gH~~ 118 (227)
T d1ni5a1 82 QLAQEGLGIEAQARQARYQAFARTLLPGEVLVTAQHL 118 (227)
T ss_dssp CCCCSSSTTTTHHHHHHHHHHHHTCCTTEEEECCCCH
T ss_pred cccccccchhhHHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 321111 123334456678888888664
|
| >d2c5sa1 c.26.2.6 (A:174-391) Thiamine biosynthesis protein ThiI, C-terminal domain {Bacillus anthracis [TaxId: 1392]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: ThiI-like domain: Thiamine biosynthesis protein ThiI, C-terminal domain species: Bacillus anthracis [TaxId: 1392]
Probab=85.64 E-value=2.4 Score=38.19 Aligned_cols=36 Identities=19% Similarity=0.103 Sum_probs=29.6
Q ss_pred CcEEEEEEcCChhhHHHHHHHHhhccCCCCeEEEEEeecC
Q 041755 4 GKVVVVGVKFDGESRELLTWALVKVAQPGDRIIALHVLDT 43 (678)
Q Consensus 4 ~r~I~VavD~s~~S~~AL~WAl~~~~~~gd~vvlvhV~~~ 43 (678)
.-||+||+-+...|.-|+.|+.+ .|..|++||+-..
T Consensus 4 ~gKvvv~~SGG~DS~vla~ll~k----~g~~v~av~~~~~ 39 (218)
T d2c5sa1 4 GGKVMVLLSGGIDSPVAAYLTMK----RGVSVEAVHFHSP 39 (218)
T ss_dssp TEEEEEECCSSSHHHHHHHHHHH----BTEEEEEEEEECT
T ss_pred CCEEEEEecCcHHHHHHHHHHHH----cCCeEEEEEEeCC
Confidence 34799999999999988877765 3789999999753
|